cell_line_id,drug_id,response,predictions
DMS 273,9952709,2.373087309160908,2.766126805974147
NCI-H522,613000,2.2856040748624347,2.58088479003994
YAPC,16038120,1.926562361021756,1.1099495459489552
NCI-H292,9935249,3.8808310590786,3.330020468689508
SNU-449,navitoclax-gemcitabine (1-1 mol-mol),5.117951975418846,-1.1077159285748033
NCI-H522,9908783,5.043768225694569,4.636802162048682
JM-1,11175137,0.9157477453434189,1.6642995333204982
NCI-H522,5287620,-2.19230412457559,-2.2499700687333495
MDA-MB-453,4917,2.8920757434762203,2.9993926370120945
DMS 273,135421197,2.3407622077730035,1.4619213110942513
SNU-449,BRD-K55473186,5.1406225681359174,4.012797457910798
SNU-61,4521392,3.90812104829802,4.258104217502056
G-401,9549297,1.736191202159007,2.0367336629381434
NCI-H146,89183176,1.451528120959232,2.611080753048205
LOU-NH91,5287620,-1.52867963951729,-1.9235833829303715
FTC-133,123631,3.8044847524269865,2.4888216530048455
KMRC-1,5291,3.811670367299954,3.629661201443473
A-673,9823820,4.6435125645675095,3.4624877789926516
FU-OV-1,168313047,2.3973799381416208,2.3890527296634367
Panc 04.03,44462760,4.978463894781355,4.053779750314213
RCM-1 [Human rectal adenocarcinoma],7326481,3.471788060157272,2.9843872002210303
OPM-2,445091,3.996829176942573,3.743193086287732
ONS-76,5746,1.4703359849180313,1.276242776946855
NCI-H661,3025944,3.908905198351104,4.342709931482267
A4/Fukuda,107970,1.5574682195612295,2.1162527723387745
CAL-51,49850262,3.6300011952383584,3.7402053131190303
NCI-H460,2858523,3.1665522277325575,3.0283406257601264
G-401,6184667,2.5094508901292487,2.679126829114086
NCI-H661,44607531,1.139733733680255,1.5419562562246625
SNU-81,6917907,-6.2756065511253185,-4.482683761724186
MSTO-211H,54678924,1.5146991125566602,2.3418780475069276
FTC-133,10127622,5.496386107928154,3.729528271538373
EFO-27,11977753,-1.8189065225127747,-1.214062435969897
SNU-61,selumetinib-decitabine (4-1 mol-mol),0.7791363138333649,2.281512327463151
MSTO-211H,19582717,3.17062921236116,4.4676695185289494
KMRC-1,53392493,3.2185750963739026,2.890831856538482
OPM-2,2749,1.7313419667612246,0.9596572727048952
NCI-H460,5351362,3.0809857123464037,1.78238203381351
SNU-449,56949517,4.374997906660537,4.3775075041605325
NCI-H146,1716436,1.8968095332546364,2.9317254538489994
MSTO-211H,9884685,-1.5007126123703023,0.5923450835461069
CA46,46926350,-5.311040218420036,-4.510565454299222
BxPC-3,72193861,-0.2425633398981322,1.6477760829638217
NCI-H522,24180719,4.104291025168841,3.5199212120547134
NCI-H292,16038120,0.8772093711483475,1.1824477124556494
NCI-H2171,11364421,-5.769988570724398,-3.228550149546858
LOU-NH91,71304818,3.9209078908272703,2.6724590231682686
NCI-H2009,71466380,3.950405172838994,4.626223962454393
EFO-27,44607530,2.237032971856772,2.0398665476917714
CAL-51,3136844,4.799885860604426,4.36955654767607
MSTO-211H,9936388,-4.464575449065994,-0.4865129418233288
A2780,66577038,2.715796351675557,2.8158254979499406
G-401,24779724,6.361263224396382,3.750207727945019
OPM-2,5470400,-0.1217933569770787,-0.15255011364824586
HCC1143,36314,1.6197332159913502,-1.4378543064224436
SW1463,54143018,1.6932952952144893,0.38931205488726855
JM-1,1317464,3.8125649173872938,2.712449376649879
DMS 273,46907787,0.4735517334159472,0.9540109317355696
MDA-MB-453,46843906,1.4379824902109608,2.9159706942324353
YAPC,6252,1.451992868069142,1.3868873368990509
MDA-MB-157,navitoclax-sorafenib (1-1 mol-mol),-1.4384143120917083,1.80128153062908
CA46,46943432,1.2105530921386296,1.1021983790374275
NCI-H292,24785538,2.1095024536235374,1.9568825613421321
NCI-H292,3038522,3.811290582208577,3.2517869832894415
NCI-H460,54454,2.7807551042334935,2.571409337257734
NCI-H661,9911463,3.595935737335879,3.877657447051366
BT-549,4261,1.9217340769001163,1.9846563154671943
FTC-133,16013152,4.199465293191842,4.0924749209221964
MDA-MB-453,54618305,5.448966988850886,4.488943204649509
LOU-NH91,56946209,-2.032751224257796,-3.840203205551691
KMRC-1,16659841,4.161446951047465,3.207160227674004
LXF 289,66577038,2.7615792990535937,3.1259886081539143
A-673,2871966,-2.1375369153988597,0.2749457575439043
EFO-27,4788,6.204062284318603,5.5761218719861265
FTC-133,5281321,-2.4880366458953196,-1.1799278125359662
JM-1,613753,2.4959303189076376,2.6910033303704224
CAL-51,168312962,1.4117577594763937,2.298291405357822
OPM-2,6450551,0.7106995413225735,1.5330877979340292
ONS-76,selumetinib-decitabine (4-1 mol-mol),-0.8020302824426914,2.7140419222706162
EFO-27,26596,4.577324640946523,-0.6620854353809861
LoVo,656346,0.766025679375412,0.9818933659607978
NCI-H522,4477,0.4448521837298123,0.5146632452338585
NCI-H727,9936388,1.6432072244848812,-1.0693304390609646
FTC-133,104842,-5.8581546696404,-2.684560793484065
EFO-27,7326481,5.957065585898912,3.283314493610644
NCI-H460,11222830,2.8861636193629323,1.6731880984719527
OPM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0894009030955245,2.9083739688330144
NCI-H460,54618771,1.6853262233131374,1.4043559167262112
JM-1,52947716,1.780956269613054,-2.6051364856948545
OPM-2,9444,2.5095115053941557,3.9083642651603197
NCI-H146,60700,-4.723399126949256,-1.1039399347160215
BxPC-3,9911830,2.611582201474507,2.7030360192869223
NCI-H146,16038120,1.7989248875403512,0.40491260068380475
LXF 289,51037431,5.679407317259089,3.1554838510553873
HCC1143,44589607,1.260451666530297,3.1820509649819737
CA46,5281321,-3.5082232289526663,-2.4529436816993897
BxPC-3,3815108,3.682439325637505,3.0418185104473734
BT-549,ISOX-bortezomib (250-1 mol-mol),0.1826356805695565,0.7219463057976339
BxPC-3,3552672,2.73628551508051,2.57299823107482
SCC-9,3081361,1.719146178558617,2.037045960828787
SCC-9,135875424,4.9754653396039314,4.075454198592215
LoVo,1716436,2.86184708699294,2.810493210791147
MDA-MB-157,9884685,1.398372779004129,0.8800263749917688
NCI-H292,9911463,4.207043029649759,3.9614447283350938
G-401,54626689,4.421186382617726,4.376905993259548
NCI-H460,6917907,-4.956095121428261,-5.044327256084825
CA46,25062766,1.483751377697603,1.5933271209637452
LXF 289,44241473,4.688676931788039,4.716292800580376
EFO-27,71680916,4.9682795090816185,4.7254231201529375
SW1463,11152667,-0.1903484351781526,-0.7330056556129705
NCI-H292,73707398,0.96137499748578,1.375260195570546
NCI-H2009,16725315,3.943728055015544,4.375058287858637
SNU-61,135440466,2.760100648324382,2.068325025259128
A2780,451668,4.676838081876032,1.585942342341973
JM-1,46191454,-0.7072965876905944,0.2879065593596695
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.3036807145205682
SNU-449,2733526,4.280379959685792,3.7931030191897834
JM-1,10302451,3.097435274235228,2.5711076686511016
DMS 273,tanespimycin-gemcitabine (1-1 mol-mol),-1.669434491650497,-1.137246287886077
EFO-27,vorinostat-carboplatin (1-1 mol-mol),2.7861871023454077,3.2817823895375358
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.4544813321614867
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.2740990745866716
OPM-2,52912189,-3.1407059889083424,0.2929335880145356
SCC-9,9549297,5.273243325738832,2.422072606552425
A-673,375860,-0.5094320760358009,-0.2514652903303555
SNU-449,15983966,0.8926749279922188,-0.5651024118409418
SNU-449,135440466,2.7536019754154375,2.239440192859366
CA46,serdemetan-SCH-529074 (1-1 mol-mol),1.5485076626446956,1.3762680186847058
NCI-H522,73707398,0.7434005611154502,0.8829298212419956
NCI-H1623,72376,-0.6301176586270604,-1.7106785983999506
SCC-9,24901704,4.548877009949327,3.4547074198975505
HSC-4,448949,2.25928901468022,1.9569915078073339
SCC-9,25102847,2.571358625043281,2.610809852629062
FTC-133,135411,0.6572104898559208,1.048018466170683
DMS 273,445643,4.452334519038606,3.802088035875095
HSC-4,24771867,2.9499855440491243,2.9589071978592387
BxPC-3,2841722,6.186043735824486,4.412030078932046
MDA-MB-157,52947716,2.709287320485668,-0.34018106820221056
HSC-4,46224516,3.389129888163455,2.706049972701281
NCI-H146,400769,-1.4971487301951925,-0.5533080083021349
LOU-NH91,387447,-3.4249375140388247,-3.9999565300036353
CA46,6610216,4.017162804005507,3.7453090002749816
LoVo,375860,-0.1162329718395109,-0.15103758240810608
FU-OV-1,9911830,2.8434321082933773,2.4172359624137996
LoVo,9840324,5.061772266378942,5.7938241564111195
MSTO-211H,56649450,2.845391743702004,3.727702132555733
HSC-4,9935249,3.700870290975298,3.2547155223387985
BT-549,44486219,4.179253703467884,4.322872287650306
SNU-449,24901704,3.9093934632949616,3.7004788854449426
FTC-133,44589607,3.1305768616958085,3.070954358216673
LOU-NH91,42642645,0.5799169530603235,1.0782739936663852
KYSE-70,51037431,6.2873914521382765,3.2070533814474076
KMRC-1,1566236,3.0378094444517645,2.5300148630415937
Panc 04.03,42642645,1.6619965718360328,1.1495533894900907
CAL-51,3689413,0.5709426612715743,-0.1268661813155924
NCI-H522,44487872,5.4176039717063915,4.190869302283363
NCI-H2009,16722836,0.9347693241342916,1.730144181138143
NCI-H522,11222830,1.4433136379668847,1.5485599313840976
CA46,72193861,0.1338517787347367,0.16657688409398688
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403,-0.05596705448862272
LoVo,119607,4.4096130331744865,5.087820278096234
MDA-MB-453,1566236,2.5975650319928434,1.9814473242043313
ONS-76,11152667,-0.1692604119623072,-0.39589403010816937
G-401,24748573,1.6686206591324024,1.8029068754859756
A2780,176870,3.0464675702719655,2.869261304028351
NCI-H727,vorinostat-navitoclax (4-1 mol-mol),3.0192408076128823,1.002511191048198
OPM-2,3385,3.5898560550490837,2.5382428718623085
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-1.0065490333709795
NOMO-1,53495165,-0.0338576092201104,-1.904157369673532
LoVo,46191454,2.275591949439888,1.447616080177061
A4/Fukuda,4096211,1.2598455852625392,1.3297912820537567
NCI-H522,25126798,3.91575296607237,3.726024804065251
FU-OV-1,135411,0.8541212220651947,0.8088905652717508
KYSE-70,10113978,1.960067513789881,3.545465685800524
FU-OV-1,24856436,0.8416503079264269,0.13339561618820694
A-498,10026128,4.231838396167064,4.038113562513195
JM-1,11626560,-0.1801568688824005,0.6216062709119146
NCI-H460,9911830,3.1326305509826824,2.5405674759111174
A-673,9911830,1.9751375507094395,2.1747350238122762
Panc 04.03,71751553,4.683117627568525,4.478012298519905
LXF 289,6450551,1.9915066986525345,2.681370033489375
NCI-H522,156414,0.937566519659893,1.233159106100592
MDA-MB-453,6610355,3.820285868995436,4.31482355997882
FU-OV-1,46843906,0.6915308493256752,3.0011945921961583
NCI-H522,42642645,1.4297074042386375,0.3365158266797794
SCC-9,4917,3.683292695011318,3.0058621181149245
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,1.1538060417472675
SBC-5,54649381,4.189343649803657,3.9149855642666735
NCI-H1623,6918837,-3.3974396350468674,-3.0402300978127634
KMRC-1,10184653,1.755388017214173,0.8535745091872987
LXF 289,9967941,3.6599941581067057,3.849366706176017
FTC-133,57519531,1.7209799050566308,2.6171616870155945
NCI-H661,19582717,3.3132894226769056,4.177194564560686
MSTO-211H,selumetinib-PLX-4032 (8-1 mol-mol),2.4533429181840307,3.477082622447187
LoVo,71466578,1.8530080227063717,4.14368853742416
NCI-H2009,46907787,0.5680124512944033,2.0516050459165
DMS 273,49793307,-3.720971975288363,-3.6714373890005954
NCI-H522,135659046,3.4944475458884012,3.417596773601926
FTC-133,5351362,2.946320615286136,1.8601297449486973
JM-1,208908,1.8689748302954872,2.114157792961366
Panc 04.03,216239,3.3806837686851923,2.5232772045104848
NOMO-1,71466445,1.8310961714544176,2.1734394246126367
NCI-H522,71680916,3.6078643166976896,4.396454934430925
EFO-27,2126,5.846579140474247,4.642222169428665
ONS-76,5284616,3.539643222518188,2.519228292820685
SCC-9,16736978,3.1048488109971664,2.0836639033110735
RCM-1 [Human rectal adenocarcinoma],46926350,-4.0983765968922485,-3.91157495513236
A4/Fukuda,23582824,-0.7377224087572002,0.9199059404110962
NCI-H661,53325874,4.390083123893945,4.4986710090902795
SNU-61,4096211,1.05462843518756,1.587019736461396
CAL-51,675434,4.354107922133551,4.486613354250219
NOMO-1,11175137,1.3676050257567425,1.5467948991486218
NCI-H2171,5335621,4.282845813975702,4.2345329612423415
SNU-449,11647372,1.9881649315547345,1.408264345726113
NCI-H522,3503,2.0960599148243557,2.0264303738771603
NCI-H2171,52947716,1.4567314464455066,-2.087005568048567
NOMO-1,5291,3.5817896511091862,3.31919905570977
NCI-H522,46843906,2.3044802452603967,2.3810696092409973
OPM-2,11494412,0.3054873199299708,0.2138942877804699
A-673,53495165,-1.305348317827654,-0.7836969169241783
KYSE-70,54618771,1.1170424016733127,1.3411121714324823
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.257504068731444
SCC-9,3062316,1.318086870144001,0.7862594329049694
LoVo,387447,-3.727342469020989,-4.040070046256619
MSTO-211H,73707386,2.8647689708389943,2.953571981664207
FTC-133,54613361,1.5430217136639572,0.17403373099626562
SNU-61,12001922,2.043150446887516,1.956222518750844
DMS 273,374536,2.442253811681885,1.260067482152603
LXF 289,10302451,1.735451917587997,3.4063335888569837
CAL-51,2858523,3.1959449804225524,3.057237233697112
Panc 04.03,23582824,1.118403221753994,0.8314237694096849
KMRC-1,6505803,1.455434702084088,-0.5047979788376233
CAL-51,4261,2.4552246887350417,1.5292212521437454
SCC-9,5746,1.774962232755205,1.2392849864553
NCI-H661,71466578,3.739107690689307,4.671515741659279
ONS-76,54619267,4.0364090976663,4.065555268895492
NCI-H522,100016,6.692385014202011,5.6616561147632645
G-401,11719255,3.853695059500007,2.8711969988117065
HSC-4,3815108,3.178044313970192,3.0592060059933304
NCI-H2171,5287620,-0.0573950216422359,-2.322265704520419
A4/Fukuda,5311,-0.1264358008137528,0.6507609209407376
NCI-H292,387447,-4.003442188855186,-3.9866928103068835
OPM-2,148124,-6.3849256320012575,-3.0686443754990607
MDA-MB-453,alisertib-navitoclax (2-1 mol-mol),3.3277558601146215,-0.2901921790167751
DMS 273,salermide-PLX-4032 (12-1 mol-mol),5.306834954267239,4.461563991735172
CA46,9967941,3.699441503938977,3.200804386327452
SNU-61,JQ-1-navitoclax (2-1 mol-mol),0.8164075639499123,0.25928204165354085
LXF 289,387447,-4.093727880786265,-4.212687780146893
CAL-51,5113032,4.55807021159329,4.983698857466198
NCI-H727,serdemetan-SCH-529074 (1-1 mol-mol),2.331809225876462,1.9738640473924618
OPM-2,241158,1.7102591321182437,2.781317873150787
ONS-76,16741245,1.9308546797770672,3.5830881559261605
Panc 04.03,322968,5.075488138121087,3.9520918573276753
BT-549,135875424,3.804392758634582,4.180698073731919
A-673,54626689,4.6393725921997415,4.424003525296782
SNU-449,navitoclax-birinapant (1-1 mol-mol),3.571225842715355,2.172566984134053
HCC1143,3543504,4.280043771428645,4.5071713145914165
BxPC-3,107970,2.2592769610294448,2.457552172814867
ONS-76,51037431,1.0002101292366832,3.0425001966070067
G-401,24785538,-1.0602782345595374,0.902172656630746
MDA-MB-453,SNX-2112-bortezomib (250-1 mol-mol),-2.8558068979293383,-1.5578435159623205
FTC-133,676352,3.9949531967924297,2.1835799513380274
NOMO-1,53232,3.2414615649348772,2.4760161532279765
LoVo,11625818,2.0848313295223844,4.178830316448383
A4/Fukuda,702558,5.147225783500614,4.339127262749348
NOMO-1,11455910,0.2303469505827257,0.5721060184678826
SNU-81,4096211,1.97800800333133,1.6136836982256597
NCI-H522,676352,1.6559488811299496,1.9889737629502198
YAPC,60750,-4.781219880342373,-1.3022927369131603
Panc 04.03,11612883,3.751429287253437,2.99808099485978
NCI-H661,67156097,-3.370555704228358,-0.7658304445961132
SNU-449,4705,3.898593282840832,3.1978601972187017
MDA-MB-157,9952709,2.6586157499418444,2.9522209320574517
NCI-H522,16038120,0.9671280612186928,0.638108130304072
A4/Fukuda,4259181,-0.5702867723998835,-0.2568744943572331
LoVo,135398744,6.330186357549225,6.265333757332189
OPM-2,637858,0.8070227403937857,0.8652359923857837
SCC-9,3038522,1.9571402343301385,3.1690151219503573
RCM-1 [Human rectal adenocarcinoma],navitoclax-gemcitabine (1-1 mol-mol),1.5505113720092498,-0.4599664786496641
A4/Fukuda,10127622,0.8035335483112384,3.6659380897771245
Panc 04.03,4378219,5.53220646065493,2.6781786456421104
EFO-27,JQ-1-vorinostat (2-1 mol-mol),1.2489296683546294,0.98412772213639
LOU-NH91,navitoclax-piperlongumine (1-1 mol-mol),-1.482580438049138,1.8462202270689319
EFO-27,11396600,3.826824277303455,3.734397112090726
LoVo,JQ-1-MK-0752 (1-1 mol-mol),1.4055408884057283,1.534235904399578
NCI-H2171,7251185,0.8673768610035957,1.836393623328358
NCI-H1623,5311281,4.903104817913162,2.576458773659902
OPM-2,11317348,2.0151792351474755,1.208905483330026
OPM-2,100016,3.804278037815123,5.0185560751856375
LoVo,46224516,4.94892102130723,2.5803047486201223
A4/Fukuda,9826308,-1.4955537783248567,-0.1412206741853108
LoVo,15547703,1.4569683263207862,3.2273116332443705
LoVo,227681,3.064150517180394,3.4902485901717584
NCI-H727,5460769,4.510942150258337,2.9426545952985794
NCI-H292,6918837,-2.538558148903755,-2.145413304569546
A2780,132971,2.947129832610188,2.097709902353776
FTC-133,4788,5.605324981437421,5.634597349180102
A-498,selumetinib-decitabine (4-1 mol-mol),2.586259947527723,4.152371723187106
A-498,23582824,2.0595934555669886,1.0359281207264963
SNU-61,8515,5.6731171982359365,3.327552871210737
MDA-MB-453,23582824,0.0198148722876335,0.8744648021803226
DMS 273,5329102,2.038563375095403,1.4633162666642086
NCI-H460,72193861,2.1658883750752844,1.5817861882132709
MDA-MB-157,6610355,3.680589360872168,4.582825233366596
Panc 04.03,56649450,4.182465283011193,3.445788773328417
NCI-H727,124202324,2.79148434895864,2.3317599200827566
MSTO-211H,24772860,-3.3585393605141824,-1.6586630479921118
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776,1.481390187188984
CAL-51,20959075,-3.1196535578382987,-2.5960960793884755
OPM-2,322968,0.7466819505545055,2.139453362671601
CA46,984333,-2.431082434536014,-0.43855838937643826
JM-1,1242560,2.356943306915098,2.9339738591015627
NOMO-1,25126798,3.9519848152055848,3.2952910004156193
MDA-MB-453,5738263,2.9414099779046934,3.4106235051068596
OVISE,10074640,3.3556303567674064,3.0402060137014697
SNU-81,JQ-1-MK-0752 (1-1 mol-mol),4.555770786077887,0.9000609187363928
MSTO-211H,159324,-0.971759723426381,3.211046400821782
Panc 04.03,46191454,2.0071895522726377,1.6814203724015586
SBC-5,9826308,0.1778598819423294,0.13728677666377714
BxPC-3,1641662,3.0109567862503654,3.6141467949178776
NCI-H460,2708,4.613368759945332,5.057398984878482
MDA-MB-453,2746,1.6853152695376463,2.9270285943832333
NCI-H292,2858523,3.0406792249868633,3.1184081580107086
LoVo,52912189,0.3784309245329977,2.0269869799978735
BxPC-3,navitoclax-gemcitabine (1-1 mol-mol),-2.057283602704844,-0.6411525938125768
NCI-H460,9936388,2.3098343611543415,-0.34691751579786045
A4/Fukuda,176870,1.9874765150136215,2.6684885743829097
LOU-NH91,49793307,0.2442451207819767,-2.256464479395118
MDA-MB-453,2945648,2.145365576847094,2.7592690776862785
SNU-449,54596490,5.440438718305218,4.496785810787728
NCI-H2171,9927531,3.1501077196413783,4.353715643768094
CAL-51,25150857,2.2346870378683934,2.4173437177251387
YAPC,navitoclax-sorafenib (1-1 mol-mol),5.55182899322967,2.1556376567113564
NCI-H727,9444,4.415864627267573,4.18735928440992
CA46,71466578,1.7711352492213497,2.5674898855526602
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.1685914399378903
G-401,11507802,0.4930201538787991,0.9333269662695711
OVISE,11214940,-0.1911189695405239,2.0965839083192934
MDA-MB-453,135999136,4.2113637134750395,3.5184387101239314
CA46,445455,4.357290874085763,3.939122589784237
KMRC-1,5335621,6.052276706579308,4.6336510254524095
Panc 04.03,36462,3.526332093717117,2.491735220712138
SBC-5,56963564,-0.838635946263744,0.9099613538887368
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997,2.3188305502013256
NCI-H727,46224516,2.477743379244975,2.1260205090858433
NCI-H292,11222830,1.205012148013641,1.7170986841575941
MDA-MB-453,24771867,4.091824937074987,2.0029115489800717
NCI-H460,72376,-0.5460239014371263,-1.8278915826292654
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023,1.2315076903413844
LXF 289,9911830,2.045852319971143,2.530871118195374
LoVo,1242560,3.2639930925900305,3.6054671788785897
NCI-H292,6918736,3.734181331597608,-1.4493595949120073
G-401,11717001,3.7897150646045863,3.7618953612934463
ONS-76,46398810,2.9642978938134004,2.5802213680187975
NCI-H522,1242560,4.210520049105227,3.2529831720784483
EFO-27,3081361,2.362036241237279,2.3279053129325167
SBC-5,11222830,1.4112085967579189,1.712008984871662
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,2.1148401844854297
CA46,11213558,2.4131379110887496,0.9618981175677174
FU-OV-1,6918837,-4.1157354170673495,-2.5357821473044675
A4/Fukuda,56946209,-6.395954164738885,-4.6857444674536515
NCI-H2171,tanespimycin-gemcitabine (1-1 mol-mol),-2.6967474652224745,-1.304485606772044
RCM-1 [Human rectal adenocarcinoma],JQ-1-vorinostat (2-1 mol-mol),0.912398125341492,0.9302923401259714
OVISE,vorinostat-navitoclax (4-1 mol-mol),1.48951856204489,0.9800429173372698
MDA-MB-453,navitoclax-birinapant (1-1 mol-mol),3.002333269444996,1.1207689976975046
A4/Fukuda,216239,1.5760740052804734,1.6760208252242859
FTC-133,4578,5.173307644971936,4.495117162973251
NCI-H146,selumetinib-JQ-1 (4-1 mol-mol),0.7874306910270304,0.9786567448700008
NCI-H460,54618164,4.49670945938676,4.10487242344145
CAL-51,42642645,0.4324607401831485,0.5828997839563272
BxPC-3,24771867,1.9124988819938955,2.8529040670417
LXF 289,JQ-1-MK-0752 (1-1 mol-mol),0.1352273684724335,1.7654157046534165
NCI-H460,15953870,5.00315267734786,3.5629694733781485
A2780,24964624,-0.4628922796959323,1.9002199764778456
CAL-51,654092,0.82886283906252,-0.13356812436928248
G-401,5281321,-2.57337969869382,-1.4649496366855308
MDA-MB-157,3634881,2.7842407118999852,3.3738510614342534
MDA-MB-453,42642645,1.5292302084545462,1.0999414082536565
BT-549,54618164,4.423974096662665,4.230806564532223
A4/Fukuda,16741245,4.963846947143099,3.472014819536956
BxPC-3,44632017,0.4026385498906549,1.2050173742962205
ONS-76,9911830,2.941904202808556,2.6648564087091398
NCI-H146,navitoclax-birinapant (1-1 mol-mol),-2.693365824422348,0.4719488495306717
ONS-76,4477,-0.2351585842599584,0.7987857431810237
JM-1,44493528,3.997956862382446,4.213568711524392
NCI-H146,5702613,3.149923076768629,2.83410806980137
NOMO-1,25150857,2.063048355345986,1.7139985789434806
LoVo,24856436,-0.7244956111709783,0.5086577023970643
OPM-2,53481919,3.0492738202957206,2.556797071227282
BxPC-3,44507138,1.658490789748868,2.4855113392430757
FU-OV-1,2113511,4.466585490981426,5.604001161776672
NCI-H661,2749,0.7713739826565964,2.2129343284268383
NCI-H1623,53495165,-0.5563852526996439,0.588143508533033
NCI-H522,6610216,4.154510920860766,4.0726023201511214
BxPC-3,148198,-2.171424706341701,-3.214603761639822
MSTO-211H,4788,5.119342350142264,5.789279549202575
A-498,1750826,-1.7479882416802337,-1.7218974055254277
HSC-4,136227924,4.2199200707906845,2.9621557185932
Panc 04.03,selumetinib-UNC0638 (4-1 mol-mol),4.963542223842957,2.8456601328196456
LoVo,54618771,0.7060685526757626,1.2004569038844144
DMS 273,10322450,3.6367733537116167,3.3325065104256715
ONS-76,1750826,-1.6505794475434372,-2.071131509534273
MDA-MB-157,135440466,3.174924928897617,2.1805639924546636
NCI-H727,241158,6.115461447477091,3.9261091010687807
HCC1143,46398810,2.1694021244377333,2.5675099356367452
A4/Fukuda,decitabine-carboplatin (1-1 mol-mol),0.1179398036962416,0.5484784997918735
SNU-449,3062316,-1.3612378425924234,1.512019034934835
SNU-449,11977753,-2.005546044599541,-1.3973490681988772
JM-1,24771867,-4.48997165682624,-0.7123617877416253
NCI-H2009,11507802,1.1556617167312242,1.8105935261569208
HSC-4,11964036,1.64347500999081,1.235872259225915
Panc 04.03,5479543,4.112837907412102,3.9403885756229466
ONS-76,439501,-2.2755976390662163,-2.0307458555352134
JM-1,54639126,4.392955654749798,2.3293022021528755
CA46,11167602,1.6890466560929325,1.7996563155324878
CA46,135411,0.0331424760277949,-0.10805079600577625
MDA-MB-453,tretinoin-navitoclax (4-1 mol-mol),3.844804044479517,1.6317678774641007
Panc 04.03,11625818,5.081289492721679,4.680243158280612
NCI-H292,12001922,1.805770236255338,2.0968892728196034
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,1.8872959009855534
MDA-MB-453,5278396,3.602107220771141,3.428397789984578
NCI-H522,6438330,2.681865372615506,1.7287066464994363
A-673,71466445,2.638210082463498,2.934798711019659
MDA-MB-453,25105715,3.2581724710849778,3.2829848144904745
A2780,17759555,2.3500586644289165,3.5109264619490723
YAPC,124202324,3.68667481758741,2.714557230365861
NCI-H522,25227462,-0.4562280137645088,-0.26694514365571803
KYSE-70,10074640,3.109810551584267,3.1902425308621853
HCC1143,5278396,2.995823973274505,3.6208931124567862
HSC-4,5479543,4.052409111099337,3.7410901097585447
NCI-H661,446155,0.1985182541705634,2.9041606224035803
YAPC,53495165,-1.0203233667221312,0.8899892322409948
FU-OV-1,11719255,3.4823701199113097,3.424519979914424
NCI-H2171,5278396,3.2627520221828115,3.3559147095669357
MDA-MB-157,9911830,0.0801478348660684,2.3325610225101006
OPM-2,9911463,3.091122447781221,3.2756235468135215
LoVo,25126798,3.7423562181337338,3.633164921618386
EFO-27,9911463,4.361076045114702,3.869281243745434
HSC-4,docetaxel-tanespimycin (2-1 mol-mol),1.367923691324148,-3.2586541624248366
A2780,5280436,2.9198027340920434,3.025571096494828
SCC-9,5311037,3.6943722712183007,3.8842106594479744
ONS-76,5978,-2.168221630618191,-2.0246361867410605
A-673,44819697,-3.745571155852308,-0.8144708010111472
CA46,24785538,1.2011715151517115,0.32384223958990405
HSC-4,9936388,2.361545024779824,-0.8442650145294398
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,2.172812698883453
NCI-H460,49793307,0.4479933662320887,-2.6738973819160834
A2780,64971,1.607646338152048,2.0837355613555077
JM-1,72193861,0.5763432020354632,0.13652577510535058
NOMO-1,11625818,1.7683333213472852,3.2007982514301103
NCI-H522,navitoclax-PLX-4032 (1-1 mol-mol),3.539669986895116,1.2004507634386832
MSTO-211H,11507802,-2.113337212450165,1.7860839517129927
NCI-H661,53232,0.4849867031297817,2.748794768427526
YAPC,16720766,-1.1916244870670316,0.6136341086785696
NCI-H522,208908,1.8410391152152548,2.043167452628641
MDA-MB-157,5284616,2.798393493195082,2.172606772891708
MSTO-211H,6505803,-0.0669493563910609,-0.47856113896660096
NOMO-1,56649450,3.0749194455734012,2.423287779041976
NCI-H727,9967941,3.73486297967426,3.5663543733892373
SW1463,15547703,3.1824451623977312,2.698911002160267
FTC-133,24951314,1.987520160616717,1.3307384677433893
MDA-MB-157,24772860,-2.2599749907314175,-1.688756216374982
G-401,2749,1.3663456978729704,1.3225600038172973
BT-549,16065773,1.5788570773866877,2.579022246067508
OPM-2,11955716,-2.9191891869850015,-2.1321937346652398
NCI-H661,176870,2.3474624932942207,3.6716538687175615
NCI-H292,66577038,2.9683700205355765,2.9732486374134557
MSTO-211H,54143018,-0.309857947329572,0.6579314711461112
OPM-2,3634881,2.0291765129520467,2.7754476573691234
LOU-NH91,navitoclax-birinapant (1-1 mol-mol),-1.5910791983061243,1.6936346038522105
A-498,44607531,1.7098722083353044,1.6609198859117424
KMRC-1,2749,2.412459730094544,1.751076178837396
NCI-H292,57519531,1.7489075965122454,2.6754323294042894
NCI-H727,11404337,0.8145711342672778,-0.2497096454621661
CA46,salermide-PLX-4032 (12-1 mol-mol),5.07380877764379,4.478098605773125
SNU-81,107985,-4.076050447844214,-3.4703317500182713
SNU-61,24785538,1.5668080683488936,0.955619762964886
SNU-449,56946209,-2.472995255165521,-3.909989745970358
KYSE-70,452548,2.3575041584151637,0.7250066845775113
BxPC-3,5280436,3.644569175052812,3.6773054390600812
JM-1,409805,3.649428990507172,3.481791715572245
SNU-81,17755052,-1.02795410661762,1.295899785563232
DMS 273,SNX-2112-bortezomib (250-1 mol-mol),0.148208176798338,-1.6457048338174314
MSTO-211H,BRD-K27188169-navitoclax (2-1 mol-mol),1.2533198226261906,2.4496618451714007
G-401,54618771,0.8582285882331511,0.8022007390005398
LoVo,4788,4.577300245187766,5.7234441036911194
A2780,24771867,-2.9740519428749055,0.5003923937742222
NCI-H292,4261,1.3935441456482582,2.0303035018363427
SCC-9,vorinostat-navitoclax (4-1 mol-mol),1.1894462341904075,1.2953631662982326
NCI-H522,2729026,3.0595997973682043,2.622864168269761
MSTO-211H,448949,1.6774063902575909,2.1450303525575904
BxPC-3,9825149,2.348819386499172,2.2662440718676438
NCI-H522,44607531,1.4505766804532754,1.333677342534834
NCI-H292,ISOX-bortezomib (250-1 mol-mol),0.5542499080925709,0.8289065462321736
A-498,1285940,4.242355519484504,3.6452158250255113
BT-549,selumetinib-BRD-A02303741 (4-1 mol-mol),5.411757040622344,4.757642681154296
NCI-H661,44543605,4.030509034099432,4.123105503826546
CAL-51,12003241,-1.2189714227076325,-0.9011350398403166
A4/Fukuda,135411,0.1560078623072997,0.18768895766744198
HCC1143,675434,4.285446752444937,4.587639397636327
CA46,11719255,3.04595311036835,2.4789522547503213
BxPC-3,654092,-0.3546902897816355,0.033664049676906053
NCI-H292,11238147,1.7384499640365698,3.0254191875696694
LoVo,285033,-2.045623665035502,-1.3723808142098834
NCI-H1623,136227924,2.959018127447204,3.0434175109381076
OPM-2,5329102,0.9197947820907424,1.0616706187774034
OPM-2,208908,1.37961789198716,2.135517033199352
MSTO-211H,124202324,2.766151060695559,2.6972615150962094
LOU-NH91,piperlongumine-MST-312 (1-1 mol-mol),1.9465172211690425,2.0827912864688956
SBC-5,selumetinib-piperlongumine (8-1 mol-mol),5.086049517752745,2.8541172862087363
SNU-81,55508,3.0035688840672767,2.8837380748178294
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.9634209979110695
A-498,24821094,3.8657770123239574,3.203042495881895
DMS 273,6918736,-3.620580414510608,-1.971673953699586
JM-1,3062316,-0.5573937765637444,0.6755895578751132
JM-1,56649450,3.7062904943567263,2.652712111874956
SBC-5,24856436,0.2896075356546521,0.44575470736402567
BT-549,285033,-1.3520552126123144,-1.4432004188203331
OPM-2,5746,0.8583790934138843,-0.062090046793308803
RCM-1 [Human rectal adenocarcinoma],135398738,5.665186147666449,4.435349888333918
G-401,6914657,-5.660532663542792,-4.78543840139696
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-1.316393877785366
HSC-4,2858523,3.1192513569149245,3.22410148702784
NCI-H522,675434,4.236381328267226,4.408161849717411
CAL-51,25183872,-0.1080661998677032,-0.7792838420889393
BT-549,4259181,2.4625999028961743,0.2468639938633525
NCI-H522,11455910,0.4156799864056491,0.8559966003505292
A4/Fukuda,decitabine-navitoclax (2-1 mol-mol),-0.552282956789893,0.44232739012018796
EFO-27,JQ-1-UNC0638 (2-1 mol-mol),3.1988831496339536,2.042406906470433
NCI-H460,3543504,4.388423548450019,4.372421843844873
LOU-NH91,11626560,1.802766880846386,2.0112756663423004
NCI-H522,2871966,1.782445654343025,0.059005099370205434
G-401,135440466,1.822823734742602,2.078436331665185
A-673,10172275,4.325815901444083,2.557352689008567
LoVo,3385,1.4948122184820352,3.913627180885163
OVISE,BRD-K27188169-navitoclax (2-1 mol-mol),1.3102218056663513,2.3315035348984314
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259,-0.9745231964177157
A-673,637858,0.7164978632133837,1.4437885737241172
OPM-2,4915,5.457147549775398,3.0896532587899332
CAL-51,11626560,0.7349282975065881,1.8093279135094733
NCI-H661,2729026,2.3445725854556696,2.705264162491622
KMRC-1,25126798,3.86147373401716,3.612990758743993
KMRC-1,107970,3.035071998795665,2.3951846464077433
MDA-MB-157,16219061,1.3123257474603047,3.384996803118762
RCM-1 [Human rectal adenocarcinoma],44202524,4.374181896011121,2.5120720034397728
NCI-H292,erlotinib-PLX-4032 (2-1 mol-mol),3.1994790670479,3.2543051201694437
NCI-H2009,24964624,2.271229049936602,2.5626220659248093
NCI-H522,7251185,1.2190943442977031,2.1751939828672877
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.4440306413189163
G-401,52912189,0.0594470173160698,1.4266070849708339
OPM-2,vorinostat-carboplatin (1-1 mol-mol),1.8335119611994213,1.9779561960039063
OVISE,702558,5.699669356311473,5.20432291912985
BxPC-3,selumetinib-navitoclax (8-1 mol-mol),-0.6113329982147029,1.978240739371746
EFO-27,54678924,2.818156902929417,2.110665682592132
LOU-NH91,44607530,2.1348137775706646,1.986803621618838
EFO-27,24180125,3.663788732934096,3.04566080164484
NCI-H661,135421197,1.0600684669241136,1.959356747774464
MDA-MB-157,56963564,-0.5852778857487072,0.29699648078019264
OVISE,navitoclax-pluripotin (1-1 mol-mol),-0.9390281108513666,-0.6449994331374702
LXF 289,6505803,-2.367756082461904,-0.30597635068892093
SCC-9,navitoclax-gemcitabine (1-1 mol-mol),1.7873613384947808,-0.9417683437890375
A-673,5278396,3.572368012209165,3.19575030542057
MDA-MB-453,135421197,0.8806711164351635,1.984794553746462
NCI-H661,11396600,4.301216087095742,3.620740482886761
G-401,148124,-6.018913106580182,-3.4727708090919576
NCI-H661,selumetinib-vorinostat (8-1 mol-mol),2.6116020455446884,2.8981668133910805
SNU-61,208908,2.000237947522829,1.879286359448833
NCI-H661,5329102,2.676948448482624,2.2498275130461343
NCI-H146,148124,-0.9007997951548676,-2.807151163886849
HSC-4,446155,4.1145986724492865,2.7813344593969025
NCI-H661,3825829,3.711058317012711,4.116610692204443
OPM-2,135411,1.0006691045824918,-0.077479922823264
CAL-51,3815108,3.0623029951861396,2.86884841639737
NCI-H522,2858523,2.9817407099898676,2.932688275254547
YAPC,2708,5.2324194580289065,4.982402974703675
Panc 04.03,4917,3.7974030923782274,3.1353702425355046
KMRC-1,51039095,3.0507646213845008,2.7095232760494956
MDA-MB-157,44632017,-0.0621812067979977,1.4728956384252399
KYSE-70,613753,3.646356391333843,3.2796803091264235
OPM-2,11364421,-7.162542415885671,-4.2403171378107265
KYSE-70,11964036,0.6479741930424838,1.7273589965676033
EFO-27,9915743,1.432055126276498,1.0007174589568824
LoVo,selumetinib-piperlongumine (8-1 mol-mol),1.883455735434258,2.437669013762741
A2780,9935249,1.4583070792637778,1.888578498863867
NCI-H292,25105715,3.507158893285561,3.4844712809018508
JM-1,5566,2.903571956440186,2.983960724577062
NCI-H460,16722836,2.818869820371906,1.968520801999922
MDA-MB-453,71466380,3.4268898477848784,4.3338624354501905
MSTO-211H,24753719,3.2448003358152286,4.401289219423474
JM-1,637858,0.5231851777275447,0.9169346720305468
MDA-MB-453,11152667,-1.4808178636693017,0.4296946304827229
HCC1143,44185566,2.5224843451498273,2.6921074043082776
SBC-5,53481919,4.872311947173971,3.7731100965561923
LXF 289,crizotinib-PLX-4032 (2-1 mol-mol),1.666725560868834,2.0191848104017067
LoVo,3038522,4.270533501697307,2.9732804537116913
OPM-2,5280436,1.5288125622159816,2.553340004175045
A-673,71680916,4.0499723530429295,4.42798428616603
LOU-NH91,6610355,5.077923698507978,4.698385034320068
SW1463,10127622,-0.1211197806374188,3.303976177877023
ONS-76,2126,3.999900921085769,4.240795426997288
NCI-H522,53301938,4.938312106360689,2.315289045890266
NCI-H2171,3552672,1.63504499488054,2.710742471406528
SNU-449,375860,2.655390537146391,0.11321320227211804
MDA-MB-157,54626689,4.568687551235484,4.600738120042865
KMRC-1,5746,2.0919022066371484,1.299406760304101
CAL-51,24964624,1.6704816041215405,2.294863509135668
EFO-27,46199207,3.7203826311454096,3.1889356541739455
A2780,439501,-2.4090624878410316,-2.502838065250729
LoVo,89183176,4.107889784939482,4.200465435219105
NCI-H661,24772860,-4.399665014096174,-1.5932676845745828
NOMO-1,46224516,2.27353152393119,2.076682311926945
NCI-H460,5281672,4.99885948312363,4.653017934130484
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935,1.5893527397592717
OVISE,navitoclax-birinapant (1-1 mol-mol),0.2692297316447783,1.507097813995835
NCI-H460,9967941,4.030885542149613,3.818495452625768
NCI-H292,44819697,-0.5623825720804246,0.08029194207769724
OPM-2,216468,0.7655721379939343,1.0432112085659113
ONS-76,60700,0.0915142349819345,-0.22207296057078466
YAPC,17755052,3.2330221121257874,1.8074857221769138
EFO-27,444795,5.488221670965637,4.6526324592771156
YAPC,24797083,1.6153709299916277,1.6168932573716552
NCI-H661,51039095,3.3700376717556315,2.8395657102192295
MDA-MB-453,25154868,3.2796937080857296,4.102795508386205
A2780,decitabine-navitoclax (2-1 mol-mol),1.762746087507787,1.3062163660266848
KMRC-1,9911463,4.4126092990485395,3.6874581471012537
NCI-H727,JQ-1-vorinostat (2-1 mol-mol),2.062672486797119,1.1671557790205505
G-401,107970,2.0352708529532824,1.899787526580342
FU-OV-1,25195348,3.3767609447508846,3.386733597148257
NCI-H1623,11234052,4.315313421055944,4.1554342582944495
MDA-MB-157,151289,0.3130009139891556,1.248193740838947
EFO-27,56973724,4.318199286965652,3.2214216489502223
NCI-H460,5328940,3.322075361136407,1.666763314872341
NCI-H2171,11964036,0.8555185627034467,1.0546924262265585
Panc 04.03,24821094,4.144896314615952,3.0040764912394904
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,2.96436257830984
Panc 04.03,selumetinib-MK-2206 (8-1 mol-mol),2.306008489562984,2.2897759518084175
FTC-133,5280436,3.005172717589714,3.4438828143848093
NCI-H292,49766530,5.348764781206105,-0.11833984719486094
NCI-H661,selumetinib-decitabine (4-1 mol-mol),5.0553831746033815,4.030678728068029
FTC-133,219104,4.114698267906641,3.886710984955835
A-498,BRD-A02303741-navitoclax (2-1 mol-mol),1.0685247130671895,2.467338512631332
ONS-76,6918736,-1.0728340962982743,-1.572597288217465
A4/Fukuda,16065773,1.900447949816596,2.0861732897819074
FU-OV-1,25126798,3.715640842708804,3.772569323063814
NCI-H460,6505803,-0.4074860596498978,-0.92910800016506
ONS-76,44491742,4.314760532803232,4.442891505223082
MSTO-211H,6914657,-1.9341273237470331,-3.826604668862192
G-401,136227924,2.3105932180874365,2.7067706291652445
Panc 04.03,148198,-3.912302089259141,-3.071955394640174
CAL-51,23725625,3.781531245600544,5.217506026139525
NCI-H1623,7251185,3.63742147878688,2.528214119490582
A2780,44589607,1.4452328541597397,2.1501479875985026
A-673,675434,3.949120496105267,4.44391412541956
KMRC-1,25227462,1.6145893273286742,-0.38199232538417827
BxPC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),1.732263513385207,3.6920009045896545
HSC-4,2749,1.8453067540575636,2.106193030847942
DMS 273,6438330,2.6669951536881182,1.7821334546791732
KMRC-1,44491742,6.09620831621162,4.457319517155073
MDA-MB-453,3465537,1.8912554302439897,2.2061381342488944
SNU-61,156414,1.6812768260110038,0.60047274415895
YAPC,11625818,4.8006567630911094,4.2922737408441956
CAL-51,9911463,4.251278022142156,3.8356239360831985
MSTO-211H,68056272,2.8034566103574825,3.950624694757477
OVISE,9911830,4.830872688345326,2.6699421514979407
MDA-MB-453,6917907,3.1299164846836796,-4.489449646785803
SNU-449,9444,4.238096768887569,4.2950710741880895
SNU-61,3062316,1.255261088163193,0.86540022028975
A2780,11178236,-3.658526043242797,-2.985611608788696
MSTO-211H,219104,2.9811404214526136,3.99785653993726
CA46,11364421,-6.636542851208846,-4.799089165285891
NCI-H1623,3689413,0.664737487618683,0.09669152175076247
YAPC,9907093,4.959151627500645,4.209842886342427
ONS-76,19582717,4.438276624405871,4.0266979402527925
LoVo,446155,3.732759169917468,2.631982247617734
G-401,5566,2.967754959970698,2.6966501537675613
JM-1,navitoclax-PLX-4032 (1-1 mol-mol),0.5328133860295355,0.1434891553934502
HSC-4,9884685,0.6492053944574516,0.5981907923920585
CA46,4788,4.772802977698259,4.953093921891601
SBC-5,selumetinib-PLX-4032 (8-1 mol-mol),4.703781138829708,2.940805107234001
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.9980582645875489
Panc 04.03,6918837,-2.8853122799888085,-2.3309539735834885
NCI-H460,71466380,4.4879606530616725,4.461949019902969
CA46,25183872,-1.226882585953409,-2.0613993309190786
NCI-H146,12001922,1.0892970499924846,1.8948957285211723
SBC-5,11625818,4.225517908096314,4.269485591007763
JM-1,vorinostat-navitoclax (4-1 mol-mol),-0.3924776625427159,0.03996956855773789
LoVo,2708,4.2308362163689415,4.889386920440869
OVISE,72193861,4.281646205908775,1.8049963239008397
NCI-H460,16720766,0.8258921674033131,0.9210923993100777
LoVo,4378219,2.040258922351895,2.348977711168869
MSTO-211H,24901704,1.657456360567008,3.401498967537863
A4/Fukuda,4477,0.5783674149898913,0.4593771256572826
RCM-1 [Human rectal adenocarcinoma],vorinostat-carboplatin (1-1 mol-mol),3.4124582914647026,3.197143039682921
CA46,107985,-3.181693098398671,-3.9209577152950805
DMS 273,JQ-1-MK-0752 (1-1 mol-mol),0.7328961203568959,0.9647357094571507
EFO-27,19582717,3.374407024388894,4.365479242627743
NCI-H1623,15953870,1.9962949386047493,3.5389158615016645
FU-OV-1,46199207,3.737847668041784,3.3506082549330154
A2780,11213558,0.737897067491707,1.103376055258927
NCI-H460,9926054,2.081701465030928,1.9155263007926215
NCI-H460,11404337,1.7201854837770862,-0.17981053365368596
NCI-H2171,2749,1.9442537074322577,1.379452686892487
HSC-4,49846579,1.975916395804951,1.0292776354032978
NCI-H2009,56963564,-0.2763231945711286,0.8020542414804624
Panc 04.03,3825829,5.002168928220905,4.073692473760725
HSC-4,5738263,3.918173826320675,3.54069639441356
MDA-MB-157,9926054,2.0716850398098368,2.0343920703268683
OPM-2,50905018,4.056598853615348,3.332682599117214
BxPC-3,9915743,0.4274244099837221,0.7547743784670399
HSC-4,16725315,4.164866459292326,4.107236770557372
SCC-9,11175137,3.431057653368815,2.754982720564777
A-673,BRD-A02303741-carboplatin (1-1 mol-mol),5.048794854025553,3.8953558554182774
NCI-H146,107985,-3.379993708562796,-3.591221109460071
SNU-61,3689413,-2.128463404187725,-0.4761124711756626
KMRC-1,9903786,4.024109374851969,2.7442952773143294
JM-1,BRD-A02303741-navitoclax (2-1 mol-mol),0.7492754152668983,0.6318674396412474
SNU-61,73707386,3.625444775073466,2.5111534381268665
ONS-76,11238147,3.0900457426442864,2.5713941076906774
KMRC-1,selumetinib-UNC0638 (4-1 mol-mol),3.730844045001738,2.91531655341676
SBC-5,JQ-1-vorinostat (2-1 mol-mol),1.350348201689009,0.9946425945520586
MDA-MB-157,piperlongumine-MST-312 (1-1 mol-mol),0.2909221181293618,1.7942691115791047
OPM-2,44607531,0.9426576866563848,1.1636863919436153
BT-549,409805,3.826135579342285,4.791228642073286
G-401,6505803,-2.085126737120111,-0.24386946660405226
ONS-76,9866186,2.0020907987509657,0.8843070193137259
BT-549,1641662,3.5282995747020514,3.6023662139782657
MSTO-211H,3384730,2.0695323326007387,3.153534778651569
NCI-H292,439501,-2.469830491210978,-2.0578880205920926
NCI-H2009,11964036,0.3874991337590915,1.4335926252542899
Panc 04.03,9840324,5.85151623174837,5.8605097031296065
NCI-H522,5311,1.356899837189567,1.2337298822079894
ONS-76,5311,1.4287655491580966,1.4519000237767026
NCI-H146,JQ-1-navitoclax (2-1 mol-mol),-2.878043275810858,0.4801463058524854
EFO-27,24775005,4.127014722833266,3.755488625753122
NCI-H460,5278396,3.885794996406102,3.5955209747474517
NCI-H2009,23725625,3.8804106674125713,5.142545932363336
NCI-H146,25102847,3.053262776547781,2.2548147794297924
JM-1,11396600,1.6173586604508372,2.6272218647703416
SBC-5,168312962,-2.5718885882949896,1.8792798196285605
DMS 273,46215462,1.755765775691153,1.5818731856781452
YAPC,107985,-3.02393363080246,-3.6188271066831117
KYSE-70,5566,3.0340425256076813,3.0801715856429666
G-401,BRD-A02303741-carboplatin (1-1 mol-mol),4.945197636740216,4.052797950058418
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984,1.2569561038287231
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704,0.2448075929497977
CAL-51,11404337,-1.4033364127444676,-0.21240943305077212
A4/Fukuda,25183872,-2.565081518812491,-2.0197221976138238
SNU-61,3815108,2.973673139417603,2.7724917119823753
KYSE-70,11507802,1.463595053056406,2.199919177794
A2780,10296883,3.5268945611299927,3.5769597287636445
FTC-133,24797083,1.5806228477994335,1.6051483248798297
MDA-MB-157,122327,5.563359607134461,4.476089788424306
NCI-H2009,ISOX-bortezomib (250-1 mol-mol),0.5557935848602048,0.7864416921012861
NCI-H146,4378219,1.8118272794434884,2.312999443587022
SNU-81,54143018,-0.9079963072010888,0.5815074076368532
NCI-H2009,49850262,3.4451640543988233,3.8479586496322487
KMRC-1,54143018,1.481383467839363,0.7014195745729468
NCI-H522,11507802,0.900021964921284,1.0794963592439444
A2780,6438330,0.9178294762259074,1.5850898277280359
A-673,selumetinib-piperlongumine (8-1 mol-mol),2.5365769801397,2.4447846062874836
SW1463,82146,3.98984472956996,3.298577620848789
BxPC-3,135984461,1.8776729747018608,3.99395263194512
NCI-H2171,56946209,-6.55665845628197,-4.589644223104916
KMRC-1,selumetinib-MK-2206 (8-1 mol-mol),2.4382383240498244,1.8386076088298506
HCC1143,54619267,5.25191473393144,4.134829107634974
NCI-H2171,46907787,0.7633638606493435,1.146944630892545
NCI-H1623,216468,3.833399887526913,3.2299819917972554
MDA-MB-453,9803433,3.6839578739817935,4.340827607483259
SCC-9,11955716,-2.333323067647372,-1.3833518933365097
A4/Fukuda,54619267,3.184419267966046,3.7790886986294443
KYSE-70,387447,-2.8804562370412765,-3.9559410866713383
FTC-133,135398744,6.510037604259866,6.376675656006389
CA46,2842253,3.7037662444842696,3.3990338727457714
BT-549,12001922,2.460799936977109,1.9869480780446074
LoVo,107970,2.0597080136849795,2.4062303790067197
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,4.021986716635288
CAL-51,3385,3.064238699960593,4.321444904823591
CAL-51,375860,-0.3577134594482877,-0.14851616713154397
OPM-2,3025944,3.8735985412418943,4.02004879080837
NCI-H522,53325874,4.347038439567835,3.7943886141414525
MSTO-211H,216239,0.7405720543436254,2.333095774532097
CAL-51,9868037,3.5441777448678615,3.35798182866491
A-673,49836020,4.096681472773702,3.3876654625994105
SNU-61,erlotinib-PLX-4032 (2-1 mol-mol),3.033607579022277,2.5843666932094562
LoVo,49836020,1.6927786584323,3.119662137027186
OPM-2,5291,3.3293230980723254,3.110684803255759
LOU-NH91,9884685,4.047485572984955,0.780781178215471
HSC-4,36462,0.7755986988683452,2.208739120369292
SNU-61,46907787,2.0753699666277936,1.1254986138837855
NCI-H522,5951923,5.621144710124551,3.5730561281679813
SBC-5,445091,4.3721050746953845,4.39135145371012
MSTO-211H,6252,0.7966303392140095,1.4591767236053954
MSTO-211H,6610355,3.5448971464264507,4.576323033974253
DMS 273,selumetinib-MK-2206 (8-1 mol-mol),1.7350778472906083,1.6329580366783332
CAL-51,15953870,3.220977372988981,3.7433809942613707
NCI-H460,25150857,3.536831166282903,2.6010095361418957
DMS 273,3854666,0.530051590236263,0.8688596014794426
LXF 289,9825149,1.6285560242869113,2.3373286082138005
NCI-H522,67156097,-2.1513446238308656,-1.5371767512926082
MSTO-211H,3062316,0.3213577633457804,1.4012575047565812
LXF 289,11485656,2.2610473771175847,2.6681293305366727
BT-549,4477,0.6326595549350394,0.5948928921768989
NCI-H2009,54454,1.843451372115344,2.622397868296704
SNU-449,16013152,4.866412327860677,4.31043382919143
SBC-5,16115403,-4.662279180425711,-4.195776516029206
A2780,2842253,3.957240977141399,4.0674461834881495
MSTO-211H,135398516,-0.6247457561994184,2.4572681880184972
NCI-H146,navitoclax-pluripotin (1-1 mol-mol),-2.9432727760472326,-1.0096790757404106
YAPC,702558,5.05880400043124,5.26058962701914
MDA-MB-453,409805,5.496183153122164,4.496817553014784
G-401,25161177,2.410029759496817,3.5322133138073624
A4/Fukuda,3025944,3.254701794903189,3.760847481047635
NOMO-1,126941,-2.339513844414448,-2.790114623800065
FU-OV-1,159324,3.7929038817112746,3.061345012213676
MSTO-211H,2113511,3.4014041807223228,5.68598507320361
A4/Fukuda,1242560,1.4412010240031818,3.128610675662872
OPM-2,327653,2.4944005218311984,2.6429517872549995
HCC1143,navitoclax-pluripotin (1-1 mol-mol),0.3469367515592647,-0.7116966334174955
KYSE-70,46398810,2.5990171625416916,2.5331585685645877
MSTO-211H,44486219,3.5621328730435216,4.2199371314301315
MDA-MB-453,6450551,2.407686053683273,2.475083473344633
A4/Fukuda,24180719,2.900503133545593,3.5545351978975774
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416,1.7374128206664663
A4/Fukuda,11234052,3.83864189929063,3.082639347275092
ONS-76,10231331,-2.145918525616272,1.95259862197933
JM-1,11656518,1.5501827619920003,0.6338857054418479
SNU-61,ISOX-bortezomib (250-1 mol-mol),1.4968983788663748,0.5427968941664573
EFO-27,16741245,5.191473652546265,4.094988433001259
DMS 273,216468,1.1199955960897896,1.5087164844739362
MSTO-211H,3689413,-2.1873545800685865,-0.07644716297889848
NCI-H727,10074640,3.0722260002613697,2.708799730886164
BxPC-3,66577038,2.7392816080167117,2.999186492261701
OPM-2,44489675,4.196628172603179,3.718479272155124
A-673,1239801,2.654695998337671,3.359341119950618
G-401,9444,5.739332402240228,3.803530130586483
NCI-H661,SNX-2112-bortezomib (250-1 mol-mol),0.017075608398325,-1.254880634025458
KYSE-70,71466380,5.08916461895765,4.379630361776077
NCI-H460,3025944,5.476008686130055,4.245275460045055
OPM-2,375860,-0.7230228450862618,-0.5707567357429602
G-401,262093,2.911602765721858,2.4062369402925645
OPM-2,12001922,1.1641343868089369,1.606748869888798
SCC-9,9903786,2.6448761987997917,2.9224253524783212
YAPC,1750826,2.252131937951327,-0.9647679182014985
JM-1,9840324,5.823306366003189,5.587189783136922
SNU-61,4705,2.600761934037586,2.6320938302027947
HCC1143,24821094,3.095995819095247,2.6840470267444765
A-673,JQ-1-vorinostat (2-1 mol-mol),0.4793000681263289,0.3926774152692204
HSC-4,15983966,0.1445652725334258,-1.1669422205986415
MDA-MB-157,9887053,3.277628039368057,3.873858346150939
KYSE-70,969516,2.5944329315988552,2.8788412256155276
CAL-51,135421197,1.6266864976107616,1.642022597412321
LOU-NH91,11175137,1.9157928307161511,2.8101710421688835
NCI-H661,168313047,3.0111797961595523,2.284276786145868
Panc 04.03,16659841,4.736684370351261,4.110555434881743
KYSE-70,16720766,1.38091635176305,0.8324966117678475
SNU-449,BRD-A02303741-navitoclax (2-1 mol-mol),3.897294679895557,2.663214180677358
NCI-H2009,9911463,4.220122302208283,3.939787769495616
HCC1143,selumetinib-navitoclax (8-1 mol-mol),3.081871684463836,2.0885514099633893
MDA-MB-157,44491742,3.772080854170876,4.564870808813272
A-673,216239,1.7434495050319987,2.0525773470418858
MSTO-211H,9967941,1.8027522151796112,3.979527274656462
YAPC,3815108,3.3369752363492315,3.0090471795042957
MSTO-211H,73707398,0.6990065379334892,1.7485534658838129
NCI-H727,4788,5.448581481072406,5.657722764364833
A2780,9911830,1.8386970616579583,2.269775981888064
JM-1,3038522,1.6953465924304043,2.540350212212945
FTC-133,107985,-2.14591043360211,-3.1094939234974164
NCI-H727,3503,3.7902677592538265,2.3401899563980466
ONS-76,selumetinib-navitoclax (8-1 mol-mol),-1.4029292063040089,2.312670176933351
KMRC-1,24771867,5.5206603877823275,1.4450937783675815
KYSE-70,3634881,3.4536977245329363,3.2044015770734564
SBC-5,119607,3.910029744126627,5.135543086426249
NCI-H292,serdemetan-SCH-529074 (1-1 mol-mol),2.3213297405207083,2.25436856120856
Panc 04.03,5329102,2.9853977590279075,2.386816727016108
SNU-449,selumetinib-JQ-1 (4-1 mol-mol),3.9590560352886457,1.9261240546408536
A2780,9826308,-0.0101157672837292,-0.37084084343819623
HSC-4,135440466,2.2202939224472655,2.1851995865855676
NCI-H727,6917907,-5.56846167215282,-4.989097092278155
MDA-MB-157,123631,3.9412563374531864,2.3050560226886825
MSTO-211H,11640390,2.078497045728262,3.7457226495919724
OVISE,54649381,4.33420809644373,3.761550536318042
MDA-MB-157,9868037,3.2071579521245823,3.560123303270538
A4/Fukuda,67291369,-0.3870993856905487,1.2192670061732602
A4/Fukuda,10113978,1.900139268592958,2.464931441191864
KMRC-1,doxorubicin-navitoclax (2-1 mol-mol),-0.3990728174038296,-0.9586028728308829
A2780,46199207,2.4758344041689093,3.0661334539219416
NCI-H2009,151289,0.8401149520435854,1.42685748262271
DMS 273,4477,0.2378478748071137,0.46683634793822065
HCC1143,6852167,2.667487538311212,2.651717912968877
NCI-H460,5335621,5.645903220513178,4.602401880906032
NCI-H460,54613361,2.8642714411834502,-0.040777363125556194
A2780,6852167,1.374383856311773,2.405099452235545
SCC-9,11707110,2.5707994933885736,0.4433623511308349
LXF 289,piperlongumine-MST-312 (1-1 mol-mol),1.396630605927831,2.0386155055764275
MDA-MB-453,BRD9876-MK-1775 (4-1 mol-mol),0.1986827293321165,0.6282938296280826
EFO-27,6610355,3.735872349212987,4.70866804044525
ONS-76,navitoclax-piperlongumine (1-1 mol-mol),2.7557969357291476,1.7422454102157676
OPM-2,16038120,-1.581922980476964,0.08235603956033583
KYSE-70,serdemetan-SCH-529074 (1-1 mol-mol),2.076858890087622,1.9994890980968156
HCC1143,10410894,4.771687149558392,3.2649180348571822
YAPC,54454,3.200830039856186,2.6685928703025126
DMS 273,6252,1.7538621935564394,-1.1909161516847049
SCC-9,doxorubicin-navitoclax (2-1 mol-mol),-1.5026968555435367,-0.9929337229754099
G-401,44491742,3.951665256591854,4.079188638435117
DMS 273,11625818,4.382645377089847,3.650427534639078
LOU-NH91,3503,2.9647844947930397,2.4573625145277016
G-401,446155,3.2535633304842144,2.403682681694738
DMS 273,675434,4.24768091674901,4.316334540008783
Panc 04.03,erlotinib-PLX-4032 (2-1 mol-mol),4.205995552769646,3.1938697627664663
YAPC,ISOX-bortezomib (250-1 mol-mol),1.2420544087730638,0.7787470110411143
Panc 04.03,168313016,6.087789512449841,4.966765403423012
NCI-H1623,24856436,0.944997546799197,0.49566687738075915
ONS-76,ISOX-bortezomib (250-1 mol-mol),0.2723721998746015,0.8671590720850193
LoVo,3025986,-0.1762115912359206,-1.0641207998503577
A-673,10184653,1.446453264453446,1.2361241470747963
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633,2.037886975385503
LoVo,66577038,2.852951614414874,3.046879873063756
NCI-H522,3136844,3.3827652175643577,4.16737732521706
A-673,3676137,4.749608800479587,4.2891805931691716
SCC-9,409805,5.497565328609373,5.0058758449243905
DMS 273,6918328,-1.955094157059326,-0.39673748578762386
LXF 289,4259181,0.8555931132792622,0.21811504403998644
OVISE,448949,2.233154508177948,2.140707637782725
JM-1,675434,3.7844228868956296,4.035204563763405
NCI-H292,5566,3.044146869319611,3.139511994772927
EFO-27,227681,1.958013080406725,3.5918996647069075
EFO-27,65064,5.385038331959097,4.9540758181779205
A-498,9907093,3.786767310891997,4.241153302080828
SNU-61,676352,2.4274144006766893,2.076846984338568
MDA-MB-157,135421197,1.265960780615991,1.8932696359855499
NCI-H460,10074640,3.83137833519258,3.244693054646518
BxPC-3,46199207,2.8626203608628416,3.1164308304128614
CAL-51,387447,-3.720200693098244,-4.185509668400849
NCI-H146,56946209,-6.937271673290349,-3.9601917385385446
EFO-27,46907787,4.067144836646944,2.5476467348646548
NCI-H292,2729026,2.9142630754738037,2.6980201421836343
LOU-NH91,1716436,1.3649900096390022,3.073804624396468
KMRC-1,8515,4.713762602344707,3.6580690852418365
MDA-MB-453,crizotinib-PLX-4032 (2-1 mol-mol),2.6505270517489596,2.0021301644653913
SNU-449,448949,1.5810053045793695,2.302188546193874
SBC-5,4096211,1.588189246491771,2.2410112716276513
NCI-H661,26596,-0.5563822784391794,-0.8194265756592384
A4/Fukuda,51037431,0.9928208538339424,3.0302843094454324
HCC1143,doxorubicin-navitoclax (2-1 mol-mol),-0.0488581620418106,-1.0456146085737221
OVISE,5311,2.608797421965248,1.4732269999557972
A2780,11238147,1.47132390494783,2.1121081236803287
NCI-H1623,676352,1.987229853680802,2.143386950752458
Panc 04.03,126941,-1.1535511280443094,-2.209525961071036
NCI-H727,9926054,2.0492739470784445,1.904542821007045
LoVo,65064,4.389937632551182,4.962217466476556
SNU-449,52947716,1.9936156354056855,0.28916884913477525
Panc 04.03,5351362,1.307383541492636,1.78830653217781
HSC-4,vorinostat-navitoclax (4-1 mol-mol),1.9548576859286355,1.2858913299637984
NOMO-1,44493952,3.580250185381126,3.0103208119435845
A-498,676352,1.77005199556574,2.3194640654173044
Panc 04.03,5280436,1.6844699655115762,3.5864781869177462
CAL-51,16736978,0.375988055286384,1.4966046595271836
MDA-MB-157,54618771,3.1146330047846877,1.481470078788749
NOMO-1,6450551,1.2307950565416117,1.1901151073961547
MDA-MB-157,tretinoin-carboplatin (2-1 mol-mol),3.238516076449109,4.9650765623598545
G-401,25105715,3.9034348367564258,3.2939384061379684
BxPC-3,151289,0.5689607060021993,1.4495985822480586
NCI-H727,44543605,4.300237824274415,3.944261816613375
SNU-81,2907,6.641268536629272,2.1437646456637323
SNU-81,613753,2.2388707005796507,2.940346194735566
JM-1,168312962,1.22629450044224,0.7735804270252552
LOU-NH91,168313200,3.810508485111527,3.1053307271621198
NCI-H146,3854666,1.3221451848305394,1.5359181141739475
KYSE-70,322968,3.381611542483835,3.7561898075598146
ONS-76,241158,4.846225597872182,3.7322947891720384
SNU-61,selumetinib-PLX-4032 (8-1 mol-mol),1.220990708913243,3.039695396438512
KMRC-1,JQ-1-vorinostat (2-1 mol-mol),1.4567711420543266,1.0563337654728109
CAL-51,5291,4.8235616489491635,3.676844700786061
SNU-61,SNX-2112-bortezomib (250-1 mol-mol),-2.113975984395572,-1.5981102980162099
MDA-MB-453,168313016,4.163913885489913,4.7443757854435615
A-498,60700,2.2087582051541257,0.25477262720750404
RCM-1 [Human rectal adenocarcinoma],65064,5.283352652805609,5.151339306475019
HSC-4,6918878,5.2813290465493505,3.00998672160335
MDA-MB-453,9884685,-1.4419247946131482,0.6012634205685427
A2780,2746,1.939184711313242,2.4041046968189037
NCI-H661,148198,-4.235070372495308,-3.745720341964157
HSC-4,54678924,3.092091974621669,2.2624928135116793
A-673,2113511,4.0082027727586,5.21128603513984
A4/Fukuda,5287620,-3.30087759062066,-2.239349931381214
SNU-449,selumetinib-MK-2206 (8-1 mol-mol),3.758556004242712,2.840794635386859
LOU-NH91,6918328,0.1478473020386815,0.2071770577968979
BxPC-3,3385,3.820290029267426,4.11952705969955
MDA-MB-453,44185566,2.487729821066063,2.474334923584557
LXF 289,46907787,-0.1426698074457199,2.477874767536095
EFO-27,piperlongumine-MST-312 (1-1 mol-mol),1.300459178940563,1.9754746918334363
EFO-27,9887053,4.025142225668377,3.9725194556652452
BxPC-3,4259181,0.1397018777458316,0.4020731827101637
SCC-9,10184653,-0.319006591471168,0.9984055779652465
SNU-449,53232,1.6560937312011326,2.759064490407759
BxPC-3,53232,2.859321527409702,2.671837873016136
NCI-H460,71304818,2.359856693071434,2.5718150885880355
NCI-H2009,11178236,-2.605718631753464,-3.2363101050840397
FU-OV-1,400769,0.1189863997269066,-0.5249222085058505
NCI-H292,vorinostat-carboplatin (1-1 mol-mol),3.668554918362719,3.4307330793081885
FTC-133,72376,-0.3430893294901544,-1.709651800195699
LOU-NH91,2858523,2.98680776080117,3.0915765836453604
LoVo,6918837,-3.586713596901602,-2.743585858914496
SNU-449,erlotinib-PLX-4032 (2-1 mol-mol),3.286095103916852,3.5531782661718756
CAL-51,6918837,-3.0563476396929703,-2.702286389642535
NCI-H292,676352,2.616071543582294,2.246086160033874
NCI-H522,11626560,2.464867345362881,1.3003180905489082
HSC-4,SNX-2112-bortezomib (250-1 mol-mol),-1.2345732834782526,-1.3325235688876784
A-673,11167602,2.442600782118551,2.1176730030670674
OPM-2,11222830,0.0961911151739945,1.1261951698751564
A4/Fukuda,7251185,1.076285820033946,1.6476851965223345
OPM-2,24978538,1.9225155298388676,-0.023982492173631423
CAL-51,135411,0.595745817277345,0.9184371095981557
NCI-H2009,selumetinib-tretinoin (2-1 mol-mol),-1.112372565869968,3.837111107761576
HSC-4,3025986,-1.9523671858491285,-1.2549333890740946
BT-549,54618771,1.4883156908959423,1.6201904607281081
DMS 273,1239801,5.369367906855259,3.182690290505956
SNU-449,374536,4.370390285639732,2.001854827004882
MDA-MB-157,168313016,4.249309770188466,4.865014908701983
NCI-H522,446155,3.2752737209903504,2.480365886269797
BxPC-3,9935249,3.9268263105803727,3.189750631937461
A2780,16725315,3.2354385253964253,3.653977280541399
NCI-H522,11647372,2.460433695225771,1.06121346355291
MDA-MB-157,3689413,-1.567220624306923,-0.06315860392690123
NOMO-1,36314,1.6795260413615891,-1.9857037795571275
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,-0.12240550178681504
ONS-76,46199207,3.062888044588984,3.305546374004333
HSC-4,2746,3.845189406581069,3.0811632025102904
A-673,126941,-4.88778992999732,-2.651252580973045
A4/Fukuda,2874250,4.0164309105299685,4.4067430523784346
DMS 273,navitoclax-piperlongumine (1-1 mol-mol),2.7902567268334786,0.8270203600511021
Panc 04.03,3136844,4.698465140769799,4.411177679167418
KYSE-70,53232,3.7067207893488017,2.7071591549236365
CAL-51,24180125,2.8082301472193203,2.98458059236004
Panc 04.03,9884685,1.6842032304446288,0.8917822540846586
NCI-H460,11626560,2.497647926194901,1.8022595413982898
SNU-449,168312962,3.745202246753347,2.298018886029301
HCC1143,9935249,3.8757786370374303,2.9732688985327176
SNU-449,613753,3.229445182846538,3.340216627265246
OPM-2,44491742,3.727542800888903,3.8477298458613416
KYSE-70,9936388,-4.915846401119174,-1.8969664465461447
CAL-51,654092,0.82886283906252,-0.13356812436928248
SBC-5,448949,2.9920694717704204,2.0261051951299502
OPM-2,46843906,-0.5330027912440064,1.4152627660920194
CAL-51,5566,3.271951139375183,3.109965186625209
KMRC-1,53232,3.79650380515527,2.9610121137803045
CAL-51,11228183,3.6770505489909007,2.316900498677144
SW1463,24785538,0.6322996420886741,0.744146101768608
A4/Fukuda,119182,-4.160589878424858,-2.247838107958323
A-498,107970,3.0044685679861054,2.347207438878732
CAL-51,11612883,1.9359641259018452,2.732216475740604
A-498,11317348,4.2355090436144875,3.398684535233366
LoVo,67291369,1.4516021942624118,2.652490169824038
A2780,11222830,0.6433638933511314,1.539314416866128
BxPC-3,241158,3.755569293331497,3.9526182369633465
SCC-9,6610216,4.4695629784882795,4.314121702961457
CAL-51,374536,3.1977545561189347,2.227741789049032
LXF 289,selumetinib-MK-2206 (8-1 mol-mol),2.3074669489760296,2.5874523184533467
RCM-1 [Human rectal adenocarcinoma],25183872,-1.7223948932282942,-0.5942205298749493
SNU-449,72376,1.1438392823146497,-1.285662498995529
A-673,4259181,-0.6373852614685119,-0.22252344228392226
DMS 273,168313200,2.725135044490621,2.6704429534068157
NCI-H460,9911463,4.421747687015995,3.9111413710802276
JM-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.988694058348957,3.9876852423411764
YAPC,119182,-1.6155541294016968,-0.21242905141636162
SBC-5,6184667,2.5027552360756946,3.1320518044353913
RCM-1 [Human rectal adenocarcinoma],89928392,1.6489632684947326,1.6253067564677508
G-401,2858523,3.0226653633513,2.919762324964804
MDA-MB-157,10184653,0.5581112583171038,1.481677337371241
A4/Fukuda,19582717,0.7629696429231957,3.232231520491437
NCI-H460,53392493,4.733063337287369,2.8276091227356193
OPM-2,72193861,0.7906161175639799,0.1904820877829393
NCI-H146,44491742,2.6808030102351323,4.3314004356232605
NOMO-1,46398810,2.1682472320454504,1.7158771578514413
DMS 273,16736978,0.9096800466601204,1.7667486708975682
NCI-H292,navitoclax-piperlongumine (1-1 mol-mol),2.359221869060842,1.999966507556792
CAL-51,16741245,4.222373420591208,3.900805653119755
MDA-MB-157,10074640,3.629475203970288,3.1106205745650612
SNU-449,2828334,6.138780539354761,6.210477549331435
HSC-4,9823820,4.434899642824078,4.189573544531902
A-673,11238147,1.6374380314183412,2.360992393727345
EFO-27,selumetinib-PLX-4032 (8-1 mol-mol),5.056777545277596,3.311107612998352
A4/Fukuda,4915,4.811112690158961,2.899056933673448
JM-1,42642645,-0.9084434189288264,-0.10613528426435685
MDA-MB-157,3854666,0.668628762558335,2.01466451507317
SBC-5,2841722,4.592516057239796,4.2011147042311325
BxPC-3,2742550,6.208235416241253,3.9218911280841557
NCI-H2171,168313200,1.615164123973231,2.6167833342279594
LOU-NH91,46843906,2.60442098689998,3.4257444621022546
DMS 273,54619267,3.628421853226673,3.8252686193161476
CAL-51,16725315,3.2794500362302,4.344053310573639
MDA-MB-157,10127622,3.2546864424502076,3.898074630874932
NCI-H2171,16725315,3.053630151756443,3.6973184213097516
SCC-9,9935249,4.690276947265519,3.2205802516714686
NCI-H460,44507138,4.578042897326484,2.601406213128011
NCI-H1623,5282054,3.865413044747809,3.9173516074131265
HCC1143,984333,-0.0539665216618622,0.830268556589177
CA46,selumetinib-PLX-4032 (8-1 mol-mol),4.812160149058309,3.260541125975526
MDA-MB-453,9840324,6.873328025428986,5.710525577562642
Panc 04.03,176870,4.897846724128431,3.3028634266908234
NOMO-1,11640390,1.5691640408186416,2.824466903692074
Panc 04.03,409805,5.536204895331733,5.076748333318031
MSTO-211H,71466445,2.2675767772231024,4.187622030603996
NCI-H2171,9915743,0.832341910278816,0.6480330185462048
A4/Fukuda,5281672,3.917758560865086,4.1503205502966765
LXF 289,11427553,2.4541082171467368,2.81912133587794
Panc 04.03,7251185,3.2944683029692237,2.7218746184414
NCI-H522,9933475,1.020852520604034,1.776667406893581
JM-1,24180719,3.5833576580940005,3.128571176560722
SCC-9,15953870,4.1491811794097995,3.5857774088265444
Panc 04.03,56946209,-4.443392589569815,-4.0524470833232975
BT-549,6918837,-1.3661230802503712,-2.2046977572130704
ONS-76,56946209,-3.559106939272703,-3.8283431702052404
OVISE,44507138,4.185704551553473,2.590039806011028
NCI-H292,441298,3.4530013870499037,2.7833255609315257
EFO-27,374536,3.468329704237433,1.7824236876978032
NCI-H292,568763,1.0095796953036382,0.6046314341707126
NCI-H522,122327,3.7548997428021904,4.290619013163336
FTC-133,409805,6.0297974484260655,4.911086047416377
KMRC-1,3384730,3.706671423221143,2.3425101064828295
HSC-4,5351362,1.6988999536887646,1.5060425770954933
BT-549,448949,1.6914375683866394,2.0643915495159986
JM-1,753704,3.307600856766594,3.9828138353442477
CAL-51,25195348,5.6667768045179905,3.1428062622215345
CAL-51,3025986,-1.0834382414923172,-0.878954218206554
HCC1143,15547703,3.062266000318877,3.0704842799115837
EFO-27,navitoclax-PLX-4032 (1-1 mol-mol),3.1574015935029083,2.0568200524879403
CAL-51,135999136,4.2132345103647015,3.9396750473042608
ONS-76,55283,0.3588409196586273,2.6337360768408473
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.2776025442819188
MDA-MB-453,selumetinib-vorinostat (8-1 mol-mol),2.0806958823850485,2.371660601110666
SW1463,25262965,-1.5690747748042335,-1.5186827461598824
FTC-133,241158,4.091507154193835,3.957839621730678
KMRC-1,23582824,0.9449566223543509,1.3638055053849438
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086,0.8284829450592313
FU-OV-1,16013152,4.2048953133679765,4.0971612876672925
MDA-MB-453,613000,0.0740651651217389,2.4059732789810946
MDA-MB-157,24797083,0.6098010922803769,1.4264246838033023
NCI-H460,10074640,3.83137833519258,3.244693054646518
CAL-51,16722836,0.8083581946159574,1.6899271672383147
NCI-H146,tretinoin-navitoclax (4-1 mol-mol),-1.851053903762128,1.8724481317469799
G-401,BRD-A02303741-navitoclax (2-1 mol-mol),3.4869097822802915,1.307961065928967
G-401,10322450,4.220475308231234,3.704078641501042
G-401,15983966,-4.354524639754001,-2.421302774390357
CA46,9887053,1.048475441216289,2.4743465871033643
RCM-1 [Human rectal adenocarcinoma],11625818,4.3229587777026035,4.448513943381815
NCI-H1623,11152667,-0.7587975819891684,-0.42948026330567124
HSC-4,11609586,5.018303752842559,2.8227307923359604
OPM-2,67156097,-3.031514601372161,-2.042578360223089
G-401,984333,0.0612358592539302,0.018536782581544006
LXF 289,9908783,5.689655754809611,5.071442048827399
SCC-9,5329102,2.2394800798474677,2.1967208839273105
NCI-H661,17759555,2.3282310316349935,3.5872606299276106
LXF 289,24856436,0.8419130403195528,0.23701672738878546
SBC-5,159324,3.4028835437957112,2.9575285696811022
JM-1,6184667,1.7187669889057045,2.436570902686193
MDA-MB-157,11396600,3.7386973485738424,3.4584735239846283
BxPC-3,216239,2.4917493719892274,2.524871920307641
MDA-MB-453,72193861,1.6700607918257404,1.812098831406
CA46,selumetinib-tretinoin (2-1 mol-mol),4.988677002369049,2.4218058309994994
KMRC-1,9915743,1.4003501061845525,0.6383407168151378
RCM-1 [Human rectal adenocarcinoma],5351362,2.343495237192863,1.5730282842364318
A-673,12001922,0.9671300191794728,1.7045357497841067
A-673,1323703,5.495685082034704,1.4494155091016256
SCC-9,2729026,3.0647326637868573,2.721195105108562
HCC1143,navitoclax-piperlongumine (1-1 mol-mol),1.8457079169425925,1.3831352308270126
NCI-H2171,3503,1.152076889590999,2.1991431072373966
JM-1,252682,6.042634536055517,6.416908882404457
CA46,44137675,2.206940954689562,2.865987264606754
CAL-51,11152667,-1.203722258692511,-0.5505570569164955
LXF 289,135984461,4.539632657840611,3.955364704709459
EFO-27,docetaxel-tanespimycin (2-1 mol-mol),2.492630012164076,-2.8618065200167764
SW1463,11507802,1.438199099446833,1.4395689953836
BxPC-3,25062766,1.590701824067561,2.1594743144094233
EFO-27,45279963,4.232301991437958,3.661890216535932
G-401,selumetinib-MK-2206 (8-1 mol-mol),1.699600486285741,2.1297403509008177
NCI-H2009,42642645,0.1491359953679814,0.9609940409097985
FTC-133,53495165,1.6157050027500164,0.8011134452250745
NCI-H292,11640390,3.2514062698758015,3.738096522268266
A-673,135423438,2.29660224903782,1.6833951760929506
SBC-5,9911830,3.21689826570876,2.5016635737379915
MDA-MB-157,36314,-4.695989096441824,-0.9209304674137432
NCI-H1623,5328940,1.639592653942716,1.750794236637151
SNU-61,135999136,5.618921387112628,3.0538921618789634
CAL-51,25102847,1.94226811064499,2.269274055439927
MSTO-211H,selumetinib-vorinostat (8-1 mol-mol),2.5507506919352037,2.5810243744418693
A2780,68056272,2.2410901197134923,3.401982091796961
NCI-H2009,selumetinib-JQ-1 (4-1 mol-mol),-2.491953444120814,1.6770339617599195
KYSE-70,24856436,0.5719980221753466,0.745228113955611
CAL-51,46398810,2.084696284876613,2.5031309248415665
NCI-H661,16720766,3.873672796747104,0.6198724366530433
LXF 289,11234052,4.719623128458786,4.365488592749349
NCI-H146,selumetinib-PLX-4032 (8-1 mol-mol),4.7955071162055,3.2151158198560768
MSTO-211H,107970,1.929708493397844,2.3816286180955144
MDA-MB-453,9929138,5.862527790185705,5.162654273846698
G-401,285033,-4.902412101243927,-2.390997376841646
OPM-2,6852167,1.7172653102666242,1.7565953286315632
EFO-27,11228183,3.371245966973651,2.383585719458551
CAL-51,17759555,3.5733302595078182,3.5401340832006296
SCC-9,24785538,2.4612574042553432,1.7972910220211396
KMRC-1,11364421,1.724167601186248,-1.5307902186972595
MDA-MB-453,24748573,1.9919110400088051,2.161121361485706
EFO-27,5460769,4.47484627366887,3.0989479008107885
HCC1143,49850262,3.2153342375189533,3.5833055247816548
Panc 04.03,66577038,3.1738099516277667,2.9963984527732244
NCI-H661,11238147,3.129195095759777,2.971119306571773
SNU-61,6623618,1.73773822434396,2.1844157245325064
EFO-27,16720766,3.656433318818957,0.3466248158439478
BxPC-3,969516,1.4378873066513898,3.0185089653055224
JM-1,54596558,3.768195826371459,4.115121793419601
LOU-NH91,5738263,3.7277759973822726,3.572223328344049
JM-1,25183872,-4.29494207596009,-2.0322446628755175
NCI-H292,89928392,1.456532385863884,1.8716575641737443
NCI-H460,119607,4.735621464768821,5.248404909755636
NCI-H460,322968,5.369771337760045,3.9880532039543546
MSTO-211H,navitoclax-sorafenib (1-1 mol-mol),-1.757065878159517,1.8005177841702522
CAL-51,9907093,3.7886359098281783,4.158545874082627
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,4.751118999030528
LoVo,123631,1.2882244486240189,2.157500580911455
NCI-H661,crizotinib-PLX-4032 (2-1 mol-mol),2.1767708357401188,2.0972707552902117
MDA-MB-453,15983966,1.8434310309669164,-0.6877584081114365
A-673,selumetinib-PLX-4032 (8-1 mol-mol),5.680938960321501,3.756885728709172
HCC1143,135440466,2.588436572703006,2.1858597207308232
NCI-H146,9926054,1.7480459470636802,1.7921655728881947
KMRC-1,5278396,3.6212610119500783,3.5233912915133603
A2780,46191454,-1.192769752942619,0.9511142004449886
A4/Fukuda,25062766,1.3929374396347198,1.652483430504883
NCI-H292,53232,1.814131755875953,2.797165174280259
ONS-76,24771867,4.286887453999452,2.219570861689501
FU-OV-1,31703,-1.7023718917237094,-0.8489919329664651
A4/Fukuda,66577038,2.118562328013949,2.7974771768827664
NOMO-1,445455,4.303833401854377,3.713189157404077
NCI-H2009,12003241,-1.6852069192913937,-1.0405354687797963
LXF 289,42642645,0.485507292149712,0.9827104832128764
NOMO-1,46199207,2.5514936314753434,2.8658123003475726
NCI-H460,322968,5.369771337760045,3.9880532039543546
Panc 04.03,5328940,2.517395347800957,1.9114360098732994
SNU-61,9936388,-6.308071034865157,-2.778357100952738
LoVo,4261,-0.8211989197292223,1.3979198322060526
A2780,136227924,2.141563547945887,2.644890058911202
DMS 273,11175137,1.5448586489611442,1.8969259981945237
LoVo,44202524,1.5416570481285088,2.411776058984597
HCC1143,9907093,3.794716934303189,4.0089140151502844
NCI-H292,6610216,4.846288432835765,4.263717363194383
BxPC-3,11178236,-3.5754762678880567,-3.1099824479215203
MDA-MB-453,5978,-2.563797038396111,-1.5222343075723266
NCI-H146,5460769,1.8747395178404,2.291619995950102
CA46,11238147,1.5462987380530164,1.857668219992241
A2780,selumetinib-vorinostat (8-1 mol-mol),1.1370776925514063,2.2904064430651276
LoVo,2828334,5.515630519838643,6.203776043900481
KMRC-1,5287969,-1.8174868244268352,-1.787240549111125
NCI-H460,676352,2.985829219207002,2.187887700391655
SNU-61,23635314,-2.2430318809352556,-1.618885111925845
NCI-H460,11612883,2.88158995470921,2.6826895939069457
HCC1143,24951314,0.9489239510798212,1.440285410212998
OVISE,387447,-4.037756707187744,-3.8772811116234926
JM-1,568763,-0.4685251193741573,-0.197614849731215
SNU-449,9907093,4.078651849005814,4.2382931637123145
BT-549,53392493,1.9491955503491856,2.8339499278481513
MSTO-211H,24180719,1.9210037149309027,3.4461499046068758
NCI-H1623,23635314,-3.504391783968502,-0.9772060478962274
MDA-MB-157,135875424,2.7117106005077276,4.181601341954116
NCI-H661,54678924,1.9600004323573317,2.3870626544896285
DMS 273,25105715,3.6490952941772496,3.362324204966418
NCI-H1623,216345,4.517328735854535,3.834091499072707
SNU-61,5282054,3.0015154117441996,3.241303444226288
SNU-61,10302451,2.848073588995495,2.8338006512327256
CAL-51,16720766,0.5416929462446769,0.628179390933901
ONS-76,BRD-A02303741-navitoclax (2-1 mol-mol),3.993242759783489,2.5044474409909805
OPM-2,selumetinib-decitabine (4-1 mol-mol),0.7585781361547917,0.9537761734801369
NCI-H522,46398810,2.2314734558486053,2.3578121875207434
JM-1,67156097,-2.627968736143573,-2.1835280650894173
LXF 289,60700,2.2902498510351528,0.14424742993489767
BxPC-3,2945648,3.219283504871713,3.0090613355058538
A4/Fukuda,65064,3.1077716650538707,3.8737794799513354
NCI-H292,tanespimycin-gemcitabine (1-1 mol-mol),0.0441766051027791,-0.6381300113052635
BxPC-3,10077130,4.243605425717339,3.381080264928674
DMS 273,JQ-1-carboplatin (1-1 mol-mol),0.4682254596147815,1.1459536918831736
NCI-H2171,tretinoin-navitoclax (4-1 mol-mol),-0.4442650177645615,0.9919797275809333
NCI-H292,carboplatin-UNC0638 (2-1 mol-mol),3.385304428653225,3.346759941844263
LoVo,168312962,0.7059894109575258,1.7845616395797228
G-401,65064,5.209946412003188,4.277870364677733
NCI-H146,148198,-5.323171419653744,-3.749813209380785
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739,-0.2860830504937034
A-673,UNC0638-navitoclax (1-1 mol-mol),0.924898873011094,0.6621116769179751
HCC1143,2746,1.9419289545652112,3.235036886431546
NCI-H2009,erlotinib-PLX-4032 (2-1 mol-mol),3.949302222933775,2.9684099963871575
JM-1,decitabine-navitoclax (2-1 mol-mol),-3.5626840909623234,-0.5747312882511061
NCI-H2009,10385095,0.2451756361843044,1.3290381178655781
OPM-2,11167602,1.1745103577473592,1.6812694007096594
CAL-51,26596,-1.4638590943230956,-0.7806231583834807
NCI-H460,1716436,4.318712917611328,3.1045710322576907
ONS-76,71304818,2.469307822454373,2.4773146621230118
BxPC-3,11626560,1.2674200020854305,1.9462780185907953
CAL-51,104842,-3.020036586723177,-2.7023691787407715
NCI-H460,49793307,0.4479933662320887,-2.6738973819160834
FTC-133,5284373,3.681008384459256,2.6649320283688507
SBC-5,11455910,0.8715920005264659,1.238908948496803
MSTO-211H,49850262,3.597717946429448,3.719454361361502
DMS 273,2871966,0.6484564569530932,0.37888423792790105
OPM-2,2729026,2.502425703285658,2.298555125187646
KMRC-1,JQ-1-navitoclax (2-1 mol-mol),1.5220385393532236,0.7905598393801845
NCI-H292,9840324,5.8141064790381884,5.833691718235617
NCI-H661,375860,0.2037463104187888,-0.006307149594489956
NOMO-1,6918328,-2.206625897840938,-1.678155643252228
NCI-H522,54143018,0.2801073306793095,0.3805115623091438
OPM-2,23635314,-4.85335222903722,-2.909087130281825
NCI-H1623,1716436,2.729344651836522,2.927166361023843
CA46,60700,-1.6899904219212585,-2.22086366451173
SNU-81,10077130,-1.1742608263747976,3.0721102111657967
MSTO-211H,9907093,3.5779290533064856,4.286503608737776
CA46,2126,3.4622152695614767,3.8667773642635916
CAL-51,49766530,0.4609697007955676,-0.20059744460808898
CAL-51,6438330,3.884194225982375,2.1470330805637503
KYSE-70,68056272,3.571583007543391,3.6772721525759717
LOU-NH91,vorinostat-navitoclax (4-1 mol-mol),-1.0050592172430175,1.3559029618468517
EFO-27,68056272,3.9995237189063784,3.7278816849546326
SCC-9,241158,3.962823581088113,3.8828177620433344
NOMO-1,5746,1.3002002606442051,-0.33163364255572886
MSTO-211H,44202524,1.4972222665959742,2.2120737666230315
NCI-H727,49793307,-2.322611372156632,-2.9099054779542484
NCI-H146,4578,4.154543455900732,4.211742349053256
NCI-H522,JQ-1-vorinostat (2-1 mol-mol),-0.7689256810946783,0.6991054912987699
LoVo,107985,-3.583734032756361,-3.43321258216556
YAPC,984333,0.9591784056691972,1.1188655629897504
SW1463,1750826,-6.63000221324875,-1.308714448000801
NCI-H1623,crizotinib-PLX-4032 (2-1 mol-mol),2.4308697458394652,2.101868295099232
HSC-4,9866186,0.7177643600632182,0.844827724956716
G-401,navitoclax-pluripotin (1-1 mol-mol),-1.0942323522272883,-1.3161209973727253
ONS-76,135398516,1.9151603507117831,2.024345561938588
LoVo,11964036,-0.4950100771581299,1.2401256320598721
KMRC-1,crizotinib-PLX-4032 (2-1 mol-mol),1.7808089870084007,1.7387530634878474
CAL-51,11964036,0.7531640395115359,1.3803669713612718
SBC-5,5328940,3.016318294707136,1.7097019429740772
SNU-61,9444,4.091366887299019,4.181639499701683
A4/Fukuda,selumetinib-UNC0638 (4-1 mol-mol),0.1859137838774149,2.4029199056266077
A2780,676352,1.788840905955693,2.055004395592028
FTC-133,JQ-1-vorinostat (2-1 mol-mol),2.666931641938378,1.3243706758923464
JM-1,7251185,0.7253388444333596,1.3837551101947279
Panc 04.03,JQ-1-navitoclax (2-1 mol-mol),4.611253227928805,0.9378600289340683
NCI-H460,52947716,-4.997624319891589,-0.4100474893312551
NCI-H2009,6505803,-0.1719772058921901,-0.4820014477274171
OVISE,25126798,4.262747569123806,3.9674126386299235
G-401,54678924,1.6253720221899297,1.8560608004254522
Panc 04.03,tretinoin-navitoclax (4-1 mol-mol),4.366288248143094,2.946893178723987
A2780,135421197,1.3895584306244824,1.6285267371191623
EFO-27,25126798,3.692256603979053,3.854844556320079
DMS 273,73707398,1.2764695344106731,0.8558598916517706
MSTO-211H,10296883,3.6762481855456985,3.995626659967123
LOU-NH91,60700,-0.2604526525302556,0.3852965209821666
Panc 04.03,8515,4.900392472396633,4.006683673283126
A4/Fukuda,216345,2.739557201577506,3.147501429290726
A-673,24978538,2.0217931845087596,0.6270593881201034
SBC-5,11152667,-0.3838978082878119,-0.441946624663801
NCI-H460,15983966,-0.5601417251503862,-1.1722839774837504
EFO-27,400769,-0.0834796845468066,-0.6619816807464792
YAPC,2858523,3.168058012530131,3.1418749096701712
LOU-NH91,navitoclax-sorafenib (1-1 mol-mol),-0.9074262006529596,2.2065443199065022
NCI-H2171,227681,1.8296199533038344,2.7381364550094838
NCI-H460,11455910,1.4134750909778395,1.1367854762682412
G-401,44566777,-0.9568944013200004,0.08699374769041164
NCI-H292,5328940,1.2067364026743148,1.6033458727243302
G-401,navitoclax-sorafenib (1-1 mol-mol),1.5806960178530294,1.1148944155879346
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-3.1749353169803136
JM-1,25154868,2.919888649987432,4.103620760323263
LoVo,44185566,1.1715497148164364,2.3230734563455
ONS-76,54618164,4.167815792355048,4.084477372058498
NOMO-1,151289,1.0922355572005962,0.3406183500757946
G-401,44493528,4.310857122389352,4.144355671683742
KYSE-70,89928392,5.113782206339635,1.7038882916890175
NCI-H661,89928392,1.5970967591597882,1.617868605996088
SCC-9,docetaxel-tanespimycin (2-1 mol-mol),-3.608220129301709,-2.249131610020963
KMRC-1,3503,2.6706031423305845,2.2149316570912783
G-401,11455910,1.3171347053017213,0.6543088814040986
SNU-449,208908,2.01293579360495,2.0280851313844805
G-401,57519531,1.5783303012871783,1.8448604049664763
MDA-MB-453,11427553,2.8599395215861567,2.661395005250449
LOU-NH91,241158,4.097895358021133,4.228380094017884
G-401,24951314,0.7541386929645643,0.7569795621822034
MDA-MB-453,208908,1.869724740513474,1.4360615435596722
YAPC,46398810,3.0625661294812216,2.670121487279423
LOU-NH91,1750826,-0.8784962447018205,-1.8515097844950614
FTC-133,ISOX-bortezomib (250-1 mol-mol),0.3351331605659957,0.6947813802988931
RCM-1 [Human rectal adenocarcinoma],24771867,4.508296832673209,2.687099269941196
MDA-MB-157,100016,3.517936084480814,6.149451031618765
HCC1143,60750,-4.413462787403808,-1.86888723756993
NCI-H661,selumetinib-BRD-A02303741 (4-1 mol-mol),5.5299727991020555,4.251927113406925
HCC1143,159324,3.533344711636858,2.9732688985327176
JM-1,1750826,-4.271139507623605,-2.9724250240883645
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205,-0.1684485826212112
A-673,11396600,2.723776149104898,3.203459714714228
NCI-H1623,24964624,2.070631930148384,2.691331252387532
MDA-MB-453,104842,-3.389911854354977,-3.0210029991501353
SNU-81,49793307,-4.215972202332142,-3.0932628628954935
A4/Fukuda,54618164,3.3817410387547575,3.7860321323568824
NCI-H2171,26596,-1.7584148860978708,-2.3515759541452046
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155,0.9391593475210785
ONS-76,676352,2.5309673509494535,2.1617027410054233
SCC-9,4378219,1.9931327421657885,2.6907974495898914
CAL-51,613753,3.3238399640193177,3.0686663259554905
Panc 04.03,49867926,4.237506736984018,4.221909869766716
NCI-H292,salermide-PLX-4032 (12-1 mol-mol),5.437042614590839,4.9035018725923
NCI-H727,selumetinib-navitoclax (8-1 mol-mol),-2.0021206675207885,1.745335865761112
MSTO-211H,3543504,4.118160915221066,4.524219449661448
NCI-H460,6252,1.4342703041264255,1.0390773043752615
OVISE,navitoclax-gemcitabine (1-1 mol-mol),-0.8912301406187855,-0.9406620573794926
NCI-H727,3825829,4.725008182252989,3.974002873044336
OPM-2,119182,-0.8289962289267476,-2.4396446563301355
LoVo,54613361,-1.4267659732177436,-0.23726467351410108
HSC-4,navitoclax-PLX-4032 (1-1 mol-mol),2.8756909366575023,1.9441475212113175
A4/Fukuda,126941,-4.18863393868508,-2.770811209852708
NCI-H2171,SNX-2112-bortezomib (250-1 mol-mol),-3.076194221484089,-1.6936443684750588
NCI-H460,136227924,3.925006850615035,2.9839743518922126
NCI-H727,3136844,6.195563862298742,4.385678616028028
MDA-MB-453,136227924,2.410345496671846,2.802672486050266
SNU-61,51037431,3.7250627983577513,3.208919173739552
SNU-61,3384730,2.3184170398790154,2.06135479504574
Panc 04.03,24753719,4.39873379823384,4.43152704674226
SNU-81,5978,-4.726956734092058,-1.4671314807483484
SNU-61,9967941,2.1294940171884043,3.4347427050945702
SNU-81,selumetinib-piperlongumine (8-1 mol-mol),-0.9226947877098262,2.3005472858533498
ONS-76,5470400,1.68546701619173,0.1333659030235363
JM-1,52912189,-1.1165299764243126,0.06066087177383954
NOMO-1,52947716,-3.339302012338735,-2.5145826949443784
JM-1,26596,-2.491901301923365,-2.652347005841627
NCI-H661,445455,5.2176896422295025,4.798785666431786
SBC-5,216468,3.330480208625043,2.9259665107310813
NCI-H292,5311,1.7806932533505695,1.5485592119980822
Panc 04.03,9935249,3.3873751996630177,3.2897769054635795
NCI-H2009,doxorubicin-navitoclax (2-1 mol-mol),-0.756296183538871,-0.7391574216976521
CA46,25262965,-5.196703638661911,-2.7434085895690465
NCI-H460,11626560,2.497647926194901,1.8022595413982898
CAL-51,54686904,4.850424917483252,3.353897736657355
KYSE-70,vorinostat-navitoclax (4-1 mol-mol),1.6518262185005994,0.7993525490015763
NCI-H2171,6918328,-2.9240080597430813,-0.48347547213152053
CAL-51,3825829,3.9510679995615257,4.047868554949875
SNU-61,65064,4.771880102821997,4.60039248078025
CAL-51,124202324,2.033990287468598,2.623204599263837
NCI-H1623,11494412,1.2552972437851018,1.957172323382988
RCM-1 [Human rectal adenocarcinoma],67156097,4.4289502620646415,-0.03980535635064077
JM-1,135398516,1.8505892369708832,1.3446379064557217
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708,3.775320095818577
HSC-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.591026933435327,2.572676121679795
LoVo,1641662,3.111662868893329,3.3908089774455594
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142,1.285887994229454
HCC1143,24856436,0.4052757500096688,0.6048693275422469
YAPC,73707398,1.1307339717786768,1.57122939370783
FU-OV-1,24771867,2.3744516407985485,2.6182059399787887
NCI-H727,piperlongumine-MST-312 (1-1 mol-mol),1.950169428347768,1.8841889917070558
SNU-61,2749,1.958913212534665,1.6442937304178893
CAL-51,20959075,-3.1196535578382987,-2.5960960793884755
A-673,6918878,1.2344260030899934,1.6861159483347707
LOU-NH91,73707398,1.1540810865513749,1.3894987634279792
NCI-H2171,107985,-3.896160678794096,-3.670649005821341
KYSE-70,12003241,-1.4257688129039825,-1.2439980823052998
MDA-MB-453,10296883,4.2989687155614735,3.747202260360205
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266,2.309820700932351
A4/Fukuda,crizotinib-PLX-4032 (2-1 mol-mol),-0.0418615820710858,1.1443747500115675
NCI-H727,selumetinib-JQ-1 (4-1 mol-mol),-0.7236905390047186,1.1773580460011084
NCI-H661,4259181,-1.4326329693308524,-0.09204905929138908
JM-1,salermide-PLX-4032 (12-1 mol-mol),5.264877641383212,4.456435955103692
A4/Fukuda,JQ-1-MK-0752 (1-1 mol-mol),-0.933197038878086,0.7301424379504243
SCC-9,25183872,-1.5689686359020558,-0.7038227744518928
NCI-H727,6438394,3.7246032061112553,1.2750772195264297
NCI-H1623,selumetinib-navitoclax (8-1 mol-mol),2.5972184822142004,1.892856457673668
Panc 04.03,9911463,4.4327726522455855,3.8419950009782293
ONS-76,2733487,6.718347537986806,5.876641871188516
MDA-MB-453,25062766,1.9156877669914651,2.322079308979899
NCI-H1623,36314,1.7259264714185265,-1.0016186260993423
SCC-9,selumetinib-piperlongumine (8-1 mol-mol),4.590174164336879,3.1123467632454878
MDA-MB-453,11234052,3.3366002038414493,3.70674524560324
NCI-H661,54143018,-0.94518686271758,0.47625844323638317
NOMO-1,72376,-3.881755374018637,-3.458640990710194
NCI-H1623,104842,-3.8091356035642434,-2.1921346303869464
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.4544813321614867
JM-1,71466445,1.831003524042788,2.3813444683714575
EFO-27,49766530,-2.657964166176686,-0.6210319293463291
NCI-H661,753704,5.093119647973415,4.994543980270386
OPM-2,11175137,1.4890519960627426,1.956356780865373
G-401,carboplatin-etoposide (40-17 mol-mol),0.9786260223785996,1.2045424200005939
A4/Fukuda,5746,-1.1009867615741116,0.06830805467281321
SNU-449,44489675,3.6193477306301927,4.1681025621766885
NCI-H661,12001922,2.629031416850278,1.8985239371719018
DMS 273,11640390,3.3173332454053717,2.683980952150013
SNU-449,4259181,0.6587440570439733,0.49116875619230704
EFO-27,24964624,2.939505532014586,2.5595905541565913
LoVo,4096211,0.5868958804653562,2.103282519588209
A2780,2841722,4.258280317113099,3.9511693024430303
CAL-51,24771867,-0.5018492111736887,2.174081871410176
G-401,46907787,-0.0293884143124787,1.468743427043285
JM-1,24772860,-4.004711239665373,-2.5870265907288372
MDA-MB-453,71680916,4.8348560692055695,4.663402833156525
JM-1,11507802,0.223918960474334,0.44439963177509173
A-673,462382,-0.040658639847304,0.7297526031497286
NCI-H661,216345,4.176204855685743,4.003451708279786
BxPC-3,9907093,4.5613416209155755,4.2952549724575935
HSC-4,216468,2.5769925673594227,3.187765896209296
NOMO-1,60700,-1.0021705320646457,-1.7509980552465292
YAPC,11455910,1.8317787914833017,1.150890093564675
SNU-449,11175137,3.183352091664916,2.8508386605335745
A2780,2113511,4.588817591987419,5.397020872153499
NCI-H146,613753,2.6314812615131222,3.112251767464217
SNU-81,10231331,-2.370371712203436,0.8588390089001794
RCM-1 [Human rectal adenocarcinoma],387447,-5.081876711684109,-3.8391198486344917
NCI-H661,168313016,5.326553105852446,4.889207245821698
CAL-51,25126798,3.926975819986009,3.8680817566902572
Panc 04.03,1716436,3.048029385411991,3.2039370521118102
EFO-27,11625818,4.615590718074381,4.476574777656571
A-498,44495899,4.223152889477574,3.515547307448535
A2780,3825829,2.5427924978442467,3.541403269727701
RCM-1 [Human rectal adenocarcinoma],675434,4.441344472745021,4.393967056330964
NCI-H1623,2858523,3.2758661507497115,3.055615164201693
A-673,49793307,-5.444897343264971,-3.685146756633571
MDA-MB-453,9935249,2.561550169446695,2.976502768457327
MSTO-211H,navitoclax-gemcitabine (1-1 mol-mol),0.5051490037024954,-1.1663286529216217
LXF 289,3062316,-3.851151802003845,1.2036972051363626
MDA-MB-157,2874250,4.29768331905581,3.8950682684268383
HSC-4,4521392,4.744801099229743,4.2274406388254695
EFO-27,23725625,5.484413053531449,5.15044587716861
MDA-MB-157,navitoclax-MST-312 (1-1 mol-mol),-3.237142139083902,0.8369873831132479
NCI-H2009,5460769,1.3316086312624285,3.078160849079359
LOU-NH91,654092,0.641619390442256,-0.1466839773216341
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,4.087612888133789
SNU-449,9887053,4.621717664819675,4.254184463452558
LOU-NH91,54618164,4.244208934703923,4.189195723528492
MDA-MB-157,24951314,0.2652102931153908,1.570741190918081
SCC-9,4261,1.568262163612179,1.9195765235540359
CAL-51,262093,2.862241975448649,3.0242120336580207
DMS 273,100016,5.677769516399485,5.18088890339398
A2780,44137675,1.3252793631369038,3.4926518931965553
DMS 273,71466578,4.37241227128359,3.0680437455560265
A4/Fukuda,1566236,1.4071330472860828,1.7649068401129744
SNU-61,navitoclax-gemcitabine (1-1 mol-mol),2.2784859242088062,-1.3350496112668295
NCI-H2171,25102847,1.8897460049958847,2.200440417172785
MDA-MB-453,60700,-1.6006047446684224,-0.7826016849837836
A-498,11404337,2.25955984981305,-0.011044996392160883
NCI-H2171,10302451,3.986494326049399,3.283378406314831
YAPC,10184653,0.1561987566095487,1.256052444086514
NCI-H661,9967941,4.170813203069281,3.7368641673296707
BT-549,24901704,3.7794480452342,3.6004090318390416
A2780,3038522,3.0311112283818864,2.8856024716864335
NCI-H522,67291369,2.1338291538877514,2.160544864078277
HSC-4,753704,4.983094182740762,5.019705048046239
G-401,44607530,1.0217800111575093,1.5991215887396095
OPM-2,19582717,1.9960397366001383,2.977867840460495
NCI-H2009,104741,-5.941055510927969,3.757403031133074
OVISE,9936388,2.6758567859836826,-0.582415027322167
NCI-H1623,11178236,-2.2917099582879144,-2.7827903100064475
CAL-51,5746,-0.6872762444946757,1.040283563482301
JM-1,3503,1.2397121319894746,1.6903018194274049
LoVo,26596,-4.043483931746528,-0.8986116106714924
ONS-76,44486219,4.293725912166159,4.3892338113455995
SNU-81,vorinostat-navitoclax (4-1 mol-mol),1.2655278546702862,1.087365778819007
NCI-H460,24964624,3.5490884182562565,2.59880704370553
A2780,448949,1.9574027813966313,1.6721839430449144
G-401,6918878,1.5849207586223315,1.5508273391529448
EFO-27,123631,3.2705036111065957,2.102904981712783
NCI-H460,71466380,4.4879606530616725,4.461949019902969
NCI-H146,126941,0.4535750644224253,-2.3664187786951576
SCC-9,JQ-1-vorinostat (2-1 mol-mol),0.3641375851810363,1.0698463157213027
JM-1,25062766,0.7257031347370316,1.5443536521494046
BxPC-3,44819697,-0.5900667288519075,-0.3426173358219687
DMS 273,49766530,-1.3487399530522592,-1.7612739869996075
G-401,6918837,-4.518653911968971,-3.1822036419320443
FTC-133,25195348,4.144583358862902,3.0651545748914155
BT-549,5281321,-3.0037540013163433,-0.8469380049076024
Panc 04.03,44241473,4.425072929332434,4.852549795686093
YAPC,5278396,4.010893890545004,3.6412541731624897
ONS-76,5287620,-2.6985711183159573,-2.098599329440784
SBC-5,11612883,3.4240653421197877,2.8310225852611435
SNU-81,doxorubicin-navitoclax (2-1 mol-mol),-2.5154002454653277,-0.8428664799193232
A-673,tretinoin-navitoclax (4-1 mol-mol),2.75284038442573,1.3901179209551275
SBC-5,219104,3.745930190487188,3.6656327510334306
SNU-61,176870,2.732721688120773,2.376249138881604
CAL-51,36314,1.3238047725901672,-2.0228363875269513
SNU-81,carboplatin-UNC0638 (2-1 mol-mol),2.7350455316868416,3.2308456852617473
DMS 273,71751553,4.31191978803821,3.8888348628194684
NCI-H2171,400769,-1.2297634018381476,-0.6974350476769652
MSTO-211H,salermide-PLX-4032 (12-1 mol-mol),5.150950565200891,4.754239640371372
NCI-H727,71304818,2.536891878991305,2.4035418928825827
G-401,JQ-1-carboplatin (1-1 mol-mol),0.2473733960236567,1.4309941881045019
CA46,135398516,0.7680931483587626,1.1066942042474954
MSTO-211H,100016,4.243846732059744,6.219529005180264
NCI-H522,selumetinib-MK-2206 (8-1 mol-mol),3.9815155524182337,2.143634540702831
NCI-H2171,carboplatin-UNC0638 (2-1 mol-mol),3.641096967492651,3.152789549883066
SW1463,25183872,-1.2446986167158185,-0.49994179453211046
EFO-27,122327,4.8281000238128,4.832088993134778
MDA-MB-157,11222830,0.6776847499576403,1.7216765949715531
NCI-H2009,25150857,2.992056775880064,2.5487700637642168
NOMO-1,216468,1.212023833941809,0.8133559257306664
JM-1,11152667,-1.617053586455527,-1.845069233215591
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,1.7273901368062772
A-673,25126798,3.569829443135804,3.600489196841853
DMS 273,148198,-4.27913692458833,-3.4790442158565
LXF 289,selumetinib-tretinoin (2-1 mol-mol),2.6390813886621203,3.2552176212687174
LXF 289,5329102,1.6667075021580833,2.2419261276481635
HSC-4,53495165,1.6708694504220498,0.8851944575023907
CAL-51,969516,2.948027689121256,2.7257645359821407
NCI-H661,5746,2.052034109930783,1.1246703286247675
A4/Fukuda,9967941,2.4411204768161983,3.4041670939809396
MDA-MB-157,89928392,-0.9485630303355488,1.4627953752153533
NCI-H460,12001922,2.3574763109101253,2.0350503028022704
SNU-81,327653,3.5323829695882267,3.071559021242
NCI-H661,124202324,2.0891928025286943,2.5682908502360213
BxPC-3,42642645,0.6313588777440967,1.0625604895489398
NCI-H2009,24772860,-3.0306018162615342,-1.7338794265301452
A-673,6610355,3.502413574243847,4.3991595410953686
SNU-61,57330099,3.603690788773508,4.163982485714908
NCI-H522,2749,2.969505400884835,1.5051370645393798
NCI-H661,57519531,4.09429699672183,2.457113604330721
MSTO-211H,2126,4.496176254172968,4.630245866952542
KMRC-1,10410894,3.4812991400934585,3.201676151506132
EFO-27,44237094,3.2066908421034332,2.582652761548994
LoVo,16725315,3.2447595903434627,4.19007932801272
RCM-1 [Human rectal adenocarcinoma],5291,3.9145533177301552,3.628293508462114
MDA-MB-453,2842253,6.29942483998937,5.229334053873638
A-498,135875424,4.978423270774445,4.327443438718139
Panc 04.03,9903786,4.611047286699123,2.754145584027307
SCC-9,54639665,4.512228528266098,3.1707373847141667
JM-1,24856436,-2.211637583066154,-0.6258837376289348
A4/Fukuda,5311037,4.577970147235868,2.6546009539978197
NCI-H522,66577038,3.0388231599187017,2.884271855378186
BT-549,25154868,5.818557590138654,4.457975216440152
KYSE-70,6505803,-1.025033993677824,-0.6972890797696923
LXF 289,11396600,4.152956454399736,3.5793210672021645
SNU-61,navitoclax-MST-312 (1-1 mol-mol),3.0006796747399394,0.7540169580311503
SBC-5,126941,-0.8684780314881991,-2.390016206207365
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667,-0.310404797866852
OPM-2,9933475,-1.3895511853659537,1.7205393726128102
YAPC,11214940,1.707662344700129,1.919825579067348
EFO-27,4259181,1.8274060730963064,0.3738314789622413
NCI-H460,446155,3.79922347841428,2.880323530480267
NCI-H1623,carboplatin-etoposide (40-17 mol-mol),1.5186330340389391,2.83983123196732
A4/Fukuda,3634881,2.7004024711225596,2.8589902968981313
NCI-H661,1566236,3.2299922345410006,2.603240579117714
MDA-MB-157,6450551,1.4635370045174534,2.616185863709835
NCI-H146,vorinostat-carboplatin (1-1 mol-mol),1.5707903367584717,2.6291757366223396
BT-549,6918328,0.6487197523295809,0.6031298846325698
NCI-H727,11175137,3.085433657363398,2.560837243691598
NCI-H460,3854666,3.1385110084048065,2.263716025554261
LoVo,44241473,4.10673515965005,4.803868127571613
G-401,10074640,2.6430496317806957,2.9410265058064793
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264,1.1110852294003524
SBC-5,2126,4.14698296213378,4.457551165757396
ONS-76,3503,2.5109588721491938,2.3587643985209104
SNU-61,5470400,-1.745187092277687,-0.7828762685890331
NCI-H661,36314,-4.592945905020296,-1.9997862283448036
JM-1,451668,-4.255879556837535,-0.6476481319359856
NCI-H1623,5978,-1.0298747552622975,-1.5173226376539974
DMS 273,136227924,2.538513279360657,2.5190463931629874
SBC-5,selumetinib-navitoclax (8-1 mol-mol),4.706526584593769,1.997195100791834
A4/Fukuda,6918638,-1.9449982869755031,-0.34444489758528585
HCC1143,16038120,0.5509172721588973,1.2017435874234301
BxPC-3,44185566,1.4327209520395616,2.5819791796873113
ONS-76,2858523,2.9452513130208975,3.1281254615908263
NOMO-1,46191454,0.6880471005756411,0.3052068684656126
NCI-H292,216239,2.858200088172953,2.551870476657886
DMS 273,11178236,-4.200581603954177,-3.3174940932631607
OPM-2,10074640,2.1693178922200813,2.721405368829311
ONS-76,5566,3.1751487050742804,2.9778514237685076
BxPC-3,10385095,1.8732992891777025,1.5171561437465977
A-673,crizotinib-PLX-4032 (2-1 mol-mol),0.1365223010669094,1.4741347870203965
MDA-MB-453,675434,4.221225816741011,4.243790545285012
SCC-9,navitoclax-pluripotin (1-1 mol-mol),-0.0123473768643266,-0.7358827618935995
CA46,9825149,2.310107059064329,1.5727772393499262
MDA-MB-453,12003241,-0.9610578830621354,-0.44220012364920036
A-673,613753,2.7839803669097134,2.906520037764704
A4/Fukuda,erlotinib-PLX-4032 (2-1 mol-mol),1.6869811830916113,2.9095208855365455
NCI-H460,3062316,3.704520183651484,1.134188800295777
CA46,carboplatin-etoposide (40-17 mol-mol),0.8336753262316364,0.27739136102377215
A2780,11427553,1.40474333506403,2.1919114070818857
CAL-51,5287620,-2.338247824560234,-2.009717080339385
KMRC-1,11640390,3.901360175468555,3.401960168541064
EFO-27,16219061,3.8100949831762296,3.3895918188493788
A2780,31703,-4.480868228272363,-1.5006909948522158
Panc 04.03,135440466,2.8713092707831116,2.3033092341544608
SCC-9,16065773,3.2014379284662864,2.518839739511264
SNU-449,148198,-4.785889264279132,-3.4301346393838816
OPM-2,2949965,2.476405976050771,2.253213323337161
ONS-76,44489367,4.840464292002439,4.731593003416885
NCI-H146,navitoclax-piperlongumine (1-1 mol-mol),-3.055255187933708,0.6958759409170845
NCI-H522,vorinostat-navitoclax (4-1 mol-mol),1.5182214624562833,0.8181663578716993
MDA-MB-453,135411,0.2962177293375728,0.9449526336664812
DMS 273,123631,3.074313122611396,2.1328773964239183
CA46,19582717,2.2741322004032716,2.8780444136325944
A2780,3676137,3.624330330130062,4.366153779254108
BxPC-3,11964036,0.7144816609502266,1.4623850863465773
G-401,71466445,3.182548969694367,3.1317497556204086
YAPC,navitoclax-piperlongumine (1-1 mol-mol),3.667001325655349,1.7104739714362163
A-673,49766530,-3.0139632371957705,-1.3234279197696452
JM-1,JQ-1-UNC0638 (2-1 mol-mol),-2.068621419812743,0.02917466387644017
SNU-449,11609586,3.2368097564340546,2.971003515561872
G-401,46199207,3.084348249789013,2.9356298753180896
A2780,11612883,1.284093973133662,2.244730087592876
KMRC-1,2708,5.927603665606935,4.469608639848184
EFO-27,SNX-2112-bortezomib (250-1 mol-mol),1.0533662240531856,-1.050515713087588
DMS 273,135875424,3.231864587804135,3.2071416047379437
Panc 04.03,2749,3.2242301239764184,2.1367601033498915
G-401,675434,4.2282934242266235,4.552668162851949
G-401,72734382,4.843742106159305,4.078707096344329
SNU-81,72376,-4.141271855112041,-2.762796307568413
LXF 289,208908,1.975389940693236,1.8512401488666976
EFO-27,11175137,3.0704812268942296,2.574354682939561
HCC1143,16736978,2.2332113551174415,2.026145714750376
LoVo,24821094,2.523288695365458,2.4784360655056763
A4/Fukuda,10322450,2.3588003127389277,3.300905119535262
EFO-27,11152667,1.7712187839859168,-0.28986009625172815
A2780,6918736,-1.942572837589071,-1.617829212660838
FU-OV-1,285033,0.0377877938075082,-1.6820390246695058
KYSE-70,11626560,2.028097573065789,1.8532365910004336
CAL-51,400769,-0.1641693790968544,-0.4129875178228852
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323,0.946279726839666
CA46,11507802,0.4399982092061076,0.6064125441239429
SBC-5,tretinoin-navitoclax (4-1 mol-mol),3.0928632602038575,2.5353985989417644
SNU-61,44607531,1.8838139804325664,1.0481067339747485
MDA-MB-157,135984461,1.8807242402896556,3.867187483785933
YAPC,68056272,3.685228443179594,4.055079375328444
KMRC-1,3025986,0.2913922358554936,-0.9929714221888046
G-401,11656518,0.9589948119457968,1.1413775276095246
CAL-51,25262965,-2.904292987251918,-1.7630461009019254
NCI-H727,31703,0.5895859224805655,-0.9156859591701931
FTC-133,3025986,2.6500554516402515,-0.8211397430052979
OPM-2,11404337,-1.9830798838769188,-0.9572860864646602
NOMO-1,54649381,4.1030759428324455,3.0869403042076136
OPM-2,45279963,2.6394525890823335,2.932273198951041
G-401,54619267,3.6389956680017495,3.897275694085952
SCC-9,613753,3.4469207135602904,3.355924377755815
FTC-133,3825829,4.910712910753543,4.190777492078249
NCI-H727,6918328,2.020699769993763,-0.025389369440542285
JM-1,3384730,1.783412153965406,1.4995563768351703
OPM-2,5335621,3.731372916139424,4.14879358763761
NCI-H727,46199207,3.049846279584177,2.9778134129325116
NCI-H2009,100016,6.24887408197215,6.173522143805143
OPM-2,2742550,2.8639715022070713,3.1743527510274587
A-673,56649450,2.339222019664337,3.110539400648952
LoVo,135928012,4.12079355273469,4.126871318707139
SNU-449,46215462,1.6240369462021291,2.0619610946615974
EFO-27,10385095,0.896347771716858,1.3692825749979054
BT-549,6917907,-5.828237871920148,-5.3418871618289065
A-673,262093,2.1198375376891705,2.269033910829705
SCC-9,crizotinib-PLX-4032 (2-1 mol-mol),2.600413424515517,2.0262627038138694
G-401,2871966,-1.4998546935779766,0.15155429648984062
NCI-H460,6610355,4.949206869720499,4.414343294581537
NCI-H292,56946209,-3.439063202171596,-3.884450058210618
MDA-MB-453,46907787,-0.524764523127372,1.8832284380855628
NCI-H661,9935249,3.279757521015836,3.230319479522269
Panc 04.03,5311281,5.064761813982229,2.4687862182130904
EFO-27,54765302,4.904683382842226,4.166255696390038
OVISE,24964624,2.347879134584806,2.5352633092515378
MSTO-211H,6918878,2.3677965777112653,3.064787916313392
KMRC-1,1641662,3.91383049133015,3.421447453528129
NOMO-1,3025944,3.969971169930392,3.979496587572316
MDA-MB-453,10322450,5.853812101119735,3.3843753880649
A-498,675434,6.195396019607132,4.723397102459536
JM-1,16736978,2.465148690257062,0.7238077412124653
HCC1143,400769,-0.895432113907658,-0.4453291167502037
JM-1,5328940,0.4457439228433418,0.9372732972982024
NCI-H522,156422,4.012108454967305,3.5551512981717583
DMS 273,135999136,4.8097980755766505,2.662489720196847
A2780,44607530,1.3884091000724437,1.6589016616608379
KMRC-1,10302451,2.629362111325239,2.646905318278735
SNU-61,6918736,-1.624439463390885,-1.8405872263939012
BT-549,135999136,1.9798336492119424,4.052192186075001
NCI-H1623,9926054,1.7409203229588674,2.0153636431036865
JM-1,16722836,0.523497579231149,0.9385110882924644
MSTO-211H,613753,2.697490548990984,3.3260836331117423
NOMO-1,16725315,4.952538276899841,3.6030046163716234
KMRC-1,16736978,2.1404631421072975,1.8798989340749648
A-498,123631,3.2458168084526564,2.6285366538523633
MDA-MB-157,decitabine-carboplatin (1-1 mol-mol),3.837030982901149,4.152035384494232
NCI-H1623,24951314,1.0133274480783143,1.6349729317296087
NCI-H661,11228183,4.275001578251326,2.429144790199026
FTC-133,5479543,4.4305420476204205,3.584405191786871
NCI-H292,136227924,3.1886204590132654,2.9858159911564077
A2780,6184667,2.4201329833494705,2.8618173719413984
SCC-9,5278396,3.934746070394729,3.6504663725107376
OPM-2,5743,-3.6176009576451142,-1.0726930262076986
DMS 273,66577038,3.0260629384717443,2.710710395298088
SBC-5,151289,0.3068057764327633,1.4767719512139177
A4/Fukuda,44491742,3.3943913096556444,3.867510965435107
MDA-MB-453,135928012,3.1518499848728534,3.7240610305318462
A-673,2828334,5.945698490544337,5.908327958085028
OVISE,44185566,3.1371413376940724,2.445113169980312
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849,-0.11938660863199779
KYSE-70,5460769,2.831605222646697,2.318526932754435
EFO-27,60700,0.0275300045157078,0.07077923048425688
SNU-449,2871966,0.0642629453363792,0.6203929096501354
A-498,135411,0.9450284346401692,1.185725350549172
CAL-51,151289,0.6583498849401344,1.3833136608894834
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.94630433755286
NCI-H292,54454,1.5363763322568371,2.796610849223435
MDA-MB-453,984333,1.2010378495759917,0.357178067715106
A2780,1242560,2.8030380184252346,3.2704491829012743
G-401,11625818,3.256149300060542,3.749515735039436
EFO-27,2729026,3.178460421270277,2.7696593217311456
CAL-51,54454,2.240351559744082,2.6823500989991755
SNU-81,5470400,-5.232383325772668,-0.7866140591144211
JM-1,selumetinib-tretinoin (2-1 mol-mol),2.58796154707147,2.604989130724556
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821,-1.0224844554309085
LoVo,51037431,2.9518330914759043,3.0819146642063457
NCI-H1623,57519531,2.253772853853667,2.7220339199585895
BxPC-3,6918837,-2.8801990347910045,-2.5887106538023743
SNU-81,452548,-0.1759999006209261,-0.394362487391159
BT-549,327653,2.9888914918454854,3.0860364073350173
CA46,46199207,1.8825158344658808,2.631923260034256
MDA-MB-157,10410894,1.6628456414259642,3.1846131807071676
SCC-9,66577038,2.999012470787333,3.0527609965463496
NOMO-1,6918878,0.4522523514749809,0.508767677273379
SNU-61,5281321,-1.743716860572046,-0.9541435599134382
SBC-5,decitabine-navitoclax (2-1 mol-mol),2.675632395894592,1.8971378590632235
HCC1143,9840324,5.44269474449066,5.953788544201774
CA46,11234052,2.4794836109026077,2.7937639375735315
CA46,11609586,1.0102139081655188,1.3201211181724761
NCI-H460,10385095,2.2920897819597896,1.343765979731126
BT-549,11625818,5.0921701677816875,4.497284583231995
SW1463,400769,-0.5224692496950973,-0.6472980577317793
Panc 04.03,10113978,5.097338218314276,3.6211923689788055
JM-1,9907093,3.962832886035932,3.330403423789205
CAL-51,23582824,1.0413279539794644,0.5979886302317542
Panc 04.03,135398738,4.347297256699442,4.403465026507883
G-401,3038522,2.1905688095022215,2.9759385658143485
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648,2.6053640300220913
NCI-H146,4261,-1.8051480987265105,1.1632530836713637
DMS 273,2729026,2.67706862921606,2.4197149215319915
SNU-81,1750826,0.9975547695410114,-1.4445756947374984
CA46,168313200,1.9493207867170304,2.408412128116113
OVISE,vorinostat-carboplatin (1-1 mol-mol),3.460247929578718,3.331750828066431
A2780,57519531,1.3251208810116586,2.1934573633614853
OPM-2,navitoclax-sorafenib (1-1 mol-mol),1.274845961219173,0.3499894560202977
A4/Fukuda,11717001,3.8123333180630103,3.7412978656135722
LOU-NH91,3634881,3.4323223488487593,3.3325857775571652
JM-1,11485656,1.6613246077420758,1.6180256303046894
SNU-61,107985,-3.1587785808489297,-3.566735291365392
FTC-133,2729026,3.353273516564875,2.7521443634742067
ONS-76,159324,2.5690437216419677,2.842467728367571
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,1.971070442734977
G-401,9927531,4.9703255494446035,4.408517452435456
LOU-NH91,25105715,3.511519280721543,3.4235654112703235
SNU-61,15953870,3.2687219409332657,3.2814634338395434
NCI-H2009,navitoclax-gemcitabine (1-1 mol-mol),0.4354090663504973,-1.2940814112760552
EFO-27,24951314,0.9989426715403756,1.5641812945733418
MSTO-211H,5311,0.950405781568164,1.5472054974078773
A-673,9444,4.054770941664931,3.987424633245183
MDA-MB-453,6852167,1.219966928776707,2.5802102052624813
DMS 273,3384730,2.794672653243152,1.7942726990094713
NCI-H522,24964624,3.0091798278143003,2.1016680565616146
DMS 273,6918878,0.6913807013381441,1.3873006266145396
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,3.5099436961767903
CAL-51,5311,1.4183219405835503,1.700206065797025
SNU-449,3136844,4.333259755823753,4.481799437430555
SNU-61,10074640,3.0465009012673923,2.9800339862081744
NCI-H292,5738263,3.605646843776872,3.552508659473366
NCI-H2009,135440466,0.1778924686528867,2.2300193024613417
SBC-5,387447,-4.42204631831661,-3.8721480069266967
HSC-4,60700,-2.3901041148359,-0.5174542645367928
Panc 04.03,navitoclax-PLX-4032 (1-1 mol-mol),3.364460655624257,2.3132310758878396
BxPC-3,322968,4.585795478380971,3.933719997201863
CA46,24821094,1.9467424475066963,2.4037011644604807
SNU-449,5282054,4.57557530009064,3.9324853919206872
CAL-51,11625818,4.1129054868405905,4.21388952864963
A2780,16038120,0.4203115446628392,0.7206480117798789
MDA-MB-453,44484893,4.218904183145372,3.781572258721661
YAPC,969516,2.7207948170212894,3.0419021245502544
SCC-9,6914657,-2.6898440352771704,-3.9460485860556713
BT-549,156414,4.402880659642667,1.6584030775851728
A2780,10410894,2.69442494781606,3.120754883495515
HSC-4,1566236,1.9723291328750472,2.705841514940392
CAL-51,53232,2.8018516258833395,2.8226997175772834
NCI-H522,73707371,4.918377506073214,4.3996341172091675
FTC-133,2858523,3.137647378022636,2.9757517215435105
NCI-H146,2949965,2.1998257096859235,2.631715871463227
A2780,5291,3.6974106280730767,3.581880133181927
A-673,11317348,1.5484644948233677,1.6972245475810832
CA46,5284616,-8.167802056045408,0.22406835031156447
FU-OV-1,9840324,7.491199941931371,5.860442556621622
NCI-H292,17759555,3.476208496969499,3.726626175702876
NCI-H2009,6918837,-3.78935135271195,-2.4083568894840606
NCI-H460,216345,3.827300936034388,3.9489890799253597
BxPC-3,54143018,-0.804639103071218,0.7528688402494708
SNU-449,11612883,3.957753067546404,3.1524640396393306
DMS 273,49867930,4.404291499076759,3.3505832766892842
FTC-133,15953870,4.441911294632587,3.5428269250166227
NCI-H522,11612883,3.3366707819202666,2.5226128475616805
A2780,9444,3.815396075990075,3.9900036073670946
NCI-H460,54619267,4.901891634717457,4.056159748841891
SNU-449,salermide-PLX-4032 (12-1 mol-mol),5.474676464487576,4.98797909914748
LXF 289,doxorubicin-navitoclax (2-1 mol-mol),0.6583204224583108,-1.043384676834664
A4/Fukuda,4521392,3.820585335578038,4.138860385109754
CA46,5328940,1.1838617633473132,0.8459122200395492
NCI-H460,452548,0.6919333948360032,0.3765111516311773
YAPC,25126798,3.983335704988987,3.869124396990376
SNU-449,322968,4.603056923598163,4.003663909008163
SNU-61,54618164,4.021673833793196,3.9693186994229297
NCI-H661,400769,-1.492892337104586,-0.6280810362421994
G-401,24964624,1.4880998129973728,2.0361350618531047
RCM-1 [Human rectal adenocarcinoma],702558,5.773616649362023,5.418940376231962
OVISE,2945648,2.8352179600513367,3.1008510587323195
FU-OV-1,JQ-1-UNC0638 (2-1 mol-mol),1.6948403130228156,1.610567044381055
BxPC-3,984333,0.8836461068661873,1.024694147600561
NCI-H1623,42642645,0.9313727170286358,0.9397961069504244
BxPC-3,71466445,4.819923879864087,4.404652309005491
MSTO-211H,126941,-2.2791548116201987,-2.9294085671056305
MSTO-211H,20959075,-3.222615813929693,-2.48348476817952
BxPC-3,16741245,5.048799679028713,3.924095955233598
OVISE,12001922,2.261742632923514,1.9955652509602413
NCI-H2171,135440466,1.9220793929810305,2.2716159182743727
BT-549,119182,-0.6766164524597643,-0.21176658396214054
KMRC-1,65064,5.386842832596526,4.966502527290267
ONS-76,16725315,4.104726960292652,4.1151542713184845
ONS-76,6505803,1.3937943977095182,-0.5723090636740359
MDA-MB-453,JQ-1-navitoclax (2-1 mol-mol),-0.5308919352690735,0.46999156108510975
FU-OV-1,25062766,2.359728819743937,2.1246260810824884
KMRC-1,5566,3.18269246163038,2.8033023226901896
NCI-H460,6438330,3.783082395235063,2.2073000935949962
CAL-51,135440466,2.9511327404143755,2.369490530666264
DMS 273,23582824,1.3511796414129456,0.8986290894817516
CAL-51,56946209,-4.496983035262223,-3.950716253954212
OVISE,176870,4.342841287056181,3.029206984064981
KMRC-1,11494412,2.978505743964039,1.1268468405519103
A4/Fukuda,54454,2.014078017992857,2.4853044660558914
MDA-MB-453,2733526,2.894784526555574,3.4268369581698064
HSC-4,11625818,4.485436042124793,4.387704903539271
NCI-H727,2733487,6.440431233061491,6.0608911826121075
HSC-4,54618771,2.9865797342969564,1.302982336977888
CAL-51,12003241,-1.2189714227076325,-0.9011350398403166
A4/Fukuda,52912189,-0.8285591911559074,0.42947102979390267
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.244824619357315
CAL-51,6610355,4.388066889778601,4.443651469312242
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448,0.2331474440995937
NCI-H1623,56649450,-0.2540238687607088,3.3312088935905013
A4/Fukuda,9444,3.1818692272898423,3.7713387172842023
NCI-H2171,55508,1.786136919471965,3.1532276416976384
NCI-H522,9840324,6.2981118504366735,5.663419436755628
DMS 273,409805,3.6932334728164826,3.9857008982388185
SNU-81,selumetinib-UNC0638 (4-1 mol-mol),-1.1313432157917445,2.43665228925392
NCI-H727,16722836,1.5817712487099789,1.4906549705100383
HSC-4,selumetinib-decitabine (4-1 mol-mol),5.3885261906416275,3.7516797808651488
G-401,5281672,4.259815588040996,4.313361432075593
FTC-133,4917,3.819256860929221,2.981135145734828
YAPC,selumetinib-UNC0638 (4-1 mol-mol),2.613021216315863,2.9235989362963917
JM-1,10113978,2.290370569955518,2.3189642550404734
RCM-1 [Human rectal adenocarcinoma],6917907,-5.490132832786946,-4.817733123146062
EFO-27,675434,4.38679148408465,4.563993754700984
SNU-81,5460769,-2.0941921209529575,2.353406139666335
BxPC-3,5282054,3.885649252328735,3.7539701473631792
OVISE,6184667,4.390472676016808,3.1372830985920173
G-401,16659841,2.2879294183156396,3.2176552340009947
HSC-4,19582717,4.479728463380205,4.389658902166467
KYSE-70,1750826,1.0050628158627442,-0.9475407145795909
LOU-NH91,135659046,3.4412725013745336,3.9152336426782375
HSC-4,11396600,3.0766488056466104,3.7312920941101657
KMRC-1,11964036,1.816670768699429,1.3130851371585845
MDA-MB-157,decitabine-navitoclax (2-1 mol-mol),-2.3403643839095607,1.987707123573675
HCC1143,54618771,1.714955024233068,1.3696315011170075
A2780,8515,1.754639935244518,3.6336141911888804
FU-OV-1,36462,2.321134275550796,2.5328147774168737
OVISE,selumetinib-UNC0638 (4-1 mol-mol),4.700379518419309,3.1069507438999127
YAPC,216345,4.822006863531136,4.06621596206692
ONS-76,tretinoin-navitoclax (4-1 mol-mol),3.585528237924169,2.8983566530035683
LOU-NH91,72193861,1.0473212139197163,2.15067335044182
NCI-H2009,piperlongumine-MST-312 (1-1 mol-mol),1.2420237661253426,1.8299936954843417
CA46,54618164,3.845436645537388,3.474588610129217
NCI-H292,446155,1.4424758906582096,2.929545451210988
HCC1143,9936388,-6.988875343339418,-1.2656597185608636
NCI-H727,9907093,4.262034183201205,4.122356927506827
ONS-76,126941,-2.856353430413947,-2.3375795583685006
A2780,11455910,-0.8495199814745813,0.6792800435597428
A2780,73707398,0.6651600447827565,1.0129066512046172
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561,-0.576364676420308
MDA-MB-157,24856436,-0.6830375019554852,0.6514584757486603
LoVo,1750826,-1.736017877496402,-0.7514490375000052
NCI-H146,49766530,4.81095512251176,-0.6575785983053645
HCC1143,409805,4.31745443409651,4.668414528163541
OVISE,159324,4.206537691518507,3.137781872170724
SNU-81,10302451,3.60256279960024,2.3301315756630667
EFO-27,5282054,3.999430083075576,3.702675098771195
LOU-NH91,4917,3.4124252266322297,3.1395298671122367
SCC-9,5328940,1.568072217369216,1.506242747789898
OVISE,637858,1.8122421616924396,2.091108813410387
NCI-H2171,44607531,0.7654225162387793,1.3269415840199092
SBC-5,7326481,1.449700392659346,3.0406299757625215
LXF 289,9907093,2.975231625485398,4.265752295331634
G-401,SNX-2112-bortezomib (250-1 mol-mol),-1.620175957239239,-1.8118758258105967
NCI-H522,navitoclax-MST-312 (1-1 mol-mol),0.9315063640095164,0.5239908530101354
KYSE-70,159324,1.7590392520862297,2.977465989205927
NCI-H2009,3025944,4.548991530576528,4.3540139565084965
SNU-81,135398516,1.5373988209241822,1.9109293739352102
A-673,9911463,3.7053308577681583,3.4954120985610087
CAL-51,9826308,0.5677925602140103,0.6824613700996437
SNU-449,10074640,3.65403010435808,3.1239850746389015
RCM-1 [Human rectal adenocarcinoma],216468,3.6601371592015273,2.975387991769572
A4/Fukuda,doxorubicin-navitoclax (2-1 mol-mol),-2.572338922039687,-2.3315703324597625
JM-1,11213558,1.11781575024048,1.3765363351210302
FTC-133,navitoclax-MST-312 (1-1 mol-mol),0.3680672721218185,0.7502528300695788
DMS 273,11396600,2.9821670224503025,2.8948314600299243
CAL-51,2742550,4.689941422286605,3.7055699193297107
SCC-9,salermide-PLX-4032 (12-1 mol-mol),5.953204050581384,4.799282371495208
NOMO-1,24856436,-0.4465471145990737,-0.22717329915031187
BxPC-3,54454,2.2110977916594945,2.7371236550978226
NCI-H2009,selumetinib-decitabine (4-1 mol-mol),-0.75536294855302,3.57746835549476
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838,3.3275867544153708
LoVo,54678924,0.9602640778132784,1.9995614310853898
MDA-MB-157,JQ-1-carboplatin (1-1 mol-mol),3.3337524262441853,2.26621675974563
NCI-H460,9911463,4.421747687015995,3.9111413710802276
CAL-51,3062316,-2.5625958708444205,1.479980789607338
G-401,11404337,0.5096427987118028,-0.924107203276358
A4/Fukuda,107985,-4.34456564276242,-3.8471654118086835
RCM-1 [Human rectal adenocarcinoma],25262965,2.4523456450078323,-1.7999502050666993
SNU-61,9956119,3.7156714580567063,3.3423799114182615
FU-OV-1,navitoclax-gemcitabine (1-1 mol-mol),3.0788972572820597,-1.6504892604247974
EFO-27,53301938,6.290465616373669,3.0570126309469146
NCI-H727,17759555,3.180616959518291,3.5062324958861826
RCM-1 [Human rectal adenocarcinoma],3503,2.644951314615224,2.5571830509142575
SNU-61,44819697,3.53302657640718,-0.6989687595380577
FTC-133,16065773,0.3113531910395277,2.418448027099999
G-401,tretinoin-navitoclax (4-1 mol-mol),3.928321185847307,1.2593735575447504
HSC-4,navitoclax-pluripotin (1-1 mol-mol),0.2476370471109345,-0.6606200250792206
NCI-H2009,107985,-3.3237358160703843,-3.183054859157144
NCI-H146,3676137,4.978597159303883,4.193736813071489
NCI-H146,16065773,1.505871551892472,2.3379299558426503
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.2734176287927643
NCI-H661,60700,0.4833445990508663,-0.24982074492461334
A-673,selumetinib-tretinoin (2-1 mol-mol),4.294042915691989,3.35444137160558
MDA-MB-453,44491742,4.088527945953042,4.167341027569209
NCI-H661,2945648,2.4705894827529984,2.819416125575905
FU-OV-1,12001922,2.2107336164209586,2.0423165319447385
SNU-81,serdemetan-SCH-529074 (1-1 mol-mol),1.2075198291977594,1.6029897910034965
FTC-133,168312962,3.97521401805193,1.6975154470973752
NCI-H2009,24951314,0.5822698862930126,1.4292538923093097
Panc 04.03,3552672,4.635312487107652,2.8784156622529364
HCC1143,16725315,4.684699585721338,4.2418185284757515
RCM-1 [Human rectal adenocarcinoma],11626560,1.948909455015208,1.7028404504466845
A4/Fukuda,67156097,-3.3575882698535526,-1.7116252972985462
NCI-H460,44507138,4.578042897326484,2.601406213128011
BT-549,262093,3.1295246575488354,3.141227795005514
A-673,BRD-A02303741-navitoclax (2-1 mol-mol),2.626339202884455,1.050162019170135
LOU-NH91,23635314,-2.2216361010230545,-1.759470091634105
HSC-4,11485656,2.41592786996926,2.4578418852130612
Panc 04.03,2858523,3.1704472292667245,3.0894894109771327
CAL-51,31703,-2.726607914110417,-1.1038385964128277
SCC-9,11485656,3.6663619913543446,2.501976233462095
EFO-27,11234052,4.354926990140025,4.093044808170479
NOMO-1,11977753,-1.9426292333262003,-1.8617960648670917
NCI-H146,5280436,1.6778415991784894,2.828446017028549
SCC-9,44589607,3.476138487776652,3.1070001730573718
YAPC,1716436,3.308380745751715,3.0689286218075087
MSTO-211H,72376,-3.945669301292739,-1.865846810196094
CA46,6438330,0.8057128440407828,1.1043989213693095
SNU-81,46907787,-1.0582449369350613,1.1451929848515376
ONS-76,53232,1.9476307600046912,2.7978941604903382
SCC-9,51037431,5.108150298111964,3.277837948049273
SNU-61,11719255,3.5581483316812275,2.81658485672928
BxPC-3,serdemetan-SCH-529074 (1-1 mol-mol),1.9726746361730008,2.2539474881690276
NCI-H522,8515,4.67214972936148,3.3073774383081274
A2780,104842,-8.58016789938804,-3.4050637135605837
KYSE-70,56946209,-4.444419695204879,-3.7374908333154315
NCI-H2171,46191454,1.782184086758524,0.889184056812578
NCI-H292,54618305,4.4370648491662195,4.510939461494771
A-498,16725315,5.296109915632034,4.564528050903422
A-498,11494412,3.741733086313002,2.094763600423675
JM-1,36314,-7.745176622378906,-2.786285917468963
RCM-1 [Human rectal adenocarcinoma],17755052,4.178055403408082,1.5560960122259804
LOU-NH91,JQ-1-UNC0638 (2-1 mol-mol),1.6963345544096158,2.10248734385616
A-673,erlotinib-PLX-4032 (2-1 mol-mol),2.801712278221697,3.312825658956123
BxPC-3,72734382,5.457836982387995,4.719615541055287
NCI-H2009,72734382,3.739945681050146,4.504329858263368
CAL-51,65064,3.306239750209062,4.892825438378341
A4/Fukuda,6252,-3.645065834912594,-0.7220413589822472
RCM-1 [Human rectal adenocarcinoma],6914657,-2.702554466691394,-3.5509744096671803
A-673,36462,-0.225010248526114,0.9328185084116402
BT-549,25195348,2.629764497852918,3.394701790615281
ONS-76,3385,3.2517912405561784,4.24503813794086
A-498,73707398,1.745059470984177,1.7990174862587849
A-673,56963564,0.0212663307031236,0.24931102999413673
NCI-H522,984333,-0.7488997443424653,0.15108746098262674
NCI-H292,452548,1.0483210578903834,0.44005311945895653
NCI-H661,57330099,4.147264508988866,4.327788428170648
KMRC-1,11167602,5.704956856257104,2.3304335968254537
YAPC,25150857,2.3485140693919178,2.647634923243211
LoVo,6918878,0.5506920931363443,2.8813108255846593
LoVo,5282054,3.3404837473565077,3.8321583199797833
G-401,445643,3.8388087856424,3.853326290096658
Panc 04.03,31703,0.9238663549391216,-0.3490395395441588
KMRC-1,25150857,2.932634990579502,2.296633021366553
LXF 289,9903786,1.8485652979864533,2.7735971255256033
MDA-MB-157,navitoclax-pluripotin (1-1 mol-mol),-3.540221681232844,-1.0026725606358036
Panc 04.03,25227462,1.6849134644206611,0.7320819278640343
LoVo,5328940,0.1711764774474706,1.7347989347883037
SNU-81,49850262,-1.5447601433950633,3.348282851303894
CA46,46215462,1.3062506059575565,1.171735536787548
MDA-MB-157,219104,2.454471278072077,3.6873479369309052
MSTO-211H,168313047,1.6297190097298295,2.2799048953545014
NCI-H522,16722836,1.5816295407965617,1.4028269909965447
OPM-2,54626689,3.88605573030338,4.075340039228838
DMS 273,60700,-0.3389173956036069,-0.7861860131130248
OPM-2,crizotinib-PLX-4032 (2-1 mol-mol),0.9302198277032876,0.9637599748407928
SNU-81,9826308,-1.744878476856413,-0.13776926613055296
NCI-H661,selumetinib-PLX-4032 (8-1 mol-mol),2.9532845148669495,3.6387111100652687
NCI-H292,72734382,4.432039940054941,4.638877234878776
NCI-H661,11507802,0.3336368123539006,1.6983566114521438
Panc 04.03,676352,2.180457258433582,2.281258602696204
FTC-133,322968,4.798855030018761,3.956493188051474
G-401,16720766,1.0481135004094,0.41088621514936646
G-401,462382,0.38796721763981,0.6810104712941737
MSTO-211H,25062766,2.0532887481804605,2.1853694582566177
A2780,16736978,-0.7643928517553599,1.4997493252933167
NCI-H727,2729026,3.015864992302643,2.651634748396953
CAL-51,135440466,2.9511327404143755,2.369490530666264
A-498,selumetinib-MK-2206 (8-1 mol-mol),1.8815723158535835,2.3299914809354383
BT-549,72376,-0.6560931555152002,-1.7857472156840195
A-673,9933475,1.583729012108943,1.9208784190080395
ONS-76,navitoclax-gemcitabine (1-1 mol-mol),0.9931716655175384,-1.2289210644709976
EFO-27,135875424,4.6207788215281465,3.722449259271774
A-673,24785538,-1.1944412082957694,0.6893611007084016
CA46,135659046,2.986085914123542,3.154137476937841
CA46,3038522,1.2076902647573031,2.4038648758492256
MSTO-211H,54626689,2.3486455994654767,4.66796785415921
SNU-61,44241473,4.262106100814371,4.425143997299873
MDA-MB-157,25126798,2.9199314308838327,3.793691812691602
SNU-449,10410894,3.985550363358928,3.6025257227774325
LXF 289,53232,1.5859701947912777,2.743639142240208
ONS-76,JQ-1-vorinostat (2-1 mol-mol),1.13707340055611,0.990576610720278
DMS 273,11234052,4.3748762471871725,3.099012072673821
A2780,107985,-4.859396565896689,-3.7081024707966894
Panc 04.03,44202524,4.489701680422056,2.178286503092152
LOU-NH91,44185566,3.062522771292805,2.7698096219742556
NCI-H727,selumetinib-vorinostat (8-1 mol-mol),-1.6328295941141144,2.3870913384700843
EFO-27,36462,3.079082429258617,2.3201364230154438
JM-1,24821094,1.723225199642946,2.1702244409904825
KMRC-1,216345,4.164305633353381,3.6160537347077497
NOMO-1,168313047,1.7455342513633885,2.0138742919642034
RCM-1 [Human rectal adenocarcinoma],carboplatin-etoposide (40-17 mol-mol),3.7784194640429822,3.1085361430557445
NCI-H522,5282054,2.516149277526254,3.015909884340682
SNU-81,26596,-2.2143193215677925,-1.2731041937905403
LOU-NH91,135875424,2.9424536382603215,4.049867101747167
HCC1143,446155,3.993343592958968,2.5761616968485237
NCI-H1623,selumetinib-piperlongumine (8-1 mol-mol),4.451549095180413,3.2748641020683738
LXF 289,3081361,2.235375481166719,2.381936432794534
Panc 04.03,6918638,0.956445062850862,0.8043107060698819
ONS-76,46907787,2.0367347893242247,2.0215063607442714
FTC-133,5470400,2.075616738071143,0.27841791999578996
SNU-449,9884685,0.40134732620175,0.6885185388801651
FTC-133,44566777,0.1715240988601806,0.6314233084430843
KMRC-1,9911830,2.7576147713752532,2.491091002085945
LoVo,navitoclax-pluripotin (1-1 mol-mol),-2.104287475086767,-0.981418950969102
SNU-61,119607,4.552023022199627,4.8199676682035
FU-OV-1,2945648,2.6612648927829348,2.9436795813357874
CAL-51,5282054,3.552468823116285,3.6427328718313583
A-673,1750826,-4.326827801164573,-2.37512623217363
NCI-H661,23582824,0.4459994130921247,0.7309969410127315
A4/Fukuda,208908,1.6750686900112284,2.121590860681818
LXF 289,24180719,2.719444673565486,3.7258492309440117
MDA-MB-453,11647372,0.3935032395331521,0.9703647992211657
NOMO-1,54454,3.4949720971193083,2.0621566449717577
SBC-5,1750826,-0.5333690682178334,-1.5362369494291839
SNU-449,11234052,5.346874708028275,4.364839617124683
LXF 289,159324,2.685439807189008,3.213438883292576
A-498,11964036,1.806054574855834,1.6352494211061241
CA46,SNX-2112-bortezomib (250-1 mol-mol),-3.5188600200549507,-2.6695149581753292
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,1.8447735966238583
NOMO-1,11178236,-2.492998231075174,-3.541606758418541
BxPC-3,3503,1.5238678808710824,2.31458485787429
A2780,5281672,4.494440141018236,4.415317580587524
NCI-H460,57519531,1.7606196796007008,2.6569226744570873
NCI-H146,3038522,1.5824622735127496,3.126179855923296
NCI-H146,alisertib-navitoclax (2-1 mol-mol),-3.5747410805145425,-0.7628790902868203
A2780,7251185,3.0282253021168835,2.0627740256496403
NCI-H2009,54143018,-0.2798924220132643,0.658670025652077
NCI-H661,navitoclax-pluripotin (1-1 mol-mol),-0.6328260588885871,-0.7814318643431224
A-673,50905018,4.224820228350104,3.6644288752086704
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557,0.6417742452842848
A2780,11640390,3.511086163886132,3.0314590131506467
NOMO-1,984333,-1.7512214516120577,-0.14772915106615986
NCI-H292,3062316,0.0480521305272509,1.2627918689865252
NCI-H1623,25183872,0.2518729007636168,-0.34098398082717735
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623,2.24923436605787
DMS 273,11647372,0.2469617170644157,0.7223033476099538
KMRC-1,12001922,2.9414276180440884,1.7562396790310921
A2780,54143018,-1.3409986451592475,0.21381897363609836
YAPC,49793307,-4.348408449857898,-2.3899963463823055
CA46,1716436,3.005257864158129,2.579528376365936
HSC-4,676352,2.328446260179327,2.068349553673501
LoVo,erlotinib-PLX-4032 (2-1 mol-mol),1.656921727064621,2.772621025543025
YAPC,12001922,1.7591466639310227,2.116097833906984
MSTO-211H,5460769,-2.0887143253822615,2.7852150822031883
CA46,3384730,2.283076300956678,1.7429194400792525
JM-1,9911830,1.0886367976495992,1.8681790835493524
BxPC-3,1242560,2.823718248478356,3.631531928179903
G-401,44237094,3.2290132612915325,2.396187627152708
BxPC-3,16736978,1.696086021540879,1.5579761583451412
SNU-61,46191454,1.739312628335972,1.2113969718788153
RCM-1 [Human rectal adenocarcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.948451755079763,1.6721458127405753
NCI-H460,5329102,3.240160570329804,2.0415547668660814
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.1151951448673314
LXF 289,216468,2.2889797638929683,3.229820354325465
SCC-9,44819697,0.1293575980749295,-0.299451979232624
Panc 04.03,675434,5.243078667682196,4.584981565333606
HCC1143,135398516,2.188515967576281,2.440255158935665
ONS-76,25262965,-0.7369683376858831,-0.9009259044401559
A4/Fukuda,53392493,1.8640822641046917,2.049461880217763
A-673,2130404,3.217416760546526,2.6857849542604715
NCI-H661,72193861,0.3965882674238952,2.061923889344291
CA46,119607,3.9558807366301374,4.503999327604992
CAL-51,24856436,-0.3083697359271743,0.5927494916115313
NCI-H2009,2828334,6.796615650463657,6.243692853636613
JM-1,135398738,1.1596934849395544,2.498791557583031
CAL-51,49793307,-3.2015156477281193,-2.599854250395864
HSC-4,10410894,2.7401570440851155,3.2774848816816546
KYSE-70,46843906,3.5210263801871498,2.8063010526381174
KYSE-70,11178236,-1.2639965798928303,-2.7950333313632494
EFO-27,6610216,4.772563131438148,4.255045391283401
JM-1,135659046,3.550517545140938,3.0858632517500384
A4/Fukuda,3136844,3.333855932915555,3.6059759914517584
KYSE-70,53495165,0.5494520653774981,0.6866905410884853
EFO-27,9926054,1.857839666788878,1.9982424504796885
NCI-H460,16741245,2.175171044948558,3.8767280772649486
NCI-H727,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.2513080779268564,3.9069978578362474
MSTO-211H,SNX-2112-bortezomib (250-1 mol-mol),-1.2312117350271496,-1.281784821841174
NCI-H661,107970,2.2398777867932473,2.2943410627740994
LoVo,selumetinib-decitabine (4-1 mol-mol),1.6918156459461149,2.903712937460294
SNU-61,51039095,2.128467827492616,2.627498316884666
YAPC,104842,-2.4249346234244302,-2.5663531140422347
EFO-27,11364421,0.0539420857608272,-1.4345623476984926
RCM-1 [Human rectal adenocarcinoma],71304818,3.0028368617128485,2.4606305698264332
HSC-4,5284616,2.67117659303102,2.549859990408016
NCI-H146,UNC0638-navitoclax (1-1 mol-mol),-1.9432589760731351,1.0573481555786863
KMRC-1,100016,6.458679548763862,5.793877947157597
A2780,JQ-1-MK-0752 (1-1 mol-mol),0.9266829250462012,1.348590135654197
SNU-81,UNC0638-navitoclax (1-1 mol-mol),0.5211429629753735,1.2101216116059954
LXF 289,10184653,0.2846387514020494,1.4968661218600472
G-401,docetaxel-tanespimycin (2-1 mol-mol),-6.677172451643826,-4.206731794215075
ONS-76,73707438,3.6763163562039103,3.999019146314453
CA46,10113978,2.0547387812543425,2.3736225256733063
RCM-1 [Human rectal adenocarcinoma],216345,4.578948480850923,4.1412301981794455
MDA-MB-453,9444,3.890114397090033,4.105546241200721
DMS 273,462382,0.1050500144131629,0.6335831656932046
RCM-1 [Human rectal adenocarcinoma],selumetinib-MK-2206 (8-1 mol-mol),1.8238867716534872,1.9748837858812032
SNU-449,327653,3.836895463512291,3.251843589644784
JM-1,4917,2.618606210388543,2.7096848579275115
A-673,7326481,2.3948672158707027,2.861403738011848
LoVo,3543504,4.109477120593384,4.392606492720926
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837,-2.033112931920302
FU-OV-1,322968,2.943455676205593,3.73971369898445
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,3.28409095686602
NCI-H522,10172275,5.332939953657848,2.905885061583995
FU-OV-1,11175137,4.687876560675478,2.620127139557639
NCI-H292,702558,5.809534673466565,5.426321006409427
JM-1,UNC0638-navitoclax (1-1 mol-mol),0.2019375485573805,0.186054021762963
FTC-133,4378219,2.0024564120700874,2.5891141710684864
A-673,322968,2.685664332943325,2.772917122099463
A4/Fukuda,11175137,1.0544671313881684,2.1194903434386756
NCI-H522,9907093,4.234502914187168,3.6765206994224333
NCI-H460,73707398,3.251551904382877,1.5971174857157595
NCI-H1623,11625818,3.770410958253076,4.476127905782853
NCI-H2171,3384730,2.17478810564445,1.7307332532591935
EFO-27,navitoclax-gemcitabine (1-1 mol-mol),2.157503731341055,-0.8273092243905538
BxPC-3,135398516,1.0474106677719497,2.0604952161405694
YAPC,6852167,3.757016833172803,3.0792428817992823
HCC1143,11178236,-3.0622306456236728,-3.1201427041336522
LoVo,168313047,1.791039731088859,2.2391830114956237
CA46,9915743,0.7447060154867644,0.15379674138180502
CA46,16065773,1.8844207098737984,1.9737793211164805
DMS 273,2749,1.7681499736943271,1.2469012340602843
OPM-2,9549297,1.1861201303789202,1.7682796769760722
MDA-MB-157,selumetinib-PLX-4032 (8-1 mol-mol),5.042710602125305,3.7198276545520255
G-401,3136844,3.887156631896907,3.9252220826647766
NCI-H727,24901704,2.771852034083143,3.4368289072456633
LOU-NH91,serdemetan-SCH-529074 (1-1 mol-mol),2.4104201077494913,2.321802081754103
ONS-76,36314,-4.67770988102335,-1.1701245903641706
A4/Fukuda,navitoclax-piperlongumine (1-1 mol-mol),0.9145762959476356,0.7429940274338219
LXF 289,navitoclax-gemcitabine (1-1 mol-mol),-0.2472011757618401,-1.1791640075075644
NCI-H146,54618771,0.1782763900918093,1.1244401457026882
LXF 289,navitoclax-pluripotin (1-1 mol-mol),-1.4421954677948514,-0.7843003385748873
BT-549,1750826,-1.15792790160721,-1.6645776409924238
A-673,4521392,3.83212246390289,4.130262727697989
A-498,10127622,2.6897842830613934,3.9404191549780774
NCI-H146,24951314,0.0243539025761212,1.1921660558404994
LXF 289,11404337,0.1273620702572638,0.10738592607364626
CAL-51,72376,-2.938334648898351,-1.9135559289087403
HSC-4,56946209,-4.10163917558625,-3.8271061339640533
OPM-2,11719255,1.0053781432887028,2.3720893169164667
EFO-27,selumetinib-vorinostat (8-1 mol-mol),2.529072801083276,2.6004279181814
OPM-2,54765302,3.66991118627716,3.7840952411587314
YAPC,107970,2.510985201601563,2.496069301158349
A4/Fukuda,6505803,0.0348674492980193,-0.5201104563984393
NCI-H146,421610,3.280213272702812,2.9772378474256884
CA46,10427712,3.800630662833656,3.736994080093969
Panc 04.03,42611257,4.903884607697216,3.5321429708370493
RCM-1 [Human rectal adenocarcinoma],24785538,2.5999055228125254,1.5328104548620067
SBC-5,54618771,0.9612938071948806,1.1734026762952903
NOMO-1,44819697,-3.3724853213010895,-1.398698408006644
SNU-449,46843906,3.9850337221839074,3.384845993328936
A-673,2733526,4.173930306540303,3.5839389470703735
Panc 04.03,387447,-4.060832381569581,-3.940054124697631
ONS-76,16038120,1.944596111088229,1.0441342330537884
Panc 04.03,12001922,2.0215480430072588,2.0739962823467137
EFO-27,56946209,-4.24663912291577,-3.6302534168907004
A4/Fukuda,15983966,4.102938700353478,-3.9596306229854923
NCI-H522,10322450,3.5945001970925787,3.257671306512726
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.5937122908325716
BT-549,16038120,1.0292862217749383,1.1300154789399988
JM-1,selumetinib-JQ-1 (4-1 mol-mol),0.3812013730118292,0.04152564197666513
FU-OV-1,selumetinib-navitoclax (8-1 mol-mol),1.6329291252143736,2.3288545860012655
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912,-0.4698698347910025
OPM-2,10302451,3.176323712036339,2.4777799356294055
BT-549,5291,3.9626748190842167,3.8420958059847874
A4/Fukuda,54143018,0.5698360241890451,-0.26749660941578524
CAL-51,5113032,4.55807021159329,4.983698857466198
A-673,navitoclax-sorafenib (1-1 mol-mol),1.9636796155178384,0.9527061059405382
KMRC-1,15983966,1.4470823508624893,-1.3166368758097582
SBC-5,409805,5.881004535625117,5.155652144983565
MSTO-211H,11717001,4.186640197436745,4.209639765104733
MSTO-211H,5351362,0.1292531164344693,1.8063701520931723
BxPC-3,navitoclax-MST-312 (1-1 mol-mol),1.414454953268366,1.1503889961154277
A-673,135398738,4.1394757023123505,3.2241875054100944
NCI-H2009,navitoclax-pluripotin (1-1 mol-mol),-1.5280134971991166,-0.6999333724011045
NCI-H2009,12001922,2.0619007134450524,2.0882672920125387
CAL-51,3634881,3.319714226315486,3.366940368253579
SCC-9,5282054,4.577178009511458,3.7769295188832923
SNU-449,6610355,5.42598000328545,4.6352198687787425
JM-1,100016,5.094244415703564,4.947067298058997
DMS 273,16720766,1.3424969772091375,-0.004214747310662759
MDA-MB-453,82146,5.197355724890258,3.5815434650896845
NCI-H727,219104,4.385991256377306,3.7917561369956836
G-401,387447,-4.890417311710873,-4.882805729065616
SNU-61,445643,4.910443238015828,3.8768063388840615
G-401,445091,4.490925944707375,3.974644864827382
Panc 04.03,10074640,3.644812120140466,3.0853515121215587
KYSE-70,3038522,4.319477989558539,2.891044605290237
NCI-H727,5311281,4.417954223041409,2.3612476111756577
OPM-2,24889392,2.046562304125139,3.3358595378029827
OPM-2,9866186,1.7779199456036283,0.13710754947655135
NCI-H292,65628,4.3235700442832625,4.499011685914279
JM-1,5284329,3.614100674193798,2.5550280701882473
LoVo,49850262,2.4887252685350227,3.6651462973927327
BxPC-3,24785538,1.143761767664292,1.5767017971128952
LoVo,176870,1.1282563754131285,2.9794054931155034
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163,1.57444572921707
EFO-27,73707398,1.1269975883077623,1.3822603715169144
CAL-51,49850262,3.6300011952383584,3.7402053131190303
NCI-H2009,1750826,0.0733322198534379,-0.5203033546964336
LOU-NH91,9903786,3.184012464559237,2.91464509576423
NOMO-1,9911463,3.1879476164010243,3.1757968910717493
A2780,16722836,0.6661441985838381,1.4694865203644936
MDA-MB-453,11238147,2.2482376857817856,2.739263442259775
NCI-H2009,11626560,0.9059448501577204,1.9608742497374103
LoVo,2746,2.3133613771451524,3.157018195892742
NCI-H661,9840324,5.7754199175322825,5.729654131187807
SNU-61,10385095,2.7560205308704044,1.3274488435247258
A4/Fukuda,24771867,-3.7385177445932585,-0.5714117141978367
NCI-H727,654092,0.4388886539996767,-0.08923502083015046
NCI-H661,44507138,1.7319125686737762,2.31300143935297
EFO-27,16013152,4.523705738143722,4.254576043411983
CAL-51,4259181,-0.5132501801478601,-0.007639061412731114
A4/Fukuda,2746,1.0000278581130588,2.2028856075117274
NOMO-1,10184653,1.080224838410231,0.5621529566825351
Panc 04.03,135398516,3.776050709281408,2.410668676084679
YAPC,3038522,4.3203914817087234,3.1802431555468718
NCI-H292,9926054,1.8794077191249725,1.9876192115901414
NCI-H661,5278396,2.727600530538007,3.5405258564418296
BxPC-3,JQ-1-carboplatin (1-1 mol-mol),1.4385682837687654,2.2882262061548384
A2780,9803433,4.475774001896097,4.528116171808218
MDA-MB-157,11178236,-4.597953573249134,-3.232397584080364
ONS-76,44137675,3.612845962454732,3.6983547790000744
LoVo,51039095,1.8047028032602028,2.7246263028803
NCI-H522,tanespimycin-gemcitabine (1-1 mol-mol),-2.467840431866496,-1.817293330312504
SNU-61,25183872,0.0265852822027559,-0.7056572793613259
NCI-H661,10410894,2.079430431888453,3.3835705483111513
NCI-H1623,11497983,5.112351206162292,3.967926429516189
FTC-133,navitoclax-gemcitabine (1-1 mol-mol),-2.9541403252647744,-1.224808139327837
NCI-H522,6184667,2.532079714436212,2.825891874534704
MDA-MB-157,selumetinib-navitoclax (8-1 mol-mol),-0.2333098537360622,2.3103258270026243
NCI-H2009,44589607,3.679148722712513,3.0460726020841635
EFO-27,44137675,3.925812188621705,3.6698086883994887
FTC-133,5328940,3.204514542529291,1.6975917873038102
FTC-133,2708,3.4116435244290773,4.682563429791663
NCI-H661,24901704,2.3315866691701395,3.44380299779892
MSTO-211H,11719255,2.56955632094912,3.619125170773149
OVISE,11626560,2.348997135596899,2.117496505684766
OPM-2,ISOX-bortezomib (250-1 mol-mol),-0.1945134958657626,0.43703697813580505
CAL-51,9868037,3.5441777448678615,3.35798182866491
MDA-MB-157,5328940,1.5742504795877947,1.7735216171431267
BxPC-3,19582717,4.685369750995796,4.515496774151851
MSTO-211H,6852167,2.890925130180435,2.9876603455220954
CAL-51,5746,-0.6872762444946757,1.040283563482301
OVISE,17759555,4.197708618199663,3.6610345561457707
EFO-27,6918638,-0.5643283195590469,0.7916810560961572
JM-1,439501,-5.872076466297635,-2.576372143876059
NCI-H522,44486219,4.336787525166091,4.160716777275238
SNU-449,11167602,2.762483283064935,2.500374882181605
NCI-H661,11640390,3.9877189690607993,3.5477913147070343
SNU-449,216239,2.7953722371364473,2.412007704531479
NOMO-1,17755052,-0.2814114025249274,0.9224801864949467
EFO-27,UNC0638-navitoclax (1-1 mol-mol),3.21943648938414,2.021365363419667
A-498,54618771,1.1394352833671273,1.4431475609770892
CAL-51,176870,2.9999818119422175,3.211713420177572
NCI-H292,11404337,-1.5117614396305947,-0.18283963433837094
HSC-4,9911463,3.832706037448295,3.9446813668635134
DMS 273,5470400,-1.1243568241206934,-0.015391241438566697
OPM-2,25183872,-4.3499490255982085,-1.7490647983332108
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894,-1.0095521508298273
LOU-NH91,31703,0.5806868540812907,-0.47537903891522665
NCI-H661,44493528,5.823125515558819,4.267778324397362
SCC-9,10074640,3.673307032160535,3.1217081837064553
A4/Fukuda,11427553,0.0702382308883879,1.3710818944416265
SBC-5,568763,0.2965266090010964,0.7115699015866841
BT-549,25126798,3.990115132251306,3.9332155487796836
SNU-449,9933475,1.8242814161965168,1.986894655108419
BT-549,2113511,7.745487386721322,5.646176959041983
SCC-9,969516,2.533129063350548,2.871073397466493
A-498,11178236,-0.0767055613398424,-2.8936183852468687
YAPC,1242560,3.336355906074855,3.629475801781695
YAPC,54626689,5.597039319211252,4.64591681233267
SBC-5,BRD-A02303741-navitoclax (2-1 mol-mol),3.4496626470660807,2.5380267702620483
NCI-H522,JQ-1-carboplatin (1-1 mol-mol),0.3092817510850776,1.2771336002997398
HSC-4,6918837,-1.8301723200742368,-2.7490385350328275
YAPC,656346,3.528875898488543,1.089261283326762
LXF 289,5470400,3.745756378340341,-0.1742196527776857
NCI-H2171,168312962,2.801787293375821,1.3135762595872742
MDA-MB-453,6918638,-1.2403270134347248,0.21162378759055042
NCI-H522,1566236,1.6835491869847783,2.1861223595957533
NCI-H661,24964624,2.8216778680067836,2.7319933313404237
NCI-H2009,5281672,4.642324044569225,4.635996473614876
Panc 04.03,navitoclax-gemcitabine (1-1 mol-mol),1.3720951008161577,-0.07286141609203217
NCI-H1623,16065773,2.4078381094703456,2.5174048302885628
CAL-51,46398810,2.084696284876613,2.5031309248415665
OPM-2,54143018,-0.7196855693728514,-0.30275219858405134
SCC-9,15547703,2.91115041464476,3.2946033381937805
DMS 273,6914657,-3.971712341208325,-4.440226788028988
OPM-2,3676137,3.169610101166173,3.9739664163408883
OVISE,3025944,5.5857056433387235,4.334964521823743
Panc 04.03,4259181,1.0934261994249337,0.545467029752465
A2780,11683005,3.0394905793504963,2.833579536469645
HCC1143,5328940,1.7305674649682683,1.7221188240894094
NCI-H2009,72193861,0.2482611586799762,1.8095140296800236
NCI-H292,6914657,-3.659053204598075,-3.712397914982454
NCI-H522,46199207,1.8719788650663136,3.080707317635937
CA46,53481919,3.755788894439918,2.607716638159654
LoVo,444795,4.8141558651213145,4.710798400692171
FTC-133,9823820,4.816748988305079,4.207924707467217
KMRC-1,6918837,-1.4377118656295438,-2.224143849863494
HSC-4,44486219,5.375029781512573,4.3052419112527165
NCI-H292,54613361,2.8419740491204957,0.2596321941114165
A4/Fukuda,alisertib-navitoclax (2-1 mol-mol),-3.158247130795727,-0.4436642982337223
CAL-51,11234052,5.18044926966805,4.034733020282708
SNU-449,387447,-3.8386512960067862,-4.062716304105131
SNU-61,53232,3.65751057839411,2.6993662148688227
LoVo,16038120,0.8839921956645777,1.0102395320152067
BxPC-3,219104,3.7528053800812615,3.9958237104986254
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148,0.9144363860755937
SNU-81,24748573,1.8214275246808207,2.0869725999190947
MSTO-211H,16725315,3.290115596802182,4.16799233689019
SNU-61,25154868,4.341936394973705,4.246482176858681
MDA-MB-453,1716436,1.6727209102312437,2.868885065251214
G-401,5329102,1.4807949874052762,1.7126527710165715
BxPC-3,6610216,4.298723179439111,4.307249834301355
ONS-76,5738263,4.146346761655981,3.3386466761894007
A2780,51037431,1.9184867581168112,3.0043883095949964
CA46,46398810,1.9636985074186508,1.9947195779547342
BxPC-3,9936388,-5.112429278661846,-0.5139112141025584
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544,1.5980487505177765
MSTO-211H,637858,1.3984482263345202,2.0385468361006502
A-673,5284373,2.9730764803314496,2.624400018227587
JM-1,5284616,2.861882362083186,-0.31637553400275314
A-673,64971,3.704564654457452,2.104734124391439
ONS-76,6918289,2.669224964930956,2.5778246135447294
HSC-4,11167602,1.6360881716966182,2.6378209234319225
NCI-H661,3689413,0.5447440822016135,-0.6517148126565714
A4/Fukuda,12003241,-4.192136354440014,-1.142963985930435
LoVo,10231331,-0.6826574775964468,1.2325469128472095
NCI-H292,219104,4.068792108053485,4.093522826760701
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.804510708715108
NCI-H460,216468,4.763843832635099,3.3790791290314814
SBC-5,322968,4.849411960208385,3.900915179100961
MDA-MB-157,135411,-1.5273896245850724,1.008351030808144
A-498,6918837,-1.461997313484149,-2.147562630047338
MSTO-211H,decitabine-navitoclax (2-1 mol-mol),0.593652289859318,2.3584535108434768
MDA-MB-157,doxorubicin-navitoclax (2-1 mol-mol),-3.2378494218759637,-1.0654429458136412
FTC-133,36314,-6.239918298117373,-1.6462445346162426
CAL-51,23635314,-2.261837237964324,-1.4828765689515295
NCI-H292,126941,-3.055153146808903,-2.0974271472787307
A4/Fukuda,23725625,4.971593284778653,3.7205964553264725
A2780,25105715,3.052833826388835,3.3437786461712697
JM-1,9903786,1.587415218469425,1.9934076841822839
NCI-H460,5566,3.3663694984335533,3.148148704496906
OVISE,262093,2.7343448368987597,3.004905512043312
CAL-51,25262965,-2.904292987251918,-1.7630461009019254
SNU-61,448949,2.574317813231787,1.6312874303312757
SCC-9,24180125,3.671852734769843,3.1507418843983657
HSC-4,42611257,3.4394582921614933,3.237834088718618
EFO-27,46174525,4.9061854461465435,4.638097355539923
G-401,3384730,2.1525913455039474,2.111845599781785
G-401,3825829,3.962498358217521,3.6719283804234424
A2780,53232,-0.3956468617212337,2.8103971393162404
YAPC,54618164,4.31457100114165,4.295939982536493
SNU-449,54765302,4.743565917095417,4.1386756944916705
NCI-H460,24951314,1.96669984187411,1.5597604788917898
FTC-133,11364421,1.174405518858428,-1.675117326866599
MDA-MB-453,carboplatin-etoposide (40-17 mol-mol),3.9287174119504225,1.799550903012736
RCM-1 [Human rectal adenocarcinoma],16038120,1.1652003457864657,0.968104866471147
NCI-H2171,24771867,-2.6220866978549444,-0.16285212786008027
A-498,11427553,3.7697046176741185,3.038212607347848
MDA-MB-157,5394,4.303334925677516,3.7943790371624475
RCM-1 [Human rectal adenocarcinoma],44589607,3.248085405337134,3.03741298861631
RCM-1 [Human rectal adenocarcinoma],10184653,2.2395944761831372,1.254890397594461
RCM-1 [Human rectal adenocarcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.3016699371514477,-0.6640377026948624
SNU-61,15983966,-2.103596771317332,-2.5362077835143033
A2780,9927531,3.2712332494904226,4.429781927029915
MDA-MB-157,UNC0638-navitoclax (1-1 mol-mol),-2.9600993667864275,1.8113326653060948
NCI-H661,168312962,0.9705864877614524,2.131044793713703
OPM-2,135440466,0.016624870652288,1.8630806845570935
NCI-H727,44486219,4.75896405378265,4.3746846520036256
NOMO-1,637858,1.0893367728071195,0.886544346530784
NCI-H727,23725625,5.500914308976136,5.184872594860874
NCI-H661,444795,4.831383676329662,4.552121476065379
NCI-H1623,10427712,4.824592613381889,4.207876747993023
CAL-51,11507802,1.2528060552922216,1.8202917949079431
SNU-81,tanespimycin-gemcitabine (1-1 mol-mol),-5.141011099555512,-0.7270178408694542
RCM-1 [Human rectal adenocarcinoma],5328940,2.0329581384082944,1.6188628555310987
A-673,2949965,2.43157797191215,2.571945804997335
FTC-133,46907787,3.491897677971775,2.527383572783884
BxPC-3,JQ-1-MK-0752 (1-1 mol-mol),0.0240612102256537,1.6663985572011708
JM-1,12003241,0.2073989775302392,-1.7464531715315386
DMS 273,72376,-2.307681046282287,-2.9241519550557706
A-673,3025986,-4.4852998426095985,-0.9891588232182206
A2780,9823820,2.6289512031423836,3.5045207010636723
HCC1143,11152667,-1.9901975183751028,-0.28653565492814603
A2780,119607,4.019563194528792,4.688442996598704
MSTO-211H,136227924,2.717505566177341,2.944934029422129
A-673,3025944,3.970835118137527,3.994770673193543
NCI-H146,11222830,0.9953145616857674,1.6193482288458068
NCI-H146,1750826,0.7822669653178473,-1.2132283939030684
JM-1,selumetinib-PLX-4032 (8-1 mol-mol),4.727165716436182,3.3229624846574746
BxPC-3,1750826,-1.1292189334445044,-1.0988286227536743
CA46,6450551,1.1375422858810305,1.151836889583319
NCI-H1623,46191454,1.8980276717062192,1.8123287869461755
CAL-51,24797083,1.5666479073716466,1.3795159400747403
CA46,448949,1.4123991312197492,1.4381296188961452
OVISE,135999136,4.426271635938179,3.6914422713104345
HSC-4,2742550,4.46855499399167,3.7689371264809775
NCI-H460,168313200,3.91056508525232,2.9774714492536503
NCI-H292,1750826,1.4118366921158176,-1.0914956245924352
HCC1143,452548,1.7974899966046338,0.47367715803835464
SCC-9,53325874,4.533787552290022,4.458038188863439
CA46,24771867,-0.8036362931877258,-1.2708395400742092
A2780,72199292,-0.0351373222218005,1.0841421692995363
MDA-MB-157,216468,1.0474678727125786,3.345028620242729
SNU-449,65064,5.2463646910054536,4.935768437361727
NCI-H292,9952709,2.799114874088216,3.2539951936666864
LOU-NH91,24964624,2.935669445800335,2.7244119129191375
MSTO-211H,5566,3.048712391825719,2.813300067746311
MDA-MB-157,3384730,2.532514051685687,3.0535785539213522
BxPC-3,753704,5.46289082133378,5.209399795412235
A2780,SNX-2112-bortezomib (250-1 mol-mol),-3.4792243011702957,-1.7189079537634329
SCC-9,12003241,-1.125345709331217,-1.09149947913586
HCC1143,285033,-0.1452813325821209,-1.7196749878035993
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.2833094450671094
FTC-133,9956119,4.526890245155382,3.787711479338822
SNU-61,3854666,2.8565665342705735,1.7444524282353477
G-401,16065773,1.1067048318222386,2.018755299212674
G-401,11214940,0.8244141998238856,1.497310468231864
HCC1143,54618164,3.885707225557291,4.21115108601251
MDA-MB-453,16013152,4.031304285322853,3.8228975451506013
SBC-5,24951314,1.1707148737631825,1.2918573675211593
FTC-133,135398516,3.4482633492568913,2.1388995650364895
KYSE-70,11625818,4.1356453826336965,4.520785204933436
BT-549,16722836,2.2023880033470893,1.9116457401120561
MDA-MB-157,54678924,0.1283777680712135,2.3374271972433647
SNU-81,10410894,4.450607476297739,3.0523322779387287
KYSE-70,9926054,2.326174845830733,1.8486080049045677
KYSE-70,SNX-2112-bortezomib (250-1 mol-mol),-1.0131042472486071,-1.1393593029779878
EFO-27,25102847,3.020723568572887,2.5439699636890194
MDA-MB-453,5351362,1.2969167061447922,1.4937982901516103
LoVo,9926054,1.9069881185353632,1.9241232883136552
NCI-H1623,46926350,-4.300601402935136,-3.699696766036539
SNU-61,16065773,0.792903808301444,2.1415836876054466
A-673,5287620,-2.2582011832849824,-2.0254572453477446
NCI-H727,9903786,3.725485605999375,2.889509827683196
KMRC-1,72376,-0.8386976675707333,-1.9836395210833988
JM-1,11640390,2.558073354039076,2.5877199507776023
A-498,104842,-1.4921326822698753,-1.8700168606133623
LoVo,10127622,2.21220618035224,2.7223906050138917
LoVo,11364421,-3.7348040522268624,-1.8422152451294063
FU-OV-1,57519531,3.042184872303348,2.5963094507414546
MDA-MB-453,serdemetan-SCH-529074 (1-1 mol-mol),1.825240779322759,1.9027939242718273
DMS 273,6917907,-5.615473283892677,-5.377632764691547
MDA-MB-453,2828334,5.6655606940020755,6.057479630011939
HSC-4,navitoclax-piperlongumine (1-1 mol-mol),2.6552743905338905,1.7560985519748522
A2780,3025944,3.330273751246369,4.062094591819535
MSTO-211H,vorinostat-navitoclax (4-1 mol-mol),-1.2418766725750991,1.1512255440737158
Panc 04.03,11152667,-0.1106415062306802,-0.5464547836146951
SNU-449,selumetinib-decitabine (4-1 mol-mol),5.489476406274314,3.903232667797573
SBC-5,374536,0.1871414147839566,2.027790132566036
NCI-H661,11222830,1.6760341955617937,1.6724553854568658
BxPC-3,89183176,5.843393871566337,4.4133368327259666
JM-1,135999136,3.9281924738089016,2.569473731228969
BxPC-3,selumetinib-UNC0638 (4-1 mol-mol),1.3922516322535516,3.2214470227935657
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.3425900687610879
SBC-5,navitoclax-MST-312 (1-1 mol-mol),1.562622268083127,1.0647504479427747
SBC-5,56946209,0.800516243447007,-3.871969701271086
NCI-H2009,5328940,1.7426808664178373,1.789285788183696
NCI-H2171,navitoclax-pluripotin (1-1 mol-mol),-1.0064664066659004,-1.256646336106831
LOU-NH91,decitabine-navitoclax (2-1 mol-mol),-0.8280147922678951,2.468740475670174
SNU-449,9911463,3.778924364931394,4.002751322693445
HCC1143,3025944,4.170847171640537,4.344300792259889
JM-1,969516,2.095061675415332,2.2498171324202545
NCI-H460,3384730,3.247736649900264,3.042466637140046
LOU-NH91,135411,2.1671070624345674,0.7859633145837103
FTC-133,44607531,1.7603587928522244,1.6543816988129652
NCI-H146,decitabine-navitoclax (2-1 mol-mol),-2.2755638944126644,0.435514672440665
MDA-MB-157,445091,2.3343110617588785,4.0262958522120895
HSC-4,16013152,3.4985623845199956,4.178806936294632
Panc 04.03,11427553,3.7212087866143433,3.0953821507057215
KMRC-1,10113978,4.2388531684480615,3.2232100050233496
A2780,10127622,1.5174517910950884,3.6623691430502534
JM-1,navitoclax-gemcitabine (1-1 mol-mol),-5.563041913768145,-1.922573280484423
NCI-H2171,89183176,2.3651641452605747,3.1651016626389485
Panc 04.03,54618771,1.7180394725494992,1.3686987358363911
NCI-H292,11485656,2.2579953762585725,2.475341627775367
LXF 289,322968,3.971478433961818,3.9879041031070677
SBC-5,vorinostat-carboplatin (1-1 mol-mol),1.8980945585311684,3.0616977783419164
YAPC,10385095,1.3302689043535871,1.5259240421156735
LOU-NH91,5329102,1.7122787452562382,2.3078727243631025
SNU-61,19582717,4.214212535444011,3.6670629626847018
HSC-4,49850262,4.158516161733518,3.8097385982161325
FU-OV-1,selumetinib-UNC0638 (4-1 mol-mol),1.7956327688699871,3.0978000176596483
NCI-H661,123631,1.2265867761007856,2.5887751206474507
KMRC-1,3062316,-0.7612421720697753,0.5430132390568122
BT-549,9936388,-4.888200161073446,-0.8155863088885154
HSC-4,24951314,1.4348411807415282,1.489887875963924
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.804510708715108
A2780,navitoclax-pluripotin (1-1 mol-mol),-1.8595742905962285,-1.1187727397289915
SCC-9,9933475,1.8547363245124415,1.7766294556013327
CAL-51,9936388,-5.638746232401389,-1.061796652523543
KMRC-1,ISOX-bortezomib (250-1 mol-mol),0.316621545277449,0.8059861721247689
CA46,72734382,3.577472012209052,3.433852026351035
NCI-H661,16741245,3.244500107466936,3.945829116575604
SNU-81,docetaxel-tanespimycin (2-1 mol-mol),-6.596466940190321,-3.1440997688504435
HCC1143,11964036,1.1986784595252613,1.566642032684581
NCI-H661,selumetinib-UNC0638 (4-1 mol-mol),3.9317627584077695,3.162411285011318
A2780,126941,-2.3178428604154746,-2.753026342393771
A2780,navitoclax-PLX-4032 (1-1 mol-mol),1.492192553915411,1.6062565200594252
NCI-H661,24753719,3.905315348750775,4.38965957753116
SBC-5,25126798,4.2020115243555285,3.7002741569124438
NCI-H146,6917907,-6.190181636892531,-4.5970645451696175
NCI-H661,1750826,-0.2904028146963975,-0.9277292121730997
Panc 04.03,navitoclax-birinapant (1-1 mol-mol),3.2417464009141845,1.624865277595612
ONS-76,613753,4.08215787211526,3.1119280150248105
SBC-5,3689413,-0.1482568941323282,-0.07504447606404671
FU-OV-1,446155,2.635089718837861,2.6783286471435246
SNU-449,216345,4.054978999003172,4.115511343359142
CA46,6918328,-3.721989268042841,-1.4934288415843062
CAL-51,5978,-2.6819752982341463,-2.1072643409923204
MDA-MB-157,57519531,1.1252399396652772,2.5820437173027653
NCI-H1623,51037431,4.287686451446288,3.365555952376937
A4/Fukuda,5394,2.6676913787283305,3.4448749088068076
MSTO-211H,151289,1.1545674452198869,1.6334590395620148
HCC1143,3825829,3.893715702367038,3.856508448607892
MSTO-211H,374536,3.2477584475462904,2.317690780777475
NCI-H460,6610216,4.838717363885395,4.303749695253518
CAL-51,54618771,0.0049145289548569,1.473841277606501
CA46,1239801,3.4142476342729817,2.8582978616932952
A-673,9956119,3.229119212963112,3.4309134446793297
NCI-H460,73707438,4.549718141383013,3.8480803456049135
YAPC,9936388,2.1810367621372095,-0.23949332232531387
LXF 289,4705,5.10311909598278,3.2091618394511183
CAL-51,54454,2.240351559744082,2.6823500989991755
JM-1,4788,5.493172342149484,4.860582724549925
SNU-449,262093,3.0394524195162766,3.0917657116969597
EFO-27,46926350,-4.056205960361391,-3.937624416430438
SNU-61,5566,2.945300560810773,2.957677616004665
Panc 04.03,6610355,5.365295116093154,4.544972363761578
NCI-H727,navitoclax-piperlongumine (1-1 mol-mol),2.3472848325526448,1.6379778433410797
NCI-H1623,56963564,0.7315466561739135,0.5545665832781769
HCC1143,10113978,4.851592729588868,3.2526368582224396
NCI-H2009,navitoclax-piperlongumine (1-1 mol-mol),2.538490249667484,1.9300998068092008
LOU-NH91,5311281,1.0411900413843744,2.2875617774760184
KMRC-1,24856436,1.3740575733249207,0.6890566987792266
SBC-5,400769,-0.0932857286492618,-0.7069382451325157
OVISE,11964036,1.5054845636014844,1.4947615445806144
JM-1,1716436,2.291915875842717,2.5740843667140187
SW1463,6505803,0.5252870082270547,-0.8409557800207951
A-673,navitoclax-pluripotin (1-1 mol-mol),-1.5806846608606773,-1.1381706673932357
CAL-51,119182,-1.323881847361974,-0.43975070176895065
A4/Fukuda,4788,3.9402862208503753,5.275548806901748
SBC-5,9926054,3.0567796435466628,1.9725743191479959
EFO-27,vorinostat-navitoclax (4-1 mol-mol),0.8763520950927793,1.220604123995696
G-401,3634881,2.5006119442923938,2.699005762280012
NCI-H727,9911830,2.860892848593743,2.5474097130613496
G-401,9911463,2.712760379614347,3.469066804450152
NCI-H460,15983966,-0.5601417251503862,-1.1722839774837504
BT-549,serdemetan-SCH-529074 (1-1 mol-mol),2.72716237465292,2.1978224719304027
NCI-H292,31703,-1.868725819699569,-0.4684350633634676
NCI-H292,11175137,3.5103695935197328,2.8680618056596563
NCI-H2009,3543504,4.270240870629309,4.420793774067113
EFO-27,702558,4.734643042503988,5.252311226565217
NCI-H292,107985,-2.5053359043606043,-3.403042953901184
HSC-4,25154868,3.1331848354363063,4.317850843012609
KYSE-70,docetaxel-tanespimycin (2-1 mol-mol),-4.718411789937545,-2.2434413713599595
SBC-5,doxorubicin-navitoclax (2-1 mol-mol),-2.1214883367160113,-1.2362342588277555
MSTO-211H,11364421,-5.484172518994792,-1.998801262938725
NCI-H460,11238147,4.460003386993959,2.741289780329888
NCI-H2171,60700,-0.3771090207819011,-1.0092872810518356
LXF 289,1641662,3.640483694902119,3.680429345074081
MDA-MB-157,49793307,-3.250396628323611,-2.2672475060504946
A-673,3503,1.5343061624145853,1.761458457672108
LoVo,10296883,3.831816674357036,3.8818860969468068
HCC1143,6917907,-6.676374133945339,-4.778712930105301
NCI-H661,44185566,2.810411867420033,2.738834909084386
NCI-H522,23725625,7.287275637495971,4.236355952876434
BT-549,11175137,0.9532540120968724,2.6067802713376222
BT-549,9840324,5.7680719211185005,5.835202860104707
DMS 273,42642645,-0.2214891751848421,0.3055944132731143
LXF 289,24797083,1.462636821965973,1.6204108816003753
A2780,9887053,0.4462184617201571,3.0193090085897545
G-401,3689413,-2.428789331956376,-0.8198693052989995
NCI-H460,65064,5.803776096144955,5.03418048998919
MDA-MB-453,JQ-1-carboplatin (1-1 mol-mol),-0.0296980532629666,1.956976431602812
CAL-51,452548,-0.9080095532304931,0.4020638108143693
NCI-H460,54613361,2.8642714411834502,-0.040777363125556194
YAPC,675434,4.582728256156342,4.53703552779101
KMRC-1,4578,4.295676817145532,4.215954447903651
BT-549,387447,-4.9509675804959,-4.247976472795487
MDA-MB-453,selumetinib-JQ-1 (4-1 mol-mol),1.824440496752652,1.8443777370509977
EFO-27,11719255,3.4932821683662865,3.6297912504551335
OPM-2,219104,1.446566622432128,2.335801117832467
NCI-H1623,6610216,4.306736710776884,4.220674891686944
NOMO-1,23582824,0.0799476906959343,0.797303974647109
NCI-H292,6610355,4.982353204264952,4.655377997275585
NCI-H2009,46191454,2.1369399253900347,1.9151263959180769
NOMO-1,3062316,2.517026306117631,0.31625720440284316
NOMO-1,119182,-3.695250738066314,-2.762949597823153
SNU-61,decitabine-carboplatin (1-1 mol-mol),5.043967029141517,2.8474328414552947
FU-OV-1,11364421,-3.956792545928709,-1.8051577841877997
OPM-2,17755052,0.9533058757913144,0.8784797184438174
SNU-449,doxorubicin-navitoclax (2-1 mol-mol),1.3165597718985669,-0.7392074823766301
DMS 273,46199207,3.605640907411319,3.056760129403707
NCI-H522,55508,2.4640988254574356,3.103193758245524
NCI-H292,10385095,1.2562128411100733,1.4712376391429773
SNU-61,piperlongumine-MST-312 (1-1 mol-mol),2.3794490551959107,1.544805178892608
CA46,107970,1.651382626144423,2.037132916928451
EFO-27,5746,1.7615281276545924,1.3235239560211465
OPM-2,24856436,-0.767009816479034,-0.12279788006825912
CA46,25126798,3.582571225160254,3.230731698639183
YAPC,89928392,2.607647468641453,1.9314132002284605
MDA-MB-453,3062316,2.3886014193927285,1.4603329336854447
MDA-MB-453,387447,-4.667010811634082,-3.841179620430404
G-401,107985,-4.394015959361378,-3.724723476432662
A2780,decitabine-carboplatin (1-1 mol-mol),3.747400322321459,2.5174613454276997
SBC-5,135875424,3.947045576812926,4.127454125497604
KYSE-70,24785538,1.5800117539652696,1.808823830934076
BT-549,25262965,-2.559107571112332,-1.1242073471506904
G-401,selumetinib-PLX-4032 (8-1 mol-mol),2.777074550060763,3.374866349135139
BxPC-3,2828334,6.44946379786602,6.19791499335737
NCI-H460,3025986,0.3909368316008428,-1.0075392154343688
DMS 273,11656518,1.6608448179793895,1.4103845677721194
EFO-27,3825829,4.213579429540561,3.9479391979094367
NCI-H146,44493528,1.3818057906729433,4.228555469996775
CAL-51,73707398,0.7053044464230985,1.3739011800480383
NCI-H292,148198,-2.0841293800573446,-3.2041216130603236
NCI-H460,2828334,6.134119597935603,6.163283711640146
CAL-51,439501,-2.444412450902406,-2.3200149959533776
SNU-449,73707398,1.8238531786702632,1.466638784956839
A-673,10322450,2.1969870036583323,3.6643768420841356
NCI-H2171,71466380,3.3392440967630797,4.223107891759768
HSC-4,53392493,2.986961827224748,2.660630843610524
OPM-2,1239801,3.3443313732590543,2.8937443840893677
LoVo,9935249,1.1872155844887071,2.908543371476223
G-401,1566236,1.5621622205700352,1.748717392713948
HSC-4,9907093,5.592562690426939,4.125035676667556
MDA-MB-453,445091,4.203535883394564,4.201789539862236
EFO-27,24821094,3.745327872256005,3.0409252718797264
KMRC-1,3038522,2.3225128068669676,3.238547479611378
NCI-H2009,11427553,1.9586555200212517,2.8351543207087158
SNU-449,25227462,3.4571199035251565,0.655530556292684
CAL-51,136227924,2.079284078064279,2.8281286511313306
ONS-76,452548,1.1046001555889895,0.14283716478631242
SNU-449,25105715,3.5056666677867625,3.484508322432881
CA46,156414,1.2808873732328336,0.7469103205272127
SNU-449,400769,-0.6000208096132458,-0.3980121378903416
HSC-4,tretinoin-navitoclax (4-1 mol-mol),4.058213789004076,2.6826089169345613
NCI-H146,462382,-0.5302162316770459,0.5876374582508958
NCI-H460,613753,5.368273372553464,3.230952536866571
MDA-MB-453,3136844,3.6967063162994114,3.824313545392471
A-673,5281672,3.4533278359325323,4.2145140631068925
A2780,salermide-PLX-4032 (12-1 mol-mol),4.80403055299543,4.796824543597207
EFO-27,1716436,3.5844471141038823,3.0029002844925645
SNU-449,3825829,4.613153689576251,4.1538684561415975
NOMO-1,73707398,0.2786764614411772,0.14579052182792876
A2780,568763,-1.431759576680003,-0.05284369999152872
HCC1143,6918878,5.533567107436573,2.973071776448869
LoVo,11455910,2.8170443999319574,1.0469658021367547
EFO-27,23582824,2.0177544133250187,0.5362713634048949
DMS 273,crizotinib-PLX-4032 (2-1 mol-mol),1.107090848194829,1.3838277619033539
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711,2.3058481751467457
MDA-MB-453,44819697,-2.6195477020037696,-0.3037750436971369
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.2563884558815195
A4/Fukuda,7326481,2.3355820774301206,2.864377520913195
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935,-0.01875312295290011
DMS 273,5566,3.001039957404815,2.728430183382051
MDA-MB-157,148124,-6.016678597172854,-1.2480251874813475
LoVo,11507802,0.9778049572121082,1.8729135188265098
NCI-H522,9444,4.166279980928258,4.1941333754940215
SNU-61,crizotinib-PLX-4032 (2-1 mol-mol),2.112541337520524,1.6939782633132159
MDA-MB-157,9549297,2.7932032986762008,2.3420644863088227
YAPC,3689413,3.09003195173071,-0.016407299326627055
KYSE-70,10385095,0.9665013844498838,1.5508206244797609
ONS-76,11222830,1.7336224967240552,1.6456109629489089
JM-1,11625818,3.7613008305210727,3.250114902589351
LoVo,16736978,-0.2277330125842315,1.6253774867791513
NCI-H2009,10074640,3.329342225437922,3.176977613660044
MDA-MB-157,selumetinib-piperlongumine (8-1 mol-mol),2.303505265933228,3.1875935457130735
NCI-H460,9866186,0.4176494313944011,0.6304128244532118
DMS 273,piperlongumine-MST-312 (1-1 mol-mol),1.0735064497414797,1.257716361616206
A2780,60750,-0.3844759756013921,-1.9930709799387796
MSTO-211H,5329102,1.1990183253858175,2.256599043477042
NCI-H292,60700,-1.1983388185725197,0.10078028907200196
OPM-2,16659841,1.643311806599576,2.5271946684044675
NCI-H661,11427553,3.4193847918785782,2.7934596432263703
DMS 273,445455,4.9732665628078045,3.8914044904153666
NCI-H460,9967941,4.030885542149613,3.818495452625768
NCI-H460,5281321,2.142807178276493,-0.8985805677837585
HSC-4,44137675,2.9134227764609735,3.3997848791959875
HCC1143,2729026,2.66692124656069,2.558196169464673
LoVo,1566236,1.5203890875485482,2.1341884466391097
NCI-H146,2842253,3.419228107779433,4.58223529646504
BxPC-3,crizotinib-PLX-4032 (2-1 mol-mol),1.1893497843020568,1.929438071674856
G-401,navitoclax-birinapant (1-1 mol-mol),1.830641570341204,0.7258831221837901
NCI-H522,5311281,2.6748920868920125,2.103675120616583
NCI-H2171,2945648,2.4840683519833835,2.3508733217822604
OVISE,9840324,5.37005208850368,5.770505170986451
NCI-H522,11485656,1.866098793785005,2.018739652290347
LoVo,5280436,3.7935840263164984,3.458959081825161
SNU-61,11152667,-1.0116802565381595,-0.6616495800653087
NCI-H460,2708,4.613368759945332,5.057398984878482
JM-1,6918328,-3.1408711543116854,-1.4756476172968402
ONS-76,1716436,4.404636467874722,3.07693374097653
A-673,vorinostat-carboplatin (1-1 mol-mol),1.8302271851347216,2.5422957779509328
EFO-27,241158,4.165561573655071,4.033101191360511
A2780,7326481,2.2466116261364215,2.953893407349649
SNU-61,11507802,1.2021022137126776,1.285780596695564
MDA-MB-157,11404337,0.0143481506183785,-0.016096741964440994
CA46,71466445,1.6737757590775906,2.351724410074927
NCI-H727,5329102,2.005304296489746,2.0048306940949017
HSC-4,51039095,3.5449735354798,2.7761508953930307
SNU-61,135411,1.4786327368897634,0.4366235095774785
KYSE-70,23635314,-2.258343718513796,-0.6386155510936851
LoVo,54619267,3.1603381625719,4.0498518094966665
A4/Fukuda,71751553,4.0599050322296995,3.848164696413367
MSTO-211H,156414,0.8242215144670997,1.5299489997131526
OPM-2,salermide-PLX-4032 (12-1 mol-mol),5.221268337510566,4.553263802837158
FTC-133,44185566,3.3632936032593403,2.6803663364739223
DMS 273,448949,2.08082767357287,1.63102064317166
NCI-H2009,71466578,3.1093531088855797,4.581856865571468
G-401,44632017,0.8985354611426208,1.220292192566558
BT-549,selumetinib-MK-2206 (8-1 mol-mol),3.7435094380917793,2.680912956296641
HCC1143,107970,2.31840177997234,2.42390721145677
NCI-H661,156414,0.2928474479064595,1.6567732038557352
OVISE,216345,4.54917324344274,3.8091716668800997
SCC-9,25227462,0.3695734481821194,0.5415820728943755
FTC-133,46199207,4.2182762440826576,3.114900333964349
Panc 04.03,9926054,1.9560696374821285,1.9124573012088435
G-401,6918736,-2.2327850291733577,-2.001378147276918
SCC-9,44607531,1.3853072214617428,1.5916889149029136
NCI-H146,serdemetan-SCH-529074 (1-1 mol-mol),0.832618254010713,1.8858331504327555
HSC-4,171352865,4.360447231593142,2.9428671901415795
OVISE,613753,2.681502253258482,3.3888540740921225
A-673,5282054,2.3452018577417166,3.0348406321221106
CAL-51,5328940,1.595278406971918,1.6920394341376106
G-401,426756,4.944025345893246,4.155179920100653
BxPC-3,selumetinib-PLX-4032 (8-1 mol-mol),0.9505923867338788,2.9989816681479726
FTC-133,73707398,1.7335394908123083,1.5179113129329016
LoVo,20959075,-3.964629838563966,-2.5193131804119604
LoVo,46907787,0.5340804086119918,1.7445096789192667
FU-OV-1,9907093,3.428205270837273,4.2328269848298445
NCI-H146,5470400,-3.389889619220011,0.08102703415228886
FTC-133,60750,-2.331663889988264,-1.6136037914145525
NCI-H661,637858,2.3544841299222927,2.170338536867892
NCI-H460,24772860,-0.596461213785507,-1.7625075094862417
FTC-133,135999136,5.800253145127344,3.64542461789547
SNU-61,2945648,3.4316222719918903,2.4657268743947203
SBC-5,52947716,-5.148190181120178,-0.7629421376416972
G-401,5311,0.6627378317361174,0.907386803695935
SNU-449,25183872,-0.2769192593247403,-0.4932548132369068
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.11070561289334
A2780,444795,1.1255727490438436,3.790337911102313
HCC1143,11404337,-0.7051632820466462,-0.18815316953025904
LOU-NH91,23582824,0.7266398713670753,0.9624286774219337
JM-1,24964624,1.3785887120991174,1.0406249680764013
SCC-9,6918328,0.8244293983868239,0.25110963308380735
SBC-5,44507138,1.9527307391432291,2.4107737389749286
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084,-0.4425747173683197
HSC-4,3081361,1.976322212956416,1.9530239644823533
MDA-MB-453,navitoclax-piperlongumine (1-1 mol-mol),1.490500263606314,1.1831686595305297
A4/Fukuda,73707398,-0.4328093310020208,0.6868956990451547
NCI-H146,2130404,3.7873290414593983,2.660689361271559
NCI-H522,11656518,2.6059049947054533,1.4708271918117821
A-498,11626560,2.3564203123568648,2.1123392338971168
A2780,17755052,-1.4995675278651837,1.1576553029111414
HSC-4,2841722,4.578140166849417,4.479745305275613
JM-1,44462760,2.3346005220819785,2.954265330981396
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372,1.2848410010578193
FTC-133,4261,1.6400921135700228,1.7695457302695028
LOU-NH91,54618771,2.8270991446030593,1.39393831548141
NCI-H1623,16720766,0.9555863303424396,0.7634122244511218
BT-549,44632017,1.021144372127497,1.65528406311868
NCI-H292,107970,2.31632347859771,2.393990962557086
SCC-9,24753719,4.411411644196846,4.468838782129054
KMRC-1,4917,3.6746853329943248,2.9593983455252673
NCI-H661,72734382,5.266471995298585,4.53715805177019
SNU-449,4578,4.5704959764236675,4.584691613489027
KYSE-70,9887053,4.5630363901990565,3.8473756314117633
NCI-H460,81146,4.483282466350705,4.8894398401175
G-401,637858,0.5800115670130345,1.3729471038862113
BT-549,5280436,2.325988989460079,3.6512425704870566
HSC-4,107970,2.304506496588027,2.320388886391468
NCI-H292,421610,4.310067764922952,3.4759984591999533
MSTO-211H,11175137,1.4320314455831638,2.6866645072055872
BxPC-3,11175137,2.81920931641519,2.6977232338704793
G-401,vorinostat-navitoclax (4-1 mol-mol),0.632092146955943,0.6979461834863642
NCI-H292,11625818,5.668815438823822,4.584389704522493
BxPC-3,3025986,-1.3024282207469429,-1.0207441612979895
NCI-H460,11364421,0.3566052665939138,-1.5702314235208832
MDA-MB-157,3385,-0.6145392702282009,4.331764457323816
DMS 273,44589607,2.105355871894398,2.182736868517766
SCC-9,107970,3.0149180037966095,2.417518266555821
Panc 04.03,17755052,3.2992451395509503,1.730994007023483
LoVo,10427712,4.119455144779727,4.1627999225260455
MDA-MB-453,ISOX-bortezomib (250-1 mol-mol),-0.3200221310037367,0.45675951230536044
OVISE,9825149,2.776616936788869,2.3005492942921197
DMS 273,44185566,2.401025824688418,1.8148909842493612
SBC-5,selumetinib-MK-2206 (8-1 mol-mol),4.137952563186265,1.815021662665221
EFO-27,5329102,3.2209933806874926,2.352878938486369
NCI-H2009,3503,2.6223022737526085,2.2394685908836798
SNU-449,66577038,3.1506640300230075,3.20904888618029
SNU-449,135999136,4.264029635041134,4.032678676393332
MDA-MB-453,16725315,3.1590887754383847,4.0969709470544995
SNU-61,6505803,-0.8091898598550518,-0.9912135322962453
Panc 04.03,6438330,3.1739512088269968,2.44759473690343
SNU-81,124202324,-1.5604837877349913,1.9685817143298687
Panc 04.03,navitoclax-piperlongumine (1-1 mol-mol),2.817487895898936,1.8836705762121668
FU-OV-1,49850262,3.0107305406398206,3.853698701253693
FU-OV-1,selumetinib-MK-2206 (8-1 mol-mol),-0.4869777969309855,2.1169310159623063
ONS-76,54618771,0.5276024038238057,1.3185102466828107
SNU-61,5311,1.5459052759872411,1.1046701082328851
CA46,11612883,1.866301185217262,1.9955458490592952
A4/Fukuda,selumetinib-MK-2206 (8-1 mol-mol),0.2592073552888009,1.5816160050705788
A-673,11960529,3.1772019850221054,3.597557873109049
YAPC,400769,-0.4056066486406303,-0.3806874246681277
KYSE-70,107970,2.5727619321994353,2.462467124679883
JM-1,5291,3.241129374385646,3.2370937034863174
KMRC-1,9444,4.31479767249553,3.7607746150384878
NCI-H727,44819697,-0.26094531007839,-0.5310684809402052
NCI-H2009,5351362,1.2372754831617516,1.7236031293187246
LXF 289,53495165,1.0389398894889437,0.9425123797161219
ONS-76,vorinostat-carboplatin (1-1 mol-mol),3.120131426487973,2.90894932254912
NCI-H727,123631,2.758434269009812,2.2368389160547677
NCI-H2009,5311,0.3641463076187463,1.383575822850939
MDA-MB-157,241158,1.407364121620741,3.9168481254881273
LXF 289,24785538,0.6202102990423739,1.6668330857527403
BxPC-3,10074640,2.675443562621253,3.2735675445875647
G-401,4378219,4.593157039926137,2.3117032486351095
CAL-51,445643,4.334473435217703,3.984344487966719
OPM-2,2858523,3.124441680057984,2.6835081922063857
NCI-H522,tretinoin-navitoclax (4-1 mol-mol),4.26592131531013,2.005029138973843
HSC-4,11175137,3.5997845208099797,2.7008785714961028
MDA-MB-453,25126798,3.9955340419002057,3.798189778921227
SNU-81,159324,-2.5700546068481502,1.913931954868452
SNU-61,3552672,2.025857953798933,2.913278526471572
FTC-133,246676,4.92384525208296,4.389065266038812
MDA-MB-453,11364421,-1.677319267600166,-1.5665975148647282
CA46,122327,3.963727711050333,3.7992219563214435
LXF 289,262093,3.4150141342974605,2.890319722929699
NCI-H292,6918289,2.42392533304279,2.673985672024153
NCI-H661,25154868,3.681430006213129,4.550802128673232
NCI-H522,327653,3.011425661783578,3.087897391700541
KYSE-70,44202524,1.884457998669868,2.464056514888246
A-673,8515,3.2253171108003023,3.5943105870566687
SNU-449,6505803,1.2866498789511422,-0.5684740869868368
FTC-133,10074640,3.79174067417729,3.2627421111478387
NCI-H522,72734382,6.037966635177564,4.224206299988154
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-1.316393877785366
NOMO-1,46943432,0.592792127892358,0.8894172643116063
RCM-1 [Human rectal adenocarcinoma],2828334,6.287208595728056,6.309794569023113
MSTO-211H,15953870,2.3250629767102273,3.534793047177768
RCM-1 [Human rectal adenocarcinoma],5281321,1.2119883175444373,-1.4523513932947847
NOMO-1,24951314,-0.0494287054100275,0.187073096623508
NCI-H292,6918328,0.4467511585294103,0.31433933583637697
SNU-81,72193861,-0.4444993909438327,0.7183979370631406
SCC-9,9956119,4.352516606884389,3.844017364851016
CAL-51,66577038,4.134711160885491,2.9004396653551
MSTO-211H,44489675,3.600660518296678,3.9840981906302546
SNU-449,11494412,2.814472666417892,1.8996950887393902
OPM-2,navitoclax-MST-312 (1-1 mol-mol),0.8084377370546902,0.4396544413863538
NCI-H522,11364421,-6.31463288554187,-2.8229343101416675
OVISE,11222830,0.6942836946088363,1.782231116199728
LoVo,135398516,0.8347424818537327,2.1388828802903475
MSTO-211H,409805,4.793476239157615,4.837014683669056
SNU-449,selumetinib-piperlongumine (8-1 mol-mol),4.611443902148163,3.5463537965041265
MSTO-211H,9926054,1.9546831701161536,2.007122110394454
NCI-H292,2749,1.484796478537434,1.9456766114365465
OPM-2,702558,4.8466631372101725,4.248770005927218
LoVo,71466445,2.646256567071358,3.8383480772659886
BT-549,16659841,4.205377629414311,4.20344946157969
KYSE-70,3025986,-0.3454993097331295,-0.9407921265011693
NCI-H2171,15953870,3.344319567560605,3.3348656460598187
Panc 04.03,11640390,3.824707626147026,3.7457616525565585
NCI-H292,5278396,3.8202006656128735,3.544115210082039
NCI-H460,5311,2.161812802665503,1.4660218742311217
CA46,54596558,4.227379600712383,4.029634762315758
NCI-H522,50905018,5.2003053075185734,3.6783092516017075
JM-1,54596490,4.858476490911798,4.354683968035335
KMRC-1,5281672,4.43646792139098,4.672758679412036
SBC-5,46199207,3.436092011920994,3.246053156205018
NCI-H661,46907787,3.1119891404607083,2.384271120828222
NCI-H1623,11222830,2.056201659978474,1.8119766483462165
SBC-5,3038522,3.9213361824350024,2.8282406849488204
NCI-H661,9926054,1.7811448977738318,2.1150287560281793
LOU-NH91,969516,2.9922565120136944,2.9857736436090097
MDA-MB-157,5329102,3.39801486229995,2.0151745205239306
SNU-449,445643,4.11461116511151,3.9898111791596302
NCI-H522,9887053,3.177768808520637,3.376355777450139
NOMO-1,16065773,2.6012917178973405,1.7785164431219487
G-401,67291369,1.7656191364648908,2.060034297915143
HSC-4,crizotinib-PLX-4032 (2-1 mol-mol),2.8141472051881076,1.9154625109981809
MSTO-211H,11609586,2.648073114002603,2.998839623900253
A4/Fukuda,25195348,0.8993846970771071,2.7408841964318444
NCI-H2009,54649381,3.659944396907473,3.8866029651089775
CAL-51,3025986,-1.0834382414923172,-0.878954218206554
EFO-27,52912189,5.780518526906142,2.5119682454936223
RCM-1 [Human rectal adenocarcinoma],104842,-3.5875650629821942,-2.1897929460050714
A-673,123631,1.860693828866879,2.1900190241376167
A2780,44632017,0.0856486258730489,1.2012423961939422
A-673,24901704,3.0162186042420966,2.6034403947566034
OPM-2,168312962,0.8773607091058507,0.6481524219458548
NCI-H292,46398810,2.6001901820453166,2.638131736775631
SNU-449,53495165,1.8844225218094013,0.7281306056292273
YAPC,2749,2.2394739682848512,2.162718402971719
NCI-H460,4788,5.894567383019075,5.608865612721611
LOU-NH91,637858,2.168731257760998,2.0352434684952647
NCI-H727,11427553,2.8726920198872397,2.614908113319227
NCI-H2171,5978,-3.1305615418900468,-2.8786055088864013
EFO-27,969516,2.57565712333896,2.9622467246126956
SNU-81,11152667,-1.3658791794225291,-0.6861283330197965
LoVo,2858523,2.923658201852042,2.9994955075722043
FU-OV-1,56946209,-4.492733112758285,-3.693257363334402
CA46,9549297,1.0960598621603344,1.6181567713337848
ONS-76,6917907,-5.751164378556486,-5.0149591731830085
NCI-H460,51037431,2.104101453867928,2.7473060326846883
CA46,68056272,3.136594245199668,3.0363182999513243
CAL-51,54143018,-0.6388505972102335,0.6060270575927048
SNU-449,5284329,2.300938885216567,3.5720230039579857
A4/Fukuda,11609586,0.4485915276425587,2.249041215881314
NCI-H146,9933475,1.6402256772331771,1.7724648524135964
NOMO-1,9927531,5.049638663441057,4.483554773225946
A-673,148198,-7.755828732328633,-3.4903080038239325
SNU-449,2113511,6.338115821615388,5.882154313070386
NCI-H522,49793307,-5.2014711504438,-3.175875127225642
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332,6.292424898464061
FU-OV-1,44493952,2.9850522959236883,3.6353843351432973
NCI-H661,5328940,0.9675290055268168,1.8586791810986043
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693,3.971733156223382
NCI-H727,60700,1.7894131654495464,-0.38055964945592413
MDA-MB-157,10385095,0.7848337329764868,1.4645756630001536
DMS 273,46224516,2.6849968878024297,2.176601120608029
G-401,1641662,3.2482177517563766,3.089415388608215
NCI-H292,448949,2.3471350598248795,2.135203985634401
ONS-76,3038522,3.87205505246704,3.043804264501765
G-401,216468,0.7704979015554879,2.0100070909829766
NCI-H727,10127622,-2.4732053445147333,3.5755196869189967
JM-1,erlotinib-PLX-4032 (2-1 mol-mol),3.366484807659052,2.978895606322242
LXF 289,16722836,0.8079280065417594,1.7400712613605789
FTC-133,11167602,2.051836472120041,2.865524003089679
LXF 289,3825829,3.6707575370566534,4.132413404541655
CA46,25150857,1.719157108492683,1.695641036539296
NCI-H727,3025986,0.1020219293656271,-0.9333191743491451
MDA-MB-453,107985,-4.386344018126506,-3.5458284370762105
NCI-H1623,72193861,2.1993190803521423,1.5157582571167567
MDA-MB-453,decitabine-navitoclax (2-1 mol-mol),3.3987025983008468,1.2925923347105748
ONS-76,12001922,1.7268373273866384,1.937067989538686
LXF 289,5460769,3.06478422280727,2.822617012492125
MDA-MB-453,doxorubicin-navitoclax (2-1 mol-mol),-1.00600213948852,-1.4984437765290164
LoVo,9967941,3.621110602900207,3.7400008318237754
HSC-4,navitoclax-MST-312 (1-1 mol-mol),0.8559820038991849,1.096846760971241
NCI-H727,5113032,6.018394893069797,5.014404160607192
MDA-MB-157,5351362,0.7984725267524495,1.7858135892921592
JM-1,1641662,2.861679408031504,2.7854924601085567
A-673,JQ-1-navitoclax (2-1 mol-mol),0.2328293171340499,0.1302225768440496
MSTO-211H,445091,2.4700472101717312,4.381594868432608
NCI-H146,11404337,-1.5914515878545687,-0.5828721713597458
CAL-51,11364421,-3.809863778172731,-1.608687058597053
A2780,4096211,0.5297517602102724,1.5854355772733093
SW1463,23635314,0.7077124425294024,-1.6688041345299072
EFO-27,9933475,2.2279721994416364,2.037687568587216
CAL-51,135875424,4.33643967165441,3.81860871307639
NCI-H1623,15983966,2.013058792543676,-0.9691590443396326
SNU-449,3038522,2.1807259662851735,3.0966689505240077
SNU-81,969516,2.098687325749346,2.6400406312839793
SNU-449,9935249,2.650976699885872,3.3257258186830962
LoVo,10385095,1.3603816893768768,1.2807922351442025
ONS-76,322968,4.979501026393853,3.8193702960182736
DMS 273,9933475,2.0005654751864865,1.9562879419401653
CAL-51,71466578,5.340961831553399,4.7815849726938895
Panc 04.03,selumetinib-PLX-4032 (8-1 mol-mol),4.2289817394660805,3.5292138963713744
MDA-MB-157,1750826,-3.091616753079083,-1.503116976242846
G-401,salermide-PLX-4032 (12-1 mol-mol),5.25337589730296,4.520150294664613
NOMO-1,702558,2.777027807122979,3.869953065341428
YAPC,60700,-0.2763967023007928,-0.05723282315480969
CA46,5287969,-2.5448622649608925,-2.346979292119176
CA46,15953870,3.0438117584706164,2.968637826051975
A2780,selumetinib-UNC0638 (4-1 mol-mol),2.0119949051388493,3.1713829770808286
YAPC,6610355,5.243598963135711,4.553121021307018
SNU-449,4477,0.3396527753410003,0.519821318075457
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152,1.9064930233370176
SCC-9,168312962,1.0708744032070256,2.146029552019367
SNU-449,119607,5.345576432951938,5.407025074929211
LoVo,135999136,5.7154474843469565,3.748739629644512
NCI-H146,984333,-0.904410626141992,0.28382634959761394
KMRC-1,54619267,4.117989845600413,4.301708572453266
A4/Fukuda,11485656,1.5130746228374388,1.788914177073235
BxPC-3,5311,1.3160685062040935,1.734670799038352
NCI-H522,3038522,2.4524519125835473,2.765947686648536
SNU-61,89928392,1.2163192063780537,1.1033332188366067
FTC-133,5287969,-0.5047683720981219,-1.7153606980470186
ONS-76,25062766,2.430053801867403,2.106799708980603
NCI-H2009,44486219,4.368704582532332,4.366050779338515
NCI-H522,637858,0.9732265340904396,1.5460711706648056
NCI-H522,44632017,0.530418286591973,1.2183388961389674
SW1463,11485656,1.9271812519349985,1.9320744631763767
SCC-9,46843906,3.309522412048413,3.1548871649859005
A4/Fukuda,6914657,-5.308594861321554,-4.3567794733559735
LOU-NH91,36462,3.2256365983613677,2.5617815811651763
NCI-H1623,3825829,4.488518875119825,4.186613257492508
MSTO-211H,56946209,-4.75779739938848,-3.843240016106461
YAPC,11427553,3.397606686380644,2.7823802963308752
JM-1,426756,3.661156723786521,3.7671345627670534
JM-1,10184653,1.3269176228991806,0.9487230933848363
NOMO-1,11497983,-3.443590431300748,-0.8609168367747564
JM-1,JQ-1-carboplatin (1-1 mol-mol),-0.8945850233452926,-0.14972131368174496
A2780,9952709,2.339079626269582,2.8739651002439524
MDA-MB-157,9866186,-1.7048510464532898,1.084057433818329
CA46,216239,1.3191761483145148,1.6982747681640662
MSTO-211H,176870,1.3974668510804569,3.60588871169014
LoVo,vorinostat-navitoclax (4-1 mol-mol),1.8172554757062631,1.0287333790124902
OPM-2,135928012,2.8826672527394956,3.7506763963166154
BT-549,9915743,2.34179420613382,1.6592100202541362
LXF 289,71304818,2.1201305139291033,2.6587630681493537
HCC1143,11214940,2.1301365232114144,1.9739394997020148
RCM-1 [Human rectal adenocarcinoma],2871966,0.2370033726564668,0.6305703082553249
KYSE-70,11404337,0.2060464556058333,-0.3639326970242604
NCI-H2171,11152667,-0.915095731247344,-1.0786984871768481
HCC1143,46191454,1.52291312584366,1.6288690639711638
SNU-449,71680916,5.959793136995753,4.820349876500637
YAPC,219104,4.027438046449075,3.9419284749156294
JM-1,446155,2.7706022090916793,2.15669546062064
BxPC-3,46398810,2.2883583084835126,2.63687296549522
OPM-2,2828334,5.82639787583413,5.784968560144586
A-673,44137675,3.4578104481213905,3.241596435962109
FTC-133,7251185,3.0292037228467628,2.592079253660695
KMRC-1,676352,1.883475825529446,1.9815525372824498
EFO-27,1641662,3.8267974599371417,3.732292499667887
G-401,168312962,3.2015141434031547,1.373332399697711
CAL-51,2945648,2.7250935788350064,2.89528588056308
CAL-51,71466445,4.7818956768695715,4.113750290641971
JM-1,5113032,4.766616079684312,4.415788688190999
SCC-9,24821094,2.906183993814488,3.058303558722809
NCI-H661,piperlongumine-MST-312 (1-1 mol-mol),1.6507934598054954,2.017444680350028
NCI-H292,216345,3.474677020151061,4.0616927987616736
MSTO-211H,JQ-1-MK-0752 (1-1 mol-mol),2.3232645118005015,1.4233667179386138
SBC-5,9549297,3.510799485826288,2.286088845353608
CA46,156422,3.7635879578153126,2.6488815294476598
MDA-MB-453,71466445,1.9167870178623896,3.5859083534331133
A-673,54596558,3.847043372257958,4.27966974946594
OPM-2,10231331,0.6444733525039235,0.9489310491053693
HSC-4,5335621,5.235604448739508,4.582507823129892
CAL-51,11719255,2.5837610433465588,3.3993259629842343
Panc 04.03,44493528,4.362737332857046,4.323012504504715
SBC-5,carboplatin-etoposide (40-17 mol-mol),1.335045540127449,2.693525444384632
NCI-H522,24821094,2.425713290484283,2.621841790345326
CAL-51,6610355,4.388066889778601,4.443651469312242
MDA-MB-453,6438330,2.0150251794967655,1.9408270785201418
Panc 04.03,46199207,3.759856924739056,3.3204411623202894
SNU-61,9866186,1.5207851909017442,0.8097590243875075
RCM-1 [Human rectal adenocarcinoma],10427712,4.591789634520137,4.281687133641255
RCM-1 [Human rectal adenocarcinoma],72193861,4.277039631190645,1.975060978326926
Panc 04.03,71466578,5.726073349824824,4.6336850398181255
NCI-H727,107970,3.133468251114326,2.207469894290963
BT-549,60700,-0.4810674620852896,0.28173070060305067
OPM-2,51037431,4.229346700902662,3.0563453683990165
MDA-MB-453,56946209,-4.730570165381635,-3.9251622785916447
NCI-H460,72376,-0.5460239014371263,-1.8278915826292654
BT-549,44241473,4.976602861760902,4.844476407539921
A2780,24748573,1.2286507677110594,1.7860393209787562
NOMO-1,5311,-0.031303965270056,0.4126193791764986
A-673,9927531,4.216692000672551,4.536839017588253
NCI-H1623,46199207,3.747077477678168,3.142413991843676
NCI-H292,71304818,2.830949431838268,2.5891732825880562
NCI-H1623,9911463,3.95788841498078,3.8809603173683325
SBC-5,9825149,2.9056064620320896,1.8512355825135136
NCI-H460,11612883,2.88158995470921,2.6826895939069457
OVISE,6918878,5.066606594706477,2.9354578867600254
FTC-133,5278396,3.726623182659884,3.5750572599764507
Panc 04.03,24775005,4.54660450697204,3.7531297475780843
CA46,1641662,3.144498035259472,2.797612827719991
MDA-MB-453,16722836,1.2443221263797826,1.7824553055564605
CA46,54618771,1.203400154931592,-0.02167371922235078
HCC1143,613753,3.4353326628352714,3.0830061569866545
A-673,60750,-4.61356677624384,-2.780145171978151
A4/Fukuda,1641662,2.3667755294261297,2.9215319259698607
OVISE,navitoclax-piperlongumine (1-1 mol-mol),0.5165659112827317,1.076756227978337
MSTO-211H,375860,0.0606650448750636,-0.22974852206544694
BxPC-3,6184667,3.26727461265582,3.226499419902993
CA46,227681,1.829365253324193,2.6318320233967274
SW1463,11964036,0.627645429671571,1.456583112566414
NCI-H2009,vorinostat-navitoclax (4-1 mol-mol),0.5355412888346941,1.6332476079957012
FTC-133,49766530,-1.1381086002707512,-0.6700749419100818
SNU-449,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2718140952083585,4.7263057593115585
NCI-H292,11364421,1.76762986564817,-1.1010363642430447
KMRC-1,44819697,1.235264283084374,-0.1536114989354863
NCI-H661,9907093,3.834837743900246,4.220269438458324
DMS 273,17755052,0.9609599247674856,1.3892334347842379
SCC-9,11364421,-0.952029021799848,-1.5391148821921048
FTC-133,135984461,4.350998124633342,3.7350883173291045
JM-1,11497983,-3.7280544169699192,-0.5705352418391079
MDA-MB-453,24753719,4.38597739181452,4.066778936396648
ONS-76,168313047,2.901208476511606,2.3886042743531535
NCI-H460,67156097,3.7191617083219097,-0.5931093359473623
SNU-81,selumetinib-decitabine (4-1 mol-mol),-2.7455044109926168,2.129667819255468
A2780,9866186,0.3046354439957303,0.4727145515886428
HSC-4,219104,4.150323587810277,3.930762148070725
SBC-5,168313047,3.954131669958023,2.4707924824304413
RCM-1 [Human rectal adenocarcinoma],19582717,3.1254677854052333,4.18698845936719
NCI-H292,15953870,3.631273190289841,3.592368825166375
SNU-449,5281321,-2.557888043471457,-1.212039262039382
HCC1143,702558,5.703077608026742,5.011761706436531
EFO-27,644241,3.241988529302909,2.375487641650966
Panc 04.03,9911830,2.4999304852863404,2.8675341539796557
NCI-H522,9967941,3.44539283334302,3.458518981650639
BT-549,44607531,1.5480457992975702,1.7326710204193398
BxPC-3,44607531,1.3275313586220698,1.5151780312563108
KMRC-1,24951314,2.7376925539969927,1.4355195157114085
JM-1,10231331,5.343116821873739,1.166541690207668
A-673,25262965,-3.9892118887375303,-1.8104635967238338
FTC-133,1716436,3.3698315146098015,2.903327935434255
OPM-2,2733526,4.066729211955922,3.4759168697862233
RCM-1 [Human rectal adenocarcinoma],168312962,3.7277757368773345,1.866417120108694
DMS 273,3825829,3.788583241717048,3.330216903306383
KYSE-70,3825829,3.6022414485207452,3.9429998640878705
BxPC-3,5351362,0.9304368738373464,1.4930165691086912
NOMO-1,6918736,-3.755126975181922,-2.324568226603974
A4/Fukuda,11977753,-3.131569873612884,-2.0563882477378064
SBC-5,navitoclax-pluripotin (1-1 mol-mol),2.5594903061856744,-0.9676174417304501
MDA-MB-157,navitoclax-piperlongumine (1-1 mol-mol),-2.7470196870152894,1.674607389960754
A2780,73707386,2.710080958425795,2.480600801252956
SW1463,44819697,-0.8614164905769626,-0.11006823549633678
YAPC,24180125,3.806846010722946,2.9819927166451827
NCI-H727,54649381,3.660865770056845,3.88345568795965
SNU-449,2708,5.735631765174737,5.081657622949829
CAL-51,54143018,-0.6388505972102335,0.6060270575927048
LXF 289,753704,4.962227230589067,5.0186900493937765
NCI-H2009,9907093,4.391694288558607,4.200360075503881
EFO-27,387447,-3.111228692284437,-4.000230886562171
NCI-H661,65064,3.46809117241053,4.683555388253116
SNU-61,5278396,3.627128978826316,3.13712360287069
NCI-H727,452548,3.7056139041011034,0.7371434186550454
NCI-H292,16720766,0.3451831901206211,0.8760753673040963
SBC-5,serdemetan-SCH-529074 (1-1 mol-mol),2.482890846632963,2.0080725676752538
A4/Fukuda,100016,4.8831896191852096,5.192298032788812
G-401,25126798,3.708942608188802,3.6122087324220478
SNU-61,24951314,1.416243399270427,0.8867300521550878
CA46,89183176,2.547561715641907,3.0398593630221638
Panc 04.03,2746,3.3610494767062513,3.423215392329407
FTC-133,107970,3.2744864550719126,2.346079345686961
NCI-H661,6918878,1.4921814323330362,3.1001553262859187
YAPC,24951314,2.2257819926279243,1.4114104609575648
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925,2.432190033315361
LXF 289,216345,3.67485776854348,3.9335106217393916
G-401,5287969,-2.352936827953192,-2.0252415333385256
LXF 289,5566,2.9960878643930218,3.075297281376416
JM-1,71680916,3.747509118270568,3.967884926881122
LoVo,16741245,3.141864677583783,4.0366944604774435
NCI-H661,54649381,3.920223147571483,3.8660242349724974
EFO-27,25154868,5.200143123549252,4.407744490325329
SCC-9,25126798,4.663845786250664,3.924551320747631
A4/Fukuda,24964624,-0.76967256635286,1.5226043041098336
A-673,11178236,-6.344930978772708,-3.529115469565794
SNU-81,3825829,3.873341985908314,3.282633478171431
KMRC-1,36462,3.0698954920529324,2.194874687541304
NCI-H661,262093,3.4983141095274126,2.7253857042456673
LXF 289,JQ-1-navitoclax (2-1 mol-mol),-0.1811537886614743,1.033183910553783
G-401,676352,1.5550652369933835,1.9514657724535538
SNU-81,11228183,0.0397441918833689,1.2092799724599146
MDA-MB-453,10385095,0.8735195901829151,1.4673662710814919
KMRC-1,16065773,3.457331493974802,2.5224117593028517
CAL-51,5328940,1.595278406971918,1.6920394341376106
CAL-51,56946209,-4.496983035262223,-3.950716253954212
FU-OV-1,5329102,1.609553320034118,2.065633013609013
YAPC,3062316,1.4892918633711576,1.2716823911115485
NCI-H661,11609586,3.2377833862635206,2.960650365868612
RCM-1 [Human rectal adenocarcinoma],5329102,2.5793782122473985,2.0345769030097527
NCI-H661,serdemetan-SCH-529074 (1-1 mol-mol),2.3260585064542014,2.097088516969046
JM-1,36462,-2.702351282209385,0.4625525915476404
EFO-27,55508,5.431657737658487,3.460439616110342
CAL-51,10296883,4.0377332681132305,4.0194282888372825
CAL-51,123631,2.4616591372530605,2.3575774398614633
A-673,53481919,3.7180877845578073,3.3423590676216035
JM-1,107970,1.4704012549786991,1.79808468240832
CAL-51,5278396,3.885366261927898,3.610293784888953
RCM-1 [Human rectal adenocarcinoma],44819697,-0.1720631569254475,-0.12097071261738479
KYSE-70,4096211,2.254549645630953,2.134672050428261
DMS 273,11609586,1.9163652577621844,1.9906621495853267
EFO-27,9903786,4.039986452778869,2.89349836658914
CAL-51,6917907,-8.395782425589301,-4.73198746741546
A-498,54454,2.893611310147977,2.5290505079789773
A4/Fukuda,49793307,-5.572580515048152,-4.047926133844316
NOMO-1,4259181,0.2459758371125145,-0.36094470029421616
SNU-449,107985,-3.1392486992039235,-3.311843964912868
FU-OV-1,5278396,3.713343254157872,3.6392072529209565
SCC-9,selumetinib-decitabine (4-1 mol-mol),6.773727258865908,3.770530446563338
A-673,5460769,1.3883868162718005,2.3832016175762103
SCC-9,568763,0.9120329628896908,0.668770510945593
CAL-51,72199292,1.0008292341873897,0.5032946994634433
MDA-MB-157,8515,2.4995790404865983,3.83773708616902
NCI-H661,374536,3.546483103952357,2.292024693592214
KYSE-70,selumetinib-navitoclax (8-1 mol-mol),3.975968679943077,1.7737951295759218
FTC-133,53392493,3.195209876090235,2.71324574910989
SBC-5,selumetinib-tretinoin (2-1 mol-mol),5.430491518611957,3.322764174908999
SNU-61,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6699368728217061,3.2752349909832468
BxPC-3,selumetinib-MK-2206 (8-1 mol-mol),0.2275715298784707,2.277429001143498
NCI-H2009,3825829,4.333180881174198,4.0891961070879
A-673,6610216,4.190818336865809,3.847082989541322
LXF 289,1750826,-0.5305094201812034,-1.7232658378857926
MDA-MB-453,44543605,3.7347256504274418,3.704476108137319
BT-549,24964624,2.3327253679943696,2.701343000895556
DMS 273,24797083,1.0969779553781829,1.3271490852634031
NCI-H2009,24856436,-1.037334288977755,0.7114567123988854
ONS-76,73707440,4.1934861569389845,3.9760642328287314
NCI-H2009,1242560,3.090706196906407,3.625762498808644
NCI-H2009,6610355,3.511475006316147,4.612524690844895
CAL-51,51039095,2.1842093640891416,2.77171774517727
CA46,11404337,-2.4021967063511434,-1.192650039204517
A-673,decitabine-navitoclax (2-1 mol-mol),0.9419890820834614,0.42697484173125133
NCI-H292,11152667,0.5464898224488388,-0.48584030705056525
CAL-51,25154868,4.656760297450745,4.35751516447211
NCI-H727,doxorubicin-navitoclax (2-1 mol-mol),0.353164953880874,-0.7299578802122881
HSC-4,66577038,3.591157601556467,3.130019609435796
LoVo,11175137,1.7419612548831422,2.4523173667005684
Panc 04.03,46215462,2.9027075063139804,2.0888529633319752
G-401,1750826,-3.031444880989549,-1.8890406919074467
SCC-9,462382,0.912003027061621,0.5383147812111662
NCI-H2171,71304818,1.9125624841179896,2.1536057366424
NCI-H2171,6252,2.1051572182795,-0.7074940661774758
G-401,51037431,3.9974576184013726,2.9589225517136675
SNU-61,219104,3.1068483513637033,3.296974424922264
SBC-5,60750,-3.858196401702703,-1.516639140928501
JM-1,72734382,2.7239851923699443,3.591212813796683
EFO-27,2733526,4.707486415914075,3.703630643972417
A4/Fukuda,71466445,1.4546499284121797,2.3831713501454406
RCM-1 [Human rectal adenocarcinoma],54454,4.0573540170920355,2.8604454283707286
NCI-H460,24797083,0.9153025805785596,1.4294542094621725
A4/Fukuda,54596558,4.022693113590735,4.291738938411701
RCM-1 [Human rectal adenocarcinoma],15983966,2.238460019878405,-0.3633063861490037
NCI-H2009,serdemetan-SCH-529074 (1-1 mol-mol),2.304731385362492,2.2084707374929455
HSC-4,44202524,5.184990397771561,2.1840427407826892
MSTO-211H,erlotinib-PLX-4032 (2-1 mol-mol),1.1572104860425592,3.343892615000722
SNU-61,selumetinib-piperlongumine (8-1 mol-mol),1.4116770683714617,1.8516881252303756
OPM-2,9915743,0.7579871544404475,0.31032477246383033
CA46,56949517,4.303265452215328,3.6329209475078756
HSC-4,tanespimycin-gemcitabine (1-1 mol-mol),-4.488052486534361,-1.6083031034678816
CAL-51,24785538,0.7720267524795773,1.470124155996232
EFO-27,navitoclax-piperlongumine (1-1 mol-mol),2.507192070148125,1.6432600950018548
CAL-51,10322450,3.881825194853649,3.8464868825534144
A2780,241158,1.61479428578643,3.197432373173919
CA46,JQ-1-UNC0638 (2-1 mol-mol),-0.7861923396287928,-0.2282569939869712
LXF 289,10074640,2.806214579062189,3.259388426876119
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928,-0.6790565788822646
NCI-H522,119607,5.115168095819997,4.7985522966870136
A-498,6918638,1.620608219340894,0.9716679080942144
CA46,10302451,0.2515382956842912,2.470485798660489
NCI-H727,11152667,-1.354343634557878,-0.25209326418833045
NCI-H292,135999136,4.360218039072087,4.180279374335846
NCI-H292,322968,4.489137987914782,4.05242096469276
KMRC-1,11238147,2.6910045327617422,2.747777685735964
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264,0.7661106111669718
NCI-H522,9911463,3.273817127322074,3.4658916364015533
A4/Fukuda,26596,-3.7061252239164553,-2.3518095952614955
CAL-51,2945648,2.7250935788350064,2.89528588056308
FTC-133,10113978,5.149340897630058,3.2171686243566997
G-401,25227462,-4.354739504605027,0.005602241547750373
CAL-51,3634881,3.319714226315486,3.366940368253579
NCI-H522,5280436,1.9285860105900432,2.976283295104204
LOU-NH91,JQ-1-MK-0752 (1-1 mol-mol),2.239144963977278,1.6234131045925184
A-673,285033,-3.783680268063714,-2.5237246911452114
KYSE-70,11497983,4.3699696445826035,3.611693260953046
EFO-27,135423438,3.7049046399150134,2.306614191656738
CA46,26596,-3.5845712744961324,-2.83907614082414
A2780,24785538,0.5365701421591345,0.7852173186909708
NCI-H2009,8515,4.894015987740437,4.019961284974631
DMS 273,carboplatin-etoposide (40-17 mol-mol),3.245479848916456,2.028736945346424
JM-1,387447,-6.033292615187937,-5.054260533930177
DMS 273,9956119,4.190734481617164,3.196207117597215
A2780,navitoclax-birinapant (1-1 mol-mol),-1.2503932555480053,1.046819428710902
NCI-H146,36462,-0.9223549938225544,1.7897215995195817
NCI-H1623,11485656,1.644044907667622,2.433168774202009
NCI-H1623,24821094,-0.2323488781711246,2.9928294953334027
HSC-4,53301938,4.738168418112686,3.2876525881233607
LOU-NH91,676352,2.464978676736505,2.1225628520544872
NCI-H146,46926350,-6.324766796143129,-4.356605329917452
ONS-76,16722836,1.7132123007700326,1.5964974361993325
YAPC,327653,3.117178905090827,3.3226246662655363
OVISE,24901704,4.2849421736627615,3.438039799351296
JM-1,54618164,3.458143614246244,3.6968142694675685
A-673,445091,4.1466370846962075,3.854044042964799
OVISE,5329102,2.956482132219437,2.1241833349829373
HCC1143,5470400,2.3870928447001867,-0.27038740140794204
BxPC-3,salermide-PLX-4032 (12-1 mol-mol),4.912455807166081,4.737623763613657
SNU-61,3503,2.986460298481687,2.106417821366421
DMS 273,11455910,0.4737958394902512,0.5258748623305628
NCI-H460,46907787,4.3372157131836255,2.4494216350473175
CAL-51,216345,2.9520334452605637,3.7999897847301596
A2780,6450551,0.1349302943593443,1.8149364732189703
LoVo,46398810,1.578557668618055,2.445719104565479
SNU-81,15953870,1.3050219745867302,3.4535822385683725
A-673,54613361,-0.6759826855411176,-0.6068708664493845
SBC-5,11234052,4.136817608168693,3.935870683622982
NCI-H460,36462,3.103581216464206,2.0005022768910443
MDA-MB-157,selumetinib-JQ-1 (4-1 mol-mol),4.112916907677963,1.8626819328317301
A-673,168313200,1.7801049656035806,2.7371828140139947
A4/Fukuda,vorinostat-carboplatin (1-1 mol-mol),1.5546210220419645,2.1054107341120614
A2780,100016,4.757543521992015,5.646230520757801
NCI-H727,selumetinib-tretinoin (2-1 mol-mol),0.6638203077807998,3.578100153994803
CA46,25105715,3.628482142858773,3.2013689392557323
HCC1143,9911463,3.749174224015704,3.979447863950893
LOU-NH91,4477,1.3512747052000795,0.5990509661410006
A2780,UNC0638-navitoclax (1-1 mol-mol),1.9262711606440108,1.1211711187549587
FU-OV-1,25154868,3.6525772823030502,4.5812664372783125
A2780,168313016,3.896841135664639,4.402126770545997
MDA-MB-453,JQ-1-UNC0638 (2-1 mol-mol),-0.1830175507337199,0.9204181732095559
FU-OV-1,selumetinib-piperlongumine (8-1 mol-mol),2.8006116127321463,2.9246984748081535
NCI-H292,15547703,3.23498204624142,3.1585741136750385
JM-1,5329102,1.4301495534996294,1.2866546456500592
NCI-H522,3384730,2.8239588226941104,2.190144188063424
A2780,9911463,2.7303797257759235,3.4712321646818767
RCM-1 [Human rectal adenocarcinoma],5746,1.2509488539194744,1.3450314579099412
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642,3.2166541779989495
YAPC,9887053,4.707664045043398,3.890076982367398
HCC1143,10074640,2.8253679093766104,3.246273756482663
LXF 289,11178236,-2.9660816129263297,-3.098052989654012
A2780,ISOX-bortezomib (250-1 mol-mol),0.49630436037141,0.5884233547330662
KYSE-70,135398516,2.3739819683449697,2.1048315114370557
A-498,57519531,4.461574036812888,2.906114039078338
NOMO-1,9840324,6.741383080584752,5.3871246305577465
BxPC-3,10427712,4.346184062898943,4.316750980092898
NCI-H292,selumetinib-decitabine (4-1 mol-mol),4.672876887029793,3.8488448811871026
LoVo,25062766,1.8850615394111836,2.1537068154042602
FTC-133,262093,3.024825063724614,2.9853979534516237
HCC1143,44819697,-2.8669414823386115,-0.6134824486640196
BT-549,5351362,2.1022372489581227,1.5493269872304447
FTC-133,selumetinib-navitoclax (8-1 mol-mol),3.0170288782836163,2.16719414689549
MSTO-211H,53325874,5.432400358349695,4.435178848387227
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.1151951448673314
DMS 273,7326481,3.48743847164077,2.9191087807077496
JM-1,11955716,-2.692308040243548,-2.058068753540226
SNU-61,JQ-1-vorinostat (2-1 mol-mol),1.221813874955551,0.30236659102625224
MDA-MB-157,2842253,6.170125707570699,5.523824753165632
SNU-61,54454,3.789888893365768,2.301067775138807
NOMO-1,5460769,4.769752092364765,1.7793153838774918
A2780,285033,-3.502152061737446,-2.896660496541817
HCC1143,44495899,4.517503920361928,3.0009102517224386
NCI-H661,31703,-1.814857416200904,-0.789167456351729
A-498,piperlongumine-MST-312 (1-1 mol-mol),3.2083615282552853,2.178773349609421
YAPC,navitoclax-pluripotin (1-1 mol-mol),-0.110540489139909,-0.6497970899369979
A2780,2729026,1.9590477988732768,2.5464203105426635
JM-1,89928392,-1.0810313065311572,0.05871033344997452
JM-1,10410894,1.2527004533251185,2.578896740898799
NCI-H661,16038120,1.553795977052523,1.1298519047243827
LoVo,135421197,2.0078610802467307,1.8707476776686178
HSC-4,24901704,4.088081803824046,3.3774207707654313
HSC-4,135411,-0.261300177061483,0.6522221228109676
NCI-H522,4917,2.9130794248329392,2.8267933065862216
JM-1,11364421,-7.32386861469755,-4.7673803905861085
NCI-H2009,10127622,-1.471627480680591,3.856630576973014
DMS 273,4917,3.103248515982538,2.894611804042654
OPM-2,44462760,2.3304413416808463,2.4797489288232373
YAPC,9956119,3.92905072911681,3.717519482273232
A4/Fukuda,5113032,4.450145517718883,4.645127696892035
NCI-H1623,49793307,-1.4788317062169576,-2.7038731133371554
BxPC-3,637858,2.219072546092823,2.0103065498447745
NCI-H1623,1566236,4.077529389730835,2.471611602120529
G-401,23725625,4.115882586635449,4.026218905517265
SNU-81,crizotinib-PLX-4032 (2-1 mol-mol),1.4380831221683867,1.4891060996614278
DMS 273,252682,6.321322886147215,6.411184629109592
KYSE-70,135411,1.9014599224142343,0.878229663061331
NCI-H2171,49867930,3.814749813399888,3.4167472539720056
SW1463,10302451,2.197754569420114,2.7387962690965124
Panc 04.03,salermide-PLX-4032 (12-1 mol-mol),5.297407479315669,4.811080932473654
NCI-H522,71466445,4.480637973076106,3.3094946920309827
NCI-H727,6610355,5.167779637611195,4.442653043044179
A4/Fukuda,613753,2.966875582154842,2.9428606690908254
ONS-76,4261,2.2909626551681757,1.5977354007105589
YAPC,serdemetan-SCH-529074 (1-1 mol-mol),2.033605312871709,2.1724234631669117
KMRC-1,31703,0.3325905755235477,-1.0772418110162096
SNU-449,445455,4.484776409201516,4.952917686890527
A-498,6918878,4.306638073301365,3.2175271159650913
SCC-9,selumetinib-tretinoin (2-1 mol-mol),3.7791942672746974,2.9395701103687033
OPM-2,1750826,-5.079410714013139,-2.5113914831556596
NCI-H1623,9915743,-1.6977137550638366,0.9432770652496114
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,1.971070442734977
SNU-449,7251185,2.777592648573664,2.688206663049416
NCI-H522,2733526,4.089503686239825,3.6569105163050084
LoVo,24180719,2.381979820549913,3.4593322980394756
A-498,49793307,2.582548635431232,-1.9647005275631042
FU-OV-1,selumetinib-PLX-4032 (8-1 mol-mol),1.0793153404708502,3.5609799497115433
NCI-H522,4788,5.8756804910396925,5.3589269583488495
G-401,374536,1.448879337840406,1.1724192684275077
SBC-5,135440466,3.787084066930897,2.2238418280568357
BxPC-3,36314,4.043064497836865,-1.2351949538558884
SBC-5,11626560,2.9533832336239985,1.7681454308710896
OPM-2,613753,2.6904302784099845,2.879668373071532
G-401,71466380,4.3225707153388,4.2791032718826925
G-401,45279963,3.527434868311602,3.331216905851619
MDA-MB-453,1239801,4.069717893467032,4.113602130877728
A2780,11719255,1.8256962189728296,3.006912228403402
KMRC-1,navitoclax-gemcitabine (1-1 mol-mol),-4.218093403904549,-1.5874332038004744
HSC-4,11404337,-0.2351979780524762,-0.49183004596722735
A2780,crizotinib-PLX-4032 (2-1 mol-mol),0.8552062968209889,1.7824446982692461
JM-1,5978,-5.097158196512326,-3.4913500927966123
BxPC-3,6917907,-5.822397614063261,-5.332116830768333
NCI-H2009,52912189,1.2519346625881922,2.159544450857445
KMRC-1,6917907,2.5901706443444477,-4.107110348742198
YAPC,selumetinib-JQ-1 (4-1 mol-mol),3.639146337556592,1.5072925511931223
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367,3.913634292749458
KYSE-70,2746,2.8005709054024224,3.29925237062697
BxPC-3,638278,3.0042450495358923,3.370378749078114
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.8868479349671113
HSC-4,31703,-2.446577735650292,-0.9440121806951604
NCI-H661,11152667,-1.7022631730770723,-0.34932872075407284
SCC-9,73707398,1.5896934234406246,1.3415441071721435
FU-OV-1,148198,-3.302287500778492,-3.560752158355687
MDA-MB-157,5287969,-2.775456728988527,-1.6631727758773474
OVISE,6918289,3.317561176891493,2.6910448273964938
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.9634209979110695
HCC1143,10296883,4.463772522749199,3.7363135377252505
FU-OV-1,25150857,2.264135178575504,2.452979497339018
LOU-NH91,ISOX-bortezomib (250-1 mol-mol),1.5845315088477396,0.7140664189973037
BxPC-3,16725315,4.1100247270568815,4.412046050065138
EFO-27,11707110,4.483747329636401,0.31099746154662833
A-673,2858523,3.068752318729834,2.9127837323278176
OVISE,5280436,4.204860612632051,3.396595086565867
NCI-H727,122327,5.896927010318378,4.730527705179082
CAL-51,448949,2.479839067238928,1.9863886293494553
NCI-H2171,serdemetan-SCH-529074 (1-1 mol-mol),1.0572285020282108,1.4757865340423248
HSC-4,72199292,2.0552941548988506,1.0181859343122714
NCI-H2009,36462,0.0033291412741449,2.27971268155561
Panc 04.03,JQ-1-vorinostat (2-1 mol-mol),1.3014737329174946,1.202210625715533
JM-1,71466578,1.9829041072742877,2.597576483673237
A2780,JQ-1-vorinostat (2-1 mol-mol),0.2041997396935529,0.7430695060883906
LXF 289,67291369,3.4412292386368746,2.826313612155613
NOMO-1,5281321,-2.1390969134868656,-2.6316421315129945
NCI-H661,387447,-3.746079371333459,-4.192752141273648
NCI-H460,10385095,2.2920897819597896,1.343765979731126
EFO-27,3543504,5.270070957864149,4.610916262482101
NCI-H2009,11497983,-2.437134563400756,3.9123385440914
NCI-H2171,4917,1.7834364774656617,2.944574930584095
MDA-MB-157,4578,4.4846224734546025,4.44970646346998
A-673,9935249,0.595201632659186,2.0112003820676696
NCI-H146,4096211,2.4692816884948856,1.6671582007793566
NOMO-1,60750,-2.6028640292275567,-2.9401534287054347
NOMO-1,676352,2.3647709516043336,1.8784589169030437
SNU-81,168312962,1.078666024421789,1.5305612515488516
A-673,3081361,1.7117642477526505,1.935115870084373
NCI-H460,46398810,3.30325787352206,2.5507407545099703
FTC-133,24771867,3.849205905915908,2.490220370524186
KMRC-1,409805,5.852991634240623,4.452542856211907
LXF 289,2708,6.094251503540483,4.814791450519393
A4/Fukuda,11647372,-0.68075141177871,0.7686684909416337
RCM-1 [Human rectal adenocarcinoma],25195348,3.936962209730735,3.4051691730816462
NCI-H522,3025944,4.039653719751215,4.179037606114036
HSC-4,6918289,2.856015155241233,2.5839252576860345
MDA-MB-453,erlotinib-PLX-4032 (2-1 mol-mol),2.999832239704596,2.6104885845879204
MDA-MB-453,67291369,1.3466484853812946,2.6587636779197408
A4/Fukuda,11178236,-5.149024442366163,-3.5344465185412917
NCI-H661,168313200,3.81404568417466,2.9434463109133056
EFO-27,219104,4.121088157278177,4.014626936656546
KYSE-70,46191454,2.1451937437577575,1.389273092095688
SCC-9,9927531,5.254709651648818,4.932186658393084
A-673,navitoclax-piperlongumine (1-1 mol-mol),0.5796855962539734,0.7286354723202095
CAL-51,16038120,-0.248771562775031,1.0282455055718422
JM-1,3634881,1.559410928505107,2.5640868055211463
SCC-9,5113032,4.570528604758655,4.880482749788758
CAL-51,68056272,3.9955701948507247,3.371804138894133
CAL-51,4521392,4.667802355757324,4.146018419469225
BxPC-3,navitoclax-piperlongumine (1-1 mol-mol),1.3224342280969303,1.8423750836935247
Panc 04.03,BRD-A02303741-navitoclax (2-1 mol-mol),3.819752111817625,2.519671586050076
A-673,serdemetan-SCH-529074 (1-1 mol-mol),0.8484968738221454,1.6341417623621695
SNU-61,9887053,4.377899885829067,3.231286775693793
NCI-H2009,25102847,2.121570289721804,2.347127017954217
NCI-H661,54454,0.5886754914082402,2.6128898285054665
RCM-1 [Human rectal adenocarcinoma],24901704,4.114962911798603,3.4472152973675496
MDA-MB-157,46174525,4.215722898807237,4.542461098686125
LoVo,5978,-0.9838296745754056,-1.4789349266628455
NOMO-1,44137675,1.7607667559168472,2.7185790821133793
JM-1,ISOX-bortezomib (250-1 mol-mol),-0.4363685688396392,0.04708048898629701
FTC-133,216468,3.7386330008080018,3.4563021926618536
NCI-H522,5284616,3.1429047752915036,1.3063595220792317
A-673,6450551,1.2504532759531255,1.6104571527910028
MDA-MB-453,2126,4.599537631708682,4.596549721883566
FTC-133,12001922,3.1425787892022656,2.088558065510089
BxPC-3,6610355,3.939463034432562,4.416844105493673
Panc 04.03,72193861,4.339971647759762,2.1106459288105337
DMS 273,984333,0.9143511576606916,0.3179971853148603
NCI-H460,126941,-2.220790788147435,-2.5522566175446797
SBC-5,11178236,-5.106449128542812,-3.1819387979998903
A2780,11497983,-3.587231584220661,1.7138260260035156
EFO-27,5278396,3.98166727080577,3.5009625368698107
NCI-H460,40482356,5.06381124686115,3.910033326243062
OVISE,51039095,3.497583622307714,2.829082942312553
HCC1143,56946209,-4.25120546555742,-3.7088844538261894
NCI-H2009,3025986,-0.6988289053859157,-0.5076811357267728
DMS 273,44543605,5.15097132829554,3.8231696833938087
HSC-4,23635314,4.118860430098142,-1.235740735289223
FU-OV-1,107970,2.0514231206369686,2.438422962883448
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744,1.2515655354275268
A-498,5284329,4.906845392884974,3.67546314981808
NCI-H522,selumetinib-piperlongumine (8-1 mol-mol),2.5567872657123307,2.571886386167102
A-673,11612883,1.6900414301434703,2.3260064962705864
DMS 273,11507802,0.7884214749573938,0.8145785592523577
NCI-H661,44486219,4.876697308801278,4.439081066255039
RCM-1 [Human rectal adenocarcinoma],51037431,4.999864104870178,3.227107700363605
CA46,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304542005494123,3.687236397117153
LOU-NH91,JQ-1-navitoclax (2-1 mol-mol),-0.9494893938719444,0.9310203336041716
SNU-449,135875424,4.841371934548395,4.137097748461293
HSC-4,carboplatin-etoposide (40-17 mol-mol),1.986163410800157,2.6982564117787353
NCI-H292,72376,-2.1951743702669573,-1.5130992587077179
CA46,36462,0.0715644321871689,-0.0049528753713263506
A2780,54678924,1.3135335490837166,1.7787409908123928
JM-1,9926054,1.6867956204893688,1.734878093314181
LOU-NH91,4788,5.956614254075031,5.848923899574925
G-401,navitoclax-piperlongumine (1-1 mol-mol),0.8522562027001119,0.6002923805119945
YAPC,9929138,5.651296587688524,5.508603354376412
CA46,613753,2.777360120502711,2.8236021816547647
BxPC-3,159324,1.5239234886257875,3.189750631937461
DMS 273,9911830,2.0619640796568848,1.9796775368043598
LOU-NH91,selumetinib-navitoclax (8-1 mol-mol),0.0322992078492161,2.2146124863138708
ONS-76,17755052,2.9613727126940126,1.817003863784812
Panc 04.03,navitoclax-MST-312 (1-1 mol-mol),2.2985193388482177,1.3671744759654176
DMS 273,serdemetan-SCH-529074 (1-1 mol-mol),2.0860866366199584,1.5704998299184156
BT-549,56963564,0.7590937126260752,0.547994865946302
A4/Fukuda,135398738,0.2588260022635366,2.606466404495575
FU-OV-1,6918328,-0.3184221939986219,0.037815063282968846
NCI-H2171,119182,5.854927706564024,-1.6681975362267831
LXF 289,46224516,3.632609368126253,2.6477441155692474
BT-549,66577038,3.347380186099457,3.1386378246621622
LXF 289,navitoclax-MST-312 (1-1 mol-mol),0.8889120523673528,1.0704546790274287
NCI-H460,25183872,2.110783783288614,-0.7123214689471395
CAL-51,17759555,3.5733302595078182,3.5401340832006296
HCC1143,4788,5.8180322078124265,5.587103513805757
NCI-H727,selumetinib-PLX-4032 (8-1 mol-mol),-1.7195859584086806,3.1483122126541074
LOU-NH91,selumetinib-JQ-1 (4-1 mol-mol),1.3495947131381103,2.027030381890239
A-673,11656518,-0.6930464248114873,1.0017356871215244
NCI-H522,12003241,-1.5672925136718587,-1.0646590754433478
NCI-H2009,19582717,2.816304614086765,4.203996905510838
LXF 289,9911463,2.935801973679381,3.93941265705832
NCI-H1623,44202524,1.6623127043604982,2.461589282943919
NCI-H522,9952709,3.5153076410238477,2.7995664722872515
EFO-27,4378219,5.419366677908557,2.5473478905808955
FU-OV-1,11404337,-0.2130364442314083,-0.3109881540575451
FU-OV-1,119607,4.651010364988691,5.42770145514092
NCI-H146,135875424,2.9115600315347057,3.611373688144079
LOU-NH91,11152667,-0.304989451834292,-0.3558815940952468
SW1463,439501,-0.3046644173954531,-2.172355372495286
LoVo,25022340,4.929882293123705,3.092184282290961
NCI-H1623,23725625,5.633484297207613,5.35941410121179
KMRC-1,439501,-2.7889227637684773,-1.9724698851640228
A4/Fukuda,9907093,3.513986602103764,3.708588365203268
A2780,969516,2.2684147801302155,2.644525104295393
HCC1143,24753719,5.247680835091332,4.103206096791953
DMS 273,25183872,-1.4455230978287994,-1.0788865289075245
SNU-81,3854666,0.9917295007006844,1.8719700919282583
NCI-H522,57330099,4.380671698756577,3.9927275005010245
A-673,135421197,0.3124298336996849,1.580710524724835
NCI-H460,46398810,3.30325787352206,2.5507407545099703
NCI-H661,52947716,-6.022145864838143,-1.0380676114237835
CAL-51,9907093,3.7886359098281783,4.158545874082627
FTC-133,erlotinib-PLX-4032 (2-1 mol-mol),4.762605584233989,2.961269352744954
SCC-9,11640390,4.170413196512925,3.6235125508607933
SW1463,56973724,0.8689023909239705,2.6015198538688016
HCC1143,24180719,4.266131781804432,3.4286183965572032
KMRC-1,135398738,5.381791034510906,3.8208285872273153
BxPC-3,36462,3.4182720226712457,2.3063652539605544
MDA-MB-157,4261,1.9483424687424111,1.6684967632050454
NOMO-1,2708,4.2098167660909525,3.1348105612515575
A4/Fukuda,10410894,1.64506751408979,2.973355246227164
A2780,3384730,1.1479192192658911,2.1188432776807984
SNU-449,439501,-4.772752939359215,-2.1093562704073086
RCM-1 [Human rectal adenocarcinoma],SNX-2112-bortezomib (250-1 mol-mol),-0.995249621859288,-0.9491581222508241
DMS 273,51037431,4.4079331684726775,2.979069430389876
A2780,16741245,2.3123767413084786,3.6483554519317156
SNU-81,42642645,1.3921275935464503,0.0939493505061989
CA46,44632017,0.5480853683486498,0.7914447688606363
A-673,71304818,1.350808371963784,2.0885994326049384
SNU-449,6914657,-4.967870149056919,-4.009359960546632
MSTO-211H,25150857,2.632878402859221,2.365610407746862
MDA-MB-157,26596,-2.8480155125253623,-0.7336167039488524
LXF 289,9929138,7.38651684018349,5.349087252030374
G-401,25183872,-1.5190566583165497,-0.9287808392694208
A-673,241158,1.6738540084680422,3.2032196041591954
SNU-61,25195348,2.878615726844662,3.214086828702152
MDA-MB-157,53392493,1.7008245883035995,2.7562761657275057
LoVo,68056272,4.365145786196869,3.7757674179467364
NCI-H2171,6918837,-5.273009588122425,-4.172781218969584
NCI-H460,168312962,-1.8333752522095308,2.039655057191177
CAL-51,44259,0.1826439745217317,0.504470396568816
HSC-4,285033,-0.8602386046724618,-1.6704584563135934
EFO-27,25105715,3.778793980481446,3.5273367326466927
A-673,1641662,3.2069303925294625,3.256433729574234
KMRC-1,3854666,2.659759078644905,1.9297727519143912
DMS 273,375860,-0.4468381354972334,-0.3830744651986422
NCI-H661,10231331,4.850159308010921,2.3151292174115863
DMS 273,16725315,5.248612259787856,3.7090909829267757
NCI-H292,crizotinib-PLX-4032 (2-1 mol-mol),2.353099722482166,2.111980412033086
NCI-H661,73707398,1.1965083244926786,1.2997618773542083
OPM-2,JQ-1-vorinostat (2-1 mol-mol),-2.42287599285764,-0.5303288009241014
NCI-H1623,135421197,3.7764453326534855,2.0825086665650883
BxPC-3,24951314,1.2340413323146109,1.6991886485066872
MSTO-211H,navitoclax-birinapant (1-1 mol-mol),-0.9866972359238844,1.9101132350576913
NCI-H146,119182,2.1823445512420308,-0.7612806858862722
G-401,4578,4.054730999265937,4.005446490007916
MDA-MB-157,6918837,-2.759774975538005,-2.4055390444573588
EFO-27,9907093,4.474758252228614,4.201079911343197
HCC1143,navitoclax-gemcitabine (1-1 mol-mol),1.7090792961792267,-0.7579384362275932
NCI-H727,navitoclax-MST-312 (1-1 mol-mol),1.3064491848942938,0.9988894316393107
FU-OV-1,carboplatin-etoposide (40-17 mol-mol),3.4615233575458992,3.079202003598634
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023,-0.900270205888028
NCI-H460,3025944,5.476008686130055,4.245275460045055
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122,1.6661037701491066
NCI-H292,9915743,-0.4817131806939655,0.9426514307344543
LXF 289,44202524,1.498501439362416,2.4485986167062417
OVISE,135411,0.7729741022965545,1.0753191958947903
RCM-1 [Human rectal adenocarcinoma],46174525,4.230350619821445,4.490452762518896
NCI-H2009,5746,1.7505534195957702,1.3308043574522432
A4/Fukuda,10184653,1.3612642262853822,0.9990373719110756
SNU-61,selumetinib-vorinostat (8-1 mol-mol),-0.9807970774294382,2.0913223465893847
BxPC-3,ISOX-bortezomib (250-1 mol-mol),0.0666490306431122,0.6296224256850156
JM-1,375860,-0.4977027167273706,-0.4028620243509067
SNU-61,46943432,3.2717403410494397,1.855176749804601
NCI-H146,168313200,1.5894074456272884,2.56015726355763
HCC1143,piperlongumine-MST-312 (1-1 mol-mol),2.011691576039941,1.938589163523333
NCI-H2171,6184667,1.4164127707768046,2.3906560912796375
DMS 273,10184653,1.3805891581139824,1.0295268267128874
HSC-4,JQ-1-navitoclax (2-1 mol-mol),3.2016872805134025,0.9685828160604336
SNU-81,24856436,-0.0712468901893707,0.3839946838199206
LXF 289,71680916,5.339150924844951,4.805584086259591
CA46,5291,2.960224941202677,2.708332208300369
NCI-H2009,5329102,2.1297157842750756,2.0235152290142837
HCC1143,49793307,-2.279288310815399,-2.3157173060681675
HCC1143,15953870,6.0969880807250085,3.5493852861379374
BxPC-3,2749,2.8971498792709784,2.0763272423336043
SNU-449,12003241,0.2005365129445947,-0.792038414879934
RCM-1 [Human rectal adenocarcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.1552329187196393,2.0816462215854217
MDA-MB-157,2733487,0.3711294020076626,5.978186929095894
NCI-H292,3025944,4.3344233170115185,4.381908188060777
FTC-133,637858,3.731185140297224,2.162192722032078
NCI-H1623,387447,-3.670338978810225,-3.5431209093854092
JM-1,5394,4.3191880254190425,3.2986338621168367
NCI-H292,alisertib-navitoclax (2-1 mol-mol),2.7354640490460724,1.0777676065379826
MDA-MB-453,24964624,0.7400526464517642,2.386165992781884
SBC-5,637858,3.033148612268187,1.92891664378901
HSC-4,3825829,4.330540788358233,4.010046551226493
LOU-NH91,26596,-0.8372049149458933,-0.8002639526450537
Panc 04.03,24180719,4.502790622897018,3.598506556314315
MDA-MB-453,44486219,3.97168660448306,4.197368459284656
ONS-76,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0736426571342059,2.8959882628156497
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566,0.7484422176068282
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609,0.9746871222753637
MDA-MB-453,carboplatin-UNC0638 (2-1 mol-mol),3.2412925949460223,3.1272914724621734
A2780,46398810,1.6945681809511193,2.121774815023436
ONS-76,44493528,4.396938069944904,4.4711592596343515
HSC-4,3854666,2.969420021692798,2.1369196572179576
SNU-449,5291,3.951163668523845,3.618289567028898
MDA-MB-453,216345,3.4613524333124337,3.667257427679782
NCI-H727,71680916,5.541731669631066,4.73091999967391
NCI-H460,4261,3.676509117184606,1.7006744230619872
NCI-H2171,10184653,0.99528741531969,0.9255850388214435
FTC-133,54626689,4.834884112239084,4.438873611792847
A2780,55283,0.78738067747292,2.6130470162484953
OPM-2,753704,3.6202062566191984,4.202757043291417
NCI-H522,53392493,1.8355339375888644,2.147797238272273
DMS 273,10127622,5.766745520319409,3.26235301968884
ONS-76,BRD-K58730230,4.314454311755605,3.8115861229624084
MDA-MB-453,49766530,3.3081056054922064,0.1273954158374452
A2780,16065773,0.67384212990199,2.0624496304384152
JM-1,241158,1.7269305863155773,2.567806372088537
A4/Fukuda,71466380,2.851115718652883,4.053133270519607
RCM-1 [Human rectal adenocarcinoma],227681,1.7640901700531322,3.418851650640558
MDA-MB-157,16722836,1.792866712111087,1.7376473480529746
NCI-H460,6852167,4.590065962834362,2.9087929200469036
SCC-9,375860,0.1694000381305893,-0.1381066655900892
CAL-51,54649381,3.902782783768603,3.9892311684628545
EFO-27,2708,5.128228617584202,5.11062459534949
G-401,6450551,1.2745400494425214,1.852290090473086
SNU-449,168313016,5.914877518762689,5.103825257322014
NCI-H661,654092,0.3537062860674825,-0.345230815772482
SNU-61,5284616,3.808934677012338,1.879252938922774
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113,0.8932547336214384
KYSE-70,25195348,5.534160735777195,3.3745853801075776
NCI-H2171,135421197,2.0026019926205185,1.3926643982066105
NCI-H460,4261,3.676509117184606,1.7006744230619872
DMS 273,1641662,3.247845954250749,3.1072525659338335
BxPC-3,6914657,-4.023901786471393,-3.549542746872492
CAL-51,9936388,-5.638746232401389,-1.061796652523543
A4/Fukuda,25161177,3.5710974046751804,3.5564266112309104
NOMO-1,24821094,3.1222382635594967,2.4499428059456334
A4/Fukuda,53232,1.4709221708336295,2.4469602964570525
A-673,9840324,5.96119566119886,5.74680312456974
LoVo,613753,3.444351424595812,3.1109335404261755
FTC-133,4477,0.2258553638980791,0.6182417327393989
MDA-MB-453,11214940,4.455338804672604,2.068904471662573
A2780,56649450,-0.3009304069219352,3.0459148247375496
HCC1143,89928392,0.2924123173203115,1.652087456873323
BT-549,6852167,2.654575121453327,3.099469357159309
G-401,375860,-0.2910974790080222,-0.33166080040842993
NCI-H661,613753,3.3170674343428708,3.30101890483098
YAPC,71304818,2.728620236586343,2.7236873124580665
NCI-H292,3503,2.756562172316919,2.5363927089634917
OPM-2,44819697,-1.6539436611429392,-1.3239275291573336
HCC1143,60700,1.3373007617879429,-0.6133383971716281
MSTO-211H,446155,-0.2868964860821164,2.3851812318149563
A4/Fukuda,2708,3.0461577581065007,3.6565336840446907
SNU-61,126941,2.173772773827979,-2.195273573628773
DMS 273,selumetinib-piperlongumine (8-1 mol-mol),4.661418163963333,2.3172464240671173
HCC1143,444795,4.803024181226615,4.605938928188602
JM-1,441298,2.4952150007247393,2.3355863111854713
DMS 273,44507138,4.08877163590395,2.1740914264920894
Panc 04.03,5291,3.9842309161066063,3.748237539735102
BxPC-3,3062316,-1.891072672499,1.0961989281938973
KYSE-70,15983966,-0.1847866067827735,-0.36479391295452473
LoVo,doxorubicin-navitoclax (2-1 mol-mol),-1.249111657931932,-0.9303345301598521
DMS 273,44607531,1.5313743675110545,1.4321181963901386
NCI-H292,5746,0.9253562515034884,1.5727362936603737
NCI-H146,6914657,-5.6838858588772245,-4.305988044268287
EFO-27,25150857,3.1416161415552173,2.555215457206386
SNU-61,54618771,-0.470226071786205,0.9075033186368063
BT-549,1716436,2.964006130486385,3.2877184276918183
BxPC-3,4521392,4.6952932183187,4.350305409531062
BxPC-3,5328940,0.9544734009845622,1.519365612499833
LoVo,vorinostat-carboplatin (1-1 mol-mol),2.43633518664014,3.0306282610829687
Panc 04.03,16013152,4.359497957481629,4.224074253056199
A4/Fukuda,3062316,0.4248767517614322,1.2268614064391297
A-673,11609586,1.032418246609784,1.9612726772506779
SW1463,322968,1.9625017896764745,3.194815789582798
JM-1,11427553,0.2949480151387566,1.0891202667298077
CAL-51,11497983,2.6322425573174213,3.905362878025534
Panc 04.03,12003241,0.3752932920389255,-0.6090040966387413
FU-OV-1,216345,4.02478525181321,3.961642187877668
NCI-H522,89928392,1.1479343378844449,0.8747204237668557
NCI-H460,11485656,2.6212830818798065,2.576250055412558
LOU-NH91,6438330,3.480541802748286,2.487681567252254
MDA-MB-157,11228183,0.9797898244038654,2.283166215635442
A4/Fukuda,10385095,0.4549399411675465,1.0059942510684323
G-401,241158,1.9889661714459972,3.299046516062557
MDA-MB-157,5282054,1.4096594950320644,3.7935714362086497
NCI-H522,11404337,-1.4542746262182442,-0.7608644340671495
NCI-H661,322968,4.732962604670861,3.9199496678902594
NOMO-1,65064,5.083490310509571,4.4267923593015475
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284,-0.6132600666106556
BxPC-3,1716436,3.6064873492654943,3.1299338113100204
NCI-H2009,24753719,4.192950544032197,4.370832357191468
BxPC-3,136227924,2.62858882862477,2.889919338156119
OPM-2,alisertib-navitoclax (2-1 mol-mol),-2.0231135401510967,-1.0343757247529108
SBC-5,3854666,0.5257720708282073,2.1182459340330193
RCM-1 [Human rectal adenocarcinoma],6918328,0.3348856135951876,0.3013630622630496
NCI-H460,1750826,3.3189287492303197,-0.8435999900392919
A4/Fukuda,4705,2.104501352907832,3.0079079641822433
BT-549,24821094,3.680768028115557,2.8786423641540546
NCI-H727,vorinostat-carboplatin (1-1 mol-mol),4.5535915499208,3.181937311911946
A4/Fukuda,46398810,1.5683404384737003,2.00696618290296
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702,0.7128590563410071
MDA-MB-157,3062316,3.257879214731084,1.2306883621935296
NCI-H727,71466380,5.170266193783112,4.487951839260687
OPM-2,selumetinib-tretinoin (2-1 mol-mol),2.843446228896377,2.7858318587643187
HSC-4,16038120,1.7232268235274473,1.1344433202969681
FU-OV-1,53392493,2.412509849766808,2.548644254540119
NCI-H2171,3634881,2.317126021520602,2.9894684700624077
DMS 273,54618305,4.272082763698834,4.403058937896552
LoVo,docetaxel-tanespimycin (2-1 mol-mol),-4.329942307031701,-3.0873622102981724
SNU-61,9926054,1.8929452670989917,1.7897661975617287
MDA-MB-453,216239,1.9202357593604051,2.345475179369935
A4/Fukuda,252682,6.117343290485243,6.200456674086605
Panc 04.03,11455910,2.454958233695195,1.4043363157086106
MSTO-211H,24951314,-1.1401244239295247,1.3626540076341283
A2780,navitoclax-sorafenib (1-1 mol-mol),1.0762822607268765,1.5768012884885447
NCI-H146,67156097,-2.3396756899377595,-0.5286177467327495
NCI-H727,alisertib-navitoclax (2-1 mol-mol),5.700791179880255,0.45215579190166666
FTC-133,25150857,3.5794152247995004,2.2334560041682745
KMRC-1,24797083,0.8876318381449373,1.5957559252707931
KMRC-1,5282054,4.624285853166485,3.6970556818072526
MDA-MB-157,36462,0.1516360669313773,1.9131422447073854
SNU-61,11609586,2.423992088951442,2.1836823285371825
MDA-MB-157,4378219,2.6716514190617104,2.6959529800425632
NCI-H2171,navitoclax-PLX-4032 (1-1 mol-mol),-0.7537972454626107,0.33038069287111177
A4/Fukuda,57519531,1.5811593813701257,1.6795320926476855
EFO-27,136227331,4.702115323060179,3.7881203368875167
MDA-MB-453,9952709,3.2945084007394616,3.163193810393538
G-401,54143018,0.971383874427432,0.3443687390788099
EFO-27,9927531,5.387402639259967,4.782081727458833
DMS 273,3025986,-1.574939205922683,-1.0781062213107702
NCI-H522,26596,-2.5500947066960276,-1.8005063197348365
RCM-1 [Human rectal adenocarcinoma],676352,2.484571523504373,2.1301766492794045
CAL-51,5280436,3.749440064194485,3.250058246151896
SNU-449,25150857,3.008716268425874,2.713909523174682
KYSE-70,23582824,2.6933165956875964,0.9535274171899024
OVISE,54454,2.25285494204451,2.8863173240883304
A4/Fukuda,selumetinib-tretinoin (2-1 mol-mol),0.1306282538246569,3.103466943523451
MSTO-211H,5282054,2.057664237493602,3.8119079059658265
CAL-51,16720766,0.5416929462446769,0.628179390933901
HCC1143,selumetinib-JQ-1 (4-1 mol-mol),2.450816568945253,1.706818200533373
EFO-27,navitoclax-pluripotin (1-1 mol-mol),-0.1072190892754552,-0.6945868009777597
SNU-449,446155,0.8119451390236352,2.7947863609252006
NCI-H146,375860,0.4213004900992469,-0.053147388919607824
CAL-51,5281321,-0.4656602142962174,-1.22886101356234
SNU-449,navitoclax-piperlongumine (1-1 mol-mol),2.97767132898613,1.778239778997238
NCI-H2171,44462760,3.915746717375186,3.2667263427044726
SNU-61,151289,1.0402759766313254,0.9166503589952086
DMS 273,24856436,0.3584417497554937,0.2147892966698353
CAL-51,71466578,5.340961831553399,4.7815849726938895
HCC1143,44607530,2.3193328073886628,1.8437530658354297
SCC-9,3136844,4.895725881728452,4.339452364400388
CAL-51,148198,-3.728190383000159,-3.6611391929405146
DMS 273,25126798,4.049346019168164,3.5637406875861375
A2780,JQ-1-navitoclax (2-1 mol-mol),-0.0889318851591051,0.5957439824353182
A2780,9825149,2.396834344892177,1.8134439497236736
CAL-51,104842,-3.020036586723177,-2.7023691787407715
A-673,676352,1.522059533133182,1.9410903924423584
FTC-133,9967941,5.123707260677636,3.8066493074884757
NCI-H2171,56963564,-0.0417490265139498,-0.10951626595740688
DMS 273,753704,5.000496745911757,4.082045630676196
JM-1,6918837,-6.173851145057706,-4.652293549349446
KMRC-1,285033,-1.948983558292048,-1.742430187287138
FU-OV-1,54454,4.96368280899624,2.9287103819260993
LoVo,11152667,-3.1828514843907967,-0.37274459836149476
A2780,3081361,2.3669572433114663,2.103616887655845
CA46,11497983,3.715862022418827,-0.414177712034052
EFO-27,9952709,3.7128554087131658,2.939968647804369
SCC-9,3503,2.580691900576731,2.541378103663033
CAL-51,42642645,0.4324607401831485,0.5828997839563272
NCI-H522,462382,-0.0152056919239,0.5792149542189045
NCI-H661,44632017,0.8459474985730225,1.3367356173903895
LXF 289,44137675,2.0502885463252665,3.6557676344923933
SNU-61,11404337,-0.7844361329588494,-0.5618268713865351
FTC-133,15983966,2.5675405254421113,-0.8400330479856036
KMRC-1,56946209,-5.003023698532595,-3.563531316078487
CA46,9866186,-0.3275085520058725,0.24078326318910093
DMS 273,23635314,-4.293922540672693,-2.796304111062485
LOU-NH91,4259181,1.0248896787271708,0.40556296039262935
SCC-9,46224516,2.803045033456012,2.7152742268097074
SCC-9,6918837,-2.658799999554452,-2.284336134302317
FU-OV-1,tanespimycin-gemcitabine (1-1 mol-mol),2.043943445508653,-0.347655490037994
LOU-NH91,15983966,2.104720476479653,-1.0449221519141034
NCI-H661,285033,-2.1039671806681985,-1.8874697658459774
G-401,16722836,1.0452487365316014,1.346844505872804
SNU-61,11964036,1.5202881054490238,1.1654602492183992
MDA-MB-157,374536,-0.5698586384338129,2.0898151668170812
OVISE,168313047,2.139797955827927,2.428981842673615
LXF 289,400769,-1.8947060859446272,-0.4041402729806499
BxPC-3,10302451,2.105262518783424,2.9725374783509095
KMRC-1,446155,2.327207673229407,2.7004925949830865
KMRC-1,selumetinib-decitabine (4-1 mol-mol),7.0489920004822855,2.992540394189481
MDA-MB-453,421610,2.7771188964172664,3.199362610712618
SBC-5,navitoclax-gemcitabine (1-1 mol-mol),-2.8520173060125296,-1.312011217884759
OPM-2,2113511,3.5660346238413565,4.646933757212234
ONS-76,31703,-1.5971524717515937,-0.5203326790251316
CA46,100016,3.773189878640827,5.02116444230263
MSTO-211H,tretinoin-navitoclax (4-1 mol-mol),1.3222230725566817,2.943134531469062
EFO-27,11167602,3.5204241483481686,2.693845709057401
SNU-81,6505803,-0.5044882096333503,-0.6704218761951156
NCI-H727,1716436,2.7605133955676178,2.986855167038174
OVISE,10302451,2.747913318530857,3.0686037312435843
NCI-H292,24772860,-1.7688616980402292,-1.6821776382980687
RCM-1 [Human rectal adenocarcinoma],135398516,4.64558268257279,2.388183587668523
Panc 04.03,702558,5.6133476434957,5.2767266658682965
NCI-H727,24964624,2.2819429425827984,2.220121939668958
MDA-MB-157,2828334,5.757584300180036,6.083579905774035
NCI-H2009,67291369,0.975633217461442,3.00661524371015
EFO-27,421610,3.836140121936173,3.291302020727285
G-401,vorinostat-carboplatin (1-1 mol-mol),1.81058220615163,2.581079619963002
LXF 289,11626560,1.452143156792952,1.8514351483282498
LoVo,carboplatin-etoposide (40-17 mol-mol),1.7816353489464614,2.8073123408754337
NOMO-1,9444,3.521396869825756,3.5862606997842392
KYSE-70,24821094,5.190593902676824,2.8778721241107537
NCI-H292,104842,-3.713576042756873,-2.707019927341223
CAL-51,23725625,3.781531245600544,5.217506026139525
MDA-MB-453,11175137,2.676203543730399,2.493105605639655
LXF 289,SNX-2112-bortezomib (250-1 mol-mol),-1.375165167974982,-1.363529006108039
OPM-2,3038522,1.4393753112244685,2.593404036761829
KMRC-1,107985,-3.501321688193531,-3.359548808522538
G-401,selumetinib-piperlongumine (8-1 mol-mol),2.3292817687818768,2.395227866987933
FTC-133,9549297,5.410509835078823,2.4182468529354564
HCC1143,66577038,3.1905565845946993,3.1433879589617555
A-673,73707438,5.240927680887528,4.036060988966456
LoVo,44137675,-1.419079349485425,3.292903887906332
SNU-449,3503,2.7484718807665396,2.3918246194649364
JM-1,11960529,4.3881984442046384,3.595486145989035
FTC-133,5460769,4.281031552964228,2.7439547077625197
LoVo,3025944,2.9449078290251256,4.306869932376913
A2780,613753,3.052273906836147,2.827867717706988
NCI-H661,navitoclax-MST-312 (1-1 mol-mol),1.292744867259036,0.7399482668909241
NCI-H2171,navitoclax-piperlongumine (1-1 mol-mol),-0.1756857272470243,0.28045448173184306
NCI-H727,119607,4.980733327072692,5.173201988608582
A2780,15983966,-5.363621110890126,-2.649995532437614
LOU-NH91,52912189,2.021653283813576,2.8371311635425656
NCI-H2171,46926350,-4.867098709680934,-4.418537223364643
JM-1,11222830,1.159649219525665,1.2446395436760747
Panc 04.03,9887053,4.247469701197239,4.210086855971161
MDA-MB-157,6918878,0.7604288199483474,2.8637526570625202
DMS 273,25150857,2.151062266440261,1.8316004391326204
NCI-H2009,637858,2.463099291034241,1.9863744099292386
A-673,89928392,0.0772153864579325,0.8552686184228456
OPM-2,56646779,4.429673228200906,2.1408015082820993
CA46,selumetinib-MK-2206 (8-1 mol-mol),2.416379770776117,1.5611943111940447
MDA-MB-157,104842,-7.463907387011825,-2.6558660108443304
ONS-76,tanespimycin-gemcitabine (1-1 mol-mol),1.9345282385200928,-0.5530151144544062
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,1.7273901368062772
SBC-5,23725625,4.5493880465204235,4.641876131980816
CA46,16736978,0.453820731366511,0.9395361734332448
SNU-81,5287620,-3.371703836172312,-1.490718916758177
OPM-2,9929138,4.40255967212205,4.516396319169565
CAL-51,107985,-4.126908547019261,-3.7426650980512646
SNU-61,4261,1.9153687598051303,1.1519474340036484
KYSE-70,5311,1.3049127753558711,1.7654809510055862
A2780,2874250,4.6617329815359545,4.542696505468459
A2780,46843906,2.4977538844634637,2.4162859409034194
FTC-133,11234052,5.0298463189452445,4.250255251290992
LXF 289,serdemetan-SCH-529074 (1-1 mol-mol),1.9875604335847448,2.1208739686919715
OVISE,5282054,4.4060399380094415,3.772817318919894
HCC1143,4096211,1.556998125169598,2.121587642300815
NCI-H661,11364421,-5.690348879388773,-2.2884685924585324
MDA-MB-453,docetaxel-tanespimycin (2-1 mol-mol),-3.838890117483947,-3.098543226983683
A-673,11427553,0.6536689467636717,1.7935134762187495
JM-1,6917907,-6.147483124234289,-5.547858143282173
A4/Fukuda,9926054,1.7963505717751411,1.6776958116472775
Panc 04.03,65064,5.203402541242721,5.1799106253226235
MDA-MB-157,25154868,5.338832763625219,4.278921220647374
A2780,3689413,0.5219259729031659,-0.9133097858869657
NOMO-1,2828334,5.727397129817869,5.700207867770054
NCI-H292,selumetinib-PLX-4032 (8-1 mol-mol),2.9334189816499476,3.532399793020775
JM-1,carboplatin-etoposide (40-17 mol-mol),-1.4071886446096369,0.614434429301722
A-498,10385095,3.0502652475567347,1.466199662513234
NCI-H460,5280436,4.847067650781305,3.4503039562707936
NCI-H146,71304818,1.6140243095299662,2.0660386122382604
SNU-61,135398516,5.118120351018792,1.7956028293089081
HCC1143,9967941,5.23006520077408,3.6152117857977233
SBC-5,51039095,3.807088636542375,2.537008023843481
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-3.1749353169803136
NCI-H1623,vorinostat-navitoclax (4-1 mol-mol),1.3203635672750993,0.9027993589376087
HCC1143,44137675,2.963488174732173,3.554607710312422
EFO-27,15983966,2.453959425588555,-1.0116170195133372
NCI-H1623,10184653,-1.536462891864862,1.1300685545807785
JM-1,216468,0.5768131010636649,0.7408814509329616
KYSE-70,5278396,3.1929088159597656,3.4687486226577335
SW1463,216345,4.078496637973622,3.673262903484332
MDA-MB-157,54619267,4.18775168816921,4.055192739565144
LXF 289,16065773,1.584092119185821,2.4486486659748823
Panc 04.03,107985,-4.416167995938274,-3.4337214680917505
SNU-449,11238147,4.105269625362408,2.9540186479115276
ONS-76,66577038,3.2799369572038977,2.861527438229531
NCI-H1623,156414,-2.396664487331107,1.1952387229989059
DMS 273,4578,4.680938801431088,4.188851671258152
NCI-H2009,selumetinib-piperlongumine (8-1 mol-mol),-1.1472655544324035,3.417262093644897
OVISE,73707398,1.6715872061037895,1.5211755547787706
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818,2.3773692904232644
MSTO-211H,navitoclax-PLX-4032 (1-1 mol-mol),-0.7263097826113902,2.181939828515312
G-401,2945648,2.835527608429738,2.358638992301474
BT-549,89928392,1.2423762488932544,1.6421826054506123
NCI-H146,107970,1.621489555747201,1.9973273022186333
OPM-2,71466380,2.758760560312852,3.8891790199045353
HSC-4,15547703,3.6362413258054063,3.1439233559765802
JM-1,crizotinib-PLX-4032 (2-1 mol-mol),0.7552309582979843,1.0436715181522151
EFO-27,navitoclax-sorafenib (1-1 mol-mol),3.3507850442139024,1.7586643317513602
MDA-MB-453,navitoclax-MST-312 (1-1 mol-mol),1.1594914654574615,0.7891041787132669
HSC-4,17759555,2.4253306074953978,3.585798394948911
FTC-133,2945648,3.116487231281591,3.006097527041631
BxPC-3,3825829,3.4267099071969738,4.057343584905673
NCI-H2171,selumetinib-BRD-A02303741 (4-1 mol-mol),6.130541879028699,3.782391541652298
NCI-H1623,3025986,-1.391492623029173,-0.9906244671022071
BT-549,3025986,-1.1986125704978905,-0.9560873949074926
JM-1,25227462,-4.63830716322272,-2.3009288914044523
EFO-27,4477,1.1283660363220671,0.7742951985020422
LOU-NH91,52947716,2.984350097195249,-0.1938728263545001
CAL-51,44489367,4.725330666921359,4.676526386848304
DMS 273,2949965,2.5486766063035056,2.205969875300666
MSTO-211H,36462,1.134601353001676,2.433453806868982
BxPC-3,4917,2.980696163243889,3.1652145974260137
CA46,9903786,1.650432742323398,1.8103566461231915
CAL-51,156414,1.13799157004995,1.3070741191457886
OPM-2,6610355,3.590135914900994,3.9287630487166365
FTC-133,doxorubicin-navitoclax (2-1 mol-mol),-1.6634242865770594,-1.0434846614242093
NCI-H661,439501,-2.903837615768139,-2.0073728617713105
Panc 04.03,9952709,3.610885547265169,3.19245866546952
BT-549,navitoclax-birinapant (1-1 mol-mol),-2.097754918128948,2.008238651682802
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.2734176287927643
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.7527504606732047
OPM-2,2708,4.148168261065231,3.501305028439903
NCI-H661,10385095,0.8549868667974337,1.1886788718971326
JM-1,24785538,-0.4888535449792195,0.18066667645329595
FTC-133,6610216,5.488595178062795,4.3868150204375915
MSTO-211H,216468,0.7149646325927866,3.427333979291344
LoVo,selumetinib-MK-2206 (8-1 mol-mol),-1.1472378913456864,1.8029710390117668
NOMO-1,5978,-2.430694050184869,-2.7313373979581312
DMS 273,216345,4.389361768667068,3.5427116200028563
MDA-MB-157,selumetinib-vorinostat (8-1 mol-mol),2.3136990091285883,2.7496923359656646
LoVo,676352,2.5317553470156646,2.1622836627490813
Panc 04.03,107970,2.70125557955606,2.348854358652801
HCC1143,11427553,3.376761154443363,2.608017204728503
BxPC-3,piperlongumine-MST-312 (1-1 mol-mol),2.334096835358741,1.9342214878161403
FTC-133,salermide-PLX-4032 (12-1 mol-mol),5.419117653198884,4.732881988550769
NCI-H2171,vorinostat-navitoclax (4-1 mol-mol),-0.1406498808904326,0.13356316579087635
NCI-H292,11626560,1.446983052748098,2.0185850563545857
EFO-27,3062316,-1.351094232476051,1.1023603549498049
MDA-MB-157,2746,2.873003215594031,3.271757093441591
LOU-NH91,24180125,2.532676427085935,3.2419573156431523
JM-1,135411,-1.048960589681706,-0.005430154943162212
NCI-H146,644241,1.2089846023639548,2.235086767524616
A4/Fukuda,72199292,-0.4044306818473915,0.8936344242280722
SBC-5,135421197,2.079587314097717,1.8377033256676532
SNU-81,6918837,-2.735310336273069,-3.36302675234115
JM-1,7326481,2.606242200480973,2.4011053631393136
LXF 289,67156097,-1.7104573080698593,0.03664612240223456
CAL-51,89928392,1.068329558331595,1.6453012843325465
A-673,6505803,0.2745970276233078,-0.5355222644410453
FTC-133,carboplatin-etoposide (40-17 mol-mol),1.440649023013039,2.789798035045644
SNU-61,15547703,3.101064478021952,2.7845306176228592
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585,1.986761690599306
SNU-449,16065773,2.84526561612217,2.4662070865068526
MDA-MB-453,53392493,1.7017875748321412,2.6460422721503356
SW1463,11317348,3.510696959395443,2.546794703389739
MDA-MB-157,11214940,-0.245291289631715,2.0910737554649477
ONS-76,navitoclax-pluripotin (1-1 mol-mol),-0.9678858040482444,-0.6056808126217937
OVISE,44202524,4.183655897410181,2.480823380830828
A-673,11964036,0.9382905451812168,0.8323787988741519
LXF 289,3503,2.5386473527097837,2.0084794881143146
MDA-MB-453,54678924,1.5140521677167769,1.9850285068735247
SCC-9,2749,3.600343159035071,1.8526585127829507
CA46,9840324,5.575806842573594,5.576687789527073
DMS 273,54143018,0.522600880214995,0.12259260398216128
KMRC-1,selumetinib-PLX-4032 (8-1 mol-mol),3.77714123562175,3.413613658876388
FU-OV-1,25102847,2.696211974787464,2.4134966537520337
KMRC-1,73707398,1.5458693028147192,1.3030922898792148
A2780,5287620,-3.13264442622338,-2.2567824761479334
NCI-H460,54619267,4.901891634717457,4.056159748841891
EFO-27,2945648,3.241602940948522,3.0175940165934776
NCI-H522,25105715,3.4847863866008755,3.337176117897781
SBC-5,638278,3.4285441526954687,2.9774702086752773
KMRC-1,piperlongumine-MST-312 (1-1 mol-mol),2.0343376342805906,1.7653690048495292
CAL-51,6918328,0.3807555589851347,0.11927359129820025
NCI-H727,11497983,4.370504456176288,3.4697166716385848
NCI-H460,4259181,-0.2054535095090753,0.27806154264308225
FU-OV-1,16741245,4.362196150231273,3.574704054702898
SNU-449,9911830,2.1326623866395487,2.517821313018765
NCI-H727,5278396,3.8599732465447247,3.5888234527530836
MDA-MB-157,44566777,-1.1276584651283623,0.6392153018558868
LXF 289,656346,1.157307128170796,1.1297451059996013
CAL-51,176870,2.9999818119422175,3.211713420177572
NCI-H661,JQ-1-vorinostat (2-1 mol-mol),1.2466897580827978,1.2002462887089507
SNU-61,10184653,-0.5580603125211917,0.3749774197093247
OPM-2,25126798,3.830489811395835,3.4273216399918005
SNU-449,49793307,-2.0136733678876335,-2.083344150770499
NCI-H2009,60750,0.952457111724262,-2.1965339180921775
MDA-MB-157,60750,-2.031758614917575,-1.8579636287250876
Panc 04.03,selumetinib-tretinoin (2-1 mol-mol),5.031160903281955,3.220528167300141
MDA-MB-453,44137675,2.41330993625909,3.365852553794272
DMS 273,5287969,-2.213452126148289,-1.8258774129948758
LOU-NH91,11609586,3.3390226168587716,3.0708519974968698
NCI-H661,24951314,0.8780582238506052,1.3685527461126876
A4/Fukuda,6852167,0.513003696591474,1.7625904723699648
CA46,5311281,1.0891225881142432,1.902840263722441
A2780,11625818,1.819164792403796,3.8097753352539376
LOU-NH91,51039095,2.9779244840652295,2.803598019367991
NCI-H661,4096211,1.4698398043308702,2.2080472794958705
LoVo,4705,1.5085236639058903,2.9558444852513968
MDA-MB-453,46926350,-4.337117227146235,-3.9620645097996037
SCC-9,5738263,4.330654025732234,3.510273463345942
YAPC,46199207,3.321634350680955,3.2925697106859104
A-673,71466578,4.1904953682389,3.344610206266229
G-401,10127622,3.1466102465201793,3.6155810046020274
A-673,5311281,0.6354511881397967,1.9073152681135719
Panc 04.03,6917907,-5.49357619863333,-4.633995927094911
OPM-2,216239,1.2934585013066655,1.7675864380606574
KYSE-70,1716436,3.404085131889099,2.9129676422922213
NCI-H727,9887053,6.41036176282966,3.9134106386850833
NCI-H460,11404337,1.7201854837770862,-0.17981053365368596
CA46,24901704,2.114836921018661,1.9217498307719327
NCI-H292,9903786,2.498172259524573,2.860010796009608
A4/Fukuda,9927531,3.7257201794253776,4.208721184658483
CAL-51,2113511,6.39897875596168,5.604778430468015
OVISE,409805,6.403340651497087,4.857524348236174
HCC1143,11626560,1.5863706836040057,2.1240038872016096
CAL-51,26596,-1.4638590943230956,-0.7806231583834807
A-673,23725625,2.0065405091728272,4.036784879355061
DMS 273,6610355,5.006954006570411,4.308283170784943
A2780,24901704,1.9524214470888757,2.7037162225408373
SCC-9,11494412,1.4365999648395638,1.6265262492390533
DMS 273,4788,5.897035505528926,5.48120148865818
NOMO-1,46907787,-1.215006340822028,-0.41154145796537717
EFO-27,676352,2.5978940444924703,2.1880278229565424
A-673,44607530,1.766367479354274,1.3652674893105237
SW1463,9887053,1.032433665952219,3.402265865613294
EFO-27,54619267,4.322845534804342,4.212322214745633
G-401,9907093,3.2734126555601506,3.8651230716179428
NCI-H460,24772860,-0.596461213785507,-1.7625075094862417
NCI-H292,JQ-1-vorinostat (2-1 mol-mol),-1.255345642631911,1.2331432334742432
FTC-133,119607,5.542629368531396,5.23940659682293
SBC-5,11364421,-4.061592659681506,-1.6504063934101134
Panc 04.03,5566,3.3462548914340204,3.1085949477059738
NOMO-1,6505803,0.1224616163714439,-0.9727585941542998
NCI-H146,24772860,-4.237473750878659,-2.071242347488741
NCI-H1623,11609586,3.053283731487635,2.9508488149506245
CA46,208908,1.4900061271350116,2.027367526393425
BxPC-3,9956119,3.6276214672042975,3.654319241348544
SBC-5,BRD-K27188169-navitoclax (2-1 mol-mol),2.901601885739978,2.2759195677848965
CAL-51,10410894,3.3356149928792513,3.205522912816897
JM-1,9927531,4.0230036766634125,4.046960694197931
FTC-133,9866186,-0.0573555179634338,1.0458915610641624
OPM-2,3136844,3.3377711403827783,3.7151192553483003
FU-OV-1,3815108,2.287889788505342,3.2129504972484
CAL-51,10410894,3.3356149928792513,3.205522912816897
FTC-133,selumetinib-piperlongumine (8-1 mol-mol),4.667559315189104,3.060573163480797
LoVo,5329102,1.3429054297502294,2.15161519710086
A2780,168313047,2.060680306449853,2.188961663957612
HCC1143,104842,-3.076711821193911,-2.5838670265806845
NCI-H2171,JQ-1-MK-0752 (1-1 mol-mol),0.9706610774505884,1.1545403004075419
LOU-NH91,6918736,-0.749268328982244,-1.6318040112162868
LXF 289,11625818,3.3628594045115805,4.549624387329455
LXF 289,5311281,0.8902308213691446,2.0624023998314676
SNU-449,5351362,1.2849200933546208,1.5940343685870086
NCI-H522,135875424,3.5456342124976445,3.6628534322460786
MSTO-211H,44185566,1.3875680654995235,2.7478950464406227
BxPC-3,24964624,2.317613094015834,2.7272865272302966
HSC-4,6852167,2.6632521076475446,2.9627401694631263
NCI-H661,409805,4.01937565581764,4.858454170812535
NCI-H2009,16038120,-1.1539994385349277,1.113108759720096
NCI-H2009,5978,-2.257242885332271,-1.38230755770715
EFO-27,56649450,4.209581770525167,3.7026351205165238
DMS 273,5287620,-2.166812480100597,-2.0445361349229016
LOU-NH91,613753,3.2819891552194327,3.3919228484460535
NCI-H460,73707438,4.549718141383013,3.8480803456049135
LOU-NH91,24785538,0.7950573935003075,1.9412129947849055
KMRC-1,71304818,3.217910603872335,2.5792639952052947
MDA-MB-157,carboplatin-etoposide (40-17 mol-mol),-0.0660482957905645,2.5934298636608877
LOU-NH91,15953870,3.547895487506012,3.778594856344696
SNU-81,3384730,-0.4505726212948157,2.240790955280941
SNU-61,1750826,-4.373387519590766,-1.551565894510907
MDA-MB-453,753704,5.23059705064669,4.885318900862234
A-673,119607,5.020937738944074,4.883145541961941
KMRC-1,9907093,4.272059047954712,3.9832685142079014
CA46,11640390,3.3312213559791397,2.5633944338157537
SCC-9,24771867,5.065268858490301,3.2969934594929775
ONS-76,5280436,3.697781558026248,3.2586683875097275
JM-1,10427712,3.737784417116883,3.675991102703197
FTC-133,3081361,3.8958462184451697,2.4149913819053546
KMRC-1,56649450,3.8757723452520136,2.7679725985284263
A4/Fukuda,navitoclax-gemcitabine (1-1 mol-mol),-5.146642660406073,-1.3332016040557055
LoVo,159324,-0.9516179858777442,2.908543371476223
ONS-76,2841722,4.548555296080543,4.317816409698687
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152,-3.2849035920008958
SNU-449,5460769,0.9117409452183444,2.806989455318975
NCI-H460,6852167,4.590065962834362,2.9087929200469036
OPM-2,tanespimycin-gemcitabine (1-1 mol-mol),-0.8527630037012235,-2.0230496165251326
KYSE-70,176870,5.518340217914711,3.118702246702355
HSC-4,alisertib-navitoclax (2-1 mol-mol),1.936953944798388,0.5843368382292672
JM-1,vorinostat-carboplatin (1-1 mol-mol),1.5414150367145687,2.1148609099136944
FU-OV-1,15953870,3.743404981829692,3.755985753629625
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,0.831797187073902
SCC-9,navitoclax-MST-312 (1-1 mol-mol),0.9061907565004998,1.0432270896859055
LXF 289,654092,-0.8888310934038361,-0.07381476200792532
BxPC-3,9826308,0.5055656835854033,0.5774930318543183
LOU-NH91,25150857,3.1116403082593096,2.4448252710628826
LoVo,JQ-1-vorinostat (2-1 mol-mol),0.1759239316074218,0.8520926804107098
A2780,375860,-0.912616297645574,-0.023638676272763205
LOU-NH91,6852167,3.2671273023515934,3.244225126902235
CA46,24753719,4.040239779097469,3.1543895913804065
HCC1143,135999136,4.602247958833588,3.9325907665936324
SNU-61,selumetinib-MK-2206 (8-1 mol-mol),0.3339128925553656,1.6370131895683346
CAL-51,11960529,3.662834723962616,3.939754705768451
SNU-81,20959075,-6.025577396301825,-2.495979617878541
NCI-H522,57519531,3.3673050119485555,2.197516576035471
HCC1143,135421197,0.8918606552263807,2.0387774727774084
SW1463,24978538,1.1634359901262634,0.8794581642424071
HSC-4,445091,4.370395830414555,4.466060397547307
SNU-61,5329102,2.445912447276521,1.7203786621110115
G-401,23582824,-0.1091259215243222,0.7117494995052995
MDA-MB-157,11485656,1.3019788320898549,2.6386535668533075
NCI-H1623,11964036,0.5644570453188236,1.3928298845651481
MSTO-211H,1242560,2.686361074048806,3.6554080736253654
A-673,65064,3.1048319417370775,4.244586585569127
KYSE-70,208908,2.5295165235288004,1.9587149358515503
SBC-5,2733526,3.427490731511537,3.4871069134883936
ONS-76,6184667,3.7303112000686256,2.997641979336969
A2780,23939,3.9158411595028046,3.5786053315876667
JM-1,1566236,0.6280103536338946,1.2949183425149646
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.5859253006152736
NCI-H727,ISOX-bortezomib (250-1 mol-mol),1.608281700069038,0.6135745497347712
CA46,11396600,2.515122226404857,2.5897246562204255
BxPC-3,262093,3.443903516481154,3.1688572213582784
CAL-51,1566236,2.769525954778687,2.183044218391432
JM-1,3025944,3.553601432401545,3.7953638668943084
CA46,31703,-2.2435350155349023,-2.71888550300567
FTC-133,25105715,3.757366730830659,3.3467318192116253
LOU-NH91,54649381,2.7277802519486514,3.9974801598170213
A4/Fukuda,11364421,-5.769651092108399,-4.156908400531962
A4/Fukuda,5978,-3.163562671527086,-3.0793074321201535
NCI-H1623,969516,3.836806795163693,2.83130462819384
NCI-H2009,5113032,6.328717344861362,4.899840378481038
HSC-4,7326481,1.9301811465772087,3.106030275395917
DMS 273,54639665,4.46621146803559,3.294816387126691
YAPC,9926054,1.8358643335634888,2.0762584540989506
NCI-H460,11238147,4.460003386993959,2.741289780329888
OPM-2,9887053,1.8393709016316329,2.4631973711139725
JM-1,168313016,3.8541200519849017,4.027500637266669
NCI-H1623,285033,-2.516722374910668,-1.4011473668030618
KYSE-70,5351362,2.601126509135012,1.7225934916556724
NOMO-1,10113978,3.435868796737405,2.33081950924116
HCC1143,17759555,3.749709067386792,3.6649372135007847
NCI-H292,11964036,1.1514824488888922,1.5183025980950422
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039,4.060096448976266
FU-OV-1,46943432,0.7627718951481175,2.6759954347592463
NCI-H292,4917,3.248446822462735,3.2433856127741194
FU-OV-1,452548,0.3745426606957432,0.3306500606726943
A2780,24180125,2.723679145549484,2.7063061854959005
SNU-61,9911830,2.7749851076050187,2.1884840429787293
DMS 273,6918837,-4.776469138555483,-3.788292797012344
NCI-H460,54454,2.7807551042334935,2.571409337257734
SNU-61,5978,-3.491631614089224,-1.9074818880832296
G-401,5287620,-2.7219963273379766,-1.962101656061704
ONS-76,9884685,2.079600161824297,0.8910369089896064
NCI-H460,6610216,4.838717363885395,4.303749695253518
CAL-51,51039095,2.1842093640891416,2.77171774517727
MDA-MB-157,2871966,-0.7905554969861216,0.5569741349105707
G-401,46926350,-4.213486210672068,-4.394010421178891
LOU-NH91,navitoclax-PLX-4032 (1-1 mol-mol),-1.9251020200365585,2.0536151774726696
OVISE,10184653,1.818458167845024,0.6330373341096517
A-498,6918328,1.134294475717993,0.5773063496842529
A-498,10302451,3.720340150939392,3.1014500063104746
CAL-51,9935249,3.84795648434564,3.231346564754272
NCI-H292,24856436,1.0729923244387796,0.5021701811822588
A-498,409805,6.12415200666612,5.3097668516284156
EFO-27,24889392,4.405449300162506,4.3959011764558475
NCI-H1623,navitoclax-piperlongumine (1-1 mol-mol),2.7839098581302366,1.489053453291502
NCI-H460,159324,4.0462841352482855,3.271344181844937
LXF 289,16720766,0.4842655504206017,0.5087361550690089
LXF 289,54649381,3.6309892426510406,4.034969390206272
G-401,decitabine-navitoclax (2-1 mol-mol),2.109547843543789,0.3022483060044305
JM-1,71751553,4.311473922741218,3.5994243556040795
MDA-MB-157,2945648,2.730573332542116,2.9783935347642587
SCC-9,navitoclax-birinapant (1-1 mol-mol),1.9538462590257963,1.7869476515815472
SNU-449,67156097,3.7845495552330024,-0.14728207347593794
NCI-H2171,24951314,0.4758147687646419,0.44879735524171593
A2780,24180719,2.9021439553303026,3.4516794909655135
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175,-0.6845193988467506
A2780,54454,-0.2144211598876236,2.532357636564681
A4/Fukuda,16659841,2.2699989015311437,2.681999080342615
Panc 04.03,44137675,4.02019355498934,3.6893924415420933
HCC1143,25150857,2.69660437037969,2.412182014543137
BT-549,104842,-3.414515083122074,-2.5185242795951335
NCI-H146,11960529,3.5646000180725146,3.7162932176820442
MDA-MB-157,11238147,1.748896698587814,2.8099519563348703
SCC-9,72376,-1.0275629780171365,-1.739942381413202
MSTO-211H,57330099,2.804758704858228,4.381527217996393
MSTO-211H,135999136,4.2061059176098645,3.907797960866511
LOU-NH91,46907787,1.567116016960845,2.6043516050864097
G-401,navitoclax-MST-312 (1-1 mol-mol),0.8926313701991264,0.3954109327590333
NCI-H2009,71466445,2.5164920571758036,4.105567298233765
OPM-2,54618771,0.7318105179081044,0.010992485270637667
A-673,1716436,1.8403672814357532,2.8966274446222346
LoVo,crizotinib-PLX-4032 (2-1 mol-mol),1.6425571440672022,1.6843854967234688
SNU-449,selumetinib-tretinoin (2-1 mol-mol),6.057400941930893,4.023420700312293
FU-OV-1,327653,2.5930307991109784,3.089897123048958
KYSE-70,JQ-1-vorinostat (2-1 mol-mol),1.448223728209247,1.0151415400772448
NCI-H522,56973724,3.7409361942384183,2.3872687633590104
NCI-H146,25262965,-1.0264838155868825,-1.8445298792300298
CAL-51,2749,1.4482754145936665,2.1882145344134627
MSTO-211H,4477,1.290064962685197,0.5849521550030837
NCI-H292,637858,2.5198155256882813,2.094758638651846
DMS 273,3136844,4.133948633698644,3.851413550664161
HCC1143,654092,-0.1725481204081408,-0.16215360514548224
NCI-H727,72734382,4.575159301501077,4.630055120074366
NCI-H1623,ISOX-bortezomib (250-1 mol-mol),0.4701818373659249,0.8355092650780631
NCI-H522,6918837,-4.666914399076351,-3.269615695709167
HSC-4,11228183,2.0585180361700313,2.469552726059739
NCI-H1623,107970,2.966658693868389,2.3960965060504247
A4/Fukuda,5278396,2.678829799859676,3.222467153329185
SNU-61,25062766,2.174077685737065,2.1274913331958647
HSC-4,JQ-1-vorinostat (2-1 mol-mol),2.1995872566354864,1.0938262385577286
ONS-76,5460769,1.8809234095271896,2.8743541479868133
BxPC-3,448949,1.967823553768285,2.061436987955732
FTC-133,42642645,4.559192948180462,1.0205699695177797
MDA-MB-453,4705,2.8938913201458583,3.248442331690848
NCI-H727,54454,4.237398664855094,2.8090552659725305
SCC-9,selumetinib-MK-2206 (8-1 mol-mol),2.3963375706124967,2.2110023402241885
MDA-MB-453,tanespimycin-gemcitabine (1-1 mol-mol),-3.3001321684488825,-1.8649171996429497
NOMO-1,19582717,2.563142509513499,2.8353813866886743
A2780,445643,3.2119323974162786,3.8400111329486837
MDA-MB-453,6918837,-5.413037386455184,-3.3858503480065303
BT-549,72193861,1.0619418160757952,1.9740590708378727
HSC-4,44607530,1.7156299328297433,1.6623827295260396
A-673,11455910,-0.0977898825280259,0.3880584432361609
SCC-9,262093,3.396257832039873,2.8754597821913945
JM-1,148198,-6.864264453079388,-4.337638457695942
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576,0.8575698997044239
CAL-51,8515,3.5852991976047863,3.780378808310307
NCI-H292,49793307,-2.523289852336332,-2.2084283453309332
NCI-H1623,2708,5.67986318014104,4.959514300320982
SCC-9,3025944,4.376039606027409,4.276696679788386
LXF 289,24772860,-1.828128181459349,-1.4825385025289486
NCI-H1623,5287969,-1.6741359655835943,-1.6446842005918263
A-673,54454,2.1191092291244877,2.6452015926935872
HCC1143,10302451,1.8641137803790455,3.280174452546247
NCI-H292,54649381,3.811841265663476,4.054942519012874
FU-OV-1,44607530,1.1358438423183184,1.8118540303043864
OPM-2,5702613,2.283159730657738,2.555340196257431
LOU-NH91,11612883,2.793800542696417,2.8931371668806536
DMS 273,11214940,1.0513565801549722,1.3161806045029356
FU-OV-1,65064,4.9743661807936235,4.837390129748084
A4/Fukuda,23635314,-5.004930640559638,-2.5338923157769906
NCI-H146,44137675,3.928890295501361,3.2746694404889167
NCI-H727,carboplatin-UNC0638 (2-1 mol-mol),3.50410186086625,3.0291953359925277
YAPC,navitoclax-gemcitabine (1-1 mol-mol),-2.531110642636913,-0.5947770926421669
SCC-9,25105715,3.642638215460893,3.400692358734828
HCC1143,219104,3.69834662828724,3.7618764082844125
CAL-51,46215462,0.9657515518660452,1.89420214116213
FU-OV-1,9936388,1.7648084748519457,-0.05237250986913091
RCM-1 [Human rectal adenocarcinoma],54619267,4.6297481177667725,4.071119950626241
A2780,65628,0.1843862993724733,3.629094048834058
SNU-81,11647372,-4.046967337474091,0.4930795086102965
NCI-H460,44589607,4.73035444754351,3.032084727333303
SNU-449,9549297,4.8793656902716345,2.586573015123056
SCC-9,11625818,5.698343618019975,4.626502649313273
LOU-NH91,54619267,4.2625648850210665,4.22376280789183
SNU-81,676352,1.7899908822518449,2.1070263584072673
CA46,4096211,0.9281979530192106,0.9180742912519253
FTC-133,6918638,0.7173410835371117,0.750599215736458
A-673,10074640,2.0498537136670696,2.8785336444456067
FTC-133,9907093,5.562055210260789,4.2598594256720865
HSC-4,24775005,4.677905847548428,3.778616533367562
A-498,selumetinib-PLX-4032 (8-1 mol-mol),2.57044020856199,3.483602708523634
CAL-51,11964036,0.7531640395115359,1.3803669713612718
NCI-H146,16736978,0.7510083752799234,1.4667788523696643
YAPC,15547703,3.1542356669454055,3.325380484553961
NCI-H1623,25195348,2.589072393428722,3.446824599656548
JM-1,5311281,0.5908340552261697,1.8868542882862227
SNU-61,9840324,5.730394861191507,5.607713266138482
CAL-51,322968,3.332930006684798,3.6060183945104916
BxPC-3,613753,3.1887459622848935,3.3753083110372
A4/Fukuda,9887053,3.945623871756388,2.9076462148376665
ONS-76,119607,5.207716304164231,5.166696065336806
G-401,11955716,-2.313708507563708,-1.5522548442525745
EFO-27,9840324,6.098788849131883,5.6611056226385905
Panc 04.03,219104,4.644038290885272,3.9801803471299895
HCC1143,25262965,-0.487374364701845,-1.1077735588180762
EFO-27,25227462,1.7048102531951876,0.9967004188129576
HSC-4,10074640,3.187745953835862,3.011397949791196
SNU-449,5287969,-1.7501228923890362,-1.509008753306443
BT-549,49836020,-1.94641857460656,2.569168990475865
BT-549,36462,2.0708174288882075,2.4458772248649034
SNU-449,135421197,1.7191553190938056,2.004625501907003
EFO-27,49867926,4.359647239344765,4.307215516370599
NCI-H727,568763,0.1873556014231215,0.639203389630262
SCC-9,5287620,-3.0509576220001953,-1.873409877707965
SNU-449,3543504,4.913571994290616,4.6328581593605325
BxPC-3,12001922,2.0478076671218317,2.088830300010931
Panc 04.03,selumetinib-vorinostat (8-1 mol-mol),2.824320658243333,2.264184842947755
NCI-H661,54618164,4.023349318575714,4.203907497022677
ONS-76,JQ-1-UNC0638 (2-1 mol-mol),1.9548647661287404,1.6082817238198748
OPM-2,5287620,-2.918074250075414,-2.4284755656295745
SBC-5,71304818,1.011143162310159,2.405353258681672
NCI-H522,navitoclax-sorafenib (1-1 mol-mol),2.7725846762531856,1.1702822935041182
CAL-51,216468,1.370586512271769,3.0082458781483132
MDA-MB-157,25150857,3.068531629493821,2.447931002886054
ONS-76,10074640,3.173150149140259,3.1986438025163824
NCI-H2009,5470400,0.3791383114910072,-0.6653066619405622
CAL-51,54619267,4.1828818787298765,4.0119521201156285
A4/Fukuda,5738263,2.3624425097256676,2.8650070084263417
SCC-9,1239801,5.7667211168431205,4.314185888780061
CA46,11152667,-1.1506421067609531,-2.166517560701324
LXF 289,9444,4.020808033871241,4.140149786174401
Panc 04.03,25062766,2.3535958479396166,2.2523239242625963
MDA-MB-157,71466445,-0.8161407888171323,3.965393475430485
NCI-H661,10302451,1.6315200392387812,3.341231604245156
NCI-H522,10385095,0.7404415633977295,1.0350534205626305
LoVo,53495165,-1.2075385636979648,0.4769324081451012
NCI-H1623,613753,3.253043904005535,3.2176226888895147
SNU-81,49836020,-3.195484765979539,2.9829780971732855
A-673,73707371,5.345141037142936,3.9599130196931718
JM-1,71466380,3.0146886034862885,3.772610181999027
MDA-MB-453,135659046,3.699316020945489,3.8214708921321043
LXF 289,72193861,1.9781400147016948,1.983114157775165
RCM-1 [Human rectal adenocarcinoma],25150857,2.2320644525888165,2.485362785554874
Panc 04.03,46843906,4.199928797005276,3.299040249697695
NCI-H460,16725315,5.407057101640495,4.1609142492464954
SNU-61,375860,-0.3575080218905608,-0.08045063081632903
SNU-61,216345,4.373705885149758,3.498969563086432
CAL-51,25154868,4.656760297450745,4.35751516447211
NCI-H146,10172275,4.247153556222009,3.1933591750577146
SBC-5,122327,4.539216274618647,4.719872800611568
A4/Fukuda,24785538,-4.18833617701787,0.3431383977595401
NCI-H727,54618305,5.896457883643312,4.7155296570781795
A4/Fukuda,tretinoin-navitoclax (4-1 mol-mol),2.572216751068698,1.739156104090377
NCI-H727,6918736,5.488213607701973,-1.792829670128483
NCI-H522,168313200,1.7984937800694238,2.8804485004984857
OVISE,11396600,4.241731433198166,3.609673974436362
ONS-76,25154868,3.0856348617246048,4.55880425449341
LXF 289,135398516,1.6034740470130215,2.296013324075078
G-401,9967941,2.755238424074781,3.3868376232277124
NCI-H2171,44493528,3.677120674941258,4.148097492801585
DMS 273,135398516,0.9081791710880508,1.6333667315399751
CAL-51,219104,3.260140555917495,3.7261912191258113
SNU-449,9927531,4.924705078398161,4.676704809360348
A4/Fukuda,9840324,5.782088483619631,5.43346345573883
DMS 273,11404337,-1.7233190830375906,-0.8161001643161478
MDA-MB-157,24964624,3.531877357122639,2.3600405662881725
CAL-51,44486219,4.943814728636009,4.368796554920019
LOU-NH91,216345,4.715464564049095,4.198679561349249
LXF 289,124202324,2.1762748500922657,2.577547624299237
HSC-4,23582824,-0.585849233367442,0.6888996761878147
LXF 289,25126798,3.2757893610597923,3.9343905543705637
SBC-5,4788,5.245695847909484,5.561863504138831
ONS-76,24856436,1.9295271968291927,0.7355679729610612
SNU-61,24753719,3.71513491278392,3.9092916019879436
MDA-MB-157,vorinostat-carboplatin (1-1 mol-mol),2.089611871642824,3.090254822276603
LXF 289,54618305,4.64176895308047,4.395765491269563
CAL-51,9926054,2.2227862000004577,2.0287348936113903
DMS 273,11427553,3.72076353850383,1.6403273052887144
NCI-H460,25126798,4.092385726400508,3.7787287105910896
SNU-81,1716436,3.163180638308135,2.876811778737302
SW1463,426756,2.2352578961733967,4.057989084982276
NCI-H1623,6918638,-0.0742651507067239,0.7115912374978172
NCI-H522,46191454,1.7170402718959707,1.0420491857733873
SCC-9,JQ-1-UNC0638 (2-1 mol-mol),1.0836659373023885,1.9884681328958604
MSTO-211H,49766530,-4.866552298919663,-0.5423109323498052
NCI-H2171,11228183,-0.0614644470988351,1.1760638505270993
HCC1143,5311281,1.3434544130633397,2.5269814295109847
ONS-76,10410894,3.505250871213463,3.315134693974965
LoVo,navitoclax-piperlongumine (1-1 mol-mol),1.788433807521411,1.9643112807352237
SCC-9,46398810,2.8303032541075455,2.6248637251849662
OVISE,5351362,2.5456705040985708,1.7618917775191698
CA46,navitoclax-birinapant (1-1 mol-mol),3.397408717118992,0.23120724453554828
NCI-H522,5287969,-0.7039868347543177,-1.949713237159263
KYSE-70,9840324,6.215387239369238,5.839425261318936
G-401,2708,4.061322582720861,4.075295112952475
MDA-MB-453,selumetinib-PLX-4032 (8-1 mol-mol),5.5493324312500825,3.207772635503693
SNU-81,selumetinib-MK-2206 (8-1 mol-mol),-1.5641952931996328,1.7227720942032645
A2780,9868037,1.6123332444026346,2.2971607179374445
EFO-27,selumetinib-MK-2206 (8-1 mol-mol),3.7293539227770824,2.2572165497488266
NCI-H292,2708,4.789540620747355,5.1673354666215445
HSC-4,11238147,3.6589845000918504,2.8128487163054077
NCI-H2009,168313047,3.1000323585702083,2.344527382217684
OVISE,3689413,-2.3316050545360136,0.12120197010233678
NCI-H522,71751553,5.137300136027492,4.20358484923478
NCI-H661,9444,4.500292949687679,4.220502553901699
BxPC-3,54649381,3.6406106092590007,3.9489282115497057
KMRC-1,selumetinib-piperlongumine (8-1 mol-mol),4.604012019572112,2.992491912896404
KYSE-70,ISOX-bortezomib (250-1 mol-mol),1.0092839144289247,0.7007841405234054
KMRC-1,10427712,4.418169957842134,4.140181290109283
FTC-133,9935249,4.194644265855045,2.9394050342350817
LOU-NH91,alisertib-navitoclax (2-1 mol-mol),-1.2312433531350488,0.774212157717306
SBC-5,5280436,3.662085558148715,3.4426464883494914
JM-1,JQ-1-MK-0752 (1-1 mol-mol),-0.97629163512536,0.12475788447019501
BT-549,462382,0.0307570083617302,0.6524121277695003
Panc 04.03,445091,5.978315194185719,4.454876921695072
A4/Fukuda,3011155,4.269088750580724,2.1356302010929236
G-401,selumetinib-tretinoin (2-1 mol-mol),2.678729484296938,2.7891434081562227
A-673,57519531,1.198988142705803,1.9192245606477834
SNU-61,3025944,3.777150750907422,4.188084432471294
CAL-51,11497983,2.6322425573174213,3.905362878025534
JM-1,12001922,1.1772658700026328,1.6016477722762412
A4/Fukuda,375860,-1.1918610484687095,-0.3814713919499837
LXF 289,5978,0.6093029371771528,-1.3166859611353714
FTC-133,5329102,4.217502606235289,2.0409148678884
LOU-NH91,erlotinib-PLX-4032 (2-1 mol-mol),3.00809922416846,3.156614181622192
OPM-2,10296883,2.7550650350156474,2.986265721773918
FU-OV-1,4259181,1.2776952629591818,0.07525320713740224
BxPC-3,100016,6.453363473458683,6.319386489698965
YAPC,168313047,2.3481335437424957,2.332405157636603
NCI-H460,10184653,3.574651577310896,1.1870961522668368
OPM-2,3062316,1.3077504545650411,0.4509541570804547
NCI-H460,9956119,4.485375019847723,3.804482203267061
ONS-76,3815108,3.0019527232257555,2.935264937338618
NCI-H2009,6918878,-0.4863456687538305,3.0796353668803063
NCI-H727,10302451,3.178772538514987,2.9394397712628635
NCI-H727,2945648,2.622160220955332,2.7762466174551257
SCC-9,71751553,4.89059631642312,4.572788570979881
SBC-5,36462,0.3494520767872783,2.1366299772349238
G-401,4477,0.236688812816839,0.49140001876739203
DMS 273,9926054,1.8030373867492464,1.6624578049660708
MSTO-211H,2828334,5.714930690846282,6.203131424202542
A2780,24797083,0.8113195258872324,1.140680167536975
RCM-1 [Human rectal adenocarcinoma],984333,1.0265914359647546,1.0194219771044837
FTC-133,44486219,4.933137185021197,4.2855044853147914
CAL-51,6918736,-2.0480142356294637,-1.222120642851767
NCI-H522,72193861,-0.7243330419144597,1.175181661101773
BxPC-3,JQ-1-navitoclax (2-1 mol-mol),-0.3389644558379706,1.1885083526229674
ONS-76,25102847,3.483061373005376,2.648359681768952
NCI-H727,168313016,5.705554517808247,4.933196074702904
SNU-81,selumetinib-vorinostat (8-1 mol-mol),-1.2319110423527484,1.8128105054357908
OPM-2,25161177,3.2493247866394497,3.239567318261285
NCI-H292,374536,1.098561227965989,2.5055494751936154
NCI-H522,54618771,1.252244709003548,1.1901459616911014
KYSE-70,44486219,3.9722791166403657,4.223937445596211
FU-OV-1,72193861,4.196952295232924,1.9931693043656837
CA46,56973724,2.349278499068081,1.668727744980619
A4/Fukuda,2729026,2.569130626356953,2.4572563087768624
YAPC,148198,-3.117185181322903,-3.3479431914190236
A-673,24753719,3.397650756866718,3.6397792249106398
NCI-H1623,16659841,4.138965758514941,3.921580890441795
NCI-H727,637858,2.2360670355510086,1.9762324706058423
NOMO-1,31703,-1.8429032714500968,-2.3276514979292475
LoVo,65628,4.171555925906434,4.395447843509875
EFO-27,322968,2.5694057659070264,3.8634598076195
NCI-H2009,216345,4.438201480917741,4.06512935550278
BT-549,5282054,2.5925054001589976,3.785678465623696
FTC-133,6918837,-2.2077574090678307,-2.4360476152070203
DMS 273,54626689,4.997985813086497,4.377371833531419
HSC-4,16741245,1.7716610997683242,4.053419437911902
SNU-61,6438330,3.4216884605560085,2.276315251263006
FTC-133,9936388,3.0046059879710363,-0.8993990551629493
OVISE,3815108,2.0996140723315913,2.8853141491771503
NCI-H522,navitoclax-piperlongumine (1-1 mol-mol),1.629477440849753,1.102785111233127
NCI-H292,5281321,-0.9498489394799606,-1.367459469662187
BxPC-3,25126798,3.172026591671247,3.8644323590964174
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968,4.367613090889091
BxPC-3,11213558,1.5061777503093252,1.9021805449917988
BT-549,3503,1.5652779265398058,2.4470405456823623
FU-OV-1,1716436,3.524722071533676,2.978034370254717
MSTO-211H,15547703,3.049193057044517,3.2908524823407914
KMRC-1,11427553,3.2258060185151343,2.3039184323576247
NCI-H292,46191454,0.9903655583180804,1.7935523702534082
CAL-51,135928012,4.192641653546412,4.124763451741967
NCI-H2009,44202524,1.444691297679544,2.4089216392013855
HSC-4,erlotinib-PLX-4032 (2-1 mol-mol),2.314385393540324,2.7189873001799465
SCC-9,2858523,3.190510944053216,3.1104355168159032
BxPC-3,15953870,2.831569416015373,3.5650810499195864
RCM-1 [Human rectal adenocarcinoma],49793307,-2.331301981492291,-2.8015252557688473
SNU-449,135398516,1.5851782119809552,2.566682299004805
SNU-81,9843750,-0.6437789188002867,3.613110046202342
SNU-449,11427553,2.8197595076352564,3.066627897523424
OPM-2,11656518,2.629079922396914,0.5234262165391789
BT-549,135398516,2.1186047788766085,2.410214621462208
OPM-2,176870,3.9257377377060383,2.5598587253013507
OPM-2,46926350,-5.934740852723627,-4.570231171513581
HSC-4,2729026,2.4603123985812276,2.7336124377374578
KYSE-70,9444,4.1582482593031145,4.074590961450102
FTC-133,9933475,4.176811369298493,1.9448279321815882
MDA-MB-157,51037431,2.1321019948022046,3.222333606276994
NCI-H522,carboplatin-UNC0638 (2-1 mol-mol),3.513501660159428,3.087561541171904
FTC-133,44493528,6.31419839504633,4.365511752118912
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882,-0.5371431016212678
KMRC-1,11507802,3.5140789318254426,1.6276915342330014
KMRC-1,25183872,-1.331773303463366,-1.2921507073284653
OPM-2,16219061,1.6139038412518538,2.198995420116731
LoVo,25183872,-1.0423877479811554,-0.7301063038252198
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.7527504606732047
FU-OV-1,6623618,4.441105176868704,2.2422935697179636
DMS 273,4259181,0.4383145170351891,-0.34736389843341636
A-673,docetaxel-tanespimycin (2-1 mol-mol),-8.62633538117336,-4.43053098121453
KMRC-1,89183176,5.996613867274686,3.9909206473410133
MDA-MB-453,9825149,2.3540085594050204,2.102408826608964
Panc 04.03,decitabine-navitoclax (2-1 mol-mol),3.786860225423862,2.2505413032866057
G-401,4788,4.978954455161412,5.291457148989699
MDA-MB-453,52947716,-7.0217551266009375,-1.2251143295176854
SBC-5,6918328,-0.0891350348900322,-0.19301912731547824
HCC1143,49836020,2.702530837822698,2.7716690230927914
MDA-MB-453,9956119,4.182542041452956,3.7293110099531903
A-673,136227924,1.815433973878695,2.731438726199552
HCC1143,9956119,3.9159046092458785,3.803466723831939
OVISE,ISOX-bortezomib (250-1 mol-mol),-0.1243058727191033,0.8239276823049636
BxPC-3,11234052,5.706263551465742,4.2660506096381985
NCI-H727,44259,1.5490626006331412,0.897302656856446
SNU-449,24964624,2.993830455857875,2.748420804491871
RCM-1 [Human rectal adenocarcinoma],42642645,1.367998127032919,0.9046334703827585
LXF 289,3025944,3.4981276099044134,4.425672264060882
A-498,24964624,2.395732501339878,2.7760797919974336
DMS 273,4096211,1.7794100041919845,1.3707366470272193
NCI-H146,SNX-2112-bortezomib (250-1 mol-mol),-4.105126294975654,-1.3642793731032674
SCC-9,16722836,2.261290441734353,1.7249537238977302
LOU-NH91,452548,2.191181432305291,0.560390271499327
KYSE-70,2828334,5.886367586734188,6.099642019970782
EFO-27,6450551,4.042476340029328,2.8499845091366636
RCM-1 [Human rectal adenocarcinoma],66577038,3.167694948675542,3.0296610769501626
SCC-9,1716436,3.7585685406918783,2.9807654322033255
NCI-H2009,409805,3.859994247591149,5.011734468219291
Panc 04.03,SNX-2112-bortezomib (250-1 mol-mol),-2.269720015649412,-1.0149129513242428
SCC-9,54618164,4.4493976732458576,4.279883415255393
OVISE,5470400,-1.924229347102114,-0.6071671397180005
EFO-27,44607531,1.7985046151445,1.8809547926572794
KYSE-70,439501,-1.7979650249976522,-1.8935842038483721
FU-OV-1,JQ-1-navitoclax (2-1 mol-mol),0.4181206302825215,0.7002203579606748
NCI-H460,11175137,3.7005840280640374,2.7316450581637737
ONS-76,71680916,4.956248935312428,4.652460143796003
NCI-H1623,10410894,1.736668634267143,3.3242600887675398
KMRC-1,6918736,4.048742051120841,-1.2754072729267727
CA46,25161177,3.91788686206549,3.1300019726185684
MDA-MB-157,6852167,3.8998726158787007,2.581809508336275
HSC-4,11364421,-0.0916399418549534,-1.5273744800913087
CAL-51,2746,3.539110169106334,3.052815813526645
SNU-449,24748573,1.9316038598597545,2.3824465188018813
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188,1.6962266890725737
KMRC-1,9926054,1.768451409600443,1.922181083828952
SNU-61,4917,3.0491510397841015,2.9813996052972023
FU-OV-1,5335621,4.183078950789895,4.514074635867381
LXF 289,44607531,1.6515112206427849,1.6209780395659124
A-673,11640390,1.6795118149646189,3.080681967508712
DMS 273,51039095,3.4577395537233526,2.2882748443018226
NCI-H460,126941,-2.220790788147435,-2.5522566175446797
NOMO-1,5281672,5.39154363605107,4.0271032575402845
SW1463,11214940,-1.9875595606860448,1.8320399383893444
SW1463,72376,-4.419423024557842,-2.3837329718299003
OPM-2,613000,1.2483941007528057,2.4147818801203593
NCI-H292,445091,4.263425815338472,4.487589640243965
MDA-MB-157,46926350,-4.132103643787292,-3.904773778169198
Panc 04.03,10296883,4.422301293811254,4.0145847843976625
SCC-9,11964036,1.807051006133268,1.388046140175945
YAPC,11626560,1.7222365359336271,1.9181252569250946
LOU-NH91,375860,-0.2088041582630222,-0.2725126823964257
MSTO-211H,JQ-1-vorinostat (2-1 mol-mol),0.928346567061831,1.3875787352934859
A2780,374536,0.6453837370733745,1.434978218844977
LoVo,5351362,1.2957137522113673,1.6566985499695186
DMS 273,navitoclax-PLX-4032 (1-1 mol-mol),3.5987731605667284,1.0144674757791834
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277,-1.4129534053002595
LOU-NH91,322968,3.304915281144932,4.201125035036794
OPM-2,54596558,4.064764759335406,4.08136155859727
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448,1.5481586937478458
A-498,UNC0638-navitoclax (1-1 mol-mol),0.9874220571731112,1.952550477919498
MSTO-211H,44137675,1.9879298255329003,3.687985930010567
NCI-H2171,42642645,-0.8345775302937554,0.3787156528295724
A-673,5287969,-3.109107778120567,-1.9261861752272214
HSC-4,5566,3.1631957469062684,3.0350105349660987
NCI-H146,5284616,1.616711114994892,1.6793067661673573
FTC-133,10184653,4.443025626482117,1.364468301285756
BT-549,241158,3.5488750117076484,3.9715838702273785
CA46,25195348,1.4184238486273535,2.2723902637834645
BxPC-3,11497983,5.307904838671978,4.028217889440527
MSTO-211H,4096211,1.4030307395810702,2.4610667214393174
CA46,11175137,1.918070959510412,1.7630482682072683
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-1.0065490333709795
NCI-H1623,5566,3.3003894636357565,2.9012937541478196
SNU-449,25262965,-2.560427276701697,-0.9420055176612041
FU-OV-1,16038120,1.1817724128349547,1.01964219769062
NCI-H460,6438330,3.783082395235063,2.2073000935949962
SNU-449,selumetinib-navitoclax (8-1 mol-mol),4.616443457041138,2.071829064806168
LOU-NH91,12003241,-1.4006618643370652,-1.1316703293578385
NCI-H2009,89928392,1.462956527326012,1.625512955743118
OPM-2,selumetinib-MK-2206 (8-1 mol-mol),1.6316326577463918,1.3413657020888394
NCI-H661,53495165,0.322884771008066,0.6828058049647951
FTC-133,16659841,4.779782303247626,3.7721846477462266
FU-OV-1,176870,2.993075468358777,3.1781894382560334
MDA-MB-157,24771867,-2.9284017086321197,2.808980306712832
MSTO-211H,5328940,-0.7344582610548551,1.8264156433516479
A-498,25126798,4.108305960475203,3.9417211659464884
HSC-4,piperlongumine-MST-312 (1-1 mol-mol),1.1147970090966637,1.738498680093042
HSC-4,5460769,1.9290612526481368,2.81315486637389
JM-1,9826308,-1.254578223347674,-0.20529526081320948
ONS-76,124202324,3.376244033970937,2.112621171769591
YAPC,135984461,4.395865755985396,3.9574315192246043
DMS 273,5746,-0.0149388723107023,0.7266138014630935
FU-OV-1,4917,3.642085139957623,3.099597136088009
LXF 289,49793307,-1.960491877422628,-2.1664872605579713
OVISE,107970,3.0608588072726444,2.4262141897089466
BxPC-3,446155,2.3080345350315015,2.768057975562146
OPM-2,65064,2.528451354351822,4.235135491952629
SNU-81,5278396,1.9031243607798085,2.8949199402873274
NOMO-1,5351362,2.08054014163225,0.9290870747457767
A4/Fukuda,675434,3.712142385749843,4.067590643241129
ONS-76,44241473,4.684511997660941,4.78995544703287
NCI-H292,54619267,4.1033140795833445,4.145686494503755
NOMO-1,5470400,0.2862684612003833,0.2156545529752808
LXF 289,1716436,2.59582131383783,2.9309465044853833
OPM-2,71680916,3.9051822114426025,3.8937393073847515
YAPC,72193861,3.178335780336401,2.048123414750314
HSC-4,148198,-2.795908666323494,-3.27158417151487
Panc 04.03,piperlongumine-MST-312 (1-1 mol-mol),2.325884658046027,2.0816239473735907
A-673,25161177,3.4603475867806788,3.470792404968974
NCI-H522,9866186,0.2313673592680447,0.6305083859573617
CAL-51,24772860,-2.425084956958233,-1.5512046321255122
KYSE-70,72734382,4.428008981499565,4.559007973928968
EFO-27,44491742,4.311239061696844,4.388370720950261
CAL-51,322968,3.332930006684798,3.6060183945104916
OPM-2,68056272,3.036834126647856,2.82068926754944
RCM-1 [Human rectal adenocarcinoma],selumetinib-decitabine (4-1 mol-mol),3.6407543671140417,2.752722206590015
RCM-1 [Human rectal adenocarcinoma],1716436,2.8487797947795226,2.9128918172648848
LoVo,11485656,1.8604760547282393,2.2926734982330697
LOU-NH91,selumetinib-MK-2206 (8-1 mol-mol),3.1932369628338195,2.624285146521938
CAL-51,10074640,3.192334769578339,3.174172664193206
CA46,piperlongumine-MST-312 (1-1 mol-mol),1.0820043516957718,1.0907908626266225
SNU-61,452548,0.6134547199912214,-0.3329726686687198
MDA-MB-453,5311,-0.5257883568365231,1.3719859243563572
HCC1143,23582824,-0.3689859010226292,0.6581763772354107
SBC-5,7251185,3.120445126947185,2.5745175335328634
NCI-H292,24901704,3.391496569820259,3.405733761493729
NCI-H522,10410894,2.9293088965189553,3.1597077846643624
SNU-61,23582824,2.5643180100002225,0.9427260836332116
HCC1143,16065773,2.712611567173667,2.5467234005209485
MSTO-211H,46191454,1.2859626841233986,1.5587404360502242
DMS 273,72199292,5.337691921623293,0.6278903697739344
LOU-NH91,46398810,3.045211454343731,2.6720257702384895
HSC-4,135928012,4.241462346184107,4.248885727446865
NCI-H727,3384730,3.6794289647639737,2.883377566500029
SNU-61,4788,5.909414847709577,5.639019078681477
A2780,5329102,1.3737092942346336,1.7580563810318461
MDA-MB-453,444795,4.759998515464953,4.496860220706975
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,4.021986716635288
BxPC-3,11507802,0.9945684314547258,1.8139715120341862
Panc 04.03,24889392,4.270107644861146,4.394888603138344
MSTO-211H,46215462,0.9168806818627014,2.3375055110947254
MDA-MB-453,11167602,2.244240898320102,2.5742173229063092
A2780,400769,-2.1774855243121425,-0.9496111576597528
ONS-76,52912189,4.881284158574923,1.8671979139685364
BxPC-3,44137675,2.990010873447489,3.830448767377503
HCC1143,753704,4.831564496260181,4.851662984901713
SNU-61,9915743,-0.5579526190142376,0.26173596883971373
OVISE,1242560,3.5076159129293956,3.478988134855784
CAL-51,6914657,-5.067352950634086,-4.010952934079754
LoVo,selumetinib-UNC0638 (4-1 mol-mol),1.1151231376311057,2.520020861406104
NCI-H292,9907093,4.58058164849987,4.29095823762398
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032,1.027946381029997
Panc 04.03,vorinostat-navitoclax (4-1 mol-mol),1.7756869415630383,1.3445814672845657
EFO-27,6852167,4.289895730200754,2.9915507758808877
A4/Fukuda,148124,-6.6912736941139865,-3.1039159628275628
MSTO-211H,24785538,0.8010437121318222,1.8182899622362505
NCI-H661,49850262,3.557667726590132,3.8016970545111253
BxPC-3,navitoclax-PLX-4032 (1-1 mol-mol),1.642487970123168,2.2332861774107657
EFO-27,4521392,4.521895501485345,4.3850681951469275
A-673,65628,3.827084992759042,3.598774155559908
SCC-9,11427553,3.060791645335887,2.9047322193678093
A4/Fukuda,BRD-A02303741-navitoclax (2-1 mol-mol),4.161880654149954,1.6378767461911996
NCI-H661,36462,2.012090600363037,1.9300121774634484
CAL-51,11625818,4.1129054868405905,4.21388952864963
SNU-449,252682,6.455952915446744,6.5785923251364045
RCM-1 [Human rectal adenocarcinoma],5311,1.6255593512960202,1.6391135618318662
HSC-4,2828334,6.111197262680893,6.1836521035745955
MSTO-211H,selumetinib-navitoclax (8-1 mol-mol),0.5648552965523568,2.2979792345465353
A-673,753704,3.1138845387287657,4.324494530388219
NCI-H292,409805,3.708436738901026,5.21133116987105
NCI-H2009,72376,-1.9106633783650309,-1.867712465942771
OPM-2,24753719,4.370940438199297,3.3835026482451114
RCM-1 [Human rectal adenocarcinoma],15547703,3.173985625992098,2.958891828958156
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073,3.3894845889098195
LoVo,9915743,-0.8819018227786422,0.8325847411733686
BT-549,4788,5.920199401047736,5.799752309183754
CAL-51,2858523,3.1959449804225524,3.057237233697112
OVISE,2742550,5.280611289386831,3.9775122499261597
HSC-4,5470400,-1.775367561967962,-0.26244466265046595
FTC-133,3503,1.9089172693495084,2.2679022734685486
RCM-1 [Human rectal adenocarcinoma],ISOX-bortezomib (250-1 mol-mol),0.2714695446270951,0.6899178553290187
MDA-MB-453,4578,4.4862028800041545,4.207733931219168
EFO-27,16038120,2.346094356536249,1.1323570817111972
SNU-61,66577038,2.989851386241242,2.6600642939199894
CAL-51,4259181,-0.5132501801478601,-0.007639061412731114
CA46,decitabine-carboplatin (1-1 mol-mol),2.864981631125043,-0.47284717351033806
LoVo,SNX-2112-bortezomib (250-1 mol-mol),-2.7337701225380786,-1.3280537195050472
SNU-449,3552672,3.5064135830435563,3.0264527816383886
SNU-61,44589607,2.748444545219875,2.3055151929683295
ONS-76,2945648,2.901632251679741,2.8494431829420153
ONS-76,44607531,1.762572438348297,1.4462509461645998
DMS 273,2874250,4.3291006423311025,4.409450148197518
SNU-449,9840324,5.822936489993131,5.8931312452274645
NCI-H460,6610355,4.949206869720499,4.414343294581537
HSC-4,11612883,3.5946567658341197,2.734562840414517
NCI-H522,11175137,2.853962760117135,2.3300513297939687
RCM-1 [Human rectal adenocarcinoma],selumetinib-BRD-A02303741 (4-1 mol-mol),2.266377175881345,3.019739485233404
A-498,5281321,-0.4472251536664238,-1.158728144125953
OVISE,25154868,4.508600245054991,4.246578535403481
Panc 04.03,44185566,3.115745823738928,2.705367963345947
SNU-61,49793307,-2.3504304765085573,-3.3879303262383123
CA46,44607530,1.320133740199814,1.064089983093441
SCC-9,10385095,1.4052834583911455,1.367687049382723
HSC-4,675434,4.235689784331333,4.404136385898762
NCI-H522,16725315,3.2253372097194752,3.9145625903013554
FU-OV-1,1750826,-4.024957616345245,-1.293277326480088
HSC-4,57519531,1.2769425534379089,2.7328946478763703
NCI-H292,9868037,4.01216306257403,3.495347037622675
G-401,52947716,-7.497954818853376,-1.058169837363268
EFO-27,5280436,2.3763113561475997,3.5851578495669956
SNU-449,11625818,4.573588862325648,4.809174381237502
CAL-51,135999136,4.2132345103647015,3.9396750473042608
NCI-H146,19582717,2.457603508665216,3.0924502812092403
HCC1143,1716436,2.8430583337953284,2.9216375255226126
DMS 273,9911463,3.7655644930376257,3.331207633436084
NCI-H460,54649381,4.173104904963283,4.01032302812131
NCI-H727,6918837,-1.02939028052569,-2.5680294236375585
BxPC-3,6852167,2.5268139587107754,3.0371242439990005
MSTO-211H,168312962,-1.9489367550084584,2.1716641193364983
CA46,17755052,1.7120394846678155,1.039361125055413
ONS-76,3676137,5.654292431942107,4.719411470918994
A2780,11175137,0.1901581111291173,2.120666448068459
NCI-H727,10427712,4.338841626329874,4.32878097220711
LoVo,241158,4.012317425862525,3.7090746717939775
Panc 04.03,3062316,3.5966054915380647,1.2060907041007283
SNU-81,54454,2.7601348658589,2.9400696850550347
SBC-5,3136844,4.085952663076754,4.34487080261529
BxPC-3,4261,1.8613797726144792,1.5980212175912094
YAPC,11364421,2.3126725462898508,-1.0494726858458312
NCI-H727,387447,-3.6268426938273457,-4.193902167008091
A-673,11955716,-2.8120675934907107,-1.736201552485918
Panc 04.03,selumetinib-decitabine (4-1 mol-mol),4.200719534788661,3.718952223472453
FU-OV-1,135440466,0.9480137026796296,2.28530594318942
NCI-H146,25150857,0.3973439930915976,2.0635721559440303
SNU-449,46926350,-1.1609870247475182,-3.9190900032963354
MSTO-211H,9840324,5.369584805162093,5.752111042176015
G-401,5460769,-1.872739736028161,2.292870593464729
CAL-51,568763,0.0917223714484538,0.43218420997531276
MDA-MB-453,5951923,4.303369563038856,4.166499028447296
KYSE-70,66577038,3.0162273972396005,2.9491849672250914
LOU-NH91,16722836,1.148829534310261,1.8895713258525604
FU-OV-1,613753,3.071481920375854,3.2125048210268385
KYSE-70,doxorubicin-navitoclax (2-1 mol-mol),1.6680875974880454,-1.0342886445531319
CA46,49766530,-5.499020578204802,-2.1646436611521978
SNU-61,11175137,3.4257878627613505,2.417100074850802
HSC-4,969516,2.6364274978390703,2.8434707642974844
A2780,10074640,2.580771204793581,3.039617302207127
EFO-27,10410894,3.5790791622635907,3.295256119275014
SNU-81,8515,4.116210915577815,3.5505697449031284
KMRC-1,322968,4.639571189041566,3.620801962962933
EFO-27,54626689,4.866384531477491,4.582953990326127
LOU-NH91,9911830,2.650870613913377,2.7222287488368617
OPM-2,135659046,2.7260896342727396,3.233349662114228
OPM-2,6917907,-6.048813777211379,-5.220742957501581
SCC-9,151289,2.789872420286255,1.282974601929782
NCI-H661,4705,2.5155315968978127,3.493101413223241
RCM-1 [Human rectal adenocarcinoma],15953870,5.063824663341904,3.7144019487076823
LOU-NH91,25154868,5.6992218929630205,4.577427503946313
NCI-H522,54619267,4.072629967998864,3.8930213493678485
BT-549,11222830,1.721965279957128,1.6658689659105446
NCI-H146,53301938,3.7804038583893504,2.5063094926713236
FU-OV-1,selumetinib-JQ-1 (4-1 mol-mol),-0.403195367038434,2.0254979373112856
NCI-H727,selumetinib-MK-2206 (8-1 mol-mol),-1.8356480928534216,1.9662560293988187
MDA-MB-453,7326481,2.376694251985227,2.935812454780736
HSC-4,6914657,-3.070952064512468,-3.878806940620853
MDA-MB-453,72376,-2.4391350280385033,-1.6973470673010644
SCC-9,selumetinib-JQ-1 (4-1 mol-mol),2.082538789678548,1.2663064244520001
CA46,2130404,5.640885888744477,2.095461054990541
G-401,216345,1.83916726924219,3.1912797815526073
LXF 289,54143018,0.7636513295056184,0.9209515357572099
MDA-MB-453,246676,1.942789144720036,3.9874588669672137
A-498,19582717,5.689025629434131,4.37406459595803
MSTO-211H,11964036,1.836732040985672,1.690772066391117
A-673,3552672,1.3462933778606576,2.7614984037553607
CAL-51,11152667,-1.203722258692511,-0.5505570569164955
CAL-51,67156097,-2.385254348530768,-0.7042087843943498
CAL-51,65064,3.306239750209062,4.892825438378341
A-673,piperlongumine-MST-312 (1-1 mol-mol),1.0809583866306374,1.5815826588497623
KYSE-70,navitoclax-pluripotin (1-1 mol-mol),-0.6013562023885967,-0.7143379991885632
MDA-MB-157,6917907,-6.62909111977728,-4.231933754554868
HSC-4,64971,1.7199562834608897,2.80622582812501
NCI-H460,135440466,3.295247648571462,2.277248856147487
MSTO-211H,57519531,1.3086690033484818,2.3982279688423067
G-401,9926054,1.744192331951833,1.9877627885408768
OPM-2,24821094,1.5161257655930716,2.5015134532736836
NCI-H727,1641662,3.969866081416476,3.5747762547382935
YAPC,66577038,3.3954554117120224,3.0935662200943823
A4/Fukuda,36462,-0.7730347482869518,0.9330956357567816
DMS 273,135440466,3.3485559592244214,2.0172310270373894
FTC-133,445455,5.178470647326205,4.66000131001257
Panc 04.03,72376,-2.048199615123948,-1.5837211744220128
CAL-51,10302451,1.350542324147247,2.996955552377945
JM-1,11214940,0.7147440273172748,0.8247666516415936
A-498,25183872,-0.6220750954527926,-0.23269310160706982
OVISE,44607531,3.0758971794813093,1.4784564745098532
A-673,53392493,1.8369213613876785,1.9734364359820358
LoVo,11719255,3.552916809155198,3.4666599666821942
SNU-61,439501,-1.3808373898758073,-2.189471082261715
NCI-H460,104842,-2.7771726159534773,-2.1532723835432503
CAL-51,11364421,-3.809863778172731,-1.608687058597053
BxPC-3,71466578,5.509660254732227,4.673966130847118
NCI-H522,12001922,1.5621076115514363,1.8151825059940412
KMRC-1,11626560,2.283484204530191,1.6720491948405753
MDA-MB-453,5329102,2.150481946774112,1.9351240909915794
DMS 273,navitoclax-gemcitabine (1-1 mol-mol),-2.068576653592491,-1.3343031203480848
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-0.957248672130662
ONS-76,16720766,0.8880370259188662,0.39063667326366924
EFO-27,56949517,4.565823410262603,4.348860074046551
DMS 273,11222830,1.4389641717758948,1.287760393292069
LoVo,36462,0.97058855741136,2.050996840270044
OVISE,SNX-2112-bortezomib (250-1 mol-mol),-0.8591608441303084,-0.9503811622611917
Panc 04.03,16038120,1.7157321990683845,1.1711776842498214
LOU-NH91,3062316,-1.7568876367320156,1.3914979817063267
A2780,9903786,1.372407357095215,2.479142095114266
OVISE,49766530,-2.0570642495309004,-0.45059584562785276
G-401,doxorubicin-navitoclax (2-1 mol-mol),-2.722419727945218,-1.779640408496043
SNU-61,11427553,3.286064968901604,2.2356357202854706
A-673,72193861,0.2228627716233472,0.8607860242986612
Panc 04.03,tanespimycin-gemcitabine (1-1 mol-mol),-1.7855747696836677,-0.9014498227463421
NCI-H2009,3815108,3.061482559784255,3.0087796932779662
A-673,2126,5.190382873813306,4.086451544545264
ONS-76,10302451,3.399700001459874,3.293029543616363
G-401,9825149,1.4427851681991832,1.7575426656844966
NCI-H522,44202524,1.1337498661514331,1.7095526024744299
SNU-61,52947716,-2.831948664567002,-0.5790480957604092
A4/Fukuda,2945648,2.3216808345706035,2.3362682658726333
A-673,25105715,3.2161270828318207,3.2841911066527074
NCI-H522,11178236,-5.864645603629742,-3.0681601849135673
JM-1,216239,1.5816975151035817,1.731199411511672
CAL-51,9903786,2.1849161121493847,2.807153479453486
SNU-449,9936388,0.4589950900054629,0.3808734919597752
NCI-H292,9927531,4.942242070848643,5.008259398066206
NCI-H2171,25262965,-0.9052216234257174,-1.5378869441025536
OVISE,selumetinib-MK-2206 (8-1 mol-mol),3.824616242676661,2.1016438357675886
JM-1,24901704,1.786623485766962,2.320617876779246
SBC-5,656346,0.6270929807498155,1.0522851349712057
KMRC-1,89928392,3.173061856078121,1.368224769704085
NCI-H292,156414,1.4083938325335852,1.5855067682824853
LXF 289,135875424,3.2815298243266553,4.013336799881603
A-673,11494412,0.2373053627626316,0.9019646441053055
A-673,5746,-2.085801833901771,0.28392898900601826
DMS 273,9935249,1.448801275140577,1.720784729023154
FTC-133,11404337,1.1811341910019733,-0.21163462589517756
MDA-MB-453,57519531,4.708696705883037,2.648698304444726
FU-OV-1,11152667,-0.9879051128837576,-0.2880035868339448
A-673,44493528,4.641329710074662,4.275937133623172
NCI-H460,2828334,6.134119597935603,6.163283711640146
NCI-H2171,16659841,2.989016667138281,2.9064995494097974
FU-OV-1,73707386,2.8924737769549633,2.9203646833579917
FU-OV-1,24901704,3.02942514713799,3.4150489701146682
NCI-H727,4259181,-0.7375001764594127,0.3888845097528983
LOU-NH91,tretinoin-navitoclax (4-1 mol-mol),-1.081702007915755,2.7677078083378035
KMRC-1,navitoclax-PLX-4032 (1-1 mol-mol),3.702338136233157,1.3847048600285836
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574,0.09326491488478034
MDA-MB-453,17755052,-0.3952702915340721,1.348573777663347
DMS 273,46398810,2.5474695176149527,2.129824932934876
G-401,5278396,3.0023073980849424,3.3232765075155712
NCI-H661,24821094,2.278259467148376,2.857564846571181
NCI-H146,11364421,-6.559818289293388,-2.5878622606731416
JM-1,24797083,0.8026470280931975,0.9900105180733675
NCI-H522,168312962,3.69802370811012,1.2330360125679762
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764,0.8363744179000104
BT-549,16736978,2.673955173636492,1.865467872507678
A4/Fukuda,46907787,-1.6446005772830188,-0.3183900845638362
ONS-76,654092,-0.1261556450149646,-0.22054866787706964
NCI-H661,6610355,4.759868911507443,4.754281567389339
Panc 04.03,JQ-1-UNC0638 (2-1 mol-mol),2.939045539650312,1.8772156407832064
G-401,25154868,3.6071608181606063,4.29388833349369
MDA-MB-453,4788,3.7423511350995255,5.194442160647529
MDA-MB-157,11960529,3.789984251684095,3.7433011380648105
SCC-9,16720766,1.7269628893506093,0.6949923547128677
NOMO-1,753704,4.4431191000277375,4.1509970338614535
A4/Fukuda,6450551,1.0528971846899622,1.2334982781836015
YAPC,24964624,2.625771283300636,2.4790335491904414
A2780,82146,3.1377115486631273,3.1409994709788203
MDA-MB-157,1566236,1.4232096904008935,2.499454757764936
LXF 289,25183872,-1.882522005728347,-0.6093604868122496
KMRC-1,24753719,4.192591897270876,4.167854935841983
LoVo,44607530,0.9946707755477716,1.689666176372317
SBC-5,44632017,0.6241642112624288,1.170058089217125
SBC-5,23635314,-2.6646956028329223,-1.887713417880011
LXF 289,54619267,4.7435335143288935,4.080991269914614
BT-549,46199207,3.7007120058669623,3.2689951217011513
KYSE-70,6914657,-2.943523310206574,-3.454474593840835
A2780,89928392,-0.8241966309638568,0.99157238918935
MDA-MB-453,54618164,4.967166731196573,4.002367943839643
SNU-81,selumetinib-tretinoin (2-1 mol-mol),-2.852334261178199,2.8355822290721595
NCI-H460,4788,5.894567383019075,5.608865612721611
DMS 273,24951314,0.5391494064850418,0.6216704660559443
NCI-H460,1750826,3.3189287492303197,-0.8435999900392919
CAL-51,2749,1.4482754145936665,2.1882145344134627
OPM-2,1566236,0.7571858740606694,1.3183285023371258
A-673,selumetinib-decitabine (4-1 mol-mol),3.170233971616513,2.0406910473544615
EFO-27,11626560,3.0674086659258646,1.9438586062918475
BT-549,216345,4.357029009920563,4.227292542332739
KYSE-70,3081361,2.4267899196210982,2.1092969635413312
NCI-H146,156414,1.153076826996135,1.060923976290994
NCI-H522,135411,0.5669945497970937,0.5237563894404307
BxPC-3,6438330,1.9774707221451924,2.2779370105856245
MDA-MB-453,9903786,4.505035222499518,2.907153632613522
YAPC,5281321,0.2366473375234088,-0.36908031718142964
MDA-MB-157,71304818,1.9463509570918949,2.662419662812856
BxPC-3,56946209,-3.950691768305054,-3.9686264834911005
LOU-NH91,6450551,3.4853298595759687,3.0017704115091717
G-401,1242560,3.581659075050411,3.3162476681142734
MSTO-211H,3854666,2.1662920246080963,2.1135941310464785
NCI-H522,25062766,2.616535601519866,1.7600575891109573
Panc 04.03,3038522,3.0958365698912154,3.256234570285552
NCI-H460,25183872,2.110783783288614,-0.7123214689471395
SCC-9,71304818,2.8421374335972653,2.6485671826406114
SCC-9,65064,5.356580923551092,4.956397743341168
NCI-H727,25183872,0.4102957812787974,-0.6266663433286714
NCI-H460,81146,4.483282466350705,4.8894398401175
OPM-2,navitoclax-piperlongumine (1-1 mol-mol),0.7945063119799598,0.2524173620812281
MDA-MB-453,54765302,2.0573663082868405,4.033241184654623
KYSE-70,10302451,3.1884398798129525,3.0196489719608803
LoVo,49793307,-4.412709808216002,-2.4790029912442733
SNU-81,36314,-5.848392982376778,-1.5014374645854875
A-673,navitoclax-birinapant (1-1 mol-mol),1.618517186072499,0.6726334479809695
Panc 04.03,2733526,4.292486036611722,3.7927867194262648
CA46,9926054,1.6892727173627182,1.6340791294743595
NCI-H522,2746,2.8917767436803414,2.8978234620862735
LOU-NH91,67156097,-3.1227398262817587,-0.5888601879726562
NCI-H146,5284329,3.6277290639514455,3.01240921148086
KMRC-1,644241,4.9037113640465035,1.8256087653730686
A4/Fukuda,60700,-1.3381290141173086,-1.2465977137990365
NOMO-1,24753719,4.496099764979975,3.416172161277908
NOMO-1,9903786,1.612481289648159,1.988968351413557
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182,2.383960216447808
JM-1,54618771,-0.5043757930015165,0.12290168568257637
G-401,3854666,0.6606077023561356,1.3371725955145815
EFO-27,24978538,3.143555245211511,1.1159078988152602
OVISE,322968,2.654176014952692,3.8882358222987246
EFO-27,alisertib-navitoclax (2-1 mol-mol),2.9537662820479693,0.6728343135291662
FU-OV-1,637858,1.762395691671764,2.035736023315103
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.9053705175781528
ONS-76,11626560,1.9844806011562912,1.743740923937138
LoVo,216345,1.1599721320761718,3.8005323858250075
SNU-449,9926054,1.9385314164963827,2.092548354560801
HCC1143,568763,-0.6390257750571487,0.5211115252181675
MDA-MB-157,JQ-1-MK-0752 (1-1 mol-mol),3.739596804581883,1.866909622024498
NCI-H292,72193870,4.439424680926146,2.9455108599872726
NCI-H522,11228183,3.862798460505377,1.5603906835672003
CAL-51,4788,6.061217822513647,5.513837318564885
LoVo,4521392,4.145025799048703,4.344263942134302
HSC-4,11626560,2.5873766751252436,1.923884357815031
NCI-H460,60750,-0.8382921927225392,-1.9615858671005202
JM-1,44137675,3.718094845766921,2.7828461835597214
HSC-4,71304818,1.898043557267106,2.4600192408816404
CAL-51,25150857,2.2346870378683934,2.4173437177251387
CA46,2871966,-1.7971239931694716,-0.529206406437965
DMS 273,54454,3.225049529812471,2.560138619029721
ONS-76,25183872,-0.170903852827654,-0.8084329119500441
SNU-61,984333,6.216581141210495,0.3829864491432661
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.214235849739628
A2780,71466578,2.665399831677294,3.474000314623436
HCC1143,docetaxel-tanespimycin (2-1 mol-mol),-1.7966403961348645,-2.628216323448935
CA46,24797083,-0.1839530161688024,1.1309420010349012
CAL-51,135875424,4.33643967165441,3.81860871307639
NCI-H2171,3689413,-2.7117222930063867,-0.888737124905155
A2780,11396600,2.9320615716687564,3.0719238748576068
SNU-449,navitoclax-PLX-4032 (1-1 mol-mol),3.4557412405701258,2.46126731492339
G-401,56963564,0.504836775176006,0.1559410783536351
LOU-NH91,44632017,2.871860814691948,1.444214354556541
CA46,11214940,-0.2735426892992921,0.9765938619211498
NOMO-1,67156097,-2.629595584457773,-2.0431087611458283
NOMO-1,26596,-2.074766602044621,-2.492067744983533
JM-1,50905018,4.16446369685189,3.4092115454276404
NCI-H2171,445455,3.811797523558628,3.9843951139866025
EFO-27,16736978,1.8793599511128067,1.984385188361026
JM-1,54678924,1.2599632015511184,1.4301399772621204
NCI-H460,5281321,2.142807178276493,-0.8985805677837585
SNU-449,5738263,4.026622535351311,3.6333964516537685
SCC-9,216239,3.331867398285969,2.486477829690655
G-401,10410894,3.279247022117546,2.982770526748125
SNU-61,11222830,1.6415416447740467,1.6149975790910034
CA46,2113511,3.5674790523720317,4.513619250021039
NCI-H146,72734382,2.9399655016804114,4.036565351312079
NCI-H522,613753,2.504960527289346,2.9497448019902452
G-401,156414,1.0662464633968871,1.307106973948718
BxPC-3,5470400,-0.5134005920596514,-0.30387795053053235
KMRC-1,1242560,3.860865345198952,3.4541950650722377
BT-549,1242560,4.319126066576065,3.6789164919856407
OPM-2,66577038,2.8274271292709536,2.6080454625220995
RCM-1 [Human rectal adenocarcinoma],613753,3.402609507762531,3.146303349912614
DMS 273,16013152,3.9042510131977353,3.346273965757108
NCI-H522,448949,1.6947060599097594,1.621161197862781
MDA-MB-157,5566,3.489209385839125,3.1198554648110166
Panc 04.03,53392493,3.71782736184095,2.7583604334252123
BxPC-3,55508,4.124435576281598,3.390574931274455
EFO-27,carboplatin-UNC0638 (2-1 mol-mol),4.02907602487195,3.533449387091122
NCI-H661,4521392,4.344795346058825,4.383942340782019
JM-1,119607,3.9456515069078,4.310872628566055
NCI-H292,SNX-2112-bortezomib (250-1 mol-mol),-1.594180190580018,-1.2367126055112718
NCI-H460,3385,3.2657114863965573,4.198528363744726
A2780,327653,2.026169684275287,2.9667093342136157
SBC-5,vorinostat-navitoclax (4-1 mol-mol),1.5319499176143987,0.9538198339379107
MSTO-211H,crizotinib-PLX-4032 (2-1 mol-mol),1.678384538966045,1.9950946596079
JM-1,4261,-0.3533034531676731,0.3288855622868253
HSC-4,135875424,3.4627713632233537,4.024511607452706
A2780,44491742,3.4077888459991774,4.142125881416784
Panc 04.03,135999136,5.549073334475873,4.036332173705534
SCC-9,57519531,3.918058558817349,2.679400616545868
LoVo,3815108,2.2685826541267615,2.9735412500352556
DMS 273,71466445,2.157471967137961,2.7480576995612904
NCI-H661,44241473,4.80522256986357,4.783177925164372
ONS-76,6438330,3.0471678199579206,2.508007028908932
Panc 04.03,2949965,2.626604824548014,2.90306598530758
OPM-2,676352,1.691725548140899,1.8935279801499483
SNU-449,16722836,2.5551835494173325,1.8266156535428082
A-673,11152667,-2.304412849002376,-0.9949434940452769
RCM-1 [Human rectal adenocarcinoma],53232,3.9030972816172262,3.0133119462075637
G-401,151289,0.7906130786084481,0.6580798511411268
OPM-2,serdemetan-SCH-529074 (1-1 mol-mol),1.0013874340560274,1.3328321556244853
LoVo,25195348,3.880726101323461,3.2507209616220094
NCI-H1623,11404337,1.3417738865788873,-0.1034375354399669
BT-549,3062316,0.532185160328145,1.6804878732937616
NCI-H146,doxorubicin-navitoclax (2-1 mol-mol),-3.7183112313857216,-1.7427562847527824
EFO-27,44185566,3.1194970070950276,2.710120734181237
A4/Fukuda,16725315,3.095723533871789,3.807645862353321
LOU-NH91,3854666,2.9087049696787544,2.33292484265951
NCI-H460,676352,2.985829219207002,2.187887700391655
MSTO-211H,23725625,2.234746785874409,5.306748516903152
SCC-9,5351362,1.6846115382104403,1.626560004659332
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699,-0.6941878073746612
NCI-H522,241158,3.3210308536521156,3.4808046865850595
A-673,10127622,5.418104152685571,3.538193168094435
MDA-MB-157,serdemetan-SCH-529074 (1-1 mol-mol),2.3164799956967665,2.105534315027136
G-401,53232,3.5991410971239866,2.746256420407114
OPM-2,5287969,-2.4106191892149185,-2.0929908722520913
SCC-9,637858,3.7694424070181127,1.9906608075943557
NCI-H2171,5282054,2.409902559914623,2.861704781492151
NCI-H292,1242560,3.487131794973456,3.5064570666705492
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974,1.1509645126207078
CAL-51,3503,3.2899889427654245,2.2738814679120476
DMS 273,selumetinib-BRD-A02303741 (4-1 mol-mol),7.1319495853751045,3.077354675416912
Panc 04.03,51039095,3.732934843851844,2.992918229231984
NOMO-1,5329102,1.5937414073922636,0.8304187168490461
ONS-76,1242560,3.484199229378892,3.5907984970953275
G-401,24180719,3.4290114124184568,3.3425241731015984
A-673,11485656,1.6006257465541904,1.7693264999298939
NCI-H460,5278396,3.885794996406102,3.5955209747474517
ONS-76,4788,5.851184911612036,5.677117749213928
NCI-H661,11234052,4.193192571907383,4.097098542138375
LoVo,46174525,4.300656487428364,4.384250576999866
CA46,135875424,2.985562686352135,3.198917320541811
SNU-81,6610355,3.7225360861185592,4.330726483065066
MDA-MB-453,JQ-1-MK-0752 (1-1 mol-mol),0.5621675718726626,1.3484752992183981
A-673,1566236,1.6605846703776754,1.7637680884288238
LXF 289,55283,4.7983814176360715,2.5729368506222317
DMS 273,1566236,1.8001113918747356,2.0036606398708345
SCC-9,4477,0.0462068475019735,0.5657748653302641
BxPC-3,439501,-2.27553783948146,-2.1652357707922456
G-401,3503,1.5245243202568906,1.9353446134355492
SNU-449,5280436,2.098309971831213,3.6458480844201353
LOU-NH91,119607,5.561970464467383,5.405918140510739
MSTO-211H,6918328,-0.4462053694736546,0.17422697377088642
A2780,10231331,0.3686619766312378,1.6355375094572724
SNU-449,44137675,3.6126407514409378,3.6219997549114726
Panc 04.03,9866186,0.4755964236535121,0.9504733356458119
JM-1,40482356,5.622716652052393,3.4192950351582247
CAL-51,49766530,0.4609697007955676,-0.20059744460808898
G-401,11960529,4.93979495553103,3.484999768905647
HCC1143,6505803,-0.5233928936461414,-0.38389920686774104
KYSE-70,676352,2.557270596786296,2.115377122348084
A2780,135398516,-0.3122960179418635,1.7168975098650672
NCI-H292,23635314,4.8326715815763395,-1.1759859236970724
SNU-449,15547703,3.400796461378631,3.1404829640082865
CA46,navitoclax-piperlongumine (1-1 mol-mol),1.4441341288477034,0.095406296871731
LXF 289,46843906,2.101940493524925,3.2872560709163605
DMS 273,46174525,4.164871991455526,3.4948592904123994
NCI-H727,selumetinib-decitabine (4-1 mol-mol),-1.5172256962408457,3.1901387652938586
SNU-449,6917907,-5.317414756413243,-4.684157360933619
A2780,4705,2.567744201920244,3.2725171837322136
KYSE-70,73707438,4.323396479680616,4.1996271214345
NCI-H460,5329102,3.240160570329804,2.0415547668660814
NCI-H661,5282054,3.5253080606128133,3.7052527713564523
NCI-H1623,119607,5.952206355872506,5.297333784416808
NCI-H522,64971,2.9291780846019413,2.241180416709035
CAL-51,11222830,1.6762547521470548,1.5319715757692507
A2780,vorinostat-carboplatin (1-1 mol-mol),2.197042842116113,2.549609659885493
SCC-9,25062766,2.812414712404745,2.0236347636977428
YAPC,31703,-0.7401868256368748,-0.6331418862024063
KYSE-70,2858523,3.054228167220651,3.0578909909359844
MDA-MB-453,1242560,3.902800159671119,3.604425653628853
MSTO-211H,71466380,4.302501611697816,4.562549619022369
NCI-H2009,3689413,0.5343246791806224,0.005831363608071332
G-401,15547703,3.220896426279267,2.8097828321321687
NCI-H522,11719255,2.5592835843852337,2.932843553887007
LXF 289,46191454,2.351463869671111,1.893415094730189
LoVo,71304818,2.0724805960279027,2.3448181468801077
A-673,5311,0.6764453858481513,0.927669151776777
KMRC-1,11175137,2.246406512349146,2.6064867013578574
MDA-MB-157,568763,-0.4149964884485024,0.6890510111340623
LOU-NH91,11213558,0.661761515775888,1.755889417535888
CAL-51,2733487,8.211583338705053,5.825334282921391
LXF 289,16741245,5.010251526780332,3.8372553276813046
SNU-61,24797083,1.0556452382424049,1.4422702687515434
BT-549,44137675,4.586830027774197,3.797279148328165
CAL-51,15547703,3.503799403292956,3.239538644065165
JM-1,3136844,3.4340507925237307,3.527474616228117
NCI-H460,46191454,1.6495265120274705,1.9553939454593752
CAL-51,16722836,0.8083581946159574,1.6899271672383147
FTC-133,25227462,2.318225674680384,0.6307066147452691
A2780,51039095,0.059669762784491,2.543699474267538
OPM-2,54613361,-1.307423897840743,-0.8341349973417358
LOU-NH91,5328940,1.6284519107294106,1.6838676130224106
HSC-4,11640390,4.10313790521596,3.7017895300358816
LoVo,11222830,1.6500045227885836,1.6425785157068031
NCI-H2171,53495165,-2.473385034422452,-1.3652848664290058
MDA-MB-453,5281321,-0.6344069396712416,-0.8087614211477291
FU-OV-1,9926054,2.079351745951841,2.0151000924612736
G-401,36462,-0.1566510321668276,0.8935807351891688
A-673,JQ-1-carboplatin (1-1 mol-mol),1.1518421458333987,1.2048651774185173
NCI-H1623,11427553,2.6307082318350132,2.85414914379577
A-673,6918638,-0.1443248090306654,0.07089928153639599
OPM-2,54596490,4.128803973627264,4.296046145853832
G-401,24753719,3.1602445998928186,3.811912993243935
FTC-133,selumetinib-MK-2206 (8-1 mol-mol),6.933601402972985,2.0121810937278384
DMS 273,637858,1.5802330029013405,1.2249898495653664
OPM-2,72199292,0.0645754970830883,0.8716372930080063
SNU-449,5328940,1.97588831229785,1.756653965122685
OVISE,49793307,0.0210083556696064,-2.8490603118558897
A-673,11647372,1.3285775791052634,0.713661465526993
OVISE,6918328,1.4244682512544402,-0.0937915277785764
Panc 04.03,25154868,5.1819399857498025,4.510242416234746
EFO-27,17755052,1.748867275877649,2.089403176221891
EFO-27,decitabine-navitoclax (2-1 mol-mol),3.595019869203868,2.216706354175618
SBC-5,375860,-0.6399303579455221,0.15502743526301577
HCC1143,selumetinib-piperlongumine (8-1 mol-mol),2.549848868109157,3.0951933588900937
MDA-MB-157,451668,4.959725465812671,3.8464664946844858
YAPC,54619267,5.29132207947154,4.265693000416656
OPM-2,36462,1.377546018006998,-0.011578589799797543
BxPC-3,3081361,1.7902484572067556,2.1771169077123944
SNU-449,11455910,0.8938620280411973,1.1895968382205948
NCI-H1623,25022340,5.5347014016683875,3.234450891778658
NCI-H522,409805,3.737006742854017,4.348969691380218
CAL-51,568763,0.0917223714484538,0.43218420997531276
HSC-4,12001922,2.169357927696289,1.9981634478939798
CA46,2742550,3.5037926309603944,3.034237025506759
LOU-NH91,11507802,2.1124947170440533,1.841476892682919
LXF 289,6852167,2.2044562779321635,2.8292230121571134
ONS-76,26596,0.1332187247782509,-1.1146495543182666
KYSE-70,9903786,2.353212274658888,2.8793316384908847
DMS 273,10385095,0.5027476993233067,1.1295215443675193
ONS-76,3025986,-0.4351415981508911,-1.1951815047078447
MDA-MB-453,89928392,1.7795585771799345,1.6161854431496234
LXF 289,676352,2.537691956872654,2.1383683960399096
OPM-2,navitoclax-gemcitabine (1-1 mol-mol),-1.0437605792762972,-2.359017621145576
HSC-4,135659046,3.804399419736421,3.637152004320718
OVISE,alisertib-navitoclax (2-1 mol-mol),-0.6471026369576864,0.8018992938857156
SNU-81,6623618,-2.7236989498385733,2.3757868055708227
HSC-4,5282054,3.7951129778884822,3.737753430088761
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798,0.741547510775047
A-673,16219061,2.4523595679466954,2.567276577046515
SCC-9,123631,1.8109604294388877,2.4237685426583386
A-673,11364421,-5.84995188170368,-3.355096377598488
A-673,216345,3.678855080389337,3.5811506336184813
A-673,439501,-3.092013019617277,-2.4125895561561874
NCI-H460,1566236,4.3513012021592505,2.3939607345735983
LOU-NH91,25195348,3.759766884877561,3.2880152219076053
DMS 273,23725625,4.676663171220921,4.008536986633289
ONS-76,selumetinib-vorinostat (8-1 mol-mol),-1.377626233169706,2.3102636167709916
CAL-51,6852167,2.546662292056567,2.949337622769796
OPM-2,5738263,2.0935625564909737,2.636551028433482
SCC-9,5311,1.75647433259966,1.6865783189454782
SNU-81,5291,3.232691727920098,3.1951212636343467
FU-OV-1,262093,2.4810055989466018,2.663771212960264
LoVo,56949517,2.258326270055845,4.166660743332039
A4/Fukuda,9825149,-2.050748608979426,1.8403839131498156
CAL-51,53392493,1.8808489153668793,2.494376258563517
NCI-H522,4521392,3.962796694444569,4.312406354174326
NOMO-1,navitoclax-birinapant (1-1 mol-mol),-1.0294989244517518,0.042777702321926514
NCI-H2009,11612883,2.3268324416241777,2.811290681618633
NCI-H292,65064,3.148033598452649,5.163926890383175
NCI-H292,44589607,3.354505508461316,3.134898792565768
KMRC-1,462382,0.2791911345900462,0.6752681307085543
A4/Fukuda,5291,3.6218734753047226,3.278635075806795
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.839636765260042
A-673,135440466,1.1776565801361647,1.9927627534647134
Panc 04.03,60700,0.3719609401953118,-0.25529863534580405
LOU-NH91,66577038,3.4622279905398052,3.191161371287543
A2780,24856436,-0.502193855863573,0.2726736131351871
CAL-51,6852167,2.546662292056567,2.949337622769796
JM-1,5311037,4.072371281952103,2.4478583871105486
NCI-H460,374536,2.933441634270558,1.9416418660380759
NCI-H460,216468,4.763843832635099,3.3790791290314814
SW1463,421610,3.2195561799423804,2.777088416562105
NCI-H460,439501,-2.362377537788676,-2.0695784787084524
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393,-0.5215991817788693
MDA-MB-157,24978538,3.306703195844951,1.3560048390429578
MDA-MB-453,54618795,1.052632381834858,1.0940997749787789
EFO-27,6914657,-5.685084863882177,-3.765337121816583
NCI-H661,9866186,1.9017456959186525,0.8624744135612488
CAL-51,6623618,2.223133904662847,2.1632387343717303
OPM-2,5281672,3.1701528707347015,3.920409443318716
CAL-51,1716436,3.275997904874087,3.1353199550261013
NOMO-1,25183872,-0.6960845434284378,-1.9307826000311843
EFO-27,216239,3.3875560857040887,2.476843952197826
NOMO-1,54619267,3.207870909981956,3.5668185305892295
NCI-H460,400769,-0.4007490431715684,-0.5084021680282977
SNU-61,6610355,3.885584601382451,4.284767052486993
BT-549,vorinostat-carboplatin (1-1 mol-mol),4.114114464716558,3.2998478506827795
JM-1,10077130,2.0136903876831993,2.255288613555052
NCI-H661,81146,4.823771143587,4.7590684305284086
LoVo,56946209,-4.467950537911531,-3.8467180175563005
NCI-H522,5460769,0.5614535105182378,2.719802703910247
CA46,9927531,3.0223750820915978,4.070230697671697
CAL-51,11612883,1.9359641259018452,2.732216475740604
CAL-51,11427553,2.069280384014222,2.870363004449688
NCI-H727,5746,2.1304383256196293,1.1041472394432843
MDA-MB-453,16219061,1.5030881414961583,3.125034382579389
MDA-MB-453,68056272,3.261695748545246,3.338355616717369
A4/Fukuda,6610216,3.4719570509087445,4.0545478615113835
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.94630433755286
SCC-9,107985,-2.37702169012632,-3.3786459282897328
MDA-MB-157,23939,3.513284021833553,3.9673114517607013
OPM-2,262093,0.5720462757198622,1.4692367508672635
NCI-H661,5351362,2.412641003608378,1.7171579564506063
BT-549,53495165,-2.465962418573161,0.8108482711489187
A-673,decitabine-carboplatin (1-1 mol-mol),2.7905557903359246,2.329227672724835
HSC-4,1716436,3.018983829466311,2.890690152857139
A4/Fukuda,10231331,-0.0070700765814584,1.5466431266215936
OPM-2,25105715,2.7306053213312027,3.2617862723778597
CAL-51,3384730,2.4775948365465905,2.970870157188385
DMS 273,vorinostat-navitoclax (4-1 mol-mol),0.8220813286666946,0.5057166585044761
KMRC-1,262093,3.6313310555506817,2.7696638030599763
KYSE-70,5311281,3.780874632943925,2.374906211928722
Panc 04.03,135659046,3.760242578723066,3.9602964459726775
NCI-H460,46199207,3.5033257005335163,3.3124720011271847
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062,-0.21451158439063067
NCI-H522,285033,-5.015646919007219,-2.413248355153199
NCI-H1623,31703,-1.093718795909536,-0.45800666429420767
CA46,8515,3.648186715161825,3.0856634282167166
A-673,54618164,3.9765209939943857,3.8650815302191095
MDA-MB-453,71304818,1.4463301677266325,2.392994038482636
SNU-81,656346,0.6811147423088999,0.8088323639376721
A4/Fukuda,JQ-1-vorinostat (2-1 mol-mol),-1.448511600529376,-0.2891172327478031
SCC-9,alisertib-navitoclax (2-1 mol-mol),1.3350821103573205,0.6983608021950914
OVISE,71680916,3.981894618274443,5.041338397700298
LOU-NH91,56963564,0.9665729866263152,0.814676826082655
NCI-H661,23635314,-2.0342629068452056,-1.3702372951111377
LOU-NH91,12001922,2.55699926148122,2.086300266841555
JM-1,31703,-4.919166892515249,-2.58824007536989
EFO-27,16065773,2.8503557299543063,2.5629067142627724
DMS 273,107970,2.226748766743483,1.9893398501104027
MDA-MB-157,67156097,-2.087594374926874,-0.1740622039317637
BxPC-3,JQ-1-UNC0638 (2-1 mol-mol),0.9591872546469856,1.8595355883678386
LOU-NH91,46199207,3.3608515659177147,3.129530479846547
DMS 273,JQ-1-vorinostat (2-1 mol-mol),0.2212996861992737,0.534009626364396
BT-549,2871966,1.6191257261573118,0.65289772337562
BT-549,46926350,-4.493585638609818,-3.948676510715145
OVISE,54626689,4.712933516379989,4.646342579158801
NCI-H460,119182,0.2489341964189734,-0.5573440298194936
MDA-MB-453,7251185,1.8406187352582624,2.301297539728842
JM-1,4521392,4.181937683636394,3.9609558473140862
LoVo,44589607,1.625549992230134,2.919593752898484
LXF 289,vorinostat-navitoclax (4-1 mol-mol),1.5886672686618393,1.383782945386839
A-673,24951314,0.6400096482448101,0.7512935735839011
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525,1.2626290677639453
A2780,11152667,-1.0749204847082217,-1.083207851894394
BT-549,5329102,2.9790267437316285,2.0789890511733025
G-401,17755052,0.028133790527295,1.4235252772751619
CAL-51,11238147,2.100409816322544,2.9177025157820715
FTC-133,16725315,5.918216987208106,4.1512069112875345
HSC-4,10127622,4.548794444843462,3.773364382221893
NCI-H2009,JQ-1-MK-0752 (1-1 mol-mol),0.489585373897599,1.970772997488383
HSC-4,72376,-2.108784759313747,-1.7297099218338396
HCC1143,11455910,1.411815978618001,1.1845712217425257
G-401,6610216,3.9425308150709,4.103080163727364
OPM-2,73707398,-1.391957592490296,0.11122895051995244
Panc 04.03,crizotinib-PLX-4032 (2-1 mol-mol),2.2047528734152655,2.074870385233007
MSTO-211H,11396600,3.2938939565791765,3.8810285504609565
NCI-H2171,15983966,-6.379176066325201,-2.4223922418379575
HCC1143,9903786,3.3387804215378885,2.9367246920735823
JM-1,3385,1.6679469335870958,2.63616464170144
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.244824619357315
JM-1,44487872,4.651129481786086,4.177029053606322
NOMO-1,439501,-2.35226533453039,-2.4356473411367885
Panc 04.03,568763,0.8595160951448656,0.6539290787329074
A-673,15953870,2.6171812575314757,3.2618210079897234
CA46,6917907,-5.812984110767001,-5.641343709117072
A4/Fukuda,11404337,-2.650657466190433,-0.9409690098061266
MDA-MB-157,6184667,1.80494393962058,3.16647668060084
NCI-H2009,JQ-1-vorinostat (2-1 mol-mol),0.1591835457896471,1.2958248068278122
NCI-H522,25102847,2.0692872541383784,2.5028244653453653
EFO-27,2113511,5.820212709586459,5.533742494332568
Panc 04.03,2729026,3.1546590032208948,2.849105081648197
MDA-MB-453,9866186,-0.0857862406385878,1.3002052797342036
CA46,44491742,3.801952242992866,3.762351289684101
MDA-MB-157,16720766,-3.610201854539628,0.32329981344379055
NCI-H522,168313016,4.366007701234683,4.362559783775311
JM-1,53232,3.389128909220105,2.5863321739995024
ONS-76,24901704,3.4855009095109435,3.137517226855412
FTC-133,3136844,4.271719807093853,4.5039870028526545
CAL-51,54619267,4.1828818787298765,4.0119521201156285
NCI-H146,17755052,1.2442303799433287,1.5581629352417414
FU-OV-1,2858523,3.1344850445874752,3.129648089350464
NCI-H292,5280436,4.014624366310106,3.4628593378479047
BT-549,15547703,2.0718927663287703,3.3885881910108666
A2780,25126798,3.236047242798602,3.6538710852376393
Panc 04.03,2945648,3.066534391812563,3.0322560866795114
SCC-9,56963564,0.633234370730304,0.4604376405318987
A4/Fukuda,11507802,0.3746235533355334,0.866294745791987
Panc 04.03,3025944,4.694936485248253,4.30559069651347
SBC-5,46398810,3.6562963267762183,2.387207397933114
JM-1,49793307,-5.3555461291239075,-4.384010706347377
SNU-81,67156097,-1.5845934662844448,-0.970683959601826
A2780,72376,-3.651935268939024,-2.9450618556662613
CAL-51,25195348,5.6667768045179905,3.1428062622215345
NOMO-1,10074640,3.0496099519927435,2.639593278547282
FTC-133,46174525,5.692041239325808,4.4426343524067695
YAPC,409805,4.253424942012428,4.958187383149547
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276,1.7998689721879153
SNU-61,11626560,1.823906724750755,1.527480707472436
A-498,16736978,3.6467697702535182,2.089518764270922
JM-1,9967941,2.969647244173239,3.0190631351621
MSTO-211H,3815108,2.5678993468563913,2.9516805798661405
KYSE-70,637858,2.812350468450961,1.9931914912890054
A-673,16013152,4.069813049540754,3.489871931251126
A2780,4521392,3.924686212385386,4.076501856095487
A2780,23635314,-2.3171748001501635,-2.01703650052833
JM-1,3689413,-3.612287026066889,-1.8226346783213478
CA46,navitoclax-PLX-4032 (1-1 mol-mol),3.7945066500570057,0.01328708792773989
OPM-2,64971,2.0053510879561296,2.0532713151732747
LXF 289,9935249,3.315625346230847,3.213438883292576
Panc 04.03,984333,1.398892433045171,1.2367984438339428
DMS 273,676352,1.7083859345894283,1.913965643730766
MDA-MB-453,4096211,1.6956492567589403,2.3654019738987504
DMS 273,9903786,1.811418424711566,2.684445875375772
BxPC-3,3634881,3.024771766376516,3.355305530374261
ONS-76,54618305,5.4771970245541866,4.5608460687552705
Panc 04.03,44491742,4.30815140156182,4.3905269867402525
A-673,tretinoin-carboplatin (2-1 mol-mol),4.33843308891482,4.252124300638346
MDA-MB-453,123631,2.1950816453081545,2.1374391285941754
A4/Fukuda,426756,4.168045276817785,3.851263492442709
CA46,252682,5.8821335535914905,6.3661469442222
Panc 04.03,2828334,6.268769524950107,6.244589046281395
EFO-27,135411,0.9008731550993504,0.8474367415006383
LXF 289,15983966,-1.3187435990338214,-1.1375545262583617
A4/Fukuda,3384730,1.825152720179272,1.5748126099272985
SCC-9,11404337,-1.771041191231111,-0.1971560118936549
SNU-61,6610216,4.086517799339023,4.093009712837107
LOU-NH91,446155,1.33101507486467,2.355705864370242
KMRC-1,71466380,4.698779777562497,4.795715644780829
SNU-61,46398810,2.7474251169458346,2.360940303212247
NCI-H2009,9826308,-0.026532071259288,0.7867148810492052
NCI-H2009,56946209,-2.630012103472263,-3.670432199117846
HCC1143,46843906,3.1964507186723305,3.3117859166592765
A-673,2742550,4.033526638201744,3.47021740994585
SNU-81,11507802,0.99367607100598,1.406703044407199
KMRC-1,11485656,3.5314695534539045,2.3903809184481886
SBC-5,57330099,2.8388792643726295,4.35660525919894
LXF 289,219104,4.555444774518925,3.937780475158428
Panc 04.03,9907093,4.451330392346362,4.319016478229181
DMS 273,19582717,4.273838780275844,3.29294229707932
SBC-5,3815108,2.9831729144642956,2.9767980984411118
OPM-2,168313016,3.5498730155612863,3.733958174068492
ONS-76,10427712,4.642311539672088,4.199357377676683
NCI-H522,54765302,4.051221649365855,4.081174183170875
JM-1,44620216,4.114569245447781,3.4957191299050043
MDA-MB-453,9887053,5.45770037243801,3.6427344883923887
A4/Fukuda,72193861,-0.8043632874402014,0.544540589156577
G-401,25102847,1.393287045797279,2.0889674167935834
SBC-5,11507802,0.0977610232609949,1.6203320819726548
JM-1,168313200,1.89690041567587,2.5935639624726012
FTC-133,3634881,3.4388146515237468,3.476430688909397
NOMO-1,10427712,4.067466468396052,3.710029410873698
SNU-61,6918328,0.4046547109968232,-0.12466198076674907
NCI-H2171,23635314,-3.6505205606038382,-2.8178804348262587
SNU-449,6438330,2.777557669825017,2.3670906670244545
JM-1,25161177,3.865095276574429,3.1982278176633034
LOU-NH91,3025986,-0.3413799803632848,-0.6121694784093265
HCC1143,53232,5.137172207040132,3.072347934774528
LOU-NH91,53232,2.5403477328432933,2.570054245524777
NCI-H1623,24797083,2.165751455730843,1.5816731822288086
RCM-1 [Human rectal adenocarcinoma],10074640,3.542423635061651,3.187993283597155
LOU-NH91,crizotinib-PLX-4032 (2-1 mol-mol),1.9615360492611609,2.01715335580523
SNU-449,3025986,4.266276949739511,-0.638071323241673
NOMO-1,2858523,2.9127751570608136,2.8770387665636874
A-673,6918736,-0.9753951922870552,-2.017780835564448
A2780,44202524,1.0300821380640774,1.930042929989686
DMS 273,25154868,4.488535380180048,4.341475923005569
NCI-H146,navitoclax-gemcitabine (1-1 mol-mol),-4.8472150579078646,-1.1703740726115213
BT-549,100016,6.139281322747303,6.4332025229442245
RCM-1 [Human rectal adenocarcinoma],11609586,3.4054743637312006,3.008861753860653
SCC-9,148124,-0.9222891029936632,-1.8872333557624499
DMS 273,11494412,0.2734180035919979,0.6754744616339213
A-673,ISOX-bortezomib (250-1 mol-mol),0.1019689677537875,0.3220913973205499
A4/Fukuda,selumetinib-decitabine (4-1 mol-mol),-0.8212818207724355,1.4530715697957206
EFO-27,16725315,5.151426492732951,4.289359962573261
KYSE-70,3689413,0.9447440025313596,0.5044082105490196
A2780,navitoclax-MST-312 (1-1 mol-mol),0.9234968671687596,0.7689188221165725
NCI-H460,285033,-0.7054560098467199,-1.7225728081174372
KMRC-1,5311,2.4483949186029794,1.4499413715972995
Panc 04.03,54618164,4.2869772681873695,4.27776590781696
NCI-H727,676352,2.629502567411482,2.1265881733698206
HSC-4,24779724,5.454925638847944,4.28648914379833
A2780,23725625,2.4195603562256873,3.978830118938476
CA46,56946209,-5.9555571874685755,-5.1992049710800075
NCI-H146,6252,-1.7817409080320272,0.6038464933433038
SNU-449,44589607,3.7188226068257872,3.2690837527318464
LoVo,969516,2.402995535890804,2.6787334534459863
KMRC-1,carboplatin-etoposide (40-17 mol-mol),4.177751638329711,2.9972166397350644
CAL-51,9935249,3.84795648434564,3.231346564754272
NCI-H1623,53392493,3.831222645051568,2.7591755367135935
MDA-MB-453,54596490,5.641262539800198,4.557959712086561
A-498,42642645,1.5845020846141176,1.2057740119804488
FU-OV-1,4788,6.1006518616017615,5.7903894926986474
DMS 273,6852167,2.1769146352356707,2.051065209646031
LoVo,11612883,2.4190290931093954,2.837114785838779
A4/Fukuda,54618305,3.964460418875751,3.9552358504978953
NCI-H2009,17755052,1.0629457660851225,1.9638753549503116
EFO-27,5113032,5.5462842201226925,4.942397175934176
LoVo,9907093,0.4604974674369004,4.137747647437444
SCC-9,44491742,4.764074483400304,4.528631598781913
NOMO-1,53392493,1.775943290565707,1.652451163322417
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924,2.4471720949773994
SNU-449,16725315,5.255161508937853,4.418464879701447
SNU-81,9825149,1.815233140933264,1.9353863830417626
NCI-H522,60700,-0.5552110519793028,-0.7811448650623904
NCI-H2009,375860,-0.9754800160336818,-0.07985877527525387
OPM-2,44607530,0.8834373674969361,1.3858285471981089
MSTO-211H,2708,3.2234156242084073,4.709598405260644
OPM-2,15953870,2.653227585048534,3.091763769571721
DMS 273,11238147,3.12717198165546,2.122685899608351
OVISE,3062316,1.3579552700407893,0.7046022441802573
NCI-H522,11955716,-2.355417617820864,-1.5830692281753789
LXF 289,44486219,3.8558224358877298,4.505369670406742
NCI-H522,4261,1.255814980012561,1.344673113776008
SBC-5,11396600,3.6683316442381617,3.522352065936568
NCI-H727,448949,2.521247711014773,2.029077766595047
CAL-51,126941,-2.448006630223804,-2.7385108770076867
MDA-MB-157,156414,1.5733069512528617,1.6963378924065673
Panc 04.03,selumetinib-BRD-A02303741 (4-1 mol-mol),4.320411537707366,3.663892697239008
A2780,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4355880611725125,3.6970244301526574
FTC-133,2871966,2.512715884905784,0.5338444980872821
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-0.957248672130662
KYSE-70,168313047,2.1859183661660624,2.265553146732127
OVISE,serdemetan-SCH-529074 (1-1 mol-mol),2.136633519186749,2.154971029666522
LoVo,54454,2.7172548619434025,2.766519808804338
SNU-61,73707398,0.7144154314829279,1.0829004692410515
MSTO-211H,9866186,-1.5986440722967756,0.8212929282102961
RCM-1 [Human rectal adenocarcinoma],23582824,0.8636405428481416,0.6997716147899979
BT-549,selumetinib-vorinostat (8-1 mol-mol),4.066811248351909,2.7905819158648297
NCI-H2171,57519531,1.5586354952126105,1.8964642728570775
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.214235849739628
NOMO-1,451668,-1.632426084818391,-0.7119351788254598
CA46,5282054,2.3254868404716755,2.793556650289691
MDA-MB-157,54618795,2.0481333451118204,1.481470078788749
OPM-2,11707110,-2.1571352516283113,0.6610224499422124
CA46,3136844,3.7113001526336338,3.533336829852828
NCI-H2171,984333,-0.9596445260901963,-0.13982016153713375
NCI-H1623,11507802,3.5238050648518136,1.8362892709681486
NCI-H460,46191454,1.6495265120274705,1.9553939454593752
EFO-27,BRD-A02303741-navitoclax (2-1 mol-mol),3.819919815231351,2.613908154181873
MDA-MB-157,7326481,2.299098205794017,3.118078326910598
EFO-27,1239801,4.748117996702423,4.272195181773749
NCI-H460,969516,4.1763077592827225,2.99774314212588
G-401,44202524,1.447982360696086,1.6745253408437657
A-673,JQ-1-MK-0752 (1-1 mol-mol),1.0252952721702926,1.2638074499254532
NCI-H460,2749,2.5004778765083695,2.165455905451198
DMS 273,119607,5.531574360726778,4.592136339059328
FU-OV-1,10074640,3.835416148861087,3.231323898842626
DMS 273,navitoclax-MST-312 (1-1 mol-mol),0.9055949261710712,0.6514691277620546
MSTO-211H,9911830,2.3480580098381747,2.6609014061161314
SBC-5,135411,0.301348299555382,0.6444351252137085
MDA-MB-453,6610216,3.7821562137745217,4.136062457082903
SBC-5,2708,2.061546130614232,5.050314831020098
KYSE-70,11396600,3.829938839575827,3.6198589511567816
OPM-2,vorinostat-navitoclax (4-1 mol-mol),0.1768151572883334,0.0794054272318583
A4/Fukuda,11152667,-2.4230854517211977,-1.6737062006662609
SBC-5,36314,-4.885811702708602,-1.7552593241258347
DMS 273,9884685,-1.1971048738595964,0.12623826883751726
SNU-61,vorinostat-navitoclax (4-1 mol-mol),2.3944367596721547,0.3517163471498694
NCI-H2009,439501,-2.087429471182781,-1.8733299183366707
MDA-MB-157,1716436,1.1718034720311097,2.9721592300707336
ONS-76,216239,1.6729885995968985,2.488279465422321
NCI-H460,9911830,3.1326305509826824,2.5405674759111174
A-498,2858523,3.0988346297597293,3.1332470524159475
RCM-1 [Human rectal adenocarcinoma],51039095,3.29886736232205,3.0149865219623475
OVISE,969516,2.883429877122848,2.82898459582118
SBC-5,3825829,3.3495967392740953,4.133305129018034
LOU-NH91,5278396,3.7974378044691495,3.6809992270615353
MSTO-211H,9935249,0.534197831206919,3.211046400821782
JM-1,9911463,2.675259516581914,3.06834188534277
RCM-1 [Human rectal adenocarcinoma],6184667,3.2761425368749477,2.9767870473450153
SCC-9,60750,4.9910553033212866,-1.6440278843530383
SCC-9,387447,-4.584813930042193,-4.190641439640746
SNU-81,25062766,1.4859068805404914,1.9755367099701946
NCI-H661,2708,6.321788786635088,4.741948639594114
NCI-H460,57519531,1.7606196796007008,2.6569226744570873
KMRC-1,613753,3.207263348750723,3.2487837766500682
KYSE-70,67156097,-2.3379446798215127,0.4409034397478194
OPM-2,10127622,2.4771662101119194,3.4800973009722673
LOU-NH91,5291,3.971687681340124,3.5527378205211124
DMS 273,6918638,-0.6329393875591668,-0.04828085594878056
A4/Fukuda,16722836,0.6102638619225811,0.9730822995938692
NCI-H1623,11175137,3.026300100874371,2.80059052110394
SCC-9,122327,5.629849115039079,4.717288160237182
CA46,11625818,3.63093624941088,3.2892336549767625
FTC-133,navitoclax-piperlongumine (1-1 mol-mol),0.208088727166438,1.3686516366336903
Panc 04.03,156422,4.828457411788627,4.20085824963823
DMS 273,5278396,3.2906012116635694,3.2940940741602778
HCC1143,53495165,-2.177337144630303,0.7643843101037829
OPM-2,1641662,3.0681099569104653,2.9912249865105616
A2780,BRD-K27188169-navitoclax (2-1 mol-mol),1.5548908643939203,1.4902700028712095
NCI-H1623,doxorubicin-navitoclax (2-1 mol-mol),-1.3303127155633732,-0.5450210719441277
FU-OV-1,navitoclax-MST-312 (1-1 mol-mol),2.560090479517714,0.8989991594417586
A-498,6917907,2.9475757171512575,-4.24063476385329
G-401,10385095,0.8697787767816428,1.0237119745039398
MDA-MB-453,702558,3.1332940697725435,5.029098774505935
BxPC-3,15547703,0.9056764589340796,3.241974917092191
A-673,44632017,0.706241354368095,0.9337668006247565
FTC-133,JQ-1-navitoclax (2-1 mol-mol),0.6314108059190333,0.4937237242814308
NCI-H661,11626560,1.806538061239003,1.948532753995333
SBC-5,9840324,4.760330511699364,5.787758064634315
NCI-H727,46398810,3.032466795061864,2.4764617791573613
HSC-4,654092,0.2566378579351391,-0.19773378601747396
G-401,5978,-3.1887203575088727,-2.664153762973112
A4/Fukuda,11238147,1.0973923844128086,2.147314830698538
MDA-MB-157,JQ-1-navitoclax (2-1 mol-mol),-0.7190689296194697,0.8188660804791297
NOMO-1,54678924,1.1055951494804663,1.3303437235425006
JM-1,135421197,0.410328587733175,1.393586297640978
RCM-1 [Human rectal adenocarcinoma],5287620,-1.851018785369774,-2.1863644823197244
BT-549,216468,4.5222519285579885,3.5733268444660196
NCI-H2009,136227924,2.9896301065010933,3.1770731420576688
SCC-9,2828334,6.128266495621781,6.206602878281095
LOU-NH91,3025944,4.356407657994756,4.255619168479479
ONS-76,5329102,2.3644433253395545,2.0373717330755645
DMS 273,53495165,-0.9870251488119351,-1.2163272679538606
NCI-H1623,3634881,3.389178636612412,3.250694591471127
NCI-H1623,446155,4.270765867841268,2.972223251764837
ONS-76,984333,0.6472143254241693,1.0111876293522242
SBC-5,3081361,3.306292226806483,2.282719967458573
NCI-H2009,11625818,4.7000574258268255,4.252428441707123
CA46,24775005,3.732581966598925,3.441615664875367
SCC-9,11222830,1.8600220042192213,1.6718270596152296
KMRC-1,12003241,-1.418239320082467,-0.9159662159624881
SNU-61,613753,3.0121134483838037,3.028893853022248
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433,0.736254518282041
SBC-5,4261,2.0931810634834105,1.5128531052495164
HSC-4,serdemetan-SCH-529074 (1-1 mol-mol),2.5503350460616505,2.2182059404222105
JM-1,445091,4.048660068158945,3.68549051417922
NCI-H292,44185566,2.325959343920572,2.6893887966697463
SNU-81,6918328,0.0758058419703895,-0.06097405446296608
A-498,16659841,6.0591016575330325,4.07833115351602
NCI-H460,51037431,2.104101453867928,2.7473060326846883
MSTO-211H,5978,-2.861470631068365,-1.982142227098105
SBC-5,6918736,-1.7962623830849138,-1.040354653364416
NCI-H2171,11178236,-6.134942659978268,-3.271386009701025
ONS-76,11427553,2.8550216000544695,2.4215876005202412
JM-1,11234052,3.3092904099829115,2.9719857920249133
NCI-H661,ISOX-bortezomib (250-1 mol-mol),0.8750807194042233,0.5565323128721568
MDA-MB-453,11719255,3.0016884563631057,3.5379766485464357
HSC-4,241158,3.797905223062241,4.048147749251729
SNU-61,49766530,-2.178873950286192,-1.163964334889073
ONS-76,54454,1.5364254879481318,2.6242437665629796
NCI-H2009,54618164,4.160237516111787,4.161506392790306
CAL-51,3136844,4.799885860604426,4.36955654767607
DMS 273,selumetinib-JQ-1 (4-1 mol-mol),2.4189081702185096,0.7409178306030217
SCC-9,46926350,-4.135183666473923,-4.110781596675974
YAPC,5460769,2.316930709954587,3.231973886330128
YAPC,135411,0.9254838530178896,0.8598419553547086
A-673,11228183,1.918128583172148,0.9429436519348349
MSTO-211H,24856436,-1.8779899697418416,0.6449613631881499
LXF 289,44185566,2.4809324153017265,2.6200649285995827
OVISE,654092,-1.3076939787912127,-0.18019533926655248
A2780,6918328,-1.1386748973241003,-0.405425873924196
FU-OV-1,44819697,-2.23904448126328,-0.3101067466975259
BT-549,42642645,1.6219324424635808,1.0933781212466744
JM-1,216345,2.231105973795255,3.0152663648139155
G-401,73707398,0.5507155331982622,0.8009505945003148
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,0.8816128500793464
KMRC-1,16722836,1.9243244677044424,1.58930306959238
NCI-H1623,135875424,3.67415188779786,4.257743764236782
NCI-H2009,638278,3.464543124143687,3.0910837864563145
NCI-H727,168313047,2.9561297907786717,2.2192555066745703
SNU-81,439501,-1.707157001292212,-1.6106083678758223
MDA-MB-157,11234052,1.0821323764870938,4.125718430632007
NCI-H727,11364421,1.2179988120980565,-1.4192248677493458
BxPC-3,2729026,2.140647578797141,2.7564218204196775
NCI-H292,46224516,2.488403107417036,2.625422703304131
MSTO-211H,5746,0.1838030897357816,1.3276156367194614
NCI-H727,5280436,4.172163827724594,3.6589330849101604
NCI-H727,9911463,4.409308573364914,3.8534398627147204
LOU-NH91,9907093,4.908801109640004,4.305977035292954
HSC-4,24772860,-3.179601965562413,-1.5572872758084784
MDA-MB-453,10302451,3.3014196832790628,3.140292963375379
A-673,2945648,0.1856393110329161,2.5066380724864907
G-401,56946209,-5.714614119541748,-4.274588688808401
MSTO-211H,452548,-2.0931551112296742,0.3629389790247211
NCI-H2009,5280436,3.59103147994178,3.65765947905094
CAL-51,241158,3.781489879449518,3.848569683870711
FU-OV-1,24772860,-2.86759244210788,-1.6077808803541727
DMS 273,54596558,4.317274835352231,4.426842338561095
DMS 273,71466380,4.5698020131067745,4.2230558997593
ONS-76,11175137,2.2807611594224975,2.6294788402020264
NCI-H522,136227331,5.948504593030567,3.512025841379984
KYSE-70,262093,3.701785722517592,2.859393591971381
KMRC-1,119607,5.885636542486439,5.009467861583834
CA46,16722836,1.2778374610309875,0.8349499258186348
RCM-1 [Human rectal adenocarcinoma],6918878,1.3044693080210874,2.9910882271373107
SNU-61,24772860,-2.9174361907600592,-2.092551309783243
LoVo,322968,3.2361743048313536,3.8737960257883066
NCI-H460,168313047,3.736921155938788,2.5704433232191213
LOU-NH91,123631,3.064358892537756,2.733410254417608
NCI-H146,10410894,2.10877812565835,2.991092632591239
OPM-2,107985,-4.911691484457119,-3.8763724045855783
HSC-4,4917,3.66079963002401,3.1067606246211357
SBC-5,72376,-1.1693945126287038,-1.715557390110671
KYSE-70,11238147,3.36128873589197,2.833962939294438
CA46,9935249,0.2545497442771542,1.433049946007086
SCC-9,135421197,2.7056920215811293,2.1863531272392103
FU-OV-1,123631,2.446979601054181,2.4770815988610737
MSTO-211H,12001922,2.4775669078904397,1.9337676285457164
NCI-H661,3543504,4.269759852401949,4.659586019922398
FU-OV-1,53495165,2.0201630022514263,1.1824164012136615
NCI-H2009,448949,2.535639173937985,2.1305688928574096
EFO-27,285033,-1.172211692399995,-1.2088570722280954
YAPC,5978,3.3733616775717716,-1.1264519895715004
BT-549,9911463,4.268645247281358,4.116668897317327
NCI-H522,2113511,5.298827483301359,5.460854009491077
SNU-61,1242560,3.7603648536411622,3.31354523622874
A2780,3503,2.123197367997407,2.004260731982593
JM-1,262093,0.3077511100871351,1.5024769213274296
DMS 273,11612883,3.047294051558191,1.9403686586637425
A-673,156414,1.4246196000990916,1.3354207687609223
HSC-4,JQ-1-UNC0638 (2-1 mol-mol),5.303785757115223,1.65506521897684
SNU-81,3385,3.194341332216005,3.404144007903068
SNU-449,44486219,4.185988120780244,4.457263662541777
SCC-9,25262965,-0.8228501050995407,-1.3534212801700938
NCI-H146,9967941,1.5373910611842192,3.2753495759724576
HCC1143,969516,2.4763079586135546,2.8323777890704576
ONS-76,12003241,-1.3579895274230906,-1.277429173147104
SNU-61,selumetinib-tretinoin (2-1 mol-mol),0.2011452068154318,2.519673999789264
OPM-2,26596,-3.75281027154887,-2.114710441524242
KMRC-1,11955716,1.3700469468180672,-1.2965718757784956
ONS-76,445091,4.207927105180806,4.197143558693826
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.44222963633274776
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,3.749296636137534
JM-1,11964036,0.6346833811859819,0.6709934782998161
MDA-MB-453,24180719,3.640576555720147,3.530187088599772
NCI-H146,3689413,0.5626872136369616,-0.8031833394400809
A-673,5335621,4.03269099593382,4.303611417719842
FTC-133,44491742,4.538470926749077,4.322075344526469
RCM-1 [Human rectal adenocarcinoma],44607531,1.8642852142992712,1.4452461591061059
LXF 289,23725625,4.938564251049365,5.021264171352338
OPM-2,11612883,1.2708799210561326,1.8588859217588516
CA46,11485656,1.2289823963881294,1.7540617238010916
SNU-61,227681,2.9666568152307993,3.1056334241133445
NOMO-1,135421197,1.2386186938920458,1.2126725739113673
NCI-H1623,vorinostat-carboplatin (1-1 mol-mol),3.549282836614641,3.3900952330754928
BxPC-3,135421197,1.4419000032460958,2.045512518749703
CAL-51,66577038,4.134711160885491,2.9004396653551
BxPC-3,11485656,2.0481416814216375,2.46068451747254
LOU-NH91,3689413,0.742189593443008,-0.2607017929852221
OVISE,crizotinib-PLX-4032 (2-1 mol-mol),2.5474980530955844,2.09098855282518
JM-1,49766530,-3.0151701370453794,-1.7951514982626418
NOMO-1,15983966,-5.011559396504552,-4.278216481450455
HSC-4,24856436,1.7831446753384608,0.7877377181784176
OPM-2,387447,-6.258797979541162,-4.786877114451218
A-673,54765302,3.022220101838166,3.8105406249560705
A-673,5479543,3.2499245267113928,3.187455892717137
SBC-5,docetaxel-tanespimycin (2-1 mol-mol),-4.858337371172803,-3.123522227664351
A2780,441298,1.2276441630256645,2.3213545671297053
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923,0.436703369409743
HSC-4,65064,5.180183799352401,5.0490506464349725
OPM-2,3384730,1.6721258053175836,1.446623204277595
NCI-H522,387447,-5.403881314975521,-4.37195069274159
MDA-MB-157,11640390,1.4666591993417384,3.6667797953595693
CA46,9911463,2.565133854881976,3.0578682481486226
FTC-133,227681,2.0408407851095416,3.3329424278463904
JM-1,285033,-4.464347137363986,-3.496729698458735
KYSE-70,16736978,1.1213704825993671,1.2695715872409266
MSTO-211H,2729026,1.9618514095460544,2.8113458634406436
NCI-H661,24180719,3.917772031076744,3.603831639420801
NCI-H1623,400769,-1.0076663191396935,-0.5044215280334323
YAPC,9840324,5.782457936566159,5.919708076917646
Panc 04.03,57330099,4.388225142481581,4.3099250187034235
G-401,135659046,3.5574575455214608,3.4754679615739263
A4/Fukuda,148198,-4.99238512913244,-3.5913147778698944
CA46,126941,-4.174426911659592,-3.1828440742998407
SCC-9,6610355,5.330005746360321,4.556386690360307
KYSE-70,44185566,2.2395157674699875,2.499621253216293
NCI-H1623,462382,1.1150663609789129,0.5965647458549068
CAL-51,6914657,-5.067352950634086,-4.010952934079754
A-673,selumetinib-BRD-A02303741 (4-1 mol-mol),7.378712483637354,3.897533321505303
EFO-27,54618164,4.628305371415217,4.1872413885851305
JM-1,23582824,0.2805180690676545,0.5501362827709653
NCI-H460,44185566,3.2105564381381035,2.555800931660805
CA46,52912189,-0.9978651387823436,-0.04605485826349023
NCI-H2009,9935249,4.414461781647313,3.304434832587913
NCI-H2009,135928012,4.098076343567735,4.346335850493642
CAL-51,60750,-3.4379358682898973,-1.5895044437392842
MSTO-211H,8515,1.6806311840995682,4.026077653634481
ONS-76,15983966,-3.1712265481751243,-1.5851428328648374
NOMO-1,56946209,-4.862706213909506,-4.600274050095903
NOMO-1,24772860,-3.4546209155075687,-2.7790361827970167
FU-OV-1,44185566,3.182046500186311,2.7262154987671763
NCI-H2171,11977753,0.3036523614034643,-1.7128646450223162
FTC-133,31703,-0.768913830642622,-0.8045560292986746
EFO-27,984333,0.9554706085777084,1.0132720647210616
NCI-H292,5329102,1.7855476735914897,2.1725322895884878
CA46,409805,3.3808362620175187,3.6902340595971044
MSTO-211H,25183872,0.3972499543283658,-0.7798458160782681
LOU-NH91,24180719,4.451607655435679,3.72738121254287
A2780,44185566,1.1999498835751436,2.1676948218132055
JM-1,piperlongumine-MST-312 (1-1 mol-mol),0.8602384647056689,1.2225309984314794
NCI-H2171,6505803,-0.0596794204500112,-0.5782751923148092
CA46,66577038,2.896384523521911,2.408843839852993
NCI-H2009,navitoclax-PLX-4032 (1-1 mol-mol),4.434532653738059,2.2501795744309088
CA46,12003241,-2.799565618947511,-1.6407081916878394
NCI-H661,10427712,3.832896992750264,4.343823459415815
SNU-449,107970,2.557902386411369,2.381407688956483
Panc 04.03,2874250,5.078270927101478,4.5696062851942125
NCI-H292,54626689,4.661071465435288,4.720432061785251
NCI-H460,23725625,5.666756485817308,5.0611541433032485
CAL-51,53232,2.8018516258833395,2.8226997175772834
FTC-133,decitabine-navitoclax (2-1 mol-mol),1.1951853583551142,2.0819776179581457
EFO-27,53495165,0.9078503906950024,0.6743334927022576
SNU-81,65064,4.179756271690876,4.300904240370496
BT-549,3689413,-0.9397914335397376,-0.3211577468036346
NCI-H2009,66577038,3.427367822074961,3.0142992324328803
LOU-NH91,10302451,4.426232341068122,3.4971524438237123
CAL-51,168313047,1.9592520089902103,2.1946703117289412
NCI-H292,135411,0.5538002090667975,0.863059699115468
LXF 289,2874250,5.409057432200043,4.221828194442838
EFO-27,4261,1.4655103146060633,1.9790150997877518
ONS-76,25150857,2.480326692853007,2.346643377974409
G-401,11175137,1.9335599830838224,2.185818009823638
OPM-2,5460769,4.223891374112808,1.830628580606111
NOMO-1,10385095,1.0593467546243338,0.973922233866505
LOU-NH91,2126,5.273491801207327,4.693399454181982
MDA-MB-453,11625818,5.002273286989784,4.175285990751185
OPM-2,44632017,0.7121474472673729,0.7437038893058482
LoVo,135411,-0.4629764704945864,0.7535258050758254
EFO-27,16722836,2.503686118945589,1.8053760678576611
LOU-NH91,10074640,3.3386477352477715,3.222497133947601
DMS 273,11719255,4.586791904076426,2.574949431854959
OPM-2,136227924,1.7425170628423947,2.466635051698518
YAPC,vorinostat-navitoclax (4-1 mol-mol),1.7986594173334518,1.3018791299115338
KMRC-1,vorinostat-carboplatin (1-1 mol-mol),4.1908249815251075,2.98445676138307
NCI-H522,2828334,6.021027928266713,5.834958559147069
KYSE-70,72193861,1.5917149982909504,1.7983874461023563
MSTO-211H,9911463,2.6842905920893108,3.944669782197417
MDA-MB-453,969516,2.9001694226946153,2.8108541090637114
CAL-51,44632017,0.9975947899898204,1.2173258553230806
LXF 289,10231331,2.4249622135671824,2.4928890615549006
A2780,25195348,2.1109786238814943,3.1109445876090955
NCI-H2171,44202524,1.9759332673432517,1.9708530735437662
Panc 04.03,1641662,4.251343925322988,3.6644586606779335
NCI-H292,54686904,5.52345614596139,3.610814329805775
DMS 273,7251185,2.13119393000196,1.8893063157722008
LoVo,9956119,3.291456775833892,3.6269456618117264
BxPC-3,11404337,-0.6361724208993981,-0.4410269024788383
NCI-H2009,119182,-1.1305543955582442,-0.5988693889097488
BxPC-3,selumetinib-JQ-1 (4-1 mol-mol),-2.4444526852208206,1.458124911160079
NCI-H2009,5278396,3.446569775137936,3.755816052679039
SNU-61,327653,2.3439595497702985,3.085701108523738
Panc 04.03,11238147,2.6863632300229936,3.0529589209092585
LOU-NH91,9926054,3.1176474597994908,2.084233206759934
NCI-H727,5566,3.3170373665309416,3.067143736335979
SBC-5,25150857,3.1636616713903893,2.4007636987335697
A4/Fukuda,11719255,2.014724282446697,2.474595666716672
NCI-H460,374536,2.933441634270558,1.9416418660380759
Panc 04.03,135875424,4.739147054003967,4.131449925673059
NCI-H522,9825149,2.538976142931882,1.8882251865184703
NCI-H522,11964036,1.1738559849313974,1.2255074663014638
NCI-H727,docetaxel-tanespimycin (2-1 mol-mol),-0.2306371483754844,-2.5181202722688742
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.5176773250717219
SCC-9,5566,3.224791432055543,3.0304008691078095
NCI-H460,9936388,2.3098343611543415,-0.34691751579786045
A-673,salermide-PLX-4032 (12-1 mol-mol),5.197476716146756,4.683602940400095
NCI-H460,16720766,0.8258921674033131,0.9210923993100777
FTC-133,54618164,4.149608396421597,4.160515345088794
NCI-H727,5281321,2.7498034475542803,-0.9245022181743998
BT-549,31703,-0.610163723442028,-0.5883396050296534
JM-1,11609586,0.7887510712984062,1.477080156122834
MSTO-211H,65628,3.7458295220001,4.314131753372468
NCI-H661,9887053,5.171148908960024,4.169270046185988
LXF 289,vorinostat-carboplatin (1-1 mol-mol),3.3134202255532053,3.254712509022894
G-401,9887053,1.7608751069117703,3.0707216476508985
HSC-4,ISOX-bortezomib (250-1 mol-mol),1.0749923378755126,0.7160002566489445
A-673,7251185,1.3487938120123666,2.1018801128999844
ONS-76,4259181,0.68334491499701,-0.13106215351575265
NCI-H292,613753,2.7114183475644857,3.392235088502358
CA46,tretinoin-navitoclax (4-1 mol-mol),4.197829514755647,0.8781313885000404
JM-1,25126798,3.029145333632086,3.3115007831682606
CAL-51,3815108,3.0623029951861396,2.86884841639737
SCC-9,16725315,5.212889946477865,4.47024739072456
NCI-H661,alisertib-navitoclax (2-1 mol-mol),3.068945671773435,0.3424172373668043
NCI-H522,serdemetan-SCH-529074 (1-1 mol-mol),2.019053107898385,1.8403144663786906
LoVo,16722836,0.1488668556579147,1.756615195569449
A4/Fukuda,25262965,-4.823082336145625,-2.0401986744650795
OPM-2,53392493,1.6243275023991692,1.838250959396529
HSC-4,9926054,2.0278633205902468,1.982662055539829
SNU-81,9936388,-6.314751034125396,-3.691949646449246
G-401,9823820,1.4384887897470693,3.2469195116454115
YAPC,24753719,5.0641073859888,4.347574968878275
OPM-2,24772860,-2.8738620885527153,-2.80667153190543
MDA-MB-157,10427712,3.542893078297904,4.197882433418027
A-498,4259181,1.547873530266754,0.5431611976709835
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196,-0.5965538915762021
SBC-5,9927531,4.452264212548339,4.628577561479015
LXF 289,119607,4.549732560104057,5.270138344686014
MDA-MB-453,piperlongumine-MST-312 (1-1 mol-mol),1.140334319354309,2.125127304586824
NCI-H2009,11396600,4.054693544346837,3.850023720575524
SNU-81,15983966,-3.5187473914136738,-2.1302427988158583
Panc 04.03,11494412,3.764008563191269,2.064138261396814
OPM-2,216345,2.3930113976289364,3.055338266197114
JM-1,66577038,2.266129645862272,2.5407355953433006
SNU-449,15953870,3.8419288275174326,3.718333536171307
BT-549,9903786,2.513972936103366,2.9467382378685683
OPM-2,44202524,1.1830318509158162,1.404095998674594
OVISE,6623618,2.0550481440983153,2.264073198225048
SNU-449,11657048,5.413893492178721,4.0214779202279685
NCI-H2171,67291369,-0.2342814323553679,1.194967222508292
MDA-MB-453,UNC0638-navitoclax (1-1 mol-mol),2.401691334113767,0.8234118277554023
NCI-H522,11238147,3.4337502548923404,2.5472379957082585
MDA-MB-453,16065773,1.7584918793826552,2.2959696721619864
LoVo,136227924,4.6796674015936075,2.732658228998917
LXF 289,3854666,2.0847029854583377,2.4212916588629363
OVISE,984333,-1.5189255907846522,0.6034571924219195
A2780,159324,-2.166969557176003,1.888578498863867
SCC-9,17755052,1.3521912896367647,1.9149102217758134
OPM-2,9823820,1.0965123517529505,3.080617498963958
DMS 273,12001922,1.9670879212293255,1.715767271566263
KMRC-1,24180719,3.956198558970242,3.226760666561998
KMRC-1,637858,3.0556928718558707,1.7633723228511737
NCI-H2009,6917907,-5.363195379340594,-4.803011560759804
SBC-5,24748573,1.8248605513332548,2.0441816467209297
CAL-51,452548,-0.9080095532304931,0.4020638108143693
BT-549,2858523,3.192172893232417,3.0403666490719634
KMRC-1,219104,4.439460794922528,3.507796442008519
LXF 289,2858523,3.038787864461457,3.057515967091742
NCI-H1623,9907093,3.838952634819664,4.242103843102103
NCI-H460,168313047,3.736921155938788,2.5704433232191213
JM-1,5287969,-2.2665073107333997,-2.197411094877136
NCI-H1623,2828334,5.745033734102683,6.242201385226824
NCI-H522,53232,3.4340993190045763,2.660900418545044
MDA-MB-157,24180719,1.846017762198611,3.397233514327602
NCI-H727,2858523,2.9690043699309094,2.8118347135697968
HSC-4,3384730,1.6775009570022803,3.132209662831721
MDA-MB-453,66577038,2.2210808109899687,2.98737363682597
CA46,54619267,3.4754479185856604,3.404928738600095
BxPC-3,selumetinib-decitabine (4-1 mol-mol),1.0861669276123684,3.2560266172854266
RCM-1 [Human rectal adenocarcinoma],3136844,4.175493618298147,4.4536208168939355
DMS 273,89183176,4.012998903778193,3.604082312404338
LXF 289,89183176,5.264029999533809,4.5117238048260075
HCC1143,25154868,3.6479876335061863,4.354167741877795
NCI-H460,5566,3.3663694984335533,3.148148704496906
EFO-27,3384730,3.632582575012134,2.950694309808087
YAPC,3854666,3.60977300269674,2.493852859989131
CAL-51,11960529,3.662834723962616,3.939754705768451
NCI-H522,4096211,1.7167000910654833,1.5999423322444477
LXF 289,46199207,3.0446562724495676,3.2463293371118676
MSTO-211H,44507138,3.561974329612715,2.6073447327563626
BxPC-3,10127622,0.1850831315580212,3.413632459334808
SNU-81,57519531,3.6375637578947098,2.2625766289855034
NCI-H522,46926350,-4.757002390021422,-4.5913479871918605
LXF 289,675434,4.434927450149955,4.693589199061406
SBC-5,2858523,3.0625939376722147,2.998323634160782
YAPC,3025986,-1.0818355674515514,-0.6448063447126333
G-401,753704,3.840031862409327,4.4637378832969725
NCI-H2171,9933475,1.8341202855706125,1.8870365362984143
RCM-1 [Human rectal adenocarcinoma],24821094,4.372062930620609,2.8176833704033766
BT-549,5746,2.744550621458616,1.4061900253702808
MSTO-211H,2733487,6.00734552009151,6.015653915948703
LoVo,9908783,4.437010992006648,4.755904107095877
NCI-H2009,46398810,2.5614683956162554,2.5930008487808265
NCI-H292,15983966,2.054572304908195,-0.49731924721617843
G-401,46943432,1.6295589064479152,1.955041633742461
LXF 289,54618771,-0.5375230222620658,1.6173288533615966
NCI-H2009,4261,0.1994590765469732,2.052238644466931
NCI-H292,119182,-1.3574963176080912,-0.5898470523821859
LoVo,675434,4.114717976727459,4.537271309049165
CAL-51,613753,3.3238399640193177,3.0686663259554905
OVISE,tanespimycin-gemcitabine (1-1 mol-mol),2.9974689860461785,-0.6509679276310182
RCM-1 [Human rectal adenocarcinoma],9967941,4.297033846683125,3.5615949836504637
MDA-MB-157,7251185,1.2275966709755557,2.62804204157068
LOU-NH91,168313047,3.5347026371928565,2.492255155287334
Panc 04.03,11175137,3.811547013287204,2.86570649094088
YAPC,46191454,1.528991916080322,1.826497114804681
Panc 04.03,246676,4.5210437514033615,4.489502966215364
LOU-NH91,107985,-2.204555775629559,-3.1818786513867092
JM-1,9884685,0.5602575931973728,-0.15317896336598863
KYSE-70,26596,-1.4453873864890578,-0.8955759860143361
SBC-5,11238147,3.923057921789592,2.903165863292853
CAL-51,5351362,1.1872361858703535,1.5355694702817115
CAL-51,148198,-3.728190383000159,-3.6611391929405146
MSTO-211H,10074640,2.8901374693183848,3.2009593403409218
CA46,navitoclax-gemcitabine (1-1 mol-mol),-1.1536671772218576,-2.154339128472937
Panc 04.03,54618305,4.994656380487723,4.40670817290194
HSC-4,9444,4.231424733159592,4.072542297618586
ONS-76,136227924,2.542073211711186,2.5187547913883477
CA46,navitoclax-MST-312 (1-1 mol-mol),1.8648125815203176,-0.19809003907413217
NCI-H2171,JQ-1-UNC0638 (2-1 mol-mol),0.4857053438992066,0.9002717787120703
A-498,4705,4.1964696083385595,3.113227979555214
NCI-H292,4788,6.000922818610643,5.719614328437584
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293,1.8926103115508204
A4/Fukuda,168312962,0.589698091471745,1.028890717898999
MSTO-211H,135421197,0.8053711662366769,2.2792567458676176
G-401,9826308,0.736562536874994,0.002595765126863534
JM-1,44202524,1.2333959484520816,1.4935177946902416
SNU-449,135984461,4.468051833024593,4.126965055828901
LOU-NH91,UNC0638-navitoclax (1-1 mol-mol),-2.1290518505040854,2.3543297807496284
HSC-4,135999136,1.7584955345229645,4.034487408503847
HCC1143,6918328,-0.4969866258783406,0.3091990394949498
A4/Fukuda,2871966,-1.2628046939905593,-0.1703658925721198
HSC-4,89928392,1.9678897287961257,1.603178961421455
CA46,7251185,0.9564015595877396,1.423791585322383
A4/Fukuda,serdemetan-SCH-529074 (1-1 mol-mol),0.8122212024039632,1.5469202691398445
RCM-1 [Human rectal adenocarcinoma],5280436,3.538296903160907,3.3644194832632746
LOU-NH91,navitoclax-pluripotin (1-1 mol-mol),-2.6950691306043297,-0.7775279812785021
YAPC,9967941,3.379913520192136,3.8626857236400682
Panc 04.03,119607,5.706581209982884,5.467038075250173
KMRC-1,46926350,-4.153095302049271,-3.7210041920556103
OPM-2,JQ-1-MK-0752 (1-1 mol-mol),-1.5972514317296775,0.4427676754566569
OVISE,5287620,-0.8119274098935182,-2.1343428004988985
NOMO-1,135440466,1.6123042261647436,1.7300127664833669
A-673,11507802,0.3878845266361032,0.9769150974765566
G-401,tanespimycin-gemcitabine (1-1 mol-mol),-2.3448363007854325,-1.4566534663743766
NCI-H2009,3854666,0.912328636385412,2.3747447210974757
SNU-81,2749,0.983670801340458,1.385449862963124
A4/Fukuda,25105715,3.290295740743095,3.3203392388269397
OVISE,erlotinib-PLX-4032 (2-1 mol-mol),3.714460286615586,2.954617616354368
ONS-76,salermide-PLX-4032 (12-1 mol-mol),5.250502452848782,4.751744927725373
CAL-51,9903786,2.1849161121493847,2.807153479453486
LXF 289,5113032,5.558232749512156,4.875324756527901
NCI-H522,46224516,2.9506377913569244,2.1760463796013756
FU-OV-1,56649450,4.970206677695459,3.010298214186895
CA46,erlotinib-PLX-4032 (2-1 mol-mol),3.1947109713205033,2.77410459558925
MSTO-211H,9887053,4.1066593545259975,4.119958509872356
CA46,6610355,3.575030613446337,3.8302448615026234
NCI-H522,445643,3.9693726836499863,3.9060235457559873
A-673,46224516,0.8314688808424526,2.2205532674852044
NCI-H661,6918736,-3.5059805921507823,-1.608035822098264
NCI-H522,selumetinib-PLX-4032 (8-1 mol-mol),4.633194208623746,3.4261526021819413
A-673,3825829,3.830298825271896,3.7108939556229075
ONS-76,11396600,3.887590392789339,3.337873162508093
LXF 289,5282054,3.512278681739004,3.6389816144576344
A-673,54618771,0.7910545462175201,1.0078161524279448
KMRC-1,25062766,1.7411663615582824,1.926591194598811
EFO-27,71751553,4.378478985868248,4.426327508071242
EFO-27,10074640,3.872803440374816,3.1124787001741776
ONS-76,24964624,2.710261416606334,2.2538690031022894
LOU-NH91,53392493,2.3846272258457737,2.878137788243541
CAL-51,46199207,3.548155956826357,3.1884280554411943
DMS 273,227681,4.814934070367145,2.9451736645138635
HSC-4,9908783,6.127900398037499,5.005928107041883
HSC-4,10184653,-0.7296444895073179,0.9536635041644049
NCI-H292,selumetinib-vorinostat (8-1 mol-mol),2.7823927532205546,2.6439162261593014
NCI-H1623,44185566,3.0587688781610667,2.4845086779131744
KYSE-70,6918328,0.2213620303324437,0.17139812593116083
MDA-MB-453,327653,2.9444810987281533,2.9918631675048153
FTC-133,4259181,2.1331002918337925,0.3274874564858601
NCI-H292,60750,-3.187051343712646,-1.2090340956997547
KYSE-70,60700,2.818490002790748,0.3341084407348086
MDA-MB-453,24821094,0.7464785951288041,2.3657833268330046
NCI-H2009,656346,1.3969032628362248,1.2371637212854103
SNU-61,24964624,2.494415785344137,1.824000288915401
NCI-H661,4261,1.9569329914003135,1.625171892863945
SNU-449,54618305,4.668068655096509,4.648727019255516
LoVo,135875424,3.182508442374063,3.9156788718059796
LoVo,6623618,1.7195113979524326,2.17085614282891
A-498,135398516,3.177268179593805,2.801631527037896
BxPC-3,26596,-1.629746525957504,-1.1984449663081045
NCI-H460,2749,2.5004778765083695,2.165455905451198
KMRC-1,46398810,3.012918063271682,2.382205437831929
NCI-H522,5291,3.860595721411624,3.3878902242904663
SNU-449,36462,4.301758862194218,2.5932337596718713
SNU-449,6918837,-1.494845192804234,-2.080342719209401
CA46,11955716,-2.7152267118714204,-2.236616752974722
NCI-H1623,168313200,4.911870039242249,3.030386265642056
NCI-H2171,10427712,3.6918148562663937,3.809673871869374
NCI-H522,262093,3.0660845932794656,2.3798875256605942
BT-549,168312962,3.315695506914068,1.9783482507005372
MDA-MB-157,15953870,0.7968689532543627,3.63358461693161
BxPC-3,carboplatin-etoposide (40-17 mol-mol),4.727119373262846,2.887607041917536
SNU-61,11364421,-2.983927558247801,-1.8685863643270912
SNU-61,3101542,4.3555934573063695,2.8468350418447854
NCI-H460,52947716,-4.997624319891589,-0.4100474893312551
CAL-51,44543605,3.919885801001582,3.826195845420176
NCI-H292,12003241,-1.027467238096921,-0.7885397603975057
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957,0.9538370741866454
Panc 04.03,navitoclax-sorafenib (1-1 mol-mol),3.337045495454646,1.6157532351778172
NCI-H292,25154868,5.001413217408079,4.522340390289094
NCI-H292,36462,2.4286801987130486,2.334813961523986
HSC-4,navitoclax-gemcitabine (1-1 mol-mol),-4.75214371637746,-0.9073660007986942
NCI-H292,159324,3.210621191245253,3.330020468689508
SNU-81,24978538,1.1236702452048486,1.111798625363648
A2780,9929138,3.988043631552867,5.425994276482361
HSC-4,16065773,3.311693132411482,2.520348931534547
A4/Fukuda,400769,-1.555916482707746,-1.3469365913614524
A2780,11977753,-3.718954593203518,-1.4206107427827062
FU-OV-1,60700,0.8482129777629449,0.1370707931764919
DMS 273,168312962,2.633531304827929,0.9822901484113818
SCC-9,8515,4.77911141452934,4.04952611299075
A2780,71680916,3.658218554445846,4.338810139785643
FU-OV-1,5328940,2.1307155577669143,1.4359109218352302
NCI-H661,42642645,1.2812432760018797,0.8281266746563801
A4/Fukuda,2113511,3.845432548996496,4.817318410851896
SBC-5,19582717,5.27972019168548,4.016809762720465
HSC-4,11222830,1.068056053085511,1.6413543552707597
CAL-51,10427712,4.2973287072996085,4.334168223586854
A4/Fukuda,44185566,1.3030950937163224,1.8577563189094428
ONS-76,5278396,3.742938248744769,3.6680673323351725
MDA-MB-453,46943432,1.9398007817238585,2.5619386841117535
NCI-H727,984333,1.9308701128060968,0.6795489781521219
MDA-MB-157,24889392,2.1225906954298535,4.3699800717478725
FU-OV-1,ISOX-bortezomib (250-1 mol-mol),0.954548859556388,0.7654788023852187
A4/Fukuda,46843906,1.071626560517578,1.6097554254102429
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,1.922293314185687
HCC1143,44241473,5.874360916813842,4.855726966768771
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.2740990745866716
EFO-27,6918878,4.955152670116511,2.7128207438422787
CAL-51,5281672,3.9430830045045857,4.4428828985633855
NCI-H146,9915743,-0.2957101551438801,0.5920375065630155
G-401,89928392,0.7343580800154272,0.7782409101981649
SCC-9,navitoclax-piperlongumine (1-1 mol-mol),2.9839395541067515,1.8217370951517853
EFO-27,6184667,5.467001643500489,2.957698730817029
NCI-H727,3854666,3.6466691501950512,2.160587130724535
LOU-NH91,9825149,6.244850491409518,2.4712645650011003
NCI-H146,11178236,-6.140205122942071,-3.0161026236463955
HCC1143,navitoclax-birinapant (1-1 mol-mol),-1.1255303234100646,1.5979941729821387
ONS-76,448949,2.486443038536461,2.1485188625729097
BT-549,57330099,4.335540938726609,4.405077905039433
CAL-51,44819697,-1.9765663783606575,-0.8616483817696188
SNU-449,5278396,3.499051739077657,3.7117489152036645
LXF 289,9956119,3.057634534881657,3.571350385674233
A-498,9933475,2.3013420942123655,2.1134847528429828
DMS 273,10074640,2.948045052381196,3.0117963592040793
LOU-NH91,25102847,2.3579155704363206,2.514208110433339
G-401,5311281,1.6046025374895514,2.0447322219884527
A-673,219104,2.2996165619151507,2.8381486849644153
FU-OV-1,42642645,1.0692746742635495,1.012472424406508
NCI-H460,135411,0.3374737909082799,0.8328866420800396
CAL-51,6252,-0.2076922850947726,1.4220700412709038
NCI-H1623,selumetinib-JQ-1 (4-1 mol-mol),2.0981342871867903,1.6998490553011234
LXF 289,10296883,3.609856485747645,3.8636637350054044
KMRC-1,54626689,4.972873475873264,4.684444241527279
A-673,JQ-1-UNC0638 (2-1 mol-mol),0.3202130450215845,1.1350282764774824
HCC1143,1750826,-1.2654463091368686,-1.131244322161943
SNU-449,24785538,2.8069089427026346,1.9239902892325496
LOU-NH91,53495165,1.612116489462364,0.9181598434058909
EFO-27,11609586,3.640431752283184,2.8627639208343423
LoVo,tanespimycin-gemcitabine (1-1 mol-mol),0.1756680673297083,-0.821522763511207
Panc 04.03,104842,-1.0125052126256155,-2.2809764572153144
NCI-H522,6610355,5.34603712705315,4.360354810057699
NCI-H661,11656518,2.215339329496845,1.6970946754169902
NCI-H661,6505803,-0.5859050253944337,-0.4753736098810976
NCI-H292,5351362,1.0382380370911135,1.6608332581915795
EFO-27,11612883,3.4595212211892377,2.8099109769097548
FU-OV-1,vorinostat-carboplatin (1-1 mol-mol),2.1636839207385914,3.2263321716208435
HSC-4,10302451,2.384078053411002,2.839160823176328
NCI-H292,46199207,3.366381535989616,3.272014248211771
LoVo,262093,2.370412929490009,3.017783750069968
BxPC-3,445643,4.432772060189362,3.9980160445631494
A-673,carboplatin-UNC0638 (2-1 mol-mol),1.4546927004142935,3.015323496303452
A4/Fukuda,46224516,1.3171235816864948,2.225661856148286
JM-1,3854666,0.4999957819555636,0.5002021992482032
NCI-H292,124202324,2.857386903129287,2.7206237057679017
BT-549,1566236,1.7296376770428397,2.45089075851071
LXF 289,11364421,-2.6687395721676577,-1.6611962082809044
NCI-H146,navitoclax-sorafenib (1-1 mol-mol),-1.8992247000680913,1.0071062036538956
FTC-133,148198,-1.6568063805549866,-2.9898243152742383
LXF 289,11640390,5.398484732926136,3.7446183521144896
RCM-1 [Human rectal adenocarcinoma],24951314,1.1143156240073944,1.5690334074812673
LXF 289,2749,2.818144236178911,2.3508496616420724
NOMO-1,decitabine-carboplatin (1-1 mol-mol),1.4040518072476522,0.23269879500753685
JM-1,135875424,2.019666731209586,3.1433198904787405
SCC-9,4705,2.492131143046821,2.85419323161053
NCI-H2171,151289,1.4157771037164255,0.9049476108597875
NCI-H522,644241,2.1349742590503427,1.4676285800130515
A-673,445643,4.040507929851862,3.8673538264905485
JM-1,6252,-5.0324479776154885,-1.5386770616303103
NCI-H292,208908,4.322795663590344,1.8016098604925501
A-498,2871966,1.0686849145956876,0.7178600508271726
G-401,12001922,1.3873374697674952,1.8197752028961367
DMS 273,44491742,3.7307306463602545,4.195761991300502
A4/Fukuda,11396600,-8.215434514364686,3.078564546939304
HSC-4,3689413,2.5472025828962055,-0.004411579566833151
MDA-MB-453,4378219,1.7417226469020404,2.073352791013265
ONS-76,387447,-4.115404850127739,-4.190615452053378
LOU-NH91,656346,1.0077735762311986,1.104040441571666
A4/Fukuda,3081361,1.810117399969756,1.8327855978588656
NCI-H460,6505803,-0.4074860596498978,-0.92910800016506
NCI-H146,45279963,2.8359939324557706,3.231258882313538
OPM-2,6184667,1.6391974127027074,2.4450405744827917
HCC1143,148198,-3.881060339055355,-3.4522953359696635
A-673,421610,1.6759942643549426,2.704181167750203
SNU-61,4259181,0.2985440005718957,0.18012946422929907
LXF 289,44819697,0.5606163889857397,-0.21238784107977285
KYSE-70,168312962,-0.2970816131627225,1.5178522412428022
NCI-H146,11494412,-1.136229477240518,1.2133824829445452
OPM-2,2746,0.9082445461467812,1.881090027417996
MDA-MB-157,6918736,-2.3678025624565175,-1.3043359465950766
DMS 273,135659046,3.477426326571923,3.227261777014698
HSC-4,126941,-2.3076253927529127,-2.5017103355345243
CAL-51,57519531,1.893237876741888,2.4573627851774127
MDA-MB-157,3038522,4.043799431595376,2.8617943417570375
ONS-76,SNX-2112-bortezomib (250-1 mol-mol),-0.0712128201037348,-1.048041461408244
BxPC-3,54613361,-0.6294380958983512,0.23832846630467755
CA46,25102847,1.8345278315547784,2.0274310783818557
FTC-133,5746,0.3858378554684238,1.3075232499827347
BT-549,10113978,3.95693770646699,3.659448697920939
A2780,54618771,-0.248592168161829,1.0047228336171203
SNU-61,6917907,-7.995083965311066,-5.299276380727679
ONS-76,3384730,2.185678697527176,2.5868029289991963
LOU-NH91,11228183,0.5456186750940368,2.4662992953881813
MDA-MB-157,25227462,1.286146426910961,0.053756326973748665
Panc 04.03,selumetinib-JQ-1 (4-1 mol-mol),2.1482953038113286,1.7315003109278486
BT-549,439501,-3.1266914034371567,-2.1030295709852256
LXF 289,409805,5.2068809837223435,4.800434695257853
OVISE,148198,-3.4121309130102055,-3.6265947896477546
YAPC,262093,3.6115167721531343,2.965598396127881
NCI-H727,5738263,3.354715168796171,3.5035531896969143
A-673,6918328,-0.9424380212903694,-0.304688188661595
MSTO-211H,navitoclax-piperlongumine (1-1 mol-mol),-1.4716070020924246,1.8519295817861205
JM-1,445643,3.755930816022248,3.6099720010980976
A2780,25154868,3.617715738937927,4.182141395837097
Panc 04.03,81146,4.4293645850092735,4.7353659537018675
MDA-MB-453,4521392,4.261545411784443,3.9823238173993247
CAL-51,5460769,1.3780575552768597,3.1233134527139885
SNU-81,9926054,1.3093723678717843,1.7718267261225515
CAL-51,2113511,6.39897875596168,5.604778430468015
NCI-H460,136227924,3.925006850615035,2.9839743518922126
NCI-H522,24856436,0.0798065953372803,0.3190556269819868
SBC-5,9967941,3.629642521259923,3.284104165160946
A4/Fukuda,462382,-0.2406989279082468,0.5930482064025697
OVISE,11640390,4.491956307789174,3.691838150454184
NCI-H522,selumetinib-vorinostat (8-1 mol-mol),2.6916205553530843,2.139917175685443
CAL-51,24180125,2.8082301472193203,2.98458059236004
LXF 289,25262965,-2.558275633709226,-1.5010716358458367
NCI-H2009,9903786,1.8298580590992315,2.8073777302970218
SNU-61,54678924,1.5881868934361725,1.755408050170325
YAPC,24785538,1.575520805381804,1.7490577288578435
NCI-H2171,676352,1.591250217642193,1.9975804824186014
SCC-9,carboplatin-UNC0638 (2-1 mol-mol),3.5571818540455413,3.4453627730883314
ONS-76,BRD-K27188169-navitoclax (2-1 mol-mol),3.629677877626108,2.562959176929356
NOMO-1,3689413,-2.5325178418163174,-1.6032046742857435
OPM-2,5284373,2.335601496737994,1.9721909006240272
NCI-H661,10127622,4.958480333722226,4.134780986965871
ONS-76,44185566,2.3053400119978735,2.365469421350532
RCM-1 [Human rectal adenocarcinoma],11427553,3.480492721904053,2.963541385543507
HCC1143,11485656,1.8564802256291268,2.509468165146749
G-401,613753,2.8041503953296187,2.8598180314897026
MDA-MB-157,11657048,4.26764748298064,3.874503840963012
ONS-76,24951314,1.2212354664419371,1.1853454577695126
A2780,36462,-2.0824592368546893,1.485208955310427
FTC-133,vorinostat-carboplatin (1-1 mol-mol),4.046796900888368,3.3358027518911655
OPM-2,72376,-3.1510357921092376,-3.382557422505144
OPM-2,6918328,-2.875264730320658,-1.572197053473532
NCI-H522,decitabine-navitoclax (2-1 mol-mol),4.970964992537572,0.8599198537436901
EFO-27,168312962,3.0506772104926343,1.7764019856388145
NCI-H1623,107985,-2.7226564689550488,-3.0918763227481905
MDA-MB-453,46398810,2.51328952557295,2.4894829381096657
SNU-449,49766530,-0.9876450445747244,-0.15334975974283604
OPM-2,25102847,1.4573873057147737,1.910702723952304
G-401,3081361,2.1638535645332664,2.1822303220910673
RCM-1 [Human rectal adenocarcinoma],71576739,4.46778033750866,3.859627971451209
A2780,24951314,0.3580646626980762,0.9476193310480815
SCC-9,2871966,2.1501352130214695,0.7927102735944318
EFO-27,53232,3.845715413797161,2.909529998678902
A2780,5460769,-5.6757466443406575,2.5445877879711585
Panc 04.03,10322450,4.721553837851545,3.899913891829278
NCI-H292,selumetinib-JQ-1 (4-1 mol-mol),0.7417417133593783,1.5025411113646618
SNU-449,23582824,0.6769149785817056,0.7838410727742321
LoVo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3489379302549531,3.0455598909795465
ONS-76,3854666,0.984876663182433,1.790792438262059
MDA-MB-453,71466578,1.854784458712459,4.137721993932254
BT-549,piperlongumine-MST-312 (1-1 mol-mol),1.4526674208496635,2.0118109339325163
MDA-MB-453,15547703,3.861172408325267,3.213576880963402
MDA-MB-157,252682,6.150103454129247,6.674568425465886
G-401,46398810,1.5664917458517695,2.074262388029902
NCI-H1623,327653,3.600793829240414,3.2229999554037057
SBC-5,6610355,5.221010400785003,4.457027085433893
A4/Fukuda,6918878,-0.3411937140873722,0.7485090773467152
SNU-81,3062316,2.330723232319837,1.4708355625953973
OPM-2,9903786,2.6412283094975657,2.4043896360297383
HSC-4,15953870,4.269670192757531,3.6182822648437116
JM-1,984333,-1.6115401451915106,-0.5100948274652168
Panc 04.03,46174525,5.826098059849913,4.621537579120958
NCI-H292,5460769,0.0770188109309223,2.9038041159482453
FTC-133,216345,4.490711794352075,3.8424084968731536
BT-549,alisertib-navitoclax (2-1 mol-mol),-0.0458580768045358,0.9801065749653843
FU-OV-1,5311,1.028726852721831,1.5627665209666737
LoVo,9911830,1.9062113768292104,2.388993101046723
CA46,23582824,0.075225101675958,0.7308394186405595
JM-1,alisertib-navitoclax (2-1 mol-mol),-3.873969254990661,-1.3348567806499425
EFO-27,24797083,1.960036113572856,1.5364720382181303
NCI-H1623,5460769,3.63452416726077,2.920822200892394
NCI-H661,5311,1.0541651051557333,1.5295753705142414
G-401,119182,-0.7625552993148171,-1.489277311244483
KMRC-1,navitoclax-MST-312 (1-1 mol-mol),0.8819471903820566,0.9538103004118562
ONS-76,11507802,1.2556507557201144,1.4053547725495164
KYSE-70,6918736,-3.61435843984592,-1.084069846291309
NCI-H2009,4788,5.716428228211685,5.766985612052278
ONS-76,54686904,4.527599605979478,3.572276517309467
CAL-51,2729026,2.5757432896171517,2.6696190862987845
ONS-76,3689413,-0.2845128895134612,-0.12726767154206586
JM-1,676352,1.381688063426603,1.8648136822947805
NCI-H2171,11238147,2.9150011478889795,2.134673737973518
EFO-27,JQ-1-carboplatin (1-1 mol-mol),5.5199687531263715,2.471087408340652
Panc 04.03,5738263,4.451939152518209,3.678832550374152
HCC1143,71304818,2.928848735179534,2.572772217594159
OPM-2,9826308,-1.153894104617258,-0.23486849672233676
OVISE,73707438,4.551111956107329,4.119737514603376
KMRC-1,448949,2.0346247593103257,2.063803030713111
NCI-H661,44589607,2.97822499860898,3.0179941043626686
YAPC,3503,2.818608145608573,2.317798171306229
NCI-H522,3825829,3.960912701697082,3.518202752189847
NCI-H661,5738263,2.7657344337958687,3.4185458002770757
CAL-51,168312962,1.4117577594763937,2.298291405357822
CA46,4261,-0.8863355705331979,0.3268296114629938
CAL-51,241158,3.781489879449518,3.848569683870711
A-673,2874250,4.616954738528679,4.2551088979699365
BT-549,46191454,1.72486803708685,1.897900890634183
JM-1,6918878,0.0294179493888284,0.7121194259956556
CAL-51,4521392,4.667802355757324,4.146018419469225
CAL-51,9915743,1.1260994347217144,0.8812371105692055
NCI-H146,46943432,1.2283557348915184,2.1970898572089994
YAPC,168312962,3.6522382892319185,2.235694714764155
NCI-H522,44493528,4.173254194812623,4.246590249251029
BT-549,10296883,4.161421407524775,3.950711940139736
OVISE,11152667,1.81896217810704,-0.3113104075353562
G-401,6852167,1.9492633511801831,2.217176328020518
NCI-H292,168313047,2.7678931286458974,2.4351749711487596
A-673,5329102,0.93841525470917,1.5790749633418664
A-673,11404337,-2.7698937773977033,-0.702921603189048
BxPC-3,11222830,1.6538054387944447,1.78935857624143
KMRC-1,25102847,3.2500467863275735,2.5995849923217462
MDA-MB-453,400769,-1.402270827463697,-0.5368157102674808
OVISE,89928392,2.0483381338479907,1.8306259280129171
MDA-MB-157,136227924,3.402219650297347,2.9365087245654524
SNU-449,JQ-1-UNC0638 (2-1 mol-mol),5.2681139205860354,2.0461018685205534
BxPC-3,5738263,3.0337675506106576,3.6042169957451313
NCI-H292,16741245,5.797273118380107,3.9622748609653566
Panc 04.03,11404337,1.3784278741672673,-0.004512539685945769
HSC-4,2130404,3.512147769522711,2.9967748186037166
SBC-5,5329102,3.79532117952851,1.6600071735222974
SNU-449,57519531,5.8010509150022145,2.7307196787412606
KMRC-1,1750826,-1.909836969824086,-1.8106296466001945
DMS 273,53245473,3.723579099176344,2.8109794697499946
A4/Fukuda,44137675,1.307300702935143,3.2260529281127197
LoVo,72734382,4.052668353480041,4.453336510652517
SW1463,57519531,1.6287135351441295,2.198801460892056
SNU-61,16038120,1.3103584397228891,0.7840222013542298
CAL-51,9926054,2.2227862000004577,2.0287348936113903
KMRC-1,15953870,4.40931040558564,3.6066114943518164
A4/Fukuda,46191454,-2.2780561859524457,0.7225945933566517
EFO-27,6505803,0.9411407576336728,-0.23427152119546388
A4/Fukuda,24951314,0.2081517019188384,0.4180373306946785
A-498,10184653,1.9377607214538883,1.658600137737485
HSC-4,doxorubicin-navitoclax (2-1 mol-mol),-1.2623488821486932,-0.9460622167349225
NCI-H522,9911830,2.121034111225194,2.07709788345065
YAPC,53392493,3.0834263437199705,2.8720604538498065
FU-OV-1,JQ-1-MK-0752 (1-1 mol-mol),1.194664031604259,1.6763254121195967
FTC-133,15547703,3.427766539334031,3.3992859329263445
SBC-5,11404337,1.1992857421773124,-0.5116668615138888
NOMO-1,654092,-2.6158486127541343,-0.8244481693468689
JM-1,navitoclax-sorafenib (1-1 mol-mol),0.8658356793776997,0.4589767562282535
OPM-2,49793307,-4.879066461483742,-4.317080219433508
JM-1,11717001,4.327873015149225,3.7475292777648086
MSTO-211H,969516,2.440842922513423,3.084215431829914
NCI-H460,9926054,2.081701465030928,1.9155263007926215
LXF 289,9936388,-5.793518221083613,-0.6822803650592694
LoVo,10184653,-0.0525672628767589,1.3229701191722858
G-401,9866186,0.2347893748246883,0.40927918534140545
ONS-76,BRD-K99584050,5.369990310930208,2.182179226579382
KMRC-1,168312962,3.867746451267385,1.676844630067648
YAPC,452548,0.3485834104810916,0.5996496015649068
RCM-1 [Human rectal adenocarcinoma],selumetinib-navitoclax (8-1 mol-mol),2.9022286191617597,1.8393758529760524
FU-OV-1,6450551,4.626381712180732,2.71507977899897
EFO-27,carboplatin-etoposide (40-17 mol-mol),3.749556119159122,2.664101135384998
SNU-449,5978,1.8233754703073703,-1.261471554388528
LOU-NH91,44589607,2.878199319266369,3.049873799751646
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,4.751118999030528
A4/Fukuda,65628,3.8428022223998366,3.5632508384486465
A2780,42611257,2.862805810765337,3.2355123711984235
FTC-133,49867930,5.271360985380777,4.372458671407879
SNU-61,56946209,-2.5026309203687314,-4.1507876084331174
FU-OV-1,3062316,-5.013660753129892,1.128863483029732
KMRC-1,vorinostat-navitoclax (4-1 mol-mol),1.4468975732833491,0.9186153830484024
NCI-H522,123631,2.114949756755372,2.2282788923091026
NOMO-1,52912189,-0.5265680930430634,0.05065067295508614
HCC1143,selumetinib-tretinoin (2-1 mol-mol),4.123174212921891,3.3547371333340705
CA46,2733526,4.193969711090682,3.313275504871939
G-401,44819697,-1.6952135460319926,-0.8277097009699564
MDA-MB-453,44507138,1.496822662467132,2.220645678577184
NCI-H2171,9825149,1.181898582623386,1.7119871042019812
OPM-2,8515,3.0418796641091226,3.077971506772043
Panc 04.03,4096211,3.5665133346619684,2.420420896058343
KMRC-1,6610216,4.1544949822147,3.986712857995623
NCI-H460,25150857,3.536831166282903,2.6010095361418957
OPM-2,11977753,-4.6820583055789,-2.1612516761577263
G-401,49793307,-5.199300209786212,-3.238642320546474
A2780,1239801,3.465676691044825,3.3859747544349132
Panc 04.03,46398810,3.688960594211219,2.825440327869704
G-401,65628,4.0909837295628275,3.7172629180921484
BT-549,53232,2.511840395622571,2.819062932059501
NCI-H727,104842,-0.3454800108905812,-2.2969920526192538
NCI-H292,6852167,2.409220580223775,3.0011391146733546
KMRC-1,15547703,4.785371110425684,3.10758154017376
SCC-9,vorinostat-carboplatin (1-1 mol-mol),4.0549639225779615,3.3158574912978906
BxPC-3,16722836,0.8866010617403134,1.6779764622568714
OPM-2,BRD-A02303741-navitoclax (2-1 mol-mol),2.1588596939971625,0.7602739493232065
LXF 289,168312962,1.364587801939814,2.1642250864975954
G-401,11626560,1.1843690178322546,1.1994458765114313
YAPC,3825829,4.484241364021175,4.002905797804753
NCI-H2009,46943432,2.8478796444115835,2.9358400014610284
SNU-449,16038120,1.104181711259477,1.1442793698531348
MDA-MB-157,72193861,0.2105280638919307,1.5350436545263226
ONS-76,46191454,1.5088295462826262,1.4757403133822329
LXF 289,439501,-1.653941874457911,-1.8546861056765795
MDA-MB-453,54649381,4.094182376460235,3.7154364619677103
EFO-27,11507802,4.116687062031661,1.7319582824306285
ONS-76,crizotinib-PLX-4032 (2-1 mol-mol),2.136807968488312,1.703069575312925
SNU-81,11427553,2.1196099795437733,2.240459505072322
SNU-61,54143018,-0.3273600933762652,0.3787177977834354
HSC-4,17755052,1.8179922614483863,1.6554970044612418
EFO-27,2130404,3.4270754566369748,3.1500927376178485
FTC-133,24821094,3.776872089794721,2.606660686058774
SNU-449,44607531,1.5485785292308227,1.8265105082206972
KYSE-70,24772860,-1.2328668610311222,-1.5995704360098586
NCI-H522,11214940,1.077396173859641,1.7633013249138998
SNU-449,1474550,4.524224948734458,3.9267229281214946
LXF 289,44589607,3.4320685896186585,3.1145132403709876
OPM-2,31703,-1.5109362720248076,-2.51249060421288
A4/Fukuda,445455,4.756694709293823,4.128583639684028
LoVo,71680916,4.224958300762603,4.694707570149036
KMRC-1,25262965,-3.4791684180939,-1.4658172442709116
NCI-H1623,54613361,0.8976129642368637,0.0713437062172175
DMS 273,15547703,2.68216153568037,2.7410697281158485
HCC1143,5311,1.090656828429124,1.5214700727423836
SNU-81,JQ-1-navitoclax (2-1 mol-mol),0.6755199584386623,0.6012555280424646
MSTO-211H,11977753,-3.756718801235006,-1.6025972998905718
NCI-H661,51037431,4.262261435001038,2.9891883756570365
EFO-27,25183872,0.6822597295955183,-0.5694322160738615
BT-549,docetaxel-tanespimycin (2-1 mol-mol),-6.584782072874471,-3.48771631180648
MDA-MB-453,16659841,4.43927192393091,3.4632927400963767
SNU-449,3854666,3.254678167809475,2.4001303085944103
JM-1,selumetinib-navitoclax (8-1 mol-mol),1.96596855152698,0.6287436279218246
HSC-4,46174525,4.818915916273074,4.487756715696628
NCI-H727,25062766,3.0095924827905813,2.2884325236689937
EFO-27,9823820,4.474335567240953,4.319494212932545
CAL-51,4917,3.122174268556499,3.114737451444313
SCC-9,676352,2.0394457592349093,2.171738384788876
MSTO-211H,4259181,-0.7585521679245923,-0.002133923088600163
Panc 04.03,3854666,3.6180263181428622,2.5576315754783088
A2780,11214940,1.8716907673631955,1.6127266839873289
Panc 04.03,445455,5.108054343544362,4.772905269427051
SCC-9,SNX-2112-bortezomib (250-1 mol-mol),-2.0018823279326776,-0.9453495067011722
DMS 273,3081361,3.0365977955778805,2.199254366719601
BxPC-3,126941,-2.8667568441276083,-2.378041763080315
EFO-27,6918837,-4.778560341054376,-2.3408161721499887
JM-1,9956119,1.3894298966841814,2.6907562025551424
CAL-51,60750,-3.4379358682898973,-1.5895044437392842
SNU-449,12001922,2.031450773900583,2.066185764597531
SNU-81,119182,-3.3799134284972614,-0.8970013858260651
CAL-51,6918878,3.0110486558166274,2.828770809558299
CA46,44819697,-3.819793103454841,-1.4076465462666203
OPM-2,46199207,2.048842595102616,2.776454096404373
JM-1,11977753,-2.0561747941195674,-2.2152930391475407
MDA-MB-453,16038120,1.4822204990084098,1.146436659302666
BT-549,selumetinib-tretinoin (2-1 mol-mol),5.357160165486871,4.126962334456358
G-401,135928012,4.758772301459146,3.8823868588170365
LoVo,445455,4.556737788306169,4.581354083609931
FU-OV-1,11964036,-0.3048537688067435,1.4466703731119475
CAL-51,3825829,3.9510679995615257,4.047868554949875
NOMO-1,66577038,2.985459327680272,2.5517008288073013
YAPC,4259181,0.8211273757017798,0.4929423325072813
BT-549,2708,5.415828272287544,4.82777056321294
OPM-2,4477,0.1075725295912922,0.4639156960057673
ONS-76,23635314,-1.3572631369234491,-1.6962282298604654
Panc 04.03,168313200,2.993774278353398,2.9425794682415773
A2780,25262965,-4.532154518345387,-1.7986416448121727
LoVo,24951314,0.8531724175888866,1.348392522096156
SNU-61,6918837,-2.02709157063253,-3.279670978596352
LOU-NH91,6918878,5.623996708869271,3.2341235701233817
LOU-NH91,16725315,5.120050781978422,4.058756614486328
RCM-1 [Human rectal adenocarcinoma],9866186,0.0174318535432376,1.1107950614129605
NCI-H661,16722836,1.177222753188902,1.8058096781103063
A-498,9935249,3.347418171794467,3.555598941443005
NCI-H2009,44185566,3.0429431135599607,2.7031906618761314
Panc 04.03,25126798,3.7756614801897377,3.8029862412071003
LOU-NH91,24771867,3.0978851297923895,3.1395836191060607
Panc 04.03,10231331,4.944041434313903,1.9976563781454297
Panc 04.03,9967941,5.787601223768576,3.9160264996221383
HCC1143,11497983,5.345504804401821,4.079452993341981
MDA-MB-453,6505803,-3.8322805026755806,-1.2060217889821412
LXF 289,285033,-1.4335563326434544,-1.3426365151076272
NCI-H292,3689413,1.7536313837601494,-0.0523940584125925
OVISE,54618771,1.319775250733869,1.3794074178255002
SNU-81,135411,1.0381613293566891,0.5472779333805117
NCI-H2009,451668,5.323035746604961,3.9843280566201957
SNU-81,3689413,1.1974270464491454,-0.7136940971216772
FTC-133,5738263,4.07617232189308,3.466251814854672
NCI-H1623,5291,3.880629558524794,3.788870215785132
NCI-H727,51039095,2.7124063556691267,2.7599895214332135
DMS 273,262093,2.141936221481062,2.184371960054105
CAL-51,6918328,0.3807555589851347,0.11927359129820025
A-498,24951314,2.536702379510054,1.7819778276103242
OVISE,135440466,-0.9475229728449716,2.3081558472502928
A2780,11404337,-0.8981705286722745,-0.7536847384821844
OVISE,selumetinib-navitoclax (8-1 mol-mol),1.5927997425042688,1.9641585171044664
Panc 04.03,24951314,1.470760951451068,1.8318988065232293
NOMO-1,4705,2.5023829157060926,3.0125953899666977
BxPC-3,176870,2.768163283404042,3.240393128023231
G-401,11609586,0.8694160359503889,2.0437318846468777
EFO-27,doxorubicin-navitoclax (2-1 mol-mol),0.6327917719948324,-0.46065890895587763
NCI-H2009,tanespimycin-gemcitabine (1-1 mol-mol),0.2582692893190324,-0.802163169767778
NCI-H2009,15983966,-3.9047819028388178,-1.598692079195675
JM-1,16659841,2.088291676862089,2.500246612183032
NCI-H146,5311,-0.0389435386139853,1.5431770994934362
A2780,72734382,3.371521062177298,4.188036247737636
A-673,2708,2.956024737310482,3.8488950820033057
NCI-H460,11152667,1.2005763717636435,-0.6941232321778068
A4/Fukuda,tretinoin-carboplatin (2-1 mol-mol),3.3716994915899945,3.89072061025349
G-401,60700,-0.931594906554522,-1.1883507296407492
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633,-0.651567614012899
NCI-H146,31703,-2.278385754586821,-1.2716913332260338
KMRC-1,445643,4.4248475697731005,3.940375812195262
SNU-61,tanespimycin-gemcitabine (1-1 mol-mol),-0.5770554338848054,-1.113321547097901
KYSE-70,54613361,0.0645626216296427,-0.11181511202983811
CAL-51,444795,5.053001195278548,4.624901558770913
KYSE-70,54619267,5.587983352589812,4.037002089207567
RCM-1 [Human rectal adenocarcinoma],16065773,2.083422102332506,2.483756825874347
NCI-H522,135984461,5.248212763135773,3.119077899008348
CA46,10385095,0.6992054873225039,0.9569676802335334
G-401,16038120,0.8239725572719159,0.7718707084186647
A2780,selumetinib-tretinoin (2-1 mol-mol),2.739843613325444,3.3079459566868037
NCI-H1623,6918328,0.1782181011891448,0.13037778058680172
G-401,31703,-2.7567506026552904,-1.533190822026167
OPM-2,11497983,4.2316824511311,0.5173230884913237
NCI-H522,46215462,1.6065433434555243,1.467697856299244
JM-1,selumetinib-UNC0638 (4-1 mol-mol),2.9715297614660474,2.119572962187625
A-498,selumetinib-BRD-A02303741 (4-1 mol-mol),2.466660305447313,4.059256410862376
A-673,16741245,3.6856166817392393,3.6625607554623274
DMS 273,44486219,3.889102530118227,4.179241019872871
ONS-76,3062316,0.3527292351029743,1.1343369753522503
NCI-H1623,4521392,4.396491619301915,4.311783192876853
SBC-5,3062316,3.347274022566764,1.2929374057028908
OPM-2,374536,1.7033153768622478,0.9160455903687861
NCI-H292,5291,3.74340966649761,3.6226613690405878
G-401,123631,2.330078370852269,2.148227275732402
HSC-4,135423438,1.814117839489682,2.390468116339825
CAL-51,25126798,3.926975819986009,3.8680817566902572
NCI-H727,409805,5.9670224431598875,5.081921490902684
A-673,4917,1.8117239982797952,3.0465112450253637
DMS 273,57519531,1.9430749026869305,2.0942165436648295
MSTO-211H,vorinostat-carboplatin (1-1 mol-mol),3.1229894172951043,3.310031149302834
HSC-4,25262965,-0.4495508061813805,-1.6366654384936448
OVISE,327653,2.506626214633075,3.1463617528648644
A4/Fukuda,71680916,4.641498651595925,4.075709891234826
EFO-27,104842,-1.4311942194738418,-2.090357257041488
A-673,11626560,-0.097195247735582,1.170494270720032
NCI-H146,3384730,2.6214971804948908,2.533528121080154
MSTO-211H,26596,-0.5653018529577997,-0.692748156250387
JM-1,445455,3.9843646189648863,3.785285565991002
CAL-51,11427553,2.069280384014222,2.870363004449688
SNU-61,20959075,-3.60077638491687,-2.539130250784161
LXF 289,25062766,1.8533275351899623,2.0827798389761316
LOU-NH91,24797083,1.602297413523094,1.5763145283136157
CAL-51,24771867,-0.5018492111736887,2.174081871410176
NOMO-1,44632017,0.9405041708842384,0.7694484120088457
NCI-H146,25195348,0.0229507172684141,3.034847938522828
A-673,151289,0.5990139557366498,0.8166882509777272
JM-1,72376,-3.929922218649067,-3.3396712497673904
NCI-H727,12003241,-0.657143782776601,-0.8283913929629878
JM-1,24180125,1.1035620934920058,2.13906686864254
LoVo,24964624,-0.96112559187181,2.412050625464846
NCI-H2171,UNC0638-navitoclax (1-1 mol-mol),-0.3565063117120224,0.6451902807427675
OVISE,6610216,4.867128617935935,4.257419690032591
RCM-1 [Human rectal adenocarcinoma],5113032,4.670023295767466,4.902060363365164
CAL-51,11507802,1.2528060552922216,1.8202917949079431
A4/Fukuda,25227462,-5.883792654516593,-1.648427494712893
BxPC-3,5566,2.8001360517565628,3.0191579336571697
DMS 273,119182,1.6620070398785467,-1.667910593523475
RCM-1 [Human rectal adenocarcinoma],3062316,2.514926182355465,1.2956420819934642
NOMO-1,168313200,3.152434526133537,2.5306363093748834
A-673,navitoclax-PLX-4032 (1-1 mol-mol),0.8994506626912233,0.7502892701286049
NCI-H727,24856436,1.7647429516878397,0.5842215133259905
KMRC-1,72734382,5.690666345136703,4.036884343490633
A-673,56949517,4.212065281653062,3.9656086852394465
BT-549,135421197,3.4062158650675265,2.017418169592437
DMS 273,vorinostat-carboplatin (1-1 mol-mol),2.6049111550172506,2.2406308618474533
NCI-H1623,10074640,3.727129107489099,3.178696163530608
YAPC,5329102,2.676937714502371,2.144092011136289
YAPC,docetaxel-tanespimycin (2-1 mol-mol),2.5986620559096902,-2.7055019222938324
NCI-H2009,4917,2.9963488408029417,3.028389417983355
NCI-H727,44589607,2.894616632949603,3.0563695405872653
G-401,5328940,1.7098947779411977,1.5680532347043543
FTC-133,10410894,5.920528547603018,3.26334378719641
CAL-51,216468,1.370586512271769,3.0082458781483132
MDA-MB-453,227681,3.97271964535407,3.289500309609519
A4/Fukuda,5284616,3.229953451024844,0.9829855646179986
NCI-H460,753704,5.635234970240753,5.148316975796644
NCI-H2009,vorinostat-carboplatin (1-1 mol-mol),1.7172571438659243,3.2777414746624522
SBC-5,crizotinib-PLX-4032 (2-1 mol-mol),2.792734881189652,1.8121616835818108
NCI-H1623,25150857,2.7146098705885127,2.4716681841366346
YAPC,JQ-1-vorinostat (2-1 mol-mol),2.9118979144458548,1.1436640797367874
LOU-NH91,2729026,2.877851429076431,2.8720171334529043
CA46,46191454,-0.333651418813281,0.3319751780456339
FTC-133,65628,4.302527639906617,4.228179486471503
A2780,72193861,-0.1120033238626439,1.0046287714819402
SCC-9,49793307,-2.052824266331224,-2.428400993723318
BxPC-3,135440466,1.2091890795281053,2.0726564176895796
NCI-H146,11455910,-0.4209962248823531,1.102581745132194
A-673,46398810,1.6125076634642133,2.157511271175876
SNU-81,11626927,-0.7774954189098839,2.416159735838558
JM-1,45279963,2.536030346276664,2.9158236081361166
MDA-MB-157,5746,1.4435337882328911,1.522494992225135
RCM-1 [Human rectal adenocarcinoma],16725315,5.393896472431684,4.217232159502145
ONS-76,2874250,6.058821088556036,4.671575126749796
A2780,5284329,2.502098244540034,2.6315316596628975
LoVo,53232,3.084407514553567,2.7687829141927103
ONS-76,navitoclax-PLX-4032 (1-1 mol-mol),4.335120397658034,2.1281515329857665
OPM-2,9927531,3.0625153090482757,4.126649516945189
SNU-449,44202524,4.173676721592596,2.25147832589515
SNU-61,124202324,2.5924607447988643,1.8860988544934627
JM-1,SNX-2112-bortezomib (250-1 mol-mol),-3.853804462612268,-2.5896935043632165
CAL-51,44819697,-1.9765663783606575,-0.8616483817696188
FU-OV-1,2708,5.501261259949465,4.8336734158465715
EFO-27,selumetinib-JQ-1 (4-1 mol-mol),3.927546340306408,1.6414398368302212
SNU-81,16722836,0.5712028725805488,1.4385384438747062
SNU-61,1716436,2.6740680266491763,2.8722311694226206
OPM-2,3854666,0.6659331794855328,0.6706690647150243
DMS 273,71304818,2.423766397759693,2.180582265272147
OPM-2,44185566,1.967847411757682,1.4668633549919943
SNU-449,25154868,5.089625763576692,4.531681120627049
JM-1,serdemetan-SCH-529074 (1-1 mol-mol),0.850280297026697,1.3758395372603207
NCI-H661,5281321,0.7671093512543088,-0.7398066332660774
SCC-9,44185566,3.0958673753547785,2.62812183128153
MDA-MB-453,16736978,1.2653262263884038,1.1995731585698706
KYSE-70,9935249,3.427959003246725,2.977465989205927
MDA-MB-453,11178236,-5.341922221503707,-2.9814740982256698
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496,4.9128389216863555
EFO-27,24180719,4.15462806748021,3.595989489440804
NCI-H727,44607531,2.33451518290986,1.5589618984125355
NCI-H292,10410894,3.620691172443616,3.3569001781763825
A4/Fukuda,SNX-2112-bortezomib (250-1 mol-mol),-3.583227894628943,-2.290804476245
MDA-MB-453,10184653,1.4947310227918462,0.5748055316859442
MDA-MB-453,11228183,3.436796326739784,2.0022406758260187
DMS 273,67291369,1.8884432049214537,1.5104448170785483
NCI-H2171,54619267,3.4799425585632204,3.85129604596533
MDA-MB-453,448949,2.258073743229602,2.184443752528063
A2780,135440466,1.248320725279374,2.3793140581927914
NCI-H146,9866186,0.8123633746782326,0.8823967880648612
CAL-51,JQ-1-UNC0638 (2-1 mol-mol),2.957186158032418,1.5486852149318426
A4/Fukuda,10074640,2.009206402328629,2.665723033553951
KYSE-70,31703,-0.0860185315527888,-0.5776475462461261
A-673,11497983,-0.3979292238924095,0.8269674226847197
A2780,12003241,-2.743381978251489,-1.2066833035158853
A4/Fukuda,25102847,0.4372365282678318,1.923617277275513
KMRC-1,11717001,4.773123606238519,3.6035527752852436
FTC-133,36462,0.6793689394766376,2.3253174119408175
SCC-9,23582824,0.351039434592286,1.0079214728181127
BT-549,2729026,3.014205222238777,2.7154546373760855
EFO-27,selumetinib-piperlongumine (8-1 mol-mol),4.5130277383980015,3.3028409745234364
LXF 289,46943432,1.4312531154305732,2.9574209257488793
NCI-H727,11625818,5.425399240643101,4.464232709734637
HSC-4,44507138,3.308450875381542,2.6494084001017866
A-673,969516,1.3043572294505754,2.597028927074671
FTC-133,969516,2.842702479050133,2.8800069164777025
HCC1143,11609586,3.6708937391840206,2.9333747178632854
DMS 273,2733487,6.43119993607997,5.4009485200267076
LoVo,10302451,1.0215583424111876,2.7643846588399748
KYSE-70,46174525,4.613744209458669,4.590521773983459
SBC-5,65628,3.417870630997437,4.5156117534478994
DMS 273,24180125,3.0640550148835812,2.3965174066955273
OVISE,452548,1.282500130328104,0.39067452424477067
BxPC-3,71304818,2.4465042326182247,2.5888820058860693
ONS-76,54143018,0.4309751541382265,0.5375090794469605
OVISE,24856436,2.006053298804951,0.7276500655391956
MDA-MB-453,71729975,-0.0804754192781109,2.0202845068506696
NCI-H1623,65628,4.265717950525356,4.446247221892649
DMS 273,9927531,4.953960158421894,4.5496118097067235
BxPC-3,426756,6.38858222821808,4.299826673028793
NCI-H2009,49766530,0.9767616789625324,-0.23367018008075288
JM-1,2858523,2.95851246958296,2.639778955681005
YAPC,9935249,3.6850704434892823,3.2148374985980963
A2780,654092,-1.3080416104753447,-0.4006846081425043
OPM-2,6918638,-1.573449675489913,-0.6761560148128264
NCI-H2009,alisertib-navitoclax (2-1 mol-mol),-2.130413891599744,0.5562005240516565
SBC-5,25105715,3.9151038194938352,3.3646855003352822
SNU-61,168313047,1.9617236271133212,2.2406087414153286
A4/Fukuda,11317348,1.1392337694005448,1.3763586356578417
NCI-H522,25262965,-1.3157493467877637,-2.0187877600444115
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021,1.1137215372147973
LXF 289,docetaxel-tanespimycin (2-1 mol-mol),-5.172665265297567,-3.1108308503627495
MSTO-211H,44607530,1.4093785076150551,1.890376143649239
HSC-4,984333,1.2474358256824072,0.6188441520324212
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,-0.12240550178681504
ONS-76,9967941,2.912852232249919,3.778927278837239
DMS 273,24753719,4.257561408038297,3.6028904394559866
CAL-51,24772860,-2.425084956958233,-1.5512046321255122
MSTO-211H,44632017,1.2059374560785627,1.4266735823093741
NCI-H146,5978,-4.422435519224839,-2.749584802268203
G-401,2746,2.560873344661061,2.615106009107871
A-498,navitoclax-sorafenib (1-1 mol-mol),1.1504287043269172,1.8473284065350393
NCI-H2009,11152667,-0.3244172236423036,-0.3600379980743517
BxPC-3,erlotinib-PLX-4032 (2-1 mol-mol),3.269235353902274,2.679960112987944
MDA-MB-453,219104,3.605347452429255,3.3893170754568156
KMRC-1,5280436,0.1724698964633139,3.3277113642088896
A-673,25154868,2.9619598302203176,4.39154946886447
A-673,135999136,4.231524255529223,3.1410704819884545
FU-OV-1,9884685,-0.2158788705773567,0.8055204887993012
NCI-H727,11626560,1.656358651993978,1.7403812044954492
CAL-51,9866186,1.45916914556855,0.9197361856449007
HCC1143,44507138,1.5952303095871043,2.66602328469423
CA46,9823820,1.6053302041689723,2.687874526017838
NCI-H522,docetaxel-tanespimycin (2-1 mol-mol),-6.262465399444894,-3.174503957327749
CAL-51,12001922,2.008779489179369,1.9499203682232866
FTC-133,selumetinib-PLX-4032 (8-1 mol-mol),5.295700336992507,3.243978857827886
NCI-H292,19582717,5.466560288208149,4.2328443375948455
A4/Fukuda,374536,-1.0311095755670416,1.4970833692504022
OPM-2,10113978,1.3298356496360293,2.3709441315514788
SNU-449,9903786,3.696408358539977,2.9396664798389525
JM-1,25195348,3.46638875562813,2.3105942688639884
NCI-H1623,5746,-0.5390712999232294,1.1329512357551612
KYSE-70,71466445,4.079477869375345,4.146265710440933
NCI-H460,44185566,3.2105564381381035,2.555800931660805
MSTO-211H,6918837,-2.204195063499652,-2.309961067514397
CAL-51,54613361,0.2180057854442524,0.03188005933988855
A2780,216345,1.0708930445758365,3.238510526356455
HCC1143,100016,7.122041956726765,6.463453352541983
NCI-H522,5278396,4.518604091155278,3.202616770994932
SNU-61,54619267,4.677926252875765,3.993845631150042
OPM-2,135421197,1.341685947169011,1.6434435190118497
G-401,72193861,1.057396802085585,0.7825767581352835
NCI-H727,15547703,3.504014494953252,2.99932305872271
NCI-H292,11178236,-4.939590057195551,-3.1495385378090712
MDA-MB-453,44241473,4.685974466458818,4.471796563829645
MSTO-211H,60700,-2.4521642225491065,-0.5135302369923557
BxPC-3,SNX-2112-bortezomib (250-1 mol-mol),-2.5266408566121297,-1.5601972863282862
NCI-H2171,4096211,1.8093642806404184,1.2980816116051213
NCI-H146,68056272,3.3997347898500063,3.1226214750679935
A2780,984333,-1.5561630492039429,0.4123543662525671
NCI-H2171,5479543,3.509510962528721,2.6117983106436267
ONS-76,6610355,5.379398654611739,4.617932530009139
G-401,2742550,4.179048555325354,3.3906293200820867
OPM-2,44137675,3.238695939616315,2.7997920715242217
NCI-H661,selumetinib-navitoclax (8-1 mol-mol),5.100563052002661,2.2931083895825632
FU-OV-1,387447,-1.63105242136749,-3.951744714892365
LoVo,3825829,3.571391318080427,3.847627467604917
JM-1,11404337,-2.1014875230304315,-1.448439771087626
FU-OV-1,9929138,5.415072941349914,5.4527699986746265
SBC-5,5738263,3.46908634421933,3.4587045969914567
KMRC-1,navitoclax-piperlongumine (1-1 mol-mol),1.9271011950938683,1.2282958339443462
G-401,4917,3.172752348635073,2.779236449877194
A-673,44589607,3.5509265356046305,2.35826969877325
A-673,selumetinib-navitoclax (8-1 mol-mol),2.703259710676399,1.248840320835163
CAL-51,2828334,6.190580852669228,6.217923632479874
MDA-MB-453,BRD-A02303741-navitoclax (2-1 mol-mol),4.399808633782925,1.7332323649620485
SNU-61,67156097,-2.2274361546113854,-1.214656327358856
OPM-2,65628,4.597670741376445,3.2121933543020225
MDA-MB-453,3038522,2.334816038150176,2.782129792671126
HSC-4,2708,2.9878251305615477,5.068201474867488
MSTO-211H,selumetinib-JQ-1 (4-1 mol-mol),1.9489551392518472,1.7358472267536065
CA46,54678924,0.940253932332064,1.2669807837378877
SNU-449,11964036,1.3997299371502423,1.4814548049182412
DMS 273,54613361,-0.0987092047967699,-0.5573802483829831
SW1463,2749,1.5016847157281326,1.6985546358691637
A2780,4477,0.2147996237825641,0.2975420065613147
NOMO-1,9907093,3.6530797436282434,3.3005491192783296
A-673,54618305,4.212251300263772,4.2772560407710145
LOU-NH91,65064,5.187256751294022,5.054927287601095
NCI-H2171,72376,-3.3432588050758296,-2.785815691917416
MDA-MB-453,72199292,1.3092335372039157,0.7266191901892333
NCI-H522,107970,1.611650854248594,2.1717864036480696
A-673,444795,4.685959151928419,3.856819100035171
HSC-4,6505803,0.688410933428746,-1.3087458953138913
CA46,11455910,-0.2967360934235351,0.436359730492774
NCI-H460,6252,1.4342703041264255,1.0390773043752615
BT-549,49793307,-0.000238716840207,-2.4627880135555555
CAL-51,68056272,3.9955701948507247,3.371804138894133
A-498,vorinostat-navitoclax (4-1 mol-mol),0.5641326032533043,1.2235971507571808
A-673,227681,3.19347186106623,3.097984358209929
BxPC-3,54618771,0.182098153600537,1.440353185725241
A4/Fukuda,3385,2.3595203579832553,2.8340046672065244
LoVo,36314,1.7018910931264415,-0.9969264440717813
BxPC-3,11152667,-1.4400195695513092,-0.5676560115489685
SCC-9,3025986,-0.0492814979551807,-0.9913347009681149
MDA-MB-453,4259181,0.7923345004369465,0.29832100693719144
Panc 04.03,9927531,5.313421559596226,4.8528973388442065
LoVo,448949,1.89047161937067,2.0698349969227525
KMRC-1,5978,0.0310598033875183,-1.6011828856767574
NCI-H292,262093,2.9868554632365556,3.115373008107767
CAL-51,9884685,-0.2528326244590672,0.4332284618393667
KMRC-1,135421197,2.781168744821282,1.6373430216374532
A2780,56973724,1.317874340119369,2.565643654108367
A4/Fukuda,46943432,-0.0927442133672991,1.1265339278392228
HSC-4,50905018,4.462883747891921,4.465678969571162
JM-1,448949,0.7740790697885386,1.2786563390373358
EFO-27,11964036,1.3211691780165964,1.3626687591422977
A4/Fukuda,637858,0.8198578842358093,1.1553071214323474
OPM-2,5282054,2.4375164125334217,2.81077202459494
ONS-76,637858,2.646425044184718,1.6863341497812554
HSC-4,439501,-1.7709622187792924,-2.000604407160965
KYSE-70,24964624,1.4483005111507754,2.584648733234056
LOU-NH91,5282054,3.3765969574471315,3.8404514332724617
A-498,selumetinib-UNC0638 (4-1 mol-mol),2.905526592026194,3.5088390966681646
SNU-81,5281321,-4.892530389502709,-1.203971910702723
HCC1143,168312962,3.1559735288767468,2.292018212353972
JM-1,126941,-4.3883192692313955,-3.3680835702706253
SCC-9,54143018,0.8755026739061308,0.7580173853158678
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798,2.347297651757307
SNU-449,1641662,3.672188762237013,3.8078627151569657
NCI-H146,54765302,2.77091239654666,3.755044221465592
NCI-H146,11427553,2.364557310661393,2.00372833853962
CAL-51,159324,3.1794720270506307,3.231346564754272
YAPC,71466445,6.285156806731666,4.1429034613513345
ONS-76,5351362,1.281569720069414,1.513934750601122
NCI-H292,doxorubicin-navitoclax (2-1 mol-mol),-1.8265545031559949,-0.7443489459314945
BxPC-3,6505803,-3.0514917868960767,-0.8689890577573135
A-673,45279963,3.7593508340409287,3.49373127369492
CA46,3465537,3.345448990020783,1.7082106105106782
HCC1143,168313016,5.718985268806146,4.636037687359761
A-498,400769,-1.6101267353788036,-0.11396961721939051
NCI-H2009,10184653,1.0890186290305244,1.5679006329916054
NCI-H522,426756,6.015863149473534,4.142284076499133
NCI-H2171,44819697,-4.1780638649943675,-0.8660193268970572
DMS 273,24785538,0.640909019865508,0.4863018380455393
NCI-H146,6918638,-1.4860665745363582,-0.20101596097020688
NOMO-1,3543504,4.095340640265792,3.541928929411835
NCI-H661,151289,0.3755226510544496,1.2482852060836482
G-401,53495165,-2.4189675718778516,-0.9759041259927481
LXF 289,selumetinib-navitoclax (8-1 mol-mol),2.675431188570136,2.126307267232484
YAPC,6918837,-0.3723714565085887,-2.4492362100323306
BT-549,219104,4.096633484715141,3.9697942287745995
LXF 289,24753719,4.56569970094865,4.365795226955615
CAL-51,25102847,1.94226811064499,2.269274055439927
A2780,doxorubicin-navitoclax (2-1 mol-mol),-3.696476342878232,-1.7639213720304716
OPM-2,54618164,3.637238343412542,3.596693603774935
MDA-MB-157,2733526,3.146610844933737,3.6694824203825935
KMRC-1,54618164,3.981312375484732,4.26900034138289
CA46,375860,-0.5712781411665353,-0.742365531501301
G-401,24772860,-1.622851891505981,-2.1967614415839396
NCI-H1623,119182,-1.1196330586869003,-0.5340945529648988
A-673,984333,-2.7710011035310074,0.20687813895897775
KMRC-1,49793307,-2.5218593870176793,-2.25646049766822
ONS-76,alisertib-navitoclax (2-1 mol-mol),2.05248890000496,0.9112081178815816
DMS 273,11152667,-1.0918930552191226,-0.9058175747415285
NCI-H460,44620216,3.8133491956675902,3.513468447447577
MDA-MB-453,19582717,2.5916230237173696,3.858625031422507
SNU-61,53495165,-0.6572534585269733,-0.5674098132150365
JM-1,6505803,0.12933264701109,-0.9734984014496385
SNU-449,60700,1.1315850608054705,0.022057227710110032
CAL-51,676352,2.3367523995253454,2.0493168165288864
LXF 289,89928392,2.4967474535679623,1.8343692193681258
LOU-NH91,11625818,5.704636625331963,4.48321445364404
MDA-MB-453,156414,0.9469838239648454,0.8960545660052764
OPM-2,462382,-0.5185214646773461,0.7168426552981211
A2780,53392493,1.4842280461046395,1.926624374754771
DMS 273,9823820,3.9764583445605006,3.1086307525255847
ONS-76,24772860,-0.9083480450936676,-1.634471927859122
KYSE-70,11612883,2.3570058511886396,2.917774244323598
SCC-9,3854666,1.6335835525169635,2.1138503479586745
KMRC-1,375860,0.0373834100132385,-0.003966697883717658
SBC-5,9866186,-0.1944977114504531,0.8695788183457752
NOMO-1,11719255,2.6566855899212944,2.1564544050605203
CAL-51,702558,3.5144984342436563,5.2460464712458155
ONS-76,51039095,3.253449307143194,2.710587712021026
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.5937122908325716
BT-549,carboplatin-etoposide (40-17 mol-mol),3.0956073566699147,3.0056988546707286
HSC-4,selumetinib-navitoclax (8-1 mol-mol),1.957846901945355,2.425987039025387
BxPC-3,216468,3.632186197150132,3.493096964619409
SBC-5,2742550,4.323082293816951,3.8423181050064703
HSC-4,24797083,0.9836127584085878,1.4689448285564077
OVISE,4788,6.030976207458705,5.6365900664737705
LXF 289,11455910,1.909862916296106,1.2320950669787365
SCC-9,16659841,4.917362195715636,3.9043556328667393
G-401,49766530,-2.7444300270308113,-1.1671945926028817
HSC-4,6450551,4.030000721690881,2.9262141705792417
CAL-51,6918736,-2.0480142356294637,-1.222120642851767
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208,-0.9407987379545216
SCC-9,4096211,2.914802879806832,2.3230572815535457
EFO-27,168313200,3.5651936579716277,3.265410630773255
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573,6.308805616063068
SCC-9,448949,2.996737074861378,1.9870537943442286
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338,4.568620238512221
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,3.749296636137534
NCI-H661,15953870,2.9876041506010003,3.494493770149954
KMRC-1,6918638,1.621172594092556,0.36716784229481264
Panc 04.03,44489675,4.301555650291772,4.1400020016624755
HSC-4,54143018,5.46718478704898,0.5379802463220886
NCI-H661,11175137,2.5272908163527745,2.601365702470758
OVISE,piperlongumine-MST-312 (1-1 mol-mol),1.6778401901556628,1.9749545105586372
NCI-H292,24753719,4.2962074219620225,4.3792773637413545
NCI-H146,11228183,-2.941805953111262,1.7808557853877485
MDA-MB-157,65064,3.084719541991811,4.791226835140792
HSC-4,44491742,4.173988284907792,4.273177249568542
CA46,9933475,1.582522184359856,1.5687310604846585
JM-1,53245473,3.7598021769733414,2.663590659624455
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.2358788611821236
KMRC-1,702558,5.7321455674333475,4.905587575424973
EFO-27,262093,3.0007323703470896,2.920415259076899
A4/Fukuda,72734382,2.815137004147321,3.5879937357502065
NCI-H727,44185566,2.6786881549102626,2.5733317539875458
OVISE,25062766,3.2029018764111896,2.2007756607324938
HCC1143,JQ-1-carboplatin (1-1 mol-mol),2.533079655753226,2.4221807128952757
CA46,3825829,3.8503527939376583,3.150739195574592
EFO-27,JQ-1-navitoclax (2-1 mol-mol),3.2464971768878086,1.0322785123510998
BxPC-3,60750,-2.6920891843690273,-1.7964776762005534
EFO-27,1566236,1.9834366009012432,2.4916581804216427
LXF 289,53392493,2.5437082258312804,2.760794647159041
NCI-H460,135421197,3.2510260026522233,1.956017262675697
JM-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.316937276009384,-2.1878928136803175
Panc 04.03,44607531,1.8924568500741572,1.7709292238314616
ONS-76,15547703,3.220128707821482,2.9619953241740147
BxPC-3,123631,1.9141625570683185,2.433987150117658
NCI-H2009,24180125,3.399696031265864,3.1367731073660714
A-673,19582717,3.777631654850071,3.3773456953457117
FU-OV-1,12003241,-1.039273875540509,-0.9405171220791577
SNU-61,409805,4.743067556302579,4.54141874211171
DMS 273,11364421,-1.741561290091182,-3.513455547255217
Panc 04.03,11214940,1.7867172186781857,2.3015059039843626
NCI-H522,31703,-1.0005486569838078,-1.3124241612454828
KYSE-70,5287620,-1.7159794680358271,-2.0585561910796772
A2780,11507802,0.380240885087182,1.0919416474272492
ONS-76,54613361,0.8570205233962582,0.38858491015894137
KMRC-1,2729026,3.101959850286169,2.7446336606443666
NCI-H522,136227924,2.2034936459857506,2.585679386851887
NCI-H661,52912189,3.763222756257729,2.586587775217223
ONS-76,262093,3.354802573562099,2.587287595127019
A2780,675434,3.840840752716624,4.211216882515494
EFO-27,24771867,3.839082818590537,2.685891664546185
BT-549,44185566,3.1570730526396407,2.7150863800662375
NCI-H2009,89183176,3.352860584382055,4.300903897975573
A2780,2949965,2.158264003903123,2.3971604118942333
MDA-MB-157,119182,-3.4496410534325093,-0.2890676034595215
MDA-MB-453,2949965,2.588847266095094,2.925138754175098
MDA-MB-453,71576739,4.365206221166654,3.616342931606725
A-498,11455910,2.747308138802023,1.60281976604921
A4/Fukuda,448949,1.1686862984883333,1.344170926656341
OPM-2,10385095,0.6586756349946576,0.8655617558941512
BxPC-3,52912189,1.4214477046132656,2.303933885670308
JM-1,46907787,-1.9243382261841309,-0.4817539520580252
G-401,3385,1.38862488630676,3.5661420802390422
LOU-NH91,24978538,-2.307670841327046,1.403403790603891
BxPC-3,25262965,-1.1326145626109247,-1.4125494713418214
KYSE-70,9915743,1.2522553618909642,0.8463177079298618
A4/Fukuda,42642645,-1.373677794386147,0.46117991762397176
A-673,44202524,1.1944686936342714,1.6738079580332894
FU-OV-1,66577038,3.5319441468561648,3.016971893851758
SBC-5,BRD-K99584050,5.772271611565925,2.3801275914461466
MSTO-211H,2749,1.2029234831790616,1.9262074203763067
EFO-27,2858523,3.4178086224101527,3.04354105342281
NCI-H2009,54613361,-1.6701870677586086,0.2551893340637952
CAL-51,11626560,0.7349282975065881,1.8093279135094733
YAPC,446155,3.8433351119798695,3.0004280569179
KYSE-70,3854666,1.6457032232411275,2.121539595573737
MDA-MB-157,49836020,-4.4611089332084335,2.4443646459587587
Panc 04.03,10385095,1.3607276101908192,1.6259726519172364
NCI-H522,piperlongumine-MST-312 (1-1 mol-mol),1.211540874463276,1.5246422391967436
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.4176287054813317
NCI-H460,31703,-0.6563705559837907,-0.7459982258239526
HSC-4,135421197,2.1482643592466495,2.091331560151194
KYSE-70,216345,3.953496119268799,3.781403637562983
NCI-H2009,44259,0.1981246725332563,0.882422148586396
NCI-H661,24771867,2.8989054210712784,2.632687993210459
LOU-NH91,89928392,1.577129115434841,1.7512285589828869
SBC-5,44819697,-0.6119786373907494,-1.0240469827455312
CAL-51,135398738,4.757337519270393,4.1672296872569925
A2780,11234052,1.762226904306368,3.600559354715979
EFO-27,5287969,-2.249416082595734,-1.3547843906607662
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167,0.9995746721095985
EFO-27,72734382,4.838814549837177,4.607880151196771
A2780,2126,3.67742533530732,4.027772197798596
NOMO-1,656346,0.9377734591624955,0.49436156240510853
NCI-H522,439501,-5.784929410118117,-2.267632850140182
NOMO-1,4521392,4.093982124965485,3.995903943661357
NCI-H2009,452548,-0.9979896146805513,0.37465477271495506
NOMO-1,327653,2.81345515165661,2.5388725259641456
A-673,46191454,-1.7005324627981964,0.8766339658021154
A2780,168312962,0.1167104942518841,1.200663532113985
HSC-4,11214940,4.953530718305131,1.955906303212015
KYSE-70,44507138,1.8487883665285316,2.464244717840616
MDA-MB-453,5566,2.956907653722259,2.755195313713367
SNU-81,selumetinib-PLX-4032 (8-1 mol-mol),-1.7498226144583562,2.5684464039716786
SNU-449,24753719,4.452712705797618,4.38922226132903
HSC-4,6184667,2.683776581109496,3.181809212626386
Panc 04.03,4477,1.027037586587599,0.6495184565440882
CA46,24951314,-0.0442972386064399,0.2541567254390247
MDA-MB-453,JQ-1-vorinostat (2-1 mol-mol),-0.5883390027404639,0.8337286805358248
NCI-H460,637858,3.384702960830197,2.0452945072085917
MSTO-211H,54618164,3.0389284404004795,3.8628774837023045
BxPC-3,135875424,4.118804534986376,4.148091159524711
LoVo,374536,3.1459286411718055,2.011970573430984
SBC-5,65064,5.87027592575748,4.929933246822922
A2780,2708,1.6817262399506028,3.8609888976267475
NCI-H292,11427553,2.7677841547579347,3.0310417031736057
EFO-27,10184653,2.474041422726229,1.3091977694558534
LXF 289,16038120,0.5250135720403194,1.1068434330053243
LoVo,piperlongumine-MST-312 (1-1 mol-mol),2.135338171440717,1.9411235641314661
OVISE,selumetinib-JQ-1 (4-1 mol-mol),1.7685285533186823,1.6578787549084606
LoVo,navitoclax-sorafenib (1-1 mol-mol),2.5511515051305893,1.8691789466055737
BxPC-3,10184653,-0.596247884950306,1.0541906769037963
KMRC-1,54618771,0.2036698487849761,1.199521629215998
FTC-133,4705,5.547028107549284,3.0238779623648755
A2780,107970,2.1177540249197246,2.0605946988217854
DMS 273,15983966,-4.308041598319055,-2.7165826140425504
DMS 273,JQ-1-UNC0638 (2-1 mol-mol),0.3284926048856003,0.9269050782000982
HCC1143,637858,1.5767538824178036,2.0310298954308847
OVISE,753704,5.218614122812972,5.016671827299142
NCI-H1623,148124,4.04127286799143,-1.5801438084951278
NCI-H661,1716436,2.7606212382296205,2.755865217317205
A2780,5328940,1.6938804432156576,1.5424238317747778
Panc 04.03,doxorubicin-navitoclax (2-1 mol-mol),0.7758881761631229,-0.33216250132925923
A-673,52947716,2.7267743407084333,-1.2198448265264534
LXF 289,51039095,1.6878089310027404,2.796346723731617
LoVo,24753719,4.853832341629896,4.20664897694842
FU-OV-1,16065773,3.3464590574422424,2.4177736718396643
Panc 04.03,439501,0.3022334331499904,-1.9937836939148295
NCI-H2009,44137675,2.9238442509206606,3.725648310558034
SCC-9,24964624,2.350052808289582,2.6576206000998726
BT-549,56946209,-4.178729112607428,-4.124668445360254
RCM-1 [Human rectal adenocarcinoma],969516,2.888727843593038,2.91992557628667
NCI-H460,1716436,4.318712917611328,3.1045710322576907
MSTO-211H,4917,2.9904400598930088,2.823584611391029
NCI-H2009,5282054,3.436101167626708,3.743168783540682
FU-OV-1,53232,3.5510277872612903,3.237326396550882
NCI-H460,3503,2.4668231300278154,2.320651697463043
CAL-51,6252,-0.2076922850947726,1.4220700412709038
CA46,44607531,1.0933116261411373,1.019253525236274
NCI-H2171,44589607,1.1207968177639505,1.9998117451866921
ONS-76,selumetinib-PLX-4032 (8-1 mol-mol),-0.2158611974685485,3.20958711563035
BT-549,5311,2.3943998607281314,1.6755268379774682
SNU-61,44491742,3.859456688826312,4.268127606129766
JM-1,46943432,-0.1491870155181681,1.1398150424517761
HSC-4,156414,0.4374127066870092,0.9729899504597929
EFO-27,tretinoin-navitoclax (4-1 mol-mol),4.088217515777896,2.996915865205318
OPM-2,42611257,3.2957467857000404,3.18108047314863
A2780,136227331,3.7351205807719863,3.4149641395352517
MDA-MB-157,71751553,2.589623955944651,4.660223545364193
HCC1143,262093,2.740628946324062,2.965631011806892
NCI-H522,56946209,-5.885513086137786,-4.052938251674371
A2780,67156097,-2.4563073864206633,-1.2906411251309768
FU-OV-1,136227924,3.2834953568281597,2.960720607282529
NCI-H1623,241158,4.3681147628536445,4.032864015985564
ONS-76,2828334,6.172523844471339,6.11238613308613
BxPC-3,11625818,4.084435736278963,4.532250050368991
DMS 273,5281321,-3.764975659067455,-2.283677654743993
KMRC-1,3825829,4.43742858244417,3.956015325233327
JM-1,5280436,0.8051765864900793,2.4655539966945366
RCM-1 [Human rectal adenocarcinoma],11175137,3.6620571654650846,2.6605597732000645
MDA-MB-157,9927531,5.35009923211275,4.821917810155245
OPM-2,56963564,0.1507827744052812,-0.17556931025069286
JM-1,9825149,1.1101255190052433,1.5366518679294612
A4/Fukuda,136227924,1.9204852137512072,2.45119804393805
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266,0.9307381724765982
Panc 04.03,16065773,3.1082338307326687,2.530840071074268
KMRC-1,148198,-3.0121915653316953,-3.1047360033075626
NCI-H727,11612883,2.6691234813665226,2.75566468261105
A-673,25183872,-1.50300168442849,-1.1085629017382677
NCI-H292,5470400,0.7410873105484811,-0.3762512559878355
SNU-61,24771867,2.3194270269791772,0.7733818161763163
ONS-76,2729026,2.9392891978845626,2.7888926055955214
NCI-H522,54618305,4.230012053256092,4.330703917288751
MDA-MB-157,6918328,-1.4439105140240134,0.1713993500067612
SCC-9,11609586,3.4579622750703902,3.1140193358272334
NCI-H2009,73707398,1.4628489872410333,1.63454234672103
BT-549,613753,3.1113642662223913,3.344628962680846
NCI-H522,11396600,3.374818989992459,3.1682365159812287
A2780,227681,3.163289337051595,2.908914795945541
SNU-61,42642645,0.1547953205487765,0.5148231547181942
EFO-27,24753719,4.6250624916483405,4.431105668754062
NCI-H522,1750826,-4.884358581349171,-1.7877387152317132
NCI-H460,3854666,3.1385110084048065,2.263716025554261
Panc 04.03,16736978,2.069266987472695,1.854322915877144
KYSE-70,135875424,3.720063911223788,3.90549770089898
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981,-0.5084673578915471
NCI-H727,4369359,4.470803757423574,3.051216788610737
SNU-61,10296883,3.559313583941647,3.487907414092773
MSTO-211H,24748573,5.719931334372704,1.9989244935507775
SNU-81,5479543,2.97701110816304,3.418928806382865
BT-549,2733526,4.582584043539932,3.6383340834814004
A2780,135423438,1.4521240670524396,1.7414422758368098
A-673,24772860,-3.1744597884682997,-2.199844694596228
G-401,15953870,2.2768915791068483,3.220085374095796
DMS 273,5738263,3.533950076223639,2.788135057876586
BT-549,SNX-2112-bortezomib (250-1 mol-mol),0.8532729508269209,-0.9537619837771125
MSTO-211H,10385095,1.0224754227931234,1.4858625745141327
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616,1.6565335363875275
EFO-27,25062766,1.510659268863457,2.0740342133467395
FTC-133,11612883,4.310092339589411,3.012283835546609
MDA-MB-453,11455910,-0.0078824359576409,0.7961420536745935
FTC-133,23582824,1.291713189645836,0.6237376546060251
MSTO-211H,6918289,3.158366552983379,2.6334118319191946
CAL-51,9826308,0.5677925602140103,0.6824613700996437
OPM-2,doxorubicin-navitoclax (2-1 mol-mol),-1.5033566295439995,-2.493362526470921
LoVo,JQ-1-UNC0638 (2-1 mol-mol),3.1589551233195428,1.4271563315649367
NCI-H292,25195348,2.925898223014509,3.320948254626574
NCI-H661,71466380,4.502023854991524,4.584395883380212
SNU-449,17755052,1.8812917370069304,2.067294370289166
SCC-9,11977753,0.680369597029185,-1.1381129226614355
DMS 273,selumetinib-PLX-4032 (8-1 mol-mol),5.046947236193085,3.681264488192428
LXF 289,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5296053048894116,3.6927645186257307
JM-1,carboplatin-UNC0638 (2-1 mol-mol),2.589326672729891,2.3911232309408663
OPM-2,56973724,2.552424788495835,1.7971298665279118
ONS-76,24785538,3.425081329750359,1.4817224936698508
OVISE,6914657,-4.467384055269322,-3.5009587838920067
CA46,7326481,2.91557869092902,2.684042787985591
SNU-61,445091,3.84586130327939,3.893313691573161
SNU-81,387447,-4.728664972971387,-3.986530792848331
A4/Fukuda,613000,-0.1954730319333323,2.5498382716764176
JM-1,54143018,0.7319009489566454,-0.140925273110676
FU-OV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.2027157770718528,-0.9027525252739812
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911,-0.2564870083110865
NCI-H2009,11222830,1.732127254120576,1.541228151824897
Panc 04.03,25105715,3.6014191473601236,3.4879286253326023
BxPC-3,3038522,3.5132521338876352,3.2851100963371853
SBC-5,2945648,3.183732803518487,2.7428419176557957
SNU-449,6450551,3.816508101047544,2.853270359284145
A2780,4261,0.5678575604143293,1.2806256296704677
JM-1,54639665,5.005029028557516,3.13095835152221
MDA-MB-453,55508,3.100658329893645,3.096656306944859
FU-OV-1,vorinostat-navitoclax (4-1 mol-mol),1.2627597867759035,0.598630702233603
OPM-2,71466578,1.093801721105574,2.552242852820832
DMS 273,219104,2.8685320291275276,2.6006129237314037
MSTO-211H,36314,2.7056254754018,-1.5931582603551535
NCI-H661,135999136,1.375733620998009,3.92606038124777
RCM-1 [Human rectal adenocarcinoma],1641662,3.738448071417011,3.615583953992113
A4/Fukuda,387447,-5.631039688913266,-4.627463460830446
ONS-76,65064,5.2757302482281005,4.8962590993793755
RCM-1 [Human rectal adenocarcinoma],JQ-1-MK-0752 (1-1 mol-mol),2.1464995044057606,1.9147919845282428
LXF 289,613753,3.241655631161551,3.1804202793404066
NCI-H661,25262965,-2.0298208680132253,-1.2847983005667636
LXF 289,6438330,5.338014468481796,2.0583053122644595
HSC-4,51037431,1.5211622982639597,3.29659875445999
HCC1143,ISOX-bortezomib (250-1 mol-mol),0.6900085602161256,0.6213455627060482
A-673,613000,2.3658771635142877,2.305162407200417
A4/Fukuda,135421197,1.440002399326734,1.6231209043781505
G-401,tretinoin-carboplatin (2-1 mol-mol),5.235487615212222,4.076861556703172
NCI-H522,322968,2.453472191773609,3.168464575111711
JM-1,702558,3.1195416036187646,3.925543713950289
NCI-H1623,60700,-0.6326390393669364,-0.1090185715532078
KYSE-70,71466578,3.801340757329347,4.65302199463304
OPM-2,969516,1.7213945625906069,2.1906912236271308
FTC-133,71751553,4.47121108066688,4.557378752930503
HSC-4,4261,2.7283942469645424,1.5934674035155119
DMS 273,60750,-2.8080851182888096,-2.754884553036474
BT-549,11955716,4.243153956403502,-1.2086833141857327
ONS-76,104842,-3.1760610756826826,-2.665389324453069
JM-1,54619267,3.2762986321752656,3.601675337048556
NCI-H460,11427553,3.3912724357702873,2.788812434384293
RCM-1 [Human rectal adenocarcinoma],4261,0.3806474761357037,1.4405224556841407
KYSE-70,3503,4.330341802091645,2.245159232639511
LoVo,6505803,-0.2027234925460443,-0.8680990389384827
A2780,123631,2.055120977987268,2.072049854859838
CA46,216345,3.098455032375494,2.741343088949738
SBC-5,216345,4.3270666561224935,3.7209553326710716
SBC-5,104842,-4.617883126488141,-2.522121528124462
KYSE-70,3025944,3.9400169946897226,4.349979067339519
JM-1,16725315,3.055633956084052,3.4212514303625774
KYSE-70,3385,2.7043091028991175,3.7473912375323626
SNU-61,241158,3.885428513145571,3.5209490714536855
Panc 04.03,44819697,-0.3269217472163675,-0.2032599730879306
LOU-NH91,151289,1.7382502757713727,1.5446244464142733
SW1463,72193861,2.3780707386668563,0.893214464225257
FU-OV-1,3081361,1.2672435670761582,2.129487690729775
NCI-H2171,5311,-0.0981787470707459,0.6466205567708873
OVISE,15983966,2.4746719809654474,-0.151602416511913
CA46,56649450,3.397645307363617,2.648861227276993
G-401,135398516,1.567409789625541,1.793423744480897
A4/Fukuda,285033,-4.063528792592557,-2.9722238587244307
RCM-1 [Human rectal adenocarcinoma],31703,0.9691163018023546,-0.2734158975036916
SNU-81,2113511,5.998073078967423,5.401026230177546
SBC-5,984333,1.1242620116457585,0.5408620325396195
DMS 273,31703,-1.0453531837534489,-1.6970898482587868
SNU-449,11955716,-1.9372940063200903,-1.483697968699288
JM-1,156414,0.9517000986854224,0.9979899990716877
A-498,5746,0.9967598286589636,1.4777028651134123
CAL-51,168313016,5.819136604546001,4.6622476982860475
SNU-61,doxorubicin-navitoclax (2-1 mol-mol),0.8790870297518688,-1.174622794630446
SNU-449,selumetinib-PLX-4032 (8-1 mol-mol),4.586042131351809,3.7752646145015336
DMS 273,285033,-4.2902604104934685,-2.43723979912459
NCI-H1623,25227462,1.3835292391956049,0.4918730485112735
SNU-449,46199207,3.2102080061749665,3.250712708177204
NCI-H727,54619267,4.766187279700058,3.9168048390656405
KYSE-70,2729026,2.877153539650856,2.649282144012054
JM-1,9866186,-1.392842627261666,0.13898312066070137
CA46,9956119,2.2503821303322864,2.7058929414904167
NCI-H1623,10302451,3.5735543079001553,2.9240758836448992
NCI-H460,119607,4.735621464768821,5.248404909755636
LXF 289,36462,2.912637639845359,2.376948002266791
HCC1143,208908,2.564266394778906,2.0661233078668597
CA46,doxorubicin-navitoclax (2-1 mol-mol),-1.6756299291036936,-2.8921612950254314
HSC-4,10296883,4.12801319058873,4.025775449346517
NCI-H460,44819697,0.8384181776379687,-0.16975174309895183
A-673,644241,3.265724898737132,1.127283346415072
SBC-5,55283,1.6476943611515316,2.6906274926609575
CAL-51,60700,-0.6497243984818711,-0.5813466035520615
NCI-H460,44819697,0.8384181776379687,-0.16975174309895183
NCI-H460,2113511,6.407699041859446,5.559724410076743
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.3036807145205682
NCI-H146,44819697,-3.0409273944044672,-0.7014004825965068
CAL-51,2729026,2.5757432896171517,2.6696190862987845
OPM-2,25262965,-5.528707504919602,-2.1957627906829016
BxPC-3,67156097,-2.0030489961064664,-0.4426858158651462
SNU-61,11455910,1.387165489844305,0.9711424128952098
MDA-MB-157,6252,-1.2956844965038024,1.3011208233225855
BxPC-3,decitabine-navitoclax (2-1 mol-mol),-0.3566314519475204,2.188976635082005
RCM-1 [Human rectal adenocarcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.6431753699859777,1.6314202183228697
MSTO-211H,5284616,-7.533473618112548,2.5549292872318508
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.44222963633274776
NCI-H146,11609586,1.562173805318663,2.443527490199987
A2780,tretinoin-navitoclax (4-1 mol-mol),1.5980580193271057,2.2524184219370387
KMRC-1,9908783,5.060189279561186,4.686008478831095
OPM-2,3825829,3.9075204590636226,3.237131046330635
FTC-133,439501,-1.0725688155870328,-2.094921231921217
MDA-MB-157,73707398,-0.5856522541525173,1.4115833466966712
YAPC,71466380,5.668462841036745,4.536666932824383
YAPC,81146,5.922853011724604,4.679162424594958
SNU-61,9935249,2.942554259952632,2.1617781617123195
FTC-133,72193861,2.4976681850124516,1.5597433483178764
NCI-H2171,3025944,4.816182739912449,3.9929918590452678
BT-549,6918638,1.3825585614023566,1.0129180202230572
A-673,24180125,1.1732098097274752,2.5651540537726927
KYSE-70,46907787,2.9670215892594793,2.2325267314822153
NCI-H2171,54678924,2.405018759443171,1.5648110903970354
FU-OV-1,15547703,4.297867355017808,3.364602863020649
EFO-27,49846579,4.098108273885428,1.1988908963590357
HSC-4,24748573,1.230311327364621,2.2982587726892976
BT-549,10427712,4.3521452258648505,4.530869989173792
EFO-27,126941,-4.256911665013358,-2.4629714814319854
NCI-H2009,4096211,1.934112859371262,2.335194614275199
MDA-MB-157,salermide-PLX-4032 (12-1 mol-mol),3.2199843556039593,4.601524744185042
NCI-H146,135999136,1.6477982136645704,3.3812543860176505
HSC-4,selumetinib-PLX-4032 (8-1 mol-mol),3.794219924107932,3.391966652416488
SNU-449,2746,3.928036011173348,3.6881103549856196
CAL-51,11228183,3.6770505489909007,2.316900498677144
Panc 04.03,123631,3.678186856777378,2.656629961419946
MDA-MB-453,6184667,2.451074325070958,3.022732973056482
EFO-27,6438330,1.8682975687900552,2.2897303663006445
NCI-H661,11497983,4.324872079299071,4.127822241526281
Panc 04.03,637858,2.9634699724220783,2.135116127371854
SNU-61,168312962,1.49910092402229,1.5412033400301908
NCI-H522,25183872,-1.6150957585419312,-1.069881910967258
A2780,6252,0.4918472463671758,-0.589382535074559
A-673,15547703,3.0802315016781843,2.8275258595393877
NCI-H1623,36462,0.862958596391428,2.2122747373021054
MSTO-211H,44819697,0.327886174428457,-0.2601152955648015
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-1.3429860541822496
SNU-81,19582717,3.466001022974326,3.6201007872630195
A2780,6610355,3.3735704633901973,4.188162033139655
SCC-9,119607,6.006958395758143,5.279901133548634
NCI-H146,11625818,3.4222174762792843,3.6284855078243123
CAL-51,11178236,-3.674192911743539,-3.274625383695315
NCI-H460,168312962,-1.8333752522095308,2.039655057191177
NCI-H661,4788,4.879892558412017,5.472378452183113
JM-1,4705,3.374089362448498,2.8449842866442525
LoVo,3634881,2.800959668083557,3.441133643245714
OPM-2,11178236,-3.008129792299995,-3.2527821754028348
CA46,9884685,-1.0270691788705264,-0.45983712273578287
MDA-MB-453,44589607,2.562256212112598,2.6950296719411004
SBC-5,54454,2.279469523172582,2.5106135733665353
LoVo,5311,0.3380696500116906,1.3850359307778368
NOMO-1,100016,4.546215242968586,4.737666033542726
CAL-51,71304818,3.0248956992793565,2.359134018661566
HCC1143,216345,3.8986832350959792,3.7388510892958653
CAL-51,54618164,4.021329289838694,4.103995743332067
NCI-H292,135398516,1.6270415918019412,2.3123371014839136
HSC-4,71466445,6.061667629347064,4.134148627429829
BT-549,51039095,3.595187367514741,2.886987382229926
MDA-MB-453,26596,-1.0726693130426117,-0.9670939030546151
CA46,4259181,0.0375174782651609,-0.3218396222720143
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345,1.001967140227365
SBC-5,9887053,2.384081187432928,3.7447293036473273
FTC-133,25154868,4.81278236826852,4.389364854636492
SNU-61,44202524,1.623676041505741,2.0482986450967857
Panc 04.03,6914657,-3.724597953552904,-3.4820155815578984
EFO-27,445091,4.884678811382666,4.59208874242139
SCC-9,54619267,4.260733417129102,4.196956952102037
LOU-NH91,3815108,3.3787088400125422,3.1710679401771413
NCI-H2171,135875424,2.950178944342904,3.355509746064057
HSC-4,selumetinib-piperlongumine (8-1 mol-mol),4.641326276625381,3.5438703462878793
LOU-NH91,11404337,-0.9599092047687252,0.0058814761474700085
SBC-5,5746,-1.5208844717109098,1.1793254650033829
NCI-H460,135440466,3.295247648571462,2.277248856147487
OPM-2,1242560,2.912152501304371,3.0908150724403334
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,3.04600322415027
BxPC-3,11364421,-1.186359589843585,-0.7692650726879896
NOMO-1,11626560,1.0628914473501356,0.4663102604134399
MDA-MB-157,5311281,2.9465431337253065,2.300614978856389
LoVo,753704,4.37626239298451,5.006291834470438
LoVo,1317464,3.6287749925486743,2.6506487886187102
LoVo,11626560,0.8234069861143318,1.7800389068807578
SCC-9,60700,0.6764265945588348,0.24686342157381147
YAPC,5351362,2.7486257978183812,1.590594710339717
KYSE-70,24797083,1.8843278101436565,1.350795570336931
LXF 289,65064,4.964411921317377,5.010889281489221
SNU-449,16736978,1.6431800441666105,1.929368065608006
HSC-4,BRD-A02303741-carboplatin (1-1 mol-mol),4.481505642686289,4.283684291917258
CAL-51,3062316,-2.5625958708444205,1.479980789607338
Panc 04.03,49793307,-2.352687994078586,-2.3569666780131255
MSTO-211H,10302451,2.2723798321327826,3.4998893742196784
A-673,54619267,3.9525164677601015,3.8408986694817755
G-401,448949,1.8289326894340776,1.6490370492085862
SCC-9,15983966,-4.042628093805887,-0.2241467194551402
CA46,3854666,0.2733202158609283,0.6187746881049876
SBC-5,42642645,2.1700569257248734,0.7287380800372599
FTC-133,6184667,4.171777093513536,3.02933206106144
A-673,3543504,4.433549859321033,3.7389542856037576
CAL-51,409805,3.8515087112009656,5.001794048478784
SNU-61,5287620,-1.5621550618200195,-2.265145570805112
BT-549,6610216,4.341228931549091,4.363088973971737
MDA-MB-453,44566777,-0.164341777615228,0.537199555207525
CAL-51,219104,3.260140555917495,3.7261912191258113
A4/Fukuda,tanespimycin-gemcitabine (1-1 mol-mol),-4.973874531854187,-1.880254407188322
A2780,65064,4.350950935999884,4.4298967788141645
G-401,9803433,5.696660690430479,4.367467493024941
BT-549,11626560,2.6049019780447473,1.9123966515237487
RCM-1 [Human rectal adenocarcinoma],3025944,4.221207920184214,4.287684476521192
A-673,107970,1.5652885370840817,2.299557213603302
A-498,46199207,3.6222117747737057,3.170020848238525
OPM-2,navitoclax-pluripotin (1-1 mol-mol),-2.4334437397089053,-1.774568445926226
BT-549,11364421,-5.683704390961643,-1.5470229624946037
G-401,25195348,3.8836243061511215,3.0476838531351187
RCM-1 [Human rectal adenocarcinoma],3552672,4.462538243049003,2.7587352817415085
LoVo,24901704,1.9806347162028537,3.395079260133139
NCI-H2009,11485656,2.228831542035607,2.6813115209985154
NCI-H2171,1750826,-2.946975931831454,-2.40846332900798
MSTO-211H,5738263,2.0448017247583996,3.419832375565318
SBC-5,2729026,3.0750341046070933,2.6047012102865272
A-673,60700,-2.9578260017137437,-1.3817549933597935
KMRC-1,216239,3.2937854483312172,2.2241336440520625
G-401,7251185,1.5631627066286176,1.8293020942186247
NCI-H522,568763,-0.6787143148403639,0.05646689150017853
MDA-MB-453,52912189,0.0253127265648339,2.2378898061107355
NCI-H1623,637858,3.185553411157662,2.122080246556344
BxPC-3,65064,4.239552039257921,5.1824155541478225
BxPC-3,44202524,1.2355479078044973,2.2799139099448276
HCC1143,10231331,3.1675049490504943,1.9883110782924982
NCI-H727,4917,3.0740580007272125,3.0811016567624194
NCI-H522,46907787,0.5375692456309028,1.091478219578547
G-401,4261,0.8301994759372666,1.1956095145698051
HSC-4,46398810,3.0881815243810897,2.5766776734427967
NCI-H460,16722836,2.818869820371906,1.968520801999922
CAL-51,107985,-4.126908547019261,-3.7426650980512646
EFO-27,445643,4.157223404562412,4.069286670967431
NCI-H661,327653,3.5614910429728295,3.087526887635739
A2780,15547703,2.917961616739491,2.8486946431641034
Panc 04.03,11222830,1.7267772277517466,1.7853271797184056
NCI-H727,445455,6.030056890362138,4.734359880984605
A-673,72199292,0.9360047714765588,0.792900113702859
DMS 273,2945648,3.171749675698132,2.4573910911647623
SCC-9,6917907,-5.592045136043938,-5.402160754342674
CAL-51,72193861,0.6423702350358801,1.8192320898339387
SBC-5,5281321,2.671163534426493,-0.8688538136239781
NCI-H2009,10231331,-1.9302715463885551,2.2041294795829547
SCC-9,3825829,4.24505295528646,3.9594545939078825
NCI-H661,702558,4.861012061293982,5.052560185675655
SCC-9,piperlongumine-MST-312 (1-1 mol-mol),2.236566574852554,2.0653995723355454
MSTO-211H,451668,4.9569649646478515,4.036498798202368
A2780,9908783,4.382006664554736,4.4864986695294
EFO-27,44566777,0.6667958565864378,0.9577216291761603
SNU-449,11228183,3.721594588319689,2.748408587071536
MSTO-211H,322968,3.0218271531726897,3.9634765584029066
NCI-H522,135999136,4.552466214525868,2.9511249201433025
BxPC-3,375860,-1.018881063070817,-0.044197327414545955
FTC-133,46398810,3.783858454202458,2.7167225523402476
LXF 289,446155,3.7142968943868073,2.573850500443828
NCI-H146,54619267,2.4574193717136663,3.8699367406688547
JM-1,400769,-1.2746733592438322,-1.3775151993294972
BT-549,5328940,1.7912058861852873,1.9154196141395154
NCI-H460,15547703,4.965379127843483,3.1657449372847344
JM-1,10026128,4.426440879951995,3.199040305283578
LoVo,327653,2.9108064375514604,3.082377180736711
HSC-4,5329102,2.7247882686097458,1.9077600011432725
BxPC-3,5460769,-0.1362128387149436,2.8296456478438956
SNU-449,148124,1.515559327544478,-1.1287769638426672
KYSE-70,24951314,1.3178292218062186,1.7024089659067072
BT-549,11485656,2.9441987555380855,2.558734051299609
CAL-51,9866186,1.45916914556855,0.9197361856449007
NOMO-1,5278396,3.0205756000124775,3.0062821078655566
LXF 289,JQ-1-vorinostat (2-1 mol-mol),0.5669885048273257,1.4048221728112953
KMRC-1,42642645,1.142476115564406,0.8899600511725048
NCI-H460,100016,5.855223104671776,6.268239796036771
MDA-MB-157,25062766,0.4624374403471977,2.159491572571268
MDA-MB-453,107970,2.0242856345207834,2.313961740589468
DMS 273,16741245,5.579276049340643,3.4803287894123764
BxPC-3,3689413,-0.056748072256038,0.33832598667735914
KYSE-70,25126798,3.963979956832577,3.701334881617107
A-673,54678924,2.025744293137832,1.7159453968197962
HCC1143,25062766,2.2830484377909492,2.3254157851394393
NCI-H2171,11625818,4.794880990749841,3.6823670804542274
MDA-MB-453,2729026,2.974469204821206,2.5900299940704223
G-401,9933475,0.0956350981602405,1.8025985405464144
NCI-H460,51039095,3.9314979002332535,2.8742047685498147
NCI-H522,219104,3.343081396349963,2.994223402395609
NCI-H661,56946209,-3.6194559692185018,-3.7935267792731593
SNU-81,568763,0.5116878508289208,0.3222210825697577
A-673,67291369,2.4007963238191854,1.7443606957015418
LoVo,3854666,1.417426416420887,2.272159373509331
MSTO-211H,439501,-1.1644309958543906,-2.2158970448452884
SNU-449,285033,1.5882926770841097,-1.236681684203389
CA46,6918878,-0.7300256707111569,0.49491572270364975
NCI-H146,71466445,0.6815814889300492,3.116339763604786
SBC-5,10385095,2.1758850118167077,1.340516075985822
A-498,637858,3.4757595298108974,2.433692746444107
ONS-76,11964036,2.0748582848578865,1.4326187912725104
NCI-H727,16725315,4.353817237787042,4.296794782438181
G-401,10427712,4.653472001336551,3.8442451115709777
CA46,10127622,5.462644164632326,3.2660599269606068
SNU-449,25161177,4.378304661297746,4.390899264355853
MDA-MB-157,49766530,-2.405889714389838,-0.6025388157491818
FU-OV-1,23582824,0.4003812349581704,0.9455898192888899
FTC-133,24180719,5.041424864241871,3.459519568892573
CA46,3689413,-3.563387503989764,-1.964855557501958
NCI-H146,JQ-1-carboplatin (1-1 mol-mol),-0.0863429597614012,1.8067322316201742
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-1.3429860541822496
RCM-1 [Human rectal adenocarcinoma],322968,4.629178663880947,3.5994719045199326
NCI-H522,6918638,0.2628749411775776,0.24060802030866546
EFO-27,10127622,7.049186817655218,4.3212305773529875
MDA-MB-157,400769,-0.9429856644264992,-0.4649207354025334
CAL-51,54618164,4.021329289838694,4.103995743332067
LOU-NH91,9935249,4.429052878520747,3.295524388696262
NCI-H727,49766530,1.5110740555461553,-0.5672836266720538
A-673,9926054,1.7717409858597033,1.820272745438339
HCC1143,5351362,1.6023771560954885,1.6750966980929736
NOMO-1,54613361,-1.5441782746277026,-1.0649915914253487
JM-1,613000,2.2697515166000355,2.385322684243319
CAL-51,49793307,-3.2015156477281193,-2.599854250395864
NCI-H1623,1750826,-0.130863987039663,-0.7714357896649308
OPM-2,JQ-1-UNC0638 (2-1 mol-mol),-3.4645520478530516,0.18707698934131176
NCI-H460,107970,2.752075604137296,2.381704089490837
SNU-81,JQ-1-vorinostat (2-1 mol-mol),0.90621526316067,0.6166312785369096
CAL-51,46199207,3.548155956826357,3.1884280554411943
NCI-H2171,10074640,2.5219754676966435,2.8771036700050727
A2780,selumetinib-navitoclax (8-1 mol-mol),1.1083480952702989,1.5769866147713907
A-498,JQ-1-carboplatin (1-1 mol-mol),4.434303177287225,2.7561661193501084
JM-1,11238147,1.2374439058156688,1.943874643554192
SNU-449,54678924,2.162306121493456,2.5252452455524863
NCI-H522,3854666,0.0482767863302698,1.4409060615830231
KMRC-1,selumetinib-JQ-1 (4-1 mol-mol),4.265974961239561,1.3020014499234756
HSC-4,10427712,3.709601221495256,4.284322465982439
KMRC-1,10296883,4.079927671527966,3.7660451193150153
A-673,46907787,1.1836850249017303,0.8561133163769631
NCI-H460,67156097,3.7191617083219097,-0.5931093359473623
Panc 04.03,11364421,2.200002813497647,-0.7760817799035529
A2780,57330099,3.934423580004946,3.967786400567749
KMRC-1,400769,0.144742351180573,-0.542342735050446
LOU-NH91,25062766,1.8056251936091945,2.130303811452357
NCI-H460,11175137,3.7005840280640374,2.7316450581637737
HSC-4,124202324,2.961748327308983,2.5622597171896513
DMS 273,46191454,0.2871755056280096,0.8170283596225051
LoVo,23582824,-0.7966748622900964,0.8499357739023357
FU-OV-1,24785538,3.56375796516153,1.7351000740070435
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883,2.4285765856379617
CAL-51,216345,2.9520334452605637,3.7999897847301596
KYSE-70,11427553,3.0124804015996185,2.846481474877038
NCI-H2009,decitabine-navitoclax (2-1 mol-mol),4.93341873674704,2.1572794672934585
DMS 273,selumetinib-vorinostat (8-1 mol-mol),1.928257280185898,2.0362151442790575
A2780,54618164,3.641335469190071,4.0390875924079
SNU-61,2708,5.501133929338057,4.07624601095298
CAL-51,702558,3.5144984342436563,5.2460464712458155
CAL-51,11175137,1.2330676481368064,2.5590860218027545
OPM-2,119607,4.667002181538018,4.343653620448006
BxPC-3,4096211,0.9773140949236826,2.3205300541716993
NCI-H146,2749,0.7789788955457625,1.7384575524880885
LXF 289,16725315,3.2486511295045677,4.224477584857294
HCC1143,4261,1.976797651434544,1.819066164961092
SNU-449,11152667,1.3844218204303944,-0.25020154757740015
CAL-51,52947716,-4.729660133739893,-0.12821422578114092
SBC-5,4477,-0.6853772163114386,0.7132226539650922
A4/Fukuda,44819697,-1.7397384839387715,-1.108519208701162
NCI-H2009,54618771,-0.2233577251443086,1.6576567888764273
LOU-NH91,2733487,6.3296049393179485,6.181930438900817
G-401,erlotinib-PLX-4032 (2-1 mol-mol),3.757739778609172,2.9424212025628758
NCI-H146,89928392,0.6603214053079605,1.3542234163475513
SW1463,10231331,-1.1566445252598772,1.6365692294468142
MDA-MB-453,11977753,-1.828846421242697,-1.3955817083776219
HSC-4,445643,4.123722857917103,3.9538511923907733
EFO-27,42642645,1.7670896576814532,0.8115569041292666
EFO-27,crizotinib-PLX-4032 (2-1 mol-mol),3.36614562688719,1.861976960676582
BxPC-3,5311281,3.739267965753581,2.208425125843208
SBC-5,44185566,3.097813648169307,2.5918634357225367
LOU-NH91,5351362,1.6461408289790205,1.6666581611751465
EFO-27,50905018,5.404252445104634,4.41145423086486
MDA-MB-453,374536,3.68630764751743,1.9511200343331696
G-401,25262965,-3.9564581939856582,-2.1937317301028116
CA46,2749,1.009648399882346,0.8337274306579703
SW1463,387447,-4.88012723681038,-4.041785172722271
A4/Fukuda,8515,2.244185004641864,3.433821596457329
NCI-H1623,24901704,3.7829050158791064,3.634049682576997
HCC1143,71680916,4.5741598898507565,4.934672936284053
YAPC,54143018,2.4773688492488892,0.8313849807742182
FU-OV-1,49793307,-0.2872221589202163,-2.2890838237712554
Panc 04.03,168312962,4.832441653848414,2.144836355449876
NCI-H292,11609586,2.9930145326420146,2.9330794438059087
NCI-H727,25150857,2.574637897952517,2.382819848775498
NCI-H292,6438330,2.681078996624105,2.6024368000330456
OPM-2,12003241,-2.9738714531294232,-1.3892287821588851
MSTO-211H,BRD-A02303741-navitoclax (2-1 mol-mol),0.3230364092955163,2.577698322722883
NCI-H522,151289,0.0217168787144745,0.8688256377322696
NCI-H146,docetaxel-tanespimycin (2-1 mol-mol),-0.2232334336717333,-3.642045445257356
BT-549,11238147,3.2866911979765803,2.861802513196684
OVISE,9866186,0.5630702781820192,1.3232194393729402
HSC-4,6918328,0.4827098957230251,-0.013930117620789537
NCI-H2009,135411,0.2253946709705592,0.8448903203061995
JM-1,10385095,0.4126425157623973,0.9414488328034775
CA46,45279963,3.66447519946476,2.972918017465509
A-673,44197249,4.247235211402652,2.872296273961396
A4/Fukuda,selumetinib-navitoclax (8-1 mol-mol),1.1983954877584069,1.350001182035201
NCI-H661,135440466,2.665416885593315,2.2466069364268395
G-401,168313016,4.483065775660181,4.229094926238884
BxPC-3,168313047,2.402437406788064,2.2770350142195515
NCI-H661,2746,2.7828270451310786,3.2554113758866383
FU-OV-1,11612883,1.8669069183790803,3.1401599172265087
DMS 273,53232,2.0931635545137266,2.594043877661773
BxPC-3,9903786,2.126136875029704,2.8136308762593183
NCI-H661,11625818,4.41260734243293,4.4757659323469055
NCI-H522,16659841,2.9113601324358287,3.198284537471846
OVISE,53232,2.4849914286727426,2.806400209299475
EFO-27,135440466,3.806006891786582,2.312774397627202
SNU-449,5746,3.348109332475853,1.4590831079803253
CAL-51,969516,2.948027689121256,2.7257645359821407
FTC-133,11238147,4.273178384451577,3.0050408748603252
NCI-H522,24748573,1.6076101041751254,1.8806175945403993
MDA-MB-453,46224516,2.0758190952131215,2.290381497345299
LXF 289,6918878,2.1668969721619833,3.081860548340621
OPM-2,451668,-1.14063259637223,-0.015623622900417855
HCC1143,3689413,0.0716522323698814,-0.04313183904254981
SBC-5,135398744,6.447254342428179,6.240638830389237
CAL-51,227681,3.694103991631346,3.3519451456394362
CAL-51,5287620,-2.338247824560234,-2.009717080339385
A2780,3062316,2.0817886994426704,1.6111902551855406
SNU-61,2858523,2.9582475566417195,3.0770434422283257
SNU-61,54649381,3.9147762798202863,3.419743792127934
A2780,10385095,0.5603604864283975,1.0479857571545874
MDA-MB-157,11152667,0.7570225590856333,-0.26357189378747364
ONS-76,400769,-0.3525004301248006,-0.338452237397723
A-673,409805,3.491559756034339,4.1453799230885195
SBC-5,10184653,2.5351322042771356,1.5004375365464793
NCI-H727,66577038,2.8647542032772604,3.107977618378693
A-498,6505803,4.020571046679738,-0.007298209818584296
RCM-1 [Human rectal adenocarcinoma],11178236,-3.001745406812045,-2.878458602076921
NCI-H522,2708,5.085998334781725,4.0742390922073195
BT-549,45279963,4.047021813577569,3.8138375603112946
LOU-NH91,25183872,2.2713164299079627,-0.5781637238526589
FU-OV-1,24797083,1.8707999880079529,1.4338464544005531
SNU-449,44607530,1.456313243054954,2.0518479651598547
MSTO-211H,1566236,2.167071233614174,2.4848439483776934
JM-1,24951314,0.1302219808330525,0.14758159200856957
EFO-27,53392493,1.9151019076026368,2.6892234158365715
FU-OV-1,16725315,4.930691545287574,4.294422437335401
NCI-H1623,12003241,-0.4868602659209724,-0.427634240899644
SBC-5,148198,-1.371938553790338,-3.9686578579563196
BxPC-3,17755052,0.5794893802598977,1.5981180894216271
SNU-61,11485656,2.115016827038527,2.104681119404693
LXF 289,2729026,2.289348740995074,2.7524703218255526
MSTO-211H,654092,-1.1984807631004837,-0.3820598570135734
A-673,5291,3.269854942504113,3.3713493721712644
LOU-NH91,4705,2.8449970854381945,3.2605966192259075
SBC-5,24753719,5.823724927288436,4.243883908445835
SNU-61,675434,4.254516948181055,4.361971923103322
A2780,5278396,2.562980728115376,3.146644469392773
DMS 273,122327,5.509571347430681,4.097305924546575
A-673,9884685,0.1604809562987641,0.271781535349546
NCI-H1623,16722836,1.0817030477122866,1.817428589707839
NCI-H661,67291369,1.7470049727917394,2.5824523343344055
A4/Fukuda,135398516,0.099848878431286,1.3186114691039774
A-673,568763,-0.0608974572236531,0.026300805626564144
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115,3.728948032798282
SNU-81,11178236,-8.196337700198193,-2.5589983422649896
OVISE,navitoclax-PLX-4032 (1-1 mol-mol),-1.1204888715090109,1.610256022815592
A4/Fukuda,46215462,1.453707580765341,1.2649635338476621
HSC-4,6252,1.1187983220422375,1.3103010263156563
HSC-4,3062316,-0.6194675763886993,0.8713534540593593
NCI-H1623,57330099,4.486652982197453,4.242057532716335
BxPC-3,23635314,-1.513116034089344,-1.1970210312176126
OPM-2,46943432,-1.735277326796896,1.0581708254742
FTC-133,11175137,3.295108533345337,2.656214356850547
SNU-61,100016,6.106397388471953,5.644607932114789
MDA-MB-453,446155,5.408001660467943,2.896224927734007
NCI-H2009,selumetinib-vorinostat (8-1 mol-mol),-1.4945582225586194,2.581220830032223
MSTO-211H,168313200,3.954855187852925,3.090066544902652
LoVo,2729026,2.166128688763036,2.4514225504250966
FU-OV-1,73707398,1.0047751906041116,1.3784650796593758
LOU-NH91,44241473,5.33179348194517,4.977747515337023
YAPC,135440466,2.1529261418392807,2.3096323749347043
KMRC-1,568763,1.1483170277588293,0.6982975920617313
CAL-51,656346,0.8466306406200714,1.1351052987702404
MDA-MB-157,327653,1.3811083957143218,2.998071722471619
NCI-H460,107985,-2.632533954936978,-3.3898754331395726
NCI-H460,135875424,3.211754300989152,3.9708720553794303
BT-549,119607,5.663531776682701,5.433431727537718
KYSE-70,4261,1.9447398866595849,1.4408147705063143
CAL-51,44543605,3.919885801001582,3.826195845420176
SCC-9,44566777,0.4714703461280546,0.9542897314802188
RCM-1 [Human rectal adenocarcinoma],16722836,2.4867038992166783,1.660002380044221
EFO-27,10322450,4.618987367546035,3.8505993190323924
LoVo,452548,-1.7762082467733018,0.4847351399380252
G-401,24821094,2.5559581237528097,2.6719049927432015
Panc 04.03,docetaxel-tanespimycin (2-1 mol-mol),-0.4013709222669032,-2.8335213987073873
KYSE-70,135999136,5.194226724950964,3.6468091192811407
NCI-H146,6438330,-0.4558524131736901,1.9886487065821894
BxPC-3,31703,-0.5929664629875476,-0.6402127782837832
Panc 04.03,5470400,0.9135030177256964,-0.35147372187658443
KYSE-70,25150857,2.5963104301055258,2.6649890498762328
OVISE,selumetinib-piperlongumine (8-1 mol-mol),3.917327807535022,3.387136026880397
A4/Fukuda,439501,-3.252400391503616,-2.677346842481467
SBC-5,107985,-2.339881885950972,-3.695903070240277
NCI-H146,25227462,0.2247724046939956,-0.5865254753331555
JM-1,44491742,3.590859136704876,3.886728462880127
YAPC,6505803,-0.1975849276423945,-0.6137848414861544
MDA-MB-453,10113978,3.193218839681212,2.82096155609559
A-673,16038120,-1.140194872712738,0.5936919399103071
FTC-133,675434,4.640800834602054,4.50209793538249
MDA-MB-157,439501,-3.062684000428755,-2.04735294522115
SBC-5,10074640,3.660613951501144,2.94193431062464
DMS 273,3689413,-1.7704206659692223,-1.3771497944060076
SCC-9,36462,2.4622585602605493,2.2103669147528957
NCI-H1623,46843906,3.212648418277938,3.3841366731986597
NCI-H2009,676352,1.803439035619831,2.161621049132453
CAL-51,387447,-3.720200693098244,-4.185509668400849
SNU-61,navitoclax-pluripotin (1-1 mol-mol),0.1014096267424324,-0.7538925711752724
CAL-51,44632017,0.9975947899898204,1.2173258553230806
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122,-0.626986863571454
DMS 273,9936388,3.4086707637717883,-4.098305441099426
NCI-H1623,24180125,3.727544824819635,3.1805041661894005
NOMO-1,969516,2.327280884248625,2.17691704356616
A4/Fukuda,1750826,-3.1003590099134284,-2.57757941788848
Panc 04.03,5281321,2.674318568781228,-1.2587735666240178
FTC-133,176870,5.80195413779655,3.47027656202675
CAL-51,10113978,3.4506321601115397,3.0869537847347255
SCC-9,selumetinib-vorinostat (8-1 mol-mol),3.604672449855193,2.5778815169246645
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566,-0.06963559970702074
A2780,3385,2.4446535707127537,3.222526115779236
DMS 273,45279963,3.8289869697511527,3.1063812725887026
OPM-2,11609586,2.7966274513563496,1.882487167200055
NCI-H1623,26596,-1.1542368606327895,-0.8961870928339706
SW1463,5479543,1.0422897086412093,2.985681939933692
SNU-449,53392493,3.0071956547718113,2.8906280049814352
Panc 04.03,11178236,-2.395899374087587,-2.667046927075045
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344,0.8881587924739632
OVISE,BRD-A02303741-navitoclax (2-1 mol-mol),0.9537570528694392,2.0598265647830867
NCI-H460,9866186,0.4176494313944011,0.6304128244532118
FTC-133,53232,1.7186310962422595,2.6095851921967337
BxPC-3,216345,4.279216843902863,4.24415571811431
A-673,10296883,3.758044639987347,3.5994990986442783
ONS-76,11178236,-3.26201925681368,-2.801161318131011
CAL-51,25062766,1.9168321284868295,2.1086910680682833
NCI-H522,6852167,2.4506568165817777,2.3257861738454966
SNU-61,72193861,1.1230875557226898,0.7170873262451891
ONS-76,vorinostat-navitoclax (4-1 mol-mol),1.54700333580169,1.1250311534445123
BxPC-3,3543504,4.240175882152398,4.576941076836763
NCI-H661,73707438,4.487630336801632,4.118821617037753
OVISE,638278,1.1296919637825429,3.382761665215252
A4/Fukuda,36314,4.126705075384559,-1.8307019235257593
SBC-5,10127622,7.037598772691409,3.9525178490669486
MDA-MB-157,selumetinib-decitabine (4-1 mol-mol),4.44139235410904,3.818104649808855
BxPC-3,49766530,0.5943123243750338,-0.19417319046079876
LoVo,54143018,-0.354466194309244,0.6036575847266414
BT-549,44589607,2.161067974853105,3.2603430271177403
LOU-NH91,3136844,4.41334270983783,4.393867722471606
OPM-2,5311,-0.071810443528602,0.5824122509409407
G-401,JQ-1-MK-0752 (1-1 mol-mol),0.1350272017197765,1.278814846573254
HCC1143,676352,2.389016147507623,1.9900210630371489
Panc 04.03,11657048,4.4356176445581,4.066774887523344
NCI-H661,navitoclax-piperlongumine (1-1 mol-mol),2.7076431504633676,1.8099089915507773
DMS 273,doxorubicin-navitoclax (2-1 mol-mol),-0.5717172949913683,-1.4687787078601824
RCM-1 [Human rectal adenocarcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.7027440652786807,1.8234901107217854
NCI-H1623,374536,0.6337427379168257,2.144447173435996
SNU-61,3825829,4.102120147241808,3.5511591795527475
DMS 273,56649450,3.5073695444545288,3.0491886560232615
CAL-51,24785538,0.7720267524795773,1.470124155996232
OVISE,16038120,2.1825815777023965,1.1653059729367026
EFO-27,6918328,-0.3264411901724555,0.15694326368192027
FTC-133,3025944,4.352563236352026,4.368430748071735
A-673,89183176,3.363943107585485,3.540747451450625
KYSE-70,123631,1.697265417228948,2.2069059150119057
MDA-MB-157,441298,1.9245422363016824,2.164789994664177
A-673,156422,4.078876073319714,3.3148896611252496
BxPC-3,676352,2.25430531813019,2.240764310827084
HSC-4,25150857,3.233332545340528,2.567720007500626
G-401,24856436,-0.0141865957174665,0.03828288971239829
MSTO-211H,49793307,-4.316049670445352,-2.374856563666645
OPM-2,11485656,1.3184852346481954,1.5455337046330788
HSC-4,208908,1.4999275809756432,2.074436050455639
MDA-MB-453,54613361,-2.035930507333412,0.11495040301710269
G-401,serdemetan-SCH-529074 (1-1 mol-mol),0.8425945982642317,1.6743533985193364
EFO-27,44589607,3.0601109795549295,3.068139295685225
SNU-61,44493528,4.287806417412906,4.235336327210038
G-401,11152667,0.9519757620011424,-1.0504321549872098
NCI-H2009,5287620,-2.745575302534365,-1.7478224667176478
ONS-76,23725625,4.840348822045759,4.791088506726617
CAL-51,44620216,5.469091994130916,3.7937436675876692
NCI-H460,9903786,4.057661845653794,2.797806856926014
A-673,11214940,1.1675505170406824,1.5691756745475485
A-673,24964624,2.426022149354347,1.6963746784484357
BxPC-3,9866186,0.8001699279354296,0.8988831227671475
FTC-133,25062766,3.8237771334178903,2.1418436653811885
HSC-4,42642645,1.8060847122685193,0.8932354802705487
HSC-4,11178236,-3.2670379451965164,-2.9442902512717124
HCC1143,JQ-1-vorinostat (2-1 mol-mol),1.5570491988867368,1.1796756548576997
NCI-H2009,selumetinib-UNC0638 (4-1 mol-mol),-1.7113919065901229,3.2730056049959875
MDA-MB-157,selumetinib-MK-2206 (8-1 mol-mol),3.246099259686085,2.293806429312882
NOMO-1,46843906,1.7610241193794407,1.4693628649766657
NCI-H2171,6917907,-6.363958938419671,-5.328174449779803
DMS 273,11707110,5.189560989731051,1.0935504874232431
LoVo,6918328,-0.3156299102516719,0.1057013108005101
HSC-4,vorinostat-carboplatin (1-1 mol-mol),3.405772607796717,3.1454006619387256
NCI-H2009,44632017,1.0717713653211387,1.476780250003365
DMS 273,11626560,1.283315066012986,1.0698568831646635
MDA-MB-157,11317348,1.0421206228140214,2.994921956585631
A2780,5311281,0.918852428114819,2.4261445502156285
DMS 273,2113511,5.781557942421417,5.317852601541088
LOU-NH91,10184653,1.5324310696398793,1.4966434531851724
BT-549,selumetinib-navitoclax (8-1 mol-mol),4.705621989339038,2.3530426099244717
Panc 04.03,73707398,1.757833710000806,1.5206494205370236
JM-1,JQ-1-navitoclax (2-1 mol-mol),-2.0715419523140883,-0.43281515331200265
BxPC-3,11455910,2.77826122800999,1.4002509318729697
MDA-MB-453,11955716,-2.2213534191245303,-0.948156709765567
A-673,navitoclax-MST-312 (1-1 mol-mol),0.824497586093143,0.13861007223955787
NCI-H661,3634881,2.923822089210327,3.4639446031572687
NCI-H460,5281672,4.99885948312363,4.653017934130484
RCM-1 [Human rectal adenocarcinoma],JQ-1-UNC0638 (2-1 mol-mol),1.043202454490808,1.5707888953415496
KYSE-70,4259181,-4.187670573846372,0.49118198522512363
BxPC-3,2756,5.8394588105914105,3.4321036931048114
HCC1143,24901704,3.259585605807663,3.333808991907243
BxPC-3,selumetinib-vorinostat (8-1 mol-mol),-1.5896818639125374,2.2553494683558823
CAL-51,5470400,4.528848471588079,-0.4639592216073465
JM-1,10296883,2.092198976716966,3.1842620478309867
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176,-0.3857704323970407
NCI-H146,46199207,1.7925573568525552,3.077106178271583
OPM-2,448949,1.278414281383,1.4637652098319
NCI-H146,216239,1.510222966819436,1.634253768599503
HSC-4,9903786,4.262681016067309,2.7168467615566736
ONS-76,57330099,4.261013423315652,4.112640225025043
NCI-H522,148124,-6.241132033807486,-2.59141564620974
SNU-449,156414,1.8120811787876097,1.9400673436724487
NCI-H2171,2746,1.1013983502046127,2.2574437506330693
RCM-1 [Human rectal adenocarcinoma],400769,-1.066885564414268,-0.3946135472316841
LXF 289,135398744,6.087135496005038,6.341086827504101
SNU-449,3689413,-2.168376107627999,-0.08073669902783624
A4/Fukuda,5351362,0.320845740356061,1.1534860157278037
A4/Fukuda,446155,1.0805751863544764,2.3359233213500463
CA46,151289,0.6780663351050565,0.516601031255412
ONS-76,selumetinib-JQ-1 (4-1 mol-mol),-2.481078216030984,1.0751506000070143
NCI-H292,UNC0638-navitoclax (1-1 mol-mol),0.2061924649473525,1.8734566843631633
NCI-H460,11625818,5.428588497019925,4.4059740648305805
A2780,119182,-2.871948238792312,-1.4847916299462838
ONS-76,10385095,1.1655527010487017,1.2069448304981005
EFO-27,51037431,5.317639691280149,3.472973114941942
A-673,72376,-3.645473298633041,-2.7485889520412377
MDA-MB-157,24748573,1.7707431454067368,2.19801685901284
JM-1,6610355,3.6312795132079136,4.123234747140165
EFO-27,44819697,-1.290536172530674,-0.5797770808707771
A2780,5702613,3.197014181878355,3.015051584043084
A-498,25102847,3.3376740856950335,2.66743703104022
KMRC-1,3634881,3.321374403116886,3.164327755496135
OPM-2,3081361,1.5210485339307265,1.957397935301151
LOU-NH91,3038522,4.554088179549466,3.187761414421231
SNU-61,216239,1.9834133881004128,2.274240305868931
FU-OV-1,124202324,1.4335087059128786,2.5399547233037567
NCI-H292,72193861,2.2952018559260363,1.9581505063456468
MDA-MB-453,53495165,1.832682106227088,0.6153941263402072
NCI-H2171,31703,-2.460746582121975,-1.8364425792537793
NCI-H460,2729026,3.0609463870825926,2.7875659494906055
SBC-5,9868037,1.591902673624677,3.411506251798297
LoVo,44632017,0.6073588127957028,1.018144781743182
JM-1,25262965,-2.478831797463893,-2.5235432016831085
SCC-9,148198,-2.735497552895971,-3.256135484601604
CA46,89928392,0.0283947615438792,0.40075074382971104
OVISE,5566,3.518034595538079,3.0356250452190476
HSC-4,5278396,3.3910828172613128,3.621114044136018
RCM-1 [Human rectal adenocarcinoma],462382,0.7838643978728388,0.651542397018021
KYSE-70,4788,5.890959200463747,5.596769129781498
SNU-61,serdemetan-SCH-529074 (1-1 mol-mol),2.1746130433144386,1.8551348058058363
Panc 04.03,374536,2.376032280196277,2.135263088730594
NCI-H661,20959075,-3.3600823520668306,-2.4656071415922813
LXF 289,3543504,4.042070583449167,4.583748429379382
SNU-449,5287620,0.008240040829162,-1.9184198639788468
HCC1143,11719255,3.553533872223464,3.4599371611717578
NOMO-1,54618164,3.731990472759892,3.6893815353152406
A4/Fukuda,piperlongumine-MST-312 (1-1 mol-mol),1.0662246579823889,1.311575369653738
NCI-H1623,5311,1.5946462199665867,1.5935704377564297
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.2563884558815195
LOU-NH91,216468,5.562373540734892,3.8085053146441528
JM-1,9915743,0.8499678141273637,0.24085250998543056
RCM-1 [Human rectal adenocarcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.7783627662163426,1.9866172947227838
NOMO-1,107985,-4.118574275669005,-3.9767463261444136
JM-1,135423438,1.5495237102322077,1.1858568280676551
A-673,24856436,-1.1403661815810562,0.0024242989938782575
CAL-51,5282054,3.552468823116285,3.6427328718313583
CAL-51,11178236,-3.674192911743539,-3.274625383695315
G-401,6252,-0.6004387834343344,-0.44462876570885984
KMRC-1,4261,3.216149224144429,1.629341427166114
MSTO-211H,54454,-0.190602208325988,2.5595561194826377
CAL-51,4917,3.122174268556499,3.114737451444313
HCC1143,54649381,3.828405406955801,3.9983063203808187
EFO-27,25262965,-3.442895730672298,-1.0990219859460886
NCI-H522,54626689,4.6269731577498066,4.346305235554392
KMRC-1,123631,2.4243478642730634,2.3050490039700713
JM-1,JQ-1-vorinostat (2-1 mol-mol),-2.067527251050835,-0.3376539129681783
MSTO-211H,6438330,1.6419113469823416,2.487346144173471
CAL-51,446155,1.9002286289262065,2.7596523679544633
MSTO-211H,25126798,3.885175037199499,3.9321587811702323
KYSE-70,54626689,6.762622459467938,4.454973991153796
FTC-133,navitoclax-pluripotin (1-1 mol-mol),-1.324010652875928,-0.9749096122585513
CA46,4705,3.1649236354970154,2.963250432190181
LOU-NH91,36314,-6.12634068503974,-0.9406700495128597
OPM-2,49766530,-3.767684481967312,-1.789418050092934
NCI-H460,135411,0.3374737909082799,0.8328866420800396
NCI-H2009,6623618,3.0922058987418315,2.2934541951091654
KMRC-1,44185566,3.110367208302614,2.159709439376383
Panc 04.03,9933475,2.3468691227324965,2.1447355048303423
NCI-H146,25105715,3.2144396386290617,3.3044118337456196
SBC-5,25062766,3.305997596539037,1.9972698306017134
G-401,11364421,-5.069536717957333,-3.2838671185072688
OPM-2,1285940,4.143301448340403,3.0479370710001223
NCI-H661,46843906,3.609730466041,3.013092494678743
JM-1,selumetinib-piperlongumine (8-1 mol-mol),2.3811879474866093,1.958954428544201
NCI-H292,selumetinib-MK-2206 (8-1 mol-mol),0.2769010439937888,2.309523829001372
ONS-76,656346,2.4725060186946974,0.9089696036733017
A-498,135421197,2.4500558267656873,1.9894898449536236
YAPC,5280436,4.973863444979394,3.732219574922329
NCI-H522,53481919,3.906372094667401,3.177911435913499
CAL-51,448949,2.479839067238928,1.9863886293494553
MSTO-211H,JQ-1-navitoclax (2-1 mol-mol),-0.1744059770900167,0.8618850276496114
NCI-H727,15953870,3.6175866373148713,3.5030785640751163
A4/Fukuda,4378219,1.9024946719152895,2.1908190778466543
ONS-76,374536,5.32668572402577,2.1715275832996106
HCC1143,387447,-2.8902460626215216,-4.221442977603561
A2780,navitoclax-piperlongumine (1-1 mol-mol),1.0612869409921282,1.3263721617288327
OPM-2,3543504,2.699241331915609,3.7044254043279548
G-401,54618305,4.431468655886698,4.466191311403701
A2780,54649381,3.634529154077109,3.5262272660430933
LXF 289,5287620,-2.3080718171081385,-1.7905812919146842
YAPC,637858,2.16601707981449,2.22353308556996
NCI-H522,9915743,1.083108246388964,1.131192382631863
KYSE-70,25183872,-0.2407157689495178,-0.4099742805464328
NCI-H522,56649450,4.1349782138767655,2.955411282760918
OPM-2,52947716,0.8847701060718332,-3.3361687325904317
SBC-5,124202324,2.6085939591802307,2.3918177778163345
DMS 273,2742550,3.72774264414297,3.1591094286311905
NCI-H522,BRD-A02303741-navitoclax (2-1 mol-mol),5.562601250875811,1.4787997690889572
NCI-H522,44491742,4.766943404170333,4.206918192616071
MSTO-211H,3503,2.7854032891391163,2.485790258584596
FTC-133,10427712,4.710340548147587,4.374710584092548
SW1463,56946209,-2.6004240108086187,-4.219937933295435
KMRC-1,11178236,-3.5821993315226175,-2.6271379235428145
NCI-H146,5281672,3.80713040102785,4.349348437902745
SBC-5,16038120,3.1431644252796835,0.8614412668631285
NCI-H522,421610,1.9391714098470076,2.8854878587901824
DMS 273,9866186,1.1265446059819233,0.44030570977475747
SNU-61,11717001,3.914635952460324,3.813155937673985
NCI-H522,JQ-1-MK-0752 (1-1 mol-mol),0.1872499419058635,1.2077414398721078
LOU-NH91,44137675,3.1585262513685612,3.5192269371328266
JM-1,5335621,3.4974928376934766,3.8679561598889136
CAL-51,444795,5.053001195278548,4.624901558770913
SNU-81,68056272,2.81466177200511,3.2863788990215297
MDA-MB-157,23582824,1.002360199735323,0.6043227406194943
CAL-51,44185566,1.8630594392382311,2.3624202208266247
MDA-MB-453,54618771,-0.4179555738274852,1.0940997749787789
MDA-MB-157,16038120,1.7351596622267822,0.9606329618652897
OVISE,44589607,3.8530354372246394,2.9155227527223375
LOU-NH91,navitoclax-MST-312 (1-1 mol-mol),-1.3828767553270485,0.9399249374322736
NCI-H460,400769,-0.4007490431715684,-0.5084021680282977
SCC-9,5460769,4.655053652221148,2.747169056135097
MDA-MB-453,135398516,1.6443590350340722,1.991307555559951
OPM-2,444795,4.04932788863876,2.901561093313643
MDA-MB-157,navitoclax-birinapant (1-1 mol-mol),-3.5674569438027977,1.5996138313662387
OVISE,navitoclax-MST-312 (1-1 mol-mol),0.1298249702458385,1.1641327188944468
HSC-4,11656518,1.5757846986297326,1.987721133911471
MDA-MB-453,navitoclax-pluripotin (1-1 mol-mol),-0.3400363144819007,-1.0317706472811994
G-401,3062316,1.3877203939609295,1.3861604601571642
SNU-61,16013152,3.3306050431250056,3.374863114024848
NCI-H292,4259181,-0.3596950747779806,0.4260996220198233
G-401,6918638,0.0373379560261908,0.1979859760719237
NCI-H460,53232,3.485336782178725,2.7483935689053256
NCI-H292,navitoclax-pluripotin (1-1 mol-mol),-0.7245377190748261,-0.7338246780404362
HSC-4,262093,2.780665409693215,2.980087653399318
LoVo,100016,6.001395250082881,6.098453298149236
OVISE,2729026,3.0624747536258843,2.7489561502978574
SNU-449,46174525,4.694645250518289,4.5810922220370625
MDA-MB-453,25102847,3.185871702253412,2.37549986150501
NCI-H661,selumetinib-piperlongumine (8-1 mol-mol),4.143402820216487,3.0959511149154664
LoVo,208908,1.8298234127328137,1.8473083611120957
DMS 273,36462,2.158918041886743,1.6349744118328662
SCC-9,252682,6.244434841835944,6.446124449137617
CAL-51,3689413,0.5709426612715743,-0.1268661813155924
ONS-76,5328940,1.5304760606777814,1.6210859779146762
KYSE-70,46199207,3.0458734214111436,3.117554746606245
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225,0.6731050277305759
NCI-H727,16720766,2.0944103672723577,0.47865041239778205
CAL-51,16741245,4.222373420591208,3.900805653119755
HSC-4,23939,4.494005895197972,4.361270069075888
LoVo,60700,-0.3967380120150421,-0.24694741229734077
MDA-MB-453,25262965,-0.03783703480807,-1.9306344510496332
A-498,374536,-1.3715174839162405,2.3069195372487967
SNU-61,107970,2.0644711824277757,2.3062821502629443
G-401,702558,4.958816468985481,4.541221300820764
MDA-MB-157,tanespimycin-gemcitabine (1-1 mol-mol),-1.0230607950179071,-0.721880299959647
NOMO-1,16038120,-0.1786929053902652,0.22890924368454862
HSC-4,3543504,3.922868331711394,4.321992353975453
NCI-H460,vorinostat-carboplatin (1-1 mol-mol),4.479996249659036,3.258072852175131
SNU-61,10410894,3.2150759349666176,3.207734473988708
JM-1,2746,0.8560843341026924,2.131003996707003
NCI-H2009,15547703,2.9018345982556935,3.2486226941967566
A2780,246676,4.314588687253318,4.086198865925963
CA46,135398738,2.145043320547598,2.3802759947284624
MDA-MB-157,55508,0.9028127001821934,3.4341681728553413
Panc 04.03,71304818,2.709197405012258,2.660189499448181
MDA-MB-453,53301938,4.664434739240087,2.9008147290417594
A-673,46843906,1.5511639515888018,2.1723911737229855
OPM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.0917216914210384,-0.37319219723411157
MDA-MB-453,3543504,4.170014094465671,4.230822640481969
NCI-H2171,5470400,-1.4637445210918176,0.0658009120116135
NCI-H292,25062766,1.6798511870535655,2.1315144783751827
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.8386505596002423
A4/Fukuda,16736978,-0.5754825114210159,0.9343276526942746
JM-1,2749,0.0460059123026362,0.789719131578213
SCC-9,46215462,2.815249887965138,1.9832950182963176
SNU-61,24821094,2.5022209832597757,2.509395116976661
LXF 289,44493528,4.295099384269069,4.288360353695809
KYSE-70,54649381,4.140433754758901,3.8118454879590633
CA46,JQ-1-navitoclax (2-1 mol-mol),-0.4595467452216603,-0.18658643736558417
SNU-61,9826308,1.2155896819085543,0.0788553989570427
NCI-H522,49766530,-2.92412408259348,-1.245093733467922
HCC1143,44493528,4.485488370266477,4.344068729691914
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555,0.18276722868784356
CAL-51,3081361,1.780158758130264,2.2501542614176078
DMS 273,2746,1.8465116882146249,2.2768754093730923
HCC1143,5282054,3.2164949694146237,3.555804443108494
LoVo,navitoclax-gemcitabine (1-1 mol-mol),0.8957448181446594,-0.9352291527172178
SBC-5,644241,3.9213876276885458,2.290420142890826
DMS 273,702558,5.649496210085508,4.351323502072263
NCI-H661,25183872,-0.013752841490686,-0.6587995716727191
NCI-H1623,71751553,5.091527890142487,4.630094149125753
SNU-61,10322450,3.828611192492266,3.3609335377149296
YAPC,44589607,1.444383642816813,3.0997825158452765
FTC-133,426756,4.37678677221598,4.403315820707665
DMS 273,25062766,2.819032107658894,1.7155758283686386
KYSE-70,375860,-0.042936769343065,0.1720806594590453
NCI-H292,6623618,2.2662127680014708,2.4046190440440878
A2780,3634881,2.2771511965432767,2.855739359005203
FTC-133,11427553,5.52425857278767,2.775335605242052
FTC-133,613753,3.41594619216373,3.3863335773179237
DMS 273,5978,-4.4169630962529896,-2.927693717911231
MDA-MB-453,135398738,3.241714649843938,4.1700607897973745
G-401,252682,7.482268639703102,6.466779941496748
CAL-51,126941,-2.448006630223804,-2.7385108770076867
KMRC-1,1716436,3.642710819139985,2.9202700837834525
KMRC-1,9967941,4.338887861114791,3.7401132447850585
ONS-76,serdemetan-SCH-529074 (1-1 mol-mol),2.2978761416603812,2.046740138673176
A-673,16725315,4.562355532440761,3.6635887767702275
NCI-H661,54613361,-0.43407763491745,-0.23587938328246608
NCI-H727,17755052,2.165535951118127,1.9682454161010805
LOU-NH91,4521392,4.279385220000522,4.231941045354407
NCI-H661,448949,1.832526735111792,2.1604866317774873
RCM-1 [Human rectal adenocarcinoma],4788,6.143393528563881,5.683290420415999
JM-1,24753719,1.6485500810507543,3.4289416842386164
CA46,42642645,0.1424242949920916,-0.12147883059164843
A2780,122327,3.970459431332868,4.156262582249903
LoVo,11609586,1.9215259939554383,2.941736777649339
NCI-H292,piperlongumine-MST-312 (1-1 mol-mol),3.188802005351175,1.9848891728412972
Panc 04.03,6918328,0.7116207668770654,0.2693294737167656
YAPC,10302451,3.503177254309001,3.036150460326111
Panc 04.03,262093,3.918875507815306,3.140446789863388
Panc 04.03,4261,1.8035720705799856,1.9884932116634906
HCC1143,11238147,3.6259374679037943,3.2556974133361622
FU-OV-1,24951314,0.7779749033617789,1.4497813676990856
CA46,135440466,2.9995621349054007,1.7127645359713979
SNU-449,675434,6.334911868299287,4.665778779763711
G-401,568763,-0.8413074079434755,0.06352048356677396
A4/Fukuda,421610,2.9916322722523425,2.7015112849500724
NCI-H727,11964036,1.415853516680377,1.393019787647925
SBC-5,53232,3.018737473370281,2.6892434975982233
NCI-H1623,2746,3.1722069840164533,3.3203594735323594
A-673,25102847,1.6240664882379,2.241079772370455
NCI-H146,71680916,3.9962882248297182,4.324442453931231
CA46,702558,3.0016875761250383,3.885498568735938
HSC-4,3465537,2.7025414883497443,2.556749861769754
SBC-5,15983966,-3.760719305706525,-1.6049108318006495
NCI-H661,10184653,-0.0970326303224196,1.841391158572558
KMRC-1,docetaxel-tanespimycin (2-1 mol-mol),-1.2179749713416546,-2.9395801008485023
MDA-MB-453,3634881,3.217596499324366,3.1870794058030576
KMRC-1,54596558,4.448003654736506,4.56184056623008
SBC-5,6438330,2.801398037891768,2.2047146185176185
DMS 273,11317348,1.436395200538785,1.4889451018506838
MDA-MB-453,241158,3.8848602363142697,3.7475243891652728
CA46,72376,-3.3789820311778764,-3.6363851718003493
EFO-27,1242560,3.615097330539702,3.492181143078931
BxPC-3,51039095,2.7952547650191297,2.939467728910115
BxPC-3,71466380,5.524538311672043,4.431585656765558
A2780,49850262,3.28716577139928,3.2935782262046356
EFO-27,148124,2.931737870457193,-1.9786400311401295
DMS 273,65064,5.260786534928717,4.494964723463432
NCI-H727,5328940,1.5210077536616875,1.7376028748728631
SBC-5,20959075,-3.707780876124786,-2.396123244409083
LOU-NH91,5281321,-2.3527775967876097,-0.9456153783270185
OVISE,123631,2.580734449711204,2.3085202700171585
BT-549,navitoclax-piperlongumine (1-1 mol-mol),2.0033323756459325,2.1206528582831448
OVISE,56946209,-1.506774361262591,-3.820770580472733
DMS 273,5282054,2.793045570742954,3.0563841303559824
SNU-449,11626560,2.613161578711923,2.079256608790619
HCC1143,vorinostat-carboplatin (1-1 mol-mol),2.950179443799285,2.9871448914679655
KYSE-70,11214940,1.7563649507227177,2.2344254636477334
Panc 04.03,15953870,4.151399322633975,3.7007130395002377
LXF 289,16736978,1.6084503302226174,1.5574915273821688
MDA-MB-157,60700,-3.9633933148193066,-0.07016579228906915
RCM-1 [Human rectal adenocarcinoma],25102847,3.88391486543544,2.5185819391387194
NCI-H522,11152667,0.761836671652074,-0.520580252082852
SCC-9,1750826,-1.358939777918893,-1.0711241990574292
CAL-51,3854666,1.1494535123186709,2.0488639710121954
CA46,11656518,1.817934601803022,0.6538820316849835
CA46,46843906,1.200591966763502,1.3812076133918374
A4/Fukuda,ISOX-bortezomib (250-1 mol-mol),-0.2493422793699864,0.3415761402818356
CA46,24772860,-2.6679944090404035,-3.128285626784784
G-401,24771867,0.701574094296253,0.7676392961283902
SBC-5,44202524,1.3408029920565403,2.0757171451107577
NCI-H2009,44507138,1.543580962147717,2.7473339176256535
OPM-2,24748573,1.2641689672749945,1.4604051603378456
NCI-H661,3025986,-0.862198206140106,-1.0124297950903216
ONS-76,107970,2.339276188405755,2.3498331610921848
BxPC-3,54619267,3.7277591748612866,4.008524518496661
ONS-76,4917,3.1821597264511863,2.898412041778723
NOMO-1,44493528,4.211717002525977,4.1443279032476
SNU-449,421610,4.477929285236737,3.298091510421465
NCI-H460,4259181,-0.2054535095090753,0.27806154264308225
G-401,327653,2.827166761380022,2.861181147039637
SNU-449,10302451,2.626140201612578,3.3787883129906264
OPM-2,24964624,1.0133948666397414,0.9479365480180675
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,4.087612888133789
SBC-5,441298,0.8643210359830038,2.4726516806043595
NCI-H727,44489367,5.9503570299169875,4.661967612450285
HSC-4,123631,0.7882754974693414,2.272128837959
ONS-76,24753719,3.8801096922841656,4.119183147507839
A2780,53495165,-2.5208465146636008,-0.8973303676484224
SCC-9,135411,1.0456929507985402,0.8269869862465921
A2780,6918878,0.724096247903148,1.3999212275034174
A-498,45279963,3.865048616527305,3.842695543212615
NCI-H522,51039095,-2.208127710853326,2.1743108403432228
LoVo,5335621,4.644708398315867,4.323914272258746
HSC-4,46199207,3.2853086951025197,3.141458018096214
KMRC-1,45279963,3.811973271229391,3.6811382409651383
LXF 289,56946209,-4.292268406284497,-3.844159042383349
OPM-2,24775005,3.1759511003243532,3.2981216456008706
MDA-MB-453,11609586,2.797782394552202,2.7253649489008995
FU-OV-1,JQ-1-carboplatin (1-1 mol-mol),0.7571969377872175,2.401066626504407
A2780,53481919,3.3933560170788355,3.261546208197098
G-401,25150857,1.6513368879801875,2.086855957273517
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.8386505596002423
G-401,126941,-1.029913917257394,-2.9233466821232543
FTC-133,JQ-1-MK-0752 (1-1 mol-mol),4.281585420865333,1.6237629364123363
MDA-MB-453,BRD-K55473186,2.6877336742225424,3.8366474848791303
MSTO-211H,5311281,0.6318902138586533,2.451746705118754
CAL-51,44589607,2.4963130908502107,2.945522182300169
KMRC-1,11234052,5.10610802043039,3.861745790607979
OPM-2,erlotinib-PLX-4032 (2-1 mol-mol),3.4874212858880314,2.697207874559047
HSC-4,5291,4.568554891244716,3.6007846227357594
KYSE-70,3543504,4.273044270546896,4.359161560813549
NCI-H522,54618164,3.979913879048498,4.036845081034649
LXF 289,selumetinib-UNC0638 (4-1 mol-mol),2.485737118348581,3.5192340434661378
DMS 273,439501,-3.5888564067388633,-2.2960047560852703
MDA-MB-453,122327,4.8881767020652775,4.547499389083516
A2780,6918837,-3.827695834319955,-3.720638227080274
A4/Fukuda,44489675,3.3968348796203003,4.028158120705324
NCI-H522,25195348,4.252884841670477,3.212126234392804
SNU-449,11404337,-0.5921655065432572,-0.05189171298808105
MSTO-211H,12003241,-2.79016034960529,-1.1907800754908364
A4/Fukuda,selumetinib-PLX-4032 (8-1 mol-mol),2.453113132843287,3.4334260199681563
SNU-61,654092,-1.5451038120184588,-0.2542317215458871
NCI-H1623,4705,0.0935418442786881,2.9822661321465995
NCI-H460,3543504,4.388423548450019,4.372421843844873
NCI-H522,23635314,-4.582316729083318,-1.9696092742727356
LXF 289,6918837,-2.0130943060067454,-2.4369686939750035
LoVo,31703,-2.470313869470646,-0.7206900383798539
MSTO-211H,ISOX-bortezomib (250-1 mol-mol),-0.1802030513255949,0.6793937957942046
FU-OV-1,654092,-1.6613932676517214,-0.07587964157405022
OPM-2,60750,-2.943046758118922,-3.108699547514115
Panc 04.03,serdemetan-SCH-529074 (1-1 mol-mol),2.4838177280551057,2.2852701901302446
A4/Fukuda,445643,2.2110077600401996,3.6838023617705575
JM-1,25105715,3.1433974364296526,3.2330153826055903
KYSE-70,9967941,5.193135802047497,3.5301270929786273
Panc 04.03,24748573,2.946919213932378,2.418662259959936
MDA-MB-453,6918878,0.409116855324534,2.5089197920760076
Panc 04.03,24901704,4.022965674422846,3.4479374544096855
CAL-51,16736978,0.375988055286384,1.4966046595271836
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885,0.5370171408992981
NCI-H727,carboplatin-etoposide (40-17 mol-mol),5.344630715975986,3.024217864203232
Panc 04.03,462382,1.207122186011881,0.6377626876344283
BxPC-3,568763,0.1839879990612418,0.7844412376253038
A4/Fukuda,11640390,-1.5428779369431247,2.6690321726570323
RCM-1 [Human rectal adenocarcinoma],5566,3.137413738775102,3.111123725548189
NCI-H522,216239,1.926799438191183,1.88386039340707
G-401,53392493,1.8463111416757765,2.3365789625966755
KMRC-1,241158,4.823138037217212,3.697864787966596
A-498,5566,2.910612965628124,3.1758825143713896
SNU-61,17755052,2.932810476371255,1.3173123854489146
HSC-4,49793307,-1.7279713732228117,-2.6839456522514054
SW1463,49793307,-1.9541064611693424,-3.386068967123901
LXF 289,11964036,0.5627528071719251,1.5136338086514451
FU-OV-1,11228183,2.3859582400300683,2.3800452286353275
EFO-27,5311,0.9089041307391243,1.6268461196807564
SNU-449,44819697,-1.6819344520854818,-0.4547062003391041
G-401,JQ-1-UNC0638 (2-1 mol-mol),-0.8221581174940659,0.9385577483281121
A-498,168313307,4.423397924448837,3.099613709263613
NCI-H522,19582717,4.722348713472889,3.7351370349058883
FU-OV-1,9903786,2.8592788804010936,2.837968074081262
DMS 273,444795,4.3404236236698495,3.390150673329537
A2780,56946209,-4.674045280410088,-4.14331184132654
A-498,tretinoin-navitoclax (4-1 mol-mol),1.5109888268131983,2.7764134572621297
A4/Fukuda,3503,1.0521499831923595,1.8167512653785334
SBC-5,6918837,-2.402107568310104,-2.6409690127112966
YAPC,23582824,3.2647123156294855,0.5794524589151976
HSC-4,159324,3.192829599869501,3.2547155223387985
ONS-76,54619238,4.4304444652836805,4.867934623339663
G-401,11228183,5.702662541402335,1.4713050432651316
JM-1,44819697,-3.7816867530650535,-1.7190119372193688
SBC-5,54143018,-0.8844414516239579,1.0580363947338718
A4/Fukuda,44589607,1.1710928843495056,2.1873851644788713
ONS-76,44543605,3.8219566402137457,3.9084476736249094
YAPC,15983966,2.0827072702810847,-0.2941819886910939
SBC-5,2749,1.818007095297154,1.9494796812619106
FU-OV-1,44487872,4.488734888040304,4.463013210000896
EFO-27,44197249,3.884486906001317,4.108127566705416
NCI-H2171,10385095,0.5588950968794439,1.1158853203466936
LXF 289,5351362,2.37199640031851,1.665456649571742
OPM-2,54618305,3.930022905522119,3.5089599750326608
NCI-H146,327653,2.704686127708374,2.895527316142764
OVISE,11497983,4.4381003844097595,4.086346467254822
NCI-H522,11977753,-0.2877362686640902,-1.6555814691442223
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.1362272246438712
NCI-H522,11707110,3.8955176091352857,0.7142003960001204
HSC-4,3676137,3.997252050059137,4.475880813864425
CA46,BRD-A02303741-navitoclax (2-1 mol-mol),3.6671520767068095,0.7492194641093399
A2780,9840324,5.381878860524984,5.5414636574670775
BT-549,crizotinib-PLX-4032 (2-1 mol-mol),2.4648473849576384,2.040352778433837
FU-OV-1,6917907,-4.405886494893828,-4.1567505192890595
CAL-51,71304818,3.0248956992793565,2.359134018661566
FU-OV-1,51039095,3.5191953123451096,2.9271449521379616
SNU-449,5470400,0.6313893315276518,-0.47831302917553237
MDA-MB-157,6438330,1.1379279588809148,1.995934112909099
NCI-H727,969516,3.103754409621015,2.7144899034793717
LOU-NH91,439501,-1.197324809082114,-1.9647264935407456
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977,0.8484471601596536
FTC-133,148124,-3.926787463073679,-1.9133263386759134
NCI-H146,24901704,3.4954665576646216,3.040363066401878
NCI-H146,6505803,-0.3489025917214021,-0.6640714043789573
BT-549,44819697,3.658602858416661,-0.77151467606427
Panc 04.03,5278396,4.260606427966062,3.5557648711126064
G-401,11647372,0.0479330615057392,0.9289989306722287
EFO-27,71466445,6.412452895571818,4.066048694672563
NOMO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.002133040962993,1.246623809363545
SNU-61,selumetinib-UNC0638 (4-1 mol-mol),1.9080621375720417,2.5547720811040704
NOMO-1,1716436,2.6410194121109773,2.470392484676966
JM-1,navitoclax-pluripotin (1-1 mol-mol),-1.136595381126137,-1.6966966329681434
SNU-61,46199207,3.1956978461436014,3.1191307801540633
LXF 289,4261,1.4002862892534345,1.7313750106812562
DMS 273,46843906,2.9019571008738763,2.0391392734720712
SCC-9,25150857,2.532575506870741,2.4986334490311473
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,1.1538060417472675
NCI-H727,24785538,-1.326987163467981,1.758503958288942
NCI-H661,11404337,-0.0954545894437525,-0.46553297122890464
MSTO-211H,66577038,3.302731292752764,2.9062220608609266
OVISE,126941,-1.5326684035544371,-1.8501320939077326
BT-549,44566777,1.3521548270810906,0.7467067428845046
A2780,3025986,-2.2950808421603983,-1.194736956557585
NCI-H727,16736978,4.598640955798025,1.4341962152337555
JM-1,6610216,3.7780643735318615,3.7723666567360565
MDA-MB-453,168312962,-1.3854623993271444,1.7132012016998033
LoVo,2749,2.494181165729376,2.142858493905129
OVISE,15547703,4.212246909591729,2.96493483115906
ONS-76,16736978,2.0849164003870877,1.7352080039751876
MDA-MB-453,1714884,2.9618056579194585,3.625545896380109
DMS 273,327653,3.1988672985426847,2.9683718537208046
YAPC,2828334,6.193046978626199,6.193040163462119
CAL-51,10184653,1.4453250777347395,1.2575859736034989
Panc 04.03,9936388,2.385451093408398,0.10813672247155565
NCI-H2009,4477,0.2115452666376647,0.5822740606525508
A2780,322968,2.566344426002007,3.1089467915454527
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596,2.5212459150097466
EFO-27,216345,4.384346641524126,4.157679835929253
Panc 04.03,UNC0638-navitoclax (1-1 mol-mol),4.190054196085194,1.7973472484125035
LOU-NH91,9956119,4.571782850484356,3.795652659185042
NCI-H661,1641662,2.9325574972427813,3.5023029792700253
CA46,44493528,3.81061502276679,4.082178439667326
OPM-2,navitoclax-PLX-4032 (1-1 mol-mol),2.9114134564638037,0.6170729837912708
A2780,11647372,-1.4335547211387447,0.7493822229887505
SCC-9,176870,2.779248818408345,3.0928812983998926
NCI-H2171,JQ-1-vorinostat (2-1 mol-mol),-0.591426926021434,0.5904552221456002
SCC-9,ISOX-bortezomib (250-1 mol-mol),0.3127664498221564,0.6407055314132877
NCI-H2009,25183872,2.394233803753281,-0.6612493980968454
BxPC-3,selumetinib-piperlongumine (8-1 mol-mol),1.5279722865269718,3.3751802359349723
FTC-133,selumetinib-JQ-1 (4-1 mol-mol),3.749238444437789,1.484863950143965
NCI-H727,11222830,1.7878002384813196,1.7479692314628377
RCM-1 [Human rectal adenocarcinoma],doxorubicin-navitoclax (2-1 mol-mol),0.7949647024919319,-0.6304836169458932
SCC-9,9823820,5.247901285797655,4.1406705393829215
FTC-133,44462760,4.267925011817446,3.361203960323243
EFO-27,salermide-PLX-4032 (12-1 mol-mol),5.523351402733512,4.7601355381412205
DMS 273,54618164,3.989243888703328,3.8171863054898334
A-673,5470400,-1.9410984929514092,0.022205879595470046
A4/Fukuda,56973724,1.7857996527787343,1.970814617952465
NOMO-1,5311281,1.2143454060885572,1.833455038620874
CA46,135423438,1.6657304721140649,0.9529241946142919
HCC1143,5287620,-1.5012475814925117,-1.9953105835456844
EFO-27,107970,2.9901836608736883,2.4149392138830934
EFO-27,7251185,1.6138148752584345,2.5211289953176674
LoVo,11214940,1.900565531770479,1.6894326145388083
NCI-H2009,6450551,1.0382100121131883,2.764662969564982
LoVo,3081361,0.9226789940369008,2.303598137819725
SBC-5,BRD-A02303741-carboplatin (1-1 mol-mol),4.575375432825298,4.031458362249888
Panc 04.03,2113511,7.412620584739622,5.8523703970129555
G-401,crizotinib-PLX-4032 (2-1 mol-mol),1.2254709557426715,1.4309717378974145
A2780,42642645,-1.071178701221225,0.0841746504173123
RCM-1 [Human rectal adenocarcinoma],46191454,2.186617263372051,1.9487023486827213
G-401,72376,-2.6056367900842745,-2.7484768454629336
NCI-H460,54618771,1.6853262233131374,1.4043559167262112
BT-549,selumetinib-piperlongumine (8-1 mol-mol),4.450190552332179,3.7857908285972304
NCI-H1623,60750,-5.650217340343659,-1.4715142736949212
BT-549,49766530,-1.005486623843658,-0.7117241090706203
NCI-H292,10184653,1.6188231902933972,1.205767631004929
NCI-H727,5282054,3.939726324876112,3.6789401884958877
Panc 04.03,11485656,3.4698409381110435,2.5086304065859415
NCI-H522,24772860,-1.6489481573528793,-2.119680051051564
NOMO-1,136227331,3.913043208951298,3.06505864338315
FU-OV-1,984333,0.3323688812243723,0.6353144812585532
LoVo,9911463,2.8816718818913176,3.7479468195949637
NCI-H661,6917907,-5.078778116905793,-4.33163237016567
SNU-81,25102847,1.5499571993593506,1.9665511078813955
CAL-51,159324,3.1794720270506307,3.231346564754272
A-673,122327,3.9666709409894527,4.179755268223319
RCM-1 [Human rectal adenocarcinoma],72734382,4.304323658475911,4.584803390263568
KMRC-1,2858523,3.233729541186922,3.236280660502601
LOU-NH91,9823820,5.384931157369051,4.21498954566099
NCI-H2171,5287969,-2.1635291246577286,-1.9760088316778615
A-673,426756,2.5032328390514365,3.9973622547689165
HSC-4,24964624,2.5086826728272538,2.463124834921335
NCI-H1623,176870,0.1873243677029567,3.321504127502464
KMRC-1,7251185,3.109058235493882,2.4485314388915373
NCI-H727,6610216,4.563405769903236,4.288114407493632
BxPC-3,15983966,-3.8778410742282694,-0.4986516182945633
G-401,46843906,1.9398273455018735,2.2020516722605366
NCI-H661,126941,-5.16742432120375,-2.5048340586024747
FU-OV-1,5746,2.910322472492285,1.5559805331131988
CAL-51,11609586,1.5077859423552509,2.78108015623413
NCI-H292,navitoclax-birinapant (1-1 mol-mol),3.1013974556417825,2.000173785950391
NCI-H1623,23582824,0.0165284592292431,0.7984283506172665
SNU-449,31703,3.0847938162993707,-0.4520873832357718
A2780,4788,4.492604658524488,5.2439851832317155
Panc 04.03,25102847,3.783052108341051,2.501881852212498
FTC-133,selumetinib-decitabine (4-1 mol-mol),6.596226241094775,3.651412764941984
NCI-H522,5113032,5.82110442960573,4.622451891024225
KYSE-70,16038120,2.0286855638164054,1.2208064559377907
RCM-1 [Human rectal adenocarcinoma],2945648,2.1413236480438544,2.8638732958331685
JM-1,2828334,5.9839290329767945,5.656471520513022
G-401,16736978,0.7492323653316314,1.445707557131428
CAL-51,107970,2.299284460939792,2.3931326905950483
NCI-H522,carboplatin-etoposide (40-17 mol-mol),3.969229835066765,1.9879233692546765
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007,2.9247062801569745
NCI-H460,51039095,3.9314979002332535,2.8742047685498147
MDA-MB-157,9903786,1.458865596348786,2.8858217624014197
RCM-1 [Human rectal adenocarcinoma],selumetinib-UNC0638 (4-1 mol-mol),2.1355082647556127,2.411122418863605
Panc 04.03,54678924,3.3151598744761626,2.405941325148167
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012,-1.1133891250175427
ONS-76,25195348,3.7356955751438754,3.2358250047826163
MSTO-211H,71466578,5.31450298723974,4.824457845954597
CA46,crizotinib-PLX-4032 (2-1 mol-mol),1.0865859048820203,1.0307374883193237
LOU-NH91,10385095,0.9698085069900604,1.2389427818712597
FTC-133,24856436,2.183528137346661,0.7399965294986512
A2780,54613361,-2.0737031658574043,-0.11349540011109527
CAL-51,5311,1.4183219405835503,1.700206065797025
NCI-H522,51037431,4.989409718658752,3.031653555508777
Panc 04.03,11647372,2.0191280123179824,1.482033227949183
NCI-H727,327653,3.8552398443183193,3.214779280901214
OPM-2,9884685,-0.7869928949425254,-0.23175090336262236
BT-549,676352,1.8104954024890367,2.1004673974083645
CAL-51,46907787,3.297361866649883,1.8837050677028886
EFO-27,11494412,4.723849828867172,1.7663916482217632
A2780,60700,-2.20534635529039,-1.2525556848890376
A-673,5281321,-1.2857978730590742,-1.94738697505198
NCI-H522,navitoclax-birinapant (1-1 mol-mol),2.79987001717094,0.9074340544342218
NCI-H661,6610216,4.875851858170822,4.177822852631032
NCI-H460,6917907,-4.956095121428261,-5.044327256084825
A4/Fukuda,5460769,3.0365194168079572,2.0826097010388005
BxPC-3,3025944,3.477531707151509,4.376002206726264
CAL-51,16065773,2.8749329306977853,2.3872996936190414
SBC-5,navitoclax-piperlongumine (1-1 mol-mol),3.0140004933884796,1.7946927581977261
EFO-27,2874250,5.869363689503336,4.6277790222952815
A-673,702558,2.7000584853196936,4.42762718613519
HCC1143,107985,-3.4652614368177432,-3.494889853343835
SNU-81,navitoclax-piperlongumine (1-1 mol-mol),0.0853232254018234,1.223383009620111
NCI-H522,3025986,-1.0139106356663683,-1.0318352727132534
NCI-H2171,439501,-3.0635131055453924,-2.3341105309577306
NCI-H522,444795,5.191031194563041,3.9817568127387797
NCI-H661,53392493,2.28152765608909,2.556040242396369
Panc 04.03,445643,3.9306423242452673,4.005800455891244
NCI-H727,selumetinib-piperlongumine (8-1 mol-mol),-1.6426158910123243,3.1876001403847054
NCI-H292,25150857,2.3048085705836563,2.5642048814041436
NCI-H727,25126798,3.836281743476004,3.843457036053108
RCM-1 [Human rectal adenocarcinoma],2708,5.228043564409416,4.969639055874427
LXF 289,tanespimycin-gemcitabine (1-1 mol-mol),-0.7803553761989187,-0.32200485950228475
ONS-76,9887053,4.335145594020597,4.050802681337884
OPM-2,675434,4.053836549963459,3.946678525260194
KMRC-1,16725315,5.238650021868635,4.154687504243468
SNU-449,piperlongumine-MST-312 (1-1 mol-mol),1.362794205944183,2.0765752381098217
A4/Fukuda,151289,0.1986917338936865,0.7323406079030538
SNU-449,ISOX-bortezomib (250-1 mol-mol),2.1712489431250437,0.9099666405823639
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291,0.8508456257358411
CA46,selumetinib-UNC0638 (4-1 mol-mol),4.090188755292698,2.2225694057494847
MDA-MB-453,56963564,1.2952259038449256,0.4587942103615104
NCI-H522,65064,5.303150406450188,4.639590144186472
NCI-H2171,24772860,-3.209318985857815,-2.264040941905656
KMRC-1,104842,1.0931359128213904,-2.3535614480401303
NCI-H460,16741245,2.175171044948558,3.8767280772649486
OVISE,4259181,0.909929291036465,0.42212424681040256
HSC-4,46191454,1.405754738797376,1.4603130951153795
KYSE-70,2749,2.2442090130660577,2.047001112053844
SNU-81,400769,-1.1944669265215293,-0.4006418488669978
NCI-H2009,6852167,1.9075911063810396,3.1325695584203275
SBC-5,241158,4.402731015442316,3.7991513127107663
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236,0.7723461125003412
HSC-4,44185566,3.0805483382503844,2.698583555624174
FU-OV-1,17755052,0.0450390211671309,2.187805191531574
KMRC-1,53495165,5.726132279462146,0.44688482556928427
NCI-H146,6184667,1.5836777358218528,2.8254849917895735
NCI-H1623,selumetinib-MK-2206 (8-1 mol-mol),1.9939850846524236,2.4101945021832596
HCC1143,55283,3.9101720152241226,2.7539618143197715
OPM-2,71466445,2.165442844786418,2.4526474966971143
A2780,49867926,3.0666746223408157,3.5770376011241707
LOU-NH91,17755052,2.4120102833965844,1.9523766981638615
MDA-MB-453,49867926,4.180155964726801,4.113867782992065
Panc 04.03,25183872,0.1973991794911014,-0.6328791943674225
CAL-51,9967941,3.511576456928413,3.4205568030626496
SBC-5,6852167,3.965917526242172,2.9714004357728556
NCI-H292,navitoclax-gemcitabine (1-1 mol-mol),-2.2738254252186314,-0.5456502962987424
KYSE-70,selumetinib-UNC0638 (4-1 mol-mol),3.25629169074294,3.1373970857739817
NCI-H522,54596558,4.342696772784201,4.56969848515903
HSC-4,2733526,3.5101027459294425,3.766342742853654
RCM-1 [Human rectal adenocarcinoma],23725625,5.154585398323981,5.177535776867038
OVISE,decitabine-navitoclax (2-1 mol-mol),0.3462958100091469,1.7492021757892062
MDA-MB-453,4477,-0.2020943624975227,0.5171134986622228
NCI-H2171,72193861,0.5955631718249997,0.8859674331743999
NCI-H292,2828334,6.458495810735601,6.198339531881445
ONS-76,7326481,1.79748139254514,3.001616208025081
A-673,44607531,1.457749077960986,1.2819270263296179
NOMO-1,73707438,4.2876330596581305,4.030844511902121
NCI-H460,60750,-0.8382921927225392,-1.9615858671005202
NCI-H522,4259181,-0.2456063667287351,-0.14492252037856412
A2780,JQ-1-carboplatin (1-1 mol-mol),-0.3248944310620366,1.4226770592503402
ONS-76,969516,2.910086136195903,2.816185972056266
YAPC,49850262,3.6789282041181095,3.9057463724132764
SNU-449,44491742,3.9284370838515903,4.435076304850015
MDA-MB-453,11485656,1.765591398344026,2.262237323135427
NCI-H460,44607530,3.4043015144880444,1.7874779028320325
OPM-2,56949517,5.349058842742104,3.6423267248405433
SBC-5,216239,1.5582588949606833,2.165079356325032
NCI-H661,219104,3.9372744940630646,3.938855133728229
NCI-H460,44484440,3.757520830720006,3.1632458807714796
MDA-MB-453,44462760,5.00879187339522,3.7119645284957055
ONS-76,5281321,-1.2480266745690851,-1.4352496854914865
LOU-NH91,5566,3.288881685822646,3.030626527686867
MSTO-211H,72193861,1.6065459514404858,2.0088379570552353
NCI-H1623,16038120,-0.158474112921266,1.2007169274143736
BxPC-3,11238147,1.751681691561693,2.9810039271044326
YAPC,3025944,4.720838189364642,4.349280772511863
SNU-61,1239801,4.195034605110225,3.5852459945881696
NCI-H522,11640390,4.472705990017258,3.3089222143276333
OPM-2,11238147,3.2386204402735874,2.0089647748056407
YAPC,16722836,1.8948218470527252,1.816324468552726
MSTO-211H,4261,1.9115438043118669,1.8987360735616314
BxPC-3,24901704,3.2492386456059266,3.4613777793591334
A2780,2742550,2.799223861459344,3.128571612521014
LoVo,6918736,-4.296362304597629,-0.9907047609194357
NCI-H292,3854666,3.3764205876154074,2.4029337333019263
G-401,11222830,1.5347756238466792,1.5560348656899867
CAL-51,44620216,5.469091994130916,3.7937436675876692
NCI-H146,6918328,-4.616864565737749,-0.7643136999987205
SNU-449,100016,6.350050439021361,6.345597464116598
CAL-51,6438330,3.884194225982375,2.1470330805637503
A4/Fukuda,451668,-0.3897468918932548,0.01270175610891271
NOMO-1,135875424,3.068632733482165,3.1048493082803343
OPM-2,selumetinib-UNC0638 (4-1 mol-mol),2.327180479574148,2.248531880910456
MDA-MB-453,9907093,5.353373126975176,3.9968780270460655
SNU-81,11404337,-1.7380856142345846,-0.17062835842367519
BT-549,3634881,2.142843752657143,3.5923294572614104
SW1463,6918837,-3.406571913442127,-3.327087508750249
HSC-4,6610216,4.241818899552939,4.1908431842527465
G-401,135421197,1.4306754302223277,1.5658751522279035
MSTO-211H,400769,-2.118881346037636,-0.5866038545000358
OPM-2,56946209,-6.715247823396851,-5.1155836065152505
OPM-2,156414,0.898749748032719,0.8389969252268705
SCC-9,2708,5.420316309291021,5.127736805081387
BxPC-3,72376,-2.7426383250741786,-1.7617720053304975
LXF 289,44607530,1.309750089611443,1.8598840782052417
A4/Fukuda,216468,0.7779788317268376,1.2488431003661968
ONS-76,9936388,2.029236983033262,-0.6459101029879425
A4/Fukuda,navitoclax-MST-312 (1-1 mol-mol),0.8742444067839383,0.695914729065514
A4/Fukuda,15953870,2.701018205920996,3.141651712734951
A4/Fukuda,3825829,2.918538307685252,3.40178821503796
NCI-H522,1716436,2.601362471636894,2.9221680165280968
NCI-H460,16725315,5.407057101640495,4.1609142492464954
NCI-H661,969516,2.7370069869182996,2.9069817196655934
SNU-449,9915743,1.6643053553641087,1.2713314047045479
NCI-H522,16219061,2.1788816492377054,2.656762504683669
NCI-H1623,25126798,4.062693377799547,3.731390772668943
LoVo,46199207,2.62459096292295,3.119815263135979
Panc 04.03,2126,5.406308275886939,4.695881641404996
NCI-H522,702558,5.065903257418961,4.501642991124797
NCI-H661,44489675,4.0470438340050086,4.112576378573797
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975,5.084101796461589
CAL-51,11175137,1.2330676481368064,2.5590860218027545
EFO-27,tanespimycin-gemcitabine (1-1 mol-mol),1.7387659506719169,-0.47058431663021627
A-498,119607,5.756544485429512,5.317324493409494
CAL-51,89183176,3.8950338695454088,4.70250532729376
FTC-133,2828334,5.859070513237425,6.205166010835447
KMRC-1,135440466,2.425894917183188,2.3996298069599815
NCI-H2009,36314,-5.253596358515139,-0.8180873940742396
G-401,11238147,2.0802759078276853,2.212031141285384
NCI-H661,452548,0.003417557634082,0.32322230946702846
NCI-H292,5282054,4.085287507740134,3.846802344900518
HCC1143,10385095,1.0799280769088206,1.3482185411685856
A4/Fukuda,11626560,-1.03034976821798,1.1575350763711405
FTC-133,65064,5.375666939367713,4.899509570854738
BT-549,753704,4.958873098850826,5.147710253467628
KYSE-70,46224516,2.993089177283032,2.5083681976224854
CA46,11707110,2.876405562319207,0.9561524236424984
LXF 289,11609586,2.9430338892136354,3.1237868200301167
KYSE-70,10296883,3.691258417269261,3.793082842343868
A2780,tanespimycin-gemcitabine (1-1 mol-mol),-1.0115297721833665,-1.8286000251120549
DMS 273,67156097,-2.1294955352549,-1.7311758598735565
NCI-H2171,11955716,-2.5749004703466976,-1.2954341043759274
LOU-NH91,124202324,3.0671378719618283,2.6323532054709116
A2780,135659046,3.385733838662662,3.374768506749019
OPM-2,11427553,0.184758700497643,1.2158292575153729
RCM-1 [Human rectal adenocarcinoma],46199207,3.748216496798377,3.1562685002948814
OVISE,11427553,3.886061021243629,3.0575428262423032
A2780,24821094,2.7975033336102095,2.6607443090037286
LoVo,10410894,2.092646303934145,3.211847954090063
CA46,327653,2.398308016277815,2.5673151134534873
NCI-H522,135440466,2.851321997265629,2.0322242861363633
NCI-H661,9903786,4.646166413465223,3.0046438468861765
ONS-76,docetaxel-tanespimycin (2-1 mol-mol),-1.0307664921769042,-3.04742007515292
CA46,11427553,1.0834968953052575,1.2867392724673083
Panc 04.03,6450551,3.8538949310121353,3.1471341910748505
A2780,644241,1.9281614760038184,1.1568564404700687
A2780,3815108,2.053113262637462,2.589552412582608
NOMO-1,71466380,3.4384411266907295,3.897067912878398
EFO-27,serdemetan-SCH-529074 (1-1 mol-mol),3.002804413616897,2.1732229910489083
A4/Fukuda,24821094,2.016569070962388,2.754302248755035
LoVo,3503,2.2987332704820016,2.1994707340732886
LXF 289,46398810,1.8383298322371264,2.6371411293269023
NCI-H146,42642645,1.3339409860624971,0.6319040007285683
A4/Fukuda,navitoclax-pluripotin (1-1 mol-mol),-2.9042967889462408,-1.3681882500401872
HCC1143,135984461,4.873829103860087,3.678467678528413
LoVo,23725625,5.102020281972671,5.259162286466519
NCI-H2171,4477,0.0540600744484099,0.4205251959495277
Panc 04.03,24964624,3.127575767188385,2.794127760880923
CA46,676352,1.5563040092860552,1.7058981130592659
ONS-76,135440466,2.234484066901876,2.1319169956474737
EFO-27,31703,1.037291503873681,-0.5537864774606953
MDA-MB-157,208908,2.741119640746793,2.128660081361889
G-401,46191454,0.141864729037356,0.8643938497931469
LoVo,439501,-1.7683171506776545,-2.2701805795104097
KYSE-70,vorinostat-carboplatin (1-1 mol-mol),2.3289614094858813,3.1827485552174637
A-498,36314,4.095863504824457,0.5402046105838084
G-401,ISOX-bortezomib (250-1 mol-mol),0.1394395041296586,0.3867289435341035
NCI-H727,9935249,3.73205967923935,3.0161606861297945
KYSE-70,53392493,3.454381994737171,2.4791822889188935
HCC1143,11234052,5.229903952882612,4.091956793481095
CAL-51,4705,2.903463840875761,3.316792996574737
MDA-MB-157,56946209,-3.6171244608990905,-3.3382020060581596
LoVo,3689413,-0.0015328635235731,-0.26667011375244043
NCI-H460,46199207,3.5033257005335163,3.3124720011271847
BxPC-3,135411,0.8341107494370649,0.7832679572470188
NCI-H727,46191454,2.1799448668848105,1.9836122124679267
OPM-2,25195348,0.9238255530721258,2.6096588275718027
SNU-61,JQ-1-UNC0638 (2-1 mol-mol),2.3060253857026343,0.909496636178494
SNU-61,656346,0.8749051442535513,1.1071730767402637
JM-1,136227924,1.2038413750130548,2.294661952351723
SNU-449,49867930,4.864159132996777,4.686103439053556
A2780,2733526,2.8794725769531997,3.5816574255834506
OVISE,23725625,5.908959950408421,5.143685616515551
BxPC-3,60700,-0.122761385712052,-0.24812482482828271
OPM-2,53495165,-4.146839218250571,-1.7758117593225702
RCM-1 [Human rectal adenocarcinoma],135411,0.5141731800260497,0.7987579721275141
A-673,25227462,-5.829932006274449,-0.11571206503777154
KMRC-1,6918328,0.9635513821249304,-0.5294256800782842
JM-1,89183176,3.1890961462334335,3.068862760828031
MSTO-211H,16038120,0.2471942161915729,1.1062981016388205
JM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.175928698896838,3.2606952878239195
ONS-76,6918878,5.0214366982824306,2.7586885147231506
CA46,60750,-0.9269398092944348,-3.27399387905151
HCC1143,42642645,1.0566197638440329,1.0310487043920842
OPM-2,3503,1.0860674816661569,1.8815224736574008
BxPC-3,11612883,2.2063280154469993,2.918423357122478
NCI-H522,16065773,1.5488087432962436,2.023617326676374
A-673,3634881,3.109333818891092,3.0172500738069084
NCI-H2171,71466445,1.378191899492029,2.6774532572526897
SNU-81,JQ-1-UNC0638 (2-1 mol-mol),0.4433096898383019,0.9337108005909255
NCI-H292,17755052,1.3393568867062529,1.6937813892574887
NCI-H522,11427553,1.733163384028149,2.1308161067036666
G-401,selumetinib-JQ-1 (4-1 mol-mol),0.629673615073819,0.9106250956059917
BT-549,24797083,1.6394182791354686,1.386713035822949
OVISE,6438330,2.2515103089504818,2.3155932097291125
LXF 289,10410894,3.939992216810496,3.4227153386254066
EFO-27,60750,5.390319994108079,-2.0601098298533174
BT-549,400769,-1.1296625579443007,-0.39641351672966935
SCC-9,2742550,4.1692460597635135,4.0434127750543265
JM-1,5281321,-3.43257780081901,-2.787732968344305
OVISE,24771867,1.656692666128474,2.7910527300850076
SBC-5,3384730,0.0954837515635063,2.8270298745948663
BT-549,navitoclax-sorafenib (1-1 mol-mol),3.9279804703061703,1.9800581038734506
A4/Fukuda,2749,1.141581020051295,1.2967979692061726
G-401,1716436,2.4290804430946547,2.7518430347862926
NCI-H2009,23635314,-2.363129056883172,-1.3545185803803943
SNU-449,3081361,2.056588488576824,2.5455239742806306
NCI-H522,969516,2.4900188230240485,2.7073455669385407
MDA-MB-157,11626560,3.460415978238755,1.8062798563111868
NCI-H292,selumetinib-UNC0638 (4-1 mol-mol),2.5678319047053244,3.265142367798297
HSC-4,11719255,4.924721636143113,3.5909613429943312
KYSE-70,17755052,0.9465092626724514,1.8103362394029832
G-401,25062766,0.8725390828623283,1.8397863833987802
KMRC-1,4477,0.198014478122684,0.6124138789257026
SNU-81,44197249,-2.185783961489413,3.191367614610381
A-673,10410894,2.502904420433103,3.1951831011393295
ONS-76,6914657,-4.101072641720643,-4.045399897401769
MDA-MB-157,53495165,-1.8622859982145463,0.7095042972695635
Panc 04.03,72734382,5.165438336919353,4.604947205566728
FU-OV-1,navitoclax-pluripotin (1-1 mol-mol),-0.2689466648852067,-0.8900944252329275
CA46,613000,1.1767209163070167,2.427720192659041
EFO-27,3503,2.721888959468924,2.474277753015222
SNU-81,decitabine-navitoclax (2-1 mol-mol),0.903824446896739,1.6494240502231425
MSTO-211H,6917907,-6.416473568686441,-4.67521646315192
CAL-51,675434,4.354107922133551,4.486613354250219
CA46,5278396,3.312720557512005,2.809440677714853
FU-OV-1,9911463,4.1305925074662575,3.8926732330422027
DMS 273,5328940,1.9629216769229116,1.4140504547540371
LXF 289,54454,1.7599180903835134,2.2535163169500496
A2780,446155,3.1527811730433366,2.58910578577835
CA46,11222830,0.90552754986452,1.1674497206319219
MDA-MB-157,15547703,2.7177027433879912,3.2719282422913176
A-673,9915743,0.6829950735134661,0.912645920543455
Panc 04.03,50905018,4.96616490546014,4.386556204803879
NCI-H146,50905018,3.857703749758686,3.6291546691437917
OPM-2,carboplatin-etoposide (40-17 mol-mol),2.4358856749484596,0.5653097407892875
CA46,148198,-5.7845042531785,-4.181059994068894
BxPC-3,11427553,2.964396595429347,2.8064584103454386
JM-1,17755052,1.8568486472237824,0.7736881073425775
MDA-MB-453,135875424,2.7753375231350104,3.678775618007105
LoVo,52947716,-5.666189039665748,-1.1527378210921304
SNU-81,3543504,4.205084802754879,4.034610370372497
CAL-51,9887053,4.486783389261201,3.7074891610369956
YAPC,SNX-2112-bortezomib (250-1 mol-mol),0.1222425985645655,-1.2972166501204199
FTC-133,6852167,4.78859095347106,2.9460268519104424
SBC-5,46907787,3.799315463541784,2.4173290890736463
SNU-449,6918638,1.2557717528626495,0.9823968482191351
NCI-H2171,6438330,1.125878118169246,1.883382211478497
ONS-76,15953870,3.841628876209717,3.687190998917693
KYSE-70,44493528,4.735176242945038,4.233824863352105
BT-549,71751553,4.2471267374516435,4.4548314899548815
NCI-H2171,46943432,3.4065574915710735,1.9089341468971477
SNU-61,carboplatin-UNC0638 (2-1 mol-mol),3.8198655410363287,3.3617477646806844
A4/Fukuda,135875424,2.943838777845953,3.2049175519317066
SCC-9,25154868,5.2906536290113975,4.5343728228985265
A4/Fukuda,11964036,-0.0142982917472374,0.7309078518445322
NCI-H292,10302451,3.577296661602114,3.1990041862805128
A2780,135999136,1.5930192405329104,3.149273800934653
NCI-H292,54618164,4.184972812062346,4.238160114222689
LXF 289,107985,-2.691798131563437,-2.9646033665017058
NCI-H522,44137675,3.8599044567005434,3.1643732498139125
CAL-51,3503,3.2899889427654245,2.2738814679120476
A2780,409805,4.989244714218352,4.280208491601084
HSC-4,71466380,3.6804948915169784,4.334769254216223
JM-1,6918638,-1.945896791217812,-0.8687636855847329
SNU-449,44566777,0.6479277578392284,0.8326834141939194
MSTO-211H,387447,-3.4382078488280063,-4.238389324076099
DMS 273,9915743,1.912374780622189,0.8955376687331751
NCI-H2171,selumetinib-JQ-1 (4-1 mol-mol),1.3266542460733022,1.022060997127431
NCI-H661,16736978,1.5408428303752983,2.030551201365951
MSTO-211H,44241473,3.911097970359605,4.906214832972723
NCI-H460,60700,-0.2314807684970784,-0.42386504005770687
A2780,serdemetan-SCH-529074 (1-1 mol-mol),0.9740349619499052,1.7984314177013474
JM-1,227681,1.6891640861629382,2.4769101403101215
G-401,JQ-1-navitoclax (2-1 mol-mol),-0.4060053682032895,0.20290091263660365
NCI-H661,656346,0.6919490200967222,1.4541344959555473
SW1463,5311,0.7635678260369684,1.1511620731416072
NCI-H460,387447,-2.436463262555682,-4.183307505621766
MSTO-211H,navitoclax-MST-312 (1-1 mol-mol),-0.7166631771213113,0.9359788900607746
HSC-4,9825149,2.985341504866837,2.331011253730368
NCI-H727,25262965,0.7692581364380534,-1.2625011868580571
A2780,10077130,2.5506457702723786,2.854131670969803
BT-549,selumetinib-JQ-1 (4-1 mol-mol),3.8001526734522617,2.2009545124444942
NCI-H661,136227924,2.7818959309662183,2.849968623308751
SCC-9,446155,1.3937663931747788,2.941783915430955
BT-549,73707398,1.468839183930599,1.6567686733076121
A-498,navitoclax-PLX-4032 (1-1 mol-mol),0.6341402769109122,1.9319320051319293
CAL-51,6623618,2.223133904662847,2.1632387343717303
LOU-NH91,327653,3.620861790086289,3.380329782998747
BT-549,67291369,4.3793706620025095,3.144961076499125
MSTO-211H,docetaxel-tanespimycin (2-1 mol-mol),-6.863228932141716,-2.7969735419012367
NCI-H460,3025986,0.3909368316008428,-1.0075392154343688
Panc 04.03,11228183,3.2874901590346934,2.4526463396899834
LoVo,25262965,-3.8912736240644694,-1.301922171782454
SBC-5,73707398,1.6541333685248465,1.3622730078689838
NCI-H661,89183176,4.289155461605826,4.4732434207510785
G-401,44241473,4.28251451131172,4.328636285260362
BT-549,2746,3.8188337512891137,3.638144969636599
YAPC,25062766,2.237282024435701,2.2493382781257814
LXF 289,20959075,-2.4089188058085,-2.614203316793425
SCC-9,53232,2.1606412524830017,2.843490835517527
G-401,56649450,1.8227428945555348,2.8741273915189236
MSTO-211H,11222830,1.162959487763126,1.7067104217715832
JM-1,15953870,2.1778700018066144,2.9347224425701643
LoVo,15953870,2.9352023189332703,3.3929048634577197
DMS 273,15953870,3.8128904638275216,3.3579796709199807
G-401,JQ-1-vorinostat (2-1 mol-mol),-0.8769966942019048,0.7165259689522672
CAL-51,1750826,-0.4147302595408071,-1.5165739490993144
NCI-H522,9884685,0.1045560296672991,0.1725084797833769
HSC-4,327653,3.5197711195347434,3.1938861039789526
BxPC-3,6918328,-0.2318480121478282,0.09537376681789339
NCI-H661,10074640,2.974634579766932,2.9793084934782983
FTC-133,11178236,-4.398882676695501,-3.067415788158149
CAL-51,6450551,1.9748462748620472,2.667207360969641
NCI-H522,SNX-2112-bortezomib (250-1 mol-mol),-2.0311318982301665,-1.4358865899698758
SCC-9,5978,-3.875351555062552,-1.5604063293073611
LOU-NH91,5311,1.697115177859265,1.5364194795435955
RCM-1 [Human rectal adenocarcinoma],45279963,4.209581344916876,3.66900856607752
A4/Fukuda,49766530,-0.1813275565198268,-1.6773470116233262
CA46,5978,-7.34958411963843,-3.555216929412694
JM-1,15547703,2.5122126082355227,2.5322720235959326
HSC-4,3038522,3.958216901800584,3.4504445260948673
MDA-MB-453,24901704,3.2296574944609735,3.312589825138385
SCC-9,23635314,-1.650613607792241,-0.69164468458244
KMRC-1,11612883,3.608500084904783,2.91440772591889
OVISE,24772860,-1.0102375693918164,-1.1573940438871004
A2780,11626560,0.43489025720173,1.3609971903258948
MDA-MB-453,51037431,1.3361098813185686,2.9876086414698957
HSC-4,4705,3.95336427523857,2.9039729147447484
A4/Fukuda,24748573,1.3032837048402657,1.6191379434839122
OPM-2,51039095,-2.6866952618976434,1.9255676730832136
KMRC-1,11609586,2.4412406506497155,2.7938939083196455
ONS-76,11609586,3.485979398565755,2.7090259640009275
LoVo,12003241,-2.8621949377385465,-1.051503843353596
DMS 273,241158,3.177272786345067,2.98781814023754
KYSE-70,20959075,-2.927604227069557,-2.5163005273589207
SNU-61,16722836,1.3959733890222568,1.4978265484808466
SBC-5,89928392,2.3719311856170537,1.710345830277194
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.9980582645875489
A-498,4261,1.667462132250413,1.9136210066536672
SNU-449,23725625,6.429990861305722,5.149923143617192
A2780,4259181,-1.27299012623329,-0.041029756921712617
ONS-76,10127622,-2.1347139098699706,3.3294966757010873
A2780,1641662,2.3828094640764412,3.1133497210740306
RCM-1 [Human rectal adenocarcinoma],52912189,1.6859492587685891,2.3312234119607047
Panc 04.03,9549297,5.2530677537073975,2.2778050455989094
MDA-MB-453,53481919,3.1180191774885735,3.8909638772441024
JM-1,56963564,0.0249959117693502,-0.09095689483731509
HSC-4,11234052,4.4583786214563865,4.296856956559629
A-498,SNX-2112-bortezomib (250-1 mol-mol),0.1538165542627618,-0.789484657795706
BxPC-3,119607,5.22613990212802,5.4636023415977615
BxPC-3,5278396,2.866816315326302,3.631711526663165
LOU-NH91,400769,-0.4518117512524929,-0.3804677833774084
A-673,doxorubicin-navitoclax (2-1 mol-mol),-4.20921708976932,-2.068442374233455
FU-OV-1,16722836,-0.0099462763207794,1.6394701753133072
SNU-449,46907787,4.480861537403045,2.549731323670602
NCI-H292,24748573,1.9235457900331792,2.1819303752883754
NCI-H460,2113511,6.407699041859446,5.559724410076743
HCC1143,selumetinib-UNC0638 (4-1 mol-mol),1.3639730576271398,3.5042969694135735
NCI-H1623,46174525,4.205988468269685,4.691087539274757
NCI-H1623,6917907,-5.728045829659389,-4.655947194098432
MDA-MB-453,1641662,3.085427143962118,3.260985107424917
NOMO-1,3854666,1.0231806307237967,0.7997472011775693
SNU-449,24821094,1.9429996101140543,3.181788924966541
SNU-449,crizotinib-PLX-4032 (2-1 mol-mol),2.114422576149497,2.141592468961834
Panc 04.03,216345,4.594435961426402,4.060683639164078
DMS 273,2708,4.711982190259564,3.5939645614293987
NCI-H2009,navitoclax-MST-312 (1-1 mol-mol),0.6133760469311309,1.0737099060757251
A-673,11222830,1.3107049031534492,1.2523296421825834
SCC-9,219104,4.323236898621614,3.9307139468329075
KYSE-70,11455910,0.6771697782379181,1.0958356983809783
MSTO-211H,9915743,-1.0722844498490078,1.4868301229147716
HCC1143,3062316,0.306898118520016,0.9206485651361938
NCI-H460,11427553,3.3912724357702873,2.788812434384293
NCI-H1623,675434,4.403585448845777,4.3880728383953285
NCI-H1623,135928012,3.849713333151309,4.220020372200855
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473,1.3348654159620403
LoVo,serdemetan-SCH-529074 (1-1 mol-mol),1.6319978332110785,1.9752070726463504
KMRC-1,11222830,1.6210071273597368,1.6734395383230614
NCI-H661,44607530,1.6067743901515843,1.767470803488504
HSC-4,24753719,5.996217074466553,4.29518099299292
NCI-H1623,44607530,0.6082825778474802,1.778182557576181
G-401,409805,3.720272745750916,4.232796536258461
MSTO-211H,24771867,-1.256499005348058,2.8850284614304536
LOU-NH91,100016,8.416108067142021,6.388584202742729
LOU-NH91,navitoclax-gemcitabine (1-1 mol-mol),-1.5749911209291652,-1.0225446641966824
MDA-MB-453,9911830,2.483477791354312,2.4728653100118017
MSTO-211H,216345,2.6222222224733702,3.9166030163218593
A-673,5738263,2.33182798743241,2.998965527273786
NCI-H292,navitoclax-MST-312 (1-1 mol-mol),1.1730740558558932,1.090568365737851
CAL-51,16038120,-0.248771562775031,1.0282455055718422
SNU-449,11222830,1.6348775900621026,1.6719825066579528
SBC-5,11656518,1.8588197700646856,1.5140101199044713
LoVo,637858,1.5179613366947162,2.021022746790953
OPM-2,16065773,1.0643824527623371,2.013529051221032
LoVo,17759555,2.3197484044750905,3.4999219488217794
LoVo,23635314,-2.3980395881052723,-1.2316666541360863
OVISE,241158,2.9923875981017134,4.098334855047933
LXF 289,6918736,-2.4177135652368476,-1.5028892723927731
NCI-H727,24180125,3.0565666249941015,3.0586357407642315
HCC1143,72193861,2.4539335535877607,1.5548759727382018
LXF 289,17755052,1.3903450452706496,1.9693287876259005
SNU-449,24797083,1.6612369643963127,1.547545555629337
A-673,9903786,1.5948741514342302,2.368385144864354
FU-OV-1,docetaxel-tanespimycin (2-1 mol-mol),1.25716738994227,-2.575412511935066
SCC-9,3552672,2.2159119862051355,2.768373562809484
G-401,9903786,2.8038927126182327,2.7007534542239604
CAL-51,36314,1.3238047725901672,-2.0228363875269513
A2780,4917,2.608891014350475,2.9034830431468692
BT-549,446155,2.043062772915461,2.6919867879462056
LOU-NH91,2828334,6.123728588021327,6.280743432934181
SCC-9,89928392,1.8759175792930969,1.608056779775553
LXF 289,54613361,1.2100808209747431,0.47283433425101895
BT-549,navitoclax-pluripotin (1-1 mol-mol),-0.784652451279203,-0.7442362735560542
YAPC,4788,5.944205132488497,5.675778792475452
NCI-H661,11485656,2.0326011859644075,2.6441302836798766
A4/Fukuda,56649450,0.8497740308893211,2.991666457627951
JM-1,151289,0.6364544108799082,0.5193079658875758
SNU-449,1566236,1.8764566240908545,2.435964196215247
NCI-H522,11234052,4.642717967560772,3.404370959942786
MDA-MB-453,262093,2.6969191096415113,2.8885500619185165
SNU-449,36314,1.881882754123643,-0.520496037248778
FTC-133,3552672,1.929463221662531,2.5378360682595082
DMS 273,44202524,0.9824733163321672,1.738334489773544
CAL-51,2708,4.939881356462198,5.099596219404992
NCI-H661,doxorubicin-navitoclax (2-1 mol-mol),-1.1391297012173984,-1.4645281736499387
LOU-NH91,44507138,2.849532358816909,2.698476674118146
A4/Fukuda,24856436,-2.105951383298443,-0.3431679222121026
EFO-27,9967941,3.205966960393555,3.83191135235991
NCI-H460,24964624,3.5490884182562565,2.59880704370553
A2780,71304818,1.3100858151797232,2.0745029127298427
LoVo,16065773,3.0239362353443195,2.4811086323616602
MDA-MB-157,19582717,3.2682056974125744,4.320918901607191
G-401,44607531,1.4405644617048554,1.1461452595697377
DMS 273,426756,5.171527401006451,3.780377491700203
A-673,selumetinib-MK-2206 (8-1 mol-mol),2.344238409661225,1.5853610872435278
A-673,3465537,3.0102553460613626,2.2529947494452363
KYSE-70,135398744,6.338938630156892,6.272336411021929
NCI-H727,439501,-2.2848783314382133,-1.8006236419776365
EFO-27,1750826,-2.462449966677767,-1.1438064867622817
NCI-H522,selumetinib-JQ-1 (4-1 mol-mol),1.1620563079754236,1.158421639345149
NCI-H2171,15547703,3.4091207334536717,2.7566481361426343
BxPC-3,24753719,4.274594841538204,4.282004492160205
A2780,49846579,2.326369228321655,0.5750358573615175
KMRC-1,135398516,2.513650186922018,2.0998165326514773
LXF 289,12001922,1.5738020993239468,1.9713677757526993
OVISE,107985,-3.603598955800668,-3.4615817628516083
FTC-133,crizotinib-PLX-4032 (2-1 mol-mol),3.9800326864083506,1.9821693649913725
MSTO-211H,51039095,-0.728954813106199,2.9047911151182757
MDA-MB-453,24856436,0.153871218683687,0.4460528675425416
OVISE,12003241,-0.8183931153803442,-0.7201434012239841
JM-1,219104,1.4868441806857289,2.233755290446637
KMRC-1,24901704,3.4724240700357414,2.9773422918677146
CAL-51,25105715,4.077363851334658,3.2918100729103386
Panc 04.03,5284616,3.514498334257777,2.654556432784785
NCI-H2009,446155,3.3217785993510884,2.625778311657405
NCI-H1623,66577038,3.365380490578284,3.0430810665786043
NCI-H460,72193861,2.1658883750752844,1.5817861882132709
NCI-H522,17755052,3.243909986839396,1.2198483030494274
A4/Fukuda,salermide-PLX-4032 (12-1 mol-mol),4.8455357298985655,4.591142626821627
LoVo,9936388,-7.372990206557469,-1.7824935359592557
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742,1.0881086187650697
A2780,46907787,0.387414270491788,1.3900412782155294
A-673,25150857,0.7583223763798244,2.078712957631757
KYSE-70,11175137,2.267736133904179,2.5052416068046544
KYSE-70,6852167,2.2981101713941814,2.9262366197255334
SNU-61,3081361,2.723820700669796,1.5979513833915961
NCI-H661,6252,2.9131036022991728,1.0444547675400901
NCI-H1623,9903786,3.0418604220511436,2.9064344783635505
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.8035776988791072
NCI-H2009,JQ-1-navitoclax (2-1 mol-mol),-0.3100400196592782,0.9505347036920457
SNU-449,10322450,2.7236273289045942,4.224965338402438
LXF 289,4096211,2.4023988219433337,2.372916174199474
SNU-81,10026128,-0.7780702377310673,3.4746323668268118
KYSE-70,6610216,4.087252338732691,4.222810400030195
MDA-MB-453,44607530,0.880863900568506,1.4218280986938985
NCI-H522,24978538,3.1859390482195216,0.9624246504190979
SBC-5,107970,3.247043743319875,2.30431338162589
DMS 273,969516,2.584462316279732,2.5140505169235574
MDA-MB-453,5284616,0.7898078062241378,1.2280294632335522
A2780,16720766,0.7344228111589829,0.3641341680674797
OPM-2,25154868,3.783948059993976,4.064625884914025
DMS 273,44493528,4.2569430545307725,4.318016055131466
MDA-MB-157,25022340,3.479219964634342,3.0981350164939454
LOU-NH91,15547703,3.808438680736899,3.3375749555157497
CA46,426756,4.77193452473935,3.6171313476753864
DMS 273,2858523,3.0502279484440233,2.9385775035257176
EFO-27,3676137,4.310046032716647,4.6465693318070675
MDA-MB-157,3025986,-1.856662168016076,-0.7908143573568697
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705,-0.4536958207386228
LOU-NH91,44607531,1.3180545967249335,1.7478417189376112
G-401,46215462,1.5390133747858452,1.4733025697345894
OPM-2,7251185,0.5721351512480617,1.4248091160863703
CAL-51,15953870,3.220977372988981,3.7433809942613707
YAPC,11964036,3.221056153642411,1.4698707973384635
BxPC-3,208908,2.4547812946400502,2.021711471995632
MDA-MB-157,44589607,1.2787513073565453,2.9742263667311795
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868,-0.4203469866366277
NCI-H727,72193861,2.684204612264405,1.7285818503912547
MDA-MB-453,5287969,-1.436813958809434,-1.7258295233349725
NCI-H727,15983966,2.109759483394555,-0.9609671966121848
KMRC-1,216468,4.973373200756221,3.01135126947962
SNU-449,52912189,4.380826008996873,2.667414045445571
SCC-9,46174525,4.3512864598075645,4.631050742924575
A2780,3011155,5.55303778809739,2.7048029097875177
SBC-5,135999136,5.333154079184271,3.818140767657826
YAPC,322968,3.8135092450764656,3.8295529463519866
SNU-449,vorinostat-navitoclax (4-1 mol-mol),2.197410731070427,1.4537024863496504
NCI-H146,5328940,1.6811042727449883,1.5567645400268992
CAL-51,168313200,3.900876548563449,3.2212433968813468
DMS 273,1750826,-1.913269562568005,-2.5878421418960045
A2780,54618305,3.781380565087532,4.631318535185809
NOMO-1,9936388,-6.523282887173488,-5.197517919724512
NCI-H460,5282054,4.802373462225767,3.8126944007713597
SBC-5,82146,3.3774942308101785,3.8329663564226837
NCI-H727,56946209,-2.7175198163763232,-3.6186332315841145
FTC-133,3062316,3.806169585149848,0.6587501978473376
A2780,9967941,1.4564169862408056,3.329150128839318
DMS 273,5351362,1.0025978169272032,1.00455945178621
SCC-9,16038120,1.877705535955449,1.2250565219818987
NCI-H522,6917907,-6.015261010654924,-5.335252964726078
CA46,4477,-0.2706834990523855,0.44670377601438593
NCI-H661,erlotinib-PLX-4032 (2-1 mol-mol),2.455448460706525,2.9719172849722613
SNU-449,11178236,-2.056078636199096,-3.196306460689917
SBC-5,5278396,3.3013936373431996,3.479297305638048
NCI-H1623,44493528,4.638812765070766,4.435352013679271
NOMO-1,16720766,-1.891739380903732,-0.6982232336173598
G-401,2729026,2.5705443446476828,2.494946437886895
G-401,6917907,-5.905222634362146,-5.608938653593409
MDA-MB-453,2858523,2.664825786894245,2.901333227180491
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.5859253006152736
LoVo,11427553,2.604805449600099,2.8271432636675926
G-401,11234052,3.7167035951130423,3.596804282222365
FU-OV-1,168312962,3.576057642182836,1.9910344248521945
JM-1,11228183,-0.9199972643114134,0.7147262332507296
ONS-76,65628,4.406189432641036,4.277489617061596
Panc 04.03,11964036,1.4501208375942458,1.4440719037190752
YAPC,17759555,4.434513834785858,3.7685423974470615
Panc 04.03,5311,1.931700632460216,1.6562995594724053
NCI-H522,tretinoin-carboplatin (2-1 mol-mol),5.2025586729101185,4.091270873647451
NOMO-1,49793307,-3.1091933140229,-4.069208169276689
MDA-MB-453,46174525,3.691895458218128,4.310006963413825
G-401,11977753,-3.640604480016117,-1.6964167096757776
A-673,16722836,0.9037523157925,1.1947331289569334
MDA-MB-453,5494449,3.8003034085581993,2.8213364272779042
NCI-H522,25150857,1.47132219158847,2.2126033857976157
OPM-2,5311037,3.4844810711382936,2.554174720343825
LXF 289,11152667,-0.4789950074309144,-0.09570386632630833
CAL-51,9911830,2.6702149728757343,2.407163478035281
KMRC-1,4378219,2.060133570967863,2.535659965543763
SNU-61,navitoclax-sorafenib (1-1 mol-mol),1.8672566595023088,1.2121964139944614
CAL-51,156414,1.13799157004995,1.3070741191457886
A4/Fukuda,carboplatin-etoposide (40-17 mol-mol),0.4853632935092173,1.587982649692605
NCI-H727,89928392,1.7873251449620886,1.5643871781273861
KYSE-70,6918837,-2.6267197721971582,-2.758067179547116
JM-1,135928012,4.176764785732949,3.663504239261363
NCI-H522,10427712,4.202859541756615,4.061119568390144
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,0.8816128500793464
CA46,5470400,3.727677755196873,0.018033350212048417
KMRC-1,navitoclax-pluripotin (1-1 mol-mol),-0.6870292633838142,-0.7872373873633548
EFO-27,9936388,3.039710224097925,-0.8508294122425087
NCI-H292,54618771,0.019803014891406,1.3698849544813951
KYSE-70,25262965,-2.1035778811550836,-1.371434377937345
ONS-76,selumetinib-piperlongumine (8-1 mol-mol),-1.0642702210035522,2.9803397419308304
MDA-MB-453,11656518,1.9818038641727111,1.1131886924865442
YAPC,5282054,4.005772938817316,3.9391084633560003
SNU-449,24180719,3.8016565421464072,3.8507270908807847
FU-OV-1,15983966,2.2280291717608947,-1.084089222789571
SBC-5,11485656,2.2866280503579812,2.415893349443515
ONS-76,702558,5.821489397293988,5.234230551621616
SCC-9,9911463,4.4493328300482995,3.96661209158796
HSC-4,72193861,2.788231918333871,1.622466347794288
DMS 273,2126,4.20633218634453,3.742697864062837
OVISE,46199207,4.361349086507746,3.142715094232068
Panc 04.03,241158,4.444137488799797,4.041860341454008
NCI-H460,654092,0.4612941847378306,-0.20044559329659248
A4/Fukuda,45279963,1.9027034071047564,3.275140491159066
NCI-H292,44259,1.4427392496176257,0.8860524878294043
FU-OV-1,17759555,4.190415677120393,3.5243764395752124
SNU-81,3634881,2.620060882721275,2.8227570022596664
NCI-H2009,107970,2.2954238398166344,2.367400229653475
LoVo,5278396,2.046108484267772,3.4317563893576657
NCI-H146,vorinostat-navitoclax (4-1 mol-mol),-3.3112811386444525,0.527068128593326
HCC1143,12003241,-0.0421467164139253,-0.9411728963446278
Panc 04.03,46926350,-3.8788763459733473,-3.7838249815647553
A4/Fukuda,4578,3.815086457915261,3.816655656494329
CAL-51,9929138,6.421072450841616,5.476132200292971
CA46,decitabine-navitoclax (2-1 mol-mol),3.2544479904294383,-0.9081234108824731
SNU-81,4259181,-0.3131255720640173,-0.08049768715082736
KYSE-70,675434,4.695192974207532,4.362317208057132
A2780,selumetinib-MK-2206 (8-1 mol-mol),0.1736531975308503,2.0023023377842875
A-673,135659046,3.595490040408381,3.4038225745814943
NCI-H522,4578,4.727447650100284,4.242134309450209
DMS 273,54765302,4.301325739041371,4.1641029665835125
A4/Fukuda,135440466,-0.9873079875011114,1.7731138457301767
LXF 289,24821094,2.4128137194258215,2.882642663143238
NCI-H460,5746,0.0249012606464236,1.166573762777032
RCM-1 [Human rectal adenocarcinoma],11964036,2.7270949198537195,1.4759455536488977
A-498,25062766,2.0793230877467166,2.13948539747635
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058,3.017523518857386
Panc 04.03,10127622,4.886231353649791,3.633070237904767
G-401,57330099,4.350194890812272,4.1186162506989215
NCI-H1623,168312962,4.13769742192025,1.8302133507343754
SBC-5,5566,3.1825236444892124,2.9696004978395703
Panc 04.03,9825149,3.055289787116955,2.4085468841768347
BT-549,11507802,2.533090965918468,1.58209598962609
OPM-2,5951923,4.162321290800766,3.539987427812
MDA-MB-453,salermide-PLX-4032 (12-1 mol-mol),3.8592412133005265,4.357230276251231
NOMO-1,9935249,2.770043096032674,1.15352260477353
LOU-NH91,11640390,4.567382593568383,3.7954079505603513
MDA-MB-453,135440466,2.739035638886915,2.192699079967835
HSC-4,644241,2.6183127396598262,2.418940237920305
MSTO-211H,17755052,-0.0733710656781619,2.129898123504574
A-498,crizotinib-PLX-4032 (2-1 mol-mol),2.697469324317316,2.240258284766098
BxPC-3,5281321,-1.5422365883768068,-0.938394191333941
MSTO-211H,9444,4.1850544738080915,4.217871979742573
LoVo,17755052,-0.1303127354802701,1.4090312611021318
KMRC-1,44137675,2.117874577310701,3.4982693276104584
A4/Fukuda,9911463,2.417745886609146,3.458108631443908
MSTO-211H,3101542,4.302130070317232,3.286655179558206
NCI-H146,426756,4.36191990335561,4.112013911982729
Panc 04.03,44589607,3.8783822611027454,3.3309612040952743
G-401,24901704,2.2796887972749307,2.8394341984687173
MSTO-211H,285033,-3.2380358495287695,-2.0322776540410956
BxPC-3,452548,1.628130986083035,0.47318984801668873
SCC-9,9926054,1.898935947612019,2.0207074853488614
MSTO-211H,1750826,-4.930051018535606,-1.7925597301422465
NCI-H2171,navitoclax-sorafenib (1-1 mol-mol),0.0359030592746101,0.6324091432933341
HSC-4,216345,4.5807127841732775,4.084116284360626
LOU-NH91,168312962,3.892175490150028,2.153490509335276
MSTO-211H,53232,-0.5437095856797647,2.673113178858494
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576,0.0019179443173860155
EFO-27,5335621,6.264647611417884,4.440998089646308
CAL-51,1716436,3.275997904874087,3.1353199550261013
NCI-H460,53232,3.485336782178725,2.7483935689053256
MDA-MB-157,54454,1.950382699789776,2.403210508571101
NCI-H292,44489367,4.492014578968512,4.675649866429131
KMRC-1,4521392,4.136909747869898,3.9919832389595604
HCC1143,selumetinib-PLX-4032 (8-1 mol-mol),-0.2774552513051289,3.6847377085793678
HSC-4,56649450,2.6853332826773144,3.2047264828473114
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.567692604959522
BT-549,9926054,1.9687680834705423,2.0762479452612808
SCC-9,9911830,2.3699428367857145,2.68187325827174
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,3.5099436961767903
FU-OV-1,409805,4.026686349090877,4.784565246823494
BxPC-3,387447,-4.571753731996322,-3.995460334630227
CA46,44486219,3.6158388001945463,3.7546861847468733
EFO-27,135659046,3.7618075322397297,3.720996178278903
NCI-H661,104842,-3.978937701952532,-2.5160024829427776
SBC-5,16741245,1.694771238369721,4.011510253372782
FU-OV-1,676352,2.7826635655764473,2.1683399639038967
CA46,969516,2.1845952347247306,2.091253068346241
ONS-76,decitabine-navitoclax (2-1 mol-mol),2.571137533276933,2.2591109061913643
HCC1143,9825149,3.0211594258387486,2.1392122532118765
RCM-1 [Human rectal adenocarcinoma],11707110,-2.81784904286785,-0.25826627854751866
KYSE-70,navitoclax-piperlongumine (1-1 mol-mol),2.418726808753935,1.6032785502687503
MDA-MB-453,selumetinib-UNC0638 (4-1 mol-mol),4.2655945403569815,2.373661136314341
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272,1.8576377751675486
MDA-MB-453,676352,1.703646310562033,2.040548974752931
CAL-51,46191454,0.2698308836515951,1.7654187257330651
Panc 04.03,9823820,5.907522872650916,4.366046237441703
SNU-81,44259,0.6272555485824429,0.5752235615153508
RCM-1 [Human rectal adenocarcinoma],selumetinib-PLX-4032 (8-1 mol-mol),2.814367803640325,2.7252529560806407
EFO-27,445455,4.405247459654703,4.82296840531321
BT-549,11152667,-0.4620191787747055,-0.37149815076646675
HSC-4,23725625,4.12890848458229,5.138304314579341
BxPC-3,11640390,3.353927872983648,3.597077833335129
HCC1143,216468,1.9778651637296407,3.1174964730358035
Panc 04.03,49766530,1.2448845141630578,-0.23955044087783184
SCC-9,10427712,3.976850957625781,4.437823669980521
HCC1143,36462,4.303888689757339,2.3354599934648292
NCI-H460,262093,3.3627537421549314,3.0370326355223387
SNU-61,56963564,0.6866306287041547,0.2771153988916947
SNU-449,2858523,3.0307383113048676,3.057033550208918
KMRC-1,11214940,1.677559369833433,1.5077520642783808
A2780,216239,1.3949646663017006,1.9995523054655093
MDA-MB-157,89183176,3.472749903375588,4.3664201727755385
NCI-H146,11152667,-0.8780602169524299,-0.33340331966013925
NCI-H460,9956119,4.485375019847723,3.804482203267061
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.257504068731444
A2780,BRD-A02303741-carboplatin (1-1 mol-mol),3.111500594060002,3.834281340590471
DMS 273,6450551,2.589238729256945,1.4603314676019732
NCI-H2171,5311281,0.8399284053106422,2.450869898636479
SNU-81,23635314,-3.737654632526069,-1.5521422377709106
FTC-133,119182,-0.5312905210850081,-0.4691396511546668
A2780,656346,0.4231070640442763,1.0338363428760127
HSC-4,441298,2.8371907900438535,2.4850305159926798
MDA-MB-157,285033,-2.194765851649468,-1.8161160134458438
JM-1,73707398,-0.8556338999048841,0.2820748835122011
JM-1,6852167,1.3157742507093588,1.719714805541622
A2780,11364421,-5.7057574677584295,-3.1422025185248286
NCI-H522,54596490,4.410611853984333,4.483535044994126
NOMO-1,159324,1.6027654254866297,1.15352260477353
A-673,107985,-4.827881226135439,-3.8074201335038054
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,1.8447735966238583
NCI-H661,5287620,-2.104840782561513,-1.6823892266591236
LOU-NH91,119182,4.180997641513534,-0.5211118594604488
SBC-5,10113978,4.162999994539472,3.2586365630034817
A-673,252682,5.861850244558702,6.37129321828107
NCI-H2171,5281321,-4.274427204887198,-2.2636122412717823
EFO-27,3854666,3.6632128701571194,2.2068633825622137
A-498,25154868,5.700321852894753,4.595094939963144
LOU-NH91,JQ-1-vorinostat (2-1 mol-mol),0.7101877793592652,1.4422055630628188
CAL-51,31703,-2.726607914110417,-1.1038385964128277
KMRC-1,9840324,5.892638074147807,5.761418829617456
BxPC-3,49850262,4.227475038244019,3.694828388868402
JM-1,6450551,1.340572992486765,1.1377236193061895
KMRC-1,148124,2.1112012667960656,-1.6960983627948383
MDA-MB-453,navitoclax-gemcitabine (1-1 mol-mol),-2.0425828682575684,-0.7113499656810939
RCM-1 [Human rectal adenocarcinoma],60700,-0.2980706312028528,-0.24890299947654437
NCI-H522,7326481,4.603358487226629,3.085327779490198
KMRC-1,3025944,4.220614757043024,4.219518066552323
EFO-27,9935249,3.352272124535396,2.9557844630839316
SNU-449,10296883,3.939630786750968,4.125896955152595
A-673,42611257,3.360985567795572,3.3856447803306677
MDA-MB-453,156422,3.699160121301749,4.063230560234178
A4/Fukuda,89928392,-0.3543848103605003,0.5922538124961373
SNU-449,10385095,1.0986031812390589,1.4777031450741
HCC1143,6438330,1.6030228226948184,2.3466045879753348
MDA-MB-453,3854666,1.8999840682298523,1.7811401610372386
SCC-9,46191454,1.8170261878735936,1.8687434321621066
OPM-2,9825149,0.9763440152106764,1.3915151704712372
NCI-H661,vorinostat-carboplatin (1-1 mol-mol),2.835829919183064,3.2328009428558344
BxPC-3,25150857,2.298115585090939,2.532148162689148
OVISE,selumetinib-vorinostat (8-1 mol-mol),2.514826548203033,2.4314873045206804
NCI-H2171,25227462,0.3993487036849301,-0.3048224026753037
JM-1,24748573,1.2692721555493711,1.37630678344295
EFO-27,selumetinib-navitoclax (8-1 mol-mol),4.865349283387626,2.1589382805192208
JM-1,doxorubicin-navitoclax (2-1 mol-mol),-4.099692246271054,-2.5909358475184656
KYSE-70,5281321,-0.9979352327108848,-0.9211494570508212
NCI-H460,11507802,2.848054270429628,1.7417138461117987
SCC-9,4259181,1.940043087837339,0.2300563169513226
ONS-76,135421197,2.4329108516652775,2.092706870045238
CAL-51,52947716,-4.729660133739893,-0.12821422578114092
JM-1,123631,2.636256127990424,1.9703103888799887
HCC1143,1641662,3.4150871228937563,3.5946769617342325
NCI-H292,8515,4.694095877434875,4.001632358313662
SNU-449,71304818,1.9790204353457292,2.6983860385476186
A2780,5566,2.7251077604344696,2.8316490711119133
EFO-27,82146,5.16738023752069,3.8249503477008675
NCI-H727,107985,-2.9799734550318204,-3.411120190068242
CAL-51,446155,1.9002286289262065,2.7596523679544633
SNU-61,4378219,2.193359587578685,2.417196253020387
NCI-H522,1641662,3.4912081270508293,3.263617350566287
FTC-133,44607530,3.0000417574370157,1.8663207825318695
A-673,448949,0.8158812974066569,1.773049112562392
LOU-NH91,20959075,-3.4746906487579494,-2.541327540681406
SNU-449,5113032,5.017862259712187,4.807556303332459
NCI-H522,6450551,3.1458433056927295,1.7815814064054931
SNU-449,16659841,4.200866251374559,4.001313179435149
NCI-H460,409805,5.4278006548731295,5.228010993668103
MSTO-211H,46943432,4.749068259324704,3.091040408288831
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425,0.6005629551119388
ONS-76,navitoclax-MST-312 (1-1 mol-mol),0.8596431807362984,1.0174643653986852
SCC-9,11455910,1.869884665357408,1.439447580871456
Panc 04.03,613753,3.3040029053289772,3.3863304053336805
OPM-2,6918736,-1.006954953557461,-2.445377680176298
A2780,3854666,-0.0414990172822217,1.1883941506481344
FTC-133,25183872,2.254027462535002,-0.6797583096930983
MDA-MB-157,387447,-4.079240132125457,-3.816268513529698
SNU-449,54618771,0.9697829427454708,1.4736705347783854
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866,1.2721619538934252
MDA-MB-157,72376,-2.1484578807410553,-1.4825425778211672
SBC-5,5287620,-1.4097460130546278,-2.090376449575501
FU-OV-1,54649381,4.3760479468817675,3.8361715233812608
NCI-H2009,26596,-1.5885219134108934,-0.5962921502957851
A-673,66577038,2.223533674143975,2.9822801589386847
SBC-5,6918878,2.928817535111611,2.9494394243662514
OPM-2,11640390,0.8264429779628358,2.4013072610150332
NCI-H460,3503,2.4668231300278154,2.320651697463043
SBC-5,156422,4.2102641448485345,4.053059098970036
ONS-76,216345,3.2166812322741043,3.769240063468392
BT-549,15983966,-4.218963036377602,-1.1106262119651762
A4/Fukuda,3038522,1.5780319148667876,2.763263013206159
BT-549,23582824,0.5256314804740283,0.8090936881133124
NCI-H146,2871966,-2.058689249756004,0.497282463079307
OVISE,17755052,3.2346427318945263,2.312285813870673
OVISE,44819697,-1.8576377458936848,-0.04693282707634129
SNU-449,46398810,3.267032406348896,2.7693258575091666
RCM-1 [Human rectal adenocarcinoma],4917,3.7649934219972727,3.092179830434251
A2780,11228183,2.2113347222865123,1.2575708824202345
NCI-H1623,piperlongumine-MST-312 (1-1 mol-mol),2.715053183810439,2.086204124288216
NCI-H661,tanespimycin-gemcitabine (1-1 mol-mol),-0.3480588357963589,-1.0562646336543657
SNU-81,46398810,0.3023493978041217,2.2606314588820138
KYSE-70,11152667,0.5949086715112851,-0.2794150624536014
LoVo,73707386,4.416344333605744,3.0031659942836266
NCI-H522,5746,0.3558137383480795,0.7790622970583752
NCI-H460,135421197,3.2510260026522233,1.956017262675697
MDA-MB-453,11507802,1.551744908234443,1.5606965599065434
A-673,4096211,1.8222389073608836,1.6995973262315627
NCI-H727,136227924,3.2179651731130585,2.8476022143373694
NCI-H460,16065773,2.454458456288103,2.5310954883898016
SNU-61,24901704,3.3171528895384115,2.9716189448262247
NCI-H292,11612883,2.84187428422206,3.080017869572532
NCI-H2171,9907093,4.086146580877247,3.7315513724946037
NCI-H522,3634881,3.092168984490579,3.104358873740417
G-401,9915743,0.7240748800691799,0.9558667665190795
SNU-61,46843906,2.645147040347038,2.241350384659741
SNU-81,73707386,1.6277005390789234,2.394172577476014
NCI-H1623,4261,0.4244365105903193,1.5797016830063595
FU-OV-1,selumetinib-vorinostat (8-1 mol-mol),1.6178932175124687,2.765487668664513
OVISE,1750826,-3.1689535405206715,-0.9254368383817423
OVISE,25183872,-0.2641805795712313,-0.6153704468684478
MDA-MB-157,753704,5.007751734334353,5.068415032546812
CAL-51,54618771,0.0049145289548569,1.473841277606501
NCI-H661,25195348,2.4001868352132445,2.96915954636659
KMRC-1,3689413,-1.8207429228817171,-0.1535819445908654
HSC-4,650361,3.951915492066197,3.4336870319854107
KYSE-70,10427712,2.9549225300897977,4.349256127785845
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842,0.8481017848220287
OPM-2,11717001,3.8340096164502135,3.5395108386362053
NCI-H727,11214940,2.165075102098245,2.3314231325430166
KMRC-1,11404337,1.3121470144090095,-0.220681937136282
MDA-MB-453,24951314,-0.4314694021522904,1.1976477918307484
SCC-9,135398516,3.38372398158662,2.3627977172698253
KMRC-1,11977753,-0.1874629547163491,-1.0536344019171335
NCI-H2009,25062766,1.439977805675878,2.230147287390513
NCI-H2171,6918638,-1.5146784294865197,-0.30583260393359846
Panc 04.03,3081361,3.5741960453568464,2.4064588112037804
BxPC-3,73707398,1.0061551215696194,1.432584588976259
RCM-1 [Human rectal adenocarcinoma],11364421,0.8746857299268361,-0.9511405042997265
BT-549,11404337,-0.1293922368150601,-0.31175668667395845
SCC-9,5281321,1.285660121438517,-0.7805051600865638
SNU-81,104842,-4.044454085478647,-2.616676029464788
CAL-51,6610216,4.7761200098267365,4.297094973040059
JM-1,9933475,1.5625695981291614,1.7008899160062763
NCI-H727,11485656,2.2939690780404423,2.5445546026592636
A2780,426756,4.623757394028108,4.0375919739662915
A2780,5311,0.5155233924036543,0.973322709402717
NCI-H146,11707110,3.3128142773805176,-0.36311319878651255
MDA-MB-157,11977753,-1.6055696025393866,-1.0828512624796547
A4/Fukuda,11494412,-1.359408079628026,0.3741247518773934
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097,1.339956534893364
LoVo,11977753,-2.85765012298846,-1.1924361359077609
FU-OV-1,56963564,3.5833852081145836,0.4648368179147633
NOMO-1,375860,-0.5184264862355304,-0.5711749299534842
EFO-27,3136844,4.472321824110979,4.4269021471313454
MDA-MB-157,selumetinib-BRD-A02303741 (4-1 mol-mol),5.186273377251054,3.8151719037403637
NCI-H292,168312962,3.5892294654935726,2.2286187156361934
CAL-51,44607530,2.3415901962162855,1.541237574546129
EFO-27,2949965,3.1309950522818277,2.843836423017134
DMS 273,carboplatin-UNC0638 (2-1 mol-mol),3.439220302346012,3.118850996399503
A4/Fukuda,12001922,1.2276815023009988,1.5830892831996954
CAL-51,24951314,1.3730048574034712,1.4152289437383114
A4/Fukuda,135928012,2.23734461349398,3.803486926742252
SNU-81,10127622,-3.2164123245129095,3.1121986958689685
MDA-MB-157,navitoclax-PLX-4032 (1-1 mol-mol),-2.380477221349832,2.1417012987646142
NCI-H2171,decitabine-navitoclax (2-1 mol-mol),-1.124671467486642,0.1435930021273216
OPM-2,122327,3.690232587907526,3.768593929178861
NCI-H522,5329102,1.9502496806074603,1.7921480746901364
NCI-H2171,9903786,1.7901794952315444,2.5490672885695234
HCC1143,SNX-2112-bortezomib (250-1 mol-mol),-0.3762551319629964,-1.0663275432224613
YAPC,676352,2.46422610000008,2.150662419030607
NCI-H292,44507138,1.692325111571909,2.728618263937506
SNU-449,2945648,2.540265867455936,3.0612361982514193
MDA-MB-157,navitoclax-gemcitabine (1-1 mol-mol),-2.3120540291625766,-1.0427872809377212
A-673,3136844,3.9161258830055736,3.936328435538781
OPM-2,151289,0.8971834485048114,0.4469626425762358
LoVo,219104,3.1119995266948237,3.787348970114125
NCI-H1623,9936388,-4.968103162812744,-0.4368720806407119
DMS 273,11485656,2.8704893197930272,1.9079424492935901
LoVo,73707398,0.5951327141059009,1.3854333604165228
NCI-H2009,135421197,1.5480281661357902,2.1186576988174153
NCI-H1623,409805,3.8984511674912943,5.096840040574924
CAL-51,1750826,-0.4147302595408071,-1.5165739490993144
MDA-MB-453,54143018,-0.7571444922765344,0.8568492894041906
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203,-0.8873526551384968
HSC-4,54619267,4.093335991980471,4.2275014163033235
BxPC-3,4378219,2.0321108717651426,2.5601730618147958
NCI-H292,5978,-1.7096488796134024,-1.4114521348743136
A2780,71466380,3.7792629508428783,4.284771378328033
MSTO-211H,44589607,1.2735087838172758,3.1283039857206303
NOMO-1,54143018,-1.1216489579847602,-0.33807847436281924
RCM-1 [Human rectal adenocarcinoma],1750826,-0.1499809417024857,-0.6640044122810568
A-673,46174525,2.7075701285598375,3.6665653863273002
NCI-H661,3854666,2.0669995151297633,1.9610586516870234
NCI-H1623,322968,2.7878661836218863,3.87485632914222
Panc 04.03,52947716,3.0713971775620448,0.40883692195911964
DMS 273,9840324,6.645778367521572,5.4843039891964445
NCI-H460,15547703,4.965379127843483,3.1657449372847344
FTC-133,11228183,0.2445093238012437,2.296646554815294
NCI-H522,9935249,3.002706281912375,2.1895140077482456
NOMO-1,6610216,4.0700997553747325,3.868427589867996
A4/Fukuda,46199207,1.9027513858957976,2.7781409019076375
EFO-27,16659841,4.389988364450653,4.146845143593463
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278,2.7406142574606984
CA46,11977753,-4.21997551918338,-2.55606589914301
OPM-2,tretinoin-navitoclax (4-1 mol-mol),3.1299009016579253,0.7541413257825509
SBC-5,54613361,-1.7173374464522142,-0.1646654270602232
MDA-MB-157,16065773,0.9216763205067852,2.5069145910171544
NCI-H1623,selumetinib-BRD-A02303741 (4-1 mol-mol),6.385895152539582,3.6907656658162025
SNU-81,44137675,1.234825635215107,3.391517099195231
OVISE,9929138,5.66720682434708,5.536137623682663
Panc 04.03,16725315,5.278537246983346,4.338039220063994
A4/Fukuda,6438330,0.8804707138455458,1.4245675521815224
NCI-H292,984333,1.6058463338689488,1.100124568036944
NOMO-1,11396600,3.3888037624860674,2.4435715309575934
SNU-81,24964624,0.6434241987426411,1.7220618890721886
BT-549,11964036,1.9997330886235436,1.6687692346540894
A-673,135411,0.3370419809316401,0.14875914583104233
NCI-H1623,10296883,4.489600285768525,3.8693437604497127
NCI-H292,2733526,4.552154891253422,3.8806189957884247
YAPC,6914657,-3.2827547721856423,-4.095656406189849
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459,1.8830857888230812
NCI-H2009,327653,3.1880644035572825,3.231118572741371
CAL-51,3384730,2.4775948365465905,2.970870157188385
FTC-133,3689413,-0.3036251064519336,-0.43459400681532073
MDA-MB-453,11964036,0.3676608059270313,1.309059490972351
NCI-H2009,5281321,-2.3281539094269843,-1.0049058810064562
FU-OV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.708642246881296,2.1648125404580174
LoVo,654092,0.3814222362545946,-0.027158968972394976
MDA-MB-453,50905018,4.488581944485688,4.1024329810806455
HSC-4,selumetinib-UNC0638 (4-1 mol-mol),3.54677113858736,3.2448969263999254
OPM-2,46215462,1.142494911690201,1.043926270849313
SCC-9,navitoclax-PLX-4032 (1-1 mol-mol),4.098864709147574,2.082472507512776
A4/Fukuda,5329102,0.822909221294871,1.3670114355174992
A4/Fukuda,11228183,1.827405863351363,0.4548881331151384
Panc 04.03,5460769,2.0457621674825224,2.628498017169422
MDA-MB-157,9933475,1.5029335433067268,2.0227492949632078
A-673,12003241,-2.2168793422392103,-1.0893135093255064
NCI-H460,54618164,4.49670945938676,4.10487242344145
NCI-H292,11656518,2.099021496243428,1.9261804610009374
SCC-9,51039095,3.242385267473305,2.9410995005087046
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685,4.256150177481799
SBC-5,3634881,3.763213110876527,3.322864581303472
SCC-9,984333,1.3591962563360305,0.9579962162228032
CAL-51,72193861,0.6423702350358801,1.8192320898339387
SNU-449,6610216,3.892858260461962,4.208395073519328
HCC1143,6918837,-2.8885170378203995,-2.422606800836812
DMS 273,10427712,3.7833762157010655,3.969888418452243
SBC-5,ISOX-bortezomib (250-1 mol-mol),0.5037473854516791,0.8144406505592958
LoVo,8515,2.0502092932288543,3.799769680721035
ONS-76,5311281,3.0534152046102507,2.208309171168928
EFO-27,100016,6.711163327148508,6.312370560499944
A-498,6610216,4.284288503720797,4.275210970317885
SNU-449,docetaxel-tanespimycin (2-1 mol-mol),0.921733403174168,-2.4048796225856126
G-401,71466578,3.958692091033976,3.4923622971998105
A2780,2749,1.2168739363641357,1.2506224587813783
LXF 289,23635314,-2.0420734326640253,-1.6960436123927594
LXF 289,24901704,2.332916050939017,3.326703976502601
LoVo,9887053,2.8676927346989265,3.876962766065376
OPM-2,6918837,-6.102124609605729,-4.635106854839875
NOMO-1,72734382,3.160209893803666,3.6043843067459136
A2780,44507138,1.3155442648841038,2.0250079983275997
NCI-H661,9915743,-0.8538809858854721,1.2428606589084037
SW1463,168313047,-3.1836020137929246,2.3583848617963
SNU-81,55283,4.080745185244615,2.340182258925973
YAPC,159324,3.323857793241652,3.2148374985980963
HCC1143,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9300366262923152,4.074836967527273
SNU-449,JQ-1-carboplatin (1-1 mol-mol),4.503532877258194,2.5646887367651425
A-673,31703,-3.778183583095139,-1.628498201091777
OPM-2,439501,-4.648238189793765,-2.6546140448699935
A2780,452548,-4.864509732913544,-0.706463721251977
CA46,71304818,1.9606514180280712,2.053699928061704
LoVo,25150857,3.1045912764862056,2.5295770663574144
KMRC-1,selumetinib-vorinostat (8-1 mol-mol),4.1266329667576915,2.3365446544411297
OVISE,446155,3.256033609420766,3.0309903369446483
SBC-5,54626689,4.608121703383126,4.50408495990149
DMS 273,11497983,-3.3171386440582467,1.1854875305233337
BT-549,46398810,3.037551805065761,2.602411238549737
KYSE-70,44819697,2.67312291481412,0.18855387718569233
DMS 273,10113978,3.3411401717417135,2.4474985862684098
YAPC,11178236,-2.1853000629740342,-3.167555170872399
EFO-27,89928392,2.3405290602814586,1.5769807688538566
NCI-H727,3062316,3.1124899612632135,1.492332678421389
MSTO-211H,9825149,1.7087798179810727,2.309640854712323
OPM-2,25062766,1.526966504091227,1.6110030462844636
LoVo,24797083,1.0858534416002044,1.3503350085898738
MDA-MB-157,11612883,1.9249665557248452,3.1714248735247828
MDA-MB-453,24978538,2.762094535978925,0.7753769356352912
A-673,55283,2.8138583621562288,2.5163976948033615
RCM-1 [Human rectal adenocarcinoma],5282054,4.302238331478781,3.6258327860179445
OPM-2,11228183,2.227238978219669,0.15263857067410241
SNU-449,11640390,3.8548607423510384,3.748778675584631
NCI-H522,5281321,-1.0736628447197911,-1.610207703096357
NCI-H460,25126798,4.092385726400508,3.7787287105910896
JM-1,9887053,1.8224498727300744,2.570649015169895
MDA-MB-453,3689413,0.605092083526794,-0.06060811893751691
BT-549,322968,4.038930181616003,4.040555866519543
G-401,969516,2.4612878169829067,2.524735416791564
FU-OV-1,10127622,2.361983631252389,3.979378918056935
G-401,5738263,2.503403034491448,3.0163773065400203
MDA-MB-453,5328940,1.6011356292327752,1.6362635815421611
HSC-4,25105715,3.6888708464756337,3.3351945842938835
G-401,5291,3.6897209629580616,3.4346610724077697
SNU-81,148198,-1.0516438667772403,-3.44388175120536
FU-OV-1,25183872,1.8271723160300688,-0.6299951246026554
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,1.8471742524482044
JM-1,9935249,0.9666917954448688,1.2022947663143453
JM-1,44607531,1.0390724505323097,1.0943424191845734
BT-549,5566,3.2694223641451887,3.032330765024152
LXF 289,637858,2.285720521187594,2.265254012391663
SNU-81,56946209,-4.781557694686043,-3.787431472296144
FU-OV-1,89928392,1.4286122200262183,1.7549570833002077
MSTO-211H,doxorubicin-navitoclax (2-1 mol-mol),-1.8407653022035375,-0.9644015394196559
CAL-51,54618359,4.544084907505638,1.2397570764808743
LoVo,15983966,-3.091518031584947,-1.8851162887628268
CA46,5746,0.6077367646083516,-0.7962675852048561
CAL-51,2733487,8.211583338705053,5.825334282921391
NCI-H522,4705,3.8595388748644375,3.0463400221909405
A4/Fukuda,5284329,2.3119801528783244,2.685977995411991
DMS 273,ISOX-bortezomib (250-1 mol-mol),0.050266361305609,0.36572551226366357
OPM-2,6505803,-0.5489645461029444,-0.880599244227667
NCI-H146,11955716,-2.61946993472624,-1.4610851495044292
Panc 04.03,19582717,5.125237161512837,4.426856036070482
LXF 289,9926054,2.043368643335034,1.9104414156593612
BT-549,136227924,3.266068806496957,2.9233025589182673
LOU-NH91,24901704,2.9181520482303585,3.471952264196733
A2780,11167602,1.1290528312474395,1.973062413854594
HCC1143,15983966,0.2074313732487278,-1.2777024475539147
G-401,piperlongumine-MST-312 (1-1 mol-mol),1.0766364038162666,1.267454960670226
JM-1,2871966,-2.1290689366468354,-0.256821325684759
FU-OV-1,6852167,2.292876265150526,2.8941313396941535
MSTO-211H,31703,-2.679199045886266,-0.8285373272421994
BxPC-3,5335621,4.830409945539455,4.601027364890453
SNU-81,6438330,3.0600940001891863,2.2183258651244553
CAL-51,6918878,3.0110486558166274,2.828770809558299
LXF 289,6610355,4.558728947318035,4.593948979350954
KYSE-70,12001922,1.7900886800743383,1.9227274934290324
BxPC-3,60168763,4.708123265391542,2.2824224743714234
CAL-51,44137675,3.485867182081199,3.463315144789096
SBC-5,carboplatin-UNC0638 (2-1 mol-mol),4.8107215741986105,3.302340079038784
NCI-H460,216345,3.827300936034388,3.9489890799253597
NCI-H522,15953870,3.615553645162116,3.569035382969827
A-673,46199207,3.2534509529249176,3.0706505875756425
SCC-9,10127622,7.404435857651999,3.6126963630133275
Panc 04.03,11977753,1.829262770264154,-1.2421975180552862
HCC1143,168313047,3.0210205197435935,2.4928340305993477
EFO-27,3465537,3.52414234339403,2.616872494031607
A-498,462382,4.566729065673536,0.8239233601441276
FTC-133,45279963,4.126382655862848,3.878891293956678
G-401,71751553,4.092007605377758,3.955822366191282
MDA-MB-453,119607,3.891659451485504,5.066637044696218
MDA-MB-453,3384730,-0.7236289420344145,3.1211550413650504
SNU-61,6184667,2.8549853776409937,2.79492666122937
NOMO-1,23635314,-2.3321691272104697,-2.924163834655592
SNU-81,54618164,-0.3986435357924686,3.8547330359975223
NCI-H727,65064,3.1010913931031867,4.924293282012737
CAL-51,44607531,1.640429423812436,1.4593620897442126
CAL-51,72376,-2.938334648898351,-1.9135559289087403
NCI-H522,126941,-2.655181013676553,-2.8244884676844126
ONS-76,3025944,4.431691617199171,4.431060646374664
NCI-H460,25154868,3.4600493825904564,4.255895253966881
FTC-133,71304818,3.18789827914798,2.667306771449258
CAL-51,151289,0.6583498849401344,1.3833136608894834
LXF 289,11238147,3.4273419568352006,2.825285505446892
BT-549,BRD-A02303741-carboplatin (1-1 mol-mol),5.675509495895237,4.218247161635954
KYSE-70,702558,6.39879445367054,5.1102919784459075
CAL-51,124202324,2.033990287468598,2.623204599263837
MSTO-211H,46907787,2.574686905184434,2.3413269157812144
MSTO-211H,4521392,4.029667841571139,4.397398587298715
EFO-27,ISOX-bortezomib (250-1 mol-mol),0.3269008359156463,0.5408407105724916
A2780,9549297,1.1491610880845489,1.9429344419921655
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277,-0.5970842669907771
NCI-H2009,2729026,1.97459320968498,2.9093853888029337
HSC-4,5311,1.8002123285320597,1.6452954418034964
YAPC,135398738,5.4751822545753415,4.462015075550741
Panc 04.03,285033,-1.1400173305697017,-1.4356304568071707
OPM-2,decitabine-carboplatin (1-1 mol-mol),3.56587263318402,0.5246098705845851
A4/Fukuda,71466578,0.6387062903604859,2.666771132243528
CAL-51,135398738,4.757337519270393,4.1672296872569925
A2780,selumetinib-PLX-4032 (8-1 mol-mol),1.6060841409900903,3.6719966662425367
A-498,24785538,3.3641680302296564,1.924911361009661
HSC-4,452548,-1.2537746146037845,0.3672173132981865
NOMO-1,6918837,-4.687337521865761,-4.193029342187654
A2780,6505803,-1.803583295606165,-0.9393017017949137
YAPC,387447,-2.999100837413036,-4.097827681444886
NCI-H292,25183872,-0.4983801682636667,-0.7338194158119346
NCI-H1623,44137675,2.921297693984664,3.5827075385092786
LoVo,46843906,2.381362357237743,2.843714243754515
MDA-MB-157,5281321,-2.46264909171439,-1.1854255228318058
NCI-H292,44137675,3.1459685562862707,3.5989832180661785
KYSE-70,navitoclax-MST-312 (1-1 mol-mol),1.2159582620106,0.8784915989523097
JM-1,5470400,3.917661049847631,-0.20465397925816087
NCI-H522,52912189,0.1662181985496506,1.684228009460031
MDA-MB-157,15983966,-4.787780953616188,-1.0961626216955374
CAL-51,10322450,3.881825194853649,3.8464868825534144
CAL-51,6918837,-3.0563476396929703,-2.702286389642535
NCI-H661,54639126,4.507619035006863,3.8187065463264735
NCI-H661,5311281,4.526772174839299,2.3673272993669254
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.11070561289334
LXF 289,3025986,-0.453776319374568,-0.579561063260147
Panc 04.03,25262965,-1.014076783670677,-1.568241284953742
MDA-MB-453,5746,3.800897853250581,0.43413446470887535
SBC-5,15953870,3.487984127844562,3.612710195388997
HSC-4,decitabine-navitoclax (2-1 mol-mol),3.5629592535507557,2.338538595624158
OVISE,3025986,-0.0395702470459638,-0.9698602324524888
FTC-133,5311,2.4215013743463647,1.5824690816099471
NCI-H2171,11485656,1.3701169509015756,1.8477584454016176
A4/Fukuda,5282054,2.418862118344995,2.8602026542525465
NCI-H1623,25102847,3.8675819706398418,2.451090005256508
OPM-2,984333,-0.0237710386013994,-0.2274353908868698
FTC-133,387447,-3.6414317999651336,-3.859618234512874
BT-549,5311281,2.333978253730499,2.554248474615611
OVISE,16720766,3.986904391501256,0.8879339342635992
NOMO-1,11612883,1.4996443311921075,1.8677503652702978
NCI-H146,5282054,2.6062567229872924,3.339026275656221
SBC-5,6917907,0.6114763356012877,-4.238867240600508
NCI-H727,24951314,2.050368453430269,1.478022811217034
MDA-MB-157,613753,2.6621381248494456,3.1300956247636242
JM-1,44486219,4.06629583721778,3.94973727030881
CA46,285033,-4.358161131916293,-3.4138982577751205
A-673,9952709,2.6406542482442545,3.050736313066514
BxPC-3,124202324,2.2278087185314694,2.7635469185398303
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.8035776988791072
A-673,6852167,1.8255345198368305,2.3496668091845923
NCI-H146,6610355,3.561762383324193,4.387401698254292
NOMO-1,46215462,1.6253213091786816,0.8415924710007349
CA46,439501,-3.521132637790176,-2.7170617687719836
KMRC-1,5329102,1.6227643750477536,2.0359659597968465
MDA-MB-453,568763,0.1355288059345826,0.25978840150468585
NCI-H2009,15953870,4.632669867834425,3.5646206583468443
G-401,16725315,3.2068580834321048,3.652897085055075
SNU-81,25154868,4.054299809836995,4.107308144513249
SNU-61,2742550,3.576212598776706,3.40848466751771
BxPC-3,44589607,1.722183316619471,3.228032286731369
SNU-61,3025986,-0.1307165413786875,-1.1036497729673318
NCI-H1623,3062316,1.6941172744123574,1.3019570257248396
ONS-76,16115403,-5.005393778847352,-3.9952750172136478
LXF 289,12003241,-2.348837864712453,-1.058739716542416
DMS 273,168313016,5.378851860414917,4.1772191416460105
CA46,54765302,3.694944477545822,3.5991724578827693
MDA-MB-453,vorinostat-navitoclax (4-1 mol-mol),-0.1886705997266854,0.597012978526939
A2780,10113978,1.7525717433500034,2.558377684140289
OVISE,9911463,4.4041109725525525,3.9289335455650445
ONS-76,44589607,2.6985455021272573,2.7606213348218125
RCM-1 [Human rectal adenocarcinoma],9887053,4.376213721678965,3.7887522457578044
FU-OV-1,JQ-1-vorinostat (2-1 mol-mol),0.8626774662663057,1.1182399282051276
NCI-H522,JQ-1-UNC0638 (2-1 mol-mol),-1.3225503189993402,1.3586011721763755
A2780,26596,-4.32263985415392,-1.7655016571414328
SNU-449,53481919,3.639889931386733,4.023951481273862
A-673,135875424,2.9734448822107886,3.286866079129094
A-673,49867926,4.049605811998934,3.7499173790010243
MSTO-211H,16720766,-0.9979081980160748,0.4484940669403481
MDA-MB-157,24785538,1.324170410962965,1.7847272851575149
CAL-51,107970,2.299284460939792,2.3931326905950483
OVISE,11178236,-4.082767785475175,-2.75906895202184
RCM-1 [Human rectal adenocarcinoma],374536,0.8021830219773941,2.0185944796229554
A4/Fukuda,25154868,2.544294393199085,4.124637718684941
CAL-51,46191454,0.2698308836515951,1.7654187257330651
NOMO-1,136227924,2.5449106490851263,2.3488072735004137
KMRC-1,24821094,3.705597482955712,2.535605583202942
A2780,5282054,2.567919090275208,3.0442786130577573
NCI-H2009,11404337,-0.0657811746758558,-0.10963924886759215
HSC-4,409805,5.399675964474335,4.925844870845944
LoVo,24772860,-3.380615847351667,-1.6492022359147347
MDA-MB-453,54626689,4.438407624810902,4.443489449159392
G-401,104842,-3.837747012299513,-3.3853011858295203
BT-549,135440466,3.2033555971359267,2.4826720263810573
MDA-MB-157,docetaxel-tanespimycin (2-1 mol-mol),-4.4000012039018594,-2.599876069133113
NCI-H460,5280436,4.847067650781305,3.4503039562707936
NCI-H727,10385095,1.3903964913374658,1.3768863790834158
NCI-H727,262093,2.950291125725139,2.8823850860539864
CA46,25227462,-5.088225796968986,-1.5085095005741842
HCC1143,439501,-0.7374061663212956,-2.083432453262563
MSTO-211H,10113978,1.403014421240365,3.7195177944752036
SNU-449,72734382,5.7131640484247805,4.695320886659659
MSTO-211H,tanespimycin-gemcitabine (1-1 mol-mol),-0.5272277437526489,-0.7193460523119455
MSTO-211H,selumetinib-decitabine (4-1 mol-mol),3.004409574636068,3.6459261218658905
BxPC-3,24772860,-3.1359973170310993,-1.7818988280146
LoVo,5281321,-2.272723057934536,-1.3872971112011174
FU-OV-1,crizotinib-PLX-4032 (2-1 mol-mol),1.9353082171221765,1.8326952907705467
MDA-MB-453,10427712,3.2513664008238874,4.006346022905921
Panc 04.03,53495165,2.8699642151767746,0.8167073724715143
FU-OV-1,54619267,4.302850520300199,4.120167333314554
MSTO-211H,24964624,0.1425074184859401,2.6232860922948236
G-401,135875424,3.147536590476696,3.445159414642731
ONS-76,selumetinib-tretinoin (2-1 mol-mol),-0.7324247564116871,2.9565504193912524
A-673,selumetinib-UNC0638 (4-1 mol-mol),2.386430695912322,2.542452118771141
MDA-MB-157,9967941,1.858403940770751,3.723413812632448
LoVo,ISOX-bortezomib (250-1 mol-mol),0.9349202186753368,0.6719664091964194
NCI-H292,11497983,4.544493181272098,4.253191705227326
HSC-4,3011155,4.427149856421904,3.899312476517038
NCI-H1623,17755052,0.7357373094762232,1.7383970674721925
SNU-61,navitoclax-piperlongumine (1-1 mol-mol),1.6755715296131175,0.9586384570460504
BxPC-3,5746,0.9856415477525818,1.3536951238222041
OPM-2,24901704,1.9220236520558196,2.20904958048072
MSTO-211H,2858523,3.0747353868294627,3.1492758856665226
BT-549,107970,2.9169966931039113,2.355239338088917
NCI-H292,135875424,4.14052752249008,3.9495578442527077
LOU-NH91,107970,2.5070848864255093,2.337660615502636
MDA-MB-453,6918328,-2.060631340343386,-0.7798612565668149
KMRC-1,44566777,-0.0538941449270197,0.9048829329901001
HCC1143,17755052,1.15684078766818,2.0886029327212996
Panc 04.03,9956119,4.202347043107845,3.7031397746961603
G-401,54613361,-0.5160099475891917,-0.5532507939771026
NCI-H460,6918837,-0.9355989207233988,-2.5514347282346805
SCC-9,10302451,2.205114392498864,2.9495681616759537
BT-549,24856436,0.2415814283223239,0.7536742132031251
Panc 04.03,25150857,3.139734816867742,2.583459096294165
A-498,9866186,-1.262750837313692,1.1983898334832954
SW1463,11497983,4.077621288565615,2.269724710126834
LoVo,124202324,1.6089295836770297,2.3025194162331304
JM-1,46215462,1.389060279673689,0.9379551383932754
A-673,2729026,1.806074207860909,2.5364397088290254
MSTO-211H,241158,2.290519528489604,3.9003452474128504
A4/Fukuda,6917907,-6.123586781218294,-5.786981865191368
NCI-H460,11485656,2.6212830818798065,2.576250055412558
A2780,135875424,2.703796648613349,3.2839219281828425
NCI-H292,10127622,7.746640801358069,3.8674293981584453
DMS 273,9887053,1.8082863610482875,3.061374940565319
EFO-27,426756,4.432789586131128,4.52562261121965
MDA-MB-453,2749,0.298775024907787,2.137372075930489
NCI-H460,11222830,2.8861636193629323,1.6731880984719527
NCI-H460,119182,0.2489341964189734,-0.5573440298194936
MSTO-211H,676352,2.2606828184976955,2.173158775608858
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816,1.3111998878458635
SNU-81,16736978,0.587276282018702,1.5766946857072588
BxPC-3,10113978,2.7603674185652536,3.5541740085513767
SCC-9,6505803,-0.8932206272709824,-0.45791462664073046
HSC-4,122327,4.034102983304833,4.775631505576338
MDA-MB-157,107985,-3.8805729202788304,-3.3671807540856564
HCC1143,5566,3.096162587379626,2.812329449884046
BT-549,5738263,2.4683192628765753,3.6763178791840114
A-498,3854666,2.914304878080617,2.706933844444229
SNU-449,navitoclax-pluripotin (1-1 mol-mol),0.5416887924611083,-0.40985806595794044
ONS-76,73707398,1.7098056225756528,1.3634143900312246
A2780,10322450,2.9165978660974545,3.376986398087175
CA46,3062316,1.4079672687586804,0.37051189877486607
HSC-4,selumetinib-MK-2206 (8-1 mol-mol),1.8625647516668664,2.041042361933472
BT-549,71466380,5.5332032048485065,4.730883003375034
RCM-1 [Human rectal adenocarcinoma],navitoclax-MST-312 (1-1 mol-mol),1.2670160922961198,1.0027833774850436
KYSE-70,24180719,3.52071426185984,3.0266171300716995
BT-549,10385095,1.777553004720717,1.432294146038347
JM-1,4259181,-0.0762731042787348,-0.4329571971201313
BxPC-3,12003241,-1.7282705692868598,-1.062203787594802
LXF 289,9840324,4.681234496405457,5.9014206046220625
KYSE-70,17759555,3.816264723168541,3.544186442129059
NCI-H292,9911830,2.887423578139022,2.642580172159494
HSC-4,9840324,5.223554072523372,5.858362155067138
G-401,selumetinib-UNC0638 (4-1 mol-mol),3.413545127228383,3.39853988890596
A2780,9915743,1.3754925129164983,1.0549941830819847
NCI-H2009,10302451,1.2105403110698565,3.0473245959400663
JM-1,tretinoin-navitoclax (4-1 mol-mol),0.3453404774126501,0.9743219797601944
ONS-76,9935249,3.5330143946083874,2.842467728367571
BT-549,11427553,2.4752578658091524,3.0271007318942043
G-401,148198,-4.717755806624399,-3.6718555781626896
NCI-H661,JQ-1-UNC0638 (2-1 mol-mol),3.1332466289853884,1.7324188149626198
NCI-H460,5351362,3.0809857123464037,1.78238203381351
BxPC-3,5978,-3.126756112961715,-1.8716493528405598
OPM-2,11396600,1.8817984525619431,2.6727132037006682
A-673,5328940,0.9058407904985936,1.4379042575552772
LoVo,16720766,-0.1141862087465287,0.46836633687132356
LoVo,11404337,-0.8407014552816361,-0.4182605242611168
JM-1,11455910,-0.0097968256607179,0.30716509092322286
A2780,54686904,3.0280150906907206,3.117154236007119
G-401,selumetinib-decitabine (4-1 mol-mol),1.9675825066475652,2.430743720745809
SNU-449,9956119,3.198924280342594,3.836870234950096
OPM-2,SNX-2112-bortezomib (250-1 mol-mol),-3.9902018365290752,-2.4020662481823165
SNU-81,60700,-1.0304958014583914,-0.40331441442117627
SBC-5,navitoclax-PLX-4032 (1-1 mol-mol),2.6386672409141756,2.1429846063802978
Panc 04.03,216468,3.559067681626077,3.595681455162889
OVISE,46398810,3.0089868889673426,2.6866705046577244
MDA-MB-453,11494412,1.83607541398336,1.9938567196606993
NOMO-1,409805,3.6617718212828874,3.58655011595904
BT-549,25062766,0.9643791751629904,2.0547411907993047
FTC-133,446155,0.3759987857405991,2.473146640271016
KMRC-1,23635314,0.7760380281113136,-1.1122241349427935
SW1463,15953870,3.283482316204368,3.6496369359367065
LoVo,46943432,3.050109964187685,2.607661524306816
HSC-4,46907787,5.727789952108257,2.2695413714754373
BT-549,navitoclax-MST-312 (1-1 mol-mol),1.130665765716481,1.1241393729210183
FTC-133,135440466,5.15132472260749,2.1905547793154114
SW1463,568763,0.7789022422759734,0.4940340323230648
JM-1,25150857,0.7748927856999902,1.7128645392444426
A4/Fukuda,71304818,1.5363144884487692,2.118673864460763
HCC1143,tanespimycin-gemcitabine (1-1 mol-mol),0.1249858816054574,-0.872632212031535
NCI-H661,24785538,4.2805678056942,1.8137477008128147
FTC-133,5282054,4.434007222498336,3.911457294318177
A2780,613000,1.210736664046428,2.3418060307307424
SNU-449,6852167,2.6501635563943977,2.9879308661136066
NCI-H1623,5280436,2.3425513929901043,3.3146703623795406
SNU-61,11625818,5.738401007397874,3.9843017666552605
NCI-H146,selumetinib-tretinoin (2-1 mol-mol),5.090146461709555,3.393882842459039
G-401,selumetinib-BRD-A02303741 (4-1 mol-mol),3.259716171612134,4.159069098984779
G-401,11396600,3.403558125152034,3.0272411736848723
LoVo,11396600,2.965288622606591,3.8812791572386636
YAPC,5311,2.641039705119952,1.5262129392455845
HSC-4,168313047,3.0036663016787015,2.1443317406741227
LXF 289,135440466,1.0541158239349229,2.0598892633106427
FTC-133,navitoclax-PLX-4032 (1-1 mol-mol),5.2980010762745415,1.8926944317520888
SW1463,16720766,2.9834843450585193,0.8065716758578502
Panc 04.03,2708,5.3340089352485816,5.020567663479714
MSTO-211H,11612883,1.8196539401694043,3.005709625319962
G-401,219104,1.9483296496250493,2.9025695972227554
OVISE,3854666,4.260793298508907,2.549664217441485
JM-1,327653,2.4402793258430786,2.650506415965148
SNU-449,984333,0.3609894515007521,1.1030657212526207
NCI-H146,40482356,6.02837292181762,3.85906412134133
NCI-H2009,selumetinib-navitoclax (8-1 mol-mol),-2.134794996272836,2.0805924146653356
HSC-4,9952709,2.643320259436509,2.8820701397609976
CA46,71680916,4.255070441315874,3.7976412693201316
MSTO-211H,119182,-3.3068023354733156,-0.6773274220947431
HSC-4,4788,5.270141450772874,5.708968110826863
MDA-MB-453,11612883,2.003650622053601,2.7970556857807183
A-498,2729026,3.0720683032694827,2.8904942554262987
CAL-51,135659046,3.6035863494873137,3.613562985372141
A-673,16736978,0.9204710311128564,1.277015422802171
SNU-61,selumetinib-navitoclax (8-1 mol-mol),-0.634937533687344,1.8204615841806882
G-401,5335621,4.041162639386401,4.228807273939632
NCI-H292,11647372,0.0082735983152987,1.3931171006805527
NCI-H661,46191454,1.844409109204796,1.8571616646707596
NCI-H460,439501,-2.362377537788676,-2.0695784787084524
NCI-H146,BRD-A02303741-navitoclax (2-1 mol-mol),-1.9757799692204725,1.062021145096207
JM-1,navitoclax-birinapant (1-1 mol-mol),0.1360362208330573,0.10155803706777115
A4/Fukuda,5328940,-0.5379688872377596,1.251332638202327
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125,4.233437853294094
LOU-NH91,25126798,3.943021506059378,3.9705528038497726
CAL-51,56963564,0.4281851677964957,0.6603880370991488
Panc 04.03,24785538,2.964340727211602,1.7185476794637828
SNU-449,56963564,1.9660320048352,0.6837935802592771
SBC-5,156414,2.5142262290401516,1.495333294800454
FU-OV-1,46398810,1.7086224401878771,2.491387444144915
MDA-MB-157,426756,4.156862898324412,4.172727015663492
G-401,4521392,4.161493335374481,4.302747553409049
OVISE,36462,4.611657944155446,2.21701047349744
SCC-9,serdemetan-SCH-529074 (1-1 mol-mol),2.940999186382139,2.206415997993673
RCM-1 [Human rectal adenocarcinoma],11955716,-2.128476517967918,-1.428948006558993
CAL-51,5351362,1.1872361858703535,1.5355694702817115
CAL-51,119182,-1.323881847361974,-0.43975070176895065
NCI-H522,24753719,5.009376195679754,3.779103804468393
JM-1,tretinoin-carboplatin (2-1 mol-mol),2.443432654603248,3.7310729881405367
HCC1143,9915743,0.7364353129897024,0.9600972718603751
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,1.8471742524482044
NCI-H522,24889392,3.251100273050004,3.9233111607980966
LoVo,11178236,-1.6059359070935737,-3.004094371624603
RCM-1 [Human rectal adenocarcinoma],44462760,4.900478491796212,3.9131117748607567
CA46,23725625,5.582899861703026,3.327317803439575
NCI-H460,25154868,3.4600493825904564,4.255895253966881
CAL-51,36462,0.7338920585832341,2.012448246217976
EFO-27,5281321,-1.9543223460886947,-0.8926753926274956
LXF 289,11612883,1.9814919247106189,3.0590855220672273
HCC1143,2828334,6.454192166435682,6.245059235350121
A4/Fukuda,3854666,-0.0838776105349313,0.8489110003198614
CA46,10322450,2.6264913036213606,3.222795264709062
NCI-H2009,51039095,1.8360035457780568,2.849485977993037
BxPC-3,10231331,0.6961573218104748,2.134356704487219
LOU-NH91,56649450,2.5557041031897705,3.849537014969245
G-401,216239,1.6826916037000108,1.997815824519307
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.4440306413189163
HCC1143,5281321,0.7613054606946723,-0.9612352391505619
EFO-27,72376,-1.8608022629783372,-1.6914617652395032
NCI-H2171,19582717,3.772812394316534,3.239615554883328
MDA-MB-453,10074640,2.421510718072182,2.8313292296705685
G-401,11317348,2.32763680059041,1.8786576852432817
FU-OV-1,selumetinib-tretinoin (2-1 mol-mol),-1.802800887870168,3.908618944000254
NCI-H146,2729026,1.2131739481587438,2.11622333458446
OPM-2,46907787,-3.368300500627006,-0.5677102536842795
HSC-4,navitoclax-sorafenib (1-1 mol-mol),2.0260640638250154,1.6002246200199053
KYSE-70,15547703,3.259406085484829,3.065606955661226
NCI-H522,107985,-4.282222583037789,-3.5233536742958598
A4/Fukuda,9933475,1.717973727652582,1.9316716189315237
CAL-51,6505803,-1.1525670311484852,-0.7189083631532679
HCC1143,5329102,2.41968992927328,2.16238776579192
MDA-MB-453,46215462,2.7539180673476986,1.9647872272916134
LoVo,151289,0.7390860710542093,1.090788436769151
SCC-9,10296883,4.238304408621306,3.931531133026646
LOU-NH91,54454,2.054793401572522,2.618499789263232
A4/Fukuda,9884685,-2.10728676228506,-0.04513501650125817
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156,-3.4274764927070276
JM-1,11317348,1.0457451678280252,1.237675352119885
MDA-MB-157,5287620,-1.8230093056434509,-1.563395825977463
FU-OV-1,24821094,1.823018038350918,2.835994942688736
Panc 04.03,15547703,3.067090198790942,3.321729165725768
DMS 273,568763,0.8680081273298318,0.2106062604383589
KMRC-1,16038120,1.697027615564608,1.1003359719424382
A4/Fukuda,11214940,3.3298423014633585,1.2252572927005219
LoVo,168313016,4.599216339831628,4.790670086881534
JM-1,3011155,4.445867330482826,1.7370430556150402
NOMO-1,135411,-0.3073928829727976,0.17259041017165938
A2780,24772860,-3.463956246093966,-2.155198451479258
MSTO-211H,11625818,2.0984197145893853,4.387051859197758
FU-OV-1,219104,2.911303350256359,3.6453984542600337
SBC-5,JQ-1-navitoclax (2-1 mol-mol),3.919217693519999,0.9723908462753167
SBC-5,49793307,2.0795512515040144,-2.7106809364220017
CA46,53232,2.437328600755792,2.7802681257238526
EFO-27,24901704,4.244323432217726,3.327968855254998
CA46,2746,0.9501634288999758,2.006724267541653
Panc 04.03,selumetinib-navitoclax (8-1 mol-mol),2.4072445179954665,1.908026235345808
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842,1.1491320657029906
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768,0.7988607066662514
NCI-H661,9956119,3.313685900900753,3.719136952201757
SW1463,44185566,1.4171512734588314,1.9119412113001704
FU-OV-1,3384730,4.633609637548597,3.0016458282668657
SW1463,3384730,2.9539510373394458,2.4110788562954677
MDA-MB-453,3825829,3.844348445708714,3.8953129884336293
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937,0.919195852278081
Panc 04.03,400769,-0.067858138339059,-0.46697437667065794
CAL-51,445643,4.334473435217703,3.984344487966719
EFO-27,156414,2.3785601677308215,1.3456939846040001
NCI-H2009,4259181,1.0344432117954978,0.20729937535566886
MSTO-211H,16722836,0.7655247341289007,1.7195102157878532
SNU-81,11364421,-4.012430935720713,-2.19507926762944
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,2.96436257830984
A-673,2746,1.857945511282164,2.723833205339685
OVISE,navitoclax-sorafenib (1-1 mol-mol),0.9257424766739848,1.4590504104753845
NCI-H460,135398516,4.13019906717736,2.1609915788143663
BT-549,25183872,-0.4430920052505824,-0.5356610824883247
JM-1,49846579,-3.8749150343559498,-0.7773805443822779
NCI-H522,10127622,6.598645867237379,3.7174733213676303
OPM-2,446155,0.7744505725193765,2.4428813388253814
G-401,10296883,3.7583450228982342,3.4480485840706474
DMS 273,1716436,3.74376938939547,2.626109463502902
SNU-449,serdemetan-SCH-529074 (1-1 mol-mol),2.2114452533334212,2.3162358894703474
NCI-H522,44566777,-0.9754694174653856,0.6475613386281652
MDA-MB-453,53393127,2.113910519669698,3.8405067248140234
FTC-133,49793307,1.1308238833509443,-2.1756268940404864
OPM-2,carboplatin-UNC0638 (2-1 mol-mol),3.55532531474596,2.6758494445788257
A-673,135928012,2.926877088120134,3.837127964839657
NCI-H661,5280436,4.871704282803626,3.6111091509287196
NCI-H661,docetaxel-tanespimycin (2-1 mol-mol),-5.324368950628822,-2.939825965644762
JM-1,5282054,2.3244175489984573,2.667739467305139
JM-1,9549297,1.5955396397117223,1.568877715483611
NCI-H460,11507802,2.848054270429628,1.7417138461117987
A-673,387447,-4.940230504934896,-4.82301621002264
LoVo,89928392,0.5944678691764933,1.5205068869074245
SNU-449,navitoclax-MST-312 (1-1 mol-mol),1.1854227296029016,1.2528785990550915
BxPC-3,doxorubicin-navitoclax (2-1 mol-mol),-1.6348135682657186,-0.687881179391256
NCI-H2171,67156097,-2.093355563734418,-1.754136842483713
CAL-51,9929138,6.421072450841616,5.476132200292971
NCI-H522,11609586,2.3447481698139545,2.27996356226304
JM-1,56946209,-6.537344033049601,-5.0992524756782664
MSTO-211H,54649381,3.373909346349482,4.161623758596453
A-673,4261,1.089626824326701,1.1172938083524604
SNU-61,56649450,4.501229591303133,2.6049539326299267
EFO-27,5738263,4.449588569174732,3.6662296486457864
RCM-1 [Human rectal adenocarcinoma],60750,2.8463966167693515,-1.5513333586674323
EFO-27,462382,1.6036436678954449,0.488507303203167
BT-549,24180719,4.750015939259711,3.554292786154156
HSC-4,73707398,0.9895931551524366,1.4623311843275117
LXF 289,52912189,-0.1394416798850269,2.4081607070741664
DMS 273,BRD-A02303741-navitoclax (2-1 mol-mol),4.151780169779293,1.023107352069678
NCI-H2009,31703,-0.97323545782719,-0.7932675664693011
NCI-H2009,219104,3.953506929532588,4.0368969699943165
A2780,11626927,5.568414170846121,2.1004009221545292
NCI-H1623,navitoclax-pluripotin (1-1 mol-mol),-0.2970825131911801,-0.5209641623499242
Panc 04.03,4788,6.095957987809042,5.730391491811879
OPM-2,4259181,-0.0185783035827133,-0.5170100767057489
LOU-NH91,9915743,1.51930479588737,1.3992362134911271
G-401,2828334,5.836351566381613,5.827155551406551
LXF 289,3689413,0.4542816941401804,-0.17772155649716634
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467,0.8983183857588622
SBC-5,119182,0.2964340092945935,-0.6406632396667372
JM-1,2729026,2.071801783442454,2.241167917303898
SNU-81,11214940,1.7135053171337324,1.7194142008430344
SBC-5,439501,-2.4874901722547977,-2.1434777984439957
OPM-2,46174525,3.627220507837432,3.1100303523027732
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402,-0.11609434483418632
FTC-133,selumetinib-vorinostat (8-1 mol-mol),4.335548645422765,2.3577246561232554
NCI-H2009,3062316,-2.678423554108453,1.37465145700548
HSC-4,6438330,1.0116267584860468,2.155918487141662
A2780,1317464,4.304763369285543,2.8010705631774364
G-401,3025944,3.816605103301755,4.003462584604939
NOMO-1,9915743,0.4758643096003905,-0.32798620971119385
CAL-51,9877608,5.917079709597661,3.3601265541611127
LoVo,71466380,3.017013363980257,4.4706156931865
HCC1143,53392493,2.60613854373917,2.7198426487933682
A-673,6918837,-5.129930095166698,-3.8262769404506294
SNU-61,60700,1.2670278964841577,-0.2086452916101627
OVISE,6918837,-1.5846953199834826,-3.0656769393758703
NCI-H727,11609586,3.3120945172723917,2.80788599224356
CA46,tretinoin-carboplatin (2-1 mol-mol),4.700900152183415,3.373783740692434
NCI-H1623,5281672,4.562545083615407,4.595499441560474
NCI-H2009,6918328,-0.9509353973047906,0.320015699409777
LOU-NH91,vorinostat-carboplatin (1-1 mol-mol),3.369896826709664,3.3760772488129156
OVISE,16722836,2.434488476233433,1.7487952210422726
JM-1,10127622,5.153041805169496,3.5996001764884547
NCI-H1623,252682,6.46254793762087,6.607784639564004
JM-1,53392493,1.8440760854554048,1.5847323374144013
MDA-MB-157,168312962,1.1798186112423137,1.719284584660777
YAPC,44819697,-1.3460219164430964,-0.22619368009840696
KMRC-1,44607531,1.585622780528836,1.4867682115709508
NCI-H2171,6918878,0.0284372668850805,1.2555788468648423
MDA-MB-453,44607531,1.359301388322155,1.3843916815727553
ONS-76,11485656,2.5953354109263262,2.4513213673193324
MDA-MB-157,135398516,1.565807276365399,2.420435463893828
A2780,24753719,3.5545225878481745,3.828510392152008
NCI-H661,6918328,-0.1140400883450083,-0.004286155728760432
JM-1,4578,4.1991230056704785,3.7589158659029103
A4/Fukuda,9903786,0.7546004224414102,2.2256585154611397
CAL-51,11485656,2.6541256228973773,2.2757283615799158
NCI-H292,24964624,2.911439833663599,2.734813029320307
NCI-H661,6918837,-3.3797686305940156,-2.256559871829302
EFO-27,71304818,3.2919872626583486,2.5560299757784937
MSTO-211H,4705,2.457156821386339,3.4685223369906573
DMS 273,107985,-4.548014092027974,-3.7018985817783703
SNU-61,2729026,2.4451253635155106,2.6127472205293527
JM-1,60700,-2.9904484465209036,-1.9013167128411166
SNU-449,JQ-1-MK-0752 (1-1 mol-mol),5.5892167281424285,2.0359611870317553
RCM-1 [Human rectal adenocarcinoma],11640390,3.7299689357319257,3.639037214343558
SNU-449,24856436,4.072390930567189,0.9324335902345898
NCI-H460,159324,4.0462841352482855,3.271344181844937
NCI-H2009,11175137,2.49599907102206,2.8357763737354604
A-673,208908,1.851861192467165,2.0940115846318346
BxPC-3,25183872,-1.12027566647844,-0.7950376014430938
EFO-27,5328940,2.731901822530229,1.8496565915086998
HSC-4,135398516,2.2759469773851224,2.138614241270821
HSC-4,11647372,1.1815136799972823,1.0947345806936988
CA46,16038120,1.1324791438314847,0.3831934869046453
MDA-MB-453,9868037,1.568237926564538,3.1038718299236066
A-673,446155,1.1478268834845686,2.303245647872802
A2780,5479543,3.565203320915574,3.317960844029356
MDA-MB-157,10322450,5.067042624032479,3.9345438150286047
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236,1.3310786519980615
MDA-MB-157,9915743,0.9957990206413116,1.1438563488052849
A4/Fukuda,219104,2.2512696330904447,2.79393421670347
RCM-1 [Human rectal adenocarcinoma],10410894,5.33973414369723,3.206468089019657
SBC-5,12001922,2.404615034975172,1.7951766108151972
A-673,51037431,1.861905373589415,3.2059215711598212
A2780,637858,1.382423379201008,1.5417536709498483
NCI-H2171,BRD-A02303741-navitoclax (2-1 mol-mol),-0.1592201049133759,0.843583377289614
A2780,9884685,-1.5939943621043984,0.041282759445835364
JM-1,5311,-0.0672732572458771,0.5535434601631054
CA46,15547703,2.518572103836232,2.43662363064868
BxPC-3,54618164,4.016743819691475,3.919401661928812
BT-549,2749,3.5786970568950913,2.1205597138229906
SNU-81,73707398,1.1294477244846828,1.0950828196237767
SNU-61,docetaxel-tanespimycin (2-1 mol-mol),-4.617294417621486,-3.344072304098477
A-673,55508,3.3138750706926157,2.97246375454381
SNU-449,carboplatin-etoposide (40-17 mol-mol),5.135900435909966,3.1476378026818708
MDA-MB-453,23725625,4.029710365908802,4.8146696853830555
A4/Fukuda,4261,-0.9007526332595048,0.8061912351307824
NCI-H727,446155,4.65589483782911,2.6952356061655602
NCI-H1623,44486219,4.206804435599472,4.442988463552444
MDA-MB-453,441298,1.8295928982069447,2.7183885393790264
SNU-449,54454,2.520106415523585,2.7120692313106116
A2780,387447,-4.368237522415053,-4.44583088239418
MSTO-211H,11152667,-3.5300772231011703,-0.5359505367251229
SNU-449,25195348,3.622170031481097,3.3615224369380763
MDA-MB-157,322968,2.1225136411127545,3.8261347488080384
A2780,168313200,1.7543183926879495,2.801508162158505
RCM-1 [Human rectal adenocarcinoma],24797083,2.1636765251680625,1.5728289796934454
SNU-449,5329102,2.0099859216843075,2.2789891736920005
NCI-H2009,322968,4.70725114827159,3.9422460300658972
KYSE-70,16722836,1.4327625680833322,1.9027563379050831
MDA-MB-157,11609586,1.0926317538630208,3.1585630975553283
FU-OV-1,10231331,3.398558944555642,2.509402740214646
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172,2.9068570195345043
NCI-H292,docetaxel-tanespimycin (2-1 mol-mol),-3.440758677710888,-2.7121002975527033
LOU-NH91,11238147,4.007302405058718,3.13617572122657
LOU-NH91,49766530,0.361985362717411,-0.40299076790197286
YAPC,9444,4.346283036692295,4.03772767778966
NCI-H522,15547703,3.471643136947843,2.822831982378726
NCI-H522,375860,-0.630771500248647,-0.04928770723176503
CA46,119182,-4.388833865288787,-2.614362110428595
OPM-2,10410894,2.9147321100270593,2.6531996151355846
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,3.04600322415027
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803,1.4577628905894706
OPM-2,docetaxel-tanespimycin (2-1 mol-mol),-6.145766231617617,-4.688822063721666
NCI-H2171,4261,0.9024779156039784,0.8835097918027083
NCI-H1623,25262965,-3.228781743363827,-1.1792669624068817
NCI-H2171,navitoclax-gemcitabine (1-1 mol-mol),-4.23755685830139,-1.6201517458416208
MSTO-211H,10427712,4.183883954719584,4.424056353876772
EFO-27,navitoclax-birinapant (1-1 mol-mol),3.2392186746278244,1.3173116412424875
A-498,9967941,4.3277437867326025,3.7608205541235495
HCC1143,25183872,-1.001460572121427,-0.7400819468486937
NCI-H522,crizotinib-PLX-4032 (2-1 mol-mol),2.133335771815486,1.5386253729045882
CAL-51,17755052,0.5283491907817935,1.69538885275963
SW1463,44137675,3.7114847318755806,3.20066780447873
BT-549,5278396,3.375604766419473,3.6120169817139924
NCI-H292,3025986,-0.8794264876923694,-1.0377503201045233
NCI-H2171,3825829,3.727904622873516,3.479907009039425
EFO-27,327653,2.4330037956805133,3.029280271631271
NCI-H460,637858,3.384702960830197,2.0452945072085917
G-401,5746,-1.2143401521495898,0.4520023679016126
A2780,5281321,-0.7497434400684011,-1.7370701227159753
NCI-H460,409805,5.4278006548731295,5.228010993668103
MSTO-211H,alisertib-navitoclax (2-1 mol-mol),-1.8568151112874771,0.5794742566133843
SNU-81,11964036,-0.3940350311201446,1.0788401413376694
OPM-2,53232,1.210133300080481,2.351292148813554
A-498,216468,3.41587450505901,3.6590961921242426
LoVo,6852167,1.8421975016001388,2.7037004548432884
SNU-449,53325874,4.456238471946744,4.536107098740677
FU-OV-1,10296883,4.259179003182187,3.9175244355031498
LoVo,3136844,3.7568853791466608,4.40211081749017
HSC-4,637858,2.398043952194309,1.9995585378129914
NCI-H522,9927531,4.749051096908956,4.537067104850685
MSTO-211H,53392493,1.8202473930982712,2.7411670357279574
Panc 04.03,11626560,2.20525660125161,2.0090938028564818
EFO-27,11178236,-5.208504296414087,-3.3120783014812782
SBC-5,3503,1.24841833111282,2.290856079509898
G-401,11640390,2.8162749001609417,3.03087654784753
NCI-H727,selumetinib-UNC0638 (4-1 mol-mol),-1.3488333019368446,3.127440508177218
RCM-1 [Human rectal adenocarcinoma],46843906,3.578406808206158,3.0654117732596236
FTC-133,54454,1.7579296666098376,2.253865954169926
MSTO-211H,54613361,-0.4311183648022992,0.20040958405936593
G-401,5282054,2.6200467258422235,3.0623011563555935
NCI-H727,135440466,0.3181577925646752,2.3546378028608683
SCC-9,6852167,2.7106856908699255,2.870224525110172
NCI-H2009,124202324,1.390796248932456,2.6822442266887827
SCC-9,54618771,0.4910288003516506,1.466678309827372
A-673,9826308,0.1905391916215918,-0.09759547237482255
KYSE-70,446155,3.830415114438346,2.694076163352508
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.0717184124257426
CA46,10296883,3.259152671675197,3.0335336050844335
NCI-H661,159324,2.633762936698375,3.230319479522269
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827,1.7133344621286832
LXF 289,5328940,2.0490491787199687,1.6401806000040589
KYSE-70,400769,-0.6610715268602807,-0.5659216389235102
BxPC-3,9911463,3.950256717526944,4.035049280521719
MDA-MB-157,119607,5.813382396653367,5.282471209614165
NCI-H727,168312962,2.354698653601169,1.6995958289548694
G-401,67156097,-1.3508759360204068,-1.4213344800020105
HSC-4,53232,3.536415160688875,2.7901638426600135
BT-549,9866186,1.9395157417186848,1.0477085855415011
A2780,46174525,3.809782337657401,3.6961331536314264
NCI-H661,24797083,0.8737198077858661,1.169419893068235
OPM-2,107970,1.3408908225452507,1.8875163732553712
HCC1143,3038522,3.729990546362485,3.2302048260442975
JM-1,5746,-1.3315669786621744,-0.7191798439071998
OPM-2,9935249,1.874633336412032,1.2754222161008
A4/Fukuda,10302451,3.353566161735505,3.053764060228262
SBC-5,1641662,2.7360117188732684,3.3360880420661
CAL-51,25183872,-0.1080661998677032,-0.7792838420889393
HCC1143,72734382,3.642829686089203,4.47747017741765
SCC-9,67156097,-0.5297515363076177,-0.07516721511944582
LOU-NH91,17759555,3.0310153631552295,3.7337865162318433
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249,1.45003539979536
FTC-133,6252,3.0791801983523297,1.135404623032477
NCI-H146,10026128,3.971012402354388,3.662560447775019
HCC1143,327653,2.9245812810780745,3.0571684460968793
NCI-H661,selumetinib-JQ-1 (4-1 mol-mol),2.8735822394027335,1.806349969938116
BxPC-3,docetaxel-tanespimycin (2-1 mol-mol),-4.5492420076102045,-3.184616004437265
SNU-449,SNX-2112-bortezomib (250-1 mol-mol),0.2827290486356496,-0.8310231194585919
A2780,71466445,2.121500658196736,3.2216358516063406
FTC-133,11640390,4.129780643497309,3.712748401184512
NCI-H661,66577038,3.3791675548307225,2.8984650553357887
A4/Fukuda,89183176,1.286008536767452,3.0266616164135796
KYSE-70,49793307,-3.275020883815728,-3.0995871273213744
NCI-H2171,36314,-6.271125424872196,-1.404238815575761
G-401,5351362,1.1066788885055705,1.1950914128660821
NOMO-1,44507138,0.557170216692965,1.5825618092217721
CAL-51,56649450,1.7310987503885624,3.4729090086524526
MDA-MB-453,100016,6.0730906594859215,6.079700202495116
NCI-H1623,6852167,1.7873387390250663,2.9305916605300126
A-673,16659841,2.6132078541729404,2.9393448899553625
OPM-2,67291369,1.773293288142809,1.0302345358560427
OVISE,374536,3.768512931442208,2.4478463134757
CAL-51,11238147,2.100409816322544,2.9177025157820715
YAPC,11175137,3.2313352651289327,2.721487464916968
NCI-H522,ISOX-bortezomib (250-1 mol-mol),0.0474854277983787,0.4206919043481479
OVISE,10427712,4.5158462716299415,4.324675808553998
EFO-27,5351362,1.1790960486008195,1.5933962935819201
NCI-H292,6505803,0.1482155149138876,-0.46349890134239125
SNU-61,vorinostat-carboplatin (1-1 mol-mol),3.629887150631109,2.6743149503896744
DMS 273,71680916,4.789726238699708,3.951847397919778
CA46,10184653,1.13668363671425,0.8766102850378364
SBC-5,49867926,4.30527508614513,4.16846934682531
LoVo,11238147,1.4038592423826672,3.003509419803196
MDA-MB-157,11427553,2.127814795485051,2.482934255640429
SNU-61,11178236,-3.475859478717308,-2.7630050496146117
SBC-5,piperlongumine-MST-312 (1-1 mol-mol),2.5701291604117045,1.6589756910259723
FU-OV-1,11214940,1.6800576649286882,2.075807518357593
LoVo,9903786,0.6551100591729495,2.5215533590782058
NCI-H1623,135411,0.3784026464220375,0.8753291799295646
LoVo,3062316,-2.119304437973892,1.2121105067848823
NCI-H661,46174525,4.042428757819544,4.661614636943886
SBC-5,51037431,0.5420283127367359,2.8525961913743036
A-498,3689413,-0.327867250415736,-0.31983401095514885
DMS 273,selumetinib-UNC0638 (4-1 mol-mol),4.157627757757485,2.9100576180192577
CAL-51,54649381,3.902782783768603,3.9892311684628545
A4/Fukuda,16038120,-3.113498344638628,0.3568069260409679
A-673,135398516,1.4288802928040978,1.891613164038623
NOMO-1,135398744,6.340708200805823,4.555937031838958
KYSE-70,216468,2.031191966418552,2.504202611868436
A2780,67291369,1.1130592599106983,1.8594035800046413
NCI-H2009,654092,0.0283248260105453,0.04373158043980318
NCI-H661,UNC0638-navitoclax (1-1 mol-mol),4.1455150469586535,1.8161112293457868
NCI-H146,navitoclax-PLX-4032 (1-1 mol-mol),-2.8852479543284617,1.105818373185366
SNU-61,11612883,3.050953505253589,2.4437640437323807
SNU-61,5746,1.3298489283886064,0.7981141611264428
KYSE-70,124202324,2.186627813347476,2.4769064155298097
SNU-449,carboplatin-UNC0638 (2-1 mol-mol),4.161475175536438,3.2784761765181445
BxPC-3,409805,3.7922849099240734,4.918315727752951
A4/Fukuda,3552672,1.9607713184754867,2.8551082387581266
KYSE-70,9907093,3.6347338213446454,4.280735155849457
SNU-61,12003241,0.1572719330395487,-0.7231755964600082
HSC-4,322968,4.636798889333657,4.042928782291921
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673,2.337642987713643
CAL-51,16115403,-4.643171700082743,-3.863686225758538
LOU-NH91,2746,5.002248002286792,3.5460448919834415
A2780,3543504,4.147653095225295,3.803835580626501
NCI-H661,25126798,3.9237728184770946,3.809427423278883
DMS 273,4521392,4.235410021964807,4.095843562193661
BxPC-3,49836020,-2.380895293574403,3.1708043075652497
NCI-H146,JQ-1-vorinostat (2-1 mol-mol),-0.8208901447975969,0.5949022314330089
OPM-2,3689413,-4.501811354570108,-1.0691404661434498
Panc 04.03,selumetinib-piperlongumine (8-1 mol-mol),4.132461761791421,3.7240026321160076
NCI-H727,navitoclax-gemcitabine (1-1 mol-mol),1.335724896470854,-0.5085981361678591
NCI-H460,5328940,3.322075361136407,1.666763314872341
ONS-76,25126798,4.148768722347094,3.7260856399908273
OPM-2,57519531,1.419627244644159,1.7830870837347041
BxPC-3,20959075,-3.864209289368053,-2.6722306525227726
OVISE,54618164,4.29678583267412,4.227626784139668
YAPC,10074640,3.068654585130056,3.190123531896687
BxPC-3,5287620,-2.837282092833542,-2.131495659748977
SNU-81,24785538,-0.3807988804027284,0.4150623365087066
NCI-H292,5287620,-2.1513248285430997,-2.052168287410999
NCI-H146,104842,-5.965892600420639,-2.9816897551756893
NCI-H1623,selumetinib-vorinostat (8-1 mol-mol),2.11860807065236,2.5039873133006463
KMRC-1,17755052,1.9475900469511016,1.4600908828785302
NCI-H2171,24856436,-0.4096039036242957,0.2751505480935551
NCI-H2009,11364421,-4.013811791110126,-1.2394720856689387
MDA-MB-157,5470400,0.4579153499304774,0.047324378286492115
HCC1143,51039095,3.6749130279746938,2.8076127395005233
G-401,11964036,0.0453230579510409,1.1411067106573374
NOMO-1,1641662,3.174576963224712,2.7424245406028955
MSTO-211H,25102847,1.842661618149511,2.498159798734765
A-673,9908783,4.713034696547774,4.55871222072185
BT-549,71680916,6.0821013857398745,4.915260364974667
JM-1,11719255,1.4438675590466743,2.413883576969426
HSC-4,2874250,5.810325396532396,4.675436765200411
RCM-1 [Human rectal adenocarcinoma],25227462,1.022239632483553,0.5494747834005256
NCI-H460,654092,0.4612941847378306,-0.20044559329659248
OPM-2,5328940,0.8145180628284293,1.1436657413161369
A4/Fukuda,44202524,1.0259860145116777,1.7168565433719103
G-401,11213558,0.7886605378704363,1.5069361203398963
OVISE,135984461,1.6429740508824469,3.5999599757186376
NOMO-1,11964036,-1.1045639043109698,0.44822732894935063
CA46,6184667,1.8666466805539537,2.26247782236762
NCI-H460,9903786,4.057661845653794,2.797806856926014
BxPC-3,25102847,2.0998558206838913,2.5889108138782664
SCC-9,5470400,0.9401931564199802,0.09785067830477091
ONS-76,5284329,2.36276815665719,3.300950122331805
DMS 273,25227462,-3.883072621079263,-0.5864512486690991
A-673,42642645,-0.8052568071576633,0.2592833937554598
A4/Fukuda,9549297,1.6255879909683784,1.9672965185021243
FU-OV-1,11427553,3.01783779671809,2.8364755811351356
SNU-61,5328940,1.147707594205283,1.4554190176874582
HSC-4,5281321,1.7816899121848235,-1.1100438486844157
KYSE-70,656346,0.9492660515895844,1.1625234776199722
NCI-H1623,72734382,4.853935764849827,4.748616088291389
MSTO-211H,67156097,-3.635314822435898,-0.5439677668907346
MDA-MB-453,637858,1.2138352699902215,2.11757196496889
CAL-51,56963564,0.4281851677964957,0.6603880370991488
A-673,10113978,2.507382463710335,2.7645635031826292
YAPC,2946601,6.339465197306548,3.271198088240967
NCI-H2171,ISOX-bortezomib (250-1 mol-mol),-0.1667670458768617,0.3043875402285081
RCM-1 [Human rectal adenocarcinoma],2858523,3.3395777905719872,3.1193064142881237
HSC-4,65628,3.12205826618997,4.4895361223371255
HCC1143,227681,3.1373347590378335,3.591867892627074
A-673,53301938,4.3782771731899555,2.215805433588286
G-401,66577038,2.320880294749871,2.8152657132936283
NCI-H661,9884685,0.1767392095869446,0.5613180010911895
SNU-449,6184667,3.7989058233577566,3.3127946989199457
OPM-2,24951314,0.2222837933942169,0.3256203601627901
LXF 289,56963564,0.2991276479966406,0.45303462771075687
HCC1143,11364421,-2.85203888888326,-1.6429452773586517
NCI-H292,9936388,-1.1579069678838152,-0.15745566809615236
G-401,10231331,2.894718734978725,1.7103640953033201
CAL-51,89928392,1.068329558331595,1.6453012843325465
NCI-H2171,53392493,1.8740494203136608,1.934016624721223
A-673,136227331,4.241984110268528,3.335792700074074
NCI-H727,11717001,2.7053596974758594,3.974898666523328
A2780,16219061,2.814782356526162,2.7946835865275363
SCC-9,54454,3.1137155512464596,2.6716720204998294
YAPC,12003241,-0.7644111057992425,-1.0159680479771456
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.567692604959522
SNU-81,5335621,4.181800470543683,4.173133460240818
CAL-51,5329102,2.0492492410301484,2.16404457263111
NCI-H146,10385095,0.6869778017915235,1.4227223496094594
RCM-1 [Human rectal adenocarcinoma],53392493,3.4798204288234165,2.705310875552202
SCC-9,2113511,6.3303497429476625,5.804192338408932
ONS-76,2708,5.792421817961339,4.7486958647772015
SNU-449,11485656,3.58452534173841,2.6814826741286435
A-673,46215462,1.2771489946566346,1.348861248338915
FTC-133,285033,-1.2963608176743802,-1.3286819208029745
SCC-9,6184667,3.279451062583292,3.1444611358129038
NCI-H146,16722836,0.0677462505380894,1.5823339836497023
NCI-H661,44137675,3.7576040576240257,3.4932992475295506
NCI-H1623,11612883,1.5649574760969076,3.1372493894058726
LOU-NH91,3825829,4.327670981782257,4.207925917077038
SCC-9,5287969,-2.1272191034883874,-1.768014182582204
Panc 04.03,10410894,3.886544188244091,3.4628207629138372
NCI-H146,135398516,1.5035346569298091,1.8337923404023644
A-498,4096211,4.004902569915099,2.4750078904779915
OVISE,104842,-0.680714151991963,-2.402214714756193
SCC-9,135440466,2.439160969941936,2.3614776656717154
ONS-76,10322450,3.321198163736043,3.489985909754753
SNU-449,81146,6.119223793669881,4.773283037458231
JM-1,148124,-7.840698833354439,-4.0498093987705905
BT-549,5460769,6.35928800843138,2.7580921280578963
MDA-MB-157,969516,1.7670354115722269,2.8471985359349246
LXF 289,5278396,2.6487510770020104,3.7495493026985276
ONS-76,100016,6.019166856387977,5.79747251375186
A4/Fukuda,11707110,-3.666992219196893,0.9023017071380618
JM-1,6438330,0.1685207017328377,1.2655146510022626
SBC-5,navitoclax-sorafenib (1-1 mol-mol),1.4051935643931297,2.0571952984764543
BT-549,10074640,3.6929061121608577,3.2985918715504408
A4/Fukuda,46926350,-6.021657358635238,-4.669489014900218
SNU-81,selumetinib-JQ-1 (4-1 mol-mol),-1.924488986117384,0.9155218468669969
SNU-81,4917,2.3748179961814375,2.6018254053292083
A4/Fukuda,119607,3.918640768426122,4.5791704278641205
HSC-4,613753,3.3632883902358715,3.38714695739023
DMS 273,135411,0.7219297948054574,0.32472065909685244
KMRC-1,46907787,3.729545872280723,1.8886792715788316
LXF 289,44489675,4.904101073680104,4.216165664405658
BxPC-3,6918736,-1.9181543280529496,-1.580681047026246
KYSE-70,65064,5.1318583658275205,4.749884280947061
HSC-4,25062766,1.8609848482730849,2.2914522902486114
SW1463,15983966,1.3055923116721375,-2.1295582436972764
HCC1143,11396600,3.529486359294858,3.6479181449310842
SCC-9,45279963,4.124125049817703,3.813274702651798
RCM-1 [Human rectal adenocarcinoma],docetaxel-tanespimycin (2-1 mol-mol),0.3001853485414289,-2.4698054366774995
NCI-H661,5113032,4.99918939361245,4.819884247833735
LXF 289,17759555,2.434653643868842,3.6700801435750243
DMS 273,46926350,-4.333780789364997,-4.298089598269909
OPM-2,46224516,2.1207785622277373,2.071466229970143
A4/Fukuda,9908783,4.281950187885367,4.262818293880294
A4/Fukuda,1716436,2.785785051354721,2.7630026008135684
KMRC-1,54454,2.958009627513852,3.0178348971574143
HSC-4,73707371,4.771220465805862,4.7992758871466545
KYSE-70,9911830,3.1951659700149886,2.551065068698887
KYSE-70,tanespimycin-gemcitabine (1-1 mol-mol),0.2674613674270346,-0.6588291315516325
HSC-4,16720766,-1.6245250648624636,0.8779127013841825
OPM-2,11964036,0.2409704368173301,0.4360069728655344
LXF 289,3038522,4.104388560491244,3.3605817744678
A2780,49793307,-3.5064247630527494,-3.532496311281352
MDA-MB-157,12003241,-1.4339892472843776,-1.0142315677346871
MSTO-211H,53495165,-2.281905985837366,0.6289671380918824
MDA-MB-453,24797083,1.319210590833939,1.2764566594046989
HSC-4,25126798,3.2488654911973196,3.84026083053341
BxPC-3,3854666,3.4835595653471167,2.228241673253054
HSC-4,176870,2.813832788377266,3.0484427783077526
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128,-0.7353811654087717
MDA-MB-157,alisertib-navitoclax (2-1 mol-mol),-2.615500389933575,0.4886106491204179
YAPC,135398744,6.484368053683043,6.364433254596807
MDA-MB-453,51039095,2.709903892694302,2.256290864088566
CAL-51,24821094,3.2618915388877023,2.9788302456010127
NCI-H522,1239801,3.903810420887451,3.501368449956952
KYSE-70,7251185,4.369311092923008,2.8110609451417563
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.3425900687610879
G-401,60750,-4.380742093252711,-2.7906212741150114
YAPC,11404337,0.4717703732171429,-0.03169182989689158
MDA-MB-157,9826308,-1.0851482905673768,0.6743993225290847
MDA-MB-157,25262965,0.470934001928582,-1.2142001407270968
FU-OV-1,10427712,2.3896052276409887,4.181029661202782
CAL-51,285033,-2.914004430070481,-2.017833121318968
CA46,246676,4.699933053014099,3.588741402644228
A-498,9926054,1.5026788619071982,2.1485848232484472
LXF 289,44632017,2.313535350982782,1.391984332853047
NCI-H727,3689413,0.3749801507161196,0.0483110913474298
SNU-449,1716436,3.0856052265463023,3.1427660196287723
LOU-NH91,24951314,1.380037957351277,1.5495749530366334
SNU-81,46191454,-1.5874627182763832,1.4804728895609591
KMRC-1,119182,-0.1449504353389931,-0.40710451645680473
NCI-H522,9823820,3.261618834820585,3.4746178083192882
NCI-H460,11178236,-2.300904923417752,-3.3761286467247063
A2780,5738263,3.096886997462696,2.9636196634499097
NCI-H661,carboplatin-etoposide (40-17 mol-mol),2.8210696568936786,2.3566181052932347
BT-549,5287969,-2.055370090828861,-1.7988693953384756
BT-549,11609586,2.735581966533724,3.0674177416912674
OPM-2,1317464,3.5924971065959244,2.8150381448479154
NCI-H146,54639701,4.038686865533554,2.2268471574506425
LOU-NH91,3384730,3.7773271912609623,3.2773074078865205
YAPC,11152667,0.3482753398657929,-0.25415265737021836
SNU-449,702558,5.257858019653286,5.435859678587167
MDA-MB-157,selumetinib-tretinoin (2-1 mol-mol),1.8981533797930392,3.55638543258306
FTC-133,6438330,2.249518605035186,2.467304605992227
NCI-H727,12001922,1.7281936629666887,1.8428492704720498
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685,2.7291291389714063
HSC-4,60750,-5.118377280037083,-1.3559792127979875
SNU-61,1566236,1.9599867850180668,2.344252493258165
NCI-H460,5282054,4.802373462225767,3.8126944007713597
DMS 273,6610216,4.172124776089646,3.8669345519769593
NCI-H727,6852167,3.356078560596427,2.936510341541067
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,2.172812698883453
SNU-61,445455,4.539446073708065,4.245752733504757
DMS 273,3062316,3.60345807305724,1.4088716719658652
MDA-MB-157,9956119,2.310937024804907,3.601286519827894
OPM-2,135423438,0.9866001177758746,1.5268943899545406
Panc 04.03,16722836,2.845252730089092,1.9143842023722124
MDA-MB-453,9936388,0.6028011486270662,-1.3461757679465771
A-673,68056272,3.7833857366006094,3.258593135123272
HCC1143,16722836,1.2433455264432278,1.68351359657306
DMS 273,72193861,0.4647891664131632,0.569619872134091
DMS 273,navitoclax-birinapant (1-1 mol-mol),3.616691876772055,1.1612471346354456
Panc 04.03,11396600,3.73844061007523,3.8199361734991713
NCI-H522,6505803,-3.5272214952237344,-1.0094317631527092
CA46,56963564,-0.0544830399645368,-0.23357043980885855
A-673,9825149,0.7138432506885886,1.902436906679212
NCI-H1623,2871966,1.4286416314522286,0.6201335924512967
SNU-449,4096211,1.9400565485658428,2.3305209552857313
CAL-51,44137675,3.485867182081199,3.463315144789096
MDA-MB-157,375860,0.0174110406826079,-0.0681789544945473
MSTO-211H,327653,2.467891014920142,3.1594754529176634
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371,0.21915438133182708
CA46,11178236,-6.883102305003874,-3.9158007468628178
NCI-H661,5291,3.8370923902638063,3.4757136230842667
FTC-133,25262965,1.6757685209235111,-0.9550934470052286
SNU-449,24771867,3.0453458349703793,3.2228567760830615
HCC1143,9911830,2.6182666070844447,2.2851515215019256
SNU-61,44185566,2.430559307269213,1.9750148075072127
SNU-449,445091,4.4459202939225815,4.495945984626649
LXF 289,123631,1.612545473594554,2.4813534933433665
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453,4.258830835577927
SNU-61,637858,1.6436621136217924,1.6688231865787175
MSTO-211H,3025944,3.596075182431598,4.341724334516011
SNU-81,11612883,1.8877401103471,2.1047084574941928
A-673,52912189,-0.9448854486243604,1.2800463197085685
NCI-H727,613753,3.184500780825273,3.300296487559839
BxPC-3,24856436,-0.8809901773698104,0.7473964629941912
SNU-61,3038522,3.6960216122526943,2.901876899433903
KMRC-1,374536,2.325099751463231,2.2587117223561237
CAL-51,54613361,0.2180057854442524,0.03188005933988855
CAL-51,10385095,1.0305027810027567,1.3614005708901633
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945,4.134673532511484
LXF 289,5281321,-2.4870532876216487,-1.2261550641383827
SNU-449,10184653,1.7910926490151993,1.6167483536015126
SNU-81,9887053,2.281153151762533,3.1812650799426216
KYSE-70,11485656,2.2230455690794404,2.3551896353467496
CAL-51,439501,-2.444412450902406,-2.3200149959533776
A4/Fukuda,72967,3.695839205584607,2.9358619735838154
NCI-H1623,navitoclax-MST-312 (1-1 mol-mol),2.6356568038196175,0.9912910248096568
BT-549,57519531,1.7866000969199525,2.5901668915538885
YAPC,9911830,4.0093640169179325,2.587684918932441
KYSE-70,54143018,-0.2928055682999507,1.0455900859870033
ONS-76,6852167,3.4771955261396252,2.600698904255032
CA46,216468,1.7849524837603168,0.9652455557355681
KYSE-70,71304818,1.8226881659751617,2.3935072278145624
SNU-449,10427712,4.716616821408685,4.453033087289715
KYSE-70,11364421,-0.2598881855214042,-1.1008084231763187
SCC-9,46199207,3.715699147831311,3.239805835203892
OVISE,tretinoin-navitoclax (4-1 mol-mol),1.2267801901076945,2.415561482823811
SNU-81,selumetinib-navitoclax (8-1 mol-mol),-4.808792251277437,1.6488407088883275
NCI-H522,45279963,2.975445810656792,3.3981102540056356
NCI-H727,44137675,3.902640688581202,3.5500121150952206
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.2776025442819188
CAL-51,3854666,1.1494535123186709,2.0488639710121954
RCM-1 [Human rectal adenocarcinoma],7251185,3.190616991183446,2.628760961000981
NCI-H2009,81146,6.16166931928307,4.7038550628661495
LoVo,135440466,2.5900307411888357,2.1885626209075
G-401,445455,4.8654155018395535,4.369124393692893
NCI-H1623,15547703,3.108106821400364,3.08592682597164
SCC-9,322968,4.6886309532040435,4.115924261340599
MDA-MB-157,23635314,-3.347178711973772,-1.565479409861271
CA46,49793307,-4.01311922110524,-4.486210790559005
CAL-51,53495165,0.3298774405260949,0.4222188653725343
SNU-449,54618164,4.194291334344069,4.121512237825357
LOU-NH91,11178236,-2.353397629942184,-2.7540658966540317
A2780,5284616,-6.357248921927095,1.5634547491723825
OVISE,11404337,1.793635825025173,-0.1066018043075917
HSC-4,216239,1.6239220207771676,2.4840546670494703
NCI-H1623,208908,0.8939149685214822,1.9272779856841453
NCI-H146,25161177,3.485806465133522,3.7471782852519397
YAPC,6918328,1.93910137978286,0.5816331100101191
EFO-27,3038522,3.6669358154068097,3.311019343197442
DMS 273,25262965,-3.6359475061731534,-1.5132412179821997
SNU-81,9803433,4.184314019267332,4.569071235271291
SBC-5,5351362,3.2358684618056164,1.7520011686805703
NCI-H661,9826308,-0.3578866099027624,0.6856062803223678
CA46,462382,0.6475442737717811,0.2694630869244898
SNU-449,168313200,1.9091128501610053,2.917742521072175
SBC-5,613753,3.3291324843640497,3.1915236853472813
HCC1143,24797083,1.671403596818138,1.4403063107387468
NCI-H522,11625818,5.118334572164132,3.803375586196543
Panc 04.03,446155,2.4976903608369994,2.8291121819982497
NOMO-1,2733487,3.664178503465112,5.110824156941777
CA46,11494412,-0.1540181126177876,0.4351082238661874
KMRC-1,168313200,3.9547474801247455,3.14457785023112
BT-549,12003241,-0.9663956127583828,-0.6826621024783722
MDA-MB-453,53232,4.528141583720988,3.0322521602128756
Panc 04.03,BRD-A02303741-carboplatin (1-1 mol-mol),4.551523048928573,4.1014610592105445
A4/Fukuda,selumetinib-piperlongumine (8-1 mol-mol),1.1723483513994604,2.106739803511572
BT-549,7251185,2.7032329014559555,2.7799285789595025
YAPC,72734382,4.459010686131963,4.705959907916687
NCI-H2171,navitoclax-birinapant (1-1 mol-mol),-1.0975266283205345,0.6808763209204295
LoVo,10113978,1.9718639606113115,3.1763830206490598
G-401,9884685,-1.463173781220529,0.24948665507425571
NCI-H460,969516,4.1763077592827225,2.99774314212588
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.2833094450671094
NCI-H522,10302451,3.5044820085806645,2.990587134028932
SNU-61,10127622,0.6703048084308344,3.1690769064952518
DMS 273,216239,1.7826696655906364,1.939774996455621
NCI-H2171,24785538,-0.9958553447114444,0.7069628585285893
OPM-2,2945648,2.5610378238786367,2.431754035306118
JM-1,5278396,3.0111139094733987,3.0308052671551047
A-673,11625818,4.166556040788123,3.8652597647137275
MSTO-211H,23582824,0.616921606097025,0.6944898010410847
CAL-51,11977753,-3.094424679361229,-1.4730111861222108
OPM-2,55283,2.954343465689474,2.208067664651173
SCC-9,445091,4.9115801471194365,4.259582847429851
FTC-133,11609586,3.5175505098064113,3.055529938901842
DMS 273,16065773,2.5819171284899873,2.089813148513894
NCI-H661,16725315,3.2574493912109315,4.0461547979964125
ONS-76,3825829,4.014711164490238,3.9399442442229127
NCI-H2009,613753,3.3208706433892483,3.1675509228162633
OVISE,72376,-0.0680425204905225,-1.3228584213942822
Panc 04.03,1566236,3.6247050899799698,2.4728243565861074
KMRC-1,10385095,1.0697515150450725,1.30701010704579
MDA-MB-157,6918638,0.523436976846598,0.7407821020085215
SNU-61,10231331,-0.1396530061474971,1.6154442514422382
SBC-5,67156097,-2.1260485275267684,-0.6070250088847198
HCC1143,16720766,1.508740109375584,0.7580372267901726
SNU-449,5311281,1.2425771495660034,2.312426127101233
EFO-27,15547703,3.36481674718985,3.3732912678183515
LOU-NH91,selumetinib-BRD-A02303741 (4-1 mol-mol),5.795599914262683,4.218800082559694
HCC1143,71466445,2.406598865609875,4.162951868341708
HCC1143,11625818,4.1599423197543395,4.291968390738845
LoVo,67156097,-2.753278115102512,-0.4034979019597749
NOMO-1,3385,1.8227638422939128,2.684325672721914
JM-1,11494412,0.2153546786296628,0.30776370717005774
SNU-449,3384730,4.130527031297823,3.3244690996833652
KMRC-1,2871966,0.6996568641549454,0.4655124918262675
MDA-MB-157,2126,3.382661447598077,4.456033164265445
SBC-5,444795,4.741830288065925,4.620335114032875
CAL-51,135398516,1.449392214756173,2.3199438565344854
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.1685914399378903
FTC-133,11626560,4.477282693511418,1.935618587136557
NCI-H2171,135411,0.036573209368321,0.28371926216777177
NCI-H522,5479543,3.719555600198391,2.907940679816458
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547,1.3839231867911985
SNU-81,44494148,1.061827805146114,3.061062760682593
OVISE,119607,5.735286818250817,5.410996533032366
CA46,4578,4.451375135730711,3.7562630246628355
FU-OV-1,navitoclax-piperlongumine (1-1 mol-mol),2.023653307095543,1.4553847900735273
MDA-MB-453,148198,-6.384072425395857,-3.5817125111820345
CAL-51,44491742,5.152478206660974,4.333607262900085
G-401,6438330,1.230579919692557,1.5426748864086546
RCM-1 [Human rectal adenocarcinoma],2749,1.6658310830765266,2.171864156189713
KMRC-1,2746,4.901784458568857,3.2276834295275694
SW1463,3025986,0.7137013515595916,-1.3454541826480229
NCI-H727,54618164,4.079418853402711,3.9846863583548644
CA46,9907093,3.753589195065423,3.3196317397624675
CA46,1750826,-4.755590130007624,-3.455221414124553
G-401,135411,0.5966957307940325,0.2980749650657783
NCI-H727,9825149,0.533141934304371,2.403688501583543
NCI-H2009,168312962,3.455210391348572,1.6929501216572869
NCI-H522,25154868,4.970187113391964,4.463560620921264
HSC-4,3503,2.6271988960037502,2.248464660984809
SNU-449,54619267,4.584813130836932,4.1222442614779595
CAL-51,44507138,2.6477043136390637,2.4851436751641343
CAL-51,24753719,3.9981702522006257,4.237979370743134
SBC-5,16725315,4.9617798252058165,4.232551664493886
CAL-51,123631,2.4616591372530605,2.3575774398614633
A2780,56963564,-1.0587892817911606,0.2678604633433395
LoVo,119182,-3.2827225124554804,-0.5003418487131547
A-498,3503,2.8872062971439436,2.5345533131881974
ONS-76,navitoclax-sorafenib (1-1 mol-mol),1.6529923050445217,1.8373637350257332
FU-OV-1,9915743,0.5010130642537969,0.9674136113290558
LOU-NH91,6917907,-5.4115573726076125,-4.49041151668169
A4/Fukuda,322968,1.909418940393303,2.622015631990381
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936,1.8367476527687845
HSC-4,54618164,4.183236352259565,4.26604039609996
SNU-81,navitoclax-MST-312 (1-1 mol-mol),0.1255158725803597,0.460471173532152
MSTO-211H,89928392,0.2675284607275224,1.6498243434871995
MSTO-211H,16741245,3.31564558456852,3.9052260375952046
FU-OV-1,969516,2.7898134338200093,2.8557404553546752
FTC-133,9840324,5.72186430729165,5.754366174501616
FU-OV-1,2828334,6.23308188240882,6.197778792413283
JM-1,docetaxel-tanespimycin (2-1 mol-mol),-7.819980451052631,-5.091741722959031
NCI-H146,25062766,0.9164062509537028,2.282472143410628
MDA-MB-453,44197249,5.538441394278097,4.017129727550469
NCI-H292,25126798,3.8121795120859865,3.939352081044756
NCI-H2009,49793307,-2.1832388254663746,-2.272307268949347
ONS-76,446155,1.9434822335598465,2.562390191765023
NCI-H460,613753,5.368273372553464,3.230952536866571
NCI-H1623,375860,-0.2497324332058591,-0.10786848245333464
NCI-H292,135440466,1.1809367948500966,2.367820145058945
DMS 273,24821094,3.2786522000090974,2.606833944423838
CA46,1566236,0.9666867201201066,1.3616445778444968
LXF 289,6914657,-2.1957863105134474,-3.8505155488024645
BxPC-3,68056272,4.30573170491611,4.035447928909967
CA46,24856436,-0.7056093623802927,-0.43878755631934124
SCC-9,136227924,3.721677265331546,2.9843060093585434
BT-549,5281672,6.431065394953252,4.510890828371788
KMRC-1,136227924,2.9529226708788734,3.1204305221594386
A2780,46224516,3.0956757820489966,2.576872030912249
OPM-2,2871966,-0.6940984937409527,0.005369887713337313
NCI-H522,44607530,1.256897748575463,1.5915337515028356
YAPC,135421197,1.6415717791988456,2.0784300735108534
Panc 04.03,11609586,3.1950022878003375,3.1169629689972838
YAPC,285033,-1.734058118132599,-1.2629789642640028
EFO-27,25161177,4.775691091389994,4.129606571319137
MDA-MB-453,285033,-3.584093663874095,-1.7250478492175236
YAPC,135398516,2.168624804585352,2.300892038701292
BT-549,10184653,2.4120945582019098,1.6500983872226485
SNU-61,322968,3.1681402320576924,3.0406508801549488
CAL-51,9911463,4.251278022142156,3.8356239360831985
NCI-H661,119607,4.8407678671423975,5.229232020911073
Panc 04.03,navitoclax-pluripotin (1-1 mol-mol),0.6568791219760653,-0.4305445098356071
CA46,16720766,0.453567173389679,-0.3314353445186962
CAL-51,11404337,-1.4033364127444676,-0.21240943305077212
SBC-5,9911463,4.310936662946409,3.883126273068531
NCI-H727,2828334,5.890997909388885,6.102185939996577
JM-1,104842,-7.303088314363844,-4.335983236208531
NCI-H460,5335621,5.645903220513178,4.602401880906032
MDA-MB-157,ISOX-bortezomib (250-1 mol-mol),0.8277419655011916,0.5730948473932627
HSC-4,12003241,-0.0373048915881231,-1.0927839320015373
MDA-MB-157,53301938,4.15898814375023,2.460706173913054
MDA-MB-453,25150857,2.1104930677980964,2.2269082274347043
HSC-4,25183872,-0.8460464512297751,-0.7561346959085488
CA46,46907787,-0.8110179268567884,-0.6236304191953969
LXF 289,5311,1.216776445363927,1.6669423639607848
NOMO-1,6610355,3.932739350210071,4.020804172520249
CAL-51,11222830,1.6762547521470548,1.5319715757692507
HSC-4,9915743,0.765957034876682,0.7698349614295958
SBC-5,72193861,-0.1091418694351138,1.5070540520336382
NCI-H460,60700,-0.2314807684970784,-0.42386504005770687
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585,-0.48514280188090936
SNU-449,2729026,2.998695944617882,2.8999145400841546
A-673,6914657,-9.096845778146204,-4.767169817220397
EFO-27,64971,3.389505323176025,2.900747874875209
MDA-MB-157,44137675,2.4962707088889524,3.4080539018391476
A-673,374536,-2.1767869041067462,1.4028358947021184
NCI-H522,24951314,1.0216385721244754,0.6833962744209624
JM-1,16038120,-0.8379540118722992,0.18688076843531232
SNU-449,25126798,3.9846076439311258,3.902161046878667
JM-1,9444,3.0857992205099616,3.819309797707329
NCI-H2009,selumetinib-MK-2206 (8-1 mol-mol),-2.109665042041408,2.4452868133134618
A-673,327653,2.521292352419487,2.908469751292927
MDA-MB-453,5470400,0.9814504444661803,0.039658608061993145
KMRC-1,71751553,4.436686890494674,4.364821478388141
FU-OV-1,52947716,3.0881190342895626,-0.7780446547984196
A2780,selumetinib-piperlongumine (8-1 mol-mol),1.4682842142884078,2.3675322464993735
JM-1,3825829,3.3725964609251005,3.367588546088811
G-401,6918328,-1.3062418496747916,-0.1315893226921681
OPM-2,136227331,3.7431952210756014,3.0318995478346658
OVISE,5281321,-1.443802792924895,-1.233017354291204
CAL-51,6450551,1.9748462748620472,2.667207360969641
DMS 273,387447,-5.016212668564022,-4.590081913250358
OPM-2,5278396,3.463635489570463,3.0710163087644577
ONS-76,445643,3.769289821936489,3.998314493042827
OVISE,676352,3.019558255819343,2.1190826051478795
OPM-2,126941,-4.73900193491969,-2.884100671400629
MDA-MB-453,11404337,-0.3002498088297632,-0.29244118471212055
NOMO-1,24797083,1.0415171353084307,1.004766173704479
NCI-H522,374536,3.894183139895475,1.8306718979839667
A-673,6252,-1.7615808961584718,-0.5729955941703571
LXF 289,9915743,1.5678711489122208,1.1438613024429212
DMS 273,72734382,4.203397510599988,3.8026483678200367
NCI-H522,selumetinib-tretinoin (2-1 mol-mol),5.363366003063694,3.6168161340145217
A4/Fukuda,BRD-K55473186,4.020373973875239,3.905981397426048
FU-OV-1,6505803,0.8019489696335256,-0.09236877095072513
NCI-H292,10074640,3.1247192788252134,3.250207636835424
A-673,3854666,0.8608139997201792,1.0106430036141476
EFO-27,637858,1.802850970746332,2.1901071516067003
MSTO-211H,123631,1.7071024302486195,2.543161168026148
OPM-2,54619267,3.38914180731132,3.5659133030531662
SCC-9,11612883,3.4111633177056992,2.931033860793811
MSTO-211H,BRD-K55473186,4.0690738661382175,4.112746008529151
CA46,25154868,4.248651634430963,3.953896421589838
LOU-NH91,6918837,-1.6936529516603684,-2.3102785430771786
OPM-2,9911830,2.101419447334853,2.014736161160941
BT-549,6438330,1.5528656655176645,2.3837554448936173
EFO-27,11647372,2.575313315468432,1.1904512526720064
SNU-61,568763,-0.2886838000487807,0.383498484450231
RCM-1 [Human rectal adenocarcinoma],selumetinib-tretinoin (2-1 mol-mol),1.4034944184327462,1.9470743909727652
Panc 04.03,5282054,4.5317440773242925,3.9349028521909992
YAPC,53232,3.166937959197618,2.9256324104185953
SCC-9,44486219,3.972056382599232,4.339861749169937
NCI-H460,104842,-2.7771726159534773,-2.1532723835432503
BxPC-3,4788,5.831531206482249,5.792296552778533
KMRC-1,753704,4.9867166993089365,4.88918333648844
MDA-MB-157,71729975,1.9097389430207852,2.2259482778783535
MDA-MB-157,46398810,3.5828771462995666,2.622627149554357
ONS-76,42642645,1.3507577274785498,1.0528144932451324
EFO-27,9956119,4.364890218263242,3.831881559589833
SNU-61,49850262,3.504538311157692,3.1594782290299106
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322,3.7266476301367453
MDA-MB-453,9967941,2.180105496017499,3.254946341425137
OPM-2,409805,3.1459770002319023,3.719949162392275
BxPC-3,11214940,1.4945762019529478,2.048660882315405
CAL-51,71466445,4.7818956768695715,4.113750290641971
YAPC,44137675,4.160217990140765,3.4866027210484014
A2780,3465537,2.6217509140821247,1.9175353594600273
SNU-449,135398744,6.632733291537939,6.253852088249943
A4/Fukuda,676352,1.592410759121419,1.9000268465546648
NCI-H522,5566,3.055916396278747,2.806813192312696
SBC-5,6252,1.1660150864515155,0.9825898637855107
NCI-H460,65064,5.803776096144955,5.03418048998919
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678,0.7838327771344376
KMRC-1,60700,1.5998244644110848,-0.4185140917277049
MDA-MB-453,72734382,3.580352840578633,4.497154944694106
FTC-133,BRD-K55473186,4.331616686106064,4.069035644332263
NCI-H661,3062316,-1.6378145648450078,1.5993790029232335
NCI-H661,11977753,-1.2976183269776842,-1.0444910016892484
KYSE-70,4477,1.3887255745641551,0.531365851440185
A2780,15953870,2.2934332620703457,3.3475232795322203
SBC-5,44589607,3.2873586375678627,2.973683821473616
NCI-H2009,3634881,3.6058977960867233,3.499144063842704
A2780,5951923,4.306994873236267,3.391347855691588
HSC-4,11152667,-1.532358108136572,-0.7025735759122808
OVISE,3543504,4.513312782724499,4.473669130098872
CAL-51,676352,2.3367523995253454,2.0493168165288864
LXF 289,100016,7.121965810949268,6.231396506562393
OVISE,JQ-1-vorinostat (2-1 mol-mol),2.753881285057562,1.0504840376359001
KMRC-1,4096211,2.4789291220770053,2.1409036742627325
NCI-H522,2949965,1.5154466163896825,2.516545437660476
G-401,613000,2.0341288465268397,2.3091753946959863
RCM-1 [Human rectal adenocarcinoma],3634881,3.579575013653745,3.1020722590881964
FU-OV-1,46907787,-0.0188806347407138,2.41594984305573
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331,1.4296077663853317
NCI-H522,9926054,1.815484319665427,1.8564650467391837
EFO-27,9866186,1.214213380462077,0.8593062944729141
DMS 273,446155,1.3230843960440628,2.5890386438648796
EFO-27,136227924,3.515702384882397,3.005310836088447
NCI-H522,25161177,5.347457629837048,3.9315525992090126
BT-549,107985,-4.157404914346088,-3.3906094341302704
CA46,vorinostat-carboplatin (1-1 mol-mol),1.5433198119850344,1.7652272034564342
CAL-51,984333,0.1261860025273146,1.0965342835812928
NCI-H2009,60700,0.1880080174398503,-0.17705324994731014
CAL-51,135421197,1.6266864976107616,1.642022597412321
MDA-MB-453,54619267,4.30313846005301,3.8482084158207304
NCI-H727,72376,-1.9917966726836325,-1.3103540645160685
A4/Fukuda,54618771,0.259551202975953,0.5520315819710102
HCC1143,5280436,2.2824596389444567,3.5853783424929175
FTC-133,168313200,3.883948141330694,2.650289378718881
LOU-NH91,11427553,1.5999683226177923,3.0619219676526255
LoVo,5287620,-2.196691557023958,-1.9493895189191226
LOU-NH91,11222830,1.619786635706389,1.7487607655926223
SNU-81,ISOX-bortezomib (250-1 mol-mol),0.4477556870323437,0.19890620991009253
ONS-76,44507138,2.3475098717107685,2.528829707529144
EFO-27,12001922,2.6878207164132517,1.971100448045469
HSC-4,25102847,2.881629074853979,2.5443871523695507
A-673,4477,0.9527863024115504,0.488243842877145
YAPC,119607,5.457421403002251,5.4167188462124685
SNU-449,11364421,1.172419453845969,-1.280193583304617
FTC-133,1566236,2.958331107997485,2.5121717046842407
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068,2.801425431566487
A2780,9956119,3.341179703016576,3.1994367777914987
A2780,421610,3.3194399172740296,2.8826170463122587
MSTO-211H,11656518,-2.9147381038014095,2.0320805654636316
YAPC,carboplatin-etoposide (40-17 mol-mol),3.290819811015708,2.927757165752581
ONS-76,5282054,3.726244399490591,3.5250097596797594
BT-549,JQ-1-vorinostat (2-1 mol-mol),2.606631722875188,1.370467296792303
SNU-449,1750826,-2.5268598200751504,-1.392320857195741
HSC-4,56949517,4.34052816497715,4.409312104929287
BxPC-3,alisertib-navitoclax (2-1 mol-mol),-2.4786410081497223,0.92470539346223
LXF 289,11175137,1.607203821415342,2.6582246294072354
LoVo,400769,-0.9988261077541156,-0.45321707004441825
SNU-449,9823820,4.446865909721317,4.271563164690239
A2780,23582824,-1.3073183780043152,0.7828024531564395
LOU-NH91,24821094,3.1074025746804854,3.163233265929462
NCI-H2171,1566236,1.862945078393334,2.032189647790775
SBC-5,alisertib-navitoclax (2-1 mol-mol),-0.5027212648938616,0.6837144501426949
SNU-81,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.6771468011681286,2.93973028486678
LXF 289,3815108,3.5075214319549683,2.9051026097566184
SCC-9,6918638,0.4192666549800527,0.7282210375473858
LoVo,54626689,4.759845357486115,4.497834630476523
HSC-4,9956119,3.775946121479013,3.779697064200151
Panc 04.03,carboplatin-UNC0638 (2-1 mol-mol),4.7376936577432405,3.5297060037483217
JM-1,2708,2.6994993672471774,3.083069095549788
A2780,151289,-0.0035192392559562,0.6246320553869079
JM-1,135440466,2.1821804764998785,1.65828582288834
SNU-449,JQ-1-vorinostat (2-1 mol-mol),1.642225062280099,1.3755465716595736
SCC-9,100016,6.423023301160456,6.234453781739245
MDA-MB-453,24180125,2.9500133631526477,2.889391263012905
MDA-MB-157,6610216,4.481014218943506,4.076126882740436
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758,-0.5680160828402632
MDA-MB-157,216239,2.048111671637324,2.2794654971661723
ONS-76,72376,-2.745447792813742,-1.717870261143908
YAPC,56946209,-4.683971162846982,-3.8436612274845903
LXF 289,11977753,-2.1467130480879217,-1.2000468920601983
A-673,46926350,-6.171938943197618,-4.668838591811541
SNU-81,44490293,1.2258782245734428,2.9145790560691665
A-673,3384730,1.4382839107098095,2.064025745867528
HSC-4,5328940,0.4436918358674775,1.6572610391559865
MDA-MB-453,15953870,2.92470748098227,3.412800162930233
ONS-76,44487061,4.494085272908884,3.517363330588921
MSTO-211H,656346,1.1626228980727835,1.0495026460610277
NCI-H522,72376,-2.490005030905514,-2.352731144593223
A2780,2945648,2.954770875487345,2.529789190407557
OPM-2,49867926,3.883283056469906,3.1204741450067544
RCM-1 [Human rectal adenocarcinoma],285033,0.1322577754861078,-1.2938786980200323
FU-OV-1,2729026,1.7636424043101242,2.7736461619221093
A-673,5351362,0.6290025594893434,1.1327655988184366
NCI-H727,crizotinib-PLX-4032 (2-1 mol-mol),1.979940863489789,1.7429496175938715
NOMO-1,3384730,0.781590014898287,1.4720099452093345
A2780,753704,5.064252843259393,4.405406032689892
LOU-NH91,104842,-1.007764649763801,-2.2262045448492946
SCC-9,selumetinib-PLX-4032 (8-1 mol-mol),4.645114234652884,3.346328218664953
NCI-H661,135398738,5.197398941249139,4.501664594509665
OPM-2,11213558,0.5330056992590615,0.8515922737005437
SCC-9,216345,4.596520649168519,3.897978010089949
LXF 289,73707398,1.5723760999376108,1.6544370643421318
KYSE-70,148198,-2.193158047226166,-3.2429361432774875
LoVo,5281672,4.34355838965171,4.5775264402108675
NCI-H292,3081361,1.6323755734101046,2.2639762953788454
NCI-H292,969516,2.7034021602074207,2.978432299168291
BxPC-3,carboplatin-UNC0638 (2-1 mol-mol),3.4079462645676815,3.3331246138575326
DMS 273,56963564,0.2331753873879126,-0.30631273648769813
CAL-51,168313047,1.9592520089902103,2.1946703117289412
CA46,2949965,2.263314804434843,2.4979048464933724
G-401,135423438,1.541142645334712,1.5145992089779425
OVISE,16741245,2.37455837119256,3.701184675229299
CA46,3634881,2.7183374991781903,2.3967897664979576
HSC-4,11427553,3.1625220487182193,2.9580993221010967
BT-549,selumetinib-UNC0638 (4-1 mol-mol),5.0457009484631365,3.756467729751634
G-401,168313200,3.793890782777564,2.7953232566142376
A-673,3689413,-2.493408888485536,-0.9666197930491193
OVISE,JQ-1-navitoclax (2-1 mol-mol),0.6695486858757606,0.9379916196934083
A-673,3062316,1.882423163055416,1.5125515079855771
RCM-1 [Human rectal adenocarcinoma],44185566,2.9642149554045,2.5550612285905236
FU-OV-1,49766530,-1.0180111021842635,-0.49622651922575156
NCI-H1623,4259181,0.7011384719609343,-0.029194195909184758
NOMO-1,11427553,1.1686106553832942,0.8697409472955664
JM-1,25102847,1.7356230100982195,1.8144228500367896
A2780,219104,2.8403974518726938,2.655696917236987
SBC-5,2113511,4.3346082595960045,5.448148472319361
BxPC-3,navitoclax-birinapant (1-1 mol-mol),-2.5138239615221907,1.767583301965385
A-498,JQ-1-vorinostat (2-1 mol-mol),1.7562292819472516,1.2702080051197198
BT-549,44607530,1.0072782741331217,2.0752182276119626
FTC-133,56946209,-2.082875590070058,-3.697523770658173
SBC-5,49766530,2.674414744921775,-0.1991393274945209
NCI-H727,1750826,-0.0055354600789778,-0.9259280111033622
SNU-449,2749,2.680740017346485,2.216366545384568
YAPC,46843906,3.8406256643083214,3.21084392236075
OVISE,3503,3.051689922997692,2.4118403540138287
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903,-0.7611810188749358
A4/Fukuda,24901704,2.035809268681581,2.62018974977205
SNU-449,2949965,2.551789087127138,2.979691131476067
MSTO-211H,65064,5.509158922836103,5.018812213894028
NCI-H460,753704,5.635234970240753,5.148316975796644
BT-549,9907093,5.687861442777729,4.397872082358808
SNU-449,89928392,1.7008506784074908,1.7926923940209634
KYSE-70,piperlongumine-MST-312 (1-1 mol-mol),2.4573232964304506,2.009126638299137
LOU-NH91,675434,4.5447066201437325,4.753230917544759
CA46,5351362,0.7524287969492447,0.9224275593095895
BT-549,3025944,4.080638158593822,4.370585803961916
SW1463,57330099,3.693611547578868,4.074799702836931
HSC-4,16722836,1.7684769334825834,1.740515435832472
G-401,4096211,1.4243357241965535,1.5038619777902045
Panc 04.03,6610216,4.328711123736605,4.313125349993019
KMRC-1,5287620,-2.779883294896464,-1.7742516424191115
BxPC-3,119182,-1.1309049402050737,-0.44418480544647054
G-401,135999136,2.1711954992798987,3.1951937379867807
KYSE-70,285033,-2.195981319752621,-1.752671695997477
NCI-H1623,selumetinib-decitabine (4-1 mol-mol),5.307511276565798,3.5471892893918606
KYSE-70,44607531,3.0404164934883733,1.5911435778721983
SCC-9,6918878,3.402250236896725,3.3174331722216706
MDA-MB-453,5282054,2.7696083041072237,3.5922210306825315
RCM-1 [Human rectal adenocarcinoma],46398810,3.3659833177824563,2.6433636973697
BxPC-3,57519531,2.3630144255947045,2.705317793808992
NCI-H2171,56949517,4.289308734480345,4.151414583329864
Panc 04.03,54619267,4.1321899610425215,4.210292302873544
G-401,11485656,1.708547873036538,1.7600148715245039
A-673,6917907,-5.646852280462545,-5.571162962487887
NOMO-1,71304818,2.372593058500035,1.9476033201980036
MSTO-211H,11214940,0.3292815706978371,1.9309751067714926
HSC-4,1750826,0.4564084690350189,-1.1722533557144432
HSC-4,426756,6.131320111521982,4.493767091448598
SCC-9,12001922,2.463166865850559,2.0257536853505465
CAL-51,656346,0.8466306406200714,1.1351052987702404
NCI-H661,49793307,-1.6947898398784864,-2.332249973548657
MSTO-211H,6450551,1.5186693992042568,2.964439803698768
LXF 289,navitoclax-piperlongumine (1-1 mol-mol),2.4157701472871005,1.6521187596105134
RCM-1 [Human rectal adenocarcinoma],JQ-1-navitoclax (2-1 mol-mol),1.3966963569100277,0.8378046131682217
NCI-H460,73707398,3.251551904382877,1.5971174857157595
CAL-51,168313016,5.819136604546001,4.6622476982860475
NCI-H292,119607,5.8072644572840915,5.368670024825101
SNU-81,31703,-2.2099083949209715,-0.930298888639557
A-673,11719255,3.0296971336672627,2.9897908898833703
HSC-4,9911830,2.7717739782698563,2.6530395159782008
CAL-51,44589607,2.4963130908502107,2.945522182300169
FU-OV-1,24180125,2.037807307003979,3.0556934372863735
EFO-27,3634881,3.530057446917586,3.352717343679269
MSTO-211H,25262965,-3.426128826799908,-1.5083504456806829
LOU-NH91,3543504,4.266458043071255,4.488837979490265
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961,0.38789431710889943
NCI-H2171,23582824,0.048802245172864,1.0905973417359331
SCC-9,11507802,1.3688807961315366,1.9959497216421533
MDA-MB-453,selumetinib-BRD-A02303741 (4-1 mol-mol),6.9656310639147305,3.2160250159600117
CAL-51,65628,4.560195683913681,4.240968881247754
RCM-1 [Human rectal adenocarcinoma],56649450,3.837346847556256,3.2964473241837715
CA46,6505803,0.7805822725654986,-1.1934610414281297
KYSE-70,327653,3.7336437717951103,3.186153317127952
NCI-H2171,11494412,-0.1110474347644453,0.8507600191579114
LXF 289,6918328,-0.239589445073231,0.34288439762341333
CAL-51,24951314,1.3730048574034712,1.4152289437383114
OPM-2,tretinoin-carboplatin (2-1 mol-mol),4.37691141446878,3.323780248034227
A4/Fukuda,2858523,2.415383768636832,2.8045726630237993
NCI-H522,753704,4.098243268802601,4.5278397193318805
A4/Fukuda,11625818,2.700159842549232,3.631110897477872
MDA-MB-157,2949965,2.5406478696331587,2.774908994415414
ONS-76,409805,3.962852167855045,4.809511623059094
NCI-H146,439501,-3.5641402563292393,-2.232688413793573
CAL-51,24856436,-0.3083697359271743,0.5927494916115313
SBC-5,31703,-1.5086983052531706,-0.7886075072710241
NCI-H522,10184653,0.5663226513641079,1.067572755957172
NCI-H522,135421197,1.9700795220087195,1.8062586998844452
A-673,alisertib-navitoclax (2-1 mol-mol),-1.8576644604152912,-0.6543204950401446
NCI-H1623,46398810,3.5623335184860196,2.563357832705594
A-673,216468,-1.1121166448103192,1.9678086710870448
BxPC-3,2708,4.650566781622339,4.990920648162222
SNU-81,6184667,-0.6614889419446587,2.827161543786516
NOMO-1,168312962,2.6221164331885003,0.4712380924241689
MDA-MB-453,16720766,-0.5495005772629474,1.1163349648197256
NCI-H522,9956119,4.024745164263863,3.43833205602245
NCI-H1623,135440466,0.8012621152288821,2.6552997907171454
CA46,3025944,4.264528242833472,3.801416497646254
CAL-51,71466380,3.802692276073616,4.565121536787829
Panc 04.03,11656518,3.295682085422899,1.9678353335808034
SNU-61,JQ-1-MK-0752 (1-1 mol-mol),2.077081766151821,1.1685239651159114
LOU-NH91,16720766,0.888730139062919,0.874417352189839
HCC1143,selumetinib-MK-2206 (8-1 mol-mol),0.0669797287296957,2.0423733504708665
JM-1,57519531,1.1574190263295916,1.6220866988549723
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.0717184124257426
MSTO-211H,148198,-2.180219295506665,-3.0481965141081826
SCC-9,4521392,4.43257578464979,4.311520821103115
FTC-133,2746,3.487652314498242,3.2845538711632276
LoVo,44819697,3.398153390084315,-0.21034746502374246
Panc 04.03,122327,5.490637645011104,4.757518640864328
BxPC-3,25154868,5.007679584209566,4.632358155875221
NCI-H661,3503,2.324538290067321,2.2749610689726065
NCI-H727,54618771,2.7901712320729333,1.4071707591565932
A2780,10302451,4.067201499125142,3.076993824820133
A4/Fukuda,5281321,-4.090150251628595,-2.478915599989964
Panc 04.03,24771867,4.398084543376112,2.743169258018782
CA46,241158,1.6221144264981358,2.544967798939417
SBC-5,26596,-2.1907470722084414,-0.9322493189481271
A-498,11625818,3.6553151033235904,4.577254907042044
G-401,9911830,0.6760173642929876,1.9847312853768164
CA46,123631,1.9024335998312112,1.9300121816971685
LoVo,104842,-3.39586805089817,-2.7437871386739214
OPM-2,5479543,3.226492982806864,2.69599671382979
HCC1143,6623618,3.4930934009716226,2.422985153121584
NCI-H2009,46199207,3.041674504763304,3.1905854822471453
NCI-H661,49766530,1.1318827683023138,-0.5081112005777912
CAL-51,1641662,3.5457804017420744,3.6678292901904057
ONS-76,44819697,-0.7397391051726983,-0.6535932744748846
BxPC-3,57330099,4.21152658046839,4.507130190947172
MSTO-211H,3038522,3.865174160499475,3.1022613671383046
LXF 289,71466380,3.888647536265504,4.601068747001105
CA46,5479543,2.004846411807367,2.5384161063558377
OPM-2,9907093,3.786753386665246,3.3063988003718476
NCI-H522,54613361,-1.014694822148615,-0.5455061010166972
NCI-H2171,25195348,2.4042641753284872,3.2558898043096924
LOU-NH91,9911463,4.226439837654448,4.006431884284556
JM-1,6918736,-2.112176013423493,-2.364365219928674
OPM-2,89183176,2.1177805080987633,2.877079071907261
OPM-2,135875424,2.796643273298537,3.3269146449514055
HCC1143,24964624,2.836653438175677,2.4212678707547863
DMS 273,44566777,1.254196350489733,0.5146983715705418
NCI-H522,49867926,4.17523654199276,3.6722606884509927
LoVo,72193861,-0.0557430791680942,1.561930449205343
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856,1.37718127544406
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008,1.1752718239123754
SNU-61,374536,-1.8297483787291275,1.5481971902265375
CA46,44566777,-1.0409480025289963,-0.07811290004995888
JM-1,54613361,-0.7111924625528845,-0.9181163658630319
LoVo,25154868,3.829103546750207,4.137688441790901
A4/Fukuda,15547703,2.4441609561923547,2.5908849599252433
KMRC-1,10074640,3.6694615069556886,3.2679720609402936
NCI-H2171,2729026,2.1337054337121466,2.563168271951855
CA46,JQ-1-vorinostat (2-1 mol-mol),-0.7880767442206768,-0.6215475513755857
HCC1143,68056272,4.744387863321378,3.9063886731870565
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,0.831797187073902
NCI-H2009,44607531,0.9822487023795796,1.6776923192308546
KYSE-70,89183176,4.766828638924323,4.235974346336314
SBC-5,25154868,3.0138435145006155,4.279439279716898
A-498,11719255,3.5352993104723245,3.5747518611647426
SCC-9,208908,2.838235608451249,1.8365788703069514
SW1463,2126,3.781949624288532,4.2608693886433056
SBC-5,5311,0.7694897344457827,1.4384289855197663
BxPC-3,11609586,2.766108761160721,3.096197674745588
CA46,71466380,3.212448709653588,3.7818533127810436
FTC-133,25126798,4.495223588633032,3.972431023421043
JM-1,44632017,0.8586744690995054,0.6929287141382072
A4/Fukuda,navitoclax-sorafenib (1-1 mol-mol),1.3354427361603598,1.154770357546503
SNU-449,4917,3.4001304631059965,3.049131703065036
JM-1,135984461,1.552881480804892,2.9003815226934
NCI-H2009,969516,2.7623608328977314,3.111661734006657
SCC-9,104842,-1.437225086828998,-2.502253766023124
CAL-51,73707398,0.7053044464230985,1.3739011800480383
KMRC-1,67156097,2.0694443843024173,-0.7406349846695782
SNU-449,135411,1.1071215925884743,0.9984881854836938
A4/Fukuda,72376,-3.4342601152101473,-3.0898470974348875
CAL-51,54619238,5.308906879487735,4.948889113612567
SBC-5,5282054,4.370273963099393,3.6756427830803324
SNU-81,vorinostat-carboplatin (1-1 mol-mol),3.3031492334396977,2.6243470115517082
OVISE,5328940,2.3935755372069676,1.6867679162042173
SNU-449,BRD-A02303741-carboplatin (1-1 mol-mol),6.10453045453208,4.518115448653968
A2780,24779724,4.3340331177123765,3.6882635311587673
A-673,400769,-0.9976419565742564,-0.9365579957690556
MDA-MB-453,3081361,2.1431734647577496,2.0864139159574675
A4/Fukuda,123631,1.573225246333458,2.1981738919673512
A-498,46224516,5.193995490382977,2.838568716682656
CA46,5738263,2.2696720462337456,2.6142812181238075
DMS 273,16722836,2.1308156944151833,1.5584572578759657
KYSE-70,119607,5.065055719995064,4.978676512282149
MDA-MB-157,637858,0.0650158223638603,2.101349828491743
KMRC-1,24180125,3.3952911821821052,3.0191766257409167
A4/Fukuda,9935249,-4.132944592984893,1.840381850268788
A4/Fukuda,9915743,-0.3554458205966057,1.0959655099796841
RCM-1 [Human rectal adenocarcinoma],56946209,-4.301528027920143,-3.7272902913518733
FU-OV-1,11222830,1.8946229471337992,1.5780716834862878
SNU-81,BRD-K27188169-navitoclax (2-1 mol-mol),2.560233422856499,1.6835455923278755
NCI-H522,24775005,3.057250054087749,3.54083984528288
NCI-H522,15983966,4.053677978120726,-2.762143150964692
DMS 273,25102847,1.54508352242066,2.203853920411677
A4/Fukuda,44543605,3.1271044447490235,3.858515956279829
CAL-51,44507138,2.6477043136390637,2.4851436751641343
SNU-61,16725315,5.215969195263621,4.004816724638895
EFO-27,448949,1.7491267397814168,2.070057348150281
A-673,5280436,1.8974559090481808,3.1160661605518243
MDA-MB-453,24779724,5.606505141806212,4.153181412440886
SCC-9,carboplatin-etoposide (40-17 mol-mol),3.166154009244092,2.732608587984292
G-401,alisertib-navitoclax (2-1 mol-mol),-1.5256164798687666,-0.8033225549316072
NCI-H522,216345,3.499198551341706,3.513030548794818
BT-549,25022340,3.398199457605664,3.0051514383648255
SCC-9,23725625,6.300420686237622,5.033539412656346
MSTO-211H,54619267,2.133098694540018,3.881699588403485
NCI-H146,JQ-1-UNC0638 (2-1 mol-mol),-1.369706115362065,1.0924231193553353
A-498,148198,-1.0809020747576437,-3.0813996944685482
SNU-449,10127622,5.039458046327855,3.9815167051073046
CAL-51,1641662,3.5457804017420744,3.6678292901904057
MDA-MB-453,5291,3.622613892398656,3.5130116915019256
A-673,168312962,-0.712468254461992,1.6123979216958795
SNU-61,52912189,0.4386789975034979,1.2921190331187784
LXF 289,2828334,5.402872149224608,6.246768712077467
BxPC-3,374536,3.0351492595764347,2.346240503438936
EFO-27,9825149,3.71226874457915,2.438378190509499
NCI-H727,216345,4.166745514794161,3.9525888308001322
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.4176287054813317
A2780,156414,1.0391092981452308,1.5345611708174531
BxPC-3,11647372,-0.5523773269560157,1.52044676127049
NOMO-1,10296883,3.647443685498321,3.1577980342918197
LOU-NH91,60750,2.5426597160889823,-1.8767734073086635
NCI-H460,16038120,2.547350732010626,1.3270285333592073
ONS-76,123631,2.7486777230854176,2.5029257966056697
OVISE,9903786,4.69480560533159,3.029499077935559
HSC-4,168312962,-1.5337410071263893,1.9712160667816763
NOMO-1,421610,4.35383474826381,2.426356761454551
NCI-H661,4917,2.840246866325883,2.8471616682991807
LXF 289,3634881,3.11935208210029,3.2091405921161367
EFO-27,9911830,3.273850069923984,2.6814477977112716
A2780,46215462,1.4920420325768875,1.461055298813694
MSTO-211H,11234052,3.0252233847843515,4.329797858911288
NCI-H522,2842253,4.095670069869479,4.179156463623017
A-673,3385,3.2869772752619033,3.5234462415920884
MSTO-211H,46398810,1.7478948810000858,2.751849376039147
ONS-76,49850262,3.849158291733923,3.577950957417548
MDA-MB-157,11507802,-0.5781039838427031,1.8065234570369397
A2780,24978538,0.9309197302054482,1.17162753223135
BxPC-3,24180719,3.164671730334926,3.576768161591441
NCI-H146,676352,1.7139908333138,2.0594033088523944
A-673,82146,3.820966427179324,3.0858510166784003
NCI-H2009,46174525,3.5250507211438107,4.582514499966756
EFO-27,10302451,6.465018307145316,3.299095865971608
A-673,135984461,3.9402009784769745,3.0998090380692047
HCC1143,4521392,4.180219407268625,4.405685496504899
A2780,5351362,1.3372825777001471,1.3392206555497759
EFO-27,10296883,4.235346466258499,3.831023823786104
SNU-61,25150857,2.1451887473522295,2.3141011822538875
LXF 289,25150857,2.4132050810476,2.724150323192016
KYSE-70,135440466,2.892957215680813,2.0358876118643967
MDA-MB-453,11222830,1.1155100991132725,1.588613862680694
A2780,6918289,-5.622064624678881,1.792039501673976
OPM-2,445455,3.93427157933256,3.8695489272311065
EFO-27,15953870,3.8448280803188233,3.6986827615485707
A4/Fukuda,4917,1.915641979161103,2.921610365228226
YAPC,44185566,2.6271326170179248,2.619499122184501
SNU-449,3634881,3.3285371967859128,3.386337872324018
OPM-2,44566777,-0.9514063433103236,0.07568635383478424
NCI-H2171,docetaxel-tanespimycin (2-1 mol-mol),-7.650275881256593,-3.7802412982948823
MDA-MB-157,4259181,-0.4671059045276012,0.3951355251460228
SNU-81,11656518,-0.0512259493867009,1.2319479364073556
NCI-H522,11494412,-0.7022253688217924,1.1131390283983433
A2780,selumetinib-decitabine (4-1 mol-mol),1.5025491201295178,2.2589530311421098
CA46,24180719,4.114109141176105,3.0931836937940544
MDA-MB-157,82146,3.0360891700929984,3.6930761963970435
G-401,23635314,-3.865618451368766,-1.934253866736934
LoVo,42642645,0.0146125142547242,0.7822131116462073
HSC-4,9826308,3.3704185574061456,0.3382829357161022
NCI-H292,176870,4.643600229240446,3.3086060694229205
ONS-76,44202524,1.6130278410730936,2.067248022209389
KYSE-70,9911463,3.4914249269651307,3.9397581699173894
NCI-H146,24779724,4.32606530761132,4.203541984880044
LoVo,44493528,4.114958638118981,4.092891870095098
CAL-51,44486219,4.943814728636009,4.368796554920019
HCC1143,serdemetan-SCH-529074 (1-1 mol-mol),1.8750312876622353,2.166672020946454
MDA-MB-453,8515,4.14044832994183,3.382653274796453
A-498,tanespimycin-gemcitabine (1-1 mol-mol),3.605685519475067,-0.02846591627030631
FTC-133,56963564,0.7376209226585526,0.5628816587537523
MDA-MB-157,11494412,-1.4760508995443156,1.7160534104796286
SNU-449,4261,2.5462586921108197,1.963252961458286
MSTO-211H,984333,0.926178476056404,0.8669493450693581
SCC-9,1641662,3.777884166860496,3.567646508205329
HSC-4,2949965,3.8536489984175097,2.9086852624601405
NCI-H2009,5566,2.98031688083636,2.9095613070177775
HCC1143,16741245,3.781249389530293,4.080543997060156
CA46,67156097,-2.616833441535583,-2.2913891566820395
SNU-449,vorinostat-carboplatin (1-1 mol-mol),4.005391500954191,3.185497652552599
G-401,55283,4.120501166008349,2.323524865194232
A-673,11977753,-4.8378783477247875,-1.6954038975578123
BT-549,637858,2.0216713295762614,2.1692812466429645
MDA-MB-453,5287620,-1.4808110009700917,-1.8159998462621665
BxPC-3,46907787,0.03250860780982,2.3145518307314323
NCI-H661,44819697,-3.610310878099198,-0.8149426659401634
Panc 04.03,vorinostat-carboplatin (1-1 mol-mol),3.8664916709741792,3.347007551631815
LOU-NH91,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3161602950159492,2.327335939519163
BxPC-3,46191454,0.7426288337003383,1.7343648073163878
MDA-MB-453,322968,3.088283756332906,3.642066786692999
NCI-H1623,16736978,1.234327001570643,1.71973405628405
KYSE-70,1641662,3.490090790744947,3.412124430889742
A2780,5470400,5.365026906170319,-0.01565423666253431
NCI-H522,23582824,0.9084599252004664,0.6398067605740548
OPM-2,BRD-A02303741-carboplatin (1-1 mol-mol),5.621987253531824,4.0242643330099765
MDA-MB-157,23725625,0.2462467633250468,5.038200019941857
SNU-61,44632017,1.0979359106396418,1.3818301093273966
ONS-76,8515,4.109060881613791,3.923781726096798
BT-549,erlotinib-PLX-4032 (2-1 mol-mol),4.9890831311831665,3.4081918615550313
HSC-4,54626689,4.284935050666877,4.394190867209819
SCC-9,42642645,1.380036396261508,1.3075362099046481
LOU-NH91,9866186,2.5706791809917258,1.0443245060979742
MDA-MB-453,3552672,1.8646445353613752,2.7343977125500003
LXF 289,11507802,1.7765111516543377,1.9890007221739494
KYSE-70,107985,-3.298359335305578,-3.205156340851049
G-401,53325874,4.831157164763357,3.71304305184523
NCI-H460,5746,0.0249012606464236,1.166573762777032
MSTO-211H,11213558,-0.8326933060339966,1.8791361720079607
KYSE-70,56963564,0.3897414986371327,0.7310882375632077
FU-OV-1,11485656,3.4521578130267336,2.494857972475085
A4/Fukuda,56963564,-0.5107551488404702,-0.025620855822243615
A-498,51039095,3.6847311434926535,2.96192552704054
BxPC-3,44486219,3.8860987116797703,4.079968940737334
RCM-1 [Human rectal adenocarcinoma],24856436,1.4266113819026696,0.6570430706875464
OPM-2,piperlongumine-MST-312 (1-1 mol-mol),0.9476168525414524,0.8957648613748411
HSC-4,44819697,-1.3561318696958864,-0.5739020220491824
LOU-NH91,selumetinib-PLX-4032 (8-1 mol-mol),3.969843428334973,3.247026479124634
A2780,148198,-4.120801514793353,-4.040682991718657
YAPC,36462,2.246335150310725,2.2731629671204767
NCI-H460,10184653,3.574651577310896,1.1870961522668368
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.2358788611821236
LOU-NH91,54678924,3.1162234647683205,2.3739830049875796
ONS-76,11214940,1.2536021206371053,1.709880255740221
SCC-9,9907093,4.490912734248418,4.296637569871994
NCI-H661,11964036,1.3116184134954847,1.6113724098509667
CAL-51,135411,0.595745817277345,0.9184371095981557
EFO-27,613753,3.260816470325069,3.3328240300830463
A-673,73707398,-0.4228078892765429,0.6431771359196164
YAPC,25262965,-0.9761970914901598,-1.3612389149517645
LXF 289,31703,0.1888440469000175,-0.6447284617612499
A-673,44486219,3.969252294689724,4.069938421531142
HCC1143,135875424,3.1375636080090925,3.739937275193873
NCI-H661,241158,4.406370209729512,3.933392242142564
A-673,17755052,1.3895683648511998,1.2822314177814023
LXF 289,4788,5.213081732847737,5.596546963585348
NCI-H522,5738263,2.340773324031017,2.920090921185186
SCC-9,4788,5.928282303581182,5.760353406128694
JM-1,46843906,0.1108259550663182,1.3116441596325812
CAL-51,9967941,3.511576456928413,3.4205568030626496
Panc 04.03,5746,1.7282227653726634,1.574803350262835
JM-1,444795,2.4559914793227597,3.0584802090276657
A2780,25183872,-0.9660294253312856,-1.2037949856867285
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.839636765260042
A-498,12001922,2.3665933531109564,2.123426830591261
NCI-H522,selumetinib-decitabine (4-1 mol-mol),5.680021227414058,1.9663099387858975
NCI-H460,3384730,3.247736649900264,3.042466637140046
NCI-H292,9884685,1.805947993429832,0.8029300882129986
RCM-1 [Human rectal adenocarcinoma],82146,3.3691200384154456,3.7991160313338406
NCI-H2009,25126798,3.423512143516965,3.94961153312469
A-673,67156097,-2.6530750558799268,-1.6701354404693034
A-673,selumetinib-JQ-1 (4-1 mol-mol),0.7422634242763538,0.9223672926683558
NCI-H1623,11364421,1.5638784569997608,-0.9457370844490742
OVISE,65064,5.3042455172619345,5.046062675922912
CAL-51,11485656,2.6541256228973773,2.2757283615799158
EFO-27,navitoclax-MST-312 (1-1 mol-mol),1.1101378003165483,0.9408477379650709
G-401,135984461,4.271777659576195,3.1264740262908544
A2780,11960529,3.87105656281655,3.6095779920679525
OVISE,168312962,-1.1497759256084987,2.1094876761073107
SNU-449,25062766,2.0173338536366776,2.2440068251240928
CA46,44462760,4.878030903037556,2.697424613508238
SNU-449,126941,-4.267074342641938,-2.6887265546782015
BxPC-3,55283,0.3092833280624811,3.09259522002497
MDA-MB-453,2708,5.180783048838842,4.827235011065828
EFO-27,441298,3.357031616162376,2.2662177353156494
A-673,25195348,4.457358631051988,3.0641991954306222
OPM-2,285033,-4.309653599496783,-3.211499919558299
FTC-133,156414,2.701071854154092,1.2354762501520182
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065,0.11741709073732315
A-673,vorinostat-navitoclax (4-1 mol-mol),0.758498532756487,0.6077169258554477
SNU-449,219104,4.193064059209751,4.0501080786972015
SNU-61,387447,-3.847354855280633,-4.352388197037359
ONS-76,89928392,2.125505613903981,1.4297354061975198
DMS 273,10296883,4.130929131041443,3.4396560362364066
SCC-9,71466380,4.753733846444339,4.56118283990097
CAL-51,11234052,5.18044926966805,4.034733020282708
FTC-133,135875424,4.265925786122884,3.9578508529419203
NCI-H292,135398738,5.91070825601545,4.602593462691676
NCI-H2009,24785538,-2.0037312151285462,1.629338952547625
KMRC-1,5281321,-2.040334048066586,-1.6092317119990136
OPM-2,9926054,1.8132463747821628,1.6427467754088931
NOMO-1,44607530,2.1799605259844914,1.3550897801579722
BxPC-3,104842,-2.6661298782325265,-2.539607435289446
JM-1,decitabine-carboplatin (1-1 mol-mol),-2.2469818975584004,-0.041491909878734266
A-498,1716436,3.6890609174990057,3.4041759729918812
NCI-H522,252682,6.061888172888063,6.517657111702562
RCM-1 [Human rectal adenocarcinoma],219104,4.304261518356908,3.7500680365244388
CAL-51,409805,3.8515087112009656,5.001794048478784
SNU-449,676352,1.7938896042567478,2.1965874859489416
NOMO-1,72193861,0.7304873005319745,0.08310217637875955
FU-OV-1,5566,3.32118213388136,2.8239761264462824
YAPC,piperlongumine-MST-312 (1-1 mol-mol),2.5050103055031356,2.079203258083989
CAL-51,5291,4.8235616489491635,3.676844700786061
NCI-H1623,73707398,1.8898657972875643,1.452810007923641
G-401,navitoclax-PLX-4032 (1-1 mol-mol),3.453832495837289,0.9932669993561392
A2780,54619267,2.083839750794981,3.9269278732442423
A4/Fukuda,25150857,1.0832866246256998,1.9563909070179917
SCC-9,25195348,3.9019221273063858,3.525127000962535
RCM-1 [Human rectal adenocarcinoma],4521392,4.2393817604075705,4.240836499445382
NCI-H2009,20959075,-3.4439076637996076,-2.521568091813101
HSC-4,navitoclax-birinapant (1-1 mol-mol),2.9615241748083907,1.81051544475952
YAPC,135875424,4.215334227700636,3.9562205196649347
NCI-H522,vorinostat-carboplatin (1-1 mol-mol),3.5371010286521827,2.5866543471052688
LOU-NH91,2708,7.798658787946165,4.93257099863577
MDA-MB-157,54613361,-1.9100924648361528,0.18011273113948167
YAPC,613753,3.436227254149273,3.4446331378292028
G-401,26596,-1.5666727843222663,-1.495611253228687
A2780,124202324,1.685811695923782,1.821686486813062
BT-549,52912189,4.655826026030035,2.7034848909442335
OPM-2,6438330,0.5735051923287856,1.2468438094663559
ONS-76,49766530,-0.8397126534273769,-0.6713175561683079
A-673,24180719,3.918829940752815,3.4643603599424138
A-673,72734382,3.862779655203366,3.9694549788891136
JM-1,46926350,-6.131969810114727,-4.752703691464243
A-498,216239,2.9738940537308203,2.4833152769973923
NOMO-1,54618771,-0.7336388686704796,0.3694304426016437
A4/Fukuda,25126798,3.529395374343333,3.4979015070854103
NCI-H522,16013152,4.870026952980287,3.6529674073435183
NCI-H1623,JQ-1-vorinostat (2-1 mol-mol),1.274501215342979,1.1031819684732036
ONS-76,6918328,0.1573953751573411,-0.08012690163385004
LOU-NH91,1566236,3.241690914019502,2.3179358056877466
HCC1143,2858523,3.0390361797055276,3.0903114516852908
BT-549,71304818,3.5849392152335713,2.4151596662579227
MDA-MB-453,49867930,4.991198207309722,4.414028574457857
LOU-NH91,4261,2.7247094190978007,1.886168260993101
NCI-H522,52947716,2.6251827866590385,-0.793254112389221
NCI-H661,6852167,3.3441449371697205,3.0629509997462296
NCI-H292,16736978,2.16203795839555,1.9795736572663085
SNU-449,637858,2.172600125936458,2.1710442780078423
SBC-5,16720766,-1.9276845300945755,0.6137063599946433
ONS-76,piperlongumine-MST-312 (1-1 mol-mol),1.8657254357935973,1.721900019972941
NCI-H661,2828334,5.966055284777512,6.248336292159112
EFO-27,9884685,1.4230112837032636,0.8908044654308331
OPM-2,25227462,-6.0467342682230445,-1.8927722114369816
A-673,3038522,2.0400506341720237,2.772569670401759
HSC-4,54686904,4.85379149564711,3.5502863791755375
A4/Fukuda,969516,2.117405484631732,2.348559587292338
MSTO-211H,JQ-1-UNC0638 (2-1 mol-mol),2.4218751645526573,1.7675730308322153
LOU-NH91,6610216,4.701575628194421,4.373531396491831
NCI-H661,24856436,-1.6135015308236011,0.8391720694551507
LoVo,6252,1.008875569338637,0.7606940531252978
CAL-51,5281672,3.9430830045045857,4.4428828985633855
YAPC,25183872,-0.4840811687838853,-0.45601518092266224
NCI-H2171,11222830,1.3474519729527985,1.2482496769608062
SBC-5,16722836,3.112579400078665,1.5024332699342358
FU-OV-1,3689413,-2.180005064661593,-0.4707808517607612
JM-1,6914657,-7.803103466538306,-5.159987671350563
A4/Fukuda,11222830,1.361211164053787,1.216177770643776
OPM-2,24180719,3.7347961717129383,3.3016382865035268
A2780,50905018,3.503420862443992,3.7909006504930223
LXF 289,168313016,5.746715572468322,5.005288102458204
MDA-MB-453,2874250,4.390759253530558,4.310590627849451
NCI-H146,3543504,3.2112662755133616,4.0387403644873014
MSTO-211H,9956119,3.2798548332341246,3.719410188496778
NOMO-1,11152667,-1.8753376491976492,-1.959326385955203
NCI-H292,241158,3.585722962787503,4.075739129120833
SCC-9,52912189,3.371588298050412,2.2214574850791875
A-673,15983966,-8.138595470092604,-2.9050909626808656
OPM-2,JQ-1-navitoclax (2-1 mol-mol),-3.008224254673695,-0.48388440599511406
NCI-H146,5287969,-2.632266530811145,-1.817113657920224
A4/Fukuda,44632017,0.3391160528514481,0.8466929682374729
CA46,1242560,2.637858421223904,2.9809847298930747
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,2.1148401844854297
NCI-H727,10184653,0.8809089143232124,1.4593393255082605
MSTO-211H,6918736,-4.031815262851263,-1.132014772971126
Panc 04.03,54454,4.748257983656133,2.6233710616427937
BxPC-3,tanespimycin-gemcitabine (1-1 mol-mol),-1.8536024337573052,-1.0112781322540028
SNU-449,6918328,2.053547134624907,0.3951011350564362
A4/Fukuda,262093,3.0357368226896178,1.8137959310649998
ONS-76,6918837,-2.636307015456442,-2.5053174607765736
RCM-1 [Human rectal adenocarcinoma],6918837,-4.6352405483445525,-2.5481065689839633
ONS-76,107985,-3.307412021608342,-3.2917678199900156
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383,2.9995065723023795
OPM-2,42642645,-0.4905470491794313,-0.11186956500051438
FTC-133,16722836,3.262117509304611,1.7984376859558753
SNU-449,123631,2.9179285945779183,2.7637482896302243
OPM-2,644241,1.6900050339542656,0.607642351864534
HSC-4,1242560,3.572222416741055,3.6243432300114637
NCI-H292,123631,3.5457837677726833,2.403932802885482
HSC-4,2842253,4.76622062087716,5.542720203533649
NCI-H2009,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.4079843447100908,3.665767823647115
Panc 04.03,3689413,0.3957464459941977,0.34125376881784725
NCI-H460,135398516,4.13019906717736,2.1609915788143663
NCI-H460,5311,2.161812802665503,1.4660218742311217
SNU-61,11238147,3.2212717665721375,2.464937360355675
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242,0.8614603341650813
HCC1143,44607531,1.4024247683472026,1.5454127939720572
NCI-H727,5351362,1.1476230363651536,1.5460713659589576
KMRC-1,6852167,3.0099217565414693,2.6283586438299475
MDA-MB-157,5311,0.9088479539093504,1.6377515782728571
CA46,BRD-A02303741-carboplatin (1-1 mol-mol),6.48045136918117,3.839028113583516
HCC1143,crizotinib-PLX-4032 (2-1 mol-mol),1.506008388614785,2.198446729834113
SNU-449,3025944,4.153676005178765,4.298094560857452
A-673,23635314,-4.460908555858267,-1.92419150162912
JM-1,5351362,0.3312371174067021,0.8980147706105542
DMS 273,24901704,3.9468378622372264,2.56703841304344
MDA-MB-453,9911463,3.8683390626627454,3.5954693243821447
OVISE,60700,1.357326318980797,-0.08880553320778864
FTC-133,448949,3.317946341403347,2.000175967560399
LoVo,5566,2.507145044552918,3.0084393036498454
DMS 273,9967941,3.979035067958665,3.167383921650895
LOU-NH91,16038120,-0.2213795856096394,1.2782556756216994
NCI-H1623,11977753,-1.4500330036408269,-0.8589815658759846
NCI-H522,JQ-1-navitoclax (2-1 mol-mol),0.228465095222191,0.262035066591873
NCI-H460,31703,-0.6563705559837907,-0.7459982258239526
A-673,9866186,-0.4052980916556575,0.3998496307516931
OVISE,31703,0.0982732174518241,-0.4102278894731814
HCC1143,124202324,1.6321362493528402,2.299147901743109
G-401,4705,3.1032512954578415,3.0611501557666543
NOMO-1,3025986,-1.4139862297409005,-1.5047362535407995
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.8868479349671113
NOMO-1,148198,-5.33573798573566,-3.822168290995578
A2780,9907093,2.8643649893432106,3.761962308338781
HSC-4,44607531,1.5153971496977892,1.4095325902917748
LXF 289,2746,3.190299829163617,3.397924074899233
MDA-MB-453,4261,0.3032353935433951,1.0697590475627485
BxPC-3,656346,-0.1234429100103727,0.9069652089781256
Panc 04.03,BRD-K55473186,5.259619810258457,4.096466927923522
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966,0.5759619047514383
CAL-51,3385,3.064238699960593,4.321444904823591
BT-549,675434,4.287026263227802,4.601709203933176
LOU-NH91,9868037,3.6278868560603574,3.5884842986653225
G-401,400769,-0.955062013548762,-0.8598110846974543
SNU-449,44185566,2.80206906512974,2.8155087507620724
DMS 273,613753,3.2268993277161524,2.9123857971116562
FTC-133,9911830,2.8814152307979946,2.583304440228489
KMRC-1,selumetinib-navitoclax (8-1 mol-mol),3.760872598946533,2.095833820136859
FTC-133,462382,1.2436445575195818,0.4332467184696571
SNU-449,selumetinib-vorinostat (8-1 mol-mol),3.605779113828276,2.8217043596845013
NOMO-1,9884685,0.4754269892492985,-0.2385341042374173
FU-OV-1,44589607,2.6910555486326397,2.9759797668651475
CA46,11228183,3.2150932794291975,0.21311868320855498
G-401,24797083,1.4378353960151609,1.325459290724992
OPM-2,4705,3.10353547990691,2.9878949138402726
SCC-9,49766530,0.4117706354329887,0.16341234929325843
DMS 273,44819697,-0.9932488797546292,-1.158085625365548
NCI-H661,56963564,-1.1338494929069671,0.8591784637862474
NCI-H727,25154868,4.680199730171404,4.298760143443487
MDA-MB-453,56649450,1.3470223737131497,2.9020051056171168
CAL-51,54678924,3.225490994604415,2.0539146158897967
NCI-H292,vorinostat-navitoclax (4-1 mol-mol),3.14329221790471,1.362505236613664
NCI-H522,56963564,-0.3134921987801757,0.21402093503773034
JM-1,10322450,2.576608882705072,3.0961081238651444
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433,0.5414180725775135
A-673,24748573,1.962021648564739,1.8663581898508292
LoVo,24785538,0.3940436885335026,1.1983495183015702
NCI-H292,135421197,1.1571557888211337,2.1203759861251656
SCC-9,19582717,4.601399638975327,4.096901172421053
NCI-H2009,5311281,-0.1357038590739554,2.2362964465586455
BT-549,24951314,1.7605147679012945,1.5936720254615464
CAL-51,10302451,1.350542324147247,2.996955552377945
HCC1143,10127622,3.54698748679943,3.5886060581511545
NCI-H460,44589607,4.73035444754351,3.032084727333303
LXF 289,10113978,1.6721223719755247,3.515682456405113
YAPC,5566,3.1204203259985044,3.0391362920765954
NCI-H522,135423438,2.202740699610144,1.7227808533723283
MDA-MB-453,5280436,1.8692407341233208,3.22306939325659
BxPC-3,400769,-1.094495387384235,-0.48880344835722256
MDA-MB-453,57330099,4.336922942952946,4.309682844041786
DMS 273,24964624,-0.4885915334424611,1.9623009984215525
LXF 289,JQ-1-UNC0638 (2-1 mol-mol),0.6373974931870546,1.6875167207752964
A2780,11964036,-0.2399638951327319,1.0235656249847032
BxPC-3,56963564,-0.5407215297938537,0.4796495259651658
A-673,9907093,4.212541297476806,3.7563686312350915
EFO-27,11427553,3.591439679350591,2.809632342140956
MDA-MB-453,439501,-3.002845657836036,-2.252224346837884
LOU-NH91,11485656,3.2972382499502935,2.6708327209114806
MDA-MB-453,25161177,4.057301598200359,3.6637260778434775
NCI-H460,54143018,2.5592633032091956,0.46080861697618064
MDA-MB-453,53325874,4.468628295310174,4.236525522516013
CAL-51,71466380,3.802692276073616,4.565121536787829
NCI-H1623,4788,5.98570816019398,5.705930647560931
RCM-1 [Human rectal adenocarcinoma],448949,2.472966773294446,1.9891999489297851
Panc 04.03,11707110,4.882480457753906,-0.5267659551844319
RCM-1 [Human rectal adenocarcinoma],6450551,4.167380741941181,2.8731496524372675
NCI-H2009,JQ-1-UNC0638 (2-1 mol-mol),1.1366258852040196,1.9762037542975006
SNU-61,285033,-2.2323165928541746,-1.5896507637746353
A2780,25150857,2.724824774969284,2.097076956521966
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825,-0.5412976469964628
SW1463,36314,3.0951531870893523,-1.971890650592379
A2780,2858523,2.134868506415456,3.090800428219014
NCI-H460,3825829,4.446795399525052,4.01757775971732
A2780,1750826,-0.9954774428329844,-1.8950341274340616
NCI-H661,carboplatin-UNC0638 (2-1 mol-mol),4.544203960519617,3.1426898406296018
MSTO-211H,selumetinib-MK-2206 (8-1 mol-mol),1.2523786732506748,2.281047165065574
RCM-1 [Human rectal adenocarcinoma],vorinostat-navitoclax (4-1 mol-mol),2.52102368660606,1.1145580427834154
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552,0.04646477907002618
MSTO-211H,107985,-3.699787970340743,-3.2848324164512825
SNU-81,navitoclax-birinapant (1-1 mol-mol),-3.02925999333472,0.9074500944301575
DMS 273,10302451,4.121656528900648,2.935096155590744
CAL-51,262093,2.862241975448649,3.0242120336580207
DMS 273,4261,-0.2104746005525494,0.9679726818447526
MDA-MB-453,148124,-4.8335014079709975,-2.1965735643627315
G-401,11178236,-6.653209761704985,-3.214749124671828
RCM-1 [Human rectal adenocarcinoma],24964624,3.1300744088166312,2.456199817670089
MDA-MB-157,262093,2.565616950913742,2.93092843899047
MSTO-211H,9868037,1.9157833543052896,3.417723209595164
HSC-4,5280436,3.1415705358429884,3.578534200763065
MSTO-211H,10231331,1.7809441814393978,2.062932675604398
NCI-H2171,969516,2.758162928931276,2.472214409662364
HCC1143,10184653,0.277782870066905,1.4466949623169214
A-673,4788,5.851137286094999,5.326820848925247
OVISE,11364421,1.999223974612241,-0.43143399264553167
NCI-H661,44202524,1.2385989199848235,2.2650904895175414
NCI-H460,3062316,3.704520183651484,1.134188800295777
NCI-H1623,44607531,0.8047036576600745,1.4692899338621717
OPM-2,9956119,3.674575368535915,2.82684910424061
OVISE,carboplatin-UNC0638 (2-1 mol-mol),3.0965224412296743,3.29693127699883
NCI-H146,54618305,4.054654997899016,4.343243611836891
OPM-2,11507802,0.0988268127526858,0.8345978709818919
CAL-51,10385095,1.0305027810027567,1.3614005708901633
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.668836584675008
A-673,71466380,3.8107210551169577,4.388144320890103
A-673,10427712,3.6867963290416346,4.0395649484389375
DMS 273,56946209,-5.704769625352934,-4.40168431937663
A2780,53301938,-5.924783673466769,2.112334270223238
MDA-MB-453,3025944,3.940846865776467,4.206937484227929
NCI-H146,9840324,5.546223512080725,5.732992103383473
HCC1143,3815108,2.289037887638348,2.8319404588092207
NCI-H460,11625818,5.428588497019925,4.4059740648305805
HSC-4,salermide-PLX-4032 (12-1 mol-mol),5.175495928614886,4.66274001345251
SNU-61,123631,1.7897165257078365,1.9796314342455354
HCC1143,73707398,0.6963565440176983,1.4214361432153026
FU-OV-1,24964624,0.6948307959675745,2.313451903279611
BxPC-3,89928392,1.339609071089843,1.673758412352554
MSTO-211H,carboplatin-etoposide (40-17 mol-mol),1.373265530821681,3.075944247914041
NCI-H661,46398810,2.545394900571619,2.614335893641221
NCI-H661,17755052,1.4228000150725233,2.0666787961028787
CAL-51,10427712,4.2973287072996085,4.334168223586854
NCI-H661,208908,1.9265593878348335,2.171107068708935
LXF 289,71466578,4.726723075051965,4.579193688945321
A-673,selumetinib-vorinostat (8-1 mol-mol),2.071525628595549,1.9989319903888096
KMRC-1,46224516,3.1277122869876064,2.6443316569852406
JM-1,2113511,3.632981632735763,4.710401125918933
LOU-NH91,2113511,6.175446639496144,5.636359336219332
A4/Fukuda,6918837,-6.1208599704470865,-4.345825223678102
FU-OV-1,11640390,5.4167064390474335,3.5022671098076086
SBC-5,44607531,2.697205944866836,1.457242678667563
OVISE,71304818,3.3064642565645572,2.583791357266008
OPM-2,11152667,-1.3080541002664456,-1.9422012515103575
NCI-H146,3552672,1.604439194031644,2.597484434011636
CAL-51,12001922,2.008779489179369,1.9499203682232866
SBC-5,969516,3.68635139774897,2.868293725044581
KMRC-1,alisertib-navitoclax (2-1 mol-mol),1.4545717666785216,0.5899363558440394
CA46,53495165,-3.0280125025934495,-2.171389569339989
SW1463,60750,0.1610513612263897,-2.4331052686783456
FU-OV-1,46215462,1.830231092617303,1.9380591876502336
ONS-76,49793307,-2.5280436252167733,-2.6244885064670065
NOMO-1,11404337,-0.1001889231988697,-1.267949072782873
SW1463,123631,0.5150504925697384,2.0211978281204153
A2780,44819697,-3.3662473846109333,-1.0351141806460031
A-673,44491742,3.844993574977925,4.145526760709928
NOMO-1,5280436,3.413613220161409,2.832421041278933
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034,3.8328276197815283
BxPC-3,2858523,2.8297817429760945,3.119970458568821
A2780,445091,3.798794327077476,4.055845634081382
OPM-2,11647372,1.2733466761832082,0.5066203418349896
CA46,71751553,4.222934016329145,3.5450433134248858
G-401,44486219,4.1772416968228505,4.087465992247316
NCI-H522,9826308,0.3930789830124517,0.05308459906187741
CAL-51,5566,3.271951139375183,3.109965186625209
G-401,89183176,4.003742825914683,3.5247285613029287
NOMO-1,12003241,-0.5951695723430065,-1.3173136055252985
MDA-MB-157,2708,2.34132544783096,4.910746254712851
YAPC,10410894,3.466680540940763,3.398702714144532
HCC1143,65064,3.71051637258464,4.864166629792636
EFO-27,2746,3.149760082978987,3.209632074913754
LoVo,216468,2.992200557668688,2.7079458224082873
DMS 273,3025944,4.590997145359233,4.153798205916012
NCI-H661,15983966,-5.492856258402122,-1.3613100567434355
BxPC-3,selumetinib-tretinoin (2-1 mol-mol),-1.7965498046170116,3.2858035684793894
CAL-51,2708,4.939881356462198,5.099596219404992
HCC1143,11175137,3.393081010308343,2.5948040130782544
CA46,42611257,2.680269393096826,2.9493405009758726
ONS-76,68056272,2.9147642388168675,3.354565758902234
Panc 04.03,2871966,2.8539977368648275,0.6386250985647698
CAL-51,25062766,1.9168321284868295,2.1086910680682833
FU-OV-1,52912189,0.1271866873311006,2.0856397250351777
EFO-27,73707371,4.965139584704115,4.939575317906573
SNU-449,24951314,2.758293516562198,1.6820425805520487
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691,-0.03448779237726078
A4/Fukuda,135999136,4.178898868342667,2.7794957681815413
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716,1.1108501414416527
HSC-4,119182,0.0150561689419209,-0.5991636465673074
LXF 289,68056272,4.660756431297166,3.6361020338904955
LoVo,selumetinib-navitoclax (8-1 mol-mol),1.0965034655670265,1.6949407127491918
SNU-61,31703,0.3335579072308824,-0.8707548838144116
SCC-9,9915743,1.0040050158500469,1.0552772317782966
NCI-H460,446155,3.79922347841428,2.880323530480267
MSTO-211H,51037431,1.7350128995421004,3.207298678780635
OPM-2,73707438,4.146852269482474,4.097159655181148
MDA-MB-453,9926054,1.6596725660557576,2.0111754548907164
FU-OV-1,selumetinib-decitabine (4-1 mol-mol),7.280025082931535,3.6273802735117355
MDA-MB-157,126941,-4.13859012935224,-2.416135418887012
NCI-H522,doxorubicin-navitoclax (2-1 mol-mol),-0.6296252861358815,-1.5471237532076856
MDA-MB-453,24785538,3.5897722779252383,1.8054790683991262
JM-1,24978538,0.0218307924501431,-0.011644003115414945
SCC-9,selumetinib-BRD-A02303741 (4-1 mol-mol),5.354085868822434,3.9618190834528946
DMS 273,3503,1.4004718919159695,2.1139482465722175
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.1362272246438712
NCI-H2009,9926054,2.181635437582939,2.073427009105153
KYSE-70,23725625,6.518030965677853,5.051924726433594
CA46,2729026,2.6315261399645755,2.1667588998819203
OPM-2,135398516,1.2750707316498222,1.3997918261637339
SNU-449,42642645,1.3579889941817174,0.9620675032993546
HCC1143,25126798,4.15297730422149,3.908256838652498
KMRC-1,9933475,1.7755712843428362,2.0645213279129884
G-401,12003241,-2.103305079214356,-0.9865089699516436
A-498,5113032,5.384850868352965,5.0066802846668965
NCI-H2009,6918736,-2.2815319513344896,-1.825404603074027
NCI-H292,11455910,1.285235050416197,1.464585628520432
NOMO-1,24889392,4.281820029392572,3.311776057478206
HSC-4,4259181,1.301377168384764,0.33642150444015473
NCI-H2171,73707371,5.940029655461802,3.548340974983414
A-498,5329102,2.2449182254359843,2.3273208049756193
JM-1,51037431,4.238886241129638,2.7852263612019073
A-673,56973724,1.675633920325915,2.480246380689985
MDA-MB-157,BRD9876-MK-1775 (4-1 mol-mol),0.1874852527806031,0.7202519163207347
MDA-MB-157,136227331,3.870321503168366,4.081076979411742
A-673,navitoclax-gemcitabine (1-1 mol-mol),-4.77481524796036,-1.6811153916321293
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128,1.7071178293464364
OPM-2,7326481,2.643641332780412,2.804322302383032
NCI-H146,135423438,2.8528911509997137,2.238025156363792
BT-549,36314,1.6954100357352504,-0.8758529656753609
A2780,11717001,3.193837101204412,4.1576452686723036
NCI-H2171,136227924,2.167829841056951,2.6304252171763927
NCI-H292,selumetinib-navitoclax (8-1 mol-mol),1.0361315723218127,2.210179105862521
NCI-H460,11152667,1.2005763717636435,-0.6941232321778068
JM-1,462382,-0.3688196944858197,0.3044514352286209
SNU-61,262093,2.836545473910542,2.4576556163981365
FU-OV-1,10385095,1.480245925499038,1.5564668257446654
SCC-9,72193861,2.3270498811162508,1.8244112470237328
NCI-H661,1242560,4.217168015363727,3.6149170692154358
CAL-51,984333,0.1261860025273146,1.0965342835812928
NCI-H522,navitoclax-pluripotin (1-1 mol-mol),-0.4896519907045426,-0.9319841416255089
MDA-MB-157,SNX-2112-bortezomib (250-1 mol-mol),-2.8250293733048615,-1.1185402290486257
BT-549,374536,3.1184462544943363,2.446146317364639
NCI-H1623,11640390,0.1271923003977441,3.5695391171732784
HSC-4,387447,-4.060952426407354,-4.010504408452793
MDA-MB-157,5311037,2.9595373739718087,3.5542269745394406
MDA-MB-453,navitoclax-sorafenib (1-1 mol-mol),1.523284542572191,1.3181060722243552
YAPC,3543504,4.3832051547821855,4.414002772735035
SNU-449,tanespimycin-gemcitabine (1-1 mol-mol),2.625273627898756,-0.5246854253982692
RCM-1 [Human rectal adenocarcinoma],11222830,1.840895437487006,1.6531035848874434
NCI-H1623,9866186,-0.0100221274837169,0.7621194039788745
SNU-449,4788,5.842775682236554,5.69975833272528
Panc 04.03,5287620,-2.39349186702993,-1.9304212425613816
MDA-MB-157,11717001,3.389932991765854,4.023746258794651
NCI-H2009,216468,1.7077485468094884,3.345080530473905
HSC-4,24821094,3.2038955653523713,3.093587641778997
A-673,4578,4.214026417190043,4.117780835264253
KMRC-1,135875424,5.075329697898493,3.848386477216292
G-401,11612883,1.6387860096052431,2.0988944910474587
HSC-4,156422,5.249929789072156,4.132497847997979
NCI-H522,2742550,2.7952007563166203,3.3576354737041485
NCI-H522,400769,-0.9806645547005408,-0.7693084495823732
NCI-H2009,selumetinib-PLX-4032 (8-1 mol-mol),-1.4525193887521055,3.1565397795457732
NCI-H661,46199207,2.8133245189521054,3.1414828890576287
A2780,10184653,1.3482388837291208,1.333866387289242
SCC-9,24856436,1.519847806890015,0.7846177636620675
NCI-H460,2729026,3.0609463870825926,2.7875659494906055
LXF 289,11222830,2.2114905387790755,1.7537894422563094
KMRC-1,46215462,1.6205494448376236,1.7962408726227974
SCC-9,tanespimycin-gemcitabine (1-1 mol-mol),-0.581626900680549,-0.3441487863061198
OPM-2,421610,2.2409150931042072,2.5445607447897625
KMRC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.70640431324625,1.7621777419644946
CAL-51,119607,5.291790266428237,5.2622002572923545
CAL-51,24753719,3.9981702522006257,4.237979370743134
KMRC-1,25154868,5.3943697684741805,4.306411790505618
Panc 04.03,89928392,1.6805018731496522,1.8689146044993947
SNU-61,25126798,4.129245799651812,3.783369393054838
NCI-H522,UNC0638-navitoclax (1-1 mol-mol),4.115450321285854,1.0591548437874971
HSC-4,11977753,4.574500022269399,-1.207300658269186
NCI-H727,4477,0.5438785176620984,0.5479470923330516
CA46,5335621,3.676802077981384,4.064044131495816
JM-1,322968,1.8634300837521185,1.8274733181470275
CAL-51,46907787,3.297361866649883,1.8837050677028886
OVISE,doxorubicin-navitoclax (2-1 mol-mol),-1.2556065332393784,-0.48095538077590916
RCM-1 [Human rectal adenocarcinoma],71680916,4.48717515696629,4.909126181209938
NCI-H522,53495165,-1.820766752755188,-0.7092621966828108
MSTO-211H,11626560,1.3885064506517848,1.9190817099301223
SBC-5,262093,2.1741934315953726,3.065715558828231
MSTO-211H,52912189,3.1066961080068123,2.0579380248941446
HSC-4,568763,1.3764913265299208,0.7160428113849197
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626,0.7597864133368084
DMS 273,25195348,3.734209419300899,3.1900140304145683
Panc 04.03,5951923,4.37213064077745,4.319557531339793
FU-OV-1,439501,-0.5556149973103641,-2.020030227148751
A2780,BRD-A02303741-navitoclax (2-1 mol-mol),1.977156193717172,2.025916842691737
LXF 289,168313047,4.113002678801054,2.393258462759874
SCC-9,67291369,5.015060977849177,2.618788518090194
OPM-2,5351362,0.2459388559982981,1.0328749907909498
FTC-133,11485656,4.087051585535102,2.7575996358625887
HSC-4,46843906,4.814917111969106,3.098117480760046
CA46,51039095,1.651262767418978,2.0041285019535913
NCI-H522,2945648,3.0823392214986343,2.4793595228862704
MDA-MB-453,selumetinib-piperlongumine (8-1 mol-mol),3.1080333616625713,2.292562039639404
YAPC,9911463,3.901904463732921,3.990321709715007
DMS 273,11977753,-2.475673354763999,-1.9007942521930807
SNU-449,46191454,5.774811831739998,1.8433664138604118
NCI-H661,25062766,2.1967321973268294,1.9748720992863653
A-498,53301938,4.241910990361246,3.4593171312901343
Panc 04.03,10302451,3.874200048588579,3.228162455366403
A-673,16065773,1.4559751864460968,2.131034393260957
NCI-H1623,135398516,1.607867961646436,2.2263554376441177
FTC-133,60700,-2.7194012548196,-0.06795584946535393
NCI-H661,3384730,1.2254103498827775,2.8732825664789083
SCC-9,168313200,4.072126418899639,3.0155954730557952
OPM-2,25150857,1.3601106429565517,1.7207827649927692
NCI-H292,3385,4.509781783210997,4.4030876140970685
NOMO-1,227681,3.177880686522457,2.743506190855363
RCM-1 [Human rectal adenocarcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.9740491797534947,2.5697391225044983
OPM-2,46191454,-0.9534482392265864,0.40973812276810867
NCI-H522,3081361,1.6470006965888542,1.9704948986228734
CA46,374536,0.6029387131655304,0.9899552210439314
SCC-9,selumetinib-UNC0638 (4-1 mol-mol),3.717663096766538,3.115531834304363
DMS 273,4705,3.496116762813734,3.0769891140573207
A4/Fukuda,17755052,-0.6813796549781841,1.3523519227113336
SNU-81,24180125,-1.7131691030529954,2.5693497493555086
Panc 04.03,969516,3.706271998961216,3.0587796194505406
CAL-51,15547703,3.503799403292956,3.239538644065165
NCI-H460,24951314,1.96669984187411,1.5597604788917898
SBC-5,446155,1.3486611419477716,2.527916609078068
Panc 04.03,6184667,3.768891848670565,3.4824414174585443
MDA-MB-157,4096211,2.1957324566584715,2.233959075270298
CAL-51,15983966,-4.387912760170627,-1.311018250406301
NCI-H2171,49793307,-5.547674326636965,-3.9062504773762536
MDA-MB-453,31703,-1.1483878700266144,-0.873691682626719
KMRC-1,24785538,2.687509195601708,1.4730477080844628
SNU-61,JQ-1-carboplatin (1-1 mol-mol),3.4608261029865615,1.184439187564976
FU-OV-1,54618164,4.603510021761196,4.095813668407045
YAPC,5287620,-1.8729921135671632,-2.0345079821757652
NCI-H661,16065773,2.6852778174065435,2.190508002013147
CA46,5329102,1.3169898780971163,1.2415500275179656
OVISE,66577038,3.7859124338920065,3.0356437892372163
LOU-NH91,57519531,4.764819520424852,2.4778238492591433
LOU-NH91,448949,2.461672905148464,2.209677036596269
LXF 289,10427712,4.0701965709145504,4.5333531959501405
CAL-51,9915743,1.1260994347217144,0.8812371105692055
NCI-H2009,11609586,4.059888202416809,3.0099750506461103
SBC-5,60700,-1.8327808511007615,-0.4840060564478996
NCI-H2009,SNX-2112-bortezomib (250-1 mol-mol),-2.754596306388576,-0.9020836485516959
OVISE,24951314,2.5954730551837386,1.566784115757395
KMRC-1,66577038,2.9827052655036206,2.771186760441057
LXF 289,36314,1.2391029615263165,-1.1737994494068489
NCI-H292,44607531,0.4181911293940362,1.6143540955221647
KYSE-70,219104,3.9271840577372705,3.8909520574520737
NCI-H460,71304818,2.359856693071434,2.5718150885880355
SNU-81,4477,1.0310003158688126,0.5337117346155916
A2780,1716436,1.933630716197044,2.6524920440787216
LOU-NH91,11964036,1.2476019563081622,1.4985781587481872
SBC-5,9936388,-5.234314033557506,-1.3719665337657643
KMRC-1,24964624,2.351358467802262,2.348623838405815
MSTO-211H,73707438,4.334782721865043,4.183930831392444
MDA-MB-453,73707438,3.778137609083601,3.6928719155729146
EFO-27,49793307,-1.9052761294403429,-2.0283246006866644
G-401,71680916,4.434691555895244,4.279712946254981
MSTO-211H,3634881,2.531877742135044,3.4273329739143223
NCI-H292,42642645,0.8145779285410705,1.0625817321038467
OPM-2,168313200,1.8002020874491595,2.787786075550784
NCI-H2009,53232,2.115043522086945,2.891317656384341
SNU-449,9825149,2.659052538489635,2.3214903681619496
CAL-51,25105715,4.077363851334658,3.2918100729103386
MDA-MB-157,53232,1.9030895496471385,2.8012478595846675
NCI-H727,2708,6.607150814967448,4.93364151328703
A-673,carboplatin-etoposide (40-17 mol-mol),0.9497431982903584,1.3306294089952257
NCI-H1623,44632017,1.5464636141196502,1.2713302509029403
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478,0.7840393673813167
FTC-133,selumetinib-tretinoin (2-1 mol-mol),5.415389433541197,3.048464242489344
SCC-9,3689413,-0.5284639903905319,0.12877918922273435
NCI-H460,23725625,5.666756485817308,5.0611541433032485
NCI-H460,100016,5.855223104671776,6.268239796036771
NCI-H2009,24771867,-1.6305331500245923,2.4888736017746296
SBC-5,9952709,3.0525329755213466,3.062697549507494
SNU-449,5566,3.0151612646695822,3.0317337721940367
NOMO-1,9926054,1.6113291347040215,1.5075187378524717
EFO-27,11404337,1.0583908830182924,-0.22059895985171699
A2780,54626689,3.943205764450006,4.510277755270497
A4/Fukuda,168313200,2.9572494196719723,2.7873424655696306
LoVo,5460769,-2.1468642890382412,2.7422190628934264
NCI-H661,25102847,2.378632231655901,2.530540660563388
A4/Fukuda,9866186,-0.2462641713744652,0.2146285762330952
MSTO-211H,selumetinib-piperlongumine (8-1 mol-mol),2.1949656994292455,3.436229098884056
KYSE-70,36314,1.2189527676950276,-0.7876463093892541
BT-549,2828334,6.061535937537666,6.171273713068597
NOMO-1,25262965,-2.043358942198166,-2.168853762115412
LXF 289,25195348,5.284501520866742,3.4248556930922893
CA46,451668,2.285623139838705,-1.0180678777694272
SNU-61,24856436,-0.371488374536367,0.3974196575153296
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,1.8872959009855534
SCC-9,44137675,3.491154886377157,3.58138113988657
BT-549,151289,0.9825598768305964,1.4749674797156778
JM-1,49836020,4.6064946369246025,3.1506404885473422
YAPC,54618771,0.5686030675412354,1.452361205744685
SCC-9,24772860,-2.0717241396099473,-1.4720644280544333
A-673,10385095,1.0544598585596625,1.0346378786805595
SNU-449,216468,4.54901774756382,3.2597330890361764
SNU-61,67291369,4.2845115751683736,2.049679448193272
FU-OV-1,5291,4.051520848138153,3.6939040646343586
LoVo,12001922,1.64420677630862,1.9352256296210462
NCI-H661,3815108,3.885074716587427,3.037855536824356
JM-1,374536,-1.2279479926310035,1.0217445096663487
LoVo,tretinoin-carboplatin (2-1 mol-mol),5.63935886980119,4.964671124038055
NOMO-1,4788,5.067002306940809,5.126232590973352
SNU-61,24748573,1.6967337473161408,2.3640891323384565
BxPC-3,16720766,0.4925277259578197,0.7056880531645833
EFO-27,46215462,2.714023108610326,1.9729103790262628
SNU-61,selumetinib-JQ-1 (4-1 mol-mol),-2.0822040932557564,0.7923559036443981
SCC-9,31703,-1.2436349312067534,-0.6295431188273807
A2780,5335621,4.014990109441054,4.396154950353111
EFO-27,4917,3.7917867214450096,3.1026401993707475
A2780,9926054,1.5482217772077662,1.7665773198975858
A4/Fukuda,3689413,-1.7998697854540155,-1.4861705291700296
OPM-2,6610216,3.8953919440086575,3.8864048604047383
NCI-H522,6918328,0.2751454024017333,-0.22926862010594018
LoVo,60750,-4.161283305326802,-1.3575164431219493
LXF 289,15547703,4.3915240757493565,3.1922625606455277
HSC-4,55283,3.529343210540244,2.9583458452698905
MDA-MB-453,6436223,-6.0469700747965325,-4.420952633508082
OVISE,54619267,4.300185321056238,4.10410911103653
CA46,12001922,1.4868064190708767,1.6214294996957528
SNU-61,53392493,2.2959575452819543,2.333297717997232
CA46,alisertib-navitoclax (2-1 mol-mol),-0.3203128616100632,-1.2764290348019731
G-401,44137675,2.141460704144857,3.5611396419956884
NOMO-1,9825149,1.4944850939332062,1.6143665048857405
CAL-51,4788,6.061217822513647,5.513837318564885
HSC-4,119607,3.948608575005578,5.117983231563452
NOMO-1,ISOX-bortezomib (250-1 mol-mol),0.07871384473645,-0.0356003387626361
LXF 289,4477,1.125394938272502,0.3988760227599204
JM-1,11657048,4.676495506604394,2.591768038608984
G-401,10302451,3.1015289114526774,3.2311292501206
HCC1143,31703,-0.2055424786168501,-0.6523853146772854
HCC1143,374536,1.384467639208202,2.3479586574974176
Panc 04.03,10184653,2.983159460505767,1.6699455519261526
NCI-H2009,crizotinib-PLX-4032 (2-1 mol-mol),1.3104929839779844,1.9838388837340162
MDA-MB-453,9915743,0.2126089191242519,0.08572490597690907
HCC1143,4477,1.746819852748151,0.31524802006947983
LoVo,44486219,3.9526381308541025,4.34573513450848
ONS-76,135875424,3.856833286433643,4.049053434556199
SCC-9,24797083,1.144476664186746,1.5203103502626316
OPM-2,4096211,1.0315429789467454,1.043164876066186
OPM-2,selumetinib-piperlongumine (8-1 mol-mol),2.005304394078306,2.2043167422144703
SNU-81,25262965,-1.8265758424412304,-1.053426480999224
KYSE-70,44137675,3.4677446622108925,3.516916977724126
NCI-H1623,3854666,1.505587442259218,2.3079313536117
HSC-4,10385095,0.4573663196580717,1.3376920831431807
EFO-27,107985,-2.474640150808475,-3.381098242594378
NCI-H2009,6610216,3.953101400309774,4.1982540312460985
SNU-61,135421197,1.1046098427392648,1.7080714557347714
HCC1143,4259181,-0.4991941409006941,0.22337402547782756
BxPC-3,16038120,0.5924635925282854,1.2202765826056399
NCI-H661,135875424,2.4725937826628006,3.755250639602837
SCC-9,9866186,1.319539660579235,1.0877846067359318
LXF 289,24964624,1.3940062455599875,2.8352528990263415
HCC1143,vorinostat-navitoclax (4-1 mol-mol),1.2828606463085703,0.8695570628314471
HCC1143,6610216,3.638345017281011,4.305351880395937
G-401,2949965,1.5385484234582818,2.4272123717850773
BxPC-3,49793307,-3.2953922214008697,-2.579887015710719
A4/Fukuda,5287969,-2.571307610380136,-2.2104820650082275
A-673,6184667,1.935989865778159,2.948947877450795
NCI-H2171,24821094,2.9775477594317743,2.821320607589617
NCI-H2009,67156097,-1.7347724318553324,-0.33201187445035507
A4/Fukuda,409805,3.596796639089143,3.9877738273397263
JM-1,5738263,2.278112606764228,2.8571758531137403
SBC-5,2828334,5.980106592077389,6.068404258027113
BxPC-3,107985,-2.51349631829315,-3.308683101184593
G-401,11427553,1.555705840809683,1.9780259768086
G-401,10113978,1.710663554595952,2.577868971460133
NCI-H661,16013152,4.678017706607999,4.054028684191667
A4/Fukuda,11497983,-1.0595923666648657,0.5515482610665949
NCI-H522,10296883,3.751667506317718,3.5549557854838865
HCC1143,6610355,4.569348514461763,4.7154071778850986
SCC-9,56946209,-4.978704692275232,-3.8480255593582497
LOU-NH91,54613361,0.2217026048603205,0.253894320663121
Panc 04.03,ISOX-bortezomib (250-1 mol-mol),0.266400908707645,0.8540660030599989
G-401,42642645,-0.5846467586678221,0.18770741315212014
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289,1.6247710481179007
NCI-H727,5287620,-1.579053209750056,-1.8098421455038425
FTC-133,16038120,2.9212616737408896,0.8784259631588418
SCC-9,11626560,2.4253223939520976,1.8605257067932643
Panc 04.03,2742550,4.347188786942969,3.909009758031611
OPM-2,15547703,2.634316496996711,2.63791212073815
NCI-H522,10074640,3.1231046963753686,2.914326202731617
HSC-4,2945648,2.59041604505869,2.9368013593861817
NCI-H661,vorinostat-navitoclax (4-1 mol-mol),1.2789358142207048,1.3021831933671515
MSTO-211H,10127622,2.776094640706434,3.9676270405260596
FTC-133,serdemetan-SCH-529074 (1-1 mol-mol),3.1500157786176777,2.1998749537660536
NCI-H661,2858523,3.1395656938248124,3.042355711761709
A-673,56946209,-5.889509916794497,-4.612882325253958
CAL-51,44185566,1.8630594392382311,2.3624202208266247
YAPC,51039095,2.046611375354791,3.1111651074549087
OPM-2,4261,-0.9911458583810344,0.6355261999207266
BT-549,969516,2.601131538014171,3.0277141055044665
RCM-1 [Human rectal adenocarcinoma],tretinoin-navitoclax (4-1 mol-mol),-2.5028847208859637,2.4636718555999746
A-498,55508,4.21947279006693,3.5444598972331973
SNU-449,71466380,4.63195087543953,4.58839335007405
MSTO-211H,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4025987585573363,3.828588804544582
A-673,11707110,3.906892758790242,0.8599408140619967
NCI-H460,54649381,4.173104904963283,4.01032302812131
KYSE-70,5282054,4.279196842795529,3.6937198893958
G-401,119607,4.5837417334889885,4.797495654334327
YAPC,24856436,1.898811352025064,0.6685606289099123
CAL-51,5460769,1.3780575552768597,3.1233134527139885
NOMO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0823481762060787,-2.700343817552347
CA46,400769,-1.5476292313826252,-1.2350676200474018
SNU-449,19582717,4.423938746946012,4.447780284030731
KMRC-1,46191454,1.86757619496812,1.4434602337339855
MDA-MB-453,45279963,3.011106079512325,3.344810625468238
BT-549,25150857,2.011062957026122,2.60497495724992
BxPC-3,navitoclax-pluripotin (1-1 mol-mol),-1.3920803089523777,-0.8726162396543806
NCI-H2009,135999136,4.285465393980956,4.0853901038738805
LXF 289,984333,0.880488465949386,1.1131489261581125
NCI-H146,11238147,0.964491846183422,2.4161078659214543
Panc 04.03,5287969,-1.8253556910298991,-1.724421358302288
NCI-H292,654092,0.1209701484650686,-0.17902294902680801
MDA-MB-453,9927531,3.885109165752666,4.082346094520538
NCI-H522,44819697,-2.38793523497331,-1.0706746085243772
LOU-NH91,11364421,-1.522672653311712,-1.5286033153433607
NOMO-1,4477,1.0767445259598296,0.53521811523689
LoVo,148198,-1.1147075342847712,-3.277592608165151
SBC-5,54619267,3.782844847718682,4.161822939220266
BxPC-3,vorinostat-carboplatin (1-1 mol-mol),1.8300641490410745,3.550421998898596
NCI-H2171,46224516,1.006764214935909,2.1336179503572748
SNU-61,55283,2.411692675664504,2.524366322461152
ONS-76,navitoclax-birinapant (1-1 mol-mol),1.131765862858429,1.8806680513682394
BxPC-3,vorinostat-navitoclax (4-1 mol-mol),1.2956332154746788,1.2715967891402766
G-401,135398738,4.751845538055463,3.2988000994487354
A2780,24889392,2.5877097444926265,3.7584847620946444
CAL-51,3081361,1.780158758130264,2.2501542614176078
MSTO-211H,3025986,-0.6925850648320051,-0.7893393630764725
NCI-H1623,10231331,4.737119210946733,1.6461340179422146
LXF 289,60750,-4.482846219959503,-1.5237974766579954
JM-1,19582717,1.6871405928140415,2.925938567923911
MDA-MB-453,24775005,1.4926368241852035,3.5660861472955903
JM-1,10074640,2.5195149680920657,2.6486655582614045
A-673,2749,0.4791921848862392,1.2851496123636292
ONS-76,9911463,3.87028315643254,3.8277693916393103
A2780,3136844,3.626688956130205,3.8943026859150995
LOU-NH91,2945648,3.130856585594597,2.914963147291751
NCI-H146,52912189,0.5266703058361273,1.5412958547398246
A2780,156422,3.602973007130472,3.567859952187191
LXF 289,969516,2.6399649875984355,3.0159014974335805
NCI-H146,25154868,-1.0719819424572428,3.988523396636797
YAPC,1641662,3.645861677961698,3.668600405054223
LOU-NH91,136227331,3.865245001267085,4.192370763496019
YAPC,46224516,2.408657893134071,2.7221499038659287
JM-1,46199207,1.915427322474508,2.7232664080597715
G-401,54618164,3.8592700204433807,3.9266912420541233
A-673,53232,1.7702469915903785,2.667847478890597
SBC-5,6918289,2.991753308414544,1.691202339135678
MDA-MB-453,selumetinib-MK-2206 (8-1 mol-mol),2.1996282854374303,2.3145197294216264
NCI-H522,24797083,1.396487413816628,1.2273182945353498
YAPC,11238147,2.574935183805209,3.0535667942787637
BT-549,9444,3.939814284899288,4.334725568002098
NCI-H460,11364421,0.3566052665939138,-1.5702314235208832
LXF 289,23582824,0.8647594683412683,0.7189938533085288
FTC-133,89928392,1.8077600838169707,1.826089206686416
NCI-H661,15547703,3.600649740500543,3.242898157450349
JM-1,8515,3.19981027650634,3.227278335237454
LXF 289,25102847,1.656353256373218,2.6550888855886883
NCI-H1623,11626560,2.1087636260711333,1.9542448017320622
NOMO-1,2729026,1.9247353379999697,2.304508582679686
A2780,carboplatin-etoposide (40-17 mol-mol),-0.855870041276873,1.8458558694579514
OPM-2,60700,-1.448416790812607,-1.6989758740179295
NCI-H292,9825149,1.7347241761388297,2.525781203137213
KMRC-1,6918878,5.2070030404450485,2.4153097297895214
SBC-5,4259181,0.3536055110585087,0.18556556216570472
KMRC-1,71466578,5.804397104747809,3.92123212209984
JM-1,selumetinib-MK-2206 (8-1 mol-mol),3.384959636780238,1.3470090962325185
SCC-9,54596490,5.620994411748341,4.615387622234256
MSTO-211H,42642645,-0.4763575861779333,1.1377553318013816
DMS 273,4378219,3.0463884183789336,2.3849008690371667
FTC-133,SNX-2112-bortezomib (250-1 mol-mol),2.186622613691835,-1.1241552737807883
MDA-MB-453,11626560,2.2881538301476696,1.9776874250631644
BT-549,46215462,1.7261150757919093,1.9768043422039563
SNU-449,45279963,4.011305658965759,3.787207473557112
HSC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.233119251645935,4.082011202075156
MSTO-211H,serdemetan-SCH-529074 (1-1 mol-mol),1.7679544322052605,2.220287950502745
A-673,10302451,3.0176041071951345,3.1812524379192375
CAL-51,5280436,3.749440064194485,3.250058246151896
OPM-2,23582824,0.3145394278485406,0.668787163153027
JM-1,5287620,-0.1298713463901946,-2.1156738306369114
MDA-MB-157,3503,1.1658051797362206,2.2155982678818087
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757,1.8953550872000997
SNU-61,16741245,4.568608723382813,3.616666234786087
SNU-449,54626689,4.585589968636992,4.717131857174632
G-401,49867930,6.047675909857249,3.7650525668900015
HCC1143,46199207,3.122692827276537,3.1437276325521277
OPM-2,445643,3.4082912819673536,3.6796922878042273
DMS 273,54618771,0.8675837195237585,0.6782471563516129
NCI-H1623,71304818,2.8160491805212615,2.672721809361333
MDA-MB-157,16659841,3.727147143419768,3.7418350874396724
RCM-1 [Human rectal adenocarcinoma],44566777,1.6377443255416146,0.8386534912013004
MDA-MB-453,1750826,0.6003684780059517,-1.402444677595364
NCI-H1623,5281321,-0.5392861044239732,-0.9404642101193619
MDA-MB-453,613753,2.5060803116052357,3.183053565301048
MDA-MB-453,2871966,-0.7610622755396385,0.5530623978439072
MSTO-211H,5281321,-2.386258436411726,-0.887184527890418
KMRC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.854846859119752,3.269212868804904
FU-OV-1,44137675,3.1043101525841377,3.713940821220929
NCI-H2171,285033,-3.2427052076981693,-2.611989101470074
FTC-133,alisertib-navitoclax (2-1 mol-mol),-1.780189218062184,0.2645935299734598
NCI-H727,5311,2.2708816030438816,1.6378274629757459
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859,-0.8819041995739245
A2780,5746,0.8697095475366516,0.7301067980987344
NCI-H2171,53232,2.7429596689347875,2.743974276882647
EFO-27,5291,4.106816055599409,3.8228465096904607
MDA-MB-453,9933475,1.6213532539721074,1.8730012083848258
OPM-2,5281321,-3.721370442971226,-2.354074606932532
SBC-5,25183872,-1.21590268467039,-0.7063912635581856
SBC-5,452548,-1.978558467437607,0.5243501628478704
NCI-H522,5351362,1.1598735323390523,1.350956578687119
MSTO-211H,3552672,1.7334798735784387,2.9018804774517366
A2780,10427712,3.0744297357135557,4.001748327628821
LOU-NH91,409805,5.248055334811583,4.937556782318894
JM-1,5460769,0.6255065324989537,1.8364829814195665
NCI-H292,9967941,4.033073764451828,3.8105783802730087
NCI-H727,16038120,-0.1646423801756905,1.0491011582403806
NCI-H460,16038120,2.547350732010626,1.3270285333592073
LXF 289,241158,4.717778097263283,4.041457008983926
OPM-2,46398810,1.9487214127979129,1.849980333933858
A2780,selumetinib-JQ-1 (4-1 mol-mol),-1.37978583005038,1.1859902389398973
RCM-1 [Human rectal adenocarcinoma],135440466,3.6704227989419738,2.3128955340575694
CAL-51,9884685,-0.2528326244590672,0.4332284618393667
LoVo,44607531,1.302221694572025,1.3859219788506199
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.5176773250717219
MSTO-211H,56963564,1.234327129960966,0.5254934416091337
MDA-MB-453,73707398,1.1537227860078607,1.5295600391072808
BxPC-3,5329102,1.9407746673909456,2.112133230372119
HSC-4,5287620,-1.917371788332746,-2.158595390102752
FTC-133,11152667,-0.4786534736280033,-0.46758149960476836
NCI-H146,9935249,1.0600603569941576,2.220106654234962
YAPC,2729026,2.7496252904978293,2.8350457819279815
SNU-449,71751553,4.402646349497825,4.598839473610741
HCC1143,9926054,1.808099247882512,1.9962410628637115
Panc 04.03,448949,2.534760210414342,2.1019066644797566
NCI-H661,5566,3.151274839096282,2.758376902414619
FTC-133,6610355,5.440540243356366,4.515727708337129
JM-1,16741245,4.187666128361383,3.505273538465865
SBC-5,navitoclax-birinapant (1-1 mol-mol),2.2573957245834246,2.0799459254159967
LXF 289,107970,2.2922723928752307,2.445846401142326
Panc 04.03,54626689,4.659724899973851,4.521371995165061
MSTO-211H,16736978,0.1439838744803616,1.9146132111753014
MDA-MB-453,151289,1.613318506724072,1.3660840947468236
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.668836584675008
CA46,6918638,-2.155597959241919,-0.8559188034640538
ONS-76,selumetinib-UNC0638 (4-1 mol-mol),0.4414887098860544,3.38749586890525
A4/Fukuda,53495165,-3.058270414187161,-1.254094103682707
DMS 273,135984461,4.327877942465965,3.078892862623377
OPM-2,89928392,0.3187576395153793,0.43826209550698614
NCI-H1623,10385095,1.1256497169747182,1.4958537710881827
ONS-76,11717001,3.327449083785458,3.9083676657869684
LoVo,6610216,4.332472846182503,4.238284112117353
NCI-H292,16722836,1.3558361632896196,1.7253384097256614
MSTO-211H,135440466,1.110539790918092,2.1298944997684917
BxPC-3,9868037,2.7194108471732243,3.3759639461788886
CA46,2874250,4.668483912698598,4.302475646978992
MSTO-211H,11238147,2.1702387480753393,2.84905113014829
JM-1,44607530,1.0639194271383936,1.3269800351744325
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.9053705175781528
ONS-76,2749,5.1102698724547375,2.003479814811981
CAL-51,36462,0.7338920585832341,2.012448246217976
CAL-51,6610216,4.7761200098267365,4.297094973040059
KYSE-70,3062316,0.8461927752800795,0.6925726710811564
LOU-NH91,285033,0.7293222441785373,-1.3036924542651775
A2780,11485656,1.5628347007454235,1.8558083995563768
A-673,26596,-3.820628112159822,-1.7945282556150055
KYSE-70,44632017,1.4611535882953923,1.1915816384690172
NCI-H2171,702558,3.801125308495619,4.362305595195989
MSTO-211H,23635314,-1.96294908215212,-1.460362494352994
SNU-81,5746,1.2061469752663514,0.39683421568824206
KMRC-1,4788,5.9167994505540475,5.6067745693348785
CAL-51,15983966,-4.387912760170627,-1.311018250406301
CA46,49867930,4.292641096024632,3.1273185725413755
HSC-4,11455910,0.337268703123225,1.15962113759365
YAPC,5281672,4.680001258160183,4.745037957487475
SBC-5,5978,-3.632907311761228,-2.0488312336080003
NCI-H460,3825829,4.446795399525052,4.01757775971732
MDA-MB-157,9444,2.0478202605503206,3.917381641004833
OPM-2,UNC0638-navitoclax (1-1 mol-mol),2.0554805477116207,0.3447267116381792
SBC-5,46191454,2.9096163569547,1.8586651697975978
CA46,644241,2.374325583681648,0.5834925221866322
EFO-27,erlotinib-PLX-4032 (2-1 mol-mol),3.67875442693599,3.1045695269249105
FTC-133,252682,6.679184103041344,6.5560584320829545
SCC-9,56649450,2.7319907342568275,3.407760808793293
CA46,5311,-0.1889513685103653,0.5821333905104378
OVISE,9967941,3.747669270164806,3.5032727702431936
KMRC-1,5328940,2.3844062156656256,1.835899797775831
NCI-H146,9825149,1.1795040286889695,1.8550589945322031
SNU-81,445091,-0.9408785363266468,3.820009874588007
FU-OV-1,6610216,4.742914927321441,4.340018171005859
A2780,56949517,4.37203598237815,4.3957319220782205
EFO-27,119607,5.664089470896734,5.238851440537689
ONS-76,57519531,2.0495811593793105,2.534167817373022
MDA-MB-157,42642645,0.4106458170856017,0.8447040727100285
CA46,135421197,1.13174100448049,1.3080525577733237
LOU-NH91,11719255,2.9529273796726394,3.455529007117854
A-673,9967941,2.0264988474191377,3.3929509818860164
A-673,23582824,0.2073680927392712,0.5322443932040369
CAL-51,374536,3.1977545561189347,2.227741789049032
SNU-449,5311,2.373513113952619,1.6598644135702951
SCC-9,11178236,-3.8920346249942264,-3.0711742820461776
SNU-61,71680916,4.248107596602719,4.199706203920375
BT-549,4578,4.840393866327907,4.663426964346402
JM-1,56973724,1.572059771180543,1.8997109953385851
BT-549,6184667,4.320802676068414,3.275999859069879
OPM-2,6918878,0.2719026340750923,0.7021307018378498
HSC-4,9967941,3.0274642479334215,3.7456534408044155
G-401,6610355,3.5029306645068696,4.308433354389041
Panc 04.03,1750826,0.308709425359425,-1.0105711326929683
KYSE-70,6610355,4.961596413135767,4.3401082253727195
A-673,24775005,3.310963685757038,3.7017263523394024
SNU-81,208908,2.232815974371363,1.6773723052864167
LXF 289,ISOX-bortezomib (250-1 mol-mol),0.4085036355152772,0.8688920735721335
NCI-H727,3543504,4.299187359877464,4.395630987429794
SCC-9,11152667,-0.1233430086603879,-0.41217447218052217
A2780,208908,2.5004436475537974,1.815379460479697
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678,-0.7809791323157236
A4/Fukuda,44607531,1.1783204907000706,1.3293821740069882
ONS-76,54649381,4.0197495944656465,3.825974978379209
A4/Fukuda,31703,-2.1013190360416147,-2.3817865047577715
EFO-27,46398810,2.9967281863964867,2.604040661882786
JM-1,119182,-5.01139227406357,-2.6834840384947944
NCI-H2171,25183872,-2.065345244597309,-1.131774614014633
SCC-9,53392493,3.3396857977581917,2.75977277593898
ONS-76,44259,0.6373390659589321,1.0209710803947867
NCI-H661,72376,-3.040643961037913,-1.7941856696933305
KYSE-70,11609586,2.827625452517046,2.8090736032961185
NCI-H727,3025944,4.64192894764355,4.2132550471790475
NCI-H460,262093,3.3627537421549314,3.0370326355223387
MDA-MB-157,tretinoin-navitoclax (4-1 mol-mol),4.215736518135254,2.510511141555986
NCI-H292,11396600,3.7365966834404225,3.8958398687281908
OPM-2,11626560,0.8852338363333486,0.8131280060961926
MDA-MB-453,24772860,-3.354356853525474,-1.3673161218681493
BxPC-3,168312962,2.7485538585474547,2.456001398921059
KMRC-1,46199207,3.449143967158838,3.1892610358399764
MDA-MB-157,2729026,3.2437974205657816,2.784393749185894
LoVo,4259181,0.2045859597859785,0.19766624213997874
KYSE-70,5329102,1.9375891375175784,2.105031867081444
EFO-27,3025944,4.337116030950391,4.312182674326827
EFO-27,2742550,4.50908635993052,3.8849170455939337
A2780,6610216,3.3472253004646593,3.8785309599823274
LOU-NH91,docetaxel-tanespimycin (2-1 mol-mol),-3.5084138300894625,-2.570971318700536
EFO-27,24856436,4.205894943099943,0.6611223089025586
Panc 04.03,9444,4.565679465533194,4.048504640432702
ONS-76,72193861,2.0006819721723197,1.526001859011296
MSTO-211H,445643,1.8400808237063873,4.066545349154428
CAL-51,8515,3.5852991976047863,3.780378808310307
OVISE,25150857,3.4132003431569524,2.472585350200211
KMRC-1,tanespimycin-gemcitabine (1-1 mol-mol),2.381825597611343,-0.8472122825308642
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442,-0.36974911570448993
OVISE,5746,2.6308159153246047,1.0793534098139235
A4/Fukuda,168313016,2.0147776130358253,4.085796046578763
LOU-NH91,54686904,4.160622905506427,3.567865757528242
LOU-NH91,8515,5.2113767400480775,4.1137213795079814
NCI-H727,73707398,1.5620380856857303,1.4075655317950266
OPM-2,16722836,0.349034656527362,0.9599977710386873
NCI-H2009,119607,5.663513162505294,5.2589539261139535
G-401,11707110,-1.5866495763270043,1.0589250451589
SCC-9,439501,-2.6581193485563737,-1.9829341867832782
NCI-H2171,4259181,0.2390230285316857,-0.19282768547527446
MDA-MB-157,45279963,1.9862312593637983,3.585105067532972
LXF 289,6610216,3.700752852024682,4.26701924716318
NCI-H2009,9936388,-6.076047204085024,-0.9587512384221116
ONS-76,11612883,3.1090836160489417,2.828289851291714
SNU-61,969516,2.346236032939849,2.593569045930367
HCC1143,3025986,-1.3091092061734078,-0.9343123867978632
NCI-H146,46398810,1.4219775291726766,2.198770217076196
HSC-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.4165254570204953,2.673201066272463
RCM-1 [Human rectal adenocarcinoma],5287969,-2.1782985548113336,-1.579106809646246
HSC-4,9887053,4.087399127765092,4.1830528565416545
JM-1,11178236,-8.647638887964375,-4.158291326918421
LOU-NH91,24856436,2.045063798311017,0.5554299826292938
JM-1,4477,0.6485766089343484,0.32060037642645434
MDA-MB-157,31703,-2.5361356877609142,-0.7976822277894011
NCI-H1623,carboplatin-UNC0638 (2-1 mol-mol),3.4805064241678627,3.3577967752955935
NCI-H661,54619267,3.8937949591354486,4.094054815768166
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452,1.0439016355028756
CAL-51,135398516,1.449392214756173,2.3199438565344854
CA46,4917,3.2539126844885757,2.642301805431153
A-673,4705,3.2416788332737454,3.1028200909496437
CA46,carboplatin-UNC0638 (2-1 mol-mol),3.486985389348746,2.7745976446666787
NCI-H661,107985,-3.0533673433660393,-3.5704237803693903
G-401,navitoclax-gemcitabine (1-1 mol-mol),-3.419368467159671,-1.4979407152528186
NCI-H727,322968,3.201201930682186,3.808066089026091
MDA-MB-453,9823820,3.844639760703811,3.821779888238084
CAL-51,44202524,1.5528850010053556,2.21158942882622
MDA-MB-157,BRD-A02303741-navitoclax (2-1 mol-mol),-1.256832531766744,2.2232283720050763
NCI-H522,216468,3.814024876197808,2.180352103307406
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244,1.668242591560101
FTC-133,46191454,4.521976640758756,1.7240702887016206
A-673,tanespimycin-gemcitabine (1-1 mol-mol),-3.600781620367816,-1.5982131595199007
NCI-H460,3385,3.2657114863965573,4.198528363744726
SBC-5,4917,3.6947166304022465,3.1256426896376115
SNU-449,241158,4.010766929552104,4.009103224645539
SBC-5,676352,1.191452976157089,2.0607388893279723
FU-OV-1,11626560,1.6217924510760422,1.8623114460810262
RCM-1 [Human rectal adenocarcinoma],12001922,1.85954377189608,1.9895412947807534
JM-1,23635314,-4.012358401321602,-2.8953788360856847
MSTO-211H,24978538,-1.489482683206989,1.249573147201488
A-673,6438330,1.8412388803722883,1.4889227128725153
LOU-NH91,selumetinib-vorinostat (8-1 mol-mol),2.951111508603088,2.823550930536559
SNU-449,11719255,4.899085715446655,3.5500051312137195
SBC-5,3025986,0.415316224839701,-1.2525582819105308
YAPC,439501,-1.3344819600707327,-2.0658336436023497
NCI-H292,25262965,-1.3774761624707286,-1.5079719969517273
OVISE,4261,2.633875372862392,1.529545606022501
SCC-9,24951314,2.365472705935838,1.5414063447227448
CAL-51,57519531,1.893237876741888,2.4573627851774127
SNU-449,4521392,4.287622659497221,4.257974132939038
SNU-61,136227924,2.341371828887226,2.8201428025940003
HCC1143,24772860,-1.4749293698634824,-1.6417483980274532
BT-549,11178236,-2.7962989267365828,-3.199175732523719
G-401,322968,2.2957138552590264,2.9510214218705344
DMS 273,322968,3.714238246037839,2.655700480201332
NCI-H460,135875424,3.211754300989152,3.9708720553794303
SNU-449,8515,3.796953450261519,4.028024816927158
EFO-27,3689413,-2.375877948841856,-0.1736484589999191
SBC-5,46224516,4.445568719663603,2.3232229801432123
SCC-9,285033,-1.0227924755741569,-1.5853497523064177
MDA-MB-157,vorinostat-navitoclax (4-1 mol-mol),-2.302516692171374,1.1790752902794053
YAPC,6610216,4.2275333940091215,4.360163806109786
DMS 273,26596,-2.1961333269229173,-2.4883969131949657
NCI-H460,15953870,5.00315267734786,3.5629694733781485
JM-1,16065773,2.0826903108024646,2.0795160849250856
CA46,5280436,1.6785665289286047,2.6350009248954263
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884,0.20835945100934677
JM-1,navitoclax-piperlongumine (1-1 mol-mol),-0.2702753374722612,0.3112878781816436
NCI-H522,40482356,5.076444098213918,3.9266564777782964
SNU-449,72193861,2.670314458690751,2.2286674178121175
A-673,44185566,1.862123250313604,1.9528769147502842
MSTO-211H,6623618,1.8328237574963773,2.1740368690769465
NCI-H661,9868037,2.6835007144938032,3.6008695449592887
NCI-H522,9903786,3.9217135447784783,2.772098580891117
A2780,2828334,5.5086207374667175,5.851304309067823
FTC-133,9887053,4.335569761437092,4.287662842065154
Panc 04.03,3503,2.292907505320521,2.234747470342971
A-498,126941,-2.1438583463370495,-2.282829767262804
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268,0.12737556032342304
OPM-2,2130404,2.9720984033823896,2.0444651673155416
HCC1143,10427712,3.6655746579836497,4.401386471471533
EFO-27,148198,-4.612142049540045,-3.341845325013499
MSTO-211H,25195348,2.7607409792089186,3.4491090143562997
NCI-H460,11455910,1.4134750909778395,1.1367854762682412
LOU-NH91,selumetinib-piperlongumine (8-1 mol-mol),4.488619060244233,3.416701931361747
NCI-H727,11640390,0.8742840152576016,3.283844125116719
EFO-27,51039095,3.8168650627357903,2.8979011716906458
OPM-2,148198,-4.827513159673032,-3.681662375443411
CAL-51,10113978,3.4506321601115397,3.0869537847347255
NCI-H2009,71304818,2.93523377765095,2.586170445127477
A4/Fukuda,24772860,-3.4983689572797307,-2.6441561061983783
NCI-H460,6918837,-0.9355989207233988,-2.5514347282346805
MDA-MB-453,3503,1.4691071846699333,2.04198508200766
EFO-27,135398516,1.6834680726831996,2.183273087346216
A2780,19582717,2.5113952618702102,3.626257221416699
SNU-61,6918289,4.130324820008196,1.923798274946973
SNU-81,navitoclax-pluripotin (1-1 mol-mol),-1.399520137964588,-0.6418993932404351
MDA-MB-157,448949,1.9498713128669924,1.9787812261106876
NCI-H727,675434,4.719754403481023,4.616738322730905
KMRC-1,11152667,-0.0604913513883814,-0.5471801049726286
ONS-76,9926054,2.5108803232151304,1.8544339945809838
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566,-0.226959595861046
CAL-51,44491742,5.152478206660974,4.333607262900085
NCI-H1623,5278396,3.5068270087169022,3.7384710403428447
DMS 273,3634881,3.2856933751991844,2.7490618701468206
NCI-H146,23582824,-0.1302486758765051,0.7447568549599147
NCI-H522,salermide-PLX-4032 (12-1 mol-mol),5.39637133830604,4.785932896997792
A-673,11175137,1.5552265537901524,2.1966689049055805
A-673,4378219,1.9880690032317576,1.993339030032585
NCI-H661,5460769,1.0320957244219937,2.9189375149543935
NCI-H522,selumetinib-BRD-A02303741 (4-1 mol-mol),6.687730464329683,3.4602140096965144
NCI-H146,2746,0.8652413173737366,2.299989482504439
NCI-H1623,11955716,5.690110889982477,-1.1106331760870085
JM-1,46224516,0.3128269384104456,1.738909489292485
NCI-H2009,docetaxel-tanespimycin (2-1 mol-mol),-5.612671071914989,-2.5417355287125596
A2780,11317348,0.9115498056774632,1.8770118358140833
NCI-H661,9911830,2.711917815790479,2.578373528202744
CAL-51,44202524,1.5528850010053556,2.21158942882622
BT-549,4096211,1.216432091282546,2.3796837288317554
FTC-133,6918328,0.7944971797491694,0.028569013891487645
CAL-51,9911830,2.6702149728757343,2.407163478035281
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482,1.5361401175553366
NCI-H146,BRD-K55473186,3.591565624419444,3.7275820435566347
ONS-76,doxorubicin-navitoclax (2-1 mol-mol),-1.5086467428383314,-0.7581473518096508
SNU-81,16720766,0.0913844680975832,0.21878946782868178
LOU-NH91,46215462,2.06389335978863,1.9992812475107633
MDA-MB-453,navitoclax-PLX-4032 (1-1 mol-mol),2.982075726164247,1.203994562199995
CAL-51,5978,-2.6819752982341463,-2.1072643409923204
CAL-51,5278396,3.885366261927898,3.610293784888953
HSC-4,4477,1.1301199037714704,0.05134120562476241
HSC-4,25195348,4.125902627491381,3.4475372941796554
NCI-H661,227681,4.255095664751994,3.5854688613872288
NCI-H292,24951314,1.8411912809473163,1.7478959523398272
NCI-H522,3543504,4.389197316233122,3.8075895335882484
NCI-H460,452548,0.6919333948360032,0.3765111516311773
SNU-61,25105715,3.603411279706935,3.279973757509113
NCI-H727,navitoclax-pluripotin (1-1 mol-mol),-0.0549082702470221,-0.2802292919964591
SW1463,11175137,3.4916395483032256,2.5780055200229737
SBC-5,6914657,-3.351925471283153,-3.7555415796451523
JM-1,65064,5.210865559450395,3.929259816808436
OPM-2,9967941,3.958466181768741,3.2720775311204937
KMRC-1,969516,2.336566526495707,2.8334952316744357
MSTO-211H,15983966,-3.5322347663594016,-1.4461650056875064
OPM-2,9952709,2.422518614873216,2.507813290999352
NOMO-1,16741245,4.369418152152245,3.1333264845723887
DMS 273,16659841,4.479005871158747,2.7596667162423563
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,3.28409095686602
JM-1,46398810,2.06860116520361,1.7907886168434368
NCI-H661,12003241,-1.8871798966926587,-0.9636184899653896
CA46,docetaxel-tanespimycin (2-1 mol-mol),-7.203765496579748,-5.053106508867268
FU-OV-1,10184653,3.943218547538411,1.0309191935314308
RCM-1 [Human rectal adenocarcinoma],25126798,4.131561769072402,3.8818395795027505
OPM-2,156422,3.8836640353636382,2.7931128364553057
BxPC-3,JQ-1-vorinostat (2-1 mol-mol),0.8253599744929256,1.1367828684532857
SNU-449,56649450,3.812927022122559,3.412605077248336
CAL-51,119607,5.291790266428237,5.2622002572923545
LOU-NH91,selumetinib-UNC0638 (4-1 mol-mol),4.70852852885549,3.580440885032079
BT-549,148124,3.591112191677911,-2.0122331533477738
A2780,216468,0.3493873836888674,1.8366218585963474
MDA-MB-453,176870,4.531738011413092,3.0180324730280113
FTC-133,docetaxel-tanespimycin (2-1 mol-mol),-1.4229742664151317,-2.4250569469506926
LXF 289,24180125,2.8590757937383517,3.205206940839881
G-401,4259181,0.5796012369716917,-0.05909067335683866
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044,4.487965567197398
SNU-81,alisertib-navitoclax (2-1 mol-mol),-2.6757706059542445,0.016565828595816883
JM-1,54618305,4.117087010604098,3.8754588472458043
NCI-H522,16736978,1.523319728114192,1.3450075326500412
NCI-H522,36462,3.1215227661343925,1.619006996720552
HSC-4,400769,-0.948607557046086,-0.5649774134982799
FU-OV-1,piperlongumine-MST-312 (1-1 mol-mol),2.3913949476666243,1.972421963581488
YAPC,20959075,1.1991758721406616,-2.52937019369717
A-498,5328940,1.8314953095149151,1.8007407805990354
YAPC,9915743,1.8269757962027744,0.9278934307327047
SNU-81,54613361,-2.01246069716893,-0.0966149311645243
CA46,navitoclax-pluripotin (1-1 mol-mol),-1.6931023620468224,-1.8811964064485855
OPM-2,1716436,2.6292767753294437,2.6163964793267915
Panc 04.03,3025986,-1.5275729109481309,-0.6824113272662182
NCI-H661,25150857,2.764254958619497,2.4050361162864
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544,2.5875696596964843
LOU-NH91,5746,1.403252091596802,1.5248199052527562
MSTO-211H,UNC0638-navitoclax (1-1 mol-mol),-1.567850255531391,2.0027534955367705
RCM-1 [Human rectal adenocarcinoma],2729026,3.1482483825414698,2.722021144974586
NCI-H146,135398738,5.0513404057578155,3.438079466120212
MDA-MB-453,25227462,0.3575965628816619,-0.08299291579669311
NCI-H460,2858523,3.1665522277325575,3.0283406257601264
SNU-449,9866186,1.4050575476777012,0.8351067207086423
CAL-51,54686904,4.850424917483252,3.353897736657355
LoVo,53392493,2.4765619401689154,2.5722816725169806
LXF 289,24951314,1.0119406639366386,1.6245629468198224
NCI-H661,JQ-1-carboplatin (1-1 mol-mol),3.6496372437464992,2.1705864704143893
NCI-H1623,5329102,1.790138577011996,2.0751225674076452
HCC1143,selumetinib-vorinostat (8-1 mol-mol),1.9962314127216017,2.381607114751537
NCI-H292,3815108,3.432884993584308,3.1141622292299975
OPM-2,400769,-3.2268127368380215,-1.3374628184326471
MDA-MB-157,9823820,1.002295209558588,4.114030683584347
MDA-MB-453,vorinostat-carboplatin (1-1 mol-mol),1.132828187068375,3.000518007713341
YAPC,135999136,4.461108174764027,4.02734824983339
A-498,71680916,6.416494665581045,4.754118536508668
BT-549,252682,5.865498031558929,6.672895145608829
NCI-H522,2130404,2.4549438882602463,2.4838748987738994
BT-549,60750,3.345812478570961,-2.3480113582379167
A2780,55508,1.942124594025635,3.137300183810241
BT-549,3136844,5.53345832245052,4.382669761938973
A-673,SNX-2112-bortezomib (250-1 mol-mol),-3.639662214518592,-1.8651281559553243
NCI-H522,135398516,2.766899162932887,1.921422663368191
Panc 04.03,45279963,4.427260741974604,3.847723523867404
MDA-MB-157,107970,2.1200224507121868,2.320479763107267
DMS 273,24180719,3.915275581303962,3.3276639272105655
Panc 04.03,71680916,5.172010716636655,4.689539012198153
DMS 273,44632017,0.8019003224742934,1.1829538992761583
NCI-H292,5311281,4.174884455345005,2.739018017577338
NCI-H2171,9549297,1.2348443580878434,1.7709762224741952
NCI-H661,135398516,2.0112722508641525,2.2061845504865754
A4/Fukuda,6918328,-3.9252329494253586,-1.4416619998251563
SBC-5,selumetinib-vorinostat (8-1 mol-mol),2.6526809527728603,2.3606462856493566
A-673,5284616,-2.8220877865693996,1.435937799390011
A-498,11222830,1.898532346529896,1.825067804201983
SNU-81,44589607,-1.0723208776906596,2.1885167068145894
SCC-9,54596558,4.378159430294897,4.441149289356693
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617,-0.2942637183795752
OPM-2,56649450,1.6365959554779024,2.7588230222129333
JM-1,2945648,1.8231052373320176,2.2233127148745653
Panc 04.03,6852167,3.6951209581653743,3.0066535984711136
OPM-2,5311281,1.024044758253736,2.0311435725754374
SCC-9,9967941,4.677287493278682,3.651421526693697
CAL-51,11609586,1.5077859423552509,2.78108015623413
SNU-61,9911463,3.407728451470452,3.5752886920300266
LOU-NH91,BRD-A02303741-navitoclax (2-1 mol-mol),0.4254312881757893,2.4024465524037093
KMRC-1,72193861,2.923138623905541,1.7517156938565999
SCC-9,168313016,4.940700460648117,4.990662419035961
NCI-H1623,46215462,1.70222177248337,2.126628814405342
MDA-MB-157,6505803,-0.678815881739905,-0.35876512097541946
A-673,25062766,1.5933001652207863,1.87177023853955
NCI-H522,148198,-5.538025476960186,-3.7228271135988473
KMRC-1,11625818,4.222506706272698,4.327811227254028
LoVo,10074640,2.9851259451828476,2.936142677430969
NCI-H1623,12001922,2.89915315578861,2.017293159392241
NCI-H460,107970,2.752075604137296,2.381704089490837
HSC-4,10322450,4.749470049467763,4.117960128295888
A4/Fukuda,JQ-1-navitoclax (2-1 mol-mol),-1.310646692558982,0.252887243812426
CAL-51,65628,4.560195683913681,4.240968881247754
LoVo,selumetinib-tretinoin (2-1 mol-mol),0.1717915474841797,2.8588859708828642
SCC-9,2746,3.644005246156997,3.4115419504218325
JM-1,107985,-4.195149425063274,-3.9879959973887007
NCI-H146,119607,3.9951566487227823,4.931520892778796
JM-1,44566777,-1.1129943275867182,-0.21524824718411867
SBC-5,11167602,1.6319389998554443,2.388619712938667
LOU-NH91,9936388,-6.294191236399446,-0.16418846892796427
SNU-61,135875424,3.609444893060012,3.63767262373846
NCI-H292,6917907,-6.008612763335491,-4.566024782435604
G-401,19582717,3.4233639988307623,3.505012685555206
LXF 289,46174525,4.3838011857350585,4.591056091451105
SW1463,10184653,-0.9517511422842978,1.0277274443277715
SCC-9,7251185,3.4755501931610486,2.719967622168684
OPM-2,4788,3.799883557086963,5.0178840906155475
MSTO-211H,selumetinib-UNC0638 (4-1 mol-mol),2.638630251212758,3.296494042574005
OPM-2,selumetinib-navitoclax (8-1 mol-mol),2.2674041559669917,0.5459870548173784
DMS 273,JQ-1-navitoclax (2-1 mol-mol),1.419130204387569,0.02649468484625645
NCI-H460,387447,-2.436463262555682,-4.183307505621766
NCI-H522,3465537,1.2201304719285595,2.2455329284109706
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637,2.155287908338664
OVISE,11228183,1.089434907795814,2.4286011420616576
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958,1.0178941148738314
NOMO-1,10410894,2.884775843935945,2.745356904934647
NCI-H522,3062316,1.3416096793720445,0.8085905282757457
NCI-H522,5328940,1.3898569828081493,1.342391823697592
OVISE,6917907,-2.8614664806523975,-4.456158868381196
DMS 273,53392493,1.951320459884087,2.025590650257103
BxPC-3,44259,0.1590720374324279,1.202002880250668
CAL-51,17755052,0.5283491907817935,1.69538885275963
RCM-1 [Human rectal adenocarcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),4.856399530140112,2.1518792866476337
NCI-H661,676352,2.2217693895783115,2.044826074431751
LXF 289,452548,0.2436004430663324,0.35516996969462583
LoVo,6438330,1.2087527750724023,2.4169250236129374
OPM-2,16736978,1.1906517256258733,0.5669707094330245
DMS 273,89928392,1.202164769006387,0.6055096139493183
CA46,3543504,2.8823298921776717,3.499418004510839
SBC-5,11427553,4.187017651849035,2.7953193342734606
CAL-51,67156097,-2.385254348530768,-0.7042087843943498
FTC-133,23725625,5.526585624025884,5.191533065632045
BT-549,25227462,1.1552638438270102,1.1282847861536338
SNU-81,374536,-2.2172994025671877,0.9956720362369886
MSTO-211H,navitoclax-pluripotin (1-1 mol-mol),-2.948162650279317,-0.9074895559745407
BT-549,65064,5.372588334008338,5.011139217072586
NOMO-1,135398738,0.7085728369009435,2.269529910055932
A-673,44566777,0.6818018070798556,0.5657656674752544
OVISE,42642645,1.7980918591344808,0.9685229288204167
CA46,637858,0.8997823848237061,0.9754840932936252
NCI-H292,9877608,5.923265260718527,3.382026298372528
DMS 273,11964036,0.5570994002779035,0.8265498621973499
FTC-133,44137675,6.176024086140045,3.77009490654784
BxPC-3,9926054,1.7603137158224154,1.946543499462848
DMS 273,5311,0.3077166337368,0.6522762775712903
SNU-61,36314,2.631499046696298,-1.76066080213231
EFO-27,6917907,-5.745836009999857,-4.943685486196514
OPM-2,11455910,0.7503761469114726,0.7758612587337583
NCI-H1623,24785538,-1.341558176424811,1.7612425684215578
SNU-449,462382,1.3667681892704822,0.6335150243194496
G-401,8515,3.316277000480566,3.5353006499065547
SNU-449,25102847,2.813788740655036,2.504705122341704
BT-549,JQ-1-UNC0638 (2-1 mol-mol),2.8120688111855845,1.9891965633905195
ONS-76,11404337,-0.4259392266769182,-0.08912975680238272
KMRC-1,49766530,-0.1675164065777726,-0.6465958307902379
HSC-4,24785538,3.772420906085344,1.6366730300808527
RCM-1 [Human rectal adenocarcinoma],119607,5.94570045924447,5.369236968043904
KYSE-70,73707398,2.029692143461395,1.5348456393345464
NCI-H1623,2729026,3.210868522276231,2.550715370878454
ONS-76,selumetinib-MK-2206 (8-1 mol-mol),-0.5692436577416031,2.185358943016717
FTC-133,56649450,4.4227260509908275,3.3744335015724216
NCI-H727,3815108,3.498449156165097,2.9405130300817155
FU-OV-1,448949,2.8154029654914137,2.055127049784399
FU-OV-1,168313200,1.721890351327649,2.9742440331904794
HSC-4,107985,-2.2656284906222144,-3.2274402142573346
NCI-H2009,44241473,6.22803294537171,4.987926948614205
CAL-51,46843906,2.776329873296567,2.9691017147958383
NCI-H1623,56946209,-3.1229213094171895,-3.8633071116948154
FU-OV-1,3825829,3.720797122696784,4.094605936525348
LXF 289,10385095,0.5776298837700374,1.3565540164628485
KMRC-1,4259181,1.968851453570829,-0.1700757320385991
G-401,11494412,0.2825252149996007,0.9172346219120157
KYSE-70,6918878,2.8589087884624673,2.9111468000744503
CA46,44185566,1.786162700750641,1.4985409134196246
LoVo,54618164,3.038824107117225,4.034368830725733
NOMO-1,16722836,0.125485002235246,0.6937402055957835
A4/Fukuda,44486219,1.5854911698245977,4.0843660544234375
LOU-NH91,10127622,4.686411868973226,4.357463429694723
KMRC-1,387447,-4.945508167403058,-3.6275390197647432
NCI-H146,54618164,3.6762408834701423,3.846689183179899
KMRC-1,5351362,3.133883590343709,1.7266485401522453
NCI-H2171,54765302,2.983840848305476,3.7434153575624163
KMRC-1,16013152,4.7431155582488325,3.977814677684518
SNU-61,71304818,2.3861681407496125,2.2277725159357695
JM-1,selumetinib-vorinostat (8-1 mol-mol),2.137722454720046,1.9727121700682122
SW1463,2708,3.597321448088185,4.215539389582074
CA46,vorinostat-navitoclax (4-1 mol-mol),0.373580583037546,-0.032370455571526915
FTC-133,piperlongumine-MST-312 (1-1 mol-mol),3.9575841468826383,1.7716376481542926
SBC-5,445643,4.051401497201939,3.8561742645180987
A4/Fukuda,241158,1.407426277414268,2.7636028451449333
NOMO-1,6852167,1.234836949550939,1.5613073620696525
A-673,9887053,2.3565868011684956,3.2014324061667025
SNU-61,6450551,3.0035817833604783,2.136256267402515
OPM-2,24771867,-0.0082042750480303,-1.0060497985742811
NOMO-1,11507802,1.1250810428603863,0.7889809253199744
CAL-51,2828334,6.190580852669228,6.217923632479874
OPM-2,selumetinib-PLX-4032 (8-1 mol-mol),2.3146569091496847,3.0642535479874136
KMRC-1,44489675,3.6404436921550607,4.156179924850011
FU-OV-1,23725625,5.156277829802871,5.2180885651401745
NCI-H1623,navitoclax-gemcitabine (1-1 mol-mol),-5.01790230865627,-0.4185622731687753
OVISE,439501,-2.343202219776273,-2.1333719551099666
CAL-51,5281321,-0.4656602142962174,-1.22886101356234
DMS 273,151289,0.7083247440682101,0.7686129613841373
MSTO-211H,9903786,1.212702371904443,2.7541382785320176
LXF 289,135421197,2.6553019911408056,2.337693615015933
NCI-H146,24771867,1.252264036368602,1.0574764887726302
CAL-51,136227924,2.079284078064279,2.8281286511313306
NCI-H522,3689413,-4.273368850016072,-1.1749994835754007
NCI-H460,46907787,4.3372157131836255,2.4494216350473175
NCI-H146,25183872,-1.3449770735764903,-1.0360224760949395
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,1.922293314185687
CAL-51,9887053,4.486783389261201,3.7074891610369956
NCI-H460,107985,-2.632533954936978,-3.3898754331395726
YAPC,65064,4.247853222703643,5.018731672459817
SCC-9,9884685,0.522968392230544,0.8034107973151535
SNU-61,6852167,3.859693430343892,2.43564680811643
NCI-H292,400769,-0.4441855968341354,-0.446865859216998
EFO-27,24748573,3.2354879524418347,2.2281845959978863
CA46,65628,4.372814936384242,2.9680059166571584
NOMO-1,1750826,-5.797741098147838,-2.3546287869587386
LOU-NH91,135440466,0.9387697781897782,2.23088800828885
MSTO-211H,11427553,1.7459714847796464,2.9000526713747106
SNU-61,9903786,2.1391845181717373,2.3506918228334532
JM-1,9952709,2.333856130884211,2.3370556008225827
YAPC,44507138,4.423761616669373,2.693685575093096
OPM-2,selumetinib-vorinostat (8-1 mol-mol),1.6127891772049152,1.7767601435490348
NCI-H727,10231331,-2.105430518957453,1.6672664558367445
NCI-H661,navitoclax-gemcitabine (1-1 mol-mol),-0.9367360763965996,-1.0505226618173376
LoVo,6610355,3.962139785065475,4.416073988673542
LOU-NH91,16065773,1.5129164046929433,2.529479028466606
NCI-H292,51039095,2.62578521626359,2.9863028909613076
NCI-H2009,135398516,3.792403018557381,2.6144994785975206
Panc 04.03,44566777,0.5187219827219705,0.6590879299454704
NOMO-1,285033,-2.4289999699368923,-2.877109967424549
LOU-NH91,doxorubicin-navitoclax (2-1 mol-mol),-1.426641258307621,-0.8955899468016802
KYSE-70,51039095,3.5490987853947247,2.8804975960712396
NCI-H460,36462,3.103581216464206,2.0005022768910443
MDA-MB-157,216345,3.882260039310166,3.9101395682771147
NCI-H522,104842,-1.8805759610000512,-2.8758115267207494
FU-OV-1,72376,-3.2802123060842283,-1.620321407574734
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302,1.6393990295188603
NCI-H661,5978,-4.21717720873681,-2.3758428216089427
A-498,54619267,3.764771843303345,4.317277260708239
SCC-9,53495165,0.7472636588137463,0.42303472750394155
MSTO-211H,9823820,1.3460489687603958,4.001747232833017
EFO-27,11222830,1.8018026478898377,1.6384020023822514
JM-1,11612883,1.345048153552996,2.0636283487313083
NCI-H146,carboplatin-etoposide (40-17 mol-mol),0.3222331814864832,2.34029125166456
EFO-27,12003241,-1.7336155023360622,-0.840798768376868
SNU-449,969516,2.7263398794742972,3.0151529030769266
NCI-H146,4259181,0.4591034911128469,-0.2882873555378155
NOMO-1,24901704,1.738276567126731,1.9096244273424674
BxPC-3,54619238,5.160880582862859,4.757663810363138
SBC-5,654092,0.9915803206550192,-0.2480103019572363
MDA-MB-453,71751553,4.5545018888168185,4.3934951857715285
MDA-MB-157,5978,-4.802538048228265,-1.373261253870457
CAL-51,24964624,1.6704816041215405,2.294863509135668
LOU-NH91,5280436,5.173335280456015,3.738702168517173
EFO-27,53481919,4.175905541374054,3.9441963489737715
ONS-76,6610216,4.821554065133985,4.145125006107225
JM-1,53495165,-3.850144918627292,-1.8500958920947574
YAPC,16065773,2.864044457230109,2.5925743021373377
SNU-449,51039095,3.650396552732121,3.0473243227058564
NCI-H661,71466445,2.1620252686029646,4.146343223756407
A4/Fukuda,984333,-0.4165614363108865,0.2803160776362934
JM-1,4096211,0.9764948319580444,0.9567077211532277
SNU-449,44197249,4.950419501644914,4.301092332113931
NCI-H460,11178236,-2.300904923417752,-3.3761286467247063
MDA-MB-453,12001922,1.470906003655458,1.7459756480167656
NCI-H460,44620216,3.8133491956675902,3.513468447447577
A-673,119182,-1.0392852637873304,-1.3310336559251619
NCI-H727,11178236,-2.542459533585497,-3.1298233523976737
NCI-H1623,erlotinib-PLX-4032 (2-1 mol-mol),-0.1422885712238643,2.8463398864499045
A4/Fukuda,753704,3.7176461109746897,4.13596514934159
SW1463,168312962,2.678519281942756,2.007639274798397
KMRC-1,SNX-2112-bortezomib (250-1 mol-mol),0.0767950067042666,-1.1412288713993934
OPM-2,227681,1.827584998281281,2.5160306974990188
HCC1143,3081361,2.3254724072420316,2.1874776268621825
CAL-51,44607531,1.640429423812436,1.4593620897442126
HCC1143,322968,3.187805633465504,3.834154279904187
FTC-133,9911463,4.36756965003986,3.8529398710467437
SNU-61,159324,1.5880493113453718,2.1617781617123195
NCI-H2171,5738263,2.6832104272478188,2.8417512964507834
CA46,49867926,4.142181337076857,3.3704523841221157
SNU-81,BRD-A02303741-navitoclax (2-1 mol-mol),0.8522567387086551,2.2527449360051937
HSC-4,44589607,3.345116081225748,2.9685051825273616
EFO-27,11485656,3.240498776862908,2.3657445862913353
SNU-81,23725625,1.2739024793065858,4.111047355208994
A4/Fukuda,9911830,0.8865121451383732,2.07847257460732
NCI-H1623,JQ-1-UNC0638 (2-1 mol-mol),2.6843347454635604,1.5594157931549224
NCI-H292,9866186,0.3072921576740348,0.997554906798415
NCI-H460,54143018,2.5592633032091956,0.46080861697618064
A2780,4378219,4.7769256594107254,2.0331882085729824
NCI-H1623,44566777,3.7111231324950102,0.794675092157657
CAL-51,10074640,3.192334769578339,3.174172664193206
RCM-1 [Human rectal adenocarcinoma],71466380,4.350719813683452,4.4203156556879835
CAL-51,60700,-0.6497243984818711,-0.5813466035520615
HCC1143,12001922,1.8011931254041345,1.9318007900294774
NCI-H727,638278,3.5555642892396744,3.223388270337148
LOU-NH91,72376,-0.6247816475402558,-1.5131465986088972
EFO-27,4578,4.426476303141277,4.384221204848822
HCC1143,119607,4.074424413991316,5.039973481215003
JM-1,selumetinib-decitabine (4-1 mol-mol),-2.432451496880968,0.7080132415391459
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878,0.25679905210128523
NCI-H727,159324,3.364651085509472,3.0161606861297945
NCI-H1623,5287620,-2.020641279124402,-1.8211358992653541
CAL-51,4261,2.4552246887350417,1.5292212521437454
JM-1,3543504,2.821603823672808,3.6120410269882455
SNU-81,11497983,2.4691665919847514,1.4540495548221732
G-401,5113032,4.898905985161468,4.789554444882548
MDA-MB-157,52912189,4.238554807379722,2.378879395343372
G-401,selumetinib-navitoclax (8-1 mol-mol),2.1097176548583407,1.3548451153378813
KYSE-70,10410894,6.372300696648814,3.3038114834344805
LXF 289,54618164,3.0378434141224617,4.226549119069744
SNU-61,11214940,-0.337645985307237,1.3718672367017737
ONS-76,11364421,-0.3098764345335473,-2.116615703368903
KYSE-70,5978,-0.772629381148284,-1.9171499982491977
Panc 04.03,53232,3.444660782403792,2.7910688338510794
FTC-133,46926350,-4.117104249862265,-3.7983900732616314
